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Foreword 
The Substance Abuse and Mental Health Services Administration (SAMHSA) is the U.S. Department of 
Health and Human Services agency that leads public health efforts to reduce the impact of substance 
abuse and mental illness on America’s communities. An important component of SAMHSA’s work is 
focused on dissemination of evidence-based practices, and providing training and technical assistance to 
healthcare practitioners on implementation of these best practices. 
The Treatment Improvement Protocol (TIP) series contributes to SAMHSA’s mission by providing science-
based, best-practice guidance to the behavioral health feld. TIPs refect careful consideration of all 
relevant clinical and health service research, demonstrated experience, and implementation requirements. 
Select nonfederal clinical researchers, service providers, program administrators, and patient advocates 
comprising each TIP’s consensus panel discuss these factors, offering input on the TIP’s specifc topics in 
their areas of expertise to reach consensus on best practices. Field reviewers then assess draft content and 
the TIP is fnalized. 
The talent, dedication, and hard work that TIP panelists and reviewers bring to this highly participatory 
process have helped bridge the gap between the promise of research and the needs of practicing 
clinicians and administrators to serve, in the most scientifcally sound and effective ways, people in need of 
care and treatment of mental and substance use disorders. My sincere thanks to all who have contributed 
their time and expertise to the development of this TIP. It is my hope that clinicians will fnd it useful and 
informative to their work. 
Elinore F. McCance-Katz, M.D., Ph.D. 
Assistant Secretary for Mental Health and Substance Use 
U.S. Department of Health and Human Services 
Substance Abuse and Mental Health Services Administration 
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Executive Summary 
This Treatment Improvement Protocol (TIP) update is intended to provide addiction counselors and other 
providers, supervisors, and administrators with the latest science in the screening, assessment, diagnosis, 
and management of co-occurring disorders (CODs). For purposes of this TIP,  the term CODs refers to 
co-occurring substance use disorders (SUDs) and mental disorders. Clients with CODs have one or more 
disorders relating to the use of alcohol or other substances with misuse potential as well as one or more 
mental disorders. A diagnosis of CODs occurs when at least one disorder of each type can be established 
independently of the other and is not simply a cluster of symptoms resulting from the one disorder. 
Many may think of the typical person with CODs as having a serious mental illness (SMI) combined with 
a severe SUD, such as schizophrenia combined with alcohol use disorder (AUD). However, counselors 
working in addiction agencies are more likely to see people with severe addiction combined with mild- to 
moderate-severity mental disorders. An example would be a person with AUD combined with attention 
defcit hyperactivity disorder (ADHD) or an anxiety disorder. Efforts to provide treatment that will meet 
the unique needs of people with CODs have gained momentum over the past two decades in both SUD 
treatment and mental health services settings. 
An expert panel developed the TIP’s content based on a review of the most up-to-date literature and on 
their extensive experience in the feld of SUD treatment. Other professionals also generously contributed 
their time and commitment to this publication. 
This TIP is organized to guide counselors and other addiction professionals sequentially through the 
primary components of proper identifcation and management of CODs. The TIP is divided into chapters 
so that readers can easily fnd the material they need. Following is a summary of the TIP’s overall main 
points and summaries of each of the eight TIP chapters. 
The primary focus of this TIP is co-occurring SUDs and mental disorders, not physical disorders. People 
with mental illness also frequently develop physical conditions that, like SUDs, can exacerbate or induce 
symptoms (e.g., HIV, hepatitis C virus, hypothyroidism). However, physical conditions are beyond the scope 
of this publication and are excluded. 
Overall Key Messages 
People with SUDs are more likely than those without SUDs to have co-occurring mental disorders. 
Addiction counselors encounter clients with CODs as a rule, not an exception. Mental disorders likely 
to co-occur with addiction include depressive disorders, bipolar I disorder, posttraumatic stress disorder 
(PTSD), personality disorders (PDs), anxiety disorders, schizophrenia and other psychotic disorders, ADHD, 
and eating and feeding disorders. 
Serious gaps exist between the treatment and service needs of people with CODs and the actual care 
they receive. Many factors contribute to the gap, such as lack of awareness about and training in CODs by 
addiction counselors, as well as workforce factors like labor shortages and professional burnout. 
Failure to routinely screen clients receiving behavioral health services for mental disorders and SUDs 
creates a problematic domino effect. A lack of screening means a lack of assessment, which results 
in a lack of diagnosis, which leads to a lack of treatment, which then reduces a person’s chances of 
achieving long-term recovery for either or both disorders. Counselors and other providers can prevent 
this cascade of negative events by understanding how and why to screen, how to perform a full 
assessment, and how to recognize diagnostic symptoms of mental disorders and SUDs. 
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CODs are treatable conditions, and a range 
of treatment modalities exists that can be 
implemented across numerous inpatient and 
outpatient settings. Counselors may need to 
adapt interventions based on the treatment 
setting as well as the unique needs and 
characteristics of clients, including their 
gender, race/ethnicity, life circumstance (e.g., 
homelessness, involvement in the criminal justice 
system), symptoms, functioning, stage of change, 
risk of suicidality, and trauma history. 
People with CODs are at an elevated risk for 
self-harm, especially if they have a history of 
trauma. Counselors, other providers, supervisors, 
and administrators should make client safety 
a priority and ensure that providers have the 
necessary training to detect and respond to 
suicidal thoughts, gestures, and attempts in COD 
clientele. 
Essential services for people with CODs are 
person centered, trauma informed, culturally 
responsive, recovery oriented, comprehensive, and 
continuously offered across all levels of care and 
disease course. 
There is no “wrong door” by which people 
with CODs arrive at treatment. Counselors and 
programs should have a range of interventions and 
services in their “toolbox” with which they can help 
all clients. 
Administrators and supervisors play a critical 
role in responding to workforce challenges, 
such as unmet training needs, low employee 
retention, staff burnout, and low competency in 
advanced COD management skills. Such workforce 
matters are directly tied to treatment availability 
and quality, so these challenges should be taken 
seriously and addressed actively by all COD 
treatment programs. 
Content Overview 
This TIP is divided into eight chapters designed 
to thoroughly cover all relevant aspects of 
screening, assessment, diagnosis, treatment, and 
programming. 
Chapter 1: Introduction to SUD Treatment 
for People With CODs 
This chapter provides a broad introduction to 
CODs and to SUD treatment for people with 
CODs. It serves as an outline of the main focus 
of this TIP. The intended audiences are addiction 
counselors and other SUD treatment professionals 
(e.g., psychologists, psychiatrists, licensed clinical 
social workers, licensed marriage and family 
therapists, psychiatric and mental health nurses 
[specialty practice registered nurses]), supervisors, 
and administrators. 
Mental illness is highly comorbid in people 
with addiction and associated with low rates of 
treatment engagement, retention, and completion. 
CODs are linked to numerous negative health 
outcomes and life circumstances, like elevated 
risk of homelessness, trauma, and self-harm. To 
close treatment gaps and ensure that people with 
SUDs and mental disorders achieve long-lasting 
recovery, educating counselors, supervisors, 
and administrators about the prevalence and 
seriousness of these conditions is essential. 
In Chapter 1, readers will learn about: 
• The appropriate terminology surrounding CODs 
and COD treatment approaches. 
• The numerous factors that led to the creation of 
this TIP update. 
• The need for this TIP, which addresses CODs 
and summarizes prevalence and treatment 
rates, trends in programming, and negative 
events associated with CODs (e.g., increased 
hospitalization). 
• The complicated and bidirectional relationship 
between mental disorders and SUDs that can 
make diagnosing and treating these conditions 
diffcult. 
Chapter 2: Guiding Principles for Working 
With People Who Have CODs 
This chapter reviews strategies and recommended 
guidelines for effective COD services. The 
intended audiences are counselors and other 
behavioral health service providers, supervisors, 
and administrators. 
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Service provision guidelines help safeguard the 
well-being of clients with CODs and ensure that 
they receive high-quality, evidence-based care. 
Counselors and other providers, supervisors, and 
administrators can take small but powerful steps 
to increase the likelihood that clients with CODs 
get the services they need, such as using person-
centered approaches, providing comprehensive 
care, and integrating research into clinical services. 
These strategies can have a large impact in terms 
of generating positive treatment outcomes. 
In Chapter 2, readers will learn that: 
• Essential services for people with CODs must 
be recovery oriented, culturally responsive, and 
inclusive of clients’ families or support system 
(including mutual-help and peer recovery 
supports). 
• Counselors should ensure that they are 
providing clients full access to treatments; 
routine screening and complete assessments; 
services tailored to clients’ symptoms and stage 
of change; and services that are integrated, 
comprehensive, and continuous across 
treatment settings and disease course. 
• Administrators and supervisors can increase 
the odds of clients achieving optimal recovery 
outcomes by ensuring that providers possess 
the appropriate basic, intermediate, and 
advanced competencies and have access to 
training opportunities—both of which are 
essential if counselors are to confdently and 
competently manage CODs. 
• Integration of evidence-based care into COD 
programming increases the chances of clients 
receiving effective therapies that improve their 
odds of lifelong recovery. 
• In addition to establishing essential services 
(e.g., screening and assessment, onsite 
prescribing, psychoeducation, mutual support), 
program developers and administrators should 
engage in ongoing assessment to ensure that 
their organization has the capacity to serve 
clients with CODs and is faithfully following 
service implementation guidelines. 
Chapter 3: Screening and Assessment of 
CODs 
This chapter describes the screening and full 
assessment process for identifying people with and 
at risk for mental illnesses and SUDs. The intended 
audiences are addiction counselors and other 
providers, supervisors, and administrators. 
To reduce gaps in treatment access and provision, 
counselors must appropriately engage in timely, 
evidence-based screening and assessment. This 
multistep process is designed to help counselors 
thoroughly explore all areas of clients’ history, 
symptoms, functioning, readiness for treatment, 
and other service needs so that treatment decision 
making is fully informed and tailored to each 
individual’s clinical situation. In short, without 
timely and effective screening and assessment, 
the chances of clients receiving appropriate care 
decrease signifcantly. 
In Chapter 3, readers will learn that: 
• All SUD treatment clients should be screened at 
least annually for SUDs, mental disorders, risk of 
harm to self and others, functional impairment, 
and trauma. 
• Screening is an informal yet highly effective 
process of initially identifying people with CODs 
who may ultimately need formal treatment or 
other services. 
• A full biopsychosocial approach to assessment 
helps counselors thoroughly explore clients’ 
physical, substance use–related, psychiatric, 
social, educational/vocational, and family 
histories for indications of addiction, mental 
illness, or both. 
• Numerous screening and assessment measures 
are validated for use with people who have 
mental disorders and SUDs to help counselors 
make diagnostic determinations and guide 
decisions about referral for further evaluation 
(e.g., psychiatric, medical). 
• Assessment is more than just administering 
questionnaires; it includes exploring clients’ 
risk of harm to self and others, trauma history, 
strengths and supports, cultural needs, and 
readiness for change. 
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• When performed correctly, a full assessment 
should help build rapport between the 
counselor and the client and foster shared 
decision making for treatment or other services. 
Chapter 4: Mental and Substance-Related
Disorders: Diagnostic and Cross-Cutting
Topics 
This chapter will help readers learn the Diagnostic 
and Statistical Manual of Mental Disorders (5th ed.; 
American Psychiatric Association, 2013) diagnostic 
criteria for mental disorders that commonly occur 
alongside SUDs, as well as symptoms of substance-
related disorders. The intended audiences 
are addiction counselors and other providers, 
supervisors, and administrators. 
Not all addiction counselors are permitted to 
diagnose mental disorders (regulations vary by 
state). However, all addiction counselors and 
other providers should become familiar with 
the diagnostic criteria for mental illnesses that 
commonly co-occur with SUDs so that they 
can refer clients for a full psychiatric evaluation 
(if needed) and tailor treatment and services 
accordingly. 
Someone with CODs will sometimes need 
treatment approaches that differ slightly from 
those for a person who has either an SUD or a 
mental disorder but not both. Counselors and 
other providers must understand how to recognize 
signs of highly comorbid mental illnesses, know 
how these disorders affect treatment decision 
making, and recognize the trauma history and 
risk of self-harm associated with these disorders. 
Equally important, clinicians should learn how to 
differentiate independent mental disorders from 
substance-induced mental disorders, as the latter 
are often treated differently than the former (if they 
require treatment at all, given that many substance-
induced conditions remit once substance use has 
ended). 
In Chapter 4, readers will learn that: 
• Mental disorders that most commonly co-occur 
with SUDs include major depressive disorder, 
persistent depressive disorder (dysthymia), 
bipolar I disorder, PTSD, borderline and 
antisocial PDs, schizophrenia and other 
psychotic disorders, generalized anxiety 
disorder, panic disorder, social anxiety disorder, 
ADHD, anorexia nervosa, bulimia nervosa, and 
binge eating disorder. 
• Although less common in the general 
population, all of these mental disorders are 
likely to be seen by counselors working in SUD 
treatment settings. 
• Counselors may need to treat SUDs in the 
presence of a mental disorder in slightly 
different ways than they would treat addiction 
without comorbid mental illness. The way in 
which treatment proceeds can vary depending 
on the mental illness. 
• Nearly all CODs carry an increased risk of 
suicide, and counselors are obligated to 
thoroughly assess and respond to a current 
report or history of self-harm. 
• Trauma is ubiquitous across CODs and needs to 
be managed using trauma-informed techniques. 
• Many mental disorder symptoms mimic 
symptoms of SUDs, and vice versa. Being able 
to differentiate between the two is a core 
competency. 
• Similarly, many mental disorders may appear 
in the context of substance intoxication or 
withdrawal. Treatment approaches for these 
substance-induced disorders can differ from the 
treatment of independent mental disorders, 
so counselors must recognize the difference 
between the two. 
Chapter 5: Strategies for Working With 
People Who Have CODs 
This chapter summarizes the importance of 
establishing a therapeutic alliance with clients 
who have CODs and discusses how providers 
can do so. The intended audiences are addiction 
counselors and other providers, supervisors, and 
administrators. 
Good provider–client rapport can enhance 
treatment outcomes and completion and is a 
cornerstone of providing high-quality care. When 
working with clients who have CODs, counselors 
and other providers should be aware of clinical 
factors and concerns—like confdentiality matters, 
use of empathy, and cultural responsiveness—that 
xii 
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can make the therapeutic relationship more 
successful and increase the chances that clients will 
achieve and maintain recovery. 
For co-occurring mental disorders, like depression, 
anxiety disorders, PTSD, and SMIs, specifc 
treatment strategies (e.g., selecting appropriate 
therapeutic interventions; structuring clinical 
sessions) can improve client adherence and 
outcomes. Counselors and other providers should 
learn these techniques and approaches before 
treating individuals with CODs so that they are 
prepared to best respond to clients’ needs and 
help establish good therapeutic alliance from the 
outset. 
In Chapter 5, readers will learn that: 
• Rapport building is essential in helping clients 
achieve and sustain positive behavior change. 
• Working with people who have CODs can be 
challenging given clients’ feelings of mistrust 
or shame. CODs can be complex and lifelong, 
causing a range of diffculties for people living 
with them. 
• A successful therapeutic alliance is built on 
empathy and support and by providing services 
fully responsive to all clients’ needs. 
• Relapse prevention and skill building are critical 
components of comprehensive care. 
• Culturally sensitive techniques can help build 
rapport and trust between counselors and 
clients from various cultural, racial, and ethnic 
backgrounds. 
• For clients with depression, cognitive–behavioral 
techniques, behavioral activation, and 
medication evaluation are core services. 
• Clients with anxiety may need treatments 
tailored to their anxiety diagnosis, such as 
individual therapy for a client with social anxiety 
and fear of group settings. 
• Safety and trust are cornerstones of effective 
treatment for people with trauma and PTSD. 
• People with SMI may have cognitive limitations 
that undermine treatment participation and 
adherence and may need help with basic living 
needs (e.g., housing, employment). 
Chapter 6: CODs Among Special 
Populations 
This chapter discusses four populations with CODs 
who may be especially susceptible to treatment 
challenges and negative outcomes: people 
experiencing homelessness, people involved in 
the criminal justice system, women, and racial/ 
ethnic minorities. The intended audiences are SUD 
counselors and other providers, supervisors, and 
administrators. 
Although all people with CODs are vulnerable to 
treatment diffculties and poor outcomes because 
of the complex and chronic nature of their illnesses, 
certain COD populations are especially susceptible 
and may beneft from tailored services. Counselors 
and other providers need to be sensitive to specifc 
treatment needs of such populations and make 
adjustments in their assessment, diagnosis, referral, 
and service provision accordingly. 
In Chapter 6, readers will learn that: 
• CODs are highly prevalent in people who are 
experiencing homelessness, but several service 
models exist to help counselors address clients’ 
behavioral health concerns and their housing 
needs. 
• People involved in the criminal justice system 
are at risk for CODs both during incarceration 
and after release into the community. 
• Treatment of CODs among justice system– 
involved people is important because, if left 
untreated, CODs can increase their risk of 
recidivism, rearrest, and reincarceration. 
• Women are a vulnerable population because 
of the increased likelihood that they will face 
trauma, which heightens the occurrence of 
CODs, and pregnancy/child care-related 
factors, which can also exacerbate CODs or 
otherwise affect treatment provision (such as 
pharmacotherapy). 
• Although research suggests that COD treatment 
outcomes for men and women are generally 
equivalent, women may beneft from gender-
specifc services in order to stay engaged in (and 
thus beneft from) interventions. 
• Compared with U.S. Whites, people from racial/ 
ethnic minorities face signifcantly greater 
xiii 
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mental health service and SUD treatment 
access barriers and are likelier to have negative 
treatment outcomes. 
• Counselors and other providers should 
learn how to provide culturally responsive 
assessments and treatments or other services to 
meet the unique needs facing clients of diverse 
racial/ethnic backgrounds who have CODs. 
Chapter 7: Treatment Models and 
Settings for People With CODs 
This chapter is an overview of treatment models 
and settings for clients with CODs. It will help 
counselors and administrators offer empirically 
supported care for this population. The intended 
audiences are counselors and other providers, 
supervisors, and administrators in addiction 
programs. 
CODs are complex conditions, and clients can 
engage in services across a multitude of inpatient 
and outpatient settings. Counselors and other 
providers have at their disposal several empirically 
validated treatment approaches designed to 
address the full scope of needs of people with 
CODs, including services to reduce symptoms, 
increase abstinence, achieve stable housing, 
and help clients make meaningful connections 
with resources and networks of support in the 
community. Although not appropriate for all 
clients with CODs, pharmacotherapies are a 
treatment option that, for certain conditions like 
AUD and opioid use disorder (OUD), can not only 
improve functioning but also reduce mortality and 
morbidity. Counselors and other providers who 
do not prescribe medication for clients with CODs 
should nonetheless be aware of their uses, side 
effects, and interactions/warnings so that they can 
help monitor clients for safety and offer referrals 
for medication evaluation as needed. 
In Chapter 7, readers will learn that: 
• COD treatment can be sequential, simultaneous 
(but in parallel), or concurrent (and integrated). 
• People with CODs face a multitude of individual, 
logistic, socioeconomic, cultural, organizational, 
systemic, and policy-related barriers to 
accessing and using SUD treatment and mental 
health services. Counselors and administrators 
play important roles in reducing these barriers 
and helping clients overcome such challenges. 
• Integrated care is recommended as a best 
practice for serving people with CODs. 
• Assertive community outreach and intensive 
case management are multidisciplinary 
approaches that can be easily adapted to 
integrated settings and thus offer clients 
comprehensive, continuous care. They can also 
be adapted to populations vulnerable to CODs 
and poor outcomes, like people without stable 
housing and those involved in the criminal 
justice system. 
• Mutual supports, including from peer recovery 
support specialists, are critical because they 
offer clients information and support from 
others with a lived experience with mental 
illness, SUDs, or both. Many COD-specifc 
mutual-support programs are available, and 
counselors should keep referral information on 
hand so they can readily refer clients interested 
in these services. 
• Providers can offer COD services in many 
different settings, including therapeutic 
communities, outpatient addiction centers, 
residential treatment facilities, and acute 
medical care facilities. 
• Pharmacotherapy is often a core part of 
COD treatment, especially for people with 
depression, bipolar I disorder, anxiety, 
schizophrenia/psychotic disorders, AUD, or 
OUD. Counselors do not prescribe medication, 
but they should understand what medications 
their clients are likely to take and the side 
effects clients are likely to experience so they 
can offer proper psychoeducation, help monitor 
for unsafe side effects, and refer clients to 
prescribers for medication management as 
needed. 
Chapter 8: Workforce and Administrative 
Concerns in Working With People Who 
Have CODs 
This chapter reviews major issues facing the mental 
health service and SUD treatment labor force 
and demonstrates how workforce matters can 
negatively affect clients with CODs. The intended 
audiences are supervisors and administrators in 
SUD treatment. 
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Projections about the behavioral health workforce 
suggest that serious gaps will only increase as 
the number of people entering and staying in the 
profession is outpaced by the number of people 
needing those professionals’ services. This trend 
will continue unless there are interventions to 
support the growing capacity and training needs 
of the feld. These gaps have resulted in people 
with CODs having fewer opportunities to access 
high-quality, evidence-based care across a broad 
continuum of settings and services. Further, 
unmet training, education, and credentialing in 
CODs means that there is an insuffcient number 
of counselors and supervisors who understand 
the treatment needs of this population and 
how best to manage their conditions. Ensuring 
better recruitment and retention of well-trained 
behavioral health professionals is paramount 
and will help broaden and strengthen the SUD 
treatment and mental health services systems. 
In Chapter 8, readers will learn that: 
• This country has a major shortage of mental 
health and addiction professionals, and the 
shortage will only continue to grow unless the 
feld uses strategies to increase the size of the 
workforce and retain current professionals. 
Workforce shortages partly account for why 
people with CODs face challenges in accessing, 
engaging in, adhering to, and beneftting from 
services. 
• Recruitment, hiring, and retention techniques 
can help programs attract and keep the right 
candidates while reducing turnover. 
• Burnout is a major component of turnover and 
is prominent in these felds because of the 
complex and challenging nature of the client 
population. 
• Many professionals working with clients who 
have CODs feel uncomfortable or inadequately 
prepared to offer effective COD services, but 
better training and active clinical supervision can 
remedy this. 
• Supervisors and administrators must ensure 
that counselors are properly trained if good 
client outcomes are to be achieved. Numerous 
training resources are available to assist with this 
process. 
• Professional certifcation and credentialing give 
counselors and supervisors the necessary skills 
to provide effective COD services and convey a 
sense of staff competency and professionalism 
within an organization. 
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TIP ORGANIZATION BY KEY TOPIC AREAS OF INTEREST 
The expansive scope of this TIP covers clinically relevant and program-related concepts, guidelines, and 
topic areas. The section “Content Overview,” broadly outlines the layout of the publication. The following 
bullets will orient readers to the location of specifc subject matter likely to be of high interest. Note 
that some of the following content may be mentioned or discussed briefy in other chapters; this listing 
refects the primary locations in the TIP. 
• Ensuring continuity of care: Chapter 2 
• Providing essential program services for people with CODs: Chapter 2 
• Determining level of service and how to match treatment: Chapter 3 
• Screening and assessing for CODs: Chapter 3 (selected tools are located in Appendix C) 
• Addressing suicide risk: Chapter 3 (screening and assessment) and Chapter 4 (prevention and 
management) 
• Using motivational enhancement: Chapter 5 
• Using relapse prevention techniques: Chapter 5 
• Dealing with common clinical challenges in working with clients who have CODs: Chapter 5 
• Understanding culture-specifc matters, including how to provide culturally competent services: 
Chapters 5 and 6 
• Modifying treatments for clients with CODs based on treatment setting and model: Chapter 7 
• Removing treatment barriers and improving service access for people with CODs: Chapter 7 
• Offering integrated care: Chapter 7 
• Designing residential and outpatient treatment programs: Chapter 7 
• Achieving core provider competencies in working with clients who have CODs: Chapter 8 
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• People with mental illness are likely to have 
comorbid substance use disorders (SUDs) and 
vice versa. Addiction counselors should expect 
to encounter mental illness in their client 
population. 
• Co-occurring disorders (CODs) are 
burdensome conditions that have signifcant 
physical, emotional, functional,  social, and 
economic consequences for the people who 
live with these disorders and their loved ones. 
Society as a whole is also affected by the 
prevalence of CODs. 
• Over the past two decades, the behavioral health
feld’s knowledge of the outcomes, service
needs, and treatment approaches for individuals
with CODs has expanded considerably. But gaps
remain in ready access to services and provision
of timely, appropriate, effective, evidence-based
care for people with CODs. 
• CODs are complex and bidirectional. They 
can wax and wane over time. Providers, 
supervisors, and administrators should be 
mindful of this when helping clients make 
decisions about treatment and level of care. 
What is health? The World Health Organization
(WHO) considers healthy states ones characterized
by “complete physical, mental, and social well-being
and not merely the absence of disease or infrmity”
(WHO, n.d.). The Department of Health and Human
Services’ (HHS) Healthy People 2020 initiative
also supports a broad defnition of optimal health,
refected by its overarching goals of (Centers for
Disease Control and Prevention [CDC], 2014): 
• Helping people achieve high-quality, long lives 
free of preventable disease, disability, injury, and 
premature death. 
• Establishing health equity, eliminating 
disparities, and improving the health of all 
groups. 
• Promoting quality of life, healthy development, 
and healthy behaviors across all life stages. 
The concept of “well-being” extends beyond 
one’s physical condition and includes other 
important areas of functioning and quality of life, 
such as mental illness and SUDs. Healthy People 
2020 policy and prevention goals include reducing 
substance use among all Americans (especially 
children) and decreasing the prevalence of mental 
disorders (particularly suicidality and depression) 
while increasing treatment access (Offce of 
Disease Prevention and Health Promotion, 2019). 
SUDs and mental disorders are detrimental to the 
health of individuals and to society as a whole. 
The tendency of these disorders to co-occur can 
make the damage they cause more extensive 
and complex. As knowledge of CODs continues 
to evolve, new challenges have arisen: What is 
the best way to manage CODs and reduce lags 
in treatment? How do we manage especially 
vulnerable populations with CODs, such as people 
experiencing homelessness and those in our 
criminal justice system? What about people with 
addiction and serious mental illness (SMI), such as 
bipolar disorder or schizophrenia? What are the 
best treatment environments and modalities? How 
can we build an integrated system of care? 
The main purpose of this Treatment Improvement
Protocol (TIP) is to attempt to answer these and
related questions by providing current, evidence-
based, practice-informed knowledge about the
rapidly advancing feld of COD research. This
1 
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TIP is primarily for SUD treatment and mental
health service providers, clinical supervisors, and
program administrators. 
This chapter introduces the TIP and is addressed 
to all potential audiences of the TIP: counselors, 
other treatment/service providers, supervisors, 
and administrators. It describes the scope of this 
TIP (both what is included and what is excluded 
by design), its intended audience, and the 
basic approach that has guided the selection of 
strategies, techniques, and models highlighted in 
the text. Next, a section on terminology, including 
a box of key terms, will help provide a common 
language and facilitate readers’ understanding 
of core concepts in this TIP. The chapter also 
addresses the developments that led to this TIP 
revision as well as the underlying rationale for 
developing a publication on CODs specifcally. 
Scope of This TIP 
The TIP summarizes state-of-the-art diagnosis, 
treatment, and service delivery for CODs in the 
addiction and mental health felds. It contains 
chapters on screening and assessment, diagnosis, 
and treatment settings and models, as well as 
recommendations to address workforce and 
administration needs. It is not intended for trainees 
or junior professionals lacking a basic background 
in mental illness and addiction (see the “Audience” 
section that follows). It therefore excludes generic, 
introductory information about mental disorders 
and SUDs. Of note: 
• The primary concern of this TIP is co-occurring 
SUDs and mental disorders, even though 
the vulnerable population with CODs is also 
subject to many other physical conditions. As 
such, co-occurring physical disorders common 
in individuals with SUDs, mental disorders, or 
both (e.g., HIV, hepatitis C virus) are beyond the 
scope of this publication and excluded. 
• Tobacco use disorder, which was treated in 
the original TIP as an important cross-cutting 
issue, is omitted from this update. Since the 
original development of this TIP, considerable 
and comprehensive treatment resources have 
become available specifc to nicotine cessation. 
• Pathological gambling, which the Diagnostic 
and Statistical Manual of Mental Disorders (5th 
ed.; DSM-5; American Psychiatric Association, 
2013) classifes along with other SUDs and which 
was included in the original TIP, is not addressed 
in this update because behavioral addictions are 
outside its scope. 
• Although the TIP addresses several specifc 
populations (i.e., people experiencing 
homelessness; people involved in the criminal 
justice system; people from diverse racial, 
ethnic, and cultural backgrounds; women; 
active duty and veteran military personnel), it 
does so briefy. It also omits content specifcally 
for adolescents. The authors fully recognize, 
and the TIP states repeatedly, that all COD 
treatment must be culturally responsive. 
Audience 
The primary audience for this TIP is SUD treatment
providers. It is meant to meet the needs of those
with basic education/experience as well as the
differing needs of those with intermediate or
advanced education. SUD treatment providers
include drug and alcohol counselors, licensed clinical
social workers and psychologists who specialize in
addiction treatment, and specialty practice registered
nurses [psychiatric and mental health nurses]). Many
such providers have addiction counseling certifcation
or related professional licenses. Some may have
credentials in the treatment of mental disorders or in
criminal justice services.
Other main audiences for this TIP are mental 
health service providers, as well as primary 
care providers (e.g., general practitioners, 
internal medicine specialists, family physicians, 
nurse practitioners), who may encounter patients 
with CODs in their clinics, private practices, or 
emergency medicine settings. 
Secondary audiences include administrators, 
supervisors, educators, researchers, criminal justice 
staff, and other healthcare and social service 
providers who work with people who have CODs. 
Approach 
The TIP uses three criteria for including a 
particular strategy, technique, or model:
1. Defnitive research (i.e., evidence-based 
treatments) 
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2. Well-articulated approaches with empirical 
support 
3. Consensus panel agreement about established 
clinical practice 
The information in this TIP derives from a variety 
of sources, including the research literature, 
conceptual writings, descriptions of established 
program models, accumulated clinical experience 
and expertise, government reports, and other 
available empirical evidence. It refects the current 
state of clinical wisdom regarding the treatment of 
clients with CODs. 
Guidance for the Reader 
This TIP is a resource document and a guide on
CODs. It contains up-to-date knowledge and
instructive material, reviews selected literature,
summarizes many COD treatment approaches,
and covers some empirical information. The scope
of CODs generated a complex and extensive TIP
that is probably best read by chapter or section.
It contains text boxes, case histories, illustrations,
and summaries to synthesize knowledge that is
EXHIBIT 1.1. Key Terms 
grounded in the practical realities of clinical cases
and real situations.
A special feature throughout the TIP—“Advice
to the Counselor” boxes—provides direct and
accessible guidance for the counselor. Readers
can study these boxes to obtain concise practical
guidance. Advice to the Counselor boxes distill what
the counselor needs to know and what steps to
take; they are enriched by more detailed reading of
the relevant material in each section or chapter. 
The chair and co-chair of the TIP consensus panel 
encourage collaboration among providers and 
treatment agencies to translate the concepts 
and methods of this TIP into other useable tools 
specifcally shaped to the needs and resources 
of each agency and situation. The consensus 
panel hopes that the reader will gain from this 
TIP increased knowledge, encouragement, and 
resources for the important work of treating people 
with CODs. 
Terminology in This TIP 
Exhibit 1.1 defnes key terms that appear in this TIP. 
• Addiction*: The most severe form of SUD, associated with compulsive or uncontrolled use of one or more 
substances. Addiction is a chronic brain disease that has the potential for both recurrence (relapse) and 
recovery. 
• Binge drinking*: A drinking pattern that leads to blood alcohol concentration levels of 0.08 grams per 
deciliter or greater. This usually takes place after four or more drinks for women and fve or more drinks 
for men (National Institute on Drug Abuse, n.d.; Center for Behavioral Health Statistics and Quality, 2019). 
However, older adults are more sensitive to the effects of alcohol and treatment providers may need to 
lower these numbers when screening for alcohol misuse (Kaiser Permanente, 2019). Additionally, other 
factors such as weight, decrease in enzyme activity, and body composition, (e.g. amount of muscle tissue 
present in the body) can also affect alcohol absorption rates. 
• Continuing care: Care that supports a client’s progress, monitors his or her condition, and can respond to 
a return to substance use or a return of symptoms of a mental disorder. Continuing care is both a process 
of posttreatment monitoring and a form of treatment itself. It is sometimes referred to as aftercare. 
• Co-occurring disorders: In this TIP, this term refers to co-occurring SUDs and mental disorders. Clients 
with CODs have one or more mental disorders as well as one or more SUDs. 
• Heavy drinking*: Consuming fve or more drinks for men and four or more drinks for women in one 
period on each of 5 or more days in the past 30 days (NIAAA, n.d.). 
• Integrated interventions: Specifc treatment strategies or therapeutic techniques in which interventions for
the SUD and mental disorder are combined in one session or in a series of interactions or multiple sessions. 
• Mutual support programs: Mutual support programs consist of groups of people who work together to 
achieve and maintain recovery. Unlike peer support (e.g., use of recovery coaches), mutual support groups 
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consist only of people who volunteer their time and typically have no offcial connection to treatment 
programs. Most are self-supporting. Although 12-Step groups (e.g., Alcoholics Anonymous and Narcotics 
Anonymous) are the most widespread and well researched type of mutual support groups, other groups 
may be available in some areas. They range from groups affliated with a religion or church (e.g., Celebrate 
Recovery, Millati Islami) to purely secular groups (e.g., SMART Recovery, Women for Sobriety). 
• Peer recovery support services: The entire range of SUD treatment and mental health services that help
support individuals’ recovery and that are provided by peers. The peers who provide these services are called
peer recovery support specialists (“peer specialists” for brevity), peer providers, or recovery coaches. 
• Relapse*: A return to substance use after a signifcant period of abstinence. 
• Recovery*: A process of change through which individuals improve their health and wellness, live a 
self-directed life, and strive to reach their full potential. Even individuals with severe and chronic SUDs 
can, with help, overcome their SUD and regain health and social function. This is called remission. When 
those positive changes and values become part of a voluntarily adopted lifestyle, that is called “being in 
recovery.” Although abstinence from all substance misuse is a cardinal feature of a recovery lifestyle, it is 
not the only healthy, pro-social feature. 
• Standard drink*: Based on the 2015–2020 Dietary Guidelines for Americans (HHS, U.S. Department of 
Agriculture, 2015) one standard drink contains 14 grams (0.6 ounces) of pure alcohol: 
12 f oz. of 
regular beer 
about 5% 
alcohol 
8-9 f oz. of 
malt liquor 
(shown in a 
12 oz glass) 
about 7% 
alcohol 
5 f oz. of 
table wine 
about 12% 
alcohol 
1.5 f oz. shot 
of 80-proof 
distilled spirits 
(gin, rum, tequila, 
vodka, whiskey, etc.) 
40% alcohol 
The percent of “pure” alcohol, expressed here as alcohol by volume (alc/vol), varies by beverage. 
• Substance*: A psychoactive compound with the potential to cause health and social problems, including 
SUDs (and their most severe manifestation, addiction). The insert at the bottom of this exhibit lists 
common examples of such substances. 
• Substance misuse*: The use of any substance in a manner, situation, amount, or frequency that can 
cause harm to users or to those around them. For some substances or individuals, any use would 
constitute misuse (e.g., underage drinking, injection drug use). 
• Substance use*: The use—even one time—of any of the substances listed in the insert. 
• Substance use disorder*: A medical illness caused by repeated misuse of a substance or substances. 
According to the DSM-5 (American Psychiatric Association [APA], 2013), SUDs are characterized by 
clinically signifcant impairments in health, social function, and impaired control over substance use and 
are diagnosed through assessing cognitive, behavioral, and psychological symptoms. SUDs range from 
mild to severe and from temporary to chronic. They typically develop gradually over time with repeated 
misuse, leading to changes in brain circuits governing incentive salience (the ability of substance-
associated cues to trigger substance seeking), reward, stress, and executive functions like decision making 
and self-control. Multiple factors infuence whether and how rapidly a person will develop an SUD. These 
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factors include the substance itself; the genetic vulnerability of the user; and the amount, frequency, and 
duration of the misuse. Note: A severe SUD is commonly called an addiction. 
Categories and examples of substances 
SUBSTANCE CATEGORY REPRESENTATIVE EXAMPLES 
Alcohol •
•
•
•
Beer 
Wine 
Malt liquor 
Distilled spirits 
Illicit Drugs Cocaine, including crack 
Heroin 
Hallucinogens, including LSD (lysergic acid 
diethylamide), PCP (phencyclidine), ecstasy, 
peyote, mescaline, psilocybin 
Methamphetamines, including crystal meth 
Marijuana, including hashish† 
Synthetic drugs, including K2, Spice, and “bath salts” 
Prescription-type medications that are used for 
nonmedical purposes 
-
-
-
-
Pain relievers—Synthetic, semisynthetic, and 
nonsynthetic opioid medications, including 
fentanyl, codeine, oxycodone, hydrocodone, and 
tramadol products 
Tranquilizers, including benzodiazepines, 
meprobamate products, and muscle relaxants 
Stimulants and methamphetamine, including 
amphetamine, dextroamphetamine, and 
phentermine products; mazindol products; 
and methylphenidate or dexmethylphenidate 
products 
Sedatives, including temazepam, furazepam, or 
triazolam and any barbiturates 
Over-the-Counter Drugs and Other Substances •
•
Cough and cold medicines 
Inhalants, including amyl nitrite, cleaning fuids, 
gasoline and lighter gases, anesthetics, solvents, 
spray paint, nitrous oxide 
† As of March 2020, most states and the District of Columbia have legalized medical marijuana use, although some
states have stricter limitations than others. Additionally, a signifcant number of states and the District of Columbia
also allow recreational use and home cultivation. It should be noted that none of the permitted uses under state laws
alter the status of marijuana and its constituent compounds as illicit drugs under Schedule I of the federal Controlled
Substances Act. 
Source: HHS Offce of the Surgeon General (2016). 
*The defnitions of all terms marked with an asterisk correspond closely to those given in Facing Addiction in America: The 
Surgeon General’s Report on Alcohol, Drugs, and Health. The standard drink image and the table depicting substance 
types and categories come from the same source, which is in the public domain. This resource provides a great deal of 
useful information about substance misuse and its impact on U.S. public health. The report is available online (https:// 
addiction.surgeongeneral.gov/sites/default/fles/surgeon-generals-report.pdf). 
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The behavioral health feld has used many terms to 
describe the group of individuals who have CODs. 
Some of these terms do not appear in this TIP, 
which attempts to refect a “person-frst” approach 
(see the “Person-Centered Terminology” section). 
Providers and other professionals working with 
people who have CODs need to understand that 
some terms that have been commonly related 
to CODs may now be outdated and, in certain 
cases, pejorative. Such terms include: 
Person-Centered Terminology 
• Dual diagnosis. 
• Dually diagnosed. 
• Dually disordered. 
• Mentally ill chemical abuser. 
• Mentally ill chemically dependent. 
• Mentally ill substance abuser. 
• Mentally ill substance using. 
• Chemically abusing mentally ill. 
• Chemically addicted and mentally ill. 
• Substance abusing mentally ill. 
All of these terms have their uses, but many have 
connotations that are unhelpful or too broad or 
varied in interpretation to be useful. For example, 
“dual diagnosis” also can mean having both mental 
and developmental disorders. Outside of this 
TIP, readers should not assume that these terms 
all have the same meaning as CODs and should 
clarify the client characteristics associated with a 
particular term. Readers should also realize that the 
term “co-occurring disorder” is not always precise. 
As with other terms, it may become distorted over 
time by common use and come to refer to other 
conditions; after all, clients and consumers may 
have a number of health conditions that “co-
occur,” including physical illness. Nevertheless, for 
the purpose of this TIP, CODs refers only to SUDs 
and mental disorders. 
Some clients’ mental illness symptoms may not 
fully meet strict defnitions of co-occurring SUDs 
and mental disorders or criteria for diagnoses in 
DSM-5 categories. However, many of the relevant 
principles that apply to the treatment of CODs will 
also apply to these individuals. Careful assessment 
and treatment planning to take each disorder into 
account will still be important. 
This TIP uses only person-frst language—such as 
“person with CODs.” In recent years, consumer 
advocacy groups have expressed concerns 
about how clients are classifed. Many object to 
terminology that seems to put them in a “box” 
with a label that follows them through life, that 
does not capture the fullness of their identities. 
A person with CODs may also be a mother, a 
plumber, a pianist, a student, or a person with 
diabetes, to cite just a few examples. Referring 
to an individual as a person who has a specifc 
disorder—a person with depression rather than “a 
depressive,” a person with schizophrenia rather 
than “a schizophrenic,” or a person who uses 
heroin rather than “a heroin addict”—is more 
acceptable to many clients because it implies 
that they have many characteristics beyond a 
stigmatized illness, and therefore they are not 
defned by this illness. 
Because this TIP’s primary audience is 
counselors in the addiction and mental health 
felds, this publication uses the term “client,” 
rather than “patient” or “consumer.” 
Important Developments That
Led to This TIP Update
Important developments in a number of areas
pointed to the need for a revised TIP on CODs:
• The revisions to the diagnostic classifcation of 
and diagnostic criteria for mental disorders in 
DSM-5 made an update necessary. See Chapter 
4 for an indepth discussion of DSM-5 diagnoses. 
• This update to TIP 42 offers a greater emphasis 
on integrated care or concurrent treatment 
(e.g., treating a client’s alcohol use disorder 
[AUD] at the same time that you treat his or 
her posttraumatic stress disorder [PTSD]), as 
this is a larger focus of the research and clinical 
feld today than when this TIP was originally 
published. More information about treatment 
approaches is in Chapter 7. 
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• This update refects a wealth of new data about 
effective treatment options for people with 
CODs, including those with SMI (see especially 
Chapter 7). 
Why Do We Need a TIP on CODs? 
Empirical evidence confrms that CODs are
serious problems in need of better management.
Treatment rates are markedly low and outcomes
often suboptimal, underscoring the importance of
advancing the feld’s knowledge about and use of
appropriate, specialized techniques for screening,
assessment, diagnosis, and coordinated care of this
population. Findings from four key areas are borne
out by prevalence statistics and other nationally
representative survey data and reveal the stark
reality of underservice in this population. 
“Comorbidity is important because
it is the rule rather than the
exception with mental health
disorders.” 
Source: Lai, Cleary, Sitharthan, & Hunt, 2015; p. 8 
1. Prevalence and Treatment Need of CODs 
National surveys suggest that mental illness 
(and SMI in particular) commonly co-occurs 
with substance misuse in the general adult 
population, and many individuals with CODs 
go untreated. The National Survey on Drug Use 
and Health (NSDUH), based on a sample of more 
than 67,700 U.S. civilians ages 12 or older in 
noninstitutionalized settings (Center for Behavioral 
Health Statistics and Quality [CBHSQ], 2019), offers 
revealing insights. Notable statistics from the latest 
survey include the following (CBHSQ, 2019): 
• In 2018, 47.6 million (19.1 percent of all adults) 
adults ages 18 and older had any mental illness 
during the previous year, including 11.4 million 
(4.6 percent of all adults) with SMI. 
- Among these 47.6 million adults with any 
past-year mental disorder, 9.2 million (19.3 
percent) also had an SUD, but only 5 percent 
of adults without any mental illness in the 
past year had an SUD. 
- Of the 11.4 million adults with an SMI in the 
previous year, approximately 28 percent also 
had an SUD. 
EXHIBIT 1.2. Co-Occurring Substance Misuse in Adults Ages 18 and 
Older With and Without Any Mental Illness and SMI (in 2018) 
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• SMI is highly correlated with substance misuse 
(Exhibit 1.2; McCance-Katz, 2019). Adults ages 
18 and older with any past-year mental illness 
were more likely than those without to use illicit 
drugs or misuse prescription medication. This 
pattern was even more pronounced among 
people with SMI. Of the 47.6 million adults with 
any past-year mental illness, more than half 
(56.7 percent) received no treatment, and over 
one-third (35.9 percent) of adults with an SMI 
in the past year received no treatment. Further, 
nearly all (more than 90 percent) of the 9.2 
million adults with both a past-year mental 
illness and SUD did not receive services for 
both conditions (McCance-Katz, 2019). 
• About 14.2 million adults (about 5.7 percent of 
all adults) saw themselves as needing mental 
health services at some point in the previous 
year but did not receive it (CBHSQ, 2019): 
- Of adults with any mental disorder, 11.2 
million (almost 24 percent), or nearly 1 
in 4 adults with any mental illness, had a 
perceived unmet need for mental health 
services in the past year. 
- Of adults with an SMI, 5.1 million (about 45 
percent), or more than 2 out of every 5 adults 
with SMI, had a perceived unmet need for 
mental health services in the previous year. 
• More than 18 million people ages 12 and older 
needed but did not receive SUD treatment in 
the previous year (e.g., they had an SUD or 
problems related to substance use). Most of 
those individuals did not see themselves as 
needing treatment (only 5 percent thought they 
needed it). 
• Almost half (48.6 percent) of adults ages 
18 and older with any mental illness and 
co-occurring SUD received no treatment at 
all in 2018. About 41 percent received mental 
health services only, 3.3 percent received SUD 
treatment only, and 7 percent received both. 
• Of adults with SMI and co-occurring SUDs, 
30.5 percent received no treatment. About 56 
received mental health services only; almost 3 
percent received SUD treatment only; and about 
11 percent received both. 
Other nationally representative survey datasets 
confrm the high rate of comorbidity and treatment 
need for mental disorders and SUDs in the general 
adult population. An analysis of Wave 3 of the 
National Epidemiologic Survey on Alcohol and 
Related Conditions (NESARC-III; Grant et al., 
2015) revealed an increased risk of comorbid 
mental illness among people with 12-month and 
lifetime AUD. Specifcally, the odds of having major 
depression, bipolar disorder, antisocial personality 
disorder (PD), borderline PD (BPD), panic disorder, 
specifc phobia, or generalized anxiety disorder 
(GAD) ranged from 1.2 to 6.4. Only 20 percent of 
people with lifetime AUD and 8 percent of people 
with 12-month AUD received treatment. 
From the same survey, any 12-month drug use 
disorder (i.e., SUD not involving alcohol) was 
associated with signifcantly increased odds of also 
having a co-occurring mental disorder, including 
1.3 times the odds of having major depressive 
disorder (MDD), 1.5 odds of dysthymia, 1.5 odds 
of bipolar I disorder, 1.6 odds of PTSD, 1.4 odds 
of antisocial PD, and 1.8 odds of BPD (Grant et 
al., 2016). Lifetime drug use disorder had similar 
comorbidities but also was associated with a 
1.3 increase in odds of also having GAD, panic 
disorder, or social phobia. Only 13.5 percent of 
people with a 12-month drug use disorder and 
about a quarter of people with any lifetime drug 
use disorder received treatment in the past year. 
2. CODs and Hospitalizations 
Compared with people with mental disorders or 
SUDs alone, people with CODs are more likely 
to be hospitalized. Some evidence suggests that 
the hospitalization rate for people with CODs is 
increasing. 
Since the 1960s, treatment for mental disorders 
and SUDs in the United States has shifted away 
from state-owned facilities to psychiatric units in 
general hospitals and private psychiatric hospitals 
(Parks & Radke, 2014). Psychiatric bed capacity 
has continued to shrink over the past few 
decades in the United States and elsewhere 
(Allison, & Bastiampillai, 2017; Lutterman, Shaw, 
Fisher, & Manderscheid, 2017; Tyrer, Sharfstein, 
O’Reilly, Allison, & Bastiampillai, 2017), despite 
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OPIOID USE DISORDER AND THE PROBLEM OF CODs 
Opioid addiction and overdose are a public health crisis and the target of numerous federal prevention 
and treatment campaigns. Among the causes for concern is the high rate of CODs among people with 
opioid use disorder (OUD). Of 2 million U.S. adults with OUD in the 2015 to 2017 NSDUH (Jones & McCance-
Katz, 2019): 
• 77 percent also had another SUD or nicotine dependence in the past year. 
• 64 percent also had any co-occurring mental illness in the past year. 
• 27 percent had a past-year comorbid SMI. 
In terms of service provision, 38 percent of people with OUD and any past-year mental illness or SMI
received SUD treatment in the previous year. Mental health services were more common, with 55 percent
of people with OUD and any mental illness and 65 percent of those with OUD and SMI receiving care in the
previous year. However, comprehensive treatment for both disorders was low and reported by only one-
quarter of people with OUD and any mental illness and 30 percent of people with OUD and SMI. 
an upsurge in mental disorder/SUD-related 
hospitalizations: 
• The Agency for Healthcare Research and Quality 
found that from 2005 to 2014, the number of 
hospital inpatient stays for people with mental 
disorders or SUDs increased by 12 percent, and 
the proportion of total inpatient stays accounted 
for by mental disorders or SUDs also increased, 
by 20 percent (McDermott, Elixhauser, & Sun, 
2017). 
• CODs are also linked to rehospitalizations for 
non-behavioral-health reasons (i.e., for physical 
health conditions). Among a large sample of 
Florida Medicaid recipients (Becker, Boaz, 
Andel, & Hafner, 2017), 28 percent of people 
with SMI and an SUD were rehospitalized within 
30 days of discharge, whereas rehospitalization 
occurred in only 17 percent of people with 
neither disorder, 22 percent of people with 
SMI only, 27 percent of people with a drug use 
disorder, and 24 percent of people with AUD. 
• In the 2000 to 2012 Treatment Episode Data Set 
(TEDS), SUD treatment-related admissions of 
adults ages 55 and older that also involved co-
occurring psychiatric problems nearly doubled, 
from 17 percent to 32 percent (Chhatre, Cook, 
Mallik, & Jayadevappa, 2017). 
• As reported in the 2012 Healthcare Cost 
and Utilization Project (Heslin, Elixhauser, & 
Steiner, 2015), almost 6 percent of all inpatient 
hospitalizations in the United States involved a 
COD, 21 percent a mental disorder diagnosis 
only, and about 6 percent an SUD only. Of 
inpatient stays involving a primary diagnosis of 
mental illness or SUD, 46 percent were because 
of a COD, whereas 40 percent of inpatient stays 
involved a mental disorder only and 15 percent 
an SUD only (Heslin et al., 2015). 
Hospitalizations and early readmissions are costly, 
potentially preventable occurrences. Identifying 
individuals at risk for either or both (such as 
individuals with CODs) could inform more effective 
discharge planning and wraparound services. 
3. Trends in COD Programming 
Some evidence supports an increased prevalence 
of people with CODs in treatment settings 
and of more programs for people with CODs. 
However, treatment gaps remain. 
Data from the Nationwide Inpatient Sample of the
Healthcare Cost and Utilization Project (Zhu & Wu,
2018) found that the number of people ages 12
and older hospitalized for inpatient detoxifcation
who had a co-occurring mental disorder diagnosis
increased signifcantly from 43 percent in 2003
to almost 59 percent in 2011. This included a
signifcant rise in co-occurring anxiety disorders
(8 percent vs. 17 percent) and nonsignifcant
but notable increases in mood disorders (35
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percent vs. 46 percent) and schizophrenia or other
psychotic disorders (3 percent vs. 5 percent).
Recent survey data (Substance Abuse and Mental
Health Services Administration [SAMHSA], 2018e)
revealed a signifcant increase in the proportion of
clients with CODs in SUD treatment facilities from
2007 (37 percent) to 2017 (50 percent).
COD programming has not kept pace with the 
increase in clients needing such services. In 2018, 
almost every SUD treatment facility surveyed 
through the National Survey of Substance Abuse 
Treatment Services (99.8 percent) reported 
having clients in treatment with a diagnosed 
COD (SAMHSA, 2019a). However, only 50 
percent of the facilities indicated that they 
provided specifcally tailored programs or group 
treatments for clients with CODs. 
The 2018 National Mental Health Services Survey 
(SAMHSA, 2019b) reported similar fndings: Only 
46 percent of mental health service facilities 
offered COD-specifc programming. Facilities 
most likely to offer COD programming were 
private psychiatric hospitals (65 percent), Veterans 
Administration medical centers (56 percent), and 
multisetting mental health facilities (59 percent), 
and community mental health centers (54 percent). 
Among those least likely to offer COD programs 
were partial hospitalization/day treatment facilities 
(37 percent) and general hospitals (40 percent). A 
national survey of 256 SUD treatment and mental 
health service programs (McGovern, Lambert-
Harris, Gotham, Claus, & Xie, 2014) found only 18 
percent of addiction programs and 9 percent 
of mental health services programs were rated 
as COD “capable” (in terms of their capacity to 
adequately deliver COD services). 
The types of assessment and pretreatment 
services at SUD treatment facilities varied 
in 2018 (SAMHSA, 2019a), with 96 percent 
providing screening for substance misuse, 93 
percent providing comprehensive substance 
misuse assessment or SUD diagnosis, 75 percent 
screening for mental disorders, and 53 percent 
providing comprehensive psychiatric assessment or 
diagnosis. 
4. Complications of CODs 
CODs can complicate treatment and, if poorly
managed, can hinder recovery. Further, rates of
mental disorders appear to increase as the number
of SUDs increases, meaning people with polysub-
stance use are especially vulnerable to CODs.
Epidemiologists have observed increasing rates 
of SUD treatment admissions among people with 
multiple SUDs. Analyses of TEDS data (SAMHSA, 
CBHSQ, 2019) reveal that in 2017, more than 25 
percent of people ages 12 and older admitted for 
SUD treatment reported both alcohol and other 
substance misuse. This could partially account for 
the increase in clients with CODs in SUD treatment 
settings, as it appears that having multiple mental 
disorders increases the odds of having multiple 
SUDs or vice versa. In the NESARC-III (McCabe, 
West, Jutkiewicz, & Boyd, 2017), people with 
one lifetime mental disorder had more than three 
times the odds of having multiple past-year SUDs 
compared with people with no lifetime mental 
disorders. But people with multiple mental 
disorders (particularly mood disorders, PDs, and 
PTSD) are nearly nine times more likely to have 
multiple past-year SUDs. Individuals with multiple 
previous SUDs were also less likely to experience 
remission from substance misuse than were people 
with a single SUD. 
SUD treatment facilities are increasingly seeing 
nonalcohol substances as the primary substance 
of misuse among people entering treatment. 
For instance, from 2005 to 2015, the proportion 
of alcohol admissions decreased from about 40 
percent to 34 percent and opiate admissions 
increased from 18 percent to 34 percent (with 
opiates other than heroin increasing from 4 percent 
to 8 percent) (SAMHSA, 2017). This and the trend 
of increased polysubstance misuse are worrisome, 
as NESARC-III data clearly demonstrate both 
drug use disorders and AUD each independently 
confer an exaggerated risk of co-occurring mental 
disorders (Grant et al., 2015; Grant et al., 2016). 
CODs can be an obstacle to addiction recovery, 
especially when untreated. Data from the 2009 
to 2011 TEDS-Discharges show that, of people 
admitted to SUD treatment, 28 percent had a 
co-occurring psychiatric condition (Krawczyk et 
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al., 2017). Prevalence rates of CODs varied across 
individual states and ranged from 8 percent to 62 
percent. People with a psychiatric comorbidity 
were signifcantly more likely than those without 
a psychiatric comorbidity to report using three 
or more substances (27 percent vs. 17 percent). 
Of people who did not complete treatment, 42 
percent had a COD, versus 36 percent without. 
This translated to about a 1.3 increase in odds of 
not completing treatment and a 1.1 increase in 
odds of earlier time to attrition for people with 
CODs compared with those with an SUD only. 
CODs are strongly associated with socioeconom-
ic and health factors that can challenge recovery, 
such as unemployment, homelessness, incarcer-
ation/criminal justice system involvement, and 
suicide. 
• According to SAMHSA’s Mental Health Annual 
Report, in 2017, 29 percent of people with 
CODs were unemployed and 50 percent 
were not in the labor force (e.g., disabled, 
retired, student) (SAMHSA, 2019d). The current 
national unemployment rate at the time of this 
publication is 3.8 percent (Bureau of Labor 
Statistics, March 3, 2020). 
• Of people 12 and older with CODs, 7.5 
percent experience homelessness, including 
8.3 percent of people with an SUD and 
schizophrenia or other psychotic disorder, 6.9 
percent with an SUD and bipolar disorders, 
and 7.8 percent with an SUD and depressive 
disorders (SAMHSA, 2019d). Rates of lifetime 
and past-year homelessness in the general 
community per NESARC-III (Tsai, 2018) are 
about 4 percent and 1.5 percent, respectively. 
The 2017 Annual Homeless Assessment Report 
to Congress (Henry, Watt, Rosenthal, & Shivji, 
2017) found that almost 23 percent of adults in 
permanent supportive housing programs had 
transferred from an SUD treatment center; 15 
percent, from a mental health services facility. 
Furthermore, of the 552,830 total individuals 
experiencing homelessness, about 20 percent 
(111,122) had an SMI and about 16 percent 
(86,647) had a chronic SUD (U.S. Department of 
Housing and Urban Development, 2018). 
• Of people incarcerated in U.S. state prisons 
(Al-Rousan, Rubenstein, Sieleni, Deol, & 
Wallace, 2017), about 48 percent have a history 
of mental illness (of whom 29 percent had an 
SMI), 26 percent, a history of an SUD. Of those 
with mental illness, 49 percent also have a co-
occurring SUD. 
• Mental disorders that commonly co-occur 
with SUDs—including depression, anxiety 
disorders, bipolar disorders, schizophrenia, 
and PTSD—are highly prevalent in people who 
have completed suicide, (Stone, Chen, Daumit, 
Linden, & McGinty, 2019). Suicide is also a 
well-known risk factor in SUDs and a leading 
cause of death for people with addiction (Center 
for Substance Abuse Treatment, 2009; Yuodelis-
Flores & Ries, 2015). In CDC’s National Vital 
Statistics System dataset (Stone et al., 2019), 
46 percent of all individuals in the United States 
who died by suicide between 2014 and 2016 
had a known mental condition, and 28 percent 
misused substances, and of this 28 percent 
almost one-third (32 percent) also had a known 
mental health condition. 
These fgures refect the need for specifcally 
tailored COD assessments, interventions, treatment 
approaches, and clinical considerations (e.g., 
COD programming specifc to people without 
stable housing; COD interventions designed for 
implementation in criminal justice settings). More 
information about how these variables factor into 
service provision and outcomes can be found in 
Chapters 4 and 6. 
The Complex, Unstable, and
Bidirectional Nature of CODs 
Counselors working with clients who have CODs 
often want to know which disorder developed 
frst. The answer is not always clear because the 
temporal nature of CODs can be inconsistent and 
nuanced. In some cases, a mental disorder may 
obviously have led to the development of an SUD. 
An example would be someone with long-standing 
major depressive disorder who starts using alcohol 
excessively to cope and develops AUD. In other 
instances, substance use clearly precipitated the 
mental disorder—such as when someone develops 
a cocaine-induced psychotic disorder. In many cases,
it will be uncertain which disorder occurred frst.
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Furthermore, CODs can be bidirectional. For
some clients, there may be a third condition that
is infuencing both or either of the two comorbid
disorders (e.g., HIV, chronic pain). Environmental
factors, like homelessness or extreme stress, can
also affect one or both disorders. Thus, even when
it is clear which disorder developed frst, the causal
relationship may be unknown. Regardless of the
temporal-causal relationship between a client’s SUD
and mental illness, the two are likely to affect, and
possibly exacerbate, one another. This means that
both need to be treated with equal seriousness. 
In addition to inducing a mental disorder, 
substance misuse can sometimes mimic 
a mental disorder. Thus, it is important to 
use thorough screening and assessment 
approaches to help disentangle all symptoms 
and make an accurate diagnosis. Learn more 
about screening and assessment for CODs in 
Chapter 3. 
CODs are not necessarily equal in severity. 
Often, one disorder is more severe, distressing, 
or impairing than the other. Recognizing this is 
important for treatment planning and requires 
a person-centered rather than cookie-cutter 
approach to determining diagnosis, comorbidities, 
functioning, treatment and referral needs, and 
stage of change. Models are available to help 
counselors make such decisions based on the 
severity and impact of each disorder. For instance, 
the Four Quadrants Model (National Association of 
State Mental Health Program Directors & National 
Association of State Alcohol and Drug Abuse 
Directors, 1999) classifes clients in four basic 
groups based on relative symptom severity, not 
diagnosis: 
• Category I: Less severe mental disorder/less 
severe substance disorder 
• Category II: More severe mental disorder/less 
severe substance disorder 
• Category III: Less severe mental disorder/more 
severe substance disorder 
• Category IV: More severe mental disorder/more 
severe substance disorder 
For a more detailed description of this model, see 
Chapter 2. To learn how to integrate the quadrants 
of care framework into assessment and treatment 
decision-making processes, see Chapter 3. 
SUDs, Mental Illness, and “Self-
Medicating” 
The notion that SUDs are caused, in whole or 
in part, by one’s attempts to “self-medicate” 
symptoms with alcohol or illicit drugs has been a 
source of debate. The consensus panel cautions 
that the term “self-medication” should not be 
used, as it equates drugs of misuse (which usually 
worsen health) with true medications (which are 
designed to improve health). Although some 
people with mental conditions may misuse 
substances to alleviate their symptoms or 
otherwise cope (Sarvet et al., 2018; Simpson, 
Stappenbeck, Luterek, Lehavot, & Kaysen, 2014), 
this is not always the case. Counselors should not 
assume self-medication is the causal link between a 
client’s mental disorder and SUD. 
Conclusion 
The COD recovery trajectory often has pitfalls, 
but our understanding of CODs and COD-specifc 
service delivery has improved over the past 20 
years. Despite these advances, signifcant gaps 
remain in the accurate and timely assessment, 
diagnosis, and treatment of people with CODs. 
To achieve lower cost mental health services and 
SUD treatment, better client outcomes, and a 
more positive treatment experience, providers and 
administrators must collectively place more focus 
on CODs in their work. By better understanding 
the risks and responding to the service needs 
of people with CODs, behavioral health service 
providers can help make long-term recovery an 
attainable goal for all clients with CODs. 
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• General guiding principles of good care for 
people with co-occurring disorders (CODs) 
ensure that counselors and other providers, 
administrators, and supervisors fully meet 
clients’ comprehensive needs—effectively and 
ethically. 
• Counselors should offer clients full access to 
a range of integrated services through the 
continuum of recovery. 
• Administrators and supervisors are responsible 
for the training, professional development, 
recruitment, and retention of qualifed 
counselors and other professional staff 
working with people who have CODs. Failure 
to attend to these workforce matters will only 
further inhibit client access to care. 
• Several core essential services exist for clients 
with comorbid conditions, and supervisors 
and administrators should regularly evaluate 
their program’s capacity and performance to 
monitor its effectiveness in providing these 
services and correct course when needed. 
Many treatment providers and agencies recognize 
the need to provide quality care to people 
with CODs but see it as a daunting challenge 
beyond their resources. Programs that already 
have incorporated some elements of integrated 
services and want to do more may lack a clear 
framework for determining priorities. Addiction 
counselors might recognize the need to be able 
to effectively treat clients with CODs but not fully 
understand the best approaches to doing so. As 
counselors and programs look to improve their 
effectiveness in treating this population, what 
should they consider? How could the experience of 
other agencies or counselors inform their planning 
process? Are resources available that could help 
turn such a vision into reality? This chapter is 
designed to help both providers and agencies 
that want to improve services for their clients with 
CODs, whether that means establishing services 
where there currently are none or learning to 
improve existing ones. 
The chapter is designed for counselors, other 
treatment/service providers, supervisors, and 
administrators and begins with a review of general 
guiding principles derived from proven models, 
clinical experience, and the growing base of 
empirical evidence. Building on these guiding 
principles, the chapter turns to the specifc core 
components for effective service delivery for 
addiction counselors and other providers and for 
administrators and supervisors, respectively. For 
providers, this includes addressing in concrete 
terms the challenges of providing access, 
screening and assessment, appropriate level 
of care, integrated treatment, comprehensive 
services, and continuity of care. For supervisors and 
administrators, effective service delivery requires 
staff to develop essential core competencies 
and take advantage of opportunities for 
professional development. Achieving optimal 
COD programming means integrating research 
into clinical services to ensure that practices are 
evidence based, establishing essential services 
to meet the varied needs of people with CODs, 
and conducting program assessments to gauge 
whether services adequately fulfll clients’ access 
and treatment needs. 
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General Guiding Principles 
The consensus panel developed a list of guiding 
principles to serve as fundamental building blocks 
for working with clients who have CODs (Exhibit 
2.1). These principles are derived from a variety 
of sources: conceptual writings, well-articulated 
program models, a growing understanding of the 
essential features of CODs, elements common to 
separate treatment models, clinical experience, and 
available empirical evidence. These principles may 
be applied at both a program level (e.g., providing 
literature for people with cognitive impairments) or 
at the individual level (e.g., addressing the client’s 
basic needs). 
Exhibit 2.1. Six Guiding Principles 
in Treating Clients With CODs 
1. Use a recovery perspective. 
2. Adopt a multiproblem viewpoint. 
3. Develop a phased approach to treatment. 
4. Address specifc real-life problems early in 
treatment. 
5. Plan for the client’s cognitive and functional 
impairments. 
6. Use support systems to maintain and extend 
treatment effectiveness. 
The following section discusses the six principles 
and the related feld experience underlying each 
one. 
Use a Recovery Perspective 
The recovery perspective has two main features: It 
acknowledges that recovery is a long-term process 
of internal change, and it recognizes that these 
internal changes proceed through various stages. 
(See De Leon [1996] and Prochaska, DiClemente, & 
Norcross [1992] for a detailed description. Also see 
Chapter 5 of this Treatment Improvement Protocol 
(TIP) for a discussion of the recovery perspective as 
a guideline for establishing therapeutic alliance.) 
The recovery perspective applies to clients with 
CODs and generates two main practice principles: 
• Develop a treatment plan that provides for 
continuity of care over time. In preparing 
this plan, the provider should recognize that 
treatment may occur in different settings over 
time (e.g., residential, outpatient) and that 
much of the recovery process typically occurs 
outside of or following treatment (e.g., through 
participation in mutual-support programs, 
through family, peer, and community support, 
including the faith community). The provider 
needs to reinforce long-term participation in 
these continuous care settings. 
• Devise treatment interventions that are specifc 
to the tasks and challenges faced at each 
stage of the COD recovery process. Whether 
within the substance use disorder (SUD) 
treatment or mental health services system, the 
provider is advised to use sensible stepwise 
approaches in developing and using treatment 
protocols. In addition, markers that are unique 
to individuals—such as those related to their 
cultural, social, or spiritual context—should be 
considered. The provider needs to engage the 
client in defning markers of progress that are 
meaningful to him or her and to each stage of 
recovery. 
Adopt a Multiproblem Viewpoint 
People with CODs generally have an array of 
mental, medical, substance use, family, and social 
problems. Most need substantial rehabilitation 
and habilitation (i.e., initial learning and acquisition 
of skills). Treatment should address immediate 
and long-term needs for housing, work, health 
care, and a supportive network. Therefore, 
services should be comprehensive to meet the 
multidimensional problems typically presented by 
clients with CODs. 
Develop a Phased Approach to Treatment 
Using a staged or phased approach to 
COD treatment helps counselors optimize 
comprehensive, appropriate, and effective care for 
all client needs. Generally, three to fve phases are 
identifed, including engagement, stabilization/ 
persuasion, active treatment, and continuing care 
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or continuing care/relapse prevention (Mueser & 
Gingerich, 2013; Substance Abuse and Mental 
Health Services Administration [SAMHSA], 2009a). 
These phases are consistent with, and parallel to, 
stages identifed in the recovery perspective. The 
use of these phases enables the provider (whether 
within the SUD treatment or mental health 
services system) to develop and use effective, 
stage-appropriate treatment protocols. (See the 
revised TIP 35, Enhancing Motivation for Change 
in Substance Use Disorder Treatment [SAMHSA, 
2019c]). 
Address Specifc Real-Life Problems Early 
in Treatment 
Growing recognition that CODs arise in a context 
of personal and social problems, with disruption of 
personal and social life, has prompted approaches 
that address specifc life problems early in 
treatment. These approaches may incorporate 
case management and intensive case management 
to help clients surmount bureaucratic hurdles 
or handle legal and family matters. Specialized 
interventions that target important areas of client 
need, such as housing-related support services 
(Clark, Guenther, & Mitchell, 2016), can also 
help. Vocational services help clients with CODs
make concrete improvements in career goal
setting, job seeking, work attainment, and earned
wages (Luciano & Carpenter-Song, 2014; Mueser,
Campbell, & Drake, 2011).
For people in recovery from mental disorders 
or SUDs, workforce participation is not only 
valuable because of its economic contributions; it 
can also enhance individual self-effcacy, improve 
self-identity (e.g., help people feel “normal” 
as opposed to “like a patient”), offer a sense of 
belonging with society at large, provide a way 
for people to build relationships with others, and 
improve quality of life (Charzynska, Kucharska, & 
Mortimer, 2015; Walsh & Tickle, 2013). A review of 
the effects of employment interventions for people 
with SUDs found that employment was associated 
with reduced substance use and more stable 
housing (Walton & Hall, 2016). 
Solving fnancial, housing, occupational, and other 
problems of everyday living is often an important 
frst step toward achieving client engagement in 
continuing treatment. Engagement is a critical part 
of SUD treatment generally and of treatment for 
CODs specifcally, because remaining in treatment 
for an adequate length of time is essential to 
achieving behavioral change. 
Plan for Clients’ Cognitive and Functional 
Impairments 
Services for clients with CODs, especially those 
with more serious mental disorders, must be 
tailored to individual needs and functioning. 
Clients with CODs often display cognitive and 
other functional impairments that affect their ability 
to comprehend information or complete tasks 
(Duijkers, Vissers, & Egger, 2016). The manner 
in which interventions are presented must be 
compatible with client needs and functioning. 
Such impairments frequently call for relatively 
short, highly structured treatment sessions that 
are focused on practical life problems. Gradual 
pacing, visual aids, and repetition are often helpful. 
Even impairments that are comparatively subtle 
(e.g., certain learning disabilities) may still have 
signifcant impact on treatment success. Careful 
assessment of such impairments and a treatment 
plan consistent with the assessment are therefore 
essential. 
Use Support Systems To Maintain and 
Extend Treatment Efectiveness 
The mutual-support movement, the family, peer 
providers, the faith community, and other resources 
that exist within the client’s community can play an 
invaluable role in recovery. This can be particularly 
true for clients with CODs, many of whom have not 
enjoyed a consistently supportive environment for 
decades. In some cultures, the stigma surrounding 
SUDs or mental disorders is so great that the client 
and even the entire family may be ostracized by 
the immediate community. For instance, some 
mutual- support programs are not very accepting 
of members with CODs who take psychiatric 
medication. Furthermore, the behaviors associated 
with active substance use may have alienated the 
client’s family and community. The provider plays a 
role in ensuring that the client is aware of available 
support systems and motivated to use them 
effectively. 
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Mutual Support 
Based on the Alcoholics Anonymous (AA) model, 
the mutual-support movement has grown to 
encompass a wide variety of addictions. AA and 
Narcotics Anonymous are two of the largest 
mutual-support organizations for SUDs; Dual 
Recovery Anonymous is most known for CODs. 
Personal responsibility, self-management, and 
helping one another are the basic tenets of mutual-
support approaches. Such programs apply a broad 
spectrum of personal responsibility and peer 
support principles. However, in the past, clients 
with CODs felt that either their mental or their 
substance use problems could not be addressed in 
a single-themed mutual-support program. That has 
changed. 
Mutual-support principles, highly valued in the 
SUD treatment feld, are now widely recognized 
as important components in the treatment of 
CODs. Mutual support can be used as an adjunct 
to primary treatment, as a continuing feature 
of treatment in the community, or both. These 
programs not only provide a vital means of support 
during outpatient treatment but also are commonly 
used in residential programs such as therapeutic 
communities (TCs). As clients gain employment, 
travel, or relocate, mutual support can become 
the most easily accessible means of providing 
continuity of care. For a more extensive discussion 
of dual recovery mutual-support programs 
applicable to people with CODs, including those 
structured around peer-recovery support services, 
see Chapter 7. 
Building Community 
The need to build an enduring community arises 
from three interrelated factors: the persistent 
nature of CODs, the recognized effectiveness of 
mutual-support principles, and the importance of 
client empowerment. The TC, modifed mutual 
programs for CODs (e.g., Double Trouble in 
Recovery), and the client consumer movement 
all refect an understanding of the critical role 
clients play in their own recovery, as well as the 
recognition that support from other clients with 
similar problems promotes and sustains change. 
Reintegration With Family and Community 
The client with CODs who successfully completes 
treatment must face the fragility of recovery, 
the potential toxicity of the past or current 
environment, and the negative impact of previous 
associates who might encourage substance use 
and illicit or maladaptive behaviors. Groups and 
activities that support change are needed. In 
this context, clients should receive support from 
family and signifcant others where that support is 
available or can be developed. Clients also need 
help reintegrating into the community through 
such resources as spiritual, recreational, and social 
organizations. 
Peer-Based Services 
Peer recovery support services typically refers 
to services provided by people with a lived 
experience with substance misuse, mental 
disorders, or both (or, in the case of family peer 
services, people who have a lived experience 
of having a loved one with substance misuse, 
mental disorders, or both). Peer recovery support 
specialists are nonclinical professionals who help 
individuals both initiate and maintain long-term 
recovery by offering support, education, and 
linkage to resources. Peers also serve as role 
models for successful recovery and healthy living. 
For more information on peer recovery support 
services for CODs and the potential role of peer 
recovery support specialists in promoting and 
maintaining recovery, see Chapter 7. 
Guidelines for Counselors and
Other Providers 
The general guiding principles described previ-
ously serve as the fundamental building blocks 
for effective treatment, but ensuring effective 
treatment requires counselors and other providers 
to attend to other variables. This section discusses 
six core components that form the ideal delivery 
of addiction counseling services for clients with 
CODs. These are: 
1. Providing access. 
2. Completing a full assessment. 
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3. Providing an appropriate level of care. 
4. Achieving integrated treatment. 
5. Providing comprehensive services. 
6. Ensuring continuity of care. 
Providing Access 
“Access” refers to the process by which a person 
with CODs makes initial contact with the service 
system, receives an initial evaluation, and is 
welcomed into services that are appropriate for his 
or her needs. There are four main types of access: 
1. Routine access for individuals seeking services 
who are not in crisis 
2. Crisis access for individuals requiring immediate 
services because of an emergency 
3. Outreach, in which agencies target individuals 
in great need (e.g., people experiencing 
homelessness) who are not seeking services or 
cannot access ordinary or crisis services 
4. Access that is involuntary, coerced, or mandated 
by the criminal justice system, employers, or the 
child welfare system 
Treatment access may be complicated by clients’
criminal justice involvement, homelessness, or
health status. A “no wrong door” policy should be
applied to the full range of clients with CODs, and
counselors (as well as programs) should address
obstacles that bar entry to treatment for those with
either a mental disorder or an SUD. (See Chapter 7
for recommendations on removing systemic barriers
to care and Exhibit 2.2 for more on the “no wrong
door” approach to behavioral health services.) 
Exhibit 2.2. Making “No Wrong Door” a Reality 
The consensus panel strongly endorses a “no wrong door” policy: effective systems must ensure that an 
individual needing treatment will be identifed and assessed and will receive treatment, either directly 
or through appropriate referral, no matter where he or she enters the realm of services (Center for 
Substance Abuse Treatment [CSAT], 2000a). 
The focus of the “no wrong door” imperative is on constructing the healthcare delivery system so 
that treatment access is available at any point of entry. A client with CODs needing treatment might 
enter the service system by means of a primary care facility, homeless shelter, social service agency, 
emergency room, or criminal justice setting. Some clients require creation of a “right door” to enter 
treatment. For example, mobile outreach teams can access clients with CODs who are otherwise 
unlikely to seek treatment on their own. 
The “no wrong door” approach has fve major implications for service planning: 
1. Assessment, referral, and treatment planning across settings is consistent with a “no wrong door” 
policy. 
2. Creative outreach strategies are available to encourage people to engage in treatment. 
3. Programs and staff can change expectations and program requirements to engage reluctant and 
“unmotivated” clients. 
4. Treatment plans are based on clients’ needs and respond to changes as they progress through 
stages of treatment. 
5. The overall system of care is seamless, providing continuity of care across service systems. This is 
only possible via established patterns of interagency cooperation or clear willingness to attain that 
cooperation. 
Source: CSAT (2000a). 
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Completing a Full Assessment 
Whereas Chapter 3 provides a complete de-
scription of the assessment process, this section 
highlights several important features of assessment 
that support effective service delivery. Assessment 
of individuals with CODs involves a combination of: 
• Screening to detect the presence of CODs 
in the setting where the client is frst seen for 
treatment. 
• Evaluating background factors (e.g., family 
history, trauma history, marital status, health, 
education, work history), mental disorders, 
SUDs, and related medical and psychosocial 
problems (e.g., living circumstances, 
employment) that are critical to address in 
treatment planning. 
• Diagnosing the type and severity of SUDs and 
mental disorders. 
• Initial matching of individual client to 
services. (Often, this must be done before a 
full assessment is completed and diagnoses 
clarifed. Also, the client’s motivation to change 
with regard to one or more of the CODs may 
not be well established.) 
• Appraising existing social and community 
support systems. 
• Conducting continuous evaluation (that is, 
reevaluating over time as needs and symptoms 
change and as more information becomes 
available). 
The challenge of assessment for individuals 
with CODs in any system involves maximizing 
the likelihood of the identifcation of CODs, 
immediately facilitating accurate treatment 
planning, and revising treatment over time as the 
client’s needs change. 
Providing an Appropriate Level of Care 
Clients enter the treatment system at various levels 
of need and encounter agencies with varying 
capacity to meet those needs. Ideally, clients 
should be placed in the level of care appropriate 
to the severity of both their SUD and their mental 
illness. 
The American Association of Community 
Psychiatry’s Level of Care Utilization System 
(LOCUS) is one standard way of identifying 
appropriate levels of care and service intensity. The 
LOCUS describes six levels of care sequentially 
increasing in intensity, based on the client’s 
individually assessed needs across six dimensions. 
Further, a treatment program’s ability to address 
CODs as “addiction-only services,” “dual diagnosis 
capable,” and “dual diagnosis enhanced” is 
another useful perspective in care determination 
and decision making (Chapter 3 discusses 
frameworks to help with treatment placement). 
Severity and Levels of Care 
Models are available to help counselors make 
treatment and referral decisions based on the 
severity and impact of each disorder. For instance, 
the quadrants of care (also called the Four 
Quadrants Model) is a conceptual framework that 
classifes clients in four basic groups based on 
relative symptom severity, not diagnosis (Exhibit 
2.3). The quadrants of care were derived from 
a conference, the National Dialogue on Co-
Occurring Mental Health and Substance Abuse 
Disorders, which was supported by SAMHSA 
and two of its centers—CSAT and the Center for 
Mental Health Services—and co-sponsored by 
the National Association of State Mental Health 
Program Directors and the National Association 
of State Alcohol and Drug Abuse Directors. The 
quadrants of care is a model originally developed 
by Ries (1993). 
EXHIBIT 2.3. The Four Quadrants Model 
III—Less severe mental disorder/more severe SUD IV—More severe mental disorder/more severe SUD 
I—Less severe mental disorder/less severe SUD II—More severe mental disorder/less severe SUD 
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Chapter 3 offers more detail about the four 
quadrants and their use in comprehensive 
assessment. 
Achieving Integrated Treatment 
The seminal concept of integrated treatment for 
people with severe mental disorders and SUDs, 
as articulated by Minkoff (1989), emphasized the 
need for correlation between the treatment models 
for mental health services and SUD treatment in 
a residential setting. Minkoff’s model stressed the 
importance of well-coordinated, stage-specifc 
treatment (i.e., engagement, primary treatment, 
continuing care) of SUDs and mental disorders, 
with emphasis on dual recovery goals as well as 
the use of effective treatment strategies from the 
mental health and SUD treatment felds. 
During the last decade, integrated treatment 
continued to evolve. Several models have shown 
success in community addiction treatment and 
mental health service programs (Chow, Wieman, 
Cichocki, Qvicklund, & Hiersteiner, 2013; Kelly & 
Daley, 2013; McGovern et al., 2014), including 
programs in which COD services were combined 
with supportive housing services (Pringle, Grasso, 
& Lederer, 2017); programs serving people in 
the criminal justice system (Peters, Young, Rojas, 
& Gorey, 2017); programs in outpatient and 
residential settings (Hunt, Siegfried, Morley, 
Sitharthan, & Cleary, 2014; Morse & Bride, 2017); 
TCs (Dye, Roman, Knudsen, & Johnson, 2012); and 
opioid treatment programs (Brooner et al., 2013; 
Kidorf et al., 2013). 
The literature from the addiction and mental health 
felds has evolved to describe integrated treatment 
as a unifed treatment approach to meet clients’ 
addiction, mental disorder, and related needs 
(Exhibit 2.4). It is the preferred model of treatment. 
Chapter 7 further discusses integrated treatment 
models. 
Exhibit 2.4. SAMHSA Practice 
Principles of Integrated 
Treatment for CODs 
• Mental illness and SUDs are both treated 
concurrently to meet the full range of clients’ 
symptoms equally. 
• Providers of integrated care receive training 
in the treatment of both SUDs and mental 
disorders. 
• CODs are treated with a stage-wise approach 
that is tailored to the client’s stage of readiness 
for treatment (e.g., engagement, persuasion, 
active treatment, relapse prevention). 
• Motivational techniques (e.g., motivational 
interviewing [MI], motivational counseling) are 
integrated into care to help clients reach their 
goals—and particularly at the engagement 
stage of treatment. 
• Addiction counseling is used to help clients 
develop healthier, more adaptive thoughts and 
behaviors in support of long-term recovery. 
• Clients are offered multiple treatment formats, 
including individual, group, family, and peer 
support, as they move through the various 
stages of treatment. 
• Pharmacotherapy is discussed in 
multidisciplinary teams, offered to clients as 
appropriate, and monitored for safety (e.g., 
interactions), adherence, and response. 
Source: SAMHSA (2009a). 
Providing Comprehensive Services 
People with CODs have a range of medical and 
social problems—multidimensional problems 
that require comprehensive services. In addition 
to treatment for SUDs and mental disorders, 
these clients often require various other services 
to address social problems and stabilize living 
conditions. Treatment providers should prepare 
to help clients access an array of services, 
including life skills development, English as 
a second language, parenting, nutrition, and 
employment assistance. Two areas of particular 
value are housing and work. (See Chapter 6 for a 
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discussion about people with CODs experiencing
homelessness and Chapter 7 for further information
about vocational services as a part of treatment.) 
Ensuring Continuity of Care 
Continuity of care implies coordination of care as
clients move across different service systems (Puntis,
Rugkåsa, Forrest, Mitchell, & Burns, 2015; Weaver,
Coffey, & Hewitt, 2017). Both SUDs and mental
disorders frequently are long-term conditions, so
treatment for people with CODs should take into
consideration rehabilitation and recovery over a
signifcant period of time. Therefore, to be effective,
treatment must address the three features that
characterize continuity of care: 
• Consistency between primary treatment and 
ancillary services 
• Seamlessness as clients move across levels of care
(e.g., from residential to outpatient treatment) 
• Coordination of present and past treatment
episodes (i.e., making sure you are aware of
previous treatments given, how the client
responded, and the client’s treatment preferences) 
It is important to set up systems that prevent gaps
between service system levels and between clinic-
based services and those outside the clinic. The ideal
is to include outreach, employment, housing, health
care and medication, fnancial supports, recreational
activities, and social networks in a comprehensive and
integrated service delivery system. 
Continuity of Care and Outpatient Treatment 
Settings 
Continuing care and relapse prevention are 
especially important with this population given 
that mental disorders are often cyclical, recurring 
illnesses and substance misuse is likewise a 
chronic condition subject to periods of relapse 
and remission. Clients with CODs often require 
long-term continuity of care that supports their 
progress, monitors their condition, and can 
respond to a return to substance use or a return 
of symptoms of mental disorder. Continuing care 
is both a process of posttreatment monitoring and 
a form of treatment itself. (In the present context, 
the term “continuing care” is used to describe the 
treatment options available to a client after leaving 
one program for another, less intense, program.) 
The relative seriousness of a client’s mental disorders
and SUDs may be very different at the time he
or she leaves a primary treatment provider; thus,
different levels of intervention will be appropriate.
After leaving an outpatient program, some clients
with CODs may need to continue intensive mental
health services but can manage their SUD through
mutual-support group participation. Others may need
minimal mental health services but require continued
formal SUD treatment. For people with serious
mental illness (SMI), continued treatment often is
warranted. A treatment program can provide these
clients with structure and varied services not usually
available from mutual support-groups. 
Encourage clients with CODs who leave a program 
to return if they need assistance with either 
disorder. The status of these individuals can be 
fragile; they need quick access to help in times of 
crisis. Regular informal check-ins with clients also 
can help alleviate potential problems before they 
become serious enough to threaten recovery. A 
good continuing care plan will include steps for 
when and how to reconnect with services. The 
plan and provision of these services also makes 
readmission easier for clients with CODs who need 
to come back. Clients with CODs should maintain 
contact postdischarge (even if only by telephone 
or informal gatherings). Increasingly, addiction 
programs are using follow-up contacts and periodic 
group meetings to monitor client progress and 
assess the need for further service. 
Continuity of Care and Residential Treatment 
Settings 
Returning to life in the community after residential 
placement is a major undertaking for clients with 
CODs, with relapse an ever-present risk. The goals 
of continuing care programming are: 
• Sustaining abstinence. 
• Continuing recovery. 
• Mastering community living. 
• Developing vocational skills. 
• Obtaining gainful employment. 
• Deepening psychological understanding. 
• Assuming increasing responsibility. 
• Resolving family diffculties. 
• Consolidating changes in values and identity. 
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The key services are life skills education, relapse 
prevention, mutual-support programs, case 
management (especially for housing), and 
vocational training and employment. 
Empirical Evidence Related to Continuity of 
Care 
A systematic review (McCallum, Mikocka-Walus, 
Turnbull, & Andrews, 2015) investigating the effects 
of continuity of care on treatment outcomes for 
people with CODs showed mixed results. Putting 
in place continuity of care has generally involved 
linking clients from one level of care to another 
and providing multidimensional services. Positive 
associations reported by some studies included 
better treatment commitment, reduced violent 
behavior, improved service satisfaction, better 
generic and disease-specifc quality of life, and 
enhanced community functioning. However, there 
was no consistent evidence that continuity of care 
was associated with abstinence. 
The belief that continuous care benefts people 
with CODs is also informed by positive research 
fndings on continuity of care for addiction 
populations and SMI populations separately. A 
meta-analysis of studies exploring continuing care 
among people with substance misuse found a small 
but positive effect on substance-related outcomes 
(Blodgett, Maisel, Fuh, Wilbourne, & Finney, 
2014). Continuity of care following residential 
detoxifcation is associated with decreased rates 
of readmission for detoxifcation (Lee et al., 2014). 
More recently, a continuing care intervention for 
people in the frst year of SUD recovery (McKay, 
Knepper, Deneke, O’Reilly, & DuPont, 2016) 
found a 70-percent adherence rate over 1 year 
for providing urine samples and a mere 4-percent 
positive urine sample rate (for drugs or alcohol). 
A review of international studies examining 
continuity of care and patient outcomes in mental 
health found wide variability in the research 
methodology and outcomes (Puntis et al., 2015). In 
studies conducted in the United States, continuity 
of care (in some but not all of the U.S. studies) 
was associated with reduced psychiatric symptom 
severity, lower risk of rehospitalization, improved 
functioning, reduced Medicaid expenditures, and 
fewer violent behaviors. 
Guidelines for Administrators and
Supervisors 
This section focuses on some key matters ad-
ministrators and supervisors face in developing a 
workforce able to meet the needs of clients with 
CODs. Guidelines to address these core topics 
include: 
1. Identifying and providing to counselors the 
essential competencies (basic, intermediate, and 
advanced), values, and attitudes to be successful 
in COD service delivery. 
2. Offering opportunities for professional 
development, including staff training and 
education. 
3. Using effective burnout and turnover reduction 
techniques, as these are common problems for 
any SUD treatment provider, but particularly so 
for those who work with clients who have CODs. 
Critical challenges face SUD treatment systems and 
programs that aim to improve care for clients with 
CODs. This section addresses these challenges by 
discussing how supervisors and administrators can 
foster more effective COD programming, such as: 
1. Integrating research and practice into 
programming. 
2. Establishing essential services for people with 
CODs. 
3. Assessing agency potential to serve clients 
with CODs via adequate and responsive 
programming. 
This section only briefy addresses guidelines for 
administrators and supervisors. More detailed 
discussions about workforce improvement and 
administrative matters, including descriptions of 
provider competencies, supervision, staff training, 
hiring, turnover, and retention, are in Chapter 8. 
Providers’ Competencies 
Provider competencies are measurable skills and 
specifc attitudes and values counselors should 
learn and develop. Attitudes and values guide 
how providers meet client needs and affect overall 
treatment climate. They are particularly important 
in working with clients who have CODs because 
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the counselor is confronted with two disorders that 
require complex interventions. Essential values 
and attitudes that inform effective care for clients 
with CODs include a desire and willingness to 
work with populations with CODs, an appreciation 
for the complexity of CODs, and an awareness of 
one’s own personal feelings about and reactions to 
working with people who have CODs. These are 
discussed primarily in Chapter 8. 
Basic competencies are rudimentary, introductory 
skills all counselors should possess, such as: 
• Performing a basic screening and assessment 
to determine whether CODs might exist and, if 
needed, referring for more thorough and formal 
diagnostic testing. 
• Conducting a preliminary screening to 
determine whether a client poses an immediate 
danger to self or others and coordinating any 
subsequent assessment with appropriate staff or 
consultants. 
• Referring a client to the appropriate mental 
health services or SUD treatment and following 
up to ensure that the client receives needed 
care. 
• Coordinating care with a mental health 
counselor serving the same client to ensure 
that the interaction of the client’s disorders is 
well understood and that treatment plans are 
coordinated. 
Intermediate competencies encompass skills 
such as: 
• Performing more indepth screening. 
• Treatment planning. 
• Discharge planning. 
• Linking clients to other mental health system 
services. 
Advanced competencies go beyond an awareness 
of the addiction and mental health felds as individ-
ual disciplines to a more sophisticated appreciation 
for how CODs interact in an individual. This can 
include: 
• Understanding the effects of level of functioning 
and degree of disability related to both 
substance-related and mental disorders, 
separately and combined. 
• Using integrated models of assessment, 
intervention, and recovery for people with both 
substance-related and mental disorders, as 
opposed to parallel treatment efforts that resist 
integration. 
• Collaboratively developing and implementing 
an integrated treatment plan based on thorough 
assessment that addresses both/all disorders 
and establishes sequenced goals based on 
urgent needs, considering the stage of recovery 
and level of engagement. 
• Involving the person, family members, and 
other supports and service providers (including 
peer supports and those in the natural support 
system) in establishing, monitoring, and refning 
the treatment plan. 
Continuing Professional Development 
Given the complexity of CODs and lagging 
treatment rates, there is a pressing need for 
professionals to develop the necessary skills 
to accurately identify and manage these 
conditions. This TIP makes an effort to integrate 
available information on continuing professional 
development. Counselors reading this TIP can 
review their own knowledge and determine 
what they need to continue their professional 
development. More information can also be found 
in Chapter 8. 
Education and Training 
Education and training are critical to ensuring 
professional development and competency of 
providers and should take place throughout the 
continuum of one’s formal education and career. 
Various forms of education and training are central 
to evidence-based, high-quality care for people 
with CODs: 
• Staff education and training are fundamental 
to all SUD treatment programs. Few university-
based programs offer a formal curriculum on 
CODs, although the past decade has seen some 
improvement. 
• Many SUD treatment counselors learn through 
continuing education and facility-sponsored 
training. Continuing education is useful 
because it can respond rapidly to the needs 
of a workforce that has diverse educational 
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backgrounds and experience. To have practical 
utility, competency training must address the day-
to-day concerns that counselors face in working 
with clients who have CODs. The educational 
context must be rich with information, culturally 
sensitive, and designed for adult students, and 
must include examples and role models. Ideally, 
the instructors will have extensive experience as 
practitioners in the feld. Continuing education is 
also essential for effective provision of services to 
people with CODs, but it is not suffcient in and 
of itself. Counselors must have ongoing support, 
supervision, and opportunity to practice new 
skills if they are to truly integrate COD content 
into their practice. 
• Cross-training is simultaneous provision of 
material and training in more than one discipline 
(e.g., addiction and social work counselors, 
addiction counselors and corrections offcers). 
Counselors with primary expertise in either 
addiction or mental health can work far more 
effectively with clients who have CODs if they 
have some cross-training in the other feld. The 
consensus panel suggests that counselors of 
either feld receive at least basic level cross-
training in the other feld to better assess, refer, 
understand, and work effectively with the large 
number of clients with CODs. 
Program Orientation and Ongoing 
Supervision 
Staff education and training have two additional 
components: (1) program orientation that clearly 
presents the mission, values, and aims of service 
delivery; and (2) strong, ongoing supervision. The 
orientation can use evidence-based initiatives as 
well as promising practices. Successful program 
orientation for working with clients who have CODs 
will equip staff members with skills and decision-
making tools that will enable them to provide 
optimal services in real-world environments. 
Skills best learned through direct supervision and 
modeling include active listening, interviewing 
techniques, the ability to summarize, and the 
capacity to provide feedback. Strong, active 
supervision of ongoing cases is a key element in 
assisting staff to develop, maintain, and enhance 
relational skills. 
Avoiding Burnout and Reducing Staf 
Turnover 
Burnout 
Assisting clients who have CODs is diffcult and 
emotionally taxing; the danger of burnout is 
considerable. Among mental health and SUD 
clinicians, the effects of working with clients with 
trauma can lead to compassion fatigue, vicarious 
traumatization, or secondary traumatic stress 
(Huggard, Law, & Newcombe, 2017; Newell, 
Nelson-Gardell, & MacNeil, 2016). If untreated, 
these can have profound negative effects on a 
clinician’s ability to function at work effectively, care 
for clients, and care for oneself (Baum, 2016). 
Program administrators must stay aware of burnout 
and the benefts of reducing turnover. In order for 
staff to sustain their morale and esprit de corps, 
they need to feel that program administrators are 
interested in their well-being. Most important, 
supervision should be supportive, providing 
guidance and technical knowledge. Programs can 
proactively address burnout by placing high value 
on staff well-being; routinely discussing well-being; 
providing activities such as retreats, weekend 
activities, yoga, and other healing activities at 
the worksite; and creating a network of ongoing 
support. 
Turnover 
The issue of staff turnover is especially important 
for staff working with clients who have CODs 
because of the limited workforce pool and the high 
investment of time and effort involved in develop-
ing a trained workforce. Rapid turnover disrupts 
the context in which recovery occurs. Clients in 
such agencies may become discouraged about 
the possibility of being helped by others. Ways to 
reduce staff turnover in programs for clients with 
CODs can include: 
• Hiring staff members familiar with both SUD and 
mental disorders who have a positive regard for 
clients with either or both disorders. 
• Ensuring that staff have realistic expectations for 
the progress of clients with CODs. 
• Ensuring that supervisory staff members are 
supportive and knowledgeable about problems 
and concerns specifc to clients with CODs. 
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• Providing and supporting opportunities for 
further education and training. 
• Offering a desirable work environment through: 
Adequate compensation. 
Salary incentives for COD expertise. 
Opportunities for training and for career 
advancement. 
Involvement in quality improvement or clinical 
research activities. 
Efforts to adjust workloads. 
Integrating Research and Practice 
To be effective, resources must be used to
implement the evidence-based practices most
appropriate to the client population and the
program needs. The importance of the transfer of
knowledge and technology has come to be well
understood. Conferences to explore “bridging the
gap” between research and feld practice are now
common. Although not specifc to CODs, these
efforts have clear implications for our attempts
to share knowledge of what is working for clients
with CODs. For instance, since 2007, the National
Institutes of Health has cosponsored the Annual
Conference on the Science of Dissemination and
Implementation in Health, designed to foster better
integration of healthcare research into practice
and policy. CODs have been an underrepresented
topic at these gatherings, but presentations on
implementation studies in addiction and in mental
health, separately, likely will still be informative for
enhancing the use and measurement of research-
based practices for CODs.
In the SUD treatment feld, implementation 
research has accelerated in response to evidence 
suggesting that the uptake of empirical fndings 
into actual practice is lagging (McGovern, 
Saunders, & Kim, 2013). This lag has persisted 
despite the availability of research supporting 
the effcacy and effectiveness of SUD treatment, 
including pharmacotherapies and psychosocial 
interventions. In mental health, signifcant efforts 
over the previous two decades have led to 
increased utilization of evidence-based practices 
and program evaluation strategies to monitor 
fdelity and outcomes (Stirman, Gutner, Langdon, 
& Graham, 2016). But more research–practice 
partnerships in mental health are needed, 
because many clients still cannot access or do 
not receive evidence-based care. Similarly, within 
COD treatment settings, more work is needed to 
provide research-based services that are feasible, 
acceptable, effective, and sustainable. SAMHSA 
(2009a) developed an evidence-based practice 
toolkit to help SUD and mental disorder treatment 
programs incorporate empirically supported 
policies and practices into their organizations, 
with the aim of giving clients the best chances at 
achieving long-term abstinence by translating COD 
knowledge into practice. 
Establishing Essential Services for People 
With CODs 
Individuals with CODs are found in all SUD 
treatment settings, at every level of care. Although 
some of these individuals have SMI or disabilities, 
many have disorders of mild to moderate severity. 
As SUD treatment programs serve the increasing 
number of clients with CODs, the essential 
program elements required to meet their needs 
must be defned clearly and set in place. 
ADVICE TO ADMINISTRATORS: RECOMMENDATIONS FOR PROVIDING 
ESSENTIAL SERVICES FOR PEOPLE WITH CODs 
Develop a COD program with these components: 5. Relapse prevention 
6. Case management 1. Screening, assessment, and referral for people 
with CODs 7. COD-specifc treatment components 
2. Physical and mental health consultation 8. Continuing care services 
3. Prescribing onsite psychiatrist 9. Double Trouble groups (onsite) 
4. Psychoeducational classes 10. Dual recovery mutual-help groups (offsite) 
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Program components described in this section 
should inform any SUD treatment program seeking 
to provide integrated addiction and mental health 
services to clients with CODs. These elements 
refect a variety of strategies, approaches, and 
models that the consensus panel discussed and 
that often appear in current clinical programming. 
The consensus panel believes these elements 
constitute the best practices for designing COD 
programs in SUD treatment agencies. What follows 
are program considerations for implementing these 
essential components. Information about designing 
residential and outpatient treatment services can 
be found in Chapter 7. 
Screening, Assessment, and Referral for 
People With CODs 
All SUD treatment programs should have 
appropriate procedures for screening, assessing, 
and referring clients with CODs. Each provider 
must be able to identify clients with both mental 
disorders and SUDs and ensure their access to 
the care needed for each disorder. For a detailed 
discussion, see Chapter 3. 
If the screening and assessment process establishes 
an SUD or mental disorder beyond the capacity 
and resources of the agency, referral should be 
made to a suitable residential or mental health 
facility, or other community resource. Mechanisms 
for ongoing consultation and collaboration are 
needed to ensure that the referral is suitable to the 
treatment needs of people with CODs. 
Physical and Mental Health Consultation 
Any SUD treatment program that serves a 
signifcant number of clients with CODs would do 
well to expand standard staffng to include mental 
health specialists and to incorporate consultation 
(for assessment, diagnosis, and medication) into 
treatment services. 
Adding a master’s level clinical specialist with 
strong diagnostic skills and expertise in working 
with clients who have CODs can strengthen an 
agency’s ability to provide services for these 
clients. These staff members could function as 
consultants to the rest of the team on matters 
related to mental disorders, in addition to being 
the liaison for a mental health consultant and 
provision of direct services. 
A psychiatrist provides services crucial to 
sustaining recovery and stable functioning for 
people with CODs: assessment, diagnosis, 
periodic reassessment, medication, and rapid 
response to crises. If lack of funding prevents the 
SUD treatment agency from hiring a consultant 
psychiatrist, the agency could establish a 
collaborative relationship with a mental health 
agency to provide those services. A memorandum 
of agreement formalizes this arrangement and 
ensures the availability of a comprehensive service 
package for clients with CODs. 
Prescribing Onsite Psychiatrist 
An onsite psychiatrist brings diagnostic, 
prescribing, and mental health counseling services 
directly to the location at which clients receive 
most of their treatment. An onsite psychiatrist 
can reduce barriers presented by offsite referral, 
including distance and travel limitations, the 
inconvenience of enrolling in another agency, 
separation of clinical services (more “red tape”), 
fears of being seen as “mentally ill” (if referred to a 
mental health agency), cost, and diffculty getting 
comfortable with different staff. 
The consensus panel is aware that the cost of an 
onsite psychiatrist is a concern for many programs. 
Many agencies that use the onsite psychiatrist 
model fnd that they can afford to hire a psychiatrist 
part time, even 4 to 16 hours per week, and that 
a signifcant number of clients can be seen that 
way. A certain amount of that cost can be billed 
to Medicaid, Medicare, insurance agencies, or 
other funders. For larger agencies, the psychiatrist 
may be full time or share a full-time position with 
a nurse practitioner. The psychiatrist can also be 
employed concurrently by the local mental health 
program, an arrangement that helps to facilitate 
access to other mental health services such as 
intensive outpatient treatment, psychosocial 
programs, and even inpatient psychiatric care if 
needed. 
Ideally, SUD treatment agencies should hire a 
psychiatrist with SUD treatment expertise to work 
onsite. Finding psychiatrists with this background 
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may present a challenge. Psychiatrists certifed by 
the American Society of Addiction Medicine or the 
American Osteopathic Association (for osteopathic 
physicians) can provide leadership, advocacy, 
development, and consultation for SUD treatment 
staff. 
Medication and Medication Monitoring 
Many clients with CODs require medication 
to control their psychiatric symptoms and to 
stabilize their mental status. The importance 
of stabilizing clients with CODs on psychiatric 
medication when indicated is now well established 
in the SUD treatment feld. (Chapter 7 covers in 
more depth the role of medication in treating 
CODs.) One important role of psychiatrists in 
SUD treatment settings is to provide medication 
based on the assessment and diagnosis of the 
client, with subsequent regular contact and review 
of medication. These activities include careful 
monitoring and review of medication adherence. 
Psychoeducational Classes 
Psychoeducational classes on mental disorders 
and SUDs are important elements in basic COD 
programs. These classes typically focus on the signs 
and symptoms of mental disorders, medication, 
and the effects of mental disorders on substance 
misuse. Psychoeducational classes of this kind 
increase client awareness of their specifc problems 
and do so in a safe and positive context. Most 
important, however, is that education about mental 
disorders be open and generally available within 
SUD treatment programs. Information should be 
presented in a factual manner. Some mental health 
clinics have prepared synopses of mental illnesses 
for clients in terms that are factual but unlikely to 
cause distress. A range of literature written for the 
layperson is also available through government 
agencies and advocacy groups (see Appendix 
B). This material provides useful background 
information for the SUD treatment counselor as 
well as for the client. 
Relapse Prevention 
Programs can adopt strategies to help clients 
become aware of cues or “triggers” that make 
them more likely to misuse substances and help 
them develop alternative coping responses to 
those cues. Some providers use “mood logs” to 
increase clients’ awareness of situational factors 
that underlie urges to use substances. These logs 
help answer the question, “When I have an urge to 
drink or use, what is happening?” Basic treatment 
programs can train clients to recognize cues for 
the return of psychiatric symptoms, to manage 
emotions, and to identify, contain, and express 
feelings appropriately. (For more information about 
relapse prevention and COD services, turn to 
Chapter 5.) 
Case Management 
CODs are complex conditions that affect many 
areas of a person’s life, including his or her 
physical and emotional functioning, vocation/ 
education, social and family relationships, and 
daily functioning. Case management is needed 
to ensure that clients receive a continuum of 
support services at the intensity and level needed 
to meet their service needs and readiness for 
change. Administrators should ensure that 
staff case managers are service providers and
advocates for the specifc needs of clients with 
CODs. Additionally, programs should offer case 
management that facilitates client transitions from 
one level of care to the next and that is responsive 
to all recovery-related needs. 
COD-Specifc Treatment Components 
People with CODs face unique challenges compared
with individuals who have only a mental illness or
an SUD. For instance, their risk of homelessness,
incarceration, and recovery relapse are particularly
high. Further, symptoms of one condition can
exacerbate the other (especially if untreated), and
treatment components should comprehensively
address all diagnoses and symptoms. Administrators
should ensure that program elements speak directly
to CODs by hiring staff with COD training and
experience and implementing programs adapted
to the particular needs of COD populations.
(See Chapter 7 for guidance on adapting various
treatment models for CODs.) 
Continuing Care Services 
Long-term follow-up is critical to recovery. SUDs 
and mental illness are chronic diseases, and clients 
will likely face struggles (including relapse) long 
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after they leave treatment. Programs have many 
options for providing continuing care, including 
mutual support and peer recovery support 
programs, relapse prevention groups, ongoing 
individual or group counseling, and mental health 
services (e.g., medication checks). For inpatient 
settings, long-term follow-up should be discussed 
collaboratively as part of clients’ discharge plan so 
clients are fully aware of the supports and services 
in place to help them succeed. (Also see the 
section “Ensuring Continuity of Care.”) 
Dual Recovery Mutual-Support Groups 
(Ofsite) 
Double Trouble Groups (Onsite) 
Onsite groups such as Double Trouble in Recovery 
provide a forum for discussing the interrelated 
problems of mental disorders and SUDs, helping 
participants to identify triggers for relapse. Clients 
describe their psychiatric symptoms (e.g., hearing 
voices) and their urges to use drugs. They are 
encouraged to discuss, rather than to act on, these 
impulses. Double Trouble groups can also be used 
to monitor medication adherence, psychiatric 
symptoms, substance use, and adherence to 
scheduled activities. Double Trouble provides a 
constant framework for assessment, analysis, and 
planning. Through participation, the individual with 
CODs develops perspective on the interrelated 
nature of mental disorders and SUDs and becomes 
better able to view his or her behavior within this 
framework. 
Various dual recovery mutual-support groups exist 
in many communities. SUD treatment programs 
can refer clients to dual recovery mutual-support 
groups tailored to the special needs of people 
with CODs. These groups provide a safe forum for 
discussion about medication, mental health, and 
substance misuse problems in an understanding, 
supportive environment where coping skills can be 
shared. Chapter 7 contains a more comprehensive 
description of this approach. 
Assessing the Agency’s Capacity To Serve 
Clients With CODs 
Every agency that already is treating or planning to 
treat clients with CODs should assess the current 
profle of its clients, as well as the estimated 
number and type of potential new clients in 
the community. It must also consider its current 
capabilities, its resources and limitations, and 
the services it wants to provide in the future. 
Organizational tasks to determine service capacity 
include: 
• Conducting a needs assessment to determine 
the prevalence of CODs in the client population, 
the demographics of those clients, and the 
nature of the disorders and accompanying 
problems they present. Data gathered can be 
used to support grant proposals for increasing 
service capacity. 
12-STEP FACILITATION AND CODs 
12-Step facilitation (TSF) is a treatment engagement strategy designed to move clients toward 
participation in mutual support as a part of their plan for achieving and sustaining long-term recovery. 
Less research has been conducted on TSF for COD populations than for SUD-only populations, but early 
fndings suggest that it may be helpful in teaching clients with CODs about their illnesses and about the 
benefts of mutual-support program participation (Hagler et al., 2015). 
In one randomized, controlled trial (Bogenschutz et al., 2014b), people with alcohol use disorder and SMI 
were exposed to 12 weeks of TSF adapted for CODs. Compared with treatment as usual, those in the TSF 
condition were more than twice as likely to participate in 12-Step groups (65.8 percent vs. 29.4 percent) 
and, on average, attended more meetings. Although there were no differences in substance use between 
the two conditions, 12-Step participation was a signifcant predictor of future proportion of days abstinent 
and drinking intensity (i.e., number of drinks per drinking day). 
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• Determining what changes need to be made in 
staff, training, accreditation, and other factors to 
provide effective services for clients with CODs. 
• Assessing community capacity to understand 
what resources and services are already 
available within their local and state systems of 
care before deciding what services to provide. 
• Identifying missing levels of care/gaps in 
services to help programs better respond to 
client needs. 
SAMHSA’s Dual Diagnosis Capability in Addiction 
Treatment (DDCAT) Toolkit (SAMHSA, 2011b) helps 
SUD treatment systems and programs assess and 
enhance their capacity to effectively serve clients 
with CODs. The toolkit features an assessment 
measure (the DDCAT Index) that provides 
feedback on numerous program elements critical 
to implementation and maintenance of competent 
service delivery for CODs. To clarify the guiding 
principles and approaches that optimize COD 
programming success, these elements are further 
classifed into seven dimensions: 
1. A structure that offers unrestricted, integrated, 
collaborative services to clients with CODs 
2. A culture that is welcoming to clients with 
CODs and readily offers education about CODs 
3. Use of routine screening, assessment, and 
diagnosis (or referral to diagnosis, if needed) for 
clients with CODs that takes into account each 
client’s severity and persistence of symptoms 
4. A clinical process that includes stage-wise 
treatment planning; ongoing assessment 
and monitoring of symptoms of both 
disorders throughout the course of care; 
and numerous approaches to interventions, 
such as pharmacotherapy management, 
psychoeducation and support (for the client 
and for family), specialized interventions in 
behavioral health, and peer-based services 
5. Provision of continuous care through 
collaborative approaches, recovery maintenance 
strategies, and follow-up services (including 
community-based and peer-based services) 
6. Attention to staffng needs, such as including 
prescribers; ensuring that clinicians possess 
required licensure, competency, and experience; 
and implementing supervision or other 
professional consultation processes (like case 
reviews or other formal approaches to staff 
monitoring and support) to ensure ethical, 
evidence-based care 
7. Staff training on CODs, including training 
that imparts basic skills and knowledge 
(e.g., screening and assessment, symptoms, 
prevalence rates) as well as advanced training 
(e.g., specifc interventions, including basic 
understanding of pharmacotherapies) 
Trauma-informed care should be the standard 
among all programs providing COD services. 
Trauma is exceedingly common among 
people with co-occurring mental disorders 
and SUDs and, if untreated, can make recovery 
very challenging. For more information 
about integrating trauma-informed services, 
like assessments and treatments, into COD 
programming, see TIP 57, Trauma-Informed 
Care in Behavioral Health Services, as well as 
Chapters 3 and 6 of this TIP. 
The consensus panel suggests the following 
classifcation system: basic, intermediate, advanced 
or fully integrated. As conceived by the consensus 
panel: 
• A basic program has the capacity to provide 
treatment for one disorder but also screens for 
the other disorder and can access necessary 
consultations. 
• A program with an intermediate level of 
capacity tends to focus primarily on one 
disorder without substantial modifcation to its 
usual treatment, but also explicitly addresses 
some specifc needs related to the other 
disorder. For example, an SUD treatment 
program may recognize the importance of 
continued use of psychiatric medications in 
recovery, or a psychiatrist could provide MI 
regarding substance use while prescribing 
medication for mental disorders. 
• A program with advanced capacity provides 
integrated SUD treatment and mental health 
services for clients with CODs. Chapter 7 
Chapter 2 28 
TIP 42
 •
Chapter 2—Guiding Principles for Working With People Who Have CODs 
EXHIBIT 2.5. Levels of Program Capacity in CODs 
More Treatment for More Treatment 
Mental Disorders for SUDs 
Fully Integrated 
COD 
Integrated 
Advanced 
COD 
Enhanced 
Advanced 
COD 
Enhanced 
Intermediate 
COD 
Basic 
Capable 
Mental 
Disorder Only 
Treatment 
Basic 
Addiction 
Intermediate 
Only 
Treatment 
Capable 
COD 
Level of Program Capacity Mental Disorder Treatment 
in CODs for SUD Treatment Providers 
Providers 
describes several such program models. These 
programs address CODs from an integrated 
perspective and provide services for both 
disorders. For some programs, this means 
strengthening SUD treatment in the mental 
health services setting by adding interventions 
that target specifc COD symptoms or 
disorders and relapse prevention strategies 
that intertwine identifcation of cues, warning 
signs, and coping skills for both disorders. For 
other programs, it means adding mental health 
services, such as psychoeducational classes 
on mental disorder symptoms and groups 
for medication monitoring, in SUD treatment 
settings. Collaboration with other agencies can 
aid comprehensiveness of services. 
A fully integrated program actively combines 
SUD and mental illness interventions to treat 
disorders, related problems, and the whole 
person more effectively. 
The suggested classifcation has several 
advantages. For one, it avoids use of the term 
“dual diagnosis” and allows a more general, 
fexible approach to describing capacity without 
specifc criteria. In addition, the classifcation 
system refects a bidirectionality of movement 
wherein either addiction or mental health agencies 
can advance toward more integrated care for 
clients with CODs, as shown in Exhibit 2.5. 
Conclusion 
Co-occurring mental disorders and SUDs are 
complex. They present signifcant clinical, 
functional, social, and economic challenges 
for people living with them as well as for the 
counselors, administrators, supervisors, and 
programs who treat them. To help address the 
full range of symptoms clients experience and 
optimize outcomes, providers and programs must 
understand the components of comprehensive, 
high-quality care for CODs and have plans in place 
to implement core strategies, skills, and services. 
By using treatment frameworks, philosophies, 
and approaches empirically shown to net the best 
outcomes for people living with CODs, the SUD 
treatment and mental health service felds can 
close gaps in access and treatment so that people 
with CODs can live healthier, more functional lives. 
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KEY MESSAGES 
• Screening and assessment are central to 
identifying and treating clients with co-
occurring disorders (CODs) in a manner that 
is timely, effective, and tailored to all of their 
needs. The assessment process helps fulfll 
a critical need, as most people with CODs 
receive either treatment for only one disorder 
or no treatment at all. 
• Most counseling professionals can initiate the 
screening process. Understanding why, whom, 
and when to screen and which validated tools 
to use are the keys to success. 
• The assessment process is a multifactor, 
biopsychosocial approach to determining 
which symptoms and diagnoses might be 
present and how to tailor decisions about 
treatment and follow-up care based on 
assessment results. 
• The 12 steps of assessment are designed to 
foster a thorough investigation of pertinent 
biopsychosocial factors contributing to, 
exacerbating, and mitigating the client’s 
current symptomatology and functional 
status. At its core is the client’s chronological 
history of past symptoms of substance use 
disorders (SUDs) or mental illness, as well 
as diagnosis, treatment, and impairment 
related to these issues. Counselors should get 
a detailed description of current strengths, 
supports, limitations, skill defcits, and cultural 
barriers. Identifcation of a client’s stage of 
change and readiness to engage in services 
will inform treatment planning and optimize 
adherence and outcomes. 
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A serious treatment gap exists between the mental 
disorder and SUD needs of people with CODs 
and the number of people who actually receive 
services. According to the 2018 National Survey 
on Drug Use and Health, of the 9.2 million U.S. 
adults ages 18 and older who had CODs in the 
past year, more than 90 percent did not receive 
treatment for both disorders, and approximately 
50 percent received no treatment at all (Center 
for Behavioral Health Statistics and Quality, 2019). 
Underlying these statistics is the failure of addiction 
and mental health professionals to adequately 
recognize CODs. 
Screening and assessment are critical components 
of establishing diagnosis and getting people on the 
right path to treatment or other needed services. 
This chapter, whose audiences are counselors, 
other treatment/service providers, supervisors, and 
administrators, offers guidance to help addiction 
counselors understand the purpose and process for 
effective screening and assessment of clients for 
possible CODs. It has three parts: 
1. An overview of the basic screening and 
assessment approach that should be a part of 
any program for clients with CODs 
2. An outline of the 12 steps to an ideal complete 
screening and assessment, including some 
instruments that can be used in assessing CODs 
(see Appendix C for select screening tools) 
3. A discussion of key considerations in treatment 
matching 
Ideally, information needs to be collected 
continually and assessments revised and monitored 
as clients move through recovery. A comprehensive 
assessment, as described in the main section of 
this chapter, leads to improved treatment planning 
and this chapter aims to provide a model of the 
optimal process of evaluation for clients with 
CODs and to encourage the feld to move toward 
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this ideal. Nonetheless, the panel recognizes that 
not all agencies and providers have the resources 
to conduct immediate and thorough screenings. 
Therefore, the chapter provides a description 
of the initial screening and the basic or minimal 
assessment of CODs necessary for the initial 
treatment planning. 
Note that medical problems (including physical 
disability and sexually transmitted diseases), 
cultural topics, gender-specifc and sexual 
orientation matters, and legal concerns always 
must be addressed, whether basic or more 
comprehensive assessment is performed. The 
consensus panel assumes that appropriate 
procedures are in place to address these and other 
important areas that must be included in treatment 
planning. However, the focus of this chapter, 
in keeping with the purpose of this Treatment 
Improvement Protocol (TIP), is on screening and 
assessment for CODs. 
Screening and Basic Assessment
for CODs 
This section provides an overview of the screening 
and basic assessment process for CODs. A basic 
assessment covers the key information required 
for treatment matching and treatment planning. 
Specifcally, the basic assessment offers a structure 
for obtaining: 
• Demographic and historical information,
established or probable diagnoses, and associated
impairments. 
• General strengths and problem areas.
• Stage of change or level of service needed for
both substance misuse and mental illness.
• Preliminary determination of the severity 
of CODs as a guide to fnal level of care 
determination. 
In carrying out these processes, counselors 
should understand the limitations of their 
licensure or certifcation authority to diagnose 
or assess mental disorders. Generally, however, 
collecting screening and assessment information is 
a legitimate and legal activity even for unlicensed 
providers, as long as they do not use diagnostic 
labels as conclusions or opinions about the 
client. Information gathered in this way is needed 
to ensure that the client is placed in the most 
appropriate treatment setting (see the section 
“Step 5: Determine Level of Care”) and to assist in 
providing mental disorder and addiction care that 
addresses each disorder. 
In addition, a number of circumstances that can
affect validity and test responses may not be
obvious to the beginning counselor, such as the
manner in which instructions are given to the client,
the setting where the screening or assessment
takes place, privacy (or the lack thereof), and trust
and rapport between the client and counselor.
Throughout the process be sensitive to cultural
context and to the different presentations of both
SUDs and mental disorders that may occur in
various cultures (see Chapter 5 of this TIP for more
information about culturally sensitive care for clients
with CODs). Detailed discussions of these important
screening/assessment and cultural matters are
beyond the scope of this TIP.
For more information on screening and assessment 
for CODs, see Screening and Assessment of 
Co-Occurring Disorders in the Justice System 
(Substance Abuse and Mental Health Services 
Administration [SAMHSA], 2015b). For information 
on cultural topics, see TIP 59, Improving Cultural 
Competence (SAMHSA, 2014a). 
Screening 
For the purposes of this TIP, screening is a formal 
process of testing to determine whether a client 
warrants further because of a co-occurring SUD or 
mental disorder. The screening process for CODs 
seeks to answer a “yes” or “no” question: Does 
the substance misuse (or mental disorder) client 
being screened show signs of a possible mental (or 
substance misuse) problem? 
Although both screening and assessment are 
ways of gathering information about the client in 
order to better treat him or her, assessment differs 
from screening in that screening is a process for 
evaluating the possible presence of a particular 
problem and typically precedes assessment, 
whereas assessment is a process for defning the 
nature of that problem and developing specifc 
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ADVICE TO THE COUNSELOR: DOS AND DON’TS OF ASSESSMENT  
FOR CODs 
• Do keep in mind that assessment is about getting to know a person with complex and individual 
needs. Tools alone cannot produce a comprehensive assessment. 
• Do always make every effort to contact all involved parties, including family members, people who 
have treated the client previously, and probation offcers, as quickly as possible in the assessment 
process. (These other sources of information will henceforth be referred to as collaterals.) 
• Don’t allow preconceptions about addiction to interfere with learning about what the client 
really needs. CODs are as likely to be underrecognized as overrecognized. Assume initially that an 
established diagnosis and treatment regimen for mental illness is correct, and advise clients to 
continue with those recommendations until careful reevaluation has taken place. 
• Do become familiar with the diagnostic criteria for common mental disorders, including serious mental
illness (SMI) (e.g., bipolar disorder, schizophrenia, other psychotic disorders). Also become familiar with
the names and indications of common psychiatric medications and with the criteria in your own state
for determining who is a mental disorder priority client. Know the process for referring clients for mental
illness case management services or for collaborating with mental health services providers. 
• Don’t assume there is one correct treatment approach or program for any type of COD. The purpose 
of assessment is to collect information on multiple variables, enabling individualized treatment 
matching. Assess stage of change for each problem and clients’ level of ability to follow treatment 
recommendations. 
• Do get familiar with the specifc role your program plays in delivering services related to CODs in the 
wider context of the system of care. This allows you to have a clearer idea of what clients your program 
will best serve and helps you to facilitate access to other settings for clients who might be better 
served elsewhere. 
• Don’t be afraid to admit when you don’t know, either to the client or yourself. If you do not 
understand what is going on with a client, acknowledge that to the client, indicate that you will 
work with the client to fnd the answers, and then ask for help. Identify at least one supervisor who is 
knowledgeable about CODs as a resource for asking questions. 
• Most important, do remember that empathy and hope are the most valuable components of your 
work with a client. When in doubt about how to manage a client with COD, stay connected, be 
empathic and hopeful, and work with the client and the treatment team to try to fgure out the best 
approach over time. 
treatment recommendations for addressing the 
problem. Thus, assessment is a more thorough and 
comprehensive process than screening. 
The consensus panel recommends that all clients 
presenting for SUD treatment, mental health 
services, or both be screened at least annually 
by SUD treatment and mental health services 
providers for past and present substance misuse 
and mental disorders. SUD treatment and mental 
health counselors should also screen clients who 
report experiencing or otherwise show signs or 
symptoms of an SUD or a mental disorder.  
Counselors can conduct screening processes, if 
properly designed (see next paragraph), using 
their basic counseling skills. All counselors can 
be trained to screen for COD. There are seldom 
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ADVICE TO THE COUNSELOR: KNOW THE BASICS OF SCREENING 
• What is screening? Screening is a simple process of determining whether more indepth assessment is 
needed, often consisting of asking the client basic “yes” or “no” questions. 
• Who should conduct screening? Nearly any counselor can screen. Generally, no special training is 
required. 
• When does screening take place? The consensus panel recommends that all SUD treatment clients 
and mental disorder treatment clients be screened for CODs at least annually. Screening is also needed 
when clients report or exhibit symptoms suggesting another disorder may be present. 
• Where does screening occur? Screening can happen anywhere that services are offered. 
• Why screen? Screening is a necessary frst step to ensure that clients receive the right diagnosis and 
treatment. 
• How should screening be performed? A variety of easy-to-administer screening tools are available and 
are located or linked to throughout this chapter as well as in Appendix C. 
any legal or professional restraints on who can 
be trained to conduct a screening. Counselors 
should work with their program administrators to 
determine how often to screen, which tools to use, 
and who will perform the screening. 
The purpose of screening is not necessarily 
to identify what kind of disorder the person 
might have or how serious it might be. 
Rather, screening determines whether further 
assessment is warranted. Screening processes 
always should defne a protocol for determining 
which clients screen positive and for ensuring that 
those clients receive a thorough assessment. That 
is, a professionally designed screening process 
establishes precisely how any screening tools or 
questions are to be scored and indicates what 
constitutes scoring positive for a particular possible 
problem (often called “establishing cutoff scores”). 
The screening protocol details exactly what takes 
place after a client scores in the positive range and 
provides the necessary standard forms to be used 
to record the results of all later assessments and to 
document that each staff member has carried out 
his or her responsibilities in the process. 
So, what can an SUD treatment or mental health 
counselor do to screen clients? Screening often 
entails having a client respond to a specifc set of 
questions, scoring those questions according to the 
counselor’s training, and then taking the next step 
in the process depending on the results and the 
design of the screening process. In SUD treatment 
or mental health service settings, every counselor 
or clinician who conducts intake or assessment 
should be able to screen for the most common 
CODs and know the protocol for obtaining COD 
assessment information and recommendations. For 
SUD treatment agencies instituting mental disorder 
screening or mental health service programs 
instituting substance misuse screening, see the 
section, “Assessment Step 3: Screen for and Detect 
COD.” Selected instruments from that section 
appear in this chapter and in Appendix C. 
Basic Assessment 
A basic assessment assessment consists of 
gathering key information and engaging clients in 
a process that enables counselors to understand 
clients’ readiness for change, problem areas, 
COD diagnoses, disabilities, and strengths. An 
assessment typically involves a clinical examination 
of the functioning and well-being of the client and 
includes a number of tests and written and oral 
exercises. The COD diagnosis is established by 
referral to a psychiatrist, clinical psychologist, or 
other qualifed healthcare professional. Assessment 
of the client with CODs is an ongoing process 
that should be repeated over time to capture 
the changing nature of the client’s status. Intake 
information includes: 
Chapter 3 34 
TIP 42
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 3—Screening and Assessment of Co-Occurring Disorders 
• Background—family, trauma history, history 
of domestic violence (as either a perpetrator 
or a victim), marital status, legal involvement 
and fnancial situation, health, education, 
housing status, strengths and resources, and 
employment. 
• Substance use—age of frst use, primary 
substance(s) used (including alcohol), patterns of 
substance use, treatment episodes, and family 
history of substance use problems. 
• Mental illness—family history of mental illness; 
client history of mental illness, including 
diagnosis, hospitalization and other treatment; 
current symptoms and mental status; and 
medications and medication adherence. 
In addition, the basic information can be 
augmented by some objective measurement 
(see “Step 3: Screen for and Detect COD” 
and Appendix C). It is essential for treatment 
planning that the counselor organize the collected 
information in a way that helps identify established 
mental disorder diagnoses and current treatment. 
The following text box highlights the role of 
instruments in assessment. 
Careful attention to the characteristics of past
episodes of substance misuse and abstinence with
regard to mental disorder symptoms, impairments,
diagnoses, and treatments can illuminate the role
of substance misuse in maintaining, worsening,
and interfering with the treatment of any mental
disorder. Understanding a client’s mental disorder
symptoms and impairments that persist during
periods of abstinence of 30 days or more can be
useful, particularly in understanding what the client
copes with even when the acute effects of substance
misuse are not present. For any period of abstinence
that lasts a month or longer, ask the client about
mental health services, SUD treatment, or both.
If mental disorder symptoms (even suicidality or
hallucinations) occur within 30 days of intoxication or
withdrawal from the substance, symptoms may be
substance induced. The best way to manage them is
by maintaining abstinence from substances. Even if
symptoms are substance induced, formal treatment
strategies should be applied to help the client newly
in recovery best manage the symptoms.
THE ROLE OF ASSESSMENT 
TOOLS 
Providers frequently ask, what is the best 
assessment tool for COD? The answer is that 
there is no single gold standard assessment 
tool for COD. 
• Many traditional clinical tools focus narrowly 
on a specifc problem. An example of such a 
tool is the Beck Depression Inventory (Beck & 
Steer, 1987), a list of 21 questions about mood 
and other symptoms of feeling depressed. 
• Other tools have a broader focus and 
organize a range of information so that the 
collection of such information is done in 
a standard, regular way by all counselors. 
The Addiction Severity Index (ASI), which is 
not a comprehensive assessment tool but 
a measure of addiction severity in multiple 
problem domains, is an example of this type 
of tool (McLellan et al., 1992). Not only does a 
tool such as the ASI help a counselor, through 
repetition, become adept at collecting the 
information, it also helps the counselor refne 
his or her sense of similarities and differences 
among clients. 
• Knowing the appropriateness of a tool is 
also critical. Has the assessment been well 
studied? Is it considered valid and reliable? Is 
it validated for use in a population the client 
represents? If the answer to any of these 
questions is “no,” that might mean that the 
results from the assessment are not reliable, 
valid, interpretable, applicable to the client, or 
some combination thereof. This is especially 
true with clients from diverse populations. 
Race/ethnicity, educational background, 
age, gender—all of these factors affect life 
experiences and can affect the answers a 
person gives to a questionnaire. Wherever 
possible, be sure to use tools that are 
appropriately matched to the client. 
• A standard mental status examination can 
also collect information on current mental 
health. Some very good tools exist, but no 
one tool stands in for comprehensive clinical 
assessment. 
Provider and client together should try to 
understand the specifc effects that substances 
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have had on mental disorder symptoms, including 
possible triggering of psychiatric symptoms 
through substance use. The consensus panel 
notes that many individuals with CODs have 
well-established diagnoses when they enter SUD 
treatment and encourages counselors to fnd out 
about any known diagnoses. 
As part of basic assessment, assess clients’ 
mental health and SUD history by asking 
questions like: 
• “Tell me about your mental ‘ups and downs’. 
What is it like for you when things are worse? 
What is it like when things are better or stable?” 
• “How do you notice using alcohol (or whatever 
substance the client is misusing) affects your 
depression (or whichever mental disorder 
symptom the client is experiencing)?” 
• “What mental disorders have you been 
diagnosed with in the past? When was that, 
and what happened after you received the 
diagnosis?” 
• “What (mental disorder or substance misuse) 
treatment seemed to work best for you?” 
• “What treatment did you like or dislike? Why?” 
The Complete Screening and
Assessment Process 
This chapter is organized around 12 specifc steps 
in the assessment process. Through these steps, 
the counselor seeks to: 
• Get a more detailed chronological history of 
mental symptoms, diagnosis, treatment, and 
impairment, particularly preceding substance 
misuse and during periods of extended 
abstinence. 
• Get a more detailed description of current 
strengths, supports, limitations, skill defcits, 
and cultural barriers related to following a 
recommended treatment regimen for a disorder 
or problem. 
ADVICE TO THE COUNSELOR: HOW TO MAKE THE ASSESSMENT PROCESS 
A SUCCESS 
Counselors can increase the chances of a successful assessment process by taking some basic steps to 
help clients feel relaxed and open. 
• First, create a welcoming environment by taking an open, nonjudgmental attitude. 
SUD and mental illness each carry their own stigma, and people who have both disorders may feel 
even more marginalized, leading to underreporting or denial of symptoms and treatment needs. 
 Research suggests that some mental health professionals possess especially negative attitudes and 
beliefs about individuals with SMI, like psychotic disorders, and SUDs (Avery, Zerbo, & Ross, 2016). 
 By being aware of personal biases and taking steps to create a warm and open environment, 
counselors can increase the likelihood that clients will feel comfortable discussing distressing 
symptoms and dysfunctions, which can better inform treatment needs. 
• Use open-ended rather than just “yes” or “no” questions. Open-ended questions will allow counselors
to elicit a greater depth of information and will feel more conversational in tone to the client. “Yes” or
“no” questions can feel more judgmental and detached. Open-ended questions are also more thought
provoking and can lead the client to greater self-exploration and self-awareness. 
• Furthermore, be sure to address motivation by talking with clients about their ambivalence toward
engaging in services. More information about motivational interviewing techniques can be found in the
update of TIP 35, Enhancing Motivation for Change in Substance Use Disorder Treatment (SAMHSA, 2019c). 
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• Determine stage of change for each problem 
and identify external contingencies that might 
help promote treatment adherence. 
Assessment steps appear sequential, but some 
can occur simultaneously or in a different order, 
depending on the situation. Providers should 
identify and attend to acute safety needs, which 
often must be addressed before a more compre-
hensive assessment process can occur. Sometimes, 
however, components of the assessment process 
are essential to address clients’ specifc safety 
needs. Furthermore, counselors should recognize 
that although the assessment seeks to identify 
individual needs and vulnerabilities as quickly 
as possible to initiate appropriate treatment, 
assessment is an ongoing process. As treatment 
proceeds and as other changes occur in clients’ 
lives and mental status, counselors must actively 
seek current information rather than proceed on 
assumptions that might be no longer valid. Exhibit 
3.1 lists general considerations for the assessment 
of clients with CODs. 
The following section discusses the availability 
and utility of validated assessment tools to assist 
counselors in this process. A number of tools 
are required by various states for use in their 
SUD treatment systems (e.g., ASI, [McLellan et 
al., 1992]; American Association of Community 
Psychiatry – Level of Care Utilization System 
[LOCUS]). Particular attention will be given to the 
role of these tools in the COD assessment process, 
with suggested strategies for reducing duplication 
of effort when possible. 
It is beyond the scope of this TIP to provide 
detailed instructions for administering the tools 
mentioned, but select information about cutoff 
scores is included in this chapter (and select 
measures are included in Appendix C). Basic 
information about each instrument is also given 
in this chapter, and readers can obtain more 
detailed information about administration and 
interpretation from the sources given for obtaining 
these instruments. 
This discussion is directed toward providers 
working in SUD treatment settings, although 
many of the steps apply equally well to mental 
health clinicians in mental health service settings. 
At certain key points in the discussion, particular 
information relevant to mental health clinicians is 
identifed and described. 
EXHIBIT 3.1. Assessment Considerations for Clients With CODs 
• Providers should maintain a nonjudgmental attitude while taking a matter-of-fact approach to asking 
about past and current substance misuse and mental illness. 
• First asking about past substance misuse and mental illness could help clients feel more open and 
amenable to discussing current problems, which people sometimes minimize. 
• Counselors should explain to clients why they are asking about substance misuse and mental illness and 
discuss the role of such information in treatment planning. 
• Self-report assessments can be informative, but counselors should gather laboratory data and collateral 
information from family and friends as needed. 
• Counselors should be able to recognize the common demographic correlates of COD, such as gender, 
younger age, lower educational attainment, and single marital status. These give counselors an idea 
of which clients may be more vulnerable to these disorders and potentially in need of screening and 
assessment. However, these factors should not be used to justify not screening or assessing certain 
people. Screen all clients for substance misuse and mental illness at least once per year. All clients 
who screen positive for symptoms, functional impairment, or other service needs should be fully 
assessed. 
Source: Mueser & Gingerich (2013). 
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Using a Biopsychosocial Approach 
Because addictions and mental disorders are 
complex conditions with multiple contributing 
factors, clinicians should conduct assessments 
using a biopsychosocial approach that thoroughly 
investigates clients’ history and current status in a 
holistic manner. “Biopsychosocial” in this context 
refers to a clinical philosophy and approach to 
care that seeks to understand clients and their 
experience through a medical, psychological, 
emotional, sociocultural, and socioeconomic lens. 
This is particularly important when assessing and 
treating CODs given that numerous determinants 
and exacerbating and mitigating factors may 
potentially be relevant to diagnosis, treatment 
planning, and outcomes. Biopsychosocial 
assessment is evidence based and the standard 
of care. It is comprehensive and widely addresses 
all aspects of clients’ lives that may be relevant 
to his or her symptoms and service needs. 
By defnition, a biopsychosocial assessment 
will rely on input from multidisciplinary team 
members including physicians and nurses 
(including psychiatric and mental health 
nurses [specialty practice registered nurses]); 
psychologists, psychiatrists, and other mental 
health professionals; social workers; and addiction 
counselors and other SUD treatment professionals. 
Addiction counselors will not be able to assess all 
biopsychosocial assessment areas (Exhibit 3.2) and 
will focus primarily on the psychological and social 
sources of information. Appendix C contains links 
to sample biopsychosocial assessment forms. 
EXHIBIT 3.2. Biopsychosocial Sources of Information in the Assessment 
of CODs 
TOPIC AREA SUD AREAS OF ASSESSMENT MENTAL DISORDER AREAS OF 
ASSESSMENT 
Biological Alcohol on the breath 
Positive urine tests 
Abnormal laboratory tests 
Withdrawal symptoms 
Injuries and trauma 
Medical signs and symptoms of toxicity 
and withdrawal 
Impaired cognition 
•
•
•
Abnormal laboratory tests (e.g., 
magnetic resonance imaging) 
Neurological exams 
Use of psychiatric and other medications 
Psychological •
•
•
•
•
Intoxicated behavior 
Functional impairment 
Responses to SUD assessments 
Documented substance misuse history 
History of trauma 
•
•
•
•
•
•
Mental status exam results 
Responses to mental disorder/symptom 
screens (e.g., depressed mood, 
psychosis, anxiety) 
History of or current diagnosis of and 
treatment for mental illness 
Stress and situational factors 
Self-image and personality 
History of trauma 
Continued on next page 
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Continued 
TOPIC AREA SUD AREAS OF ASSESSMENT MENTAL DISORDER AREAS OF 
ASSESSMENT 
Social Collateral information from others (e.g., 
family, caregivers) 
Social interactions, recreation/interests, 
lifestyle 
Family history of SUDs 
Availability of support systems (e.g., 
family, friends, close others) 
Housing, education, and job histories 
Military history 
Ethnic and cultural background 
Legal history (e.g., involvement in the 
criminal justice system) 
Collateral information from others (e.g., 
family, caregivers) 
Social interactions, recreation/interests, 
lifestyle 
Family history of mental disorders 
Availability of support systems (e.g., 
family, friends, close others) 
Housing, education, and employment 
histories 
Military history 
Ethnic and cultural background 
Legal history (e.g., involvement in the 
criminal justice system) 
TWELVE STEPS IN THE 
ASSESSMENT PROCESS 
Step 1: Engage the client. 
Step 2: Identify and contact collaterals (family, 
friends, other providers) to gather additional 
information. 
Step 3: Screen for and detect CODs. 
Step 4: Determine quadrant and locus of 
responsibility. 
Step 5: Determine level of care. 
Step 6: Determine diagnosis. 
Step 7: Determine disability and functional 
impairment. 
Step 8: Identify strengths and supports. 
Step 9: Identify cultural and linguistic needs 
and supports. 
Step 10: Identify problem domains. 
Step 11: Determine stage of change. 
Step 12: Plan treatment. 
Assessment Step 1: Engage the Client 
The frst step in the assessment process is to 
engage the client in an empathic, welcoming 
manner and build rapport to facilitate open 
disclosure of information regarding mental illness, 
SUDs, and related concerns. The aim is to create 
a safe and nonjudgmental environment in which 
sensitive personal information may be discussed. 
Counselors should recognize that cultural matters, 
including the use of the client’s preferred language, 
play a role in creating a sense of safety and 
promote accurate understanding of the client’s 
situation and options. Such topics therefore 
must be addressed sensitively at the outset and 
throughout the assessment process. 
The consensus panel identifed fve key concepts 
that underlie effective engagement during initial 
clinical contact: 
• Universal access (“no wrong door”) 
• Empathic detachment 
• Person-centered assessment 
• Cultural sensitivity 
• Trauma-informed services 
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All staff, including SUD treatment providers and 
mental health clinicians, in any service setting 
need to develop competency in engaging and 
welcoming individuals with CODs. (See Chapter 5 
for a discussion of working successfully with people 
who have CODs and establishing a therapeutic 
alliance.) Whereas engagement is presented here 
as the frst necessary step for assessment to take 
place, in a larger sense engagement represents an 
ongoing concern of the counselor—to understand 
the client’s experience and to keep him or her 
positive and engaged relative to the prospect of 
better health and recovery. 
No Wrong Door 
“No wrong door” refers to formal recognition by 
a service system that individuals with CODs may 
enter through a range of community service sites, 
that they are a high priority for engagement in 
treatment, and that proactive efforts are necessary 
to welcome them into treatment and prevent 
them from falling through the cracks. Addiction 
and mental health counselors are encouraged to 
identify individuals with CODs, welcome them 
into the service system, and initiate proactive 
efforts to help them access appropriate treatment 
in the system, regardless of their initial site 
of presentation. The recommended attitude 
counselors should embody is, “The purpose of this 
assessment is not just to determine whether the 
client fts in my program but to help the client 
fgure out where he or she fts in the system of 
care and to help him or her get there.” 
Empathic Detachment 
Empathic detachment requires the assessing 
clinician to: 
• Acknowledge that the provider and client are
working together to make decisions to support
the client’s best interest.
• Recognize that the provider cannot transform
the client into a different person but can only
support change that he or she is already making.
• Maintain an empathic connection even if the
client does not seem to ft into the provider’s
expectations, treatment categories, or preferred
methods of working.
Providers should be prepared to demonstrate 
responsiveness to the requirements of treating 
clients with CODs. Counselors should be careful 
not to label mental disorder symptoms immediately 
as caused by addiction but instead should be 
comfortable with the strong possibility that a 
mental disorder may be present independently and 
encourage disclosure of information that will help 
clarify the meaning of any CODs for that client. 
(See Chapter 4 for guidance on distinguishing 
independent mental disorders from substance-
induced mental disorders.) 
Person-Centered Assessments 
Person-centered assessments emphasize that the
focus of initial contact is not on getting forms flled
out or answering a battery of questions, or on
establishing program ft. Instead the focus is on
fnding out what the client wants, seen from his or
her perspective on the problem, what he or she
wants to change, and how he or she thinks that
change will occur.
Ewing, Austin, Diffn, and Grande (2015) developed
an evidence-based practice tool for conducting
person-centered assessment and planning with
caregivers of palliative care patients. The framework
and key approaches they propose could be
generalized to other health issues—including mental
illness and substance misuse—and offer useful
guidance for ensuring assessment processes are
focused on the client and his or her problems, goals,
and needs. However, research is needed on the use
of their framework in people with CODs.
Sensitivity to Culture, Gender, and Sexual 
Orientation 
An important component of a person-centered 
assessment is always recognizing the signifcant 
role of culture on a client’s view of problems and 
treatments. Cultures differ signifcantly in their 
views of SUDs and mental disorders, which may 
affect how a client presents. Clients may participate 
in treatment cultures (mutual-support programs, 
Dual Recovery Self-Help, psychiatric rehabilitation) 
that also affect their view of treatment. Cultural 
sensitivity requires recognizing one’s own cultural 
perspective and having a genuine spirit of inquiry 
into how cultural factors infuence the clients’ 
requests for help. 
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During the assessment process, counselors should 
learn about clients’ sexual orientation and any 
gender identity matters, as part of understanding 
the clients’ personal identity, living situation, and 
relationships. Counselors should also be aware 
that clients often have family-related and other 
concerns that must be addressed to engage them 
in treatment, such as the need for child care. 
For more information about culturally competent 
treatment, see Chapters 5 and 6 of this TIP as 
well as TIP 59, Improving Cultural Competence 
(SAMHSA, 2014a) and TIP 51, Substance Abuse 
Treatment: Addressing the Specifc Needs of 
Women (SAMHSA, 2009c). 
Trauma-Informed Care 
The high prevalence of trauma in individuals with
CODs requires a clinician to consider the possibility
of a trauma history even before beginning to assess
the client. Trauma may include early childhood
physical, sexual, or emotional abuse; experiences
of rape or interpersonal violence as an adult; and
traumatic experiences associated with political
oppression, as might be the case in refugee or
other immigrant populations. The approach to the
client must be sensitive to the possibility that the
client has suffered previous traumatic experiences
that may interfere with his or her ability to trust the
counselor. A clinician who observes guardedness on
the part of the client should consider the possibility
of trauma and try to promote safety in the interview
by providing support and gentleness, rather than
trying to “break through” evasiveness that might
look like resistance or denial. All questioning should
avoid “retraumatizing” the client. 
See Chapter 4 for information about trauma-
informed care, Chapter 6 for information on 
women’s concerns in CODs, and TIP 57, Trauma-
Informed Care in Behavioral Health Services 
(SAMHSA, 2014b). 
Assessment Step 2: Identify and 
Contact Collaterals (Family, Friends, 
Other Providers) To Gather Additional 
Information 
Clients presenting for SUD treatment, particularly 
those who have current or past mental disorder 
symptoms, may be unable or unwilling to report 
past or present circumstances accurately. For this 
reason, all assessments should include routine 
procedures for identifying and contacting family 
and other collaterals (with clients’ permission) who 
may have useful information. 
Information from collaterals is valuable as a 
supplement to the client’s own report in all of the 
assessment steps listed in the remainder of this 
chapter. It is valuable particularly in evaluating the 
nature and severity of mental disorder symptoms 
when the client may be so impaired that he or she 
is unable to provide that information accurately. 
Note, however, that the process of seeking 
such information must be carried out strictly in 
accordance with applicable guidelines and laws 
regarding confdentiality1 and with the client’s 
permission. 
Assessment Step 3: Screen for and 
Detect CODs 
Because of the high prevalence of co-occurring 
mental disorders in SUD treatment settings, and 
because treatment outcomes for individuals with 
multiple problems improve if each problem is 
addressed specifcally, the consensus panel recom-
mends that: 
• SUD treatment providers screen all new 
clients for co-occurring mental disorders. 
• Mental disorder treatment providers screen all 
new clients for any substance misuse. 
The type of screening will vary by setting. 
Substance misuse screening in mental disorder 
service settings should: 
• Screen for acute safety risk related to serious 
intoxication or withdrawal. 
1 Confdentiality is governed by the federal “Confdentiality of Alcohol and Drug Abuse Patient Records” regulations (42 C.F.R.
Part 2) and the federal “Standards for Privacy of Individually Identifable Health Information” (45 C.F.R. Parts 160 and 164). 
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• Screen for past and present substance use, 
substance-related problems, and substance-
related disorders (i.e., SUDs and substance-
induced mental disorders). 
Mental disorder screening has four major 
components in SUD treatment settings: 
• Screen for acute safety risk, including for: 
Suicide. 
Violence to others. 
Inability to care for oneself. 
Risky behaviors. 
Danger of physical or sexual victimization. 
• Screen for past and present mental illness 
symptoms and disorders. 
• Screen for cognitive and learning defcits. 
• Regardless of setting, screen all clients for past 
and present victimization and trauma. 
Exhibit 3.3 lists recommended, validated screening 
tools across behavioral health service settings. 
EXHIBIT 3.3. Recommended Screening Tools To Help Detect CODs 
Client safety 
• Columbia-Suicide Severity Rating Scale (C-SSRS) 
• Suicide Behaviors Questionnaire-Revised (SBQ-R) 
• Risk of harm section of the LOCUS 
• Humiliation, Afraid, Rape, and Kick 
Past or present mental disorders 
• ASI 
• Mental Health Screening Form-III (MHSF-III) 
• Modifed Mini Screen 
• Diagnostic and Statistical Manual of Mental Disorders (5th ed. [DSM-5]; American Psychiatric 
Association, 2013) Cross-Cutting Symptom Measure 
Past or present substance misuse 
• 10-item Drug Abuse Screening Test (DAST-10) 
• Alcohol Use Disorders Identifcation Test (AUDIT) and Alcohol Use Disorders Identifcation 
Test—Concise (AUDIT-C) 
• CAGE Questionnaire Adapted To Include Drugs 
• Michigan Alcoholism Screening Test (MAST) 
• National Institute on Drug Abuse (NIDA)-Modifed Alcohol, Smoking, and Substance Involvement
Screening Test (ASSIST) 
• Simple Screening Instrument for Substance Abuse (SSI-SA) 
Trauma 
• The Primary Care PTSD Screen for DSM-5 
• The PTSD Checklist for DSM-5 
Level of care 
LOCUS 
Functioning and impairment 
World Health Organization (WHO) Disability Assessment Schedule 2.0 
Chapter 3 42 
TIP 42
 
 
 
Chapter 3—Screening and Assessment of Co-Occurring Disorders 
Safety Screening 
Safety screening requires that, early in the 
interview, the provider specifcally ask the client 
whether he or she has any immediate impulse 
to engage in violent or self-injurious behavior, 
or whether he or she is in any immediate danger 
from others. These questions should be asked 
directly of the client and of anyone else who is 
providing information. If the answer is yes, the 
provider should obtain more detailed information 
about the nature and severity of the danger, the 
client’s ability to avoid the danger, the immediacy 
of the danger, what the client needs to do to 
be safe and feel safe, and any other information 
relevant to safety. Additional information can be 
gathered depending on counselor/staff training for 
crisis/emergency situations and the interventions 
appropriate to the treatment provider’s particular 
setting and circumstances. Once this information 
is gathered, if it appears that the client is at 
immediate risk, the provider should arrange 
for a more indepth risk assessment by a mental 
health–trained clinician, and the client should not 
be left alone or unsupervised. 
Screening for Risk of Suicide or Self-Harm 
A variety of validated tools are available for 
screening for risk of suicide or other self-harm: 
• C-SSRS is a commonly used, well-supported tool 
to quickly assess suicidal ideation, behavior, and 
lethality in adult and adolescent populations 
(Posner et al., 2011). It is available in over 100 
languages and has been used in many settings 
that serve people with CODs, including primary 
care, military hospitals, and the criminal justice 
system. Screeners can be selected based on 
the setting in which they are being used, the 
population being screened, and the language 
needed. Columbia University maintains versions 
of the C-SSRS at http://cssrs.columbia.edu/ 
the-columbia-scale-c-ssrs/cssrs-for-communities-
and-healthcare/#flter=.general-use.english. 
• SBQ-R (Osman et al., 2001) has demonstrated 
good reliability and validity in measuring past 
suicide attempts, frequency of suicidal ideation, 
previous suicidal communication, and likelihood 
of future suicide attempt in adults in inpatient 
and community settings (Batterham et al., 2015). 
For the full instrument with an overview and 
scoring instructions, see Exhibits 3.4 through 
3.6, beginning on page 44. 
• Some systems use the LOCUS (Sowers, 2016) 
to determine level of care for both mental 
disorders and addiction. One dimension of 
LOCUS specifcally provides guidance for 
scoring severity of risk of harm. 
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EXHIBIT 3.4. The Suicide Behaviors Questionnaire-Revised (SBQ-R) - 
Overview 
The SBQ-R has 4 items, each tapping a different dimension of suicidality:* 
• Item 1 taps into lifetime suicide ideation and/or suicide attempt.
• Item 2 assesses the frequency of suidical ideation over the past twelve months.
• Item 3 assesses the threat of suicide attempt.
• Item 4 evaluates self-reported likelihood of suidical behavior in the future.
Clinical Utility 
Due to the wording of the four SBQ-R items, a broad range of information is obtained in a very brief 
administration. Responses can be used to identify at-risk individuals and specifc risk behaviors. 
Scoring 
See scoring guideline on the following page. 
Psychometric Properties* 
Cutoff Score Sensitivity Specifcity 
Adult General Population 
Adult Psychiatric Inpatients 
≥7 
≥8 
93% 
80% 
95% 
91% 
*Osman A, Bagge CL, Gutierrez PM, Konick LC, Kooper BA, Barrios FX. The Suicidal Behaviors Questionnaire-Revised
(SBQ-R): Validation with clinical and nonclinical samples. Assessment, 2001, (5), 443-454.
Source: Center for Quality Assessment and Improvement in Mental Health (2007). 
EXHIBIT 3.5. SBQ-R-Scoring 
ITEM 1: TAPS INTO LIFETIME SUICIDE IDEATION AND/OR SUICIDE ATTEMPTS 
Selected response 1 Non-Suicidal subgroup 1 point 
Selected response 2 Suicide Risk Ideation group 2 points 
Selected response 3a or 3b Suicide Plan subgroup 3 points 
Selected response 4a or 4b Suicide Attempt subgroup 4 points Total Points 
ITEM 2: ASSESSES THE FREQUENCY OF SUICIDAL IDEATION OVER THE PAST 12 MONTHS 
Selected Response: Never 1 point 
Rarely (1 time) 2 points 
Sometimes (2 times) 3 points 
Often (3-4 times) 4 points 
Very often (5 or more times) 5 points Total Points 
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ITEM 3: TAPS INTO THE THREAT OF SUICIDE ATTEMPT 
Selected response 1 1 point 
Selected response 2a or 2b 2 points 
Selected response 3a or 3b 3 points Total Points 
ITEM 4: EVALUATES SELF-REPORTED LIKELIHOOD OF SUICIDAL BEHAVIOR IN THE FUTURE 
Selected Response: Never 0 point 
No chance at all 1 points 
Rather unlikely 2 points 
Unlikely 3 points 
Likely 4 points 
Rather Likely 5 points 
Very Likely 6 points Total Points 
Sum all the scores circled/checked by the respondents. 
The total score should range from 3-18. Total Score 
AUC = AREA UNDER THE RECEIVER OPERATING CHARACTERISTIC CURVE; THE AREA MEASURES 
DISCRIMINATION, THAT IS, THE ABILITY OF THE TEST TO CORRECTLY CLASSIFY THOSE WITH AND 
WITHOUT THE RISK. [.90-1.0 = EXCELLENT; .80-.90 = GOOD; .70-.80 = FAIR; .60-.70 = POOR] 
Sensitivity Specifcity PPV AUC 
Item 1: a cutoff score of ≥ 2 
Validation Reference: Adult Inpatient 
Validation Reference: Undergraduate College 
0.80 
1.00 
0.97 
1.00 
.95 
1.00 
0.92 
1.00 
Total SBQ-R: a cutoff score of ≥ 7 
Validation Reference: Undergraduate College 0.93 0.95 0.70 0.96 
Total SBQ-R: a cutoff score of ≥ 8 
Validation Reference: Adult Inpatient 0.80 0.91 0.70 0.96 
EXHIBIT 3.6. SBQ-R Suicide Behaviors Questionnaire—Revised 
Patient Name _____________ Date of Visit _________________ 
Instructions: Please check the number beside the statement or phrase that best applies to you. 
Have you ever thought about or attempted to kill yourself? (check one only) 
1. Never 
2. It was just a brief passing thought 
3a. I have had a plan at least once to kill myself but did not try to do it 
Continued on next page 
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Continued 
3b. I have had a plan at least once to kill myself and really wanted to die 
4a. I have attempted to kill myself, but did not want to die 
4b. I have attempted to kill myself, and really hoped to die 
How often have you thought about killing yourself in the past year? (check one only) 
□
□
□
□
□
1. Never 
2. Rarely (1 time) 
3. Sometimes (2 times) 
4. Often (3-4 times) 
5. Very Often (5 or more times) 
Have you ever told someone that you were going to commit suicide, or that you might do it? (check 
one only)
□
□
□
□
□
1. No 
2a. Yes, at one time, but did not really want to die 
2b. Yes, at one time, and really wanted to die 
3a. Yes, more than once, but did not want to do it 
3b. Yes, more than once, and really wanted to do it 
How likely is it that you will attempt suicide someday? (check one only) 
□
□
□
□
□
□
□
0. Never 
1. No chance at all 
2. Rather unlikely 
3. Unlikely 
4. Likely 
5. Rather likely 
6. Very likely 
Copyright © Osman et al. (2001). All Rights Reserved. 
For more indepth discussion of how to manage
suicidal ideation and behaviors in clients seeking
treatment for substance misuse, see Chapter 4
of this TIP as well as TIP 50, Addressing Suicidal
Thoughts and Behaviors in Substance Abuse
Treatment (Center for Substance Abuse Treatment
[CSAT], 2009). 
No tool is defnitive for safety screening. Providers 
and programs should use one of these tools only 
as a starting point, and then use more detailed 
questions to get all relevant information. 
Providers should not underestimate risk because
the client is actively using substances. For example,
although people who are intoxicated might only
seem to be making threats of self-harm (e.g., “I’m
just going to go home and blow my head off if
nobody around here can help me”), all statements
about harming oneself or others must be taken
seriously. Individuals who have suicidal or aggressive
impulses when intoxicated may act on those
impulses. Remember, alcohol and drug misuse are
among the highest predictors of danger to self
or others—even without any co-occurring mental
disorder.
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Chapter 3—Screening and Assessment of Co-Occurring Disorders 
Determining whether and to what extent an
intoxicated client may be suicidal requires a skilled
mental health assessment, plus information from
collaterals who know the client best. (See Chapter
4 for a more detailed discussion of suicidality in
people with CODs.) In addition, remember that the
vast majority of people who are misusing substances
will experience at least transient symptoms of
depression, anxiety, and other mental disorders.
Moreover, even a skilled clinician may not be able to
determine whether an intoxicated suicidal patient is
making a serious threat of self-harm; however, safety
is a critical and paramount concern.
Positive Suicide Screens 
If a client screens positive for suicide risk, 
counselors should conduct a suicide risk as-
sessment to more thoroughly determine the 
client’s potential for self-harm. No generally 
accepted and standardized suicide assessment 
has been shown to be reliable and valid, but 
most established suicide assessments contain 
similar elements. The assessment questions below 
are drawn from the National Institute of Mental 
Health's Ask Suicide-Screening Questions (ASQ) 
Toolkit (n.d.; https://www.nimh.nih.gov/research/ 
research-conducted-at-nimh/asq-toolkit-materials/ 
index.shtml). 
Ask questions about the client’s feelings about 
living, such as: 
• Ask questions about the client’s feelings about 
living, such as: 
“Do you ever wish you weren’t alive?” 
“Have you ever felt that your life wasn’t 
worth living any longer?” 
• For people who endorse thoughts of suicide or 
self-harm questions, ask questions like: 
“Do you have any thoughts of killing yourself 
now?” 
“Do you have a plan for how you would kill 
yourself?” 
“If you decided to kill yourself, how would 
you do it?” 
• For people who have tried to commit suicide in 
the past, ask: 
“Why did you try to commit suicide? When 
was this? What were the circumstances? What 
did you do?” 
-
-
-
“What happened after you tried to kill 
yourself?” 
“Did you want to die?” 
“Did you get medical or psychiatric treatment 
after? Was treatment offered to you? (If yes) 
How did that go for you?” 
• Also be sure to ask about other symptoms and 
factors that might increase or decrease risk of 
dying by suicide, such as: 
“What are some reasons you would not kill 
yourself?” 
“Do you know anyone who has killed 
themselves or tried to?” 
“In the past few weeks, have you felt so sad 
or down that it was hard to do things you 
normally enjoy?” 
“In the past few weeks, have you felt 
hopeless or as though things will never get 
better?” 
“Do you often act without thinking?” 
“Is there a trusted adult or other person you 
can talk to?” 
“Are there any problems in your household 
that are hard to handle?” 
The provider needs to determine, based on the 
client’s assessment responses, whether the risk of 
imminent suicide is mild, moderate, or high. The 
provider must also determine to what degree the 
client is willing and able to follow through with 
a set of interventions to keep safe. Screening 
personnel should also assess whether suicidal 
feelings are transitory or refect a chronic condition. 
Factors that may predispose a client toward 
suicide should also be considered in client 
evaluation. Vulnerable populations include (U.S. 
Department of Health and Human Services, 2012): 
• American Indians/Alaska Natives. 
• Individuals who have lost a loved one to suicide. 
• Individuals involved in the criminal justice system 
or child welfare system. 
• Individuals who engage in nonsuicidal self-injury 
(see Section III of DSM-5). 
• Individuals with a history of suicide attempts. 
• Individuals with debilitating physical conditions. 
• Individuals with mental disorders, SUDs, or both. 
• Individuals in the lesbian/gay/bisexual/ 
transgender/questioning community. 
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• Members of the armed forces and veterans. 
• Middle-aged and older men. 
Asking people about thoughts of suicide 
does not make them more likely to try to kill 
themselves. On the contrary, asking about 
suicide displays a level of care and concern that 
can help people with suicidal thoughts and 
intentions open up and feel more receptive to 
help. Counselors should not avoid asking such 
questions out of fear that asking them will “put 
the idea” of suicide into their clients’ minds; this 
is simply not true. 
Counselors should also be prepared to probe the 
client’s likelihood of inficting harm on another 
person. Specifcally, counselors should ask 
questions that establish whether homicidal 
ideation, plans, means, access, and protective 
factors are present. Also ask about past expe-
riences and future expectations. Questions can 
include the following: 
• “Have you had any thoughts of harming 
others?” 
• “Have you had any thoughts of harming anyone 
specifc? Who?” 
• “If you decided to harm (name of person), how 
would you do it?” 
•  “On a scale of 0 to 10, with 0 meaning ‘not 
likely at all,’ how likely are you to harm this 
person in the next week?” 
• “What reasons do you have to not harm this 
person? What might stop you from harming 
him/her?” 
• “What else could you do to deal with your anger 
(or name whatever other feelings the client 
reports feeling) instead of harming this person?” 
• “In the past, have you acted on thoughts of 
harming someone? What happened?” 
• “How might your life change if you harm this 
person? What might happen to you or to your 
family? What might happen to this person’s 
family?” 
• “Would you be willing to agree to tell someone 
before you do this?” 
• “How confdent are you in remaining sober over 
the next week? What can you do to increase the 
chances you will remain sober? (for example, use 
of 12-Step meetings, supports, or treatment).” 
Screening for Risk of Violence 
The U.S. Preventive Services Task Force (USPSTF) 
recommends that providers routinely screen all 
women of childbearing age for risk of intimate 
partner violence (USPSTF, 2016). Similarly, 
addiction counselors and mental health counselors 
should be vigilant for risk of victimization among 
female clients, although men too can and do 
experience intimate partner violence and should 
be screened if counselors suspect victimization. 
The screener recommended for high sensitivity 
and specifcity (Arkins, Begley, & Higgins, 2016; 
USPSTF, 2016) is called Humiliation, Afraid, Rape, 
and Kick. This four-question tool (which has been 
validated only for women) screens for emotional, 
physical, and sexual violence (Sohal, Eldridge, & 
Feder, 2007). See Appendix C for the tool. 
Screening for Past and Present Mental 
Disorders 
Screening for past and present mental disorders 
accomplishes three goals: 
1. To understand a client’s history and, if the 
history is positive for a mental disorder, to 
alert the counselor and treatment team to the 
types of symptoms that may reappear so that 
the counselor, client, and staff can watch out for 
the emergence of any such symptoms. 
2. To identify clients who may have a current 
mental disorder and need assessment to 
determine the nature of the disorder and an 
evaluation to plan for its treatment. 
3. To determine the nature of the symptoms 
that may increase and decrease to help clients 
with current CODs monitor their symptoms— 
especially how the symptoms improve or 
worsen in response to medications, “slips” (i.e., 
substance use), and treatment interventions. For 
example, clients often need help seeing that the 
treatment goal of avoiding isolation improves 
their mood. So, when they call their sponsor 
and go to a meeting, they break the cycle of 
depressed mood, seclusion, dwelling on oneself 
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and one’s mood, increased depression, and 
other symptoms or consequences of depression. 
Several screening, assessment, and treatment 
planning tools are available to assist the SUD 
treatment team (see Appendix C). Hundreds of 
assessment and treatment planning tools exist for 
assessment of specifc disorders and for differential 
diagnosis and treatment planning. The National 
Institute on Alcohol Abuse and Alcoholism offers 
professional education materials that address 
screening and assessment for alcohol misuse, 
including links to several screening instruments 
(www.niaaa.nih.gov/publications/clinical-guides-
and-manuals). A NIDA research report (NIDA, 
2018a) provides broad background information 
on assessment processes pertinent to CODs and 
specifc information on many mental disorders, 
treatment planning, and substance misuse 
tools. The mental health feld contains a vast 
array of screening and assessment devices, and 
subfelds are devoted primarily to the study and 
development of evaluative methods. 
Almost all SAMHSA TIPs, available online 
(https://store.samhsa.gov/series/tip-series-
treatment-improvement-protocols-tips), have a 
section on assessment; many have appendixes 
with wholly reproduced assessment tools or 
information about locating such tools. 
Advanced assessment techniques include 
assessment instruments for general and specifc 
purposes and advanced guides to differential 
diagnosis. Most highpower assessment techniques 
center on a specifc type of problem or set of 
symptoms, are typically lengthy, often require 
specifc doctoral training to use, and can be 
diffcult to adapt properly for some SUD treatment 
settings. For these reasons, such assessments are 
not included in this publication. 
When using any of the wide array of tools that 
detect symptoms of mental disorders, counselors 
should bear in mind that symptoms of a mental 
disorder can be mimicked by substances. For 
example, hallucinogens may produce symptoms 
that resemble psychosis, and depression commonly 
occurs during withdrawal from many substances. 
Even with well-tested tools, distinguishing between 
a mental disorder and a substance-related disorder 
can be diffcult without additional information 
such as the history and chronology of symptoms. 
In addition to interpreting the results of such 
instruments in the broader context of what is 
known about the client’s history, counselors are 
also reminded that retesting often is important, 
particularly to confrm diagnostic conclusions for 
clients who have used substances. 
The next section briefy highlights some instruments
available for mental disorder screening. 
Mental Health Screening Tools 
MHSF-III 
MHSF-III (Exhibit 3.7) has only 17 simple questions 
and is designed to screen for present or past 
symptoms of most major mental disorders (Carroll 
& McGinley, 2001). The MHSF-III was developed in 
an SUD treatment setting, and it has face validity— 
that is, if a knowledgeable diagnostician reads each 
item, it is clear that a “yes” would warrant further 
evaluation of the client for the mental disorder for 
which the item represents typical symptomatology. 
It has been used as a part of integrated behavioral 
health and physical health services (Chaple, Sacks, 
Randell, & Kang, 2016) and in behavioral health 
courts (Miller & Khey, 2016). The MHSF-III is 
reprinted in Appendix C. 
The MHSF-III is only a screening device, because 
it asks only one question for each disorder for 
which it attempts to screen. If a client answers “no” 
because of a misunderstanding of the question or a 
momentary lapse in memory focus, the screen will 
produce a “false negative.” This means the client 
might have the mental disorder, but the screen 
falsely indicates that he or she probably does not 
have the disorder. 
The MHSF-III is scored by totaling the “yes” 
responses (1 point each), for a maximum score 
of 17. A “yes” response to any of the items on 
questions 3 through 17 suggests that a qualifed 
mental health specialist should be consulted 
to determine whether follow-up, including a 
diagnostic interview, is warranted. 
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EXHIBIT 3.7. Mental Health Screening Form-III 
Please circle “yes” or “no” for each question. 
1. Have you ever talked to a psychiatrist, psychologist, therapist, social worker, or counselor Yes No 
about an emotional problem? 
2. Have you ever felt you needed help with your emotional problems, or have you had Yes No 
people tell you that you should get help for your emotional problems? 
3. Have you ever been advised to take medication for anxiety, depression, hearing voices, or Yes No 
for any other emotional problem? 
4. Have you ever been seen in a psychiatric emergency room or been hospitalized for Yes No 
psychiatric reasons? 
5. Have you ever heard voices no one else could hear or seen objects or things which others Yes No 
could not see? 
6. (a) Have you ever been depressed for weeks at a time, lost interest or pleasure in most Yes No 
activities, had trouble concentrating and making decisions, or thought about killing 
yourself? Yes No 
(b) Did you ever attempt to kill yourself? 
7. Have you ever had nightmares or fashbacks as a result of being involved in some Yes No 
traumatic/terrible event? For example, warfare, gang fghts, fre, domestic violence, rape, 
incest, car accident, being shot or stabbed? 
8. Have you ever experienced any strong fears? For example, of heights, insects, animals, dirt, Yes No 
attending social events, being in a crowd, being alone, being in places where it may be 
hard to escape or get help? 
9. Have you ever given in to an aggressive urge or impulse, on more than one occasion, that Yes No 
resulted in serious harm to others or led to the destruction of property? 
10. Have you ever felt that people had something against you, without them necessarily Yes No 
saying so, or that someone or some group may be trying to infuence your thoughts or 
behavior? 
11. Have you ever experienced any emotional problems associated with your sexual interests, Yes No 
your sexual activities, or your choice of sexual partner? 
12. Was there ever a period in your life when you spent a lot of time thinking and worrying Yes No 
about gaining weight, becoming fat, or controlling your eating? For example, by 
repeatedly dieting or fasting, engaging in much exercise to compensate binge eating, 
taking enemas, or forcing yourself to throw up? 
13. Have you ever had a period of time when you were so full of energy and your ideas came Yes No 
very rapidly, when you talked nearly nonstop, when you moved quickly from one activity 
to another, when you needed little sleep, and when you believed you could do almost 
anything? 
14. Have you ever had spells or attacks when you suddenly felt anxious, frightened, or uneasy Yes No 
to the extent that you began sweating, your heart began to beat rapidly, you were shaking 
or trembling, your stomach was upset, or you felt dizzy or unsteady, as if you would faint? 
Continued on next page 
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Continued 
15. Have you ever had a persistent, lasting thought or impulse to do something over and over 
that caused you considerable distress and interfered with normal routines, work, or social 
relations? Examples would include repeatedly counting things, checking and rechecking 
on things you had done, washing and rewashing your hands, praying, or maintaining a 
very rigid schedule of daily activities from which you could not deviate. 
Yes No 
16. Have you ever lost considerable sums of money through gambling or had problems at 
work, in school, or with your family and friends as a result of your gambling? 
Yes No 
17. Have you ever been told by teachers, guidance counselors, or others that you have a 
special learning problem? 
Yes No 
Source: Carroll & McGinley (2000). The MHSF-III may be reproduced or copied, in entirety, without permission. 
Counselors should bear in mind that symptoms 
of substance misuse can mimic symptoms of 
mental disorders. 
Modifed Mini Screen 
The Mini-International Neuropsychiatric Interview 
(M.I.N.I.) is a simple tool that takes 15 to 30 
minutes to administer and that covers 20 mental 
disorders and SUDs. Considerable validation 
research exists on the M.I.N.I. (Sheehan et 
al., 1998). However, a modifed version of the 
M.I.N.I.—the Modifed Mini Screen (MMS)—that 
contains only 22 items can be used to screen 
even more quickly for mental disorders in three 
diagnostic areas: mood disorders, anxiety 
disorders, and psychotic disorders. The MMS 
has been validated for use with adults in SUD 
treatment, social service, and criminal justice 
settings (Alexander, Layman, & Haugland, 2013; 
SAMHSA, 2015b). 
ASI 
The ASI (McLellan et al., 1992) does not screen for 
mental disorders and provides only a lowpower 
screen for generic mental health concerns. Use 
of the ASI ranges widely. Some SUD treatment 
programs use a scaleddown approach to gather 
basic information about a client’s alcohol use; 
drug use; legal status; and employment, family/ 
social, medical, and psychiatric status. Other 
programs use the ASI as an indepth assessment 
and treatment planning instrument, with a trained 
interviewer administering it and making complex 
judgments about the client’s presentation and 
attitudes about and willingness to take the 
ASI. Counselors can be trained to make clinical 
judgments about how the client comes across, 
how genuine and legitimate the client’s way of 
responding seems, whether there are any safety or 
selfharm concerns requiring further investigation, 
and where the client falls on a nine-point scale for 
each dimension. 
With about 200 items, the ASI is a lowpower 
instrument with a broad range, covering the seven 
areas mentioned previously and requiring about 
1 hour to complete. The continuing development 
of and research into the ASI includes training 
programs, computerization, and critical analyses. 
It is a public domain document that has been 
used widely for two decades. It has been found 
to be effective in predicting inpatient psychiatric 
admissions among people seeking SUD treatment 
(Drymalski & Nunley, 2016).  
DSM-5 Cross-Cutting Symptom Measure 
Among the major revisions to DSM-5 was the
inclusion of a newly developed patient assessment
tool to help providers screen for common mental
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disorders and symptoms needing treatment,
including major depression, generalized anxiety,
mania, somatic conditions, sleep disturbance,
cognitive dysfunction, and substance misuse. The
DSM-5 Self-Rated Level 1 Cross-Cutting Symptom
Measure—Adult contains 23 items that correspond
to diagnostic categories in DSM-5 (e.g., depressive
disorders, psychotic disorders) or to specifc symptom
domains (e.g., mania, anger, suicidal ideation).
Because the screener is included in DSM-5’s 
Section III for “emerging measures,” meaning 
it requires further research before being 
implemented in routine clinical practice, little 
is known about its validation. No published 
studies to date have examined its use with 
COD populations. Nonetheless, the measure is 
worthy of consideration, especially in research 
settings. It is available online with scoring 
information (https://www.psychiatry.org/ 
psychiatrists/practice/dsm/educational-resources/ 
assessment-measures#Disorder). 
Screening for Past and Present SUDs 
This section is intended primarily for counselors
working in mental health service settings and
suggests ways to screen clients for substance misuse. 
Screening begins with inquiry about past and 
present substance use and related problems and 
disorders. If the client answers “yes” to having 
problems or a disorder, further assessment is 
warranted. If the client acknowledges a past 
substance problem but states that it is now 
resolved, assessment is still required. Careful 
exploration of what current strategies the individual 
is using to prevent relapse is warranted. Such 
information can help ensure that the individual 
continues to use those strategies while focusing on 
mental health services. 
Screening for the presence of substance misuse 
involves four components, which are: 
• Substance misuse symptom checklists. 
• Substance misuse severity assessment. 
• Formal screening tools that work around denial. 
• Screening of urine, saliva, or hair samples. 
Symptom Checklists 
Checklists address common categories of
substances, problems associated with use for a
given substance, and a history of meeting SUD
criteria. Overly detailed checklists are unhelpful;
they lose value as simple screening tools. Including
misuse of over-the-counter medication (e.g., cold
medications) and of prescribed medication is
helpful.
Severity Assessment 
Monitor the severity of an SUD (if present). This 
process can begin with simple questions about 
past or present diagnosis of an SUD and the 
client’s experience of associated diffculties. 
DSM-5 offers guidance on assessing SUD severity 
based on symptom count. Specifcally, two to 
three symptoms would be considered a mild SUD, 
four or fve a moderate SUD, and six or more a 
severe SUD (American Psychiatric Association 
[APA], 2013). Some programs may use formal SUD 
diagnostic tools; others use the ASI (McLellan et 
al., 1992) or similar instruments, even in the mental 
disorder service setting. 
SCREENING AND 
INTOXICATION/WITHDRAWAL 
Counselors cannot formally screen or assess 
clients who are actively intoxicated. If clients are 
obviously intoxicated, treat them with empathy 
and frmness, and ensure their physical safety. 
If clients report that they are experiencing 
withdrawal, or appear to be exhibiting signs 
of withdrawal, formal withdrawal scales 
can help even inexperienced providers 
gather information from which medically 
trained personnel can determine if medical 
intervention is required. Such tools include 
the Clinical Institute Withdrawal Assessment 
of Alcohol Scale, Revised (Sullivan, Sykora, 
Schneiderman, Naranjo, & Sellers, 1989) for 
alcohol withdrawal and the Clinical Institute 
Narcotic Assessment (Zilm & Sellers, 1978) 
for opioid withdrawal. These are included in 
Appendix C. 
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Substance Misuse Screening Tools answers as at risk on the Quick Screen, the full 
NIDA-Modifed ASSIST should be administered. AUDIT and AUDIT-C 
The AUDIT (Babor, Higgins-Biddle, Saunders, 
& Monteiro, 2001) and its abbreviated version, 
the AUDIT-C (Bush, Kivlahan, McDonell, Fihn, & 
Bradley, 1998), have been validated for use in 
screening adults at risk for alcohol misuse (Dawson, 
Smith, Saha, Rubinsky, & Grant, 2012; Johnson, 
Lee, Vinson, & Seale, 2013). These instruments 
measure current alcohol use, drinking behaviors, 
and consequences of drinking. Cutoff scores 
suggesting hazardous alcohol use are 8 or higher 
on the AUDIT (Babor et al., 2001) and 3 or higher 
on the AUDIT-C for SUD or heavy drinking (Bush et 
al., 1998). Both measures are in Appendix C. 
DAST-10 
CAGE-AID 
The CAGE-AID (Cut Down, Annoyed, Guilty, Eye-
opener—Adapted to Include Drugs) is a variation 
of the four-question CAGE screener, which focuses 
solely on detecting alcohol misuse. The CAGE-AID 
instead screens for drug use and alcohol misuse. It 
is brief, valid, and reliable (Mdege & Lang, 2011), 
and recommended by the USPSTF and others for 
substance misuse screening, particularly in primary 
care populations (Halloran, 2013; Lanier & Ko, 
2008). Respondents who endorse one or more 
items on the CAGE-AID should be considered 
for full assessment of substance misuse. The 
CAGE-AID is online at https://www.hiv.uw.edu/ 
page/substance-use/cage-aid. 
NIDA-Modifed ASSIST 
WHO’s ASSIST tool (WHO ASSIST Working 
Group, 2002) is an effective measure for lifetime 
and current substance misuse, but its length and 
complex computer scoring system have hindered 
its widespread adoption. NIDA developed an 
abbreviated version called the NIDA-Modifed 
ASSIST, which is recommended by APA for use 
with DSM-5 (NIDA, 2015) and is recommended for 
primary care as well as general medical populations 
(NIDA, 2012; Zgierska, Amaza, Brown, Mundt, & 
Fleming, 2014). 
The NIDA-Modifed ASSIST can be completed 
online (www.drugabuse.gov/nmassist/) or on paper. 
It opens with a Quick Screen to determine whether 
further assessment is warranted. If the client 
The DAST-10 (Skinner, 1982) is a moderately-to-
highly reliable and valid measure that has been 
widely used in practice and research (Mdege & 
Lang, 2011; Yudko, Lozhkina, & Fouts, 2007). It 
assesses past-year use of substances other than 
alcohol and can be administered quickly. Scores 
of 3 or higher warrant consideration of further 
assessment for a possible SUD (Skinner, 1982). The 
DAST-10 can be accessed online (https://www.hiv. 
uw.edu/page/substance-use/dast-10). 
MAST 
The MAST (Selzer, 1971) is a widely used self-
report screening tool for problematic substance 
use. A systematic review of its psychometric 
properties suggests the MAST is moderate to 
robust in reliability and validity (Minnich, Erford, 
Bardhoshi, & Atalay, 2018). 
This 25-item measure asks about lifetime alcohol 
use and consequences. It takes 8 to 10 minutes to 
complete. A score of 0 to 3 suggests no drinking 
problems. A score of 4 suggests early or moderate 
problems. A score of 5 or higher indicates problem 
drinking and warrants further assessment. See 
Appendix C for the measure. 
SSI-SA 
Developed by CSAT, the SSI-SA (CSAT, 1994) 
screens for alcohol consumption and other 
substance use, preoccupation and loss of control, 
negative consequences of substance use, problem 
recognition, and tolerance and withdrawal. 
The SSI-SA has strong psychometric properties 
(Boothroyd, Peters, Armstrong, Rynearson-Moody, 
& Caudy, 2015) and includes items drawn from 
existing validated substance screeners, including 
the AUDIT, CAGE, DAST, and MAST. It is often 
used in criminal justice settings (SAMHSA, 2015b) 
but also has been found effective in hospital 
settings (Mdege & Lang, 2011). A score of 4 or 
higher is considered indicative of moderate to 
high risk of substance misuse and warrants further 
assessment (Boothroyd et al., 2015). See Appendix 
C for this instrument. 
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Trauma Screening 
Trauma refers to an event or circumstance 
experienced, witnessed, or learned of by an 
individual that has a protracted, negative infuence 
on his or her physical, emotional, psychological, 
social, spiritual, or functional well-being. Common 
traumatic events include childhood maltreatment 
(e.g., physical, sexual, or emotional abuse; neglect); 
being a victim of physical or sexual assault; 
experiencing a terrorist event, natural or man-made 
disaster, accident, fre, or mass casualty event; 
repeatedly being exposed to details of horrifc 
or violent events (e.g., frst responders seeing 
injured or dead victims, police offcials repeatedly 
hearing details about child abuse); or learning that 
something extremely disturbing happened to a 
loved one or close friend (e.g., learning that your 
child has died). 
Trauma is common in individuals with SUDs, 
mental disorders, or both, particularly women and 
military populations (Berenz & Coffey, 2012; Carter, 
Capone, & Short, 2011; Gilmore et al., 2016; Kline 
et al., 2014; Konkoly Thege et al., 2017; Mandavia, 
Robinson, Bradley, Ressler, & Powers, 2016; 
Mason & Du Mont, 2015; Palmer et al., 2016; Vest, 
Hoopsick, Homish, Daws, & Homish, 2018; Walsh, 
McLaughlin, Hamilton, & Keyes, 2017; see also 
Chapter 4 for more discussion). 
To determine whether trauma screening is
warranted, counselors can ask clients about past
traumatizing events directly or use a structured
tool, like the Adverse Childhood Experiences
Study Score Calculator (available online at https:// 
acestoohigh.com/got-your-ace-score/). In screening
for a history of trauma or obtaining a preliminary
diagnosis of PTSD, asking clients to describe
traumatic events in detail can be traumatizing. Limit
questioning to very brief and general questions,
such as “Have you ever experienced childhood
physical abuse? Sexual abuse? A serious accident?
Violence or the threat of it? Have there been
experiences in your life that were so traumatic they
left you unable to cope with day-to-day life?”
To screen for PTSD, assuming the client has a
positive trauma history, consider using these scales: 
• The Primary Care PTSD Screen for DSM-5 (Prins 
et al., 2015) and administration and scoring 
information are available online (www.ptsd. 
va.gov/professional/assessment/documents/pc-
ptsd5-screen.pdf). 
• The PTSD Checklist for DSM-5 (Weathers 
et al., 2013) and administration and scoring 
information are available online (https://www. 
ptsd.va.gov/professional/assessment/adult-sr/ 
ptsd-checklist.asp). 
See TIP 57, Trauma-Informed Care in Behavioral
Health Services (SAMHSA, 2014b), for more indepth
discussion of screening, assessment, and manage-
ment of trauma in behavioral health populations.
Valuable guidance about counseling people with
CODs and trauma is in Chapter 7 of this TIP. 
Assessment Step 4: Determine Quadrant 
and Locus of Responsibility 
Quadrants of care (i.e., Four Quadrants Model) is a 
conceptual framework that classifes clients in four 
basic groups based on relative symptom severity, 
not diagnosis (Exhibit 3.8). 
Quadrant assignment is based on the severity of 
the mental disorders and SUDs as follows: 
• Category/Quadrant I: This quadrant includes 
individuals with low-severity substance misuse 
and low-severity mental disorders. These 
low-severity individuals can be accommodated 
in intermediate outpatient settings of either 
mental disorder or chemical dependency 
programs, with consultation or collaboration 
between settings if needed. Alternatively, 
some people will be identifed and managed 
in primary care settings with consultation 
from mental health service or SUD treatment 
providers. 
• Quadrant II: This quadrant includes individuals 
with high-severity mental disorders who are 
usually identifed as priority clients within the 
mental health system and who also have low-
severity SUDs (e.g., SUD in remission or partial 
remission). These individuals ordinarily receive 
continuing care in the mental health system 
and are likely to be well served in a variety of 
intermediate-level mental health programs using 
integrated case management. 
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EXHIBIT 3.8. Level of Care Quadrants 
• Quadrant III: This quadrant includes 
individuals who have severe SUDs and low- or 
moderate-severity mental disorders. They are 
generally well accommodated in intermediate-
level SUD treatment programs. In some cases, 
coordination and collaboration with affliated 
mental health programs are needed to provide 
ongoing treatment of the mental disorders. 
• Quadrant IV: Quadrant IV has two subgroups.
One includes people with serious, persistent
mental illness (SPMI) who also have severe
and unstable SUDs. The other includes people
with severe and unstable SUDs and severe and
unstable behavioral problems (e.g., violence,
suicidality) who do not (yet) meet criteria for
SPMI. These individuals require intensive,
comprehensive, and integrated services for both
their SUDs and mental disorders. The locus of
treatment can be specialized residential SUD
treatment programs such as modifed therapeutic
communities in state hospitals, jails, or even
in settings that provide acute care such as
emergency departments (EDs). 
The quadrants of care were derived from a con-
ference, the National Dialogue on Co-Occurring
Mental Health and Substance Abuse Disorders,
supported by SAMHSA and two of its centers— 
CSAT and the Center for Mental Health Services— 
and co-sponsored by the National Association of
State Mental Health Program Directors (NASMHPD)
and the National Association of State Alcohol
and Drug Abuse Directors (NASADAD). The
quadrants of care model was originally developed
by Ries (1993) and used by the State of New York
(NASMHPD & NASADAD, 1999; see also Rosenthal,
1992). It has two distinct uses: 
• To help conceptualize an individual client’s 
treatment and to guide improvements in system 
integration (for example, if the client has acute 
psychosis and is known to the treatment staff 
to have a history of alcohol use disorder (AUD), 
the client will clearly fall into Category IV—that 
is, severe mental disorder and severe SUD). 
However, the severity of the client’s needs, 
diagnosis, symptoms, and impairments all 
determine level of care placement. 
• To guide improvements in systems integration, 
including effcient allocation of resources. 
The model is considered valid, reliable, and 
feasible (McDonell et al., 2012), which is 
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particularly benefcial for clients with CODs 
given that conditions tend to fuctuate over time, 
underscoring the need for a stable framework that 
can accurately classify individuals and capture their 
potential treatment needs throughout the course 
of their illnesses. 
Step 2 will collect most information necessary 
to make this determination, but there will 
sometimes be additional nuances to consider. 
Certain states formally specify procedures for 
quadrant determination. In the absence of formal 
procedures, SUD treatment providers in any setting 
can follow Exhibit 3.8. 
Determination of SMI Status 
Every state mental health system has developed
a set of specifc criteria for determining who can
be considered seriously mentally ill and therefore
eligible to be considered a mental health priority
client. These criteria are based on combinations
of specifc diagnoses, severity of disability, and
duration of disability (usually 6 months to 1 year).
Some require that the condition be independent of
an SUD. These criteria are different for every state.
It would be helpful for SUD treatment providers to
obtain copies of the criteria for their own states, as
well as copies of the specifc procedures by which
eligibility is established by their states’ mental health
systems. By determining that a client might be
eligible for consideration as a mental health priority
client, the SUD treatment counselor can assist the
client in accessing various services and benefts the
client may not know are open to her or him. 
To gauge SMI status, start by asking whether 
the client already gets mental health priority 
services (e.g., “Do you have a mental health case 
manager?” “Are you a Department of Mental 
Health client?”). 
• If the client already is a mental health client, 
then he or she will be assigned to quadrant II 
or IV. Contact the mental health case manager 
and establish collaboration to promote case 
management. 
• If the client is not already a mental health client 
but appears to be eligible, and the client and 
family are willing, arrange a referral for eligibility 
determination. 
• Clients who present in SUD treatment settings 
who look as if they might have SMI, but have 
not been so determined, should be considered 
to belong to quadrant IV. 
For assistance in determining the severity of 
symptoms and disability, the SUD treatment 
provider can use the severity criteria listed 
in DSM-5. For disorders in which DSM-5 does 
not offer any guidance on determining severity, 
counselors can use Dimension 3 (Co-Morbidity) 
subscales in the LOCUS (see the section 
“Assessment Step 5: Determine Level of Care”), 
particularly the levels of severity of comorbidity 
and impairment/functionality. 
Determination of Severity of SUDs 
Presence of active or unstable substance misuse 
or serious substance misuse as indicated by a 
DSM-5 severity rating of “severe” would identify 
the individual as being in quadrant III or IV. Less 
serious SUD (a DSM-5 severity rating of “mild” or 
“moderate”) identifes the individual as being in 
quadrant I or II. 
If the client is determined to have SMI with a 
serious SUD, he or she falls in quadrant IV; those 
with SMI and a mild SUD fall in quadrant II. A 
client with a serious SUD who has mental disorder 
symptoms that do not constitute SMI falls into 
quadrant III. A client with mild to moderate mental 
disorder symptoms and a less serious SUD falls into 
quadrant I. 
Clients in quadrant III who present in SUD 
treatment settings are often best managed by 
receiving care in the SUD treatment setting, with 
collaborative or consultative support from mental 
health providers. Individuals in quadrant IV usually 
require intensive intervention to stabilize and 
determine eligibility for mental health services 
and appropriate locus of continuing care. If they 
do not meet SMI criteria, once their more serious 
mental symptoms have stabilized and substance 
use is controlled initially, they begin to look like 
individuals in quadrant III, and can respond to 
similar services. 
Note, however, that this discussion of quadrant 
determination is not validated by clinical research. 
It is merely a practical approach to adapting an 
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ASSESSMENT STEP 5—APPLICATION TO CASE EXAMPLES (JANE B.) 
Jane B. is a 28-year-old single White woman diagnosed with paranoid schizophrenia, AUD, and 
cocaine use disorder. She has a history of multiple episodes of sexual victimization. She is experiencing 
homelessness (living in a shelter), is actively psychotic, and will not admit to substance misuse. She often 
visits the local ED for mental and medical complaints but refuses follow-up treatment. Her main requests 
are for money and food, not treatment. Jane has been offered involvement in a housing program that 
requires no treatment engagement or sobriety but has refused because of paranoia about working 
with staff in this setting. Jane B. declines medication, given her paranoia, but does not seem acutely 
dangerous to herself or others. 
The severity of Jane B.’s condition and her psychosis, homelessness, and lack of stability may lead the 
provider initially to consider psychiatric hospitalization or referral for residential SUD treatment. In 
fact, application of assessment criteria in the LOCUS might have led easily to that conclusion. In the 
LOCUS, more fexible matching is possible. The frst consideration is whether the client meets criteria for 
involuntary psychiatric commitment (usually, suicidal or homicidal impulses, or inability to feed oneself 
or obtain shelter). In this instance, she is psychotic and experiencing homelessness but has been able to 
fnd food and shelter; she is unwilling to accept voluntary mental health services. Further, residential SUD 
treatment is inappropriate, both because she is completely unmotivated to get help and because she is 
likely to be too psychotic to participate in treatment effectively. The LOCUS would therefore recommend 
Level 3 – “High Intensity Community Based Services.” 
If after extended participation in the engagement strategies described earlier, she began to take 
antipsychotic medication, after some time her psychosis might clear up, and she might begin to express 
interest in getting sober. In that case, if she had determined that she is unable to get sober on the street, 
residential SUD treatment would be indicated. Because of the longstanding severity of her mental illness, 
she likely would continue to have some level of symptoms of her mental disorder and disability even 
when medicated. In this case, Jane B. probably would require a residential program able to supply an 
enhanced level of services. 
existing framework for clinical use, in advance of 
more formal processes being developed, tested, 
and disseminated. 
In many systems, the process of assessment 
stops largely after assessment Step 4 with the 
determination of placement. Some information 
from subsequent steps (especially Step 7) may be 
included in this initial process, but usually more 
indepth or detailed consideration of treatment 
needs may not occur until after “placement” in an 
actual treatment setting. 
Assessment Step 5: Determine Level of Care 
Client placement in the appropriate care setting for 
his or her needs is necessary to optimize treatment 
completion and desirable outcomes. Placing 
a client in a level of care is also often required 
by private and public payers (i.e., Medicaid) for 
authorization of mental health services or SUD 
treatment decisions. Thus, the availability of valid 
and reliable commonly used tools can not only help 
increase the odds of effective treatment matching 
but can help providers meet documentation 
requirements for reimbursement. 
Tools for Determining Level of Care 
LOCUS 
The LOCUS Adult Version 20 (Sowers, 2016) can 
be used as a systemwide level of care assessment 
instrument for either mental disorder service 
settings only or for both mental disorder service 
and SUD treatment settings. The LOCUS uses 
multiple dimensions of assessment, including: 
• Risk of harm. 
• Functional status. 
• Comorbidity (medical, addictive, psychiatric). 
• Recovery environment. 
• Treatment and recovery history. 
• Engagement and recovery status. 
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The LOCUS (Plakun, 2018) helps: 
• Determine a client’s level of service needs. 
• Describe all levels of care, from short-term 
outpatient services to inpatient residential care. 
• Provide a quantifed approach to defning level 
of care based on scores on its six dimensions. 
LOCUS has a point system for each dimension 
that permits aggregate scoring to suggest level of 
service intensity. It permits level of care assessment 
for clients with mental disorders or SUDs only, as 
well as for those with CODs. It is highly correlated 
with the DSM-IV-TR Global Assessment of 
Functioning scale and has demonstrated good 
sensitivity in assessing severity of symptoms, 
particularly those that are psychiatric in nature 
(Thurber, Wilson, Realmuto, & Specker, 2018).  
Assessment Step 6: Determine Diagnosis 
Determining the diagnosis can be a formidable 
clinical challenge in the assessment of CODs. 
Clinicians in both mental disorder services and SUD 
treatment settings recognize that it can be impos-
sible to establish a frm diagnosis when confronted 
with the mixed presentation of mental symptoms 
and ongoing substance misuse. Of course, 
substance misuse contributes to the emergence 
or severity of mental symptoms and therefore 
confounds the diagnostic picture. Therefore, this 
step often includes dealing with confusing diagnos-
tic presentations. Three guiding principles can help 
counselors thoroughly assess the client’s current 
and past history of mental and substance-related 
symptoms and problems: 
1. Conduct a thorough interview to establish past 
mental and SUD diagnoses and treatments. 
2. Document all past diagnoses, including their 
relationship to certain time periods (e.g., just 
before the diagnosis, just after the diagnosis, 
during symptomatic phases) and events, 
symptoms, and levels of functioning during 
those time periods. 
3. Determine the timing of mental disorder
symptoms, particularly in relationship to periods
of substance use and SUDs (e.g., during periods
of abstinence, within 30 days of onset of an SUD). 
Addiction counselors who want to improve their 
competencies to address CODs are urged to 
become conversant with the basic resource used 
to diagnose mental disorders, DSM5 (APA, 2013). 
Indepth discussion of what counselors need 
to know concerning DSM-5 diagnostic criteria, 
differential diagnosis, and management of mental 
disorders in the context of co-occurring addiction 
is in Chapter 4. 
Principles of Determining Diagnosis 
1. The Importance of Client History 
Diagnosis is established more by history than 
by current symptom presentation. This applies 
to both mental disorders and SUDs. The frst 
step in determining the diagnosis is to determine 
whether the client has an established diagnosis or 
is receiving ongoing treatment for an established 
disorder. This information can be obtained by the 
counselor as part of the routine intake process. If 
there is evidence of a disorder but the diagnosis 
or treatment recommendations are unclear, the 
counselor should immediately begin the process of 
obtaining this information from collaterals. If there 
is a valid history of a mental disorder diagnosis 
at admission to SUD treatment, that diagnosis 
should be considered presumptively valid for initial 
treatment planning, and any existing stabilizing 
treatment should be maintained. In addition to 
confrming an established diagnosis, the client’s 
history can provide insight into patterns that may 
emerge and add depth to knowledge of the client. 
For example, if a client comes into the clinician’s 
offce and says she hears voices (whether or not 
she is sober currently), no diagnosis should be 
made on that basis alone. People hear voices for 
many reasons. They may be related to substance-
related syndromes (e.g., substance-induced 
psychosis or hallucinosis, which is the experience 
of hearing voices that the client knows are not 
real, and that may say things that are distressing 
or attacking—particularly when the client has a 
history of trauma—but are not bizarre). With CODs, 
most causes will be independent of substance 
use (e.g., schizophrenia, schizoaffective disorder, 
affective disorder with psychosis or dissociative 
hallucinosis related to PTSD). Psychosis usually 
involves loss of ability to tell that the voices are 
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not real and increased likelihood that they are 
bizarre in content. Methamphetamine psychosis 
is particularly confounding because it can mimic 
schizophrenia. Many clients with psychotic 
disorders will still hear voices when on medication, 
but the medication makes the voices less bizarre 
and helps clients know they are not real. 
If clients state, for example, that they have heard 
voices, although not as much as they used to; have 
been abstinent for 4 years; have remembered to 
take medication most days, but may forget; and 
have had multiple hospitalizations for psychosis 
10 years ago but none since, then they clearly 
have a diagnosis of psychotic illness (probably 
schizophrenia or schizoaffective disorder). Given 
their continuing symptoms while abstinent and on 
medication, it is quite possible that the diagnosis 
will persist. 
Chapter 4 offers additional information about 
differential diagnosis. 
2. Documenting Prior Diagnoses 
Even though SUD treatment counselors may not 
be licensed to make a mental disorder diagnosis, 
they should document prior diagnoses and gather 
information related to current diagnoses. 
Diagnoses established by history should not be 
changed at the point of initial assessment. If the 
clinician has a suspicion that a long-established 
diagnosis may be invalid, he or she needs to take 
time to gather additional information, consult with 
collaterals, get more careful and detailed history, 
and develop a better relationship with the client 
before recommending diagnostic reevaluation. 
The counselor should raise concerns related to 
diagnosis with the clinical supervisor or at a team 
meeting. 
In many instances, no well-established mental 
disorder diagnosis exists, or multiple diagnoses 
confuse the picture. Even with an established 
diagnosis, gathering information to confrm that 
diagnosis is helpful. During initial assessment, 
SUD treatment counselors can gather data that 
can assist diagnosis, either by supporting the 
fndings of the existing mental health assessment 
or by providing useful background information 
in the event a new mental health assessment is 
conducted. The key is not merely to gather lists 
of past and present symptoms but to connect 
those symptoms to periods in the client’s life that 
are helpful in the diagnostic process—namely, 
before the onset of an SUD and during periods 
of abstinence (or very limited use) or after SUD 
onset and persisting for more than 30 days. 
The clinician should determine whether mental 
disorder symptoms occur only when the client is 
using substances actively. Therefore, it is important 
to determine the nature and severity of the 
symptoms of the mental disorder when the SUD 
is stabilized. Note whether the client recently had 
a complete physical, including appropriate labs. 
Physical diseases can also present with or mimic 
mental disorders (e.g., hypothyroidism presenting 
with or like depression) and need to be identifed 
and treated accordingly. 
3. Linking Mental Symptoms to Specifc Periods 
For diagnostic purposes, it is almost always 
necessary to tie mental disorder symptoms to 
specifc periods of time in the client’s history, in 
particular those times when an active SUD was 
not present. 
Most SUD assessment tools do not require 
connection of mental disorder symptoms to 
substance use or abstinence. Mental disorder 
symptom information obtained from such tools 
can confuse counselors and make them feel that 
the whole process is not worth the effort. In fact, 
when clinicians seek information about mental 
disorder symptoms during periods of abstinence, 
such information is almost never part of traditional 
assessment forms. The mental disorder history 
and substance use history have in the past been 
collected separately and independently. As a result, 
the opportunity to evaluate interaction, which is 
the most important diagnostic information beyond 
the history, has routinely been lost. Newer and 
more detailed assessment tools overcome these 
historical and potentially misleading divisions. 
The M.I.N.I. Plus (a more detailed version of the
Mini-International Neuropsychiatric Interview
[Sheehan et al., 1998]) is structured to connect
any identifed symptoms to periods of abstinence.
Clinicians can use this information to distinguish
substance-induced mental disorders from
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independent mental disorders. The Timeline Follow-
Back Method also is a valid and practical tool that
can be used with individuals with substance misuse
or CODs (Hjorthoj, Hjorthoj, & Nordentoft, 2012) to
gather a detailed and comprehensive assessment of
patterns of substance misuse beyond just quantity
and frequency.
Consequently, the SUD treatment counselor can 
proceed in two ways: 
• Ask whether mental disorder symptoms or 
treatments identifed in screening were present 
during periods of 30 days of abstinence 
or longer, or were present before onset of 
substance use. (“Did this symptom or episode 
occur during a period when you were abstinent 
for at least 30 days?”) 
• Defne with the client specifc time periods when 
the SUD was in remission, and then get detailed 
information about mental disorder symptoms, 
diagnoses, impairments, and treatments during 
those periods of time. (“Can you recall a time 
when you were not using? Did these symptoms 
[or whatever the client has reported] occur 
during that period?”) This approach may yield 
more reliable information. 
During this latter process, the counselor can use 
one of the medium-power symptom screening 
tools as a guide. Alternatively, the counselor can 
use the handy outlines of the DSM-5 criteria for 
common disorders (provided in Chapter 4) and 
inquire whether those criteria symptoms were met, 
whether they were diagnosed and treated, and if 
so, with what methods and how successfully. This 
information can suggest or support the accuracy of 
diagnoses. Documentation also can facilitate later 
diagnostic assessment by a mental health–trained 
clinician. 
Assessment Step 7: Determine Disability 
and Functional Impairment 
Determination of both current and baseline 
functional impairment contributes to identifcation 
of the need for case management or higher 
levels of support. This step also relates to the 
determination of level of care requirements. 
Assessment of current cognitive capacity, social 
skills, and other functional abilities also is necessary 
to determine whether there are defcits that may 
require modifcation in the treatment protocols of 
relapse prevention efforts or recovery programs. 
For example, the counselor might inquire about 
past participation in special education or related 
testing. 
Assessing Functional Capability 
Current level of impairment is determined by 
assessing functional capabilities and defcits 
in each of the areas indicated in the following 
list. Similarly, baseline level of impairment is 
determined by identifying periods of extended 
abstinence and mental health stability (greater than 
30 days) according to the methods described in the 
previous assessment step. The clinician determines: 
• Is the client capable of living independently (in 
terms of independent living skills, not in terms 
of maintaining abstinence)? If not, what types of 
support are needed? 
• Is the client capable of supporting himself or 
herself fnancially? If so, through what means? 
If not, is the client disabled, or dependent on 
others for fnancial support? 
• Can the client engage in reasonable social 
relationships? Are there good social supports? 
If not, what interferes with this ability, and what 
supports would the client need? 
• What is the client’s level of cognitive 
functioning? Is there a developmental or 
learning disability? Are there cognitive or 
memory impairments that impede learning? 
Is the client limited in ability to read, write, 
or understand? Is there diffculty focusing, 
concentrating, and completing tasks? 
Functional Assessment Tools 
Several freely available, reliable, well-validated 
tools measure functioning and impairment in 
clients with mental illness, substance misuse, or 
both (Gold, 2014; National Academies of Sciences, 
Engineering, and Medicine, 2016; Sanchez-
Moreno, Martinez-Aran, & Vieta, 2017), including: 
• WHO Disability Assessment Schedule 2.0 
([WHODAS 2.0] Üstün & WHO, 2010; www. 
who.int/classifcations/icf/whodasii/en/). When 
DSM-5 removed the Global Assessment of 
Functioning (Axis V in DSM-IV), APA proposed 
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in its place the WHODAS 2.0 as a tool to rate 
global impairment and functional capabilities 
(APA, 2013). The WHODAS 2.0 assesses six 
major domains, which are: 
-
-
-
-
-
-
Understanding and communicating. 
Getting around (mobility). 
Self-care. 
Getting along with people (social and 
interpersonal functioning). 
Life activities (home, academic, and 
occupational functioning). 
Participation in society (participation in family, 
social, and community activities). 
• ASI (McLellan et al., 1992), a mental health 
screening tool that provides information about 
level of functioning for clients with SUDs. This 
is valuable when supplemented by interview 
information. (Note that the ASI also exists in an 
expanded version specifcally for women, ASI-F 
[SAMHSA, 2009c].) 
In a clinical interview, the counselor also should 
inquire about any current or past diffculties 
the client has had in learning or using relapse 
prevention skills, participating in mutual-support 
recovery programs, or obtaining medication 
or following medication regimens. In the same 
vein, the clinician may inquire about use of 
transportation, budgeting, self-care, and other 
related skills, and their effect on life functioning 
and treatment participation. 
For individuals with CODs, impairment may be 
related to intellectual/cognitive ability or the 
mental disorder, which may exist in addition to 
the SUD. The clinician should establish level of 
intellectual/cognitive functioning in childhood, 
whether impairment persists, and if so, at what 
level, during the periods when substance use is 
in full or partial remission, just as in the previous 
discussion of diagnosis. 
Determining the Need for Capable or 
Enhanced-Level Services 
A specifc tool to assess the need for capable- or 
enhanced-level services for people with CODs 
currently is not available. The consensus panel 
recommends a process of “practical assessment” 
that seeks to match the client’s assessment (mental 
health, substance misuse, level of impairment) 
to the type of services needed. The individual 
may even be given trial tasks or assignments to 
determine in concert with the counselor if his or 
her performance meets the requirements of the 
program being considered. 
ASAM criteria for COD-capable and -eligible 
programs are as follows (Mee-Lee, Shulman, 
Fishman, Gastfriend, & Miller 2013): 
• Co-occurring–capable (COC) programs in 
addiction treatment focus primarily on SUDs 
but can treat patients with subthreshold or 
diagnosable but stable mental disorders 
(Mee-Lee et al., 2013). Mental health services 
may be onsite or available by referral. COC 
programs in mental health are those that 
mainly focus on mental disorders but can treat 
patients with subthreshold or diagnosable but 
stable SUDs (Mee-Lee et al., 2013). Addiction 
counselors are onsite or available through 
referral. 
• Co-occurring–enhanced (COE) programs 
have more integrated addiction and mental 
health services and have staff who are trained 
to recognize the signs and symptoms of both 
disorders and are competent in providing 
integrated treatment for both mental disorders 
and SUDs at the same time. 
• Complexity-capable programs are designed 
to meet the needs of individuals (and their 
families) with multiple complex conditions 
that extend beyond just CODs. Physical and 
psychosocial conditions and treatment areas 
of focus often include chronic medical illnesses 
like HIV, trauma, legal matters, housing 
diffculties, criminal justice system involvement, 
unemployment, education concerns, childcare 
or parenting diffculties, and cognitive 
dysfunctions. 
Assessment Step 8: Identify Strengths 
and Supports 
All assessment must include some specifc 
attention to the individual’s current strengths, 
skills, and supports, both in relation to general 
life functioning, and in relation to his or her ability 
to manage either mental disorders or SUDs. 
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This often provides a more positive approach to 
treatment engagement than does focusing exclu-
sively on defcits that need to be corrected. This 
is no less true for individuals with serious mental 
disorders than it is for people with SUDs only. 
Questions might focus on: 
• Talents and interests. 
• Areas of educational interest and literacy; 
vocational skill, interest, and ability, such 
as social skills or capacity for creative 
self-expression. 
• Areas connected with high levels of motivation 
to change, for either disorder or both. 
• Existing supportive relationships—treatment, 
peer, or family—particularly ongoing mental 
disorder treatment relationships. 
• Previous mental health services and SUD 
treatment successes and exploration of what 
worked. 
• Identifcation of current successes: What has the 
client done right recently for either disorder? 
• Building treatment plans and interventions 
based on utilizing and reinforcing strengths 
and extending or supporting what has worked 
previously. 
ASSESSMENT STEP 8— 
APPLICATION TO CASE 
EXAMPLES (JANE B.) 
Jane B. expressed signifcant interest in
work once her paranoia subsided. She was
attempting to address her SUD on an outpatient
basis, as a residential treatment program was
unavailable. Her case management team
noted her interest and experience in caring
for animals. Via individualized placement and
support, they helped her obtain a part-time job
at a local pet shop two afternoons per week. She
was proud of her job and reported that it helped
maintain her motivation to stay away from
substances and to keep taking medication. 
For individuals with SMI or substance misuse, the 
Individualized Placement and Support model of 
psychiatric rehabilitation has demonstrated that it is 
a cost-effective way to generate positive vocational 
and mental health outcomes compared with 
other models of vocational rehabilitation for this 
population, including improved rates of obtaining 
competitive employment, greater number of hours 
worked, increased wages, improvements in self-
esteem and quality of life, and reductions in mental 
health service use (Drake, Bond, Goldman, Hogan, 
& Karakus, 2016; LePage et al., 2016). In this 
model, clients with disabilities who want to work 
may be placed in sheltered work activities based 
on strengths and preferences, even when actively 
using substances and inconsistently complying 
with medication regimens. In nonsheltered work 
activities, it is critical to remember that many 
employers have substance-free workplace policies. 
Participating in ongoing jobs is valuable to self-
esteem in itself and can generate the motivation 
to address mental disorders and substance misuse 
problems, as they appear to interfere specifcally 
with work success. Taking advantage of educational 
and volunteer opportunities also may enhance 
self-esteem and is often a frst step in securing 
employment. 
Assessment Step 9: Identify Cultural and 
Linguistic Needs and Supports 
Detailed cultural assessment is beyond the 
scope of this publication. Cultural assessment of 
individuals with CODs is not substantially different 
from cultural assessment for those with SUDs or 
mental disorders only, but some specifc areas are 
worth addressing, such as: 
• Problems with literacy. 
• Not ftting into the treatment culture (SUD or 
mental health culture); confict in treatment. 
• Cultural and linguistic service barriers. 
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ASSESSMENT STEP 9—APPLICATION TO CASE EXAMPLE (GEORGE T.) 
The client is a 34-year-old married, employed African American man with cocaine use disorder, alcohol 
misuse, and bipolar disorder (stabilized on lithium) mandated to cocaine treatment by his employer after 
a failed drug test. George T. and his family realize he needs help not to use cocaine. He complains that his 
mood swings intensify when he is using cocaine. 
George T.’s counselor originally referred him to Cocaine Anonymous (CA). When George T. went, however, 
he reported back to the counselor that he did not feel comfortable there. He felt that as a family man with 
a responsible job, he had pulled himself out of the “street culture” that this specifc meeting refected. He 
also noted that most participants were White. Unlike many people with CODs who feel more ashamed of 
mental disorders than addiction, he felt more ashamed at the CA meeting than at his support group for 
people with mental disorders. Therefore, for George T., it was culturally appropriate to address the shame 
surrounding his substance use, encourage him to try other mutual-support program meetings, and 
continue to provide positive feedback about his attendance at the support group for his mental disorder. 
Not Fitting Into the Treatment Culture 
To a certain degree, individuals with addiction 
and SMI may have diffculty ftting into existing 
treatment cultures. Many clients are aware of a 
variety of different attitudes toward their disorders 
that can affect relationships with others. Traditional 
culture carriers (parents, grandparents) may have 
different views of clients’ problems and the most 
appropriate treatment compared with peers. 
Individual clients may have positive or negative 
allegiance to a variety of peer or treatment cultures 
(e.g., mental health consumer movement, having 
mild or moderate severity mental disorders vs. SMI, 
12-Step or dual recovery mutual support) based on 
past experience or on fears and concerns related to 
the mental disorder. Specifc questions to explore 
with the client include: 
• “How are your substance use and mental health 
concerns defned by your parents? Peers? Other 
clients?” 
• “What do they think you should be doing to 
remedy these problems?” 
• “How do you decide which suggestions to 
follow?” 
• “In what kinds of treatment settings do you feel 
most comfortable?” 
• “What do you think I (the counselor) should be 
doing to help you improve your situation?” 
Cultural and Linguistic Service Barriers 
Cultural and linguistic barriers can compound 
access to COD treatment. The assessment process 
must address whether these barriers prevent 
access to care (e.g., the client reads or speaks only 
Spanish; the client is illiterate) and if so, determine 
options for providing more individualized 
intervention or for integrating intervention into 
naturalistic culturally and linguistically appropriate 
human service settings. 
Chapter 5 describes components of culturally 
responsive services. Chapter 6 offers information 
about the needs of people of diverse racial/ethnic 
backgrounds with CODs and how counselors 
can help reduce treatment access and outcome 
disparities experienced by marginalized racial/ 
ethnic groups. 
Assessment Step 10: Identify Problem 
Domains 
Individuals with CODs may have diffculties 
in multiple life domains (e.g., medical, legal, 
vocational, family, social). The ASI can identify 
and quantify substance use–related problems 
across domains, to see which require attention. 
It is used most effectively as a component of a 
comprehensive assessment. 
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A comprehensive, biopsychosocial evaluation 
for individuals with CODs requires clarifying how 
each disorder interacts with the problems in each 
domain, as well as identifying contingencies that 
might promote treatment adherence for mental 
health, SUD treatment, or both. Information about 
others who might assist in the implementation 
of such contingencies (e.g., probation offcers, 
family, friends) needs to be gathered, including 
appropriate releases to obtain information. 
Assessment Step 11: Determine Stage of 
Change 
A key evidence-based best practice for treatment 
matching clients with CODs is to match 
interventions not only to specifc diagnoses but 
also to stage of change and stage of treatment 
for each disorder. 
In SUD treatment settings, stage of change 
assessment usually involves determination of 
Prochaska and DiClemente Stages of Change: 
precontemplation, contemplation, preparation 
(or determination), action, maintenance, and 
relapse (Prochaska & DiClemente, 1992). This 
can involve using questionnaires such as the 
University of Rhode Island Change Assessment 
Scale (McConnaughy, Prochaska, & Velicer, 1983; 
available at https://habitslab.umbc.edu/urica/) or 
the Stages of Change Readiness and Treatment 
Eagerness Scale (Miller & Tonigan, 1996; available 
at https://casaa.unm.edu/inst/SOCRATESv8.pdf). 
Stage of change can be determined clinically by 
interviewing clients and evaluating their responses 
in the context of change. For example, one 
approach to stage of change identifcation is to ask 
clients, for each problem, to select the statement 
that most closely fts their view of that problem: 
• No problem, no interest in change, or both 
(Precontemplation). 
• Might be a problem; might consider change 
(Contemplation). 
• Defnitely a problem; getting ready to change 
(Preparation). 
• Actively working on changing, even if slowly 
(Action). 
• Has achieved stability, and is trying to maintain 
(Maintenance). 
Stage of change assessment ideally will be applied 
separately to each mental disorder and to each 
SUD. For example, a client may be willing to take 
medication for a depressive disorder but unwilling 
to discuss trauma, or motivated to stop using 
cocaine but unwilling to consider alcohol as a 
problem. 
For more indepth discussion of the stages of 
change and motivational enhancement, see TIP 35, 
Enhancing Motivation for Change in Substance Use 
Disorder Treatment (SAMHSA, 2019c). 
Assessment Step 12: Plan Treatment 
A comprehensive assessment is the basis for 
an individualized treatment plan. Appropriate 
treatment plans and treatment interventions can 
be quite complex, depending on what might be 
discovered in each domain. No single, correct 
intervention or program exists for individuals 
with CODs. Rather, match appropriate 
treatment to individual needs per these multiple 
considerations. 
The following case (Maria M.) illustrates how 
the noted factors help generate an integrated 
treatment plan that is appropriate to the needs and 
situation of a particular client. 
Chapter 3 64 
TIP 42
 
 
 
Chapter 3—Screening and Assessment of Co-Occurring Disorders 
ASSESSMENT STEP 12—APPLICATION TO CASE EXAMPLE (MARIA M.) 
The client is a 38-year-old Latina woman who is the mother of two teenagers. Maria M. presents with an 
11-year history of cocaine dependence, a 2-year history of opioid dependence, and a history of trauma 
related to a longstanding abusive relationship (now over for 6 years). She is not in an intimate relationship 
at present and there is no current indication that she is at risk for either violence or self-harm. She also 
has persistent major depression and panic treated with antidepressants. She is very motivated to receive 
treatment. 
Ideal Integrated Treatment Plan: The plan for Maria M. might include medication-assisted treatment 
(e.g., methadone or buprenorphine), continued antidepressant medication, a mutual-support program, 
and other recovery group support for cocaine dependence. She also could be referred to a group for both 
SUD and trauma that is designed specifcally to help reduce symptoms of trauma and resolve long-term 
problems. 
Individual, group, and family interventions could be coordinated by the primary counselor from opioid 
maintenance treatment. The focus of these interventions might be on relapse prevention skills, taking 
medication as prescribed, and identifying and managing trauma-related symptoms without using. 
Considerations in Treatment
Matching 
A major goal of the screening and assessment 
process is to ensure the client is matched with 
appropriate treatment. Acknowledging the 
overriding importance of this goal, this discussion 
of the process of clinical assessment for individuals 
with CODs begins with a fundamental statement 
of principle: Because clients with CODs are not 
all the same, program placements and treatment 
interventions should be matched individually to the 
needs of each client. 
The ultimate purpose of the assessment process is 
to develop an appropriately individualized integrat-
ed treatment plan. In this model, the consensus 
panel recommends the following approach: 
• Treatment planning for individuals with CODs 
and associated problems should follow the 
principle of mental disorder dual (or multiple) 
primary treatment, in which a specifc 
intervention is matched to each problem or 
diagnosis, as well as to stage of change and 
external contingencies. Exhibit 3.9 shows 
a sample treatment plan consisting of the 
problem, intervention, and goal. 
• Integrated treatment planning involves helping 
the client to make the best possible treatment 
choices for each disorder and adhere to that 
treatment consistently. At the same time, the 
counselor needs to help the client adjust the 
recommended treatment strategies for each 
disorder as needed in order to take into account 
problems related to the other disorder. 
These principles are best illustrated by using a 
case example to develop a sample treatment plan. 
For this purpose, the case example for George T. 
is used, incorporating the data gathered during 
assessment (Exhibit 3.9). The problem description 
presents various factors infuencing the problem, 
including stage of change and client strengths. 
No specifc person is recommended to carry out 
interventions proposed in the second column, 
as a range of professionals might carry out each 
intervention appropriately. 
The consensus panel has reviewed research 
evidence and consensus clinical practice to identify 
factors critical to the process of matching clients 
to available treatment. Exhibit 3.10 lists these 
considerations. 
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EXHIBIT 3.9. Sample Treatment Plan for Case Example George T. 
PROBLEM INTERVENTION GOAL 
Cocaine use disorder 
• Work problem, primary reason
for referral 
• Family and work support 
• Resists mutual support 
• Mental symptoms trigger use 
• Action phase 
Outpatient treatment 
• EAP monitoring 
• Family meetings 
• Address shame related to 
disorder 
• Skill-building to manage 
symptoms without using 
• Mutual-support meetings 
Abstinence 
• Negative urinalysis results 
• Daily recovery plans 
 
Rule out AUD 
• No clear problem 
• May trigger cocaine use 
• Precontemplation phase 
• Outpatient motivational 
enhancement; thorough 
evaluation of role of alcohol in 
patient’s life, including family 
education 
• Move into contemplation 
• Willing to consider the risk of 
use or possible misuse 
Bipolar disorder 
• Long history 
• On lithium 
• Some mood symptoms 
• Maintenance phase 
• Medication management 
• Help taking medication in 
recovery programs 
• Bipolar Support Alliance 
meetings 
• Advocate/collaborate with 
prescribing health professional 
• Identify mood symptoms that 
are triggers 
• Maintain stable mood 
• Able to manage fuctuating 
mood symptoms that do occur 
without using cocaine or other 
substances to regulate his 
bipolar disorder 
EXHIBIT 3.10. Considerations in Treatment Matching 
VARIABLE KEY DATA 
Acute safety needs 
Determines need 
for immediate acute 
stabilization to establish 
safety prior to routine 
assessment 
• Immediate risk of harm to self or others 
• Immediate risk of physical harm or abuse from others (Mee-Lee et al., 
2013) 
• Inability to provide for basic self-care 
• Medically dangerous intoxication or withdrawal 
• Potentially lethal medical condition 
• Acute severe mental disorder symptoms (e.g., mania, psychosis) leading to 
inability to function or communicate effectively 
Continued on next page 
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Quadrant assignment 
Guides the choice of the 
most appropriate setting
for treatment 
• SPMI vs. non-SPMI 
• Severely acute or disabling mental disorder symptoms vs. mild-moderate 
severity symptoms 
• High-severity SUD (e.g., active SUD) vs. lower severity SUD (e.g., hazardous 
substance use) 
• Substance dependence in full vs. partial remission (Mee-Lee et al., 2013; 
APA, 2013) 
 
Level of care 
Determines program 
assignment 
• Dimensions of assessment for each disorder using criteria from the 
LOCUS 
Diagnosis 
Determines the 
recommended treatment
intervention 
• Specifc diagnosis of each mental disorder and SUD, including distinction 
of substance-induced symptoms 
• Information about past and present successful and unsuccessful 
treatment efforts for each diagnosis 
• Identifcation of trauma-related disorders and culture-bound syndromes, 
in addition to other mental disorders and substance-related problems 
 
Disability 
Determines case 
management needs 
and whether a standard 
intervention is suffcient— 
one at the capable or 
intermediate level—or 
whether an enhanced-level 
intervention is essential 
• Cognitive defcits, functional defcits, and skill defcits that interfere with 
ability to function independently or follow treatment recommendations 
and which may require varying types and amounts of case management 
or support 
• Specifc functional defcits that may interfere with ability to participate in 
SUD treatment in a particular program setting and may therefore require 
a COE setting rather than a COC one 
• Specifc defcits in learning or using basic recovery skills that require 
modifed or simplifed learning strategies 
Strengths and skills 
Determines areas of prior 
success around which to 
organize future treatment 
interventions 
Determines skill-building 
needs for management of 
either disorder 
• Areas of particular capacity or motivation related to general life 
functioning (e.g., capacity to socialize, work, or obtain housing) 
• Ability to manage treatment participation for any disorder (e.g., familiarity 
and comfort with mutual-support programs, commitment to medication 
adherence) 
Availability and 
continuity of recovery 
support 
Determines availability 
of existing relationships 
and whether to establish 
continuing relationships 
to provide contingencies 
to promote learning 
• Presence or absence of continuing treatment relationships, particularly 
mental disorder treatment relationships, beyond the single episode of 
care 
• Presence or absence of an existing and ongoing supportive family, 
peer support, or therapeutic community; quality and safety of recovery 
environment (Mee-Lee et al., 2013) 
Continued on next page 
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Cultural context 
Determines most 
culturally appropriate 
treatment interventions 
and settings 
• Areas of cultural identifcation and support in relation to: 
- Ethnic or linguistic culture identifcation (e.g., attachment to traditional 
Native American cultural healing practices) 
- Cultures that have evolved around treatment of mental disorders and 
SUDs (e.g., identifcation with 12-Step and mutual recovery culture, 
commitment to mental health empowerment movement) 
• Gender and gender identity 
• Sexual orientation 
• Rural vs. urban 
Problem domains 
Determines specifc 
problems to be solved 
and opportunities for 
contingencies to promote 
treatment participation 
Is there impairment, need, or strength in any of the following areas? 
• Financial 
• Legal 
• Employment 
• Housing 
• Social/family 
• Medical, parenting/child protective, abuse/victimization/victimizer 
Phase of recovery/stage 
of change (for each 
problem) 
Determines appropriate 
phase-specifc or stage-
specifc treatment 
intervention and 
outcomes 
• Requirement for acute stabilization of symptoms, engagement, or 
motivational enhancement 
• Active treatment to achieve prolonged stabilization 
• Relapse prevention/maintenance 
• Rehabilitation, recovery, and growth 
• Within the motivational enhancement sequence, precontemplation, 
contemplation, preparation, action, maintenance, or relapse (Prochaska & 
DiClemente, 1992) 
• Engagement, stabilization/persuasion, active treatment, or continuing 
care/relapse prevention (Mueser & Gingerich, 2013; SAMHSA, 2009a) 
Conclusion 
Assessment is a systematic approach for behavioral 
health service providers to gather information that 
supports matched treatment plans for individuals 
with CODs. It is a required competency and a key 
component of the counselor–client relationship in 
which providers learn to better understand their 
clients; have opportunities to express genuine 
concern, hope, and empathy for long-term 
recovery; and help set the stage for effective 
treatment. Most of these activities are already 
a routine component of substance misuse-only 
assessment; the key additional element is attention 
to treatment requirements and stage of change 
for mental disorders, and the possible interference 
of mental disorder symptoms and disabilities 
(including personality disorder symptoms) in SUD 
treatment participation. 
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• The co-occurrence of mental disorders with 
substance use disorders (SUDs) is the rule, not 
the exception. Addiction counselors should 
expect and prepare to see clients with these 
disorders in their settings. 
• Addiction counselors generally do not 
diagnose mental disorders. But to engage 
in accurate treatment planning and to offer 
comprehensive, effcacious, and responsive 
services (or referral for such), clinicians must 
be able to recognize the disorders most 
likely to be seen in populations who misuse 
substances. 
• It is not always readily apparent whether a 
co-occurring mental disorder is directly caused 
by substance misuse or is an independent 
disorder merely appearing alongside an SUD. 
This differentiation can be diffcult to make but 
is critically important, as it informs treatment 
decision making. 
• Suicide and trauma are sadly common across
most combinations of co-occurring disorders
(CODs) and require special attention. Addiction
counselors have an ethical and professional
responsibility to keep clients safe and to provide
services that are supportive, empathic, and
person-centered, and that reduce suffering. 
Disentangling symptoms of SUDs from those of 
co-occurring mental disorders is a complex but 
necessary step in correctly assessing, diagnosing, 
determining level of service, selecting appropriate 
and effective treatments, and planning follow-up 
care. This chapter is designed to facilitate those 
processes by ensuring addiction counselors and 
other providers have a clear understanding of 
mental disorder symptoms and diagnostic criteria, 
their relationships with SUDs, and pertinent 
management strategies. 
This chapter provides an overview for working 
with SUD treatment clients who also have mental 
disorders. The audiences for this chapter are 
counselors, other treatment/service providers, 
Supervisors, and Administrators. It is presented 
in concise form so that user can refer to this one 
chapter to obtain basic information. The material 
included is not a complete review of all mental 
disorders and is not intended to be a primer on 
diagnosis. Rather, it offers a summary of mental 
disorders with special relevance to co-occurring 
SUDs (see the section “Scope of the Chapter”). 
Since the original publication of this Treatment 
Improvement Protocol (TIP), updated mental 
disorder criteria have been published in the 
Diagnostic and Statistical Manual of Mental 
Disorders (5th ed.; DSM-5; American Psychiatric 
Association [APA], 2013). This chapter contains 
these latest criteria and, where available, data from 
prevalence studies and randomized controlled trials 
in refection of DSM-5. 
Organization of the Chapter 
The chapter begins with a brief description 
of selected mental disorders and their DSM-5 
diagnostic criteria. For each disorder, material 
highlights some of the descriptive and diagnostic 
features, prevalence statistics, and relationship 
to SUDs. In general, the mental disorders in this 
chapter are presented in the following descending 
order by how commonly they co-occur with SUDs, 
although this is not applied rigidly: Depressive 
disorders, bipolar I disorder, posttraumatic stress 
disorder (PTSD), personality disorders (PDs), 
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anxiety disorders, schizophrenia and psychosis, 
attention defcit hyperactivity disorder (ADHD), and 
feeding and eating disorders. 
Because of the greater availability of case 
histories from the mental health literature, the 
illustrative material has more emphasis on the 
mental disorders. Although not intended to offer 
extensive guidance on treatment, this chapter’s 
coverage of specifc mental disorders does include 
brief information about interventions for and 
clinical approaches to managing CODs involving 
each. (Chapter 7 focuses on treatment models for 
people with CODs.) Case histories illustrate the 
interaction between mental disorders and SUDs. 
Each diagnostic topic contains an Advice to the 
Counselor box containing key considerations 
related to diagnosis, treatment, or both. 
The next main section of this chapter addresses 
substance-related disorders, including SUDs and 
substance-induced mental disorders. (DSM-5 
uses the term “substance/medication-induced 
disorders”; this TIP focuses on nonmedication 
substances and thus will exclude the term 
“medication.”) Because the primary audience for 
this chapter is addiction counselors, readers are 
assumed to be highly familiar with SUDs and their 
diagnostic criteria. Thus, the SUD section is briefer 
than the mental disorders section. The overall focus 
remains on substance-induced mental disorders, 
their relationship to independent co-occurring 
mental disorders, and what counselors need to 
know in terms of assessment and treatment. 
Licit and illicit drugs of misuse can cause 
symptoms that are identical to the symptoms 
of mental illness. Mental disorder diagnoses 
should be provisional and reevaluated 
constantly. Some mental disorders are 
really substance-induced mental disorders, 
meaning they are caused by substance use. 
Treatment of the SUD and an abstinent period 
of weeks or months may be required for a 
defnitive diagnosis of an independent, co-
occurring mental disorder. A fuller discussion of 
substance-induced disorders is provided later 
in this chapter. 
The chapter ends with an overview of two concerns 
that appear across nearly all COD populations: 
suicidality and trauma. Although suicidality is 
not strictly speaking a DSM-5-diagnosed mental 
disorder, it is a high-risk behavior requiring serious 
attention by providers. The discussion of suicidality 
highlights key information addiction counselors 
should know about risk of self-harm in combination 
with substance misuse, mental disorders, or 
both. The section offers factual information (e.g., 
prevalence data), commonly agreed-on clinical 
practices, and other general information that may 
be best characterized as “working formulations.” 
Like suicide, trauma itself is not a mental disorder 
but is extremely common in many psychiatric 
conditions, frequently coincides with addiction, and 
increases the odds of negative outcomes, including 
suicide. Having at least a basic understanding 
of suicide and trauma is a core competency for 
addiction counselors working with clients who have 
CODs and will help improve their ability to not only 
offer effective services but keep clients safe. 
Scope of the Chapter 
The mental disorder section of this chapter does 
not include all DSM-5 mental disorders. The 
consensus panel acknowledges that people with 
CODs may have multiple combinations of the 
various mental disorders presented in this chapter 
(e.g., a person could have an SUD, bipolar I 
disorder, and borderline PD [BPD]). However, for 
purposes of clarity and brevity, the panel chose to 
focus the discussion on the main disorders primarily 
seen in people with CODs and not explore the 
multitude of possible combinations. This does not 
mean that other mental disorders excluded from 
this chapter cannot and do not co-occur with 
substance misuse. But the scope of this chapter is 
such that it focuses only on mental disorders most 
likely to be seen by SUD treatment professionals. 
The consensus panel recognizes that although 
this chapter covers a broad range of mental 
disorders and diagnostic material, it cannot and 
should not replace the comprehensive training 
necessary for diagnosing and treating clients with 
specifc mental disorders cooccurring with SUDs. 
Readers of this TIP are assumed to already have 
working knowledge of mental disorders and their 
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symptoms. The “Advice to the Counselor” boxes 
cannot fully address the complexity involved in 
treating clients with CODs. These boxes distill for 
counselors the main actions and approaches they 
can take in working with clients in SUD treatment 
who have the specifc mental disorder being 
discussed. 
The consensus panel recognizes that this chapter 
cannot cover each mental disorder exhaustively 
and that addiction counselors are not expected 
to diagnose mental disorders. The panel’s 
limited goals for this chapter are to increase SUD 
treatment counselors’ familiarity with mental 
disorder terminology and criteria and to guide 
them on how to proceed with clients who have 
these disorders. The chapter also is meant to 
stimulate further work in this area and to make this 
research accessible to the addiction feld. 
Depressive Disorders
The depressive disorders category in DSM-5 
comprises numerous conditions; addiction 
counselors are most likely to encounter major 
depressive disorder (MDD) and persistent 
depressive disorder (PDD; also called dysthymia) 
among their clients. Common features of all 
depressive disorders are excessively sad, empty, or 
irritable mood and somatic and cognitive changes 
that signifcantly affect ability to function. 
Major Depressive Disorder 
MDD is not merely extreme sadness, although sad 
mood is a defning characteristic. MDD is marked 
by either depressed mood or loss of interest in 
nearly all previously enjoyed activities. At least 
one of those symptoms must be present and must 
persist most of the day, almost every day over a 
2-week period (Exhibit 4.1). Other core physical, 
cognitive, and psychosocial features of MDD 
also must be present nearly every day, with the 
exception of weight change and suicidal ideation. 
MDD is highly associated with suicide risk. A study 
reported 39 percent of people with a lifetime MDD 
diagnosis contemplated suicide; nearly 14 percent 
had a lifetime history of suicide attempt (Hasin 
et al., 2018). Yet suicide is not isolated to those 
with depressed mood. Counselors always should 
ask clients whether they have been thinking of 
suicide, whether or not they have, or mention, 
symptoms of depression. 
Severe depressive episodes can include psychotic 
features, such as an auditory hallucination of 
a voice saying that the person is “horrible,” a 
visual hallucination of a lost relative mocking the 
person, or a delusion that one’s internal body 
parts have rotted away. However, most people 
who have an MDE do not exhibit psychotic 
symptoms even when the depression is severe (for 
more information on psychosis, see the section 
“Schizophrenia and Other Psychotic Disorders”). 
WARNING TO COUNSELORS: KNOW YOUR LIMITS OF PRACTICE 
This TIP is for addiction counselors in direct clinical contact with clients who have SUDs. Legal titles, levels,
types of licenses, certifcations, and scopes of practice for addiction counselors differ across all states and the
District of Columbia (University of Michigan Behavioral Health Workforce Research Center, 2018). For instance,
in certain states, addiction counselors can only conduct assessments and offer treatments for SUDs, limiting
their ability to reach clients with CODs. Certifcation requirements and authorized services also vary by state. 
This TIP is intended to beneft all licensed or certifed addiction counselors, regardless of their titles. 
However, the diagnostic and counseling activities described in this TIP are not necessarily appropriate 
for all addiction counselors to undertake, especially given that addiction counselors do not normally 
possess the required training and clinical experience to diagnose mental disorders. Different SUD 
treatment settings will have different policies and rules about what addiction counselors can and cannot 
do. Whether certifed/licensed or not, addiction counselors should use these methods only under the 
supervision of an appropriately trained and certifed or licensed SUD treatment provider or other 
mental health clinician. Maintaining collaborative relationships with mental health service providers for 
consultation and referral is recommended, either directly or through clinical supervision. 
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EXHIBIT 4.1. Diagnostic Criteria for MDD 
A. Five (or more) of the following symptoms have been present during the same 2-week period and 
represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or 
(2) loss of interest or pleasure. 
Note: Do not include symptoms that are clearly attributable to another medical condition. 
1. Depressed mood most of the day, nearly every day, as indicated by either subjective report (e.g., feels 
sad, empty, hopeless) or observation made by others (e.g., appears tearful). Note: In children and 
adolescents, can be irritable mood. 
2. Markedly diminished interest or pleasure in all, or almost all, activities most of the day, nearly every day 
(as indicated by either subjective account or observation). 
3. Signifcant weight loss when not dieting or weight gain (e.g., a change of more than 5 percent of body 
weight in a month), or decrease or increase in appetite nearly every day. Note: In children, consider 
failure to make expected weight gain. 
4. Insomnia or hypersomnia nearly every day. 
5. Psychomotor agitation or retardation nearly every day (observable by others, not merely subjective 
feelings of restlessness or being slowed down). 
6. Fatigue or loss of energy nearly every day. 
7. Feelings of worthlessness or excessive or inappropriate guilt (which may be delusional) nearly every day 
(not merely self-reproach or guilt about being sick). 
8. Diminished ability to think or concentrate, or indecisiveness, nearly every day (either by subjective 
account or as observed by others). 
9. Recurrent thoughts of death (not just fear of dying), recurrent suicidal ideation without a specifc plan, 
or a suicide attempt or a specifc plan for committing suicide. 
B. The symptoms cause clinically signifcant distress or impairment in social, occupational, or other 
important areas of functioning. 
C. The episode is not attributable to the physiological effects of a substance or to another medical 
condition. 
Note: Criteria A–C represent a major depressive episode (MDE). 
Note: Responses to a signifcant loss (e.g., bereavement, fnancial ruin, losses from a natural disaster, a 
serious medical illness or disability) may include the feelings of intense sadness, rumination about the loss, 
insomnia, poor appetite, and weight loss noted in Criterion A, which may resemble a depressive episode. 
Although such symptoms may be understandable or considered appropriate to the loss, the presence of 
an MDE in addition to the normal response to a signifcant loss should also be carefully considered. This 
decision inevitably requires the exercise of clinical judgment based on the individual’s history and the 
cultural norms for the expression of distress in the context of loss.* 
D. The occurrence of the MDE is not better explained by schizoaffective disorder, schizophrenia, 
schizophreniform disorder, delusional disorder, or other specifed and unspecifed schizophrenia spectrum 
and other psychotic disorders. 
E. There has never been a manic episode or a hypomanic episode. 
Note: This exclusion does not apply if all of the manic-like or hypomanic-like episodes are substance-
induced or are attributable to the physiological effects of another medical condition. 
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Continued 
Specify: 
• With anxious distress 
• With mixed features 
• With melancholic features 
• With atypical features 
• With mood-congruent psychotic features 
• With mood-incongruent psychotic features 
• With catatonia 
• With peripartum onset 
• With seasonal pattern (recurrent episode only) 
Specify current severity/course: 
• Mild 
• Moderate 
• Severe 
• With psychotic features 
• In partial remission 
• In full remission 
• Unspecifed 
* In distinguishing grief from an MDE, it is useful to consider that in grief the predominant affect is feelings of emptiness
and loss, while in MDE it is persistent depressed mood and the inability to anticipate happiness or pleasure. The dysphoria
in grief is likely to decrease in intensity over days to weeks and occurs in waves, the so-called pangs of grief. These waves
tend to be associated with thoughts or reminders of the deceased. The depressed mood of MDE is more persistent
and not tied to specifc thoughts or preoccupations. The pain of grief may be accompanied by positive emotions and
humor that are uncharacteristic of the pervasive unhappiness and misery characteristic of MDE. The thought content
associated with grief generally features a preoccupation with thoughts and memories of the deceased, rather than the
self-critical or pessimistic ruminations seen in MDE. In grief, self-esteem is generally preserved, whereas in MDE feelings
of worthlessness and self-loathing are common. If self-derogatory ideation is present in grief, it typically involves perceived
failings vis-à-vis the deceased (e.g., not visiting frequently enough, not telling the deceased how much he or she was
loved). If a bereaved individual thinks about death and dying, such thoughts are generally focused on the deceased and
possibly about “joining” the deceased, whereas in MDE such thoughts are focused on ending one’s own life because of
feeling worthless, undeserving of life, or unable to cope with the pain of depression. 
Source: APA (2013, pp. 160–162). Reprinted with permission from the DSM-5 (Copyright ©2013). APA. All Rights Reserved. 
MDE must be distinguished from grief or 
bereavement, which are not mental disorders but 
rather normal human responses to loss. However, 
grief and MDD can be experienced at the same 
time; that is, the presence of grief does not rule 
out the presence of MDD. DSM-5 provides detailed 
guidance on diagnosing MDD in people who are 
bereaved. 
Persistent Depressive Disorder 
PDD presents as excessively sad or depressed 
mood that lasts most of the day, more days than 
not, for at least 2 years. PDD is somewhat of an 
“umbrella” diagnosis in that it covers two different 
types of people with depression: people with 
chronic MDD (i.e., depression lasting at least 2 
years) and people who do not meet criteria for an 
MDD (see Criteria A through C in Exhibit 4.1) but 
otherwise have had depressive symptoms for at 
least 2 years. Thus, the criteria for PDD (Exhibit 4.2) 
are similar to, but less severe than, those of MDD. 
Prevalence 
Data from a national epidemiological survey 
indicate the 12-month and lifetime prevalence rates 
of DSM-5 MDD are 10 percent and 21 percent, 
respectively (Hasin et al., 2018). Prevalence of MDD 
in emerging adults (ages 18 to 29 years) is 3 times 
higher than the prevalence in older adults (ages 60 
years and older). Women are 1.5 times as likely to 
report depression as men (Hasin et al., 2018).  
Twelve-month and lifetime prevalence rates 
for DSM-5 PDD in U.S. samples have not been 
reported at the time of this publication. Using 
DSM-IV criteria, 12-month and lifetime prevalence 
of PDD in U.S. adults are estimated at 1.5 percent 
and 3 percent, respectively; DSM-IV dysthymia has 
an estimated 12-month and lifetime prevalence of 
0.5 percent and 1 percent, respectively (Blanco et 
al., 2010). 
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EXHIBIT 4.2. Diagnostic Criteria for PDD 
This disorder represents a consolidation of DSM-IV-defned chronic MDD and dysthymic disorder. 
A. Depressed mood for most of the day, for more days than not, as indicated by either subjective account 
or observation by others, for at least 2 years. Note: In children and adolescents, mood can be irritable, and 
duration must be at least 1 year. 
B. Presence, while depressed, of two (or more) of the following: 
1. Poor appetite or overeating 
2. Insomnia or hypersomnia 
3. Low energy or fatigue 
4. Low self-esteem 
5. Poor concentration or diffculty making decisions 
6. Feelings of hopelessness 
C. During the 2-year period (1 year for children or adolescents) of the disturbance, the individual has never 
been without the symptoms in Criteria A and B for more than 2 months at a time. 
D. Criteria for an MDD may be continuously present for 2 years. 
E. There has never been a manic episode or a hypomanic episode, and criteria have never been met for 
cyclothymic disorder. 
F. The disturbance is not better explained by a persistent schizoaffective disorder, schizophrenia, delusional 
disorder, or other specifed or unspecifed schizophrenia spectrum and other psychotic disorder. 
G. The symptoms are not attributable to the physiological effects of a substance (e.g., a drug of misuse, a 
medication) or another medical condition (e.g., hypothyroidism). 
H. The symptoms cause clinically signifcant distress or impairment in social, occupational, or other 
important areas of functioning. 
Note: Because the criteria for an MDE include four symptoms that are absent from the symptom list 
for persistent depressive disorder (dysthymia), a very limited number of individuals will have depressive 
symptoms that have persisted longer than 2 years but will not meet criteria for PDD. If full criteria for an 
MDE have been met at some point during the current episode of illness, they should be given a diagnosis 
of MDD. Otherwise, a diagnosis of other specifed depressive disorder or unspecifed depressive disorder is 
warranted. 
Specify if: 
• With anxious distress 
• With mixed features 
• With melancholic features 
• With atypical features 
• With mood-congruent psychotic features 
• With mood-incongruent psychotic features 
• With peripartum onset 
Specify if: 
• In partial remission 
• In full remission 
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Continued 
Specify if: 
• Early onset: If onset is before age 21 years 
• Late onset: If onset is at age 21 years or older 
Specify if (for most recent 2 years of persistent depressive disorder): 
• With pure dysthymic syndrome: Full criteria for MDE have not been met in at least the preceding 2 years 
• With persistent MDE: Full criteria for an MDE have not been met throughout the preceding 2-year period 
• With intermittent MDEs, with current episode: Full criteria for MDE are currently met, but there have 
been periods of at least 8 weeks in at least the preceding 2 years with symptoms below the threshold for 
a full MDE 
• With intermittent MDEs, without current episode: Full criteria for an MDE are not currently met, but 
there has been one or more MDEs in at least the preceding 2 years 
Specify current severity: 
• Mild 
• Moderate 
• Major 
Source: APA (2013, pp. 168–169). Reprinted with permission from the DSM-5 (Copyright © 2013). APA. All Rights Reserved. 
Depressive Disorders and SUDs 
Depressive disorders are highly comorbid with 
SUDs. For instance: 
• Presence of a 12-month or lifetime DSM-5 
drug use disorder (i.e., a nonalcohol SUD) is 
associated with a 1.5 to 1.9 increased odds of 
having any mood disorder, a 1.3 to 1.5 increased 
odds of having dysthymia, and a 1.2 to 1.3 
increased odds of having MDD (Grant et al., 
2016). 
• Twelve-month alcohol use disorder (AUD) is also 
associated with an increased risk of MDD and 
lifetime AUD with persistent depression (Grant 
et al., 2015). 
• A lifetime diagnosis of DSM-5 MDD is more 
likely to occur in individuals with a history of 
SUDs (58 percent; for AUD, 41 percent) than in 
people with a history of any anxiety disorder (37 
percent) or PD (32 percent) (Hasin et al., 2018). 
People with depression and co-occurring SUDs 
tend to have more severe mood symptoms (e.g., 
sleep disturbance, feelings of worthlessness), 
higher risk of suicidal ideation and suicide 
attempts, worse functioning, more psychiatric 
comorbidities, and greater disease burden 
(including increased mortality) than people with 
MDD alone (Blanco et al., 2012; Gadermann, 
Alonso, Vilagut, Zaslavsky, & Kessler, 2012). 
They are less likely than people with MDD alone 
to receive antidepressants—despite strong 
evidence supporting the effcacy of antidepressant 
medication in alleviating mood and even some 
SUD symptoms (Blanco et al., 2012). 
Addiction counselors may represent a way to 
reduce lags in adequate depression care in 
people with depressive disorders and SUDs. 
Among 3.3 million people who reported both 
MDEs and SUDs between 2008 to 2014, only 55 
percent received services for depression in the 
previous year (Han, Olfson, & Mojtabai, 2017). 
However, people who had received SUD treatment 
in the past year were 1.5 times more likely to have 
received depression care than people who had 
not engaged in SUD treatment (80 percent vs. 50 
percent, respectively) and were 1.6 times more 
likely to perceive their depressive care as being 
helpful (48 percent vs. 32 percent) than people 
who did not access SUD treatment in the previous 
12 months (Han, Olfson, & Mojtabai, 2017). 
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Other facts about depression and SUDs that 
addiction counselors should know include the 
following: 
• Both substance use and discontinuance can be 
associated with depressive symptoms. 
• During the frst months of sobriety, many people 
with SUDs can exhibit symptoms of depression 
that fade over time and that are related to acute 
and protracted withdrawal. 
• People with co-occurring depressive disorders 
and SUDs typically use a variety of drugs. 
• Recent evidence suggests there is increasing 
cannabis use with depression, although 
cannabinoids have not been shown to be 
effective in self-management of depression. In 
fact, cannabis may actually worsen the course of 
MDD and reduce chances of treatment seeking 
(Bahorik et al., 2018). 
Treatment of MDD and SUD 
Psychotherapy (e.g., integrated cognitive– 
behavioral therapy [CBT], group CBT), with or 
without adjunct antidepressant use, can effectively 
reduce frequency of substance use and depressive 
symptoms and improve functioning briefy and over 
the long term (Paddock, Hunter, & Leininger, 2014; 
Vujanovic et al., 2017). In a review examining MDD 
and AUD specifcally (Riper et al., 2014), treatment 
as usual supplemented with CBT and motivational 
interviewing had small but signifcant effects in 
improving depression and decreasing alcohol 
use versus treatment as usual alone or other brief 
psychosocial interventions. 
For more extensive guidance about counseling 
clients with addiction and depression, see TIP 48, 
Managing Depressive Symptoms in Substance 
Abuse Clients During Early Recovery (Center for 
Substance Abuse Treatment [CSAT], 2008). 
Bipolar I Disorder 
Bipolar I disorder, also sometimes termed manic-
depression, refers to a mental state wherein 
a person’s mood fuctuates wildly between 
depressive and manic episodes (Exhibit 4.3). 
During depressive episodes, a person experiences 
symptoms of MDD (e.g., excessive sadness, loss of 
interest in normally pleasurably activities, physical 
and cognitive symptoms). During manic episodes, 
a person experiences the opposite—extreme 
euphoria, energy, and activity. Manic episodes vary 
with intensity and can be manifest in a variety of 
ways, such as having little or no need for sleep, 
very fast or “pressured” speech, impulsivity and 
erratic decision making (especially decisions of 
major consequence, like spending a large amount 
of money), and racing thoughts. Some manic 
episodes are milder in nature; these are known as 
hypomanic episodes. People with bipolar I disorder 
can experience both manic and hypomanic 
episodes. Bipolar II disorder is a related disorder 
in which the person only experiences hypomania 
and not full-blown mania. For the purposes of 
this chapter, only bipolar I disorder, which has 
ample research strongly linking it to SUDs, will be 
discussed. 
Sometimes, manic episodes can produce symptoms 
that confict with reality and are delusional in nature 
(e.g., a man believing he is going to marry the 
Queen of England). Because of these delusional 
and bizarre beliefs, bipolar disorder can sometimes 
appear similar to schizophrenia and other psychotic 
disorders (see the section “Schizophrenia and 
Other Psychotic Disorders”). In fact, increasing 
research supports a shared genetic risk between 
the bipolar and psychotic disorders (Cardno & 
Owen, 2014). 
Suicidal thoughts and behaviors are common 
among people with bipolar disorder (APA, 2013), 
with some believing it could have the highest 
suicide risk of all mental disorders (Schaffer et 
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ADVICE TO THE COUNSELOR: COUNSELING A CLIENT WITH A DEPRESSIVE 
DISORDER 
• Possibly as many as half of the clients an addiction counselor sees will have an MDE (Center for 
Behavioral Health Statistics and Quality [CBHSQ], 2019). Counselors should expect to encounter 
depressive symptoms and disorders in their work and proactively familiarize themselves with diagnostic 
criteria and general treatment approaches. 
• Differentiate among commonplace expressions of depression and depression associated with more 
serious mental illness (SMI), medical conditions and medication side effects, and substance-induced 
changes. Understand that it is possible to have depressive symptoms without meeting full criteria 
for MDD or another depressive disorder. Distinguishing MDD from normal moods and depressive 
symptoms is also important. 
• Symptoms of depression can persist for 3 to 6 months following abstinence and need to be treated in 
counseling. Educate clients about the relationship of depression to substance misuse so that they know 
what to expect from treatment and the course of recovery. 
• Sometimes substance use can mask depressive symptoms, and it may not become apparent that a 
client has depression until after he or she has stopped using substances. Monitor symptoms continually 
and respond immediately to any intensifcation of symptoms. 
• Clients with depression often feel hopeless and unmotivated, which can hinder their participation and 
retention in treatment. If clients seem reluctant to engage in SUD treatment, do not interpret that as 
a sign of resistance or noncompliance. Alleviating their depressive symptoms could help with this to 
an extent. But also work with clients on enhancing motivation and self-effcacy so they can develop 
confdence and internalize the belief that recovery is possible. 
• Gradually introduce and teach skills for participation in mutual-support programs. 
• Consider CBT and motivational interviewing in place of or in addition to usual psychosocial treatment. 
• Combine addiction counseling with medication and mental health services. 
• Because antidepressants have such strong effcacy in reducing depressive symptoms, keep on hand the 
names of local mental health professionals (if one isn’t available in the treatment setting) to refer clients 
for complete assessment and medication review. 
• Given that depressive symptoms can result from SUDs and not an underlying mental disorder, careful 
and continual assessment is essential. 
• Because of the increased risk of suicidality with MDD, continually assess and be vigilant for signs of 
suicidal ideation, gestures/behaviors, and attempts. Use risk mitigation strategies (e.g., safety plans) to 
protect clients from self-harm. (See the section “Cross-Cutting Topics: Suicide and Trauma” for more 
guidance.) 
al., 2015). An estimated 20 percent of people 
with bipolar disorder try to commit suicide (Carra, 
Bartoli, Crocamo, Brady, & Clerici, 2014), leading 
to a standardized mortality ratio of suicide deaths 
that is 10 to 30 times greater than that of the 
general population (Schaffer et al., 2015). People 
with bipolar disorder and SUD are signifcantly more
likely to try to commit suicide than people without
both conditions (Carra et al., 2014; Schaffer et al.,
2015). Interestingly, current or lifetime SUD is a
signifcant risk factor for suicide attempt in bipolar
disorder but not suicide death (Schaffer et al., 2015). 
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EXHIBIT 4.3. Diagnostic Criteria for Bipolar I Disorder 
For a diagnosis of bipolar I disorder, it is necessary to meet the following criteria for a manic episode. The 
manic episode may have been preceded by and may be followed by hypomanic or MDEs. 
Manic Episode 
A. A distinct period of abnormally and persistently elevated, expansive, or irritable mood and abnormally 
and persistently increased goal-directed activity or energy, lasting at least 1 week and present most of the 
day, nearly every day (or any duration if hospitalization is necessary). 
B. During the period of mood disturbance and increased energy or activity, three (or more) of the following 
symptoms (four if the mood is only irritable) are present to a signifcant degree and represent a noticeable 
change from usual behavior: 
1. Infated self-esteem or grandiosity 
2. Decreased need for sleep (e.g., feels rested after only 3 hours of sleep) 
3. More talkative than usual or pressure to keep talking 
4. Flight of ideas or subjective experience that thoughts are racing 
5. Distractibility (i.e., attention too easily drawn to unimportant or irrelevant external stimuli) as reported or 
observed 
6. Increase in goal-directed activity (either socially, at work or school, or sexually) or psychomotor agitation 
(i.e., purposeless non-goal-directed activity) 
7. Excessive involvement in pleasurable activities that have a high potential for painful consequences (e.g., 
engaging in unrestrained buying sprees, sexual indiscretions, or foolish business investments) 
C. The mood disturbance is suffciently severe to cause marked impairment in social or occupational 
functioning or to necessitate hospitalization to prevent harm to self or others, or there are psychotic 
features. 
D. The episode is not attributable to the physiological effects of a substance (e.g., a drug of abuse, a 
medication, other treatment) or to another medical condition. 
Note: A full manic episode that emerges during antidepressant treatment (e.g., medication, 
electroconvulsive therapy) but persists at a fully syndromal level beyond the physiological effect of that 
treatment is suffcient evidence for a manic episode and, therefore, a bipolar I disorder. 
Note: Criteria A–D constitute a manic episode. At least one lifetime manic episode is required for the 
diagnosis of bipolar I disorder. 
Hypomanic Episode 
A. A distinct period of abnormally and persistently elevated, expansive, or irritable mood and abnormally 
and persistently increased activity or energy, lasting at least 4 consecutive days and present most of the 
day, nearly every day. 
B. During the period of mood disturbance and increased energy and activity, three (or more) of the 
following symptoms (four if the mood is only irritable) have persisted, represent a noticeable change from 
usual behavior, and have been present to a signifcant degree: 
1. Infated self-esteem or grandiosity 
2. Decreased need for sleep (e.g., feels rested after only 3 hours of sleep) 
3. More talkative than usual or pressure to keep talking 
4. Flight of ideas or subjective experience that thoughts are racing 
5. Distractibility (i.e., attention too easily drawn to unimportant or irrelevant external stimuli) as reported or 
observed. 
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6. Increase in goal-directed activity (either socially, at work or school, or sexually) or psychomotor 
agitation. 
7. Excessive involvement in activities that have a high potential for painful consequences (e.g., engaging 
in unrestrained buying sprees, sexual indiscretions, or foolish business investments) 
C. The episode is associated with an unequivocal change in functioning that is uncharacteristic of the 
individual when not symptomatic. 
D. The disturbance in mood and the change in functioning are observable by others. 
E. The episode is not severe enough to cause marked impairment in social or occupational functioning or 
to necessitate hospitalization. If there are psychotic features, the episode is, by defnition, manic. 
F. The episode is not attributable to the physiological effects of a substance (e.g., a drug of abuse, a 
medication, other treatment). 
Note: A full hypomanic episode that emerges during antidepressant treatment (e.g., medication, 
electroconvulsive therapy) but persists at a fully syndromal level beyond the physiological effect of that 
treatment is suffcient evidence for a hypomanic episode diagnosis. However, caution is indicated so that 
one or two symptoms (particularly increased irritability, edginess, or agitation following antidepressant 
use) are not taken as suffcient for diagnosis of a hypomanic episode, nor necessarily indicative of a bipolar 
diathesis. 
Note: Criteria A–F constitute a hypomanic episode. Hypomanic episodes are common in bipolar I disorder 
but are not required for the diagnosis of bipolar I disorder. 
MDE 
A. Five (or more) of the following symptoms have been present during the same 2-week period and 
represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood 
or (2) loss of interest or pleasure. 
Note: Do not include symptoms that are clearly attributable to another medical condition. 
1. Depressed mood most of the day, nearly every day, as indicated by either subjective report (e.g., feels 
sad, empty, hopeless) or observation made by others (e.g., appears tearful). Note: In children and 
adolescents, can be irritable mood. 
2. Markedly diminished interest or pleasure in all, or almost all, activities most of the day, nearly every day 
(as indicated by either subjective account or observation). 
3. Signifcant weight loss when not dieting or weight gain (e.g., a change of more than 5 percent of body 
weight in a month), or decrease or increase in appetite nearly every day. Note: In children, consider 
failure to make expected weight gain. 
4. Insomnia or hypersomnia nearly every day. 
5. Psychomotor agitation or retardation nearly every day (observable by others, not merely subjective 
feelings of restlessness or being slowed down). 
6. Fatigue or loss of energy nearly every day. 
7. Feelings of worthlessness or excessive or inappropriate guilt (which may be delusional) nearly every day 
(not merely self-reproach or guilt about being sick). 
8. Diminished ability to think or concentrate, or indecisiveness, nearly every day (either by subjective 
account or as observed by others). 
9. Recurrent thoughts of death (not just fear of dying), recurrent suicidal ideation without a specifc plan, 
or a suicide attempt or a specifc plan for committing suicide. 
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B. The symptoms cause clinically signifcant distress or impairment in social, occupational, or other
important areas of functioning.
C. The episode is not attributable to the physiological effects of a substance or to another medical
condition.
Note: Criteria A–C constitute an MDE. MDEs are common in bipolar I disorder but are not required for the 
diagnosis of bipolar I disorder. 
Note: Responses to a signifcant loss (e.g., bereavement, fnancial ruin, losses from a natural disaster, a 
serious medical illness or disability) may include the feelings of intense sadness, rumination about the 
loss, insomnia, poor appetite, and weight loss noted in Criterion A, which may resemble a depressive 
episode. Although such symptoms may be understandable or considered appropriate to the loss, the 
presence of an MDE in addition to the normal response to a signifcant loss should also be carefully 
considered. This decision inevitably requires the exercise of clinical judgment based on the individual’s 
history and the cultural norms for the expression of distress in the context of loss.* 
Bipolar I Disorder 
A. Criteria have been met for at least one manic episode (Criteria A—D under Manic Episode, above).
B. The occurrence of the manic episode and MDE is not better explained by schizoaffective disorder,
schizophrenia, schizophreniform disorder, delusional disorder, or other specifed or unspecifed
schizophrenia spectrum and other psychotic disorder.
Specify current severity: 
• Mild
• Moderate
• Severe
Specify: 
• With psychotic features
• In partial remission
• In full remission
• Unspecifed
Specify: 
• With anxious distress
• With mixed features
• With rapid cycling
• With melancholic features
• With atypical features
• With mood-congruent psychotic features
• With mood-incongruent psychotic features
• With catatonia
• With peripartum onset
• With seasonal pattern
* In distinguishing grief from an MDE, it is useful to consider that in grief the predominant affect is feelings of 
emptiness and loss, while in MDE it is persistent depressed mood and the inability to anticipate happiness or pleasure. 
The dysphoria in grief is likely to decrease in intensity over days to weeks and occurs in waves, the so-called pangs of 
grief. These waves tend to be associated with thoughts or reminders of the deceased. The depressed mood of MDE is
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more persistent and not tied to specifc thoughts or preoccupations. The pain of grief may be accompanied by positive 
emotions and humor that are uncharacteristic of the pervasive unhappiness and misery characteristic of MDE. The 
thought content associated with grief generally features a preoccupation with thoughts and memories of the deceased, 
rather than the self-critical or pessimistic ruminations seen in MDE. In grief, self-esteem is generally preserved, whereas 
in MDE feelings of worthlessness and self-loathing are common. If self-derogatory ideation is present in grief, it typically 
involves perceived failings vis-à-vis the deceased (e.g., not visiting frequently enough, not telling the deceased how 
much he or she was loved). If a bereaved individual thinks about death and dying, such thoughts are generally focused 
on the deceased and possibly about “joining” the deceased, whereas in MDE such thoughts are focused on ending one’s 
own life because of feeling worthless, undeserving of life, or unable to cope with the pain of depression. 
Source: APA (2013, pp. 123–127). Reprinted with permission from the DSM-5 (Copyright © 2013). APA. All Rights Reserved. 
Prevalence 
The 12-month and lifetime prevalence rates of 
DSM-5 bipolar I disorder are 1.5 percent and 2 
percent, respectively (Blanco et al., 2017). Rates 
are nearly equivalent between men and women for 
both 12-month and lifetime prevalence (Blanco et 
al., 2017). 
Bipolar I Disorder and SUDs 
Individuals with bipolar I have high prevalence rates 
(65 percent) of lifetime SUD, AUD (54 percent), and 
drug use disorder (32 percent) (McDermid et al., 
2015). Presence of a 12-month or lifetime DSM-5 
drug use disorder (i.e., an SUD excluding alcohol) 
is associated with a 1.4 to 1.5 increased odds 
in having bipolar I disorder (Grant et al., 2016). 
Similarly, presence of past-year or lifetime bipolar I 
disorder carries a 2 to 5.8 times greater risk of also 
having any 12-month or lifetime SUD (Blanco et al., 
2017). A systematic review and meta-analysis found 
strong associations between co-occurring SUDs 
and bipolar illness in individuals in clinical settings, 
with the highest prevalence (average: 30 percent) 
for alcohol use, 20 percent (mean) for cannabis, and 
17 percent (mean) for any drug use disorder (Hunt, 
Malhi, Cleary, Lai, & Sitharthan, 2016b). 
Co-occurring bipolar illness and substance misuse 
are associated with numerous adverse clinical, 
social, and economic consequences, including 
increased symptom severity, poorer treatment 
outcomes, and greater suicide risk (Ma, Coles, & 
George, 2018). Presence of a co-occurring SUD 
with bipolar disorder has been linked to lower SUD 
treatment adherence and retention, protracted 
mood episodes, poorer recovery of functional 
abilities (even after abstaining from substances), 
increased utilization of emergency services, greater 
hospitalizations, more variable disease course, 
greater affective instability, more impulsivity, 
and poor response to lithium (the standard 
pharmacotherapy of choice) (Swann, 2010; Tolliver 
& Anton, 2015). 
Treatment of Bipolar I Disorder and SUDs 
Substance misuse by people with bipolar disorder 
complicates diagnosis and treatment. Evidence 
exists of a bidirectional relationship between 
bipolar disorder and SUDs, yet the ways in which 
these conditions infuence one another is still 
unclear (Tolliver & Anton, 2015). Little research 
has examined nonpharmacological approaches 
to managing comorbid bipolar I disorder and 
SUDs. Group CBT, integrated therapy, and 
relapse prevention techniques may help reduce 
hospitalizations, increase abstinence, improve 
medication adherence, reduce addiction 
severity, and (to a lesser extent) improve mood 
symptoms (Gold et al., 2018). However, results are 
inconsistent across studies, underscoring the need 
for more research. 
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ADVICE TO THE COUNSELOR: COUNSELING A CLIENT WITH BIPOLAR I 
DISORDER 
• Although true for most counseling situations, maintaining a calm demeanor and a reassuring presence 
is especially important with these clients. 
• Start low and go slow (that is, start “low” with general and nonprovocative topics and proceed gradually 
as clients become more comfortable talking about problems). 
• Monitor symptoms and respond immediately to any intensifcation. 
• At every session, strongly emphasize and monitor medication compliance and promote medication
adherence. The cyclical nature of bipolar disorder is frequently punctuated by bouts of medication
noncompliance, and it is crucial to cultivate and convey an understanding of the allure of the manic
episode. 
• Pay attention to signs of depression or mania, as medication might be able to ward off the worsening 
of the client’s condition. For developing mania, which is virtually nonresponsive to psychosocial 
interventions, a variety of mood stabilizers have demonstrated remarkable effcacy. Their timely use can 
avert potentially life-altering, negative events. (See “Pharmacotherapy” in Chapter 7.) 
• Although evidence on psychosocial treatments for bipolar I disorder and SUD is inconsistent, the 
strongest support seems to come from the use of integrated group-based interventions that use 
multiple treatment components to address both mood and substance-related symptoms. Techniques 
include counseling, relapse prevention, psychoeducation, medication management, and regular phone 
or in-person “check-in” sessions to monitor symptoms and treatment progress. 
• Gradually introduce and teach skills for participation in mutual-support programs. 
• Combine addiction counseling with medication and mental health services. 
• Suicide and suicidal behaviors are major ongoing concerns for this client population, and the addiction 
counselor should have a thorough understanding of her or his role in preventing suicide. 
Case Study: Counseling an SUD treatment Client With Bipolar I Disorder 
John W. is a 30-year-old man with bipolar I disorder and AUD. He has a history of hospitalizations, both 
psychiatric and substance related; after the most recent extended psychiatric hospitalization, he was 
referred for SUD treatment. He told the counselor he used alcohol to facilitate social contact, as well as 
deal with boredom, because he had not been able to work for some time. The counselor learned that 
during his early 20s, John W. achieved full-time employment and established an intimate relationship 
with a nondrinking woman; however, his drinking led to the loss of both. 
During one of his AUD treatments, he developed forid manic symptoms, believing himself to be 
a prophet with the power to heal others. He was transferred to a closed psychiatric unit, where he 
eventually stabilized on a combination of antipsychotic medications (risperidone) and lithium. Since that 
time, he has had two episodes of worsening psychiatric symptoms leading to hospitalization; each of 
these began with drinking, which then led to stopping his medications, then forid mania and psychiatric 
commitment. However, when he is taking his medications and is sober, John W. has a normal mental 
status and relates normally to others. Recently, following a series of stressors, John W. left his girlfriend, 
quit his job, and began using alcohol heavily again. He rapidly relapsed to active mania, did not adhere to 
a medication regimen, and was rehospitalized. 
Continued on next page 
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At the point John W. is introduced to the SUD treatment counselor, his mental status is fairly normal; 
however, he warns the counselor that after manic episodes he tends to get somewhat depressed, even 
when he is taking medications. The counselor takes an addiction history and fnds that John W. has had 
several periods of a year or two during which he was abstinent from alcohol and drugs of misuse, but he 
has never had ongoing AUD treatment or attended Alcoholics Anonymous (AA) meetings. John W. replies 
to the counselor’s questions about this with, “Well, if I just take my meds and don’t drink, I’m fne. So why 
do I need those meetings?” 
Using a motivational approach, the counselor helps John W. analyze what has worked best for him in 
dealing with both addiction and mental problems, as well as what has not worked well for him. John W. is 
tired of the merry-go-round of his life; he certainly acknowledges that he has a major mental disorder, but 
thinks his drinking is only secondary to the mania. When the counselor gently points out that each of the 
episodes in which his mental disorder led to hospitalization began with an alcohol relapse, John W. begins 
to listen. In a group for clients with CODs at the SUD treatment agency, John W. is introduced to another 
client in recovery with a bipolar disorder, who tells his personal story and how he discovered that both of his 
problems need primary attention. This client agrees to be John W.’s temporary sponsor and calls John W.’s 
case manager, who works at the mental health center where John W. gets his medication, and describes 
the treatment plan. She then makes arrangements for a monthly meeting involving the counselor, case 
manager, and John W. 
Discussion: The SUD treatment counselor has taken the wise step of taking a detailed history and 
attempting to establish the linkage between CODs. The counselor tries to appreciate the client’s own 
understanding of the relationship between the two. She uses motivational approaches to analyze what 
John W. did in his previous partially successful attempts to deal with the problem and helps develop 
connections with other recovering clients to increase motivation. Lastly, she is working closely with the case 
manager to ensure a coordinated approach to management of each disorder. 
Posttraumatic Stress Disorder 
PTSD is an exaggerated fear response that occurs 
following exposure to one or more extremely 
upsetting events. Such events can include, but are 
not limited to, war, terrorist attacks, threatened 
or actual physical or sexual violence, being 
kidnapped, natural and man-made disasters, and 
serious motor vehicle accidents. Events may be 
experienced frsthand, witnessed, experienced 
through repeated exposure as a part of one’s job 
(e.g., police offcers repeatedly hearing details 
about child abuse, murder, and other violent and 
upsetting crimes), or by learning about such events 
occurring to a close loved one (e.g., learning of the 
murder of one’s child). People with PTSD report 
the most distressing trauma to be sexual abuse 
before age 18 years (Goldstein et al., 2016). 
Symptoms of PTSD are grouped into four categories:
• Intrusive, persistent re-experiences of 
the trauma, including recurrent dreams 
or nightmares, fashbacks, and distressing 
memories 
• Persistent avoidance of people, places, objects, 
and events that remind the person of the trauma 
or otherwise trigger distressing memories, 
thoughts, feelings, and physiological reactions 
• Negative alterations in cognitions and mood, 
such as memory loss (particularly regarding 
details surrounding the event), self-blame, guilt, 
hopelessness, social withdrawal, and an inability 
to experience positive emotions 
• Marked alterations in arousal and reactivity, 
such as experiencing sleeplessness or feeling 
“jumpy,” “on edge,” easily started, irritable, 
angry, or unable to concentrate 
Exhibit 4.4 lists the DSM-5 criteria for PTSD in 
adults and children older than age 6; separate 
criteria are available for children ages 6 years and 
younger and can be found in DSM-5. 
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EXHIBIT 4.4. Diagnostic Criteria for PTSD 
Note: The following criteria apply to adults, adolescents, and children older than 6 years. 
A. Exposure to actual or threatened death, serious injury, or sexual violence in one (or more) of these ways: 
1. Directly experiencing the traumatic event(s) 
2. Witnessing, in person, the event(s) as it occurred to others 
3. Learning that the traumatic event(s) occurred to a close family member or close friend. In cases of 
actual or threatened death of a family member or friend, the event(s) must have been violent or 
accidental. 
4. Experiencing repeated or extreme exposure to aversive details of the traumatic event(s) (e.g., frst 
responders collecting human remains; police offcers repeatedly exposed to details of child abuse) 
Note: Criterion A4 does not apply to exposure through electronic media, television, movies, or pictures, 
unless this exposure is work related. 
B. Presence of one (or more) of the following intrusion symptoms associated with the traumatic events(s), 
beginning after the traumatic event(s) occurred: 
1. Recurrent, involuntary, and intrusive distressing memories of the traumatic event(s) 
Note: In children older than 6 years, repetitive play may occur in which themes or aspects of the traumatic
event(s) are expressed.
2. Recurrent distressing dreams in which the content and/or affect of the dream are related to the 
traumatic event(s) 
Note: In children, there may be frightening dreams without recognizable content. 
3. Dissociative reactions (e.g., fashbacks) in which the individual feels or acts as if the traumatic event(s) 
were recurring. (Such reactions may occur on a continuum, with the most extreme expression being a 
complete loss of awareness of present surroundings.) 
Note: In children, trauma-specifc reenactment may occur in play. 
4. Intense or prolonged psychological distress at exposure to internal or external cues that symbolize or 
resemble an aspect of the traumatic event(s) 
5. Marked physiological reactions to internal or external cues that symbolize or resemble an aspect of the 
traumatic event(s) 
C. Persistent avoidance of stimuli associated with the traumatic event(s), beginning after the traumatic 
event(s) occurred, as evidenced by one or both of the following: 
1. Avoidance of or efforts to avoid distressing memories, thoughts, or feelings about or closely associated 
with the traumatic event(s) 
2. Avoidance of or efforts to avoid external reminders (people, places, conversations, activities, objects, 
situations) that arouse distressing memories, thoughts, or feelings about or closely associated with the 
traumatic event(s) 
D. Negative alterations in cognitions and mood associated with the traumatic events(s), beginning or 
worsening after the traumatic events(s) occurred, as evidenced by two (or more) of the following: 
1. Inability to remember an important aspect of the traumatic events(s) (typically due to dissociative 
amnesia and not to other factors such as head injury, alcohol, or drugs) 
Continued on next page 
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2. Persistent and exaggerated negative beliefs or expectations about oneself, others, or the world (e.g., “I
am bad,” “No one can be trusted,” “The world is completely dangerous,” “My whole nervous system is
permanently ruined”)
3. Persistent, distorted cognitions about the cause or consequences of the traumatic event(s) that lead the
individual to blame himself/herself or others
4. Persistent negative emotional state (e.g., fear, horror, anger, guilt, or shame)
5. Markedly diminished interest or participation in signifcant activities
6. Feelings of detachment or estrangement from others
7. Persistent inability to experience positive emotions (e.g., inability to experience happiness, satisfaction,
or loving feelings)
E. Marked alterations in arousal and reactivity associated with the traumatic events(s), beginning or
worsening after the traumatic events(s) occurred, as evidenced by two (or more) of the following:
1. Irritable behavior and angry outbursts (with little or no provocation) typically expressed as verbal or
physical aggression toward people or objects
2. Reckless or self-destructive behavior
3. Hypervigilance
4. Exaggerated startle response
5. Problems with concentration
6. Sleep disturbance (e.g., diffculty falling or staying asleep or restless sleep)
F. Duration of the disturbance (Criteria B, C, D, and E) is more than 1 month.
G. The disturbance causes clinically signifcant distress or impairment in social, occupational, or other
important areas of functioning.
H. The disturbance is not attributable to the physiological effects of a substance (e.g., medication, alcohol) or
another medical condition.
Specify whether: 
With dissociative symptoms: The individual’s symptoms meet the criteria for PTSD, and in addition, in 
response to the stressor, the individual experiences persistent or recurrent symptoms of either of the 
following: 
1. Depersonalization: Persistent or recurrent experiences of feeling detached from, and as if one were an
outside observer of, one’s mental processes or body (e.g., feeling as though one were in a dream; feeling
a sense of unreality of self or body or of time moving slowly)
2. Derealization: Persistent or recurrent experiences of unreality of surroundings (e.g., the world around the
individual is experienced as unreal, dreamlike, distant, or distorted)
Note: To use this subtype, the dissociative symptoms must not be attributable to the physiological effects 
of a substance (e.g., blackouts, behavior during alcohol intoxication) or another medical condition (e.g., 
complex partial seizure). 
Specify if: 
With delayed expression: If the full diagnostic criteria are not met until at least 6 months after the event 
(although the onset and expression of some symptoms may be immediate) 
Source: APA (2013, pp. 271–272). Reprinted with permission from the DSM-5 (Copyright © 2013). APA. All Rights Reserved. 
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Prevalence 
Twelve-month and lifetime prevalence rates of 
DSM-5 PTSD are 4.7 percent and 6.1 percent, 
respectively (Goldstein et al., 2016). Rates are 
markedly higher among women than men, about 
6 percent and 8 percent for past-year and lifetime 
PTSD, respectively (Goldstein et al., 2016). Lifetime 
prevalence is even higher for female veterans (13.9 
percent) and younger adults (ages 18 to 29 years, 
15.3 percent) (Smith, Goldstein, & Grant, 2016). A 
2016 study of veterans using DSM-5 criteria found 
the lifetime prevalence of PTSD to be 6.9 percent, 
with signifcantly higher prevalence rates noted 
for women and younger age groups (Smith et al., 
2016). 
Individuals in occupations at risk of exposure 
to traumatic events (e.g., police, frefghters, 
emergency medical personnel) have higher rates 
of PTSD. Among high-risk individuals (those who 
have survived rape, military combat, and captivity 
or ethnically or politically motivated internment 
and genocide), the proportion of those with PTSD 
ranges from one-third to one-half (APA, 2013). 
PTSD and SUDs 
A strong association exists between PTSD and 
substance misuse, including lifetime SUDs (Hasin & 
Kilcoyne, 2012), lifetime drug use disorders (Grant 
et al., 2016), and lifetime AUD (Grant et al., 2015). 
Among people with SUDs, lifetime prevalence of 
PTSD is thought to range between 26 percent and 
52 percent and rates of current PTSD between 15 
percent and 42 percent (Vujanovic, Bonn-Miller, & 
Petry, 2016). Among people with PTSD, lifetime 
rates of SUD are likely between 36 percent and 
52 percent (Vujanovic et al., 2016). Presence of a 
12-month or lifetime DSM-5 drug use disorder (i.e., 
an SUD excluding alcohol) is associated with a 1.5 
to 1.6 increased odds of having PTSD (Grant et al., 
2016). Similarly, presence of 12-month or lifetime 
PTSD is associated with a 1.3 to 1.5 increased odds 
of having a past-year or lifetime SUD (Goldstein et 
al., 2016). 
Comorbid PTSD and addiction are highly complex 
and associated with worse treatment outcomes 
(including lower rates of remission and faster 
relapse), poorer treatment response, more 
cognitive diffculties, worse social functioning, 
greater risk of suicide attempt, and heightened 
mortality (Flanagan, Korte, Killeen, & Back, 2016; 
Schumm & Gore, 2016). Compared with people 
with PTSD or alcohol dependence alone, those 
with both report more traumatic childhoods, 
more psychiatric comorbidities, an increased risk 
of suicide, more severe symptoms, and greater 
disability (Blanco et al., 2013). 
People with PTSD tend to misuse the most serious 
substances (cocaine and opioids); however, misuse 
of prescription medications, cannabis, and alcohol 
also are common. 
WARNING TO COUNSELORS: 
PTSD OR DEPRESSION? 
Many people with PTSD are mistakenly 
diagnosed with depression, particularly in 
SUD treatment settings where screening for 
trauma is low. The two conditions are highly 
comorbid. Symptoms can overlap to an extent, 
and when occurring together, the combination 
results in greater symptom severity than either 
disorder alone (Post, Feeny, Zoellner, & Connell, 
2016). Subclinical traumatic stress reactions are 
commonly expressed as depressive symptoms. 
However, PTSD has unique treatment needs 
and a different disease course and treatment 
response than depression. When working with 
someone with a depressive disorder diagnosis 
who also has a history of trauma, consider 
screening for PTSD to gauge whether a referral 
for diagnostic assessment might be warranted. 
Treatment of PTSD and SUDs 
Historically, there has been debate about whether 
to treat PTSD and addiction concurrently or 
sequentially, with most providers falling on the side 
of treating the SUD separately and frst (Schumm & 
Gore, 2016). Some believe that substance misuse 
among people with PTSD is a means of self-
medicating to help manage distressing mood and 
anxiety symptoms, thus making PTSD the priority 
target for treatment. Alternatively, others have 
feared that treating PTSD frst could exacerbate 
SUD symptoms or cause clients to use substances 
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as a means of coping with the hyperarousal and 
negative mood that can occur while progressing 
through PTSD treatment. However, integrated, 
concurrent treatment that addresses both 
conditions simultaneously has generated strong 
empirical support, appears to be preferable to 
clients, and is increasingly considered the current 
standard of care, particularly when combining 
psychosocial and pharmacologic approaches 
(Flanagan et al., 2016; Schumm & Gore, 2016; 
Simpson, Lehavot, & Petrakis, 2017). 
Despite the evidence that concurrent 
treatment can be effective, people with PTSD 
and SUD are frequently only treated for 
addiction; further, clients in SUD treatment 
settings are often not even assessed for 
PTSD (Vujanovic et al., 2016). Whereas treating 
SUD alone rarely leads to improvement in 
PTSD symptoms, reducing PTSD symptoms 
can signifcantly decrease the odds of heavy 
substance (Hien et al., 2010). 
Exposure therapy can be safe and effective at 
reducing trauma and SUD symptoms—although 
more evidence is needed (Flanagan et al., 2016). 
Nonexposure-based treatments have been 
studied more widely for co-occurring PTSD 
and SUD and may be moderately effective at 
improving both PTSD and substance symptoms, 
but the evidence is still premature (Flanagan et 
al., 2016). A Cochrane Review found individual 
trauma-focused psychotherapy with adjunctive 
SUD treatment to be effective at reducing 
posttreatment PTSD severity and substance use 
at 5 to 7 months following treatment; however, 
the authors deemed the current evidence base on 
psychological treatments for PTSD-SUD to be weak 
in terms of quality and methodology, underscoring 
the need for more rigorous research in this area 
(Roberts, Roberts, Jones, & Bisson, 2016). Studies 
of pharmacologic treatments for SUD with PTSD, 
and for AUD specifcally, appear encouraging but, 
again, are understudied, often inconclusive, and 
require more data (Flanagan et al., 2016; Petrakis & 
Simpson, 2017). 
See the section “Cross-Cutting Topics: Suicide 
and Trauma” at the end of this chapter for more 
information about trauma-informed care for people 
with CODs. 
ADVICE TO THE COUNSELOR: COUNSELING A CLIENT WITH PTSD 
• As a counselor, it is important to recognize, and help clients understand, that becoming abstinent from 
substances does not resolve PTSD; both disorders must be addressed in treatment. 
• Treatment of PTSD with cooccurring SUDs requires careful planning and supervision. 
− As the client faces painful trauma memories, the desire for intoxication can be overwhelming. By 
exploring trauma memories, well-intentioned counselors inadvertently may drive a client back to 
the substance by urging her to “tell her story” or “let out the abuse.” Even if a client wants to discuss 
trauma and seems safe during the session, aftereffects may well ensue, including a food of memories 
the client is unprepared to handle, increased suicidality, and “retraumatization” (feeling like one is 
reliving the event). 
− Such treatment approaches should be undertaken only with adequate formal training in both PTSD 
and substance misuse and only under careful clinical supervision. 
• These clients need stability in their primary therapeutic relationship; hence, this work should not be 
undertaken in settings with high staff turnover and never without training and supervision. 
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• Do not try to provide trauma exploration treatment in view of the potential for highly destabilizing 
effects (including worsening of substance misuse). 
• Provide present-focused psychoeducation about PSTD, such as teaching the client to recognize 
symptoms of the disorder and how to cope with them. 
• Clinicians are advised not to overlook the possibility of PTSD in men. 
• People with PTSD and substance misuse are more likely to experience further trauma than people with 
substance misuse alone. 
• Repeated trauma is common in domestic violence, child abuse, and some substance-using lifestyles 
(e.g., the drug trade), so helping the client protect against future trauma may be an important part of 
treatment. 
• Anticipate proceeding slowly with a client who is diagnosed with or has symptoms of PTSD. Consider 
the effect of a trauma history on the client’s current emotional state, such as an increased level of fear, 
depressed mood, or irritability. 
• Trauma begets more trauma, as people with PTSD are at an increased risk of revictimization. Discuss 
with clients this increased risk, how to recognize and avoid threatening situations, and how substance 
use plays a role in increasing their vulnerability to revictimization. 
• Develop a plan for increased safety if warranted. 
• Respond more to the client’s behavior than his or her words. 
• Limit questioning about details of trauma. 
• Recognize that trauma injures an individual’s capacity for attachment. The establishment of a trusting 
treatment relationship will be a goal of treatment, not a starting point. 
• Recognize the importance of one’s own trauma history and countertransference. 
• Help the client learn to deescalate intense emotions. 
• Help the client understand the link between PTSD and substance use by providing psychoeducation. 
• Teach coping skills to control PTSD symptoms. 
• Recognize that PTSD/SUD treatment clients may have a more diffcult time in treatment and that 
treatment for PTSD may be long term, especially for those who have a history of serious trauma. 
• Help the client access long-term PTSD treatment and refer to trauma experts for trauma exploratory 
work. 
• Given the high prevalence of self-harm in this population, counselors should screen for suicide risk 
early on in treatment and throughout the course of care. Risk of suicide in people with PTSD is 
correlated with a history of childhood maltreatment and more severe PTSD symptoms—especially ones 
concerning negative mood and cognitions (Criterion D in DSM-5 diagnostic criteria). 
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CASE STUDY: COUNSELING AN SUD TREATMENT CLIENT WHO BINGE 
DRINKS AND HAS PTSD 
Caitlin P. is a 17-year-old Native American woman admitted to an inpatient SUD treatment program after 
she tried to kill herself during a drunken episode. She has been binge drinking since age 12 and also has 
tried a wide variety of pills without caring what she is taking. She has a history of depression and burning 
her arms with cigarettes. She was the victim of a date rape at age 15 and did not tell anyone but a close 
friend. She did not tell her family for fear that they would think less of her for not preventing or fghting 
off the attack. 
In treatment, she worked with staff to try to gain control over her repeated self-destructive behavior. 
Together they worked on developing compassion for herself, created a safety plan to encourage her to 
reach out for help when in distress, and began a log to help her identify her PTSD symptoms so that she 
could recognize them more clearly. When she had the urge to drink, use drugs, or burn herself, she was 
guided to try to “bring down” the feelings through grounding, rethink the situation, and reassure herself 
that she could get through it. She began to see that her substance use had been a way to numb the pain. 
Discussion: Counselors can help clients gain control over PTSD symptoms and self-destructive behavior 
associated with trauma. Providing specifc coping strategies and lots of encouragement typically appeals 
to PTSD/SUD treatment clients, who may want to learn how to overcome the emotional rollercoaster of 
their disorders. Notice that in such early-phase treatment, detailed exploration of the past is not generally 
advised. 
For more information about working with American Indian and Alaska Native clients who have SUDs or 
CODs, see TIP 61, Behavioral Health Services for American Indians and Alaska Natives (SAMHSA, 2018a). 
Personality Disorders 
A PD refers to a person’s lifelong inability to form 
healthy, functional relationships with others and 
a failure to develop an adaptive sense of self. 
These are manifest as (a) destructive or otherwise 
problematic patterns of thinking and feeling about 
oneself, one’s place in the world, and others and 
(b) negative ways of behaving toward others. 
People with PDs often lack insight into their 
dysfunctional cognitive, emotional, and behavioral 
patterns and often blame others or the world in 
general for their diffculties. Many people with PDs 
struggle to develop strong, positive relationships, 
because they view reality from the perspective 
of their own needs and therefore have a diffcult 
time understanding, empathizing with, and 
connecting with others. PDs are lifelong conditions 
that develop in adolescence or early adulthood. 
They are frequently resistant to change and 
result in signifcant impairments in interpersonal 
functioning, work/school performance, and 
self-concept. 
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There are several types of PDs, and the precise 
symptoms someone exhibits will depend on 
which type of PD he or she has. For instance, 
depending on the PD type, an individual might 
think of himself/herself in overly negative ways or 
in grandiose ways, might be overly attached to 
others or completely indifferent to others, might 
constantly try to be the center of attention or 
might be socially reclusive. People with PDs must 
frst meet the diagnostic criteria for a general 
PD (Exhibit 4.5) and then must meet additional 
diagnostic criteria for whatever PD type is 
most appropriate given their symptoms. Many 
individuals with PDs have features of, or meet full 
criteria for, other PDs. 
This TIP provides details about the two PD types
that are commonly comorbid with addiction—BPD
and antisocial PD (ASPD). Before exploring BPD
and ASPD in detail, an overview of PDs in general
follows. Readers should be aware that the diagnostic
approach to PDs continues to undergo refnement,
as researchers in psychopathology have expressed
many concerns about the meaningfulness, gender
bias, accuracy, and utility of the current categorical
diagnostic system for PDs (see Section III of DSM-5
for more information on alternative PD classifcation
and diagnostic criteria).
PD Clusters 
Once a person meets criteria for a general PD, 
his or her diagnosis is further categorized based 
on several specifc PD types, including paranoid 
PD, schizoid PD, schizotypal PD, histrionic 
PD, narcissistic PD, ASPD, BPD, avoidant PD, 
dependent PD, and obsessive-compulsive PD. If 
the symptoms do not meet any of the types, he 
or she can be diagnosed with either unspecifed 
PD or other specifed PD. Detailed descriptions 
and criteria for all 10 PD types can be found in 
DSM-5. BPD and ASPD most frequently co-occur 
with substance misuse (Köck & Walter, 2018). Thus, 
they are included in this chapter and discussed in 
respective subsections. 
In DSM5, PD types are categorized into three 
distinct clusters based on their common features: 
• Cluster A PDs describe people who may be 
seen as odd or eccentric. This eccentricity can 
express itself in many ways (e.g., paranoia and 
suspicion, extreme social withdrawal/lack of 
EXHIBIT 4.5. Diagnostic Criteria for General PD 
A. An enduring pattern of inner experience and behavior that deviates markedly from the expectations of 
the individual’s culture. This pattern is manifested in two (or more) of the following areas: 
1. Cognition (i.e., ways of perceiving and interpreting self, other people, and events) 
2. Affectivity (i.e., the range, intensity, lability, and appropriateness of emotional response) 
3. Interpersonal functioning 
4. Impulse control 
B. The enduring pattern is infexible and pervasive across a broad range of personal and social situations. 
C. The enduring pattern leads to clinically signifcant distress or impairment in social, occupational, or other 
important areas of functioning. 
D. The pattern is stable and of long duration, and its onset can be traced back at least to adolescence or 
early adulthood. 
E. The enduring pattern is not better explained as a manifestation or consequence of another mental 
disorder. 
F. The enduring pattern is not attributable to the physiological effects of a substance (e.g., a drug of abuse, a 
medication) or another medical condition (e.g., head trauma). 
Source: APA (2013, pp. 646–647). Reprinted with permission from the DSM-5 (Copyright © 2013). APA. All Rights Reserved. 
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WARNING TO COUNSELORS: PDS AND PROVIDER STIGMA 
PDs are among the most stigmatized of all mental disorders (Sheehan, Nieweglowski, & Corrigan, 2016). 
Primary care, mental health, and SUD treatment professionals sometimes have contemptuous attitudes 
toward PDs and the people who live with them. They may think or say things such as: 
• “These people cannot be treated, so why bother?” 
• “I see PDs all the time, especially in women.” 
• “Most people with addiction also have a PD.” 
• “It is not worth the time to try to diagnose or treat someone with a PD because nothing can be done for 
them anyway.” 
• “I don’t accept referrals for clients like that because they’re too much work and can’t be helped.” 
• “Most antisocial people are criminals and are just going to end up in prison.” 
• “People with ASPD are ‘psychopaths’ (or ‘sociopaths’).” 
• “These people are just manipulative liars; they don’t really want to get better or want my help.” 
• “That wasn’t a real suicide attempt. She’s borderline—she’s just seeking attention.” 
It is true that PDs are lifelong disorders, can be challenging to work with, and may be more resistant 
to change than other mental disorders or SUDs. But that does not mean that counselors cannot offer 
people with these conditions any relief, and it does not mean that people with PDs cannot improve their 
symptoms. Addiction professionals can help clients with PDs reduce substance misuse, which in turn can 
indirectly help improve functioning and quality of life by reducing risky behavior and enhancing health. 
Counselors can combat stigma and prejudice by: 
• Becoming familiar with the latest evidence in support of PD treatment. The notion that these disorders 
are completely intractable is untrue. Even in the absence of validated treatments for the PD itself, 
interventions can still help reduce disabling symptoms and CODs, including co-occurring addiction. 
• Engaging in honest self-refection about their own views of and attitudes about PDs. Talking to a 
clinical supervisor, or even engaging in brief counseling themselves, can foster self-awareness and 
behavior change. 
• Remembering that stereotypes can be dangerous and affect how counselors serve (or do not serve) the 
clients who need them. All people, regardless of symptoms or diagnoses, deserve health and happiness. 
interest in interpersonal relationships, unusual 
beliefs or behaviors). PD types included in this 
cluster are: 
Paranoid PD. 
Schizoid PD. 
Schizotypal PD. 
• Cluster B PDs are characterized by dramatic, 
overly emotional, and erratic and unpredictable 
behavior. PD types included in this cluster are: 
Histrionic PD. 
Narcissistic PD. 
ASPD. 
BPD. 
• Cluster C PDs are marked by anxious and fearful 
behaviors. PD types included in this cluster are: 
Obsessive-compulsive PD. 
Avoidant PD. 
Dependent PD. 
Prevalence 
Prevalence estimates for PDs among the general 
population are diffcult to ascertain, given lack 
of research examining large samples from the 
community (as opposed to clinical samples, in which
PDs are far more common and frequently studied).
Estimates are 9.1 percent for any PD, 5.7 percent for
any Cluster A PD, 1.5 percent for any Cluster B, and
6 percent for Cluster C (APA, 2013). In one analysis
of the National Epidemiologic Survey on Alcohol
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and Related Conditions (NESARC), the prevalence
of lifetime DSM-IV PDs varied from 0.5 percent to
7.9 percent, depending on the PD type (Hasin &
Grant, 2015). Prevalence rates for BPD and ASPD
are discussed in separate sections.
Diagnostic criteria for PDs have long been 
debated among psychopathology researchers 
and clinicians, given multiple problems with the 
way PDs are classifed and diagnosed (Paris, 
2014; Sarkar & Duggan, 2010). Problems include 
a lack of empirical evidence supporting PDs; the 
extensive overlap between diagnostic criteria 
among the specifc types of PDs as well as 
overlap with other mental disorders; the fact that 
PD criteria are insuffciently discriminant, which 
has resulted in many individuals who exhibit PD 
pathology receiving a DSM-IV “personality disorder 
not otherwise specifed” diagnosis after failing 
to “ft in” to any of the specifed PD types; and 
the diffculty mental health professionals have in 
distinguishing PD traits from variants of normal 
personality, which means that deciding whether 
a person meets PD criteria is often a subjective 
judgment. Thus, it is hard to know exactly how 
many people have a PD, including how many 
people with addiction have co-occurring PDs
(Paris, 2014). 
PDs and SUDs 
SUD counselors frequently see people with PD 
diagnoses in their treatment settings. A review 
found the prevalence of PDs among people 
with SUDs to be wide ranging but nonetheless 
extremely high, varying from about 35 percent 
to 65 percent; rates of ASPD ranged from about 
14 percent to almost 35 percent (Köck & Walter, 
For most people with SUDs, drugs eventually
become more important than jobs, friends,
and family. These changes in priorities
often appear similar to a PD, but diagnostic
clarity for PDs in general is diffcult. For
clients with substance-related disorders, the
true diagnostic picture might not emerge
for weeks or months. It is not unusual for
PD symptoms to clear with abstinence,
sometimes even fairly early in recovery. 
2018). Similarly, among people undergoing 
detoxifcation for AUD, rates of co-occurring PDs 
vary widely from 5 percent to 87 percent (Newton-
Howes & Foulds, 2018). PDs may be present in 
as much as 24 percent of people with AUD in the 
general population (Newton-Howes & Foulds, 
2018). 
People with PDs and SUDs differ from those 
with PDs only or SUDs only in important ways 
(Köck & Walter, 2018), including more severe 
mental and substance-related symptoms, longer 
persisting substance use, a greater likelihood of 
other co-occurring mental disorders (e.g., anxiety, 
depressive, and eating disorders), increased 
mortality, and higher SUD treatment dropout. 
Treatment for PDs and SUDs 
No evidence-based treatments exist for PDs
themselves (Bateman, Gunderson, & Mulder, 2015),
but effective treatments are available to address a
variety of PD symptoms, including risk of suicide
and self-harm, affective dysregulation, maladaptive
thought patterns, and poor interpersonal
functioning. Psychotherapy is the primary form of
intervention, as no medications have been approved
for the treatment of PDs. Pharmacotherapy may
be useful as an adjunctive treatment for certain
symptoms like affective lability, impulsivity,
and psychosis, but it is not useful as a primary
intervention. (See the section “Pharmacotherapy”
in Chapter 7 for more information.) Dialectical
behavioral therapy, dynamic deconstructive
psychotherapy, and dual-focused schema therapy
appear promising, particularly for BPD, and have
shown to positively affect psychiatric and addiction-
related outcomes, although, in general, the research
literature on effective treatments for PDs, with or
without co-occurring SUD, is sparse and requires
further evidence (Bateman et al., 2015; Köck &
Walter, 2018).
BPD 
The essential feature of BPD is a pervasive pattern 
of instability of interpersonal relationships, self-
image, and affects, along with marked impulsivity, 
that begins by early adulthood and is present in 
a variety of contexts (Exhibit 4.6). Relationships 
with others are likely to be unstable—for instance, 
people with BPD might remark how wonderful an 
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ADVICE TO THE COUNSELOR: COUNSELING A CLIENT WITH A PD 
• Clients with PDs tend to be limited in their ability to receive, accept, or beneft from corrective feedback. 
• A further diffculty is the strong countertransference providers can have in working with these clients, 
who may be adept at igniting reactions in a variety of ways. Specifc concerns will, however, vary 
according to the specifc PD and other individual circumstances. 
• PDs may cause diffculty forming genuinely positive therapeutic alliances. Some clients tend to frame 
reality in terms of their own needs and perceptions and not to understand the perspectives of others. 
• The course and severity of PDs can be worsened by the presence of other mental disorders, such as 
depressive, anxiety, and psychotic disorders. Be sure to offer empirical treatments for co-occurring 
conditions as well as the primary PD and SUD. 
• To get the best outcomes possible for clients with PDs and co-occurring SUDs, treatment should 
address both conditions to the extent possible and should not neglect one disorder over the other. 
EXHIBIT 4.6. Diagnostic Criteria for BPD 
A pervasive pattern of instability of interpersonal relationships, self-image, and affects, and marked 
impulsivity, beginning by early adulthood and present in various contexts, as indicated by fve (or more) of 
the following: 
1. Frantic efforts to avoid real or imagined abandonment (Note: Do not include suicidal or self-mutilating 
behavior covered in Criterion 5.) 
2. A pattern of unstable and intense interpersonal relationships characterized by alternating between 
extremes of idealization and devaluation 
3. Identity disturbance: markedly and persistently unstable self-image or sense of self 
4. Impulsivity in at least two areas that are potentially self-damaging (e.g., spending, sex, substance abuse, 
reckless driving, binge eating) (Note: Do not include suicidal or self-mutilating behavior covered in 
Criterion 5.) 
5. Recurrent suicidal behavior, gestures, or threats, or self-mutilating behavior 
6. Affective instability due to a marked reactivity of mood (e.g., intense episodic dysphoria, irritability, or 
anxiety usually lasting a few hours and only rarely more than a few days) 
7. Chronic feelings of emptiness 
8. Inappropriate, intense anger or diffculty controlling anger (e.g., frequent displays of temper, constant 
anger, recurrent physical fghts) 
9. Transient, stress-related paranoid ideation or severe dissociative symptoms 
Source: APA (2013, p. 663). Reprinted with permission from the DSM-5 (Copyright © 2013). APA. All Rights Reserved. 
individual is one day but express intense anger, 
disapproval, condemnation, and even hate toward 
that same individual a week later. The severe 
instability people with BPD experience includes 
fuctuating views and feelings about themselves. 
Those with BPD often feel good about themselves 
and their progress and optimistic about their future 
for a few days or weeks, only to have a seemingly 
minor experience turn their world upside down, 
with concomitant plunging self-esteem and 
depressing hopelessness. This instability often 
extends to work and school. 
When experiencing emotional states they cannot
handle, clients with BPD can be at high risk of
suicidal, self-mutilating, or brief psychotic states.
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About three-fourths of people with BPD have a
history of self-harm, and the disorder carries a
10-percent lifetime risk of completed suicide (Antai-
Otong, 2016).
Prevalence 
BPD has a prevalence of 1.6 percent to 5.9 percent 
in the general population but is more common 
in mental health settings (about a 10-percent 
prevalence rate for outpatient mental health clinics, 
about 20 percent among psychiatric inpatients, 
and 6 percent in primary care settings) (APA, 2013). 
Lifetime prevalence of DSM-IV BPD is 5.9 percent 
(Hasin & Grant, 2015). 
Women are much more likely to be diagnosed with 
BPD, generally at 3 times the rate of men (i.e., 
about 75 percent of cases are women) (APA, 2013). 
However, the accuracy of this pattern is dubious 
as epidemiologic surveys of the U.S. general 
WARNING TO COUNSELORS: 
THE MISDIAGNOSIS OF BPD 
PDs can be diffcult to diagnose. BPD is 
especially prone to misdiagnosis, particularly 
among women. Reasons for incorrect diagnosis 
(or, alternatively, failure to diagnose) are 
numerous and include (Fruzzetti, 2017): 
• Stigma surrounding the disorder may lead 
providers to refuse to diagnose it or to be 
overzealous in diagnosing it (the latter, 
especially in women who are “emotional,” 
unstable, argumentative, or in crisis). 
• Symptoms of BPD—including emotional 
lability, suicidality, and impulsive behaviors— 
that are also present in full or in part in many 
other disorders, including MDD, bipolar 
disorder, PTSD, SUDs, and more. This makes 
it diffcult to disentangle BPD from other 
illnesses. 
• The incorrect belief that BPD is not treatable, 
which may make clinicians less likely to give 
the diagnosis, especially when they believe 
that symptoms refect a different disorder, 
like depression or PTSD. 
• Women being signifcantly more likely to 
receive a BPD diagnosis because of gender 
bias. 
population have found the lifetime prevalence of 
BPD does not actually differ signifcantly between 
men and women (Hasin & Grant, 2015). 
BPD and SUDs 
BPD is highly prevalent in SUD treatment settings 
(and especially inpatient and residential treatment), 
with rates averaging about 22 percent across 
multiple studies but as high as 53 percent in some 
research (Trull et al., 2018). Presence of a 12-month 
or lifetime DSM-5 drug use disorder (i.e., an SUD 
excluding alcohol) is associated with a 1.7 to 1.8 
increased odds of having BPD (Grant et al., 2016). 
Approximately 45 percent of individuals with BPD 
also have a current SUD, and about 75 percent 
have a lifetime SUD (Trull et al., 2018). Opioids, 
cocaine, and alcohol are the substances with the 
strongest associations with BPD (Trull et al., 2018). 
Treatment of BPD and SUDs 
People with BPD typically seek behavioral health 
services based on their current life conditions and 
emotional state. Those who seek mental health 
services tend to be acutely emotionally distraught, 
needing some relief from how they feel. Similarly, 
those who choose (or are directed to choose) a 
program are likely experiencing the SUD as the 
immediate target for treatment. Consequently, 
the average admission of a person with BPD to 
a mental health program may be considerably 
different from the average admission of a person 
with BPD to an SUD treatment program. 
In inpatient mental health service settings, 
dialectical behavior therapy for BPD is 
recommended to help reduce suicide risk, stabilize 
behavior, and help clients regulate emotions (Ritter 
& Platt, 2016). SUD treatment for people with BPD 
can be complicated, and progress may be slow, but 
effective interventions are available to help reduce 
symptoms and improve functioning. A systematic 
review of 10 studies on treatments for BPD and co-
occurring SUDs found good support for dialectical 
behavior therapy, dynamic deconstructive therapy, 
and dual-focused schema therapy in improving 
outcomes of substance use, suicidal gestures and 
self-harm, global and social functioning, treatment 
utilization, and treatment retention (Lee, Cameron, 
& Jenner, 2015).  
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ADVICE TO THE COUNSELOR: COUNSELING A CLIENT WITH BPD 
• Anticipate that client progress will be slow and uneven. 
• Assess the risk of self-harm by asking about what is wrong, why now, whether the client has specifc 
plans for suicide, past attempts, current feelings, and protective factors. (See the discussion of suicidality 
at the end of this chapter.) 
• Maintain a positive but neutral professional relationship, avoid overinvolvement in the client’s 
perceptions, and monitor the counseling process frequently with supervisors and colleagues. 
• Set clear boundaries and expectations regarding limits and requirements in roles and behavior. 
• Understand that clients with BPD may be inconsistent in their attendance to sessions; anticipate and 
discuss these interruptions with the client. 
• Assist the client in developing skills (e.g., deep breathing, meditation, cognitive restructuring) to 
manage negative memories and emotions. 
• Help the client understand the connections between their feelings and their behaviors. 
• Monitor newly abstinent individuals with BPD for compulsive sexual behavior, compulsive gambling, 
compulsive spending/shopping, or other behaviors that result in negative or even dangerous 
consequences. 
• Medication management and monitoring should be included in the treatment plan. Individuals 
with BPD often are skilled in seeking multiple sources of medication that they favor, such as 
benzodiazepines. Once they are prescribed this medication in a mental health system, they may 
demand to be continued on the medication to avoid dangerous withdrawal. 
• Help clients manage their daily lives and responsibilities by focusing on work, family, and social 
functioning. 
• At the beginning of a crisis episode, a client with BPD may take a drink or use a different substance in 
an attempt to quell the growing sense of tension or loss of control. The client must learn that at this 
point, substance use increases harm and real loss of control. The client needs to develop positive coping 
strategies to put into play immediately upon experiencing a desire to use substances. 
• Educate clients about their SUDs and mental disorders. Clients should learn that treatment for 
and recovery from their SUD may progress at a different rate than their treatment for and recovery 
from BPD. In addition, although many clients appear to fully recover from their SUDs, the degree of 
long-term recovery from BPD is less understood and characterized. 
• Written and oral contracts that are simple, clear, direct, and time limited can be a useful part of the 
treatment plan. Contracts can help clients create structure and safe environments for themselves, 
prevent relapse, or promote appropriate behavior in therapy sessions and in mutual-support meetings. 
• To treat people with BPD, pay attention to several areas, such as violence to self or others, transference 
and countertransference, boundaries, treatment resistance, symptom substitution, and somatic 
complaints. 
• Therapists should be realistic in their expectations and know that clients might try to test them. To 
respond to such tests, therapists should maintain a matter-of-fact, businesslike attitude, and remember 
that people with PDs often display maladaptive behaviors that have helped them to survive in diffcult 
situations, sometimes called “survivor behaviors.” (See TIP 36, Substance Abuse Treatment for Persons 
With Child Abuse and Neglect Issues [CSAT, 2000c]). 
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CASE STUDY: COUNSELING AN SUD TREATMENT CLIENT WITH BPD 
Ming L., an Asian woman, was 32 years old when she was taken by ambulance to the local hospital’s 
emergency department (ED). Ming L. had taken 80 Tylenol capsules and an unknown amount of Ativan in a 
suicide attempt. Once medically stable, Ming L. was evaluated by the hospital’s social worker to determine 
her clinical needs. 
The social worker asked Ming L. about her family of origin. Ming L. gave a cold stare and said, “I don’t 
talk about that.” Asked if she had ever been sexually abused, Ming L. replied, “I don’t remember.” Ming L. 
acknowledged previous suicide attempts as well as a history of cutting her arm with a razor blade during 
stressful episodes. She reported that the cutting “helps the pain.” 
Ming L. denied having “a problem” with substances but admitted taking “medication” and “drinking 
socially.” A review of Ming L.’s medications revealed the use of Ativan “when I need it.” It soon became clear 
that Ming L. was using a variety of benzodiazepines (antianxiety medications) prescribed by several doctors 
and probably was taking a daily dose indicative of severe SUD. She reported using alcohol “on weekends 
with friends” but was vague about the amount. Ming L. did acknowledge that before her suicide attempts, 
she drank alone in her apartment. This last suicide attempt was a response to a breakup with her boyfriend. 
The counselor reads through notes from an evaluating psychiatrist and reviews the social worker’s report of 
his interview with Ming. She notes that the psychiatrist describes the client as having a severe BPD, major 
recurrent depression, and SUDs involving both benzodiazepines and alcohol. 
Discussion: Knowing the limits of what an SUD treatment counselor or agency can and cannot realistically do
is important. A client with problems this serious is unlikely to do well in standard SUD treatment unless she
is also enrolled in a program qualifed to provide treatment to clients with BPD, and preferably in a program
that offers treatment designed especially for this disorder, such as dialectical behavior therapy (Linehan et al.
1999) (although SUD treatment programs are increasingly developing their capacities to address specialized
mental disorders). She is likely to need detoxifcation either on an inpatient basis or in a long-term outpatient
program that knows how to address clients with PDs. 
ASPD 
The core features of ASPD are a pervasive
disregard for the rights, feelings, and needs of
others and a failure to form long-term, fulflling,
adaptive relationships (Exhibit 4.7). Individuals
with ASPD often display a host of challenging
traits: deceitfulness, remorselessness, aggression,
disregard for rules and laws, low conscientiousness,
impulsivity, failure to adhere to social norms,
delinquency, and recklessness. As a result, these
individuals often lead unstable lives and are at high
risk of increased mortality, violence/aggression,
suicide and suicidal behavior, accidents, criminality,
incarceration, and chronic illnesses (e.g., cancer,
HIV) (Black, 2015; Black, 2017; Dykstra, Schumacher,
Mota & Coffey, 2015; Krasnova, Eaton, & Samuels,
2018; McCloskey & Ammerman, 2018). Many
people with ASPD have experienced traumatic or
disruptive childhoods (Sher et al., 2015). 
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EXHIBIT 4.7. Diagnostic Criteria 
for ASPD 
A. A pervasive pattern of disregard for and 
violation of the rights of others, occurring since 
age 15 years, as indicated by three (or more) of 
the following: 
1. Failure to conform to social norms with 
respect to lawful behaviors, as indicated by 
repeatedly performing acts that are grounds 
for arrest 
2. Deceitfulness, indicated by repeated lying, 
use of aliases, or conning others for personal 
proft or pleasure 
3. Impulsivity or failure to plan ahead 
4. Irritability and aggressiveness, as indicated by 
repeated physical fghts or assaults 
5. Reckless disregard for safety of self or others 
6. Consistent irresponsibility, as indicated by 
repeated failure to sustain consistent work 
behavior or honor fnancial obligations 
7. Lack of remorse, indicated by being indifferent
to or rationalizing having hurt, mistreated, or
stolen from another
B. The individual is at least age 18 years. 
C. There is evidence of conduct disorder with 
onset before age 15 years. 
D. The occurrence of antisocial behavior is not 
exclusively during the course of schizophrenia or 
bipolar disorder. 
Source: APA (2013, p. 659). Reprinted with permission 
from the DSM-5 (Copyright © 2013). APA. All Rights 
Reserved. 
A particularly stigmatizing aspect of ASPD is its 
history of being equated with derisive terms like 
“sociopath” and “psychopath.” ASPD thus carries 
extremely negative connotations that might well be 
accurate in only a small percentage of those people 
with the disorder. Psychopathy and sociopathy are 
personality traits, not mental disorders. They are 
related to ASPD but are usually manifest in more 
extreme ways than ASPD (e.g., criminal behavior). 
In short, psychopathy and sociopathy are not the 
same as ASPD. (See the TIP 44, Substance Abuse 
Treatment for Adults in the Criminal Justice System 
[CSAT, 2005b] for a full discussion of psychopathy 
and its relationship to ASPD.) 
Prevalence 
Twelve-month prevalence rates for DSM-IV ASPD 
fall between 0.2 percent and 3.3 percent (APA, 
2013). Lifetime DSM-IV ASPD is estimated at 
3.6 percent (Hasin & Grant, 2015). Much higher 
prevalence rates (up to 70 percent) have been 
found in studies of men in treatment for AUD and 
SUD treatment clinics, prisons, and other forensic 
settings (APA, 2013). 
Men are 2 to 8 times more likely to have an ASPD 
diagnosis than women (Black, 2017). Lifetime 
prevalence of DSM-IV ASPD is estimated at 1.9 
percent in women and 5.5 percent in men (Hasin & 
Grant, 2015). 
ASPD and SUDs 
Presence of a 12-month or lifetime DSM-5 drug use 
disorder (i.e., an SUD excluding alcohol) is linked 
with 1.4 to 2 increased odds of having ASPD (Grant 
et al., 2016). Prevalence of ASPD is 7 percent to 
40 percent in men with existing SUDs. ASPD is 
signifcantly associated with persistent SUDs (Grant 
et al., 2015; Grant et al., 2016). 
An analysis of NESARC data (using DSM-IV 
diagnoses) revealed gender differences in 
comorbidities with ASPD (Alegria et al., 2013). 
Men with ASPD were more likely to have AUD, any 
drug use disorder, and narcissistic PD. Women with 
ASPD were more likely to have any mood disorder, 
MDD, dysthymia, any anxiety disorder, panic 
disorder, specifc phobia, PTSD, and generalized 
anxiety disorder (GAD). Women were also more 
likely to report childhood adverse events, such as 
sexual abuse. 
Another study of treatment-seeking individuals 
assessing gender differences in individuals with an 
ASPD diagnosis similarly found that women with 
ASPD tended to be younger, had fewer episodes of 
antisocial behavior and higher scores on measures 
of trauma, including emotional and sexual abuse, 
than men with an ASPD (Sher et al., 2015). Both 
women and men with ASPD had comorbid alcohol 
(43.6 percent for women and 50 percent for men) 
and cannabis use disorders (21.8 percent and 29.7 
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percent, respectively), and men had higher rates of 
comorbid cocaine use disorder (22 percent) than 
women (7.3 percent). Many people with ASPD use 
substances in a polydrug pattern involving alcohol, 
marijuana, heroin, cocaine, and methamphetamine. 
People with ASPD and SUDs have higher rates 
of aggression, impulsivity, and psychopathy than 
people with SUDs alone (Alcorn et al., 2013). 
Disregard for others’ rights is a key diagnostic 
feature of ASPD. Yet most clients who are 
actively using substances display behaviors 
at some point that show such disregard, so 
perceiving the distinction between SUD and 
ASPD can be diffcult for the mental health and 
the SUD treatment felds. 
Treatment of ASPD and SUDs 
As with most PDs, no empirically supported 
treatments exist for ASPD, much less ASPD 
combined with SUDs (Bateman et al., 2015). 
Various therapies for ASPD with addiction 
(e.g., CBT, contingency management) may help 
ameliorate substance-related outcomes, like 
substance misuse and number of urine-negative 
specimens over time, but studies are few and 
sample sizes are small (Brazil, van Dongen, Maes, 
Mars, & Baskin-Sommers, 2018). 
Anxiety Disorders
The distinguishing feature of anxiety disorders is 
excessive fear and worry along with behavioral 
disturbances, usually out of attempts to avoid or 
manage the anxiety. Anxiety disorders are highly 
ADVICE TO THE COUNSELOR: COUNSELING A CLIENT WITH ASPD 
• As with CODs in general, clients with ASPD and those with both an SUD and ASPD may be seen as 
particularly hard to treat, having poor prognoses, and warranting exclusion from treatment programs 
or group counseling. Counselors should maintain a realistic but hopeful, optimistic attitude toward 
helping clients improve symptoms and functioning. 
• Be aware of the stigma that surrounds ASPD. Many mental health professionals have strongly negative 
feelings about working with clients who have ASPD, or any PD. Some may even refuse to accept ASPD 
referrals. Treating ASPD can be challenging, but people with ASPD have the same rights to quality, 
ethical treatment as anyone else with any other mental disorder. 
• Empirical support for interventions to effectively manage ASPD itself is lacking, but effective treatments 
exist to address certain symptoms (e.g., risk of suicide or self-harm, affective instability), especially those 
of co-occurring depression, anxiety, and SUDs. For instance, CBT can be useful in restructuring negative 
thought patterns and reducing impulsivity, improving interpersonal functioning, and providing general 
support. 
• Heed the warning signs of countertransference and transference. Because many mental health 
professionals have negative attitudes or misperceptions about ASPD, countertransference can occur 
and prevent counselors from forming an empathic and effective therapeutic alliance with the client. 
• Use a positive and empathetic attitude but remain frm in enforcing the structure, rules, and boundaries 
of psychotherapy and therapeutic relationship. 
• Differentiate true ASPD from substance-related antisocial behavior. This can best be done by looking at
how the person relates to others throughout the course of his or her life. People with this disorder will have
evidence of antisocial behavior preceding substance use and even during periods of enforced abstinence.
• It also is important to recognize that people with substance-related antisocial behavior may be more 
likely to have MDD than other typical PDs. However, the type and character of depression that may be 
experienced by those with true ASPD have been less well characterized, and their treatment is unclear. 
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comorbid with each other but differ in the types 
of situations that arouse fear and the content of 
the anxiety-provoking thoughts and beliefs. Panic 
attacks are a common fear response in anxiety 
disorders but are not limited to these disorders. 
Three of the more prevalent anxiety disorders in 
the adult population that are likely to co-occur 
with addiction are GAD, panic disorder, and social 
anxiety disorder (SAD). 
GAD 
GAD is marked by excessive anxiety and worry 
(apprehensive expectation) about a range of 
topics or events, like everyday living, fnances, 
relationships, or work/school performance (Exhibit 
4.8). Anxiety is intense, frequent, chronic (i.e., 
lasting at least 6 months), and disproportionate 
to the actual threat posed by the subject of worry. 
The worry is accompanied by additional cognitive/ 
physical symptoms. 
Panic Disorder 
Panic disorder is diagnosed in people who 
experience repeated panic attacks that are 
distressing and disabling (Exhibit 4.9). A panic 
attack is an abrupt but very intense occurrence of 
extreme fear. It often only lasts for a few minutes 
but the symptoms can be extremely uncomfortable 
and upsetting, such as hyperventilation, 
palpitations, trembling, sweating, dizziness, hot 
fashes or chills, numbness or tingling, and the 
sensation or fear of nausea or choking. People 
experiencing panic attacks also can experience 
psychological symptoms, like feeling as though 
they are going to die, as though they are “losing 
their mind,” as though things are not real 
(derealization), or as if they have left their body 
EXHIBIT 4.8. Diagnostic Criteria for GAD 
A. Excessive anxiety and worry (apprehensive expectation), occurring more days than not for at least 6 
months, about a number of events or activities (such as work or school performance). 
B. The individual fnds it diffcult to control the worry. 
C. The anxiety and worry are associated with three (or more) of the following six symptoms (with at least 
some symptoms having been present for more days than not for the past 6 months): 
Note: Only one item is required in children. 
1. Restlessness or feeling keyed up or on edge 
2. Being easily fatigued 
3. Diffculty concentrating or mind going blank 
4. Irritability 
5. Muscle tension 
6. Sleep disturbance (diffculty falling or staying asleep, or restless, unsatisfying sleep) 
D. The anxiety, worry, or physical symptoms cause clinically signifcant distress or impairment in social, 
occupational, or other important areas of functioning. 
E. The disturbance is not attributable to the physiological effects of a substance (e.g., a drug of abuse, a 
medication) or another medical condition (e.g., hyperthyroidism). 
F. The disturbance is not better explained by another mental disorder (e.g., anxiety or worry about having
panic attacks in panic disorder, negative evaluation in SAD [social phobia], contamination or other obsessions
in obsessive-compulsive disorder, separation from attachment fgures in separation anxiety disorder,
reminders of traumatic events in PTSD, gaining weight in anorexia nervosa [AN], physical complaints in
somatic symptom disorder, perceived appearance faws in body dysmorphic disorder, having a serious illness
in illness anxiety disorder, or the content of delusional beliefs in schizophrenia or delusional disorder). 
Source: APA (2013, pp. 222). Reprinted with permission from the DSM-5 (Copyright © 2013). APA. All Rights Reserved 
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(depersonalization). Because of the distressing 
nature of panic attacks, people with panic disorder 
may constantly worry about having subsequent 
attacks or engage in behaviors in an attempt to 
control the attacks (like avoiding places where they 
have previously had a panic attack or fear they 
might have one). 
Panic disorder often is underdiagnosed at the 
beginning of treatment or else is seen as secondary 
to the more signifcant disorders, which are the 
primary focus of treatment. However, panic 
disorder can signifcantly impede a person’s ability 
to take certain steps toward recovery, such as 
getting on a bus to go to a meeting or sitting 
in a 12-Step meeting. Sometimes counselors 
can erroneously identify these behaviors as 
manipulative or treatment-resistant behaviors. 
EXHIBIT 4.9. Diagnostic Criteria for Panic Disorder 
A. Recurrent unexpected panic attacks. A panic attack is an abrupt surge of intense fear or intense 
discomfort that reaches a peak within minutes, and during which time four (or more) of the following 
symptoms occur: 
Note: The abrupt surge can occur from a calm state or an anxious state. 
1. Palpitations, pounding heart, or accelerated heart rate 
2. Sweating 
3. Trembling or shaking 
4. Sensations of shortness of breath or smothering 
5. Feelings of choking 
6. Chest pain or discomfort 
7. Nausea or abdominal distress 
8. Feeling dizzy, unsteady, light‐headed, or faint 
9. Chills or heat sensations 
10. Paresthesias (numbness or tingling sensations) 
11. Derealization (feelings of unreality) or depersonalization (being detached from oneself) 
12. Fear of losing control or “going crazy” 
13. Fear of dying 
Note: Culture‐specifc symptoms (e.g., tinnitus, neck soreness, headache, uncontrollable screaming or 
crying) may be seen. Such symptoms should not count as one of the four required symptoms. 
B. At least one of the attacks has been followed by 1 month (or more) of one or both of the following: 
1. Persistent concern or worry about additional panic attacks or their consequences (e.g., losing control, 
having a heart attack, “going crazy”). 
2. A signifcant maladaptive change in behavior related to the attacks (e.g., behaviors designed to avoid 
having panic attacks, such as avoidance of exercise or unfamiliar situations). 
C. The disturbance is not attributable to the physiological effects of a substance (e.g. a drug of abuse, a 
medication) or another medical condition (e.g., hyperthyroidism, cardiopulmonary disorders). 
D. The disturbance is not better explained by another mental disorder (e.g., the panic attacks do not occur 
only in response to feared social situations, as in SAD; in response to circumscribed phobic objects or 
situations, as in specifc phobia; in response to obsessions, as in obsessive-compulsive disorder; in response 
to reminders of traumatic events, as in PTSD; or in response to separation from attachment fgures, as in 
separation anxiety disorder). 
Source: APA (2013, pp. 208–209). Reprinted with permission from the DSM-5 (Copyright © 2013). APA. All Rights Reserved. 
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Agoraphobia 
One of the changes in DSM-5 concerns the 
separation of agoraphobia from panic disorder. 
Although now two distinct conditions, they are 
closely related and many of their symptoms 
overlap. In agoraphobia, people exhibit a strong 
fear of being in certain places or situations where 
escape could be diffcult should the person 
experience panic-like symptoms or otherwise feel 
anxious or a loss of control. Situations typically 
include being in crowds, on public transportation, 
in open spaces (like bridges), in closed spaces (such 
as the movie theater), or away from home. People 
with agoraphobia avoid these situations for fear 
of having panic attacks or similar incapacitating 
or embarrassing symptoms (e.g., vomiting, 
incontinence), or they tolerate them but with great 
distress and discomfort. 
Agoraphobia often occurs without panic disorder 
in community settings but frequently occurs 
with panic disorder in clinical settings; the two 
conditions are distinct yet intertwined (APA, 2013; 
Asmundson, Taylor, & Smits, 2014). SUDs can and 
do co-occur with agoraphobia (Goodwin & Stein, 
2013; Marmorstein, 2012), but literature on this 
co-occurrence is relatively small compared with 
other anxiety disorders or has been examined 
as occurring with panic disorder (Cougle, Hakes, 
Macatee, Chavarria, & Zvolensky, 2015) rather than 
occurring alone. Furthermore, research is more 
focused on its co-occurrence with nicotine than 
other substances. 
The linkage of agoraphobia with addiction may be 
explained by its relationship with panic disorder 
and not with SUD. Thus, agoraphobia is not a 
subject of focus for this chapter but is mentioned 
here because of its interrelationship with panic 
disorder, which addiction counselors are likely to 
see in their clients. 
SAD 
Social phobia describes the persistent and
recognizably irrational fear of embarrassment
and humiliation in social situations (Exhibit 4.10).
The social phobia may be quite specifc (e.g.,
public speaking) or may become generalized to
all social situations. SAD, also called social phobia
in DSM-5, involves intense anxiety or fear in social
or performance situations. Individuals may fear
being judged by others (e.g., being perceived as
stupid, awkward, or boring); being embarrassed
or humiliated; accidentally offending someone;
or being the center of attention. As a result, the
individual will often avoid social or performance
situations; when a situation cannot be avoided, they
experience signifcant anxiety and distress. Many
people with SAD have strong physical symptoms
(e.g., rapid heart rate, nausea, sweating) and may
experience full-blown attacks when confronting a
feared situation. They recognize that their fear is
excessive and unreasonable, but people with SAD
often feel powerless against their anxiety. 
EXHIBIT 4.10. Diagnostic Criteria for SAD 
A. Marked fear or anxiety about one or more social situations in which the individual is exposed to possible 
scrutiny by others. Examples include social interactions (e.g., having a conversation, meeting unfamiliar 
people), being observed (e.g., eating or drinking), and performing in front of others (e.g., giving a speech). 
Note: In children, the anxiety must occur in peer settings and not just during interactions with adults. 
B. The individual fears that he or she will act in a way or show anxiety symptoms that will be negatively 
evaluated (i.e., will be humiliating or embarrassing; will lead to rejection or offend others). 
C. The social situations almost always provoke fear or anxiety. 
Note: In children, the fear or anxiety may be expressed by crying, tantrums, freezing, clinging, shrinking, or 
failing to speak in social situations. 
D. The social situations are avoided or endured with intense fear or anxiety. 
Continued on next page 
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Continued 
E. The fear or anxiety is out of proportion to the actual threat posed by the social situation and to the 
sociocultural context. 
F. The fear, anxiety or avoidance is persistent, typically lasting for 6 months or more. 
G. The fear, anxiety, or avoidance causes clinically signifcant distress or impairment in social, occupational, 
or other important areas of functioning. 
H. The fear, anxiety, or avoidance is not attributable to the physiological effects of a substance (e.g., a drug 
of abuse, a medication) or another medical condition. 
I. The fear, anxiety, or avoidance is not better explained by the symptoms of another mental disorder, such 
as panic disorder, body dysmorphic disorder, or autism spectrum disorder. 
J. If another medical condition (e.g., Parkinson’s disease, obesity, disfgurement from burns or injury) is 
present, the fear, anxiety, or avoidance is clearly unrelated or is excessive. 
Specify if: 
• Performance only: If the fear is restricted to speaking or performing in public 
Source: APA (2013, pp. 202–203). Reprinted with permission from the DSM-5 (Copyright © 2013). APA. All Rights Reserved. 
Prevalence 
The lifetime prevalence of any anxiety disorder is 
estimated at over 30 percent; 12-month prevalence 
estimates are approximately 19 percent (Harvard 
Medical School, 2005). A recent World Health 
Organization (WHO) survey and analysis using 
DSM-5 diagnostic criteria found the community 
lifetime prevalence of GAD in the U.S. is 7.8 
percent, and 12-month prevalence is 4 percent 
(Ruscio et al., 2017). Women are twice as likely 
as men to experience the disorder (APA, 2013). 
Lifetime prevalence of panic attacks (ascertained 
as part of an analysis of data collected worldwide 
and defned per DSM-5 criteria) with or without 
panic disorder is almost 28 percent (de Jonge 
et al., 2016). The 12-month prevalence in the 
general population for panic disorder is about 2.4 
percent; lifetime prevalence is 6.8 percent (Kessler, 
Petukhova, Sampson, Zaslavsky, & Wittchen, 2012). 
The 12-month prevalence for SAD is approximately 
7 percent; rates in the community trend higher in 
women (1.5 times) than men, especially in young 
adults (APA, 2013). 
Anxiety Disorders and SUDs 
The relationship between substance use and 
anxiety disorders is complex and multifaceted, and 
the two disorders commonly co-occur. Presence of 
a 12-month or lifetime DSM-5 drug use disorder 
(i.e., an SUD excluding alcohol) is associated with 
a 1.2 to 1.3 increased odds of having any anxiety 
disorder, a 1.0 to 1.3 increased odds of having 
panic disorder, a 1.2 to 1.3 increased odds of 
having GAD, and a 1.1 to 1.3 increased odds of 
having SAD (Grant et al., 2016). Recent analyses 
indicate lifetime (but not 12-month) diagnosis 
of drug and alcohol use disorders is associated 
with GAD (Grant et al., 2015; Grant et al., 2016). 
Twelve-month prevalence of panic disorder with 
co-occurring SUD is 11 percent, and lifetime co-
occurrence is 28 percent (de Jonge et al., 2016). 
When anxiety and SUDs co-occur, the disorders 
affect development and maintenance of 
comorbidity, and each disorder modifes the 
presentation and treatment outcomes for the 
other (Brady, Haynes, Hartwell, & Killeen, 2013). 
Consequently, people with anxiety disorders and 
co-occurring SUDs experience worse outcomes 
than those with either disorder alone, including 
greater disability, more hospitalizations and 
healthcare utilization, poorer functioning, more 
diffculties in interpersonal relationships, more 
severe symptoms, worse health-related quality 
of life, and poorer treatment response (Buckner, 
Heimberg, Ecker, & Vinci, 2013; Magidson, Liu, 
Lejuez, & Blanco, 2012). GAD and addiction are 
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ADVICE TO THE COUNSELOR: COUNSELING A CLIENT WITH AN ANXIETY 
DISORDER 
• Treating only one disorder is usually insuffcient, as is treating disorders in isolation (e.g., sequentially).
Clients with both anxiety and addictions need concurrent treatment that equally targets both conditions. 
• Pharmacotherapies can effectively reduce anxiety symptoms (especially if combined with 
psychotherapy) and may need to be a part of clients’ treatment plans. But prescribing psychotropic 
medication in someone with an SUD can be tricky. As needed, refer the client to a mental health 
professional for a full assessment to determine whether medication is warranted and how to safely 
integrate it into the treatment plan. 
• People in recovery from SUDs may have conficting feelings about taking medication. Not all clients 
with anxiety disorders will need pharmacotherapy, but in many cases it can help and, when combined 
with psychotherapy, is frequently more effective at reducing anxiety symptoms and improving 
functioning than either medication or psychotherapy alone. That said, do not “push” medications on 
clients; instead, invite them to explore their feelings about taking medications and discuss advantages 
and disadvantages of such. 
• Selective serotonin reuptake inhibitors are commonly used to help manage GAD, panic disorder, and 
SAD but should not be taken with alcohol. Addiction counselors must educate clients taking anxiolytics 
(especially benzodiazepines) about the indications, contraindications, adverse effects, and dangers 
of medication–alcohol interactions. For clients with anxiety and AUD specifcally, referral to a mental 
health professional to discuss medication management may be needed. 
• Be mindful of the increased risk of dependence and abuse liability with benzodiazepines. This risk 
might be heightened in people who misuse substances to self-medicate their anxiety symptoms or 
in people with SUDs in general. Use CBT known to effectively treat anxiety disorders to minimize or 
augment the use of medications. 
• Educate clients on the dangers of using substances to self-medicate and control anxiety symptoms, and 
make distress tolerance, self-regulation, and adaptive coping skills major focuses of treatment. 
• Assess for (and advise against) over-the-counter substances that can cause or exacerbate anxiety 
symptoms, like caffeine pills and weight loss supplements. 
• Understand the special sensitivities of clients with SAD to social situations. Although group CBT can 
help people with SAD learn to become more comfortable in social environments, individual CBT can be 
equally effective and should be an option for clients who decline group treatment. 
• When clients do not improve as expected, the cause is not necessarily treatment failure or client 
noncompliance. Clients may be compliant and plans may be adequate, but disease processes remain 
resistant. 
• Expect a longer treatment duration compared with treatment for either anxiety or addiction alone. 
• Clients with severe and persistent SUDs and anxiety disorders should not be seen as resistant, 
manipulative, or unmotivated but in need of intensive support. 
• Symptoms may result from SUDs, not underlying mental disorders; careful, continual assessment is key. 
• Anxiety symptoms and disorders are risk factors for suicidal ideation and suicide attempt. Use suicide 
risk mitigation (e.g., routine assessment, thorough documentation) and collaborate with clients to 
implement safety plans. 
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CASE STUDY: GAD AND PROTRACTED WITHDRAWAL 
Ray Y., a 50-year-old husband and father of teenagers, is going through protracted alcohol withdrawal. He 
appears “edgy” and irritable, sometimes sad, and complains to his SUD treatment counselor of insomnia, 
headaches, and an upset stomach. He tells the counselor he can barely stand not to drink: “I’m jumping 
out of my skin.” Although these symptoms are common during protracted withdrawal, because they have 
persisted for over a month the counselor begins a more detailed exploration. 
The counselor asks Ray Y. whether he had these symptoms before he used alcohol, and Ray Y. says he’s 
“always been this way.” He worries about everything, even events that are weeks away. His family vacations 
are nightmares because every aspect of vacation planning troubles him and keeps him awake. During 
family therapy, it becomes apparent that his daughter deeply resents his controlling and distrustful 
behavior, as well as his overprotective stance toward all her social commitments. The counselor refers 
Ray Y. to a psychiatrist, who diagnoses GAD, begins a course of medication, and initiates mental health 
counseling. The family receives help coping with Ray Y.’s disorder, and his daughter is referred for short-
term counseling to help her address the mental problems she is beginning to develop as a result of her 
father’s excessive control. 
Discussion: Anxiety symptoms are quite common during protracted withdrawal, but counselors should 
consider the possibility that an anxiety disorder is indicated. Symptoms should be tracked to see whether 
they persist beyond the normal time that might be expected for protracted withdrawal. Protracted 
withdrawal can occur up to a few months to a year, particularly with antianxiety medication. It varies 
according to severity, duration, and type of medication. Most protracted withdrawal is between 1 and 3 
months. Counselors should also be aware of the effect of such disorders on close family members. Children 
and adolescents may not understand that a parent has a mental disorder and may be relieved to have a 
way of understanding and coping with diffcult behavior. 
associated with higher rates of heavy alcohol use, 
hospitalizations, relapse, and leaving treatment 
against medical advice compared with people with 
SUDs but no GAD (Domenico, Lewis, Hazarika, & 
Nixon, 2018). 
Anxiety symptoms and anxiety disorders are 
predictors of suicidal ideation and suicide attempt 
(Bentley et al., 2016); given that SUDs also elevate 
risk of suicide (Yuodelis-Flores & Ries, 2015), the 
combination of the two suggests efforts to mitigate 
suicide risk mitigation are warranted with these 
clients. 
Treatment of Anxiety Disorders and SUDs 
SUD treatment for people with anxiety should 
include interventions that address the anxiety 
as well as the addiction. Clients may report a 
reduction in some anxiety symptoms during 
detoxifcation or early in recovery (McHugh, 2015).
That said, SUD treatment alone is not suffcient 
to address the co-occurring anxiety. Further, 
the presence of an anxiety disorder complicates 
SUD treatment and can make achieving and 
sustaining abstinence and preventing relapse more 
problematic (McHugh, 2015). 
Concurrent, integrated treatments that include CBT
or exposure therapy can safely, effectively reduce
psychiatric and SUD symptoms but in some studies
are no more effective than placebo (McHugh, 2015).
Schizophrenia and Other
Psychotic Disorders 
Psychotic Disorders 
Psychotic disorders are characterized by a severely 
incapacitated mental and emotional state involving 
a person’s thinking, perception, and emotional 
control. Key features include distorted thoughts in 
which an individual has false beliefs, sensations, or 
perceptions that are imagined, are very extreme, 
or both; and unusual emotional and behavioral 
states with deterioration in thinking, judgment, 
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self-control, or understanding. Psychotic disorders 
are usually expressed clinically as a combination of: 
• Delusions: Beliefs that are fxed, resistant 
to change, and are directly contradicted by 
evidence or otherwise not grounded in reality 
(e.g., the belief that one is being followed 
by people from Mars, or that one is a very 
important person to whom the President wants 
to speak right away). 
• Hallucinations: Hearing, seeing, tasting, or 
feeling things that are not there and being 
unable to recognize that what is being 
experienced is not real (such as hearing voices 
that say self-condemning or other disturbing 
things, or seeing a person who isn’t really there). 
• Disorganized thinking: This is refected in 
speech that is incoherent (“word salad”), 
illogical, uses unconventional or made-up 
words (neologisms and word approximations), 
fuctuates from topic to topic (loose 
associations), or is completely unrelated to 
subject matter at hand (tangential speech). 
• Grossly disorganized or abnormal motor 
behavior: This includes a wide range of 
odd behaviors, such as laughing or smiling 
inappropriately, grimacing, staring, talking to 
oneself, purposeless or peculiar movements 
and mannerisms, mimicking others’ speech or 
movements (echolalia and echopraxia), and 
random agitation. A specifc psychomotor 
disturbance called catatonia—which includes 
immobility, stupor, and holding rigid body 
positions against gravity over extended periods 
of time (catalepsy)—can occur in schizophrenia 
but is also present in other mental disorders (like 
bipolar disorder) and some medical conditions. 
• Negative symptoms: A constellation of 
symptoms refecting diminished emotional 
expression and self-motivated purposeful 
activities (avolition). Negative symptoms also 
may include diminished speech output (alogia) 
or poverty of speech (e.g., one-word answers), 
motivation, ability to experience pleasure 
(anhedonia), or interest in social activities 
(asociality). 
Although schizophrenia is perhaps the most well 
known psychotic disorder, people with bipolar 
disorders may experience psychotic states 
during periods of mania—the heightened state 
of excitement, little or no sleep, impulsiveness, 
and poor judgment (see the section “Bipolar 
I Disorder”). Other conditions also can be 
accompanied by a psychotic state, including toxic 
poisoning, other metabolic diffculties (infections 
[e.g., latestage AIDS]), and other mental disorders 
(MDD, dementia, PTSD, alcohol withdrawal states, 
brief reactive psychoses, and others). 
SUD treatment counselors typically do not see 
clients in the throes of an acute psychotic episode, 
as such psychotic patients more likely present, or 
are referred to, EDs and mental health services 
facilities. Counselors are more likely to encounter 
such clients in a “residual” or later and less active 
phase of the illness, the time at which these 
individuals may receive treatment for their SUDs 
in an SUD treatment agency. Even if the SUD 
treatment counselor never sees a client during an 
actively psychotic period, knowing what the client 
experiences as a psychotic episode will enable 
the counselor to understand and assist the client 
more effectively. On the other hand, counselors are 
increasingly treating clients with methamphetamine 
dependence who often have residual paranoid and 
psychotic symptoms and may need antipsychotic 
medications. 
Schizophrenia 
No single symptom specifcally indicates or 
characterizes schizophrenia. Symptoms include 
a range of cognitive, behavioral, and emotional 
dysfunctions (Exhibit 4.11). Thus, schizophrenia 
is a heterogeneous clinical syndrome. Symptoms 
of schizophrenia include delusions, hallucinations, 
disorganized speech (e.g., frequent derailment 
or incoherence), grossly disorganized or 
catatonic behavior, and defcits in certain areas 
of functioning—for example, the inability to 
initiate and persist in goal-directed activities. 
These symptoms regularly develop before the frst 
episode of a schizophrenic breakdown, sometimes 
stretching back years and often intensifying prior 
to reactivations of an active, acutely psychotic 
state. Clinicians generally divide schizophrenia 
symptoms into positive and negative symptoms. 
Acute course schizophrenia is characterized by 
positive symptoms like hallucinations, delusions, 
excitement, motor manifestations (such as agitated 
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EXHIBIT 4.11. Diagnostic Criteria for Schizophrenia 
A. Two (or more) of the following, each present for a signifcant portion of time during a 1-month period (or 
less if successfully treated). At least one of these must be 1, 2, or 3: 
1. Delusions 
2. Hallucinations 
3. Disorganized speech (e.g., frequent derailment or incoherence) 
4. Grossly disorganized or catatonic behavior 
5. Negative symptoms, (i.e., diminished emotional expression or avolition) 
B. For a signifcant portion of the time since the onset of the disturbance, level of functioning in one or 
more major areas, such as work, interpersonal relations, or self-care, is markedly below the level achieved 
prior to the onset (or when the onset is in childhood or adolescence, there is failure to achieve expected 
level of interpersonal, academic, or occupational functioning). 
C. Continuous signs of the disturbance persist for at least 6 months. This 6-month period must include at
least 1 month of symptoms (or less if successfully treated) that meet Criterion A (i.e., active-phase symptoms)
and may include periods of prodromal or residual symptoms. During these prodromal or residual periods, the
signs of the disturbance may be manifested by only negative symptoms or by two or more symptoms listed
in Criterion A present in an attenuated form (e.g., odd beliefs, unusual perceptual experiences).
D. Schizoaffective disorder and depressive or bipolar with psychotic features have been ruled out because 
either (1) no major depressive or manic episodes have occurred concurrently with the active-phase 
symptoms, or (2) if mood episodes have occurred during active-phase symptoms, they have been present 
for a minority of the total duration of the active and residual periods of the illness. 
E. The disturbance is not attributable to the physiological effects of a substance (e.g., a drug of abuse, a 
medication) or another medical condition. 
F. If there is a history of autism spectrum disorder or a communication disorder of childhood onset, the
additional diagnosis of schizophrenia is made only if prominent delusions or hallucinations, in addition to the
other required symptoms of schizophrenia, also are present for at least 1 month (or less if successfully treated). 
Specify if: 
The following course specifers are only to be used after a 1-year duration of the disorder and if they are not 
in contradiction to the diagnostic course criteria. 
• First episode, currently in acute episode: First manifestation of the disorder meeting the defning 
diagnostic symptom and time criteria. An acute episode is a time period in which the symptom criteria 
are fulflled. 
• First episode, currently in partial remission: Partial remission is a period of time during which an 
improvement after a previous episode is maintained and in which the defning criteria of the disorder are 
only partially fulflled. 
• First episode, currently in full remission: Full remission is a period of time after a previous episode during 
which no disorder-specifc symptoms are present. 
• Multiple episodes, currently in acute episode: Multiple episodes may be determined after a minimum of 
two episodes (i.e., after a frst episode, a remission and a minimum of one relapse). 
• Multiple episodes, currently in partial remission 
• Multiple episodes, currently in full remission 
• Continuous: Symptoms fulflling the diagnostic symptom criteria of the disorder are remaining for the 
majority of the illness course, with subthreshold symptom periods being very brief relative to the overall 
course. 
Continued on next page 
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• Unspecifed 
Specify if: 
• With catatonia 
Specify current severity: 
• Severity is rated by a quantitative assessment of the primary symptoms of psychosis, including delusions, 
hallucinations, disorganized speech, abnormal psychomotor behavior, and negative symptoms. Each of 
these symptoms may be rated for its current severity (most severe in the last 7 days) on a 5-point scale 
ranging from 0 (not present) to 4 (present and severe). 
Note: Diagnosis of schizophrenia can be made without using this severity specifer. 
Source: APA (2013, pp. 99–100). Reprinted with permission from the DSM-5 (Copyright © 2013). APA. All Rights Reserved. 
behavior or catatonia), disorganized speech, 
relatively minor thought disturbances, and positive 
response to neuroleptic medication. Chronic 
course schizophrenia is characterized by negative 
symptoms, such as lack of enjoyment (anhedonia), 
apathy, lack of emotional expressiveness (fat 
affect), and social isolation. Some clients will live 
their entire lives exhibiting only a single psychotic 
episode; others may have repeated episodes 
separated by varying durations of time. 
Prevalence 
Community prevalence rates for schizophrenia using
DSM-5 criteria are not available at the time of this
publication. The lifetime prevalence rate for adults
with DSM-IV schizophrenia is between 0.3 percent
and 0.7 percent (APA, 2013). The National Institute
of Mental Health (NIMH; 2018) reports similar but
slightly lower numbers, ranging between 0.25
percent and 0.64 percent. Although its prevalence
is very low, schizophrenia is very burdensome and
considered one of the top 15 leading causes of
global disability (GBD 2016 Disease and Injury
Incidence and Prevalence Collaborators, 2017). 
Schizophrenia/Other Psychotic Disorders 
and SUDs 
Substance misuse often occurs in people with 
schizophrenia and other psychotic disorders. 
In a study of more than 1,200 people with 
schizophrenia (Kerner, 2015), lifetime SUD 
prevalence was 55 percent, including alcohol abuse 
Individuals with SMI (including schizophrenia,
schizoaffective disorder, and bipolar disorder with
psychotic features) die approximately 10 to 25 years
earlier than the general population, mostly because
of the effects of physical illnesses caused at least
in part by SUDs (e.g., heart disease, lung disease,
infectious disease) (Hartz et al., 2014; WHO, n.d.). 
at 17 percent, alcohol dependence at 26 percent, 
illicit drug abuse at 13 percent, and illicit drug 
dependence at 14 percent. The most commonly 
used substances were alcohol (43 percent), 
cannabis (35 percent), and other illegal substances 
(27 percent). Compared with the general 
population, people with severe psychotic disorders 
have 4 times greater risk of heavy alcohol use, 3.5 
times the risk of heavy cannabis use, and 4.6 times 
the risk of recreational drug use (Hartz et al., 2014). 
The combination of substance misuse in people 
with schizophrenia or other psychotic disorders 
contributes to shortened mortality and an 
increased likelihood of deleterious health and 
functional outcomes, including a higher risk for 
self-destructive and violent behaviors, victimization, 
suicide, housing instability, poor physical health, 
cognitive impairment, employment problems, 
legal diffculties, and unstable social relationships 
(Bennett, Bradshaw, & Catalano, 2017; Trudeau 
et al., 2018). Further, substance misuse in 
schizophrenia can worsen disease course and may 
reduce adherence to antipsychotic medication 
(Werner & Covenas, 2017). 
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CASE STUDY: COUNSELING AN SUD TREATMENT CLIENT WITH 
SCHIZOPHRENIA 
Adolfo M. is a 40-year-old Latino man who began using cannabis and alcohol at 15. He was diagnosed as 
having schizophrenia when he was 18 and began using cocaine at 19. Sometimes, he lives with his sister 
or with temporary girlfriends; sometimes, on the street. He has never had a sustained relationship, and he 
has never held a steady job. He has few close friends. He has had periods of abstinence and freedom from 
hallucinations and major delusions, but he generally has unusual views of the world that emerge quickly in 
conversation. 
Adolfo M. has been referred to an SUD treatment counselor, who was hired by the mental health center to 
do most of the group and individual drug/alcohol work with clients. The frst step the counselor takes is to 
meet with Adolfo M. and his case manager together. This provides a clinical linkage and allows them to get 
the best history. The clinical history reveals that Adolfo M. does best when he is sober and on medications, 
but there are times when he will be sober and not adhere to a medical regimen, or when he is both taking 
medications and drinking (although these periods are becoming shorter in duration and less frequent). 
His case manager often is able to redirect him toward renewed sobriety and adherence to medications, 
but Adolfo M. and the case manager agree that the cycle of relapse and the work of pulling things back 
together is wearing them both out. After the meeting, the case manager, counselor, and Adolfo M. agree 
to meet weekly for a while to see what they can do together to increase the stable periods and decrease 
the relapse periods. After a month of these planning meetings, the following plan emerges. Adolfo M. will 
attend SUD treatment groups for people with CODs (run by the counselor three times a week at the clinic), 
see the team psychiatrist, and attend local dual disorder AA meetings. The SUD treatment group he will 
be joining is one that addresses not only addiction problems but also diffculties with treatment follow-
through, life problems, ways of dealing with stress, and the need for social support for clients trying to get 
sober. When and if relapse happens, Adolfo M. will be accepted back without prejudice and supported in 
recovery and treatment of both his substance misuse and mental disorders; however, part of the plan is 
to analyze relapses with the group. His goal is to have as many sober days as possible with as many days 
adhering to a medical regimen as possible. Another aspect of the group is that monthly, 90-day, 6-month, 
and yearly sobriety birthdays are celebrated. Part of the employment program at the center is that clients 
need to have a minimum of 3 months of sobriety before they will be placed in a supported work situation, 
so this becomes an incentive for sobriety as well. 
Discussion: SUD treatment counselors working within mental health centers should be aware of the 
need not only to work with the client but also to form solid working relationships with case managers, 
the psychiatrist, and other personnel. Seeing clients with case managers and other team members is a 
good way to establish important linkages and a united view of the treatment plan. In Adolfo M.’s case, the 
counselor used his ties with the case manager to good effect and also is using relapse prevention and 
contingency management strategies appropriately (see Chapter 5 for a discussion of relapse prevention). 
ADVICE TO THE COUNSELOR: COUNSELING A CLIENT WITH 
SCHIZOPHRENIA OR ANOTHER PSYCHOTIC DISORDER 
• Understand that what looks like resistance or denial may in reality be a manifestation of negative 
symptoms of schizophrenia. 
• Use a recovery perspective and a compassionate attitude toward the client. This can convey hope and 
allow the clients to envision signifcant recovery and improvement in his or her life. 
• Obtain a working knowledge of the signs and symptoms of the disorder. 
Continued on next page 
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Continued 
• Be aware that an accurate understanding of the role of SUDs in the client’s psychotic disorder requires a 
multiple-contact, longitudinal assessment. 
• Work closely with a psychiatrist or mental health professional. 
• Expect crises associated with the mental disorder and have available resources (e.g., crisis intervention, 
psychiatric consultation) to facilitate stabilization. 
• As appropriate, assist the client to obtain Medicare, Medicaid, Temporary Assistance to Needy Families, 
disability payments, and other social services. 
• Make available psychoeducation on the psychiatric condition and use of medication. The 
psychoeducational component of treatment should include information about mental disorders and 
SUDs, from causes and the natural histories of the disorders to the recovery process and how the 
illnesses can interact. 
• Understand that medication adherence is critical to control positive symptoms and maintain stability/ 
functionality. Yet nonadherence is common. Make medication monitoring and adherence a part of 
treatment by: 
− Providing psychoeducation about its importance. 
− Checking in with clients about the status of their symptoms (given that nonresponsiveness to 
medication may be a reason for nonadherence). 
−Discussing with clients their reasons for not taking the medication (e.g., unpleasant side effects, high 
cost, failing to remember to take them). 
−Using motivational interviewing techniques to explore clients’ expectations and beliefs about taking 
(and not taking) medication, which can help identify barriers to behavior change. 
−Working with clients to develop helpful reminders, alerts, or other solutions to practical obstacles. 
If cost is an issue, connect the client to a prescription assistance program (offered by numerous 
nonproft organizations, state/county/federal agencies, and pharmaceutical companies) or consult 
with the client’s prescriber about the possibility of switching the client to a lower cost medication. 
− Enlisting, when appropriate, the help of family or loved ones to aid in giving positive reinforcement 
and supporting clients in adhering to their medication. 
• Ensure that the treatment program philosophy is based on a multidisciplinary team approach. Ideally, 
team members should be cross-trained, and there should be representatives from the medical, mental 
health service, and addiction systems. The overall goals of long-term management should include: 
− Providing comprehensive and integrated services for both the mental disorders and SUDs. 
− Taking a long-term focus that addresses biopsychosocial matters in accord with a treatment plan with 
goals specifc to a client’s situation. 
• Provide frequent breaks and shorter sessions or meetings. 
• Use structure and support. 
• Present material in simple, concrete terms with examples and use multimedia methods. 
• Encourage participation in social clubs with recreational activities. 
• Teach the client skills for detecting early signs of relapse for both mental illness and substance use. 
• Consider including family members and community supports, when appropriate, in overall treatment. 
Continued on next page 
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Continued 
• Involve family in psychoeducational groups that specifcally focus on education about SUDs and
psychotic disorders; establish support groups of families and signifcant others.
• Understand that psychotic disorders and SUDs tend to be chronic disorders with multiple relapses
and remissions, requiring long-term treatment. For clients with CODs involving psychotic disorders, a
long-term approach is imperative.
• Monitor clients for signs of substance misuse relapse and a return of psychotic symptoms.
• Remember that suicide is a signifcant risk in schizophrenia, more so when co-occurring with SUDs.
Ongoing monitoring/ assessment of suicidal ideation, gestures, plans, and attempts throughout
treatment is imperative. Work with clients to form safety plans/contracts; make positive coping skills
part of interventions.
Treatment of Schizophrenia/Other Psychotic 
Disorders and SUDs 
Antipsychotic medication is the standard of care
for reducing positive symptoms (e.g., delusions,
hallucinations) whereas various psychosocial inter-
ventions and approaches can help address addiction
recovery. Specifcally, integrated CBT, group
behavioral therapy, contingency management,
12-Step facilitation, motivational enhancement,
motivational interviewing, assertive community
treatment, or (preferably) a combination thereof
may all help reduce substance use (quantity,
frequency, and severity), increase abstinence, reduce
number of drinking days, lower relapse rates,
reduce the number of positive urine samples, and
decrease negative consequences of substance use
in people with SUDs and schizophrenia or other SMI
(including psychotic disorders) (Bennett et al., 2017;
De Witte, Crunelle, Sabbe, Moggi, & Dom, 2014).
These approaches have also been associated with
improvements in psychiatric symptoms (including
negative symptoms), scores of global functioning,
hospitalizations, and achieving stable housing (De
Witte et al., 2014). Integrated treatments appear to
yield more positive results than single interventions
and are the recommended approach (De Witte et
al., 2014).
Attention Defcit Hyperactivity
Disorder 
ADHD is marked by a chronic inability to direct, 
control, or sustain attention; hyperactivity; or 
both (Exhibit 4.12). People with ADHD often have 
diffculty concentrating for even short periods 
of time. They may be disorganized and restless 
or seem always “on the go,” constantly moving 
and fdgeting. Some people with ADHD behave 
impulsively. 
Although ADHD is frequently associated with 
children, the disorder can persist into adulthood 
and for some individuals can begin in adulthood. 
In adults, symptoms can include having a short 
temper, diffculty being productive at work, and an 
inability to sustain relationships. 
The three types of ADHD are combined type 
(person has diffculty paying attention and 
hyperactivity); predominantly inattentive; and 
predominantly hyperactiveimpulsive. 
Prevalence 
At the time of this publication, 12-month and 
lifetime ADHD prevalence rates among all age 
groups in the general population using DSM-5 
criteria are not readily available. However, data 
from the National Survey of Children’s Health show 
that 6.1 million children and adolescents ages 2 
to 17 years had ever been diagnosed with ADHD 
(Danielson et al., 2018). 
The prevalence of ADHD in adults is less studied 
than in children. The overall current prevalence 
of adult ADHD (using DSM-IV criteria) is around 
2.5 percent (APA, 2013; Simon, Czobor, Balint, 
Meszaros, & Bitter, 2009). Epidemiological 
population-based survey data on U.S. adults with 
ADHD (Kessler et al., 2005) suggest the estimated 
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EXHIBIT 4.12. Diagnostic Criteria for ADHD 
A. A persistent pattern of inattention and/or hyperactivity-impulsivity that interferes with functioning or 
development, as characterized by (1) and/or (2): 
1. Inattention: Six (or more) of the following symptoms have persisted for at least 6 months to a degree 
that is inconsistent with developmental level and that negatively impacts directly on social and academic/ 
occupational activities. Note: The symptoms are not solely a manifestation of oppositional behavior, 
defance, hostility, or failure to understand tasks or instructions. For older adolescents and adults (age 17 
and older), at least fve symptoms are required. 
a. Often fails to give close attention to details or makes careless mistakes in schoolwork, at work, or during 
other activities (e.g., overlooks or misses details, work is inaccurate) 
b. Often has diffculty sustaining attention in tasks or play activities (e.g., has diffculty remaining focused 
during lectures, conversations, or lengthy reading) 
c. Often does not seem to listen when spoken to directly (e.g., mind seems elsewhere, even in the absence 
of any obvious distraction) 
d. Often does not follow through on instructions and fails to fnish schoolwork, chores, or duties in the 
workplace (e.g., starts tasks but quickly loses focus and is easily sidetracked) 
e. Often has diffculty organizing tasks and activities (e.g., diffculty managing sequential tasks; diffculty 
keeping materials and belongings in order; messy, disorganized work; has poor time management; fails 
to meet demands) 
f. Often avoids, dislikes, or is reluctant to engage in tasks that require sustained mental effort (e.g., 
schoolwork or homework; for older adolescents and adults, preparing reports, completing forms, 
reviewing lengthy papers) 
g. Often loses things necessary for tasks or activities (e.g., school materials, pencils, books, tools, wallets, 
keys, paperwork, eyeglasses, mobile phones) 
h. Is often easily distracted by extraneous stimuli (for older adolescents and adults, may include unrelated 
thoughts) 
i. Is often forgetful in daily activities (e.g., doing chores, running errands; for older adolescents and adults, 
returning calls, paying bills, keeping appointments) 
2. Hyperactivity and impulsivity: Six (or more) of the following symptoms have persisted for at least 6 
months to a degree that is inconsistent with developmental level and that negatively impacts directly 
on social and academic/occupational activities. Note: The symptoms are not solely a manifestation 
of oppositional behavior, defance, hostility, or a failure to understand tasks or instructions. For older 
adolescents and adults (ages 17 and older), at least fve symptoms are required. 
a. Often fdgets with or taps hands or feet or squirms in seat 
b. Often leaves seat in situations in which remaining seated is expected (e.g., leaves his or her place in the 
classroom, in the offce or other workplace, or in other situations that require remaining in place) 
c. Often runs about or climbs in situations in which it is inappropriate. (Note: In adolescents or adults, may 
be limited to feeling restless.) 
d. Often unable to play or engage in leisure activities quietly 
e. Is often “on the go,” acting as if “driven by a motor” (e.g., is unable to be or uncomfortable being still for 
extended time, as in restaurants, meetings; may be experienced by others as being restless or diffcult 
to keep up with) 
f. Often talks excessively 
g. Often blurts out an answer before a question has been completed (e.g., completes people’s sentences; 
cannot wait for turn in conversation) 
Continued on next page 
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h. Often has diffculty awaiting his or her turn (e.g., while waiting in line) 
i. Often interrupts or intrudes on others (e.g., butts into conversations, games, or activities; may start 
using other people’s things without asking or receiving permission; for adolescents and adults, may 
intrude into or take over what others are doing) 
B. Several inattentive or hyperactive-impulsive symptoms were present prior to age 12 years. 
C. Several inattentive or hyperactive-impulsive symptoms are present in two or more settings (e.g., at 
home, school, or work; with friends or relatives; in other activities). 
D. There is clear evidence that the symptoms interfere with, or reduce the quality of, social, academic, or 
occupational functioning. 
E. The symptoms do not occur exclusively during the course of schizophrenia or another psychotic 
disorder and are not better explained by another mental disorder (e.g., mood disorder, anxiety disorder, 
dissociative disorder, PD, substance intoxication or withdrawal). 
Specify whether: 
• Combined presentation: If both Criterion A1 (inattention) and Criterion A2 (hyperactivity-impulsivity) are 
met for the past 6 months 
• Predominantly inattentive presentation: If Criterion A1 (inattention) is met but Criterion A2 (hyperactivity-
impulsivity) is not met for the past 6 months 
• Predominantly hyperactive/impulsive presentation: If Criterion A2 (hyperactivity-impulsivity) is met and 
Criterion A1 (inattention) is not met for the past 6 months 
Specify if: 
• In partial remission: When full criteria were previously met, fewer than the full criteria have been met 
for the past 6 months, and the symptoms still result in impairment in social, academic, or occupational 
functioning. 
Specify current severity: 
• Mild: Few, if any, symptoms in excess of those required to make the diagnosis are present, and 
symptoms result in no more than minor impairments in social or occupational functioning. 
• Moderate: Symptoms or functional impairment between “mild” and “severe” are present. 
• Severe: Many symptoms in excess of those required to make the diagnosis, or several symptoms that are 
particularly severe, are present, or the symptoms result in marked impairment in social or occupational 
functioning. 
Source: APA (2013, pp. 59–61). Reprinted with permission from the DSM-5 (Copyright © 2013). APA. All Rights Reserved. 
lifetime prevalence of DSM-IV ADHD in people 
ages 18 to 44 years is 8.1 percent. 
ADHD and SUDs 
SUDs are among the most common comorbidities 
of ADHD (Katzman, Bilkey, Chokka, Fallu, & 
Klassen, 2017), and data from clinical and 
epidemiological studies support this linkage 
(Martinez-Raga, Szerman, Knecht, & de Alvaro, 
2013). Among adults with substance misuse, the 
prevalence of ADHD is approximately 23 percent, 
although this estimate is dependent on substance 
of misuse and assessment instrument used (van 
Emmerik-van Oortmerssen et al., 2012). Among a 
sample of more than 500 children with and without 
ADHD who were followed throughout adolescence 
and early adulthood (Molina et al., 2018), early 
substance use in adolescence was greater and 
escalated more quickly in the children with ADHD. 
Further, weekly and daily cannabis use and daily 
smoking in adulthood were signifcantly more 
prevalent in the ADHD group than the non-ADHD 
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group. Adults with ADHD have been found 
primarily to use alcohol, nicotine, cannabis, and 
cocaine (Lee, Humphreys, Flory, Liu, & Glass, 2011; 
Luo & Levin, 2017). 
People with addiction who have co-occurring 
ADHD have a heightened risk for suicide attempts, 
hospitalizations, earlier onset of addiction, 
impulsivity, more severe disease course (for both 
ADHD and the SUD) and polysubstance use as 
well as lower rates of abstinence and treatment 
adherence (Egan, Dawson, & Wymbs, 2017; 
Katzman et al., 2017). ADHD and SUDs carry an 
enhanced risk of comorbidity with depression, 
conduct disorder, bipolar disorders, anxiety 
disorders, and PDs (Luo & Levin, 2017; Martinez-
Raga et al., 2013; Regnart, Truter, & Meyer, 2017; 
Young & Sedgwick, 2015; Zulauf, Sprich, Safren, & 
Wilens, 2014). Symptoms of ADHD hyperactivity 
and impulsivity are more strongly seen with 
substance misuse and SUDs than ADHD symptoms 
of inattention (De Alwis, Lynskey, Reiersen, & 
Agrawal, 2014). 
Although it is important to rule out other causes
of inattention or hyperactivity, including substance
misuse, misattribution of ADHD symptoms to
SUDs increases the likelihood of underdiagnosis
(Crunelle et al., 2018). People with SUDs who are
newly abstinent or those in active or protracted
withdrawal may experience some impairments
similar to ADHD. Many of the behavioral symptoms
of ADHD also appear during substance intoxication
and withdrawal, and functional consequences of
ADHD, such as poor job performance or job loss,
are also evident in people with addiction. Both
alcohol and cannabis can produce symptoms that
mimic ADHD. This underscores the importance of
conducting a thorough assessment (see Chapter 3)
to fully investigate symptoms in childhood, family
history of addiction and psychiatric illness, and other
biopsychosocial factors that can inform whether a
diagnosis of ADHD, SUD, or both are warranted. 
Treatment of ADHD and SUDs 
ADHD complicates SUD treatment because 
clients with these CODs may have more diffculty 
engaging in treatment and learning abstinence 
skills, be at greater risk for relapse, and have 
poorer substance use outcomes. The most 
common attention problems in SUD treatment 
populations are secondary to short-term toxic 
effects of substances, and these should be 
substantially better with each month of sobriety. 
Only a limited number of studies explore treatment 
of ADHD with comorbid SUDs (De Crescenzo, 
Cortese, Adamo, & Janiri, 2017). Treatment of 
adults with ADHD often involves use of stimulant 
or nonstimulant medication; although effcacious in 
reducing psychiatric symptoms, these medications 
generally do not alleviate SUD symptoms (Cunill, 
Castells, Tobias, & Capella, 2015; De Crescenzo 
et al., 2017; Luo & Levin, 2017). Thus, ADHD 
medication alone is an insuffcient treatment 
approach for clients with these CODs (Crunelle et 
A consensus statement by an international panel of ADHD and addiction experts (including from the U.S.) 
on the treatment of ADHD and SUDs recommends (Crunelle et al., 2018): 
• Using a combined treatment approach comprising psychoeducation, pharmacotherapy, individual or
group CBT, and peer support. 
• Integrating ADHD treatment into SUD treatment; integrating SUD treatment into mental health services. 
• Treating both disorders, but addressing the SUD frst and then the ADHD shortly afterwards. 
• Considering residential treatment for cases of severe addiction. 
• Providing pharmacotherapy for ADHD (particularly with psychotherapy), but clinicians should be aware 
that medication alone is usually not suffcient to treat the SUD. 
• Prescribing ADHD medication as needed but understand that this is a controversial topic because of 
the misuse liability of stimulants. Clinicians should consider all risks and weigh them against potential 
benefts when deciding whether to prescribe stimulant medications for people with ADHD-SUD. 
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al., 2018; Zulauf et al., 2014). Stimulant medications 
have misuse potential, and counselors should 
be vigilant for signs of diversion. Use of long-
acting or extended-release medication or use of 
antidepressants instead of stimulants can attenuate 
diversion and misuse liability. The advised 
approach to treatment involves a combination 
of psychoeducation, behavioral coaching, CBT, 
and nonstimulant or extended-release stimulant 
medication (De Crescenzo et al., 2017). 
Little research supports concurrent treatment of 
these conditions. Some researchers recommend 
frst addressing whichever condition is most 
debilitating to the client (Katzman et al., 2017; 
Klassen, Bilkey, Katzman, & Chokka, 2012). Others 
suggest that, to stabilize the client, treating the 
SUD should be prioritized (Crunelle et al., 2018). 
A systematic literature review and meta-analysis 
of pharmacotherapy for ADHD and SUD (Cunill 
et al., 2015) found no effect of timing of initiation 
of treatment but warns that treatment of ADHD 
symptoms may need to be delayed until after 
abstinence is achieved, given possible harmful 
interactions that can occur between ADHD 
medications and substances of misuse. 
Feeding and Eating Disorders 
Feeding and eating disorders have as their 
common core a persistent disturbance of eating 
or eating-related behavior, resulting in changes 
in consumption or absorption of food that 
signifcantly impair physical health or psychosocial 
functioning. The primary eating disorders linked to 
SUD and discussed in this section are AN, bulimia 
nervosa (BN), and binge eating disorder (BED). 
Anorexia Nervosa 
AN, the most visible eating disorder, is marked by a
refusal to maintain body weight above the minimally
normal weight for age and height because of an
intense fear of weight gain (Exhibit 4.13). The term
anorexia nervosa means “nervous loss of appetite,”
a misnomer; only in extreme stages of inanition
(i.e., exhaustion as a result of lack of nutrients in the
blood) is appetite actually lost. 
Individuals with AN have a dogged determination 
to lose weight and can achieve this in several ways. 
Individuals with the restricting subtype of AN 
severely limit their food intake, engage in excessive 
exercise, and fast. Those with the binge-eating/ 
purging subtype engage in episodes of binge 
eating or purging with self-induced vomiting, 
CASE STUDY: COUNSELING AN SUD TREATMENT CLIENT WITH ADHD 
John R., a 29-year-old White man, is seeking treatment. He has been in several treatment programs but 
always dropped out after the frst 4 weeks. He tells the counselor he dropped out because he would get 
cravings and that he just could not concentrate in the treatment sessions. He mentions the diffculty of 
staying focused during 3-hour intensive group sessions. A contributing factor in his quitting treatment was 
that group leaders always seemed to scold him for talking to others. The clinician evaluating him asks how 
John R. did in school and fnds that he had diffculty in his classwork years before he started using alcohol 
and drugs; he was restless and easily distracted. He had been evaluated for a learning disability and ADHD 
and took Ritalin for about 2 years (in the 5th and 6th grades), then stopped. He was not sure why, but he did 
terribly in school, eventually dropping out about the time he started using drugs regularly in the 8th grade. 
Discussion: The SUD treatment provider reviewed John R.’s learning history and asked about anxiety or 
depressive disorders. The provider referred him to the team’s psychiatrist, who uncovered more history 
about the ADHD and also contacted John R.’s mother. When the provider reviewed a list of features 
commonly associated with ADHD, she agreed that John R. had many of these features and that she had 
noticed them in childhood. John R. was started on bupropion and moved to a less intensive level of care (1 
hour of group therapy, 30 minutes of individual counseling, and AA meetings 3 times weekly). Over the next 
2 months, John R.’s ability to tolerate a more intensive treatment improved. Although he was still somewhat 
intrusive to others, he was able to beneft from more intensive group treatment. 
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EXHIBIT 4.13. Diagnostic Criteria 
for AN 
A. Restriction of energy intake relative to 
requirements, leading to a signifcantly low body 
weight in the context of age, sex, developmental 
trajectory, and physical health. Signifcantly 
low weight is defned as a weight that is less 
than minimally normal or, for children and 
adolescents, less than minimally expected. 
B. Intense fear of gaining weight or of becoming 
fat, or persistent behavior that interferes with 
weight gain, even though at a signifcantly low 
weight. 
C. Disturbance in the way in which one’s body 
weight or shape is experienced, undue infuence 
of body weight or shape on self-evaluation, or 
persistent lack of recognition of the seriousness 
of the current low body weight. 
Specify whether: 
• Restricting type: During the last 3 months, 
the individual has not engaged in recurrent 
episodes of binge eating or purging behavior 
(i.e., self-induced vomiting or the misuse of 
laxatives, diuretics, or enemas). This subtype 
describes presentations in which weight loss 
is accomplished primarily through dieting, 
fasting, and/or excessive exercise. 
• Binge-eating/purging type: During the last 
3 months, the individual has engaged in 
recurrent episodes of binge eating or purging 
behavior (i.e., self-induced vomiting or the 
misuse of laxatives, diuretics, or enemas). 
Specify if: 
• In partial remission: After full criteria for AN 
were previously met, Criterion A (low body 
weight) has not been met for a sustained 
period, but either Criterion B (intense fear of 
gaining weight or becoming fat or behavior 
that interferes with weight gain) or Criterion C 
(disturbances in self-perception of weight and 
shape) is still met. 
• In full remission: After full criteria for AN were 
previously met, none of the criteria have been 
met for a sustained period of time. 
Continued in next column 
Continued 
Specify current severity: 
The minimum level of severity is based, for 
adults, on current body mass index (BMI) (see 
below) or, for children and adolescents, BMI 
percentile. The ranges below are derived from 
WHO categories for thinness in adults; for 
children and adolescents, corresponding BMI 
percentiles should be used. The level of severity 
may be increased to refect clinical symptoms, 
the degree of functional disability, and the need 
for supervision. 
• Mild: BMI ≥ 17 kg/m2 
• Moderate: BMI 16–16.99 kg/m2 
• Severe: BMI 15–15.99 kg/m2 
• Extreme: BMI < 15 kg/m2 
Source: APA (2013, pp. 338–339). Reprinted with 
permission from the DSM-5 (Copyright © 2013). APA. 
All Rights Reserved. 
laxatives, diuretics, or enemas. They engage in 
these behaviors out of a marked fear of weight 
gain, which is reinforced by distorted perceptions 
of their body shape (e.g., believing oneself to be 
“fat” even though bodyweight is extremely low). 
Bulimia Nervosa 
The core symptoms of BN are bingeing and 
purging (Exhibit 4.14). A binge is a rapid 
consumption of an unusually large amount of food, 
by comparison with social norms, in a discrete 
period of time (e.g., over 2 hours). Integral to the 
notion of a binge is feeling out of control; thus, a 
binge is not merely overeating. An individual with 
BN may state that he or she is unable to postpone 
the binge or stop eating willfully once the binge 
has begun. The binge may only end when the 
individual is interrupted, out of food, exhausted, or 
physically unable to consume more. 
The second feature of BN is purging. Individuals 
with BN compensate in many different ways for 
overeating. Ninety percent of people with BN 
self-induce vomiting or misuse laxatives as their 
form of purging (Westmoreland, Krantz, & Mehler, 
2016). Other methods of purgation include the 
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EXHIBIT 4.14. Diagnostic Criteria for BN 
A. Recurrent episodes of binge eating. An episode of binge eating is characterized by both of the following: 
1. Eating, in a discrete period of time (e.g., within any 2-hour period), an amount of food that is defnitely 
larger than what most individuals would eat in a similar period of time under similar circumstances 
2. A sense of lack of control over eating during the episode (e.g., a feeling that one cannot stop eating or 
control what or how much one is eating) 
B. Recurrent inappropriate compensatory behavior in order to prevent weight gain includes self-induced
vomiting; misuse of laxatives, diuretics, or other medications; fasting; or excessive exercise.
C. The binge eating and inappropriate compensatory behaviors both occur, on average, at least once a 
week for 3 months. 
D. Self-evaluation is unduly infuenced by body shape and weight. 
E. The disturbance does not occur exclusively during episodes of AN. 
Specify if: 
• In partial remission: After full criteria for BN were previously met, some, but not all, of the criteria have been
met for a sustained period of time. 
• In full remission: After full criteria for BN were previously met, none of the criteria have been met for a 
sustained period of time. 
Specify current severity: 
The minimum level of severity is based on the frequency of inappropriate compensatory behaviors (see 
below). The level of severity may be increased to refect other symptoms and the degree of functional 
disability. 
• Mild: An average of 1–3 episodes of inappropriate compensatory behaviors per week 
• Moderate: An average of 4–7 episodes of inappropriate compensatory behaviors per week 
• Severe: An average of 8–13 episodes of inappropriate compensatory behaviors per week 
• Extreme: An average of 14 or more episodes of inappropriate compensatory behaviors per week 
Source: APA (2013, p. 345). Reprinted with permission from the DSM-5 (Copyright © 2013). APA. All Rights Reserved. 
misuse of diuretics and emetics; saunas; excessive 
exercise; fasting; and other idiosyncratic methods 
that people believe will lead to weight loss (such 
as “mono” dieting, in which a person eats only 
a single food for extended periods of time and 
nothing else, like apples or eggs). Many of these 
auxiliary methods are dangerous and ineffective 
because they promote loss of water and valuable 
electrolytes. As with AN, individuals with BN place 
an undue emphasis on shape and weight in their 
sense of identity. To meet criteria, bingeing and 
purging must occur, on average, at least once per 
week for 3 months. 
Binge Eating Disorder 
BED involves recurring episodes of eating
signifcantly more food in a short period of time than
most people would eat under similar circumstances,
with episodes marked by feelings of lack of control
(Exhibit 4.15). Someone with BED may eat too
quickly, even when he or she is not hungry. The
person may feel guilt, embarrassment, or disgust
and may binge eat alone to hide the behavior.
This disorder is linked with marked distress and
occurs, on average, at least once a week over 3
months. Unlike in BN, the binge is not followed by
compensatory behaviors to rid the body of food. 
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EXHIBIT 4.15. Diagnostic Criteria for BED 
A. Recurrent episodes of binge eating. An episode of binge eating is characterized by both of the following: 
1. Eating, in a discrete period of time (e.g., within any 2-hour period), an amount of food that is defnitely 
larger than what most individuals would eat in a similar period of time under similar circumstances 
2. A sense of lack of control over eating during the episode (e.g., a feeling that one cannot stop eating or 
control what or how much one is eating) 
B. The binge-eating episodes are associated with three (or more) of the following: 
1. Eating much more rapidly than normal 
2. Eating until feeling uncomfortably full 
3. Eating large amounts of food when not feeling physically hungry 
4. Eating alone because of feeling embarrassed by how much one is eating 
5. Feeling disgusted with oneself, depressed, or very guilty afterward 
C. Marked distress regarding binge eating is present. 
D. The binge eating occurs, on average, at least once a week for 3 months. 
E. The binge eating is not associated with the recurrent use of inappropriate compensatory behavior as in 
BN and does not occur exclusively during the course of BN or AN. 
Specify if: 
• In partial remission: After full criteria for binge-eating disorder were previously met, binge eating occurs 
at an average frequency of less than one episode per week for a sustained period of time. 
• In full remission: After full criteria for binge-eating disorder were previously met, none of the criteria have 
been met for a sustained period of time. 
Specify current severity: 
The minimum level of severity is based on the frequency of episodes of binge eating (see below). The level 
of severity may be increased to refect other symptoms and the degree of functional disability. 
• Mild: 1–3 binge-eating episodes per week 
• Moderate: 4–7 binge-eating episodes per week 
• Severe: 8–13 binge-eating episodes per week 
• Extreme: 14 or more binge-eating episodes per week 
Source: APA (2013, p. 350). Reprinted with permission from the DSM-5 (Copyright © 2013). APA. All Rights Reserved. 
Prevalence 
Feeding and eating disorders in the general 
population are rare. Twelve-month estimates of 
DSM-5 AN, BN, and BED are 0.05 percent, 0.14 
percent, and 0.44 percent, respectively; lifetime 
prevalence rates are 0.80 percent, 0.28 percent, 
and 0.85 percent, respectively (Udo & Grilo, 2018). 
These rates are generally lower than previously 
reported estimates using DSM-IV criteria (APA, 
2013) but were drawn from a sample roughly 12 
times larger than the samples used in other survey 
studies (Udo & Grilo, 2018). 
Eating disorders are far more prevalent in women 
than men. Women have 12 times the odds of 
having AN, 5.8 times the odds of having BN, and 
about 3 times the odds of having BED (Udo & 
Grilo, 2018). 
Feeding and Eating Disorders and SUDs 
Feeding and eating disorders are highly coincident 
with substance misuse (SAMHSA, 2011a), likely 
because the conditions share numerous physical, 
mental, and social risk factors (Brewerton, 2014). 
Most studies observe comorbidity rates that 
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exceed the general population of women of similar 
age. A meta-analysis (Bahji et al., 2019) found 
lifetime prevalence of any SUD among people 
with eating disorders to be 25 percent, including 
20 percent for AUD, about 20 percent for any illicit
drug use disorder, almost 14 percent for cocaine
and cannabis use disorder (each), and 6 percent
for opioid use disorder (OUD). Even if not rising
to the level of addiction, licit and illicit substance
use is elevated in people with eating disorders,
especially individuals with bulimic features. In a
sample of almost 3,000 people, 80 percent of those
with BN reported using alcohol, and 50 percent
used other substances; 65 percent of those with
BED used alcohol, and nearly 24 percent used other
substances; and 60 percent of those with AN (binge/ 
purge subtype) used alcohol, and 44 percent used
other substances (Fouladi et al., 2015).
SUD treatment-seeking women have higher rates 
of BN than any other feeding and eating disorder, 
and SUDs are more common alongside BN or AN 
with bulimic features than they are comorbid with 
restrictive AN (APA, 2013; CSAT, 2009; Fouladi 
et al., 2015). Some have suggested that the most 
common comorbidity among feeding and eating 
disorders and SUDs is BN (or AN with bulimic 
features) and AUD (Gregorowski, Seedat, & 
Jordaan, 2013; Munn-Chernoff et al., 2015). 
Treatment outcomes of people with eating 
disorders and SUDs are worse than those of people 
without both conditions. They have higher odds of 
early mortality, co-occurring physical and mental 
illness, and delayed recovery (Root et al., 2010). 
People in SUD treatment with feeding/eating 
disorder symptoms have higher risk of treatment 
dropout and discharge against medical advice 
(Elmquist, Shorey, Anderson, & Stuart, 2015). 
Alcohol misuse more than doubles mortality risk in 
AN (Franko et al., 2013). 
Treatment of Feeding and Eating Disorders 
and SUDs 
Feeding or eating disorders can make SUD 
assessment and treatment more complex—such as 
by raising risk of stopping SUD treatment against 
medical advice (Elmquist et al., 2015). Heightened 
mortality with feeding and eating disorders means 
that multidisciplinary care should include primary 
care providers and dietary/nutritional rehabilitation 
professionals in addition to SUD treatment 
professionals, mental health professionals (e.g., 
psychiatric and mental health nurses), and social 
workers (SAMHSA, 2011a). 
The literature does not currently describe 
randomized controlled trials for treatment of 
these CODs. In general, concurrent treatment 
is recommended; sequential interventions can 
increase likelihood of relapse or otherwise hinder 
recovery from the untreated CODs (Gregorowski 
et al., 2013). If integrated care is not possible, 
SUD treatment should proceed frst to halt 
active substance use and allow the client to fully 
participate in further care (SAMHSA, 2011a). 
“DRUNKOREXIA”: A NEW AND DANGEROUS COMBINATION OF EATING 
DISORDERS AND ALCOHOL MISUSE 
Researchers are noticing a disturbing trend of college students (particularly women) engaging in 
inappropriate compensatory behaviors prior to consuming alcohol in order to avoid or mitigate weight 
gain from drinking. For instance, a woman might fast all day or drastically reduce her caloric intake prior 
to going out to a party where she knows she will be drinking. This trend has been colloquially termed 
“drunkorexia” (Barry & Piazza-Gardner, 2012; Bryant, Darkes, & Rahal, 2012; Burke, Cremeens, Vail-Smith, & 
Woolsey, 2010; Hunt & Forbush, 2016; Wilkerson, Hackman, Rush, Usdan, & Smith, 2017) and is very serious 
given that excess consumption of alcohol on an empty stomach raises the risk of alcohol poisoning and 
damage to the brain and other organs. In light of high rates of binge and hazardous drinking in college-
aged populations, this makes the combination of disordered eating and alcohol misuse potentially very 
dangerous. 
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ADVICE TO THE COUNSELOR: COUNSELING A CLIENT WITH AN EATING 
DISORDER 
• When possible, work closely with a professional who specializes in eating disorders. Programs that 
specialize in eating disorders and SUDs are rare, so parallel treatment by different providers may be 
necessary. 
• Screen for eating disorders both at intake and intermittently throughout SUD treatment (e.g., during 
medical history, as a part of SUD assessment, as a part of daily or weekly meetings). 
• Many symptoms and features of eating disorders overlap with those of SUDs as well as other mental 
disorders, such as reduced food intake, low energy, depressed affect, diffculty concentrating, and sleep 
disturbance. This underscores the importance of early screening and a thorough differential diagnosis. 
• Addiction counselors may have a hard time detecting feeding and eating disorders because clients are 
often adept at concealing their symptoms. Contrary to popular belief, many people with feeding and 
eating disorders are not exceedingly thin. In fact, most people with BN are of normal weight or even 
overweight. Learn the symptoms of AN, BN, and BED, and have screening tools and referral information 
on hand for mental health professionals who can thoroughly assess clients for possible eating disorders 
and symptoms. Do not merely look for clients who “look like” they have an eating disorder. 
• The stereotypical picture of someone with an eating disorder is a young, heterosexual, White woman, 
but these conditions occur in both genders, among diverse ethnic/racial groups, across cultures, 
throughout the lifespan, and in people of all sexual orientations and gender identities. 
• Co-occurring depression and anxiety are common in people with eating disorders and SUDs. Assess for 
these (or their symptoms) and treat accordingly, because failure to do so can reduce overall treatment 
success. 
• Some clients may be hesitant to address their SUD out of fear that doing so will cause them to gain weight. 
• Medical stabilization is critical, as people with feeding and eating disorders are at high risk for serious 
health complications, including electrolyte imbalances, cardiovascular dysfunction (e.g., low blood 
pressure, arrhythmias), withdrawal from laxative use, and dehydration. Treatment should include 
continual collaboration with healthcare providers to ensure client safety and stability. 
• People actively using substances need to be treated for their addiction before treatment for their eating 
disorder can proceed. Ideally, both conditions would be managed concurrently using an integrated, 
continuous care approach. But given that integrated programs for these CODs are uncommon, SUD 
treatment may need to be the primary focus, assuming the client is already medically stable. 
• Family dynamics often play a prominent role in the lives of people with eating disorders. As appropriate, 
include family in the treatment process, including referral to a marriage and family therapist if needed. 
• Document through a comprehensive assessment the individual’s full repertoire of weight loss 
behaviors, as people with eating disorders will often go to dangerous extremes to lose weight. 
• Conduct a behavioral analysis of foods and substances of choice; high-risk times and situations for
engaging in disordered eating and substance misuse; and the nature, pattern, and interrelationship of
disordered eating and substance use. Develop a treatment plan for both the eating disorder and the SUD.
• Use psychoeducation and CBT techniques. 
Continued on next page 
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• Use adjunctive strategies such as nutritional consultation, the setting of a weight range goal, and 
observations at and between mealtimes for disordered eating behaviors. 
• Incorporate relapse prevention strategies for a long course of treatment and several treatment episodes. 
• In addition to “traditional” drugs of misuse and alcohol, women with eating disorders are unique in their 
misuse of pharmacological agents ingested for the purpose of weight loss, appetite suppression, and 
purging. Among these drugs are prescription and over-the-counter diet pills, laxatives, diuretics, and 
emetics. Nicotine and caffeine also must be considered when assessing substance use in women with 
eating disorders. 
• Drugs related to purging (e.g., diuretics, laxatives, emetics), are ineffective and potentially dangerous 
methods of accomplishing weight loss or maintenance. The literature suggests that, like more common 
drugs of misuse, tolerance and withdrawal occur with laxatives, diuretics, and possibly diet pills and 
emetics. 
• Alcohol and substances such as cannabis can disinhibit appetite (i.e., remove normal restraints on 
eating) and increase the risk of binge eating as well as relapse in individuals with BN. 
• Clients with feeding and eating disorders have craving, tolerance, and withdrawal from drugs linked 
with purging (e.g., laxatives, diuretics) and urges (or cravings) for binge foods similar to urges for 
substances. 
• Feeding and eating disorders are quite serious and can be fatal. Treat them accordingly. 
• Suicide risk in this population is perilously high. Regularly assess for suicidal thoughts, gestures, and 
attempts and develop methods for safety monitoring and harm prevention (e.g., safety plans). 
Only 51 percent of SUD treatment programs 
report screening clients for feeding and eating 
disorders (Kanbur & Harrison, 2016). 
Regardless of treatment modality, providers must 
frst ensure medical and weight stabilization 
so clients are healthy and able to physically and 
cognitively participate in and beneft from therapy 
(Harrop & Marlatt, 2010). Some clients with AN 
or BN may require inpatient treatment or partial 
hospitalization to stabilize weight. Depending on 
the facility, staff may not be equipped to address 
any co-occurring substance misuse simultaneously. 
The primary treatment for these disorders is 
psychosocial intervention, including individual, 
group, family therapy, or a combination 
thereof. CBT can be effective for feeding and 
eating disorders but has not been researched 
thoroughly in populations with co-occurring 
addiction (Gregorowski et al., 2013). Dialectical 
behavior therapy also can be useful in promoting 
mindfulness, improving management of negative 
emotions, and teaching affective and behavioral 
self-regulation skills in feeding and eating disorders 
and in SUDs separately (Ritschel, Lim, & Stewart, 
2015) but, again, has not been studied extensively 
in both concurrently. Pharmacotherapy may be 
warranted for BN and BED (SAMHSA, 2011a) but 
is not a frst-line treatment. Further studies are 
needed to clarify how the presence of a feeding 
or eating disorder affects SUD treatment and how 
best to integrate treatment for both conditions. 
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Substance-Related Disorders 
The primary aim of this section of the chapter is 
to describe substance-induced mental disorders 
and to clarify how to differentiate them from 
mental disorders that co-occur with SUDs.  
Substance-related disorders include two 
subcategories: SUDs and substance-induced 
disorders. SUDs identify the cluster of cognitive, 
behavioral, and physical symptoms that occur as a 
result of continued and frequent use of substances. 
These consequences are not immediate. Rather, 
they occur over time as addiction progresses. 
Substance-induced mental disorders refer to the 
immediate effects of substance use (intoxication), 
the immediate effects of discontinuing a substance 
(substance withdrawal), and other substance-
induced mental disorders (APA, 2013). 
SUDs 
The essential feature of an SUD is a cluster of 
cognitive, behavioral, and physical symptoms 
indicating that the individual continues using the 
substance despite signifcant substance-related 
problems. All DSM-5 SUDs have their own 
diagnostic criteria, but criteria are largely the same 
across substances. Addiction counselors should be 
familiar with SUD diagnostic criteria and refer to 
DSM-5 as needed. 
Prevalence 
Lifetime and 12-month prevalence rates of DSM-5 
drug use disorders (i.e., non-alcohol-related SUDs) 
are nearly 10 percent and 4 percent, respectively 
(Grant et al., 2016). Lifetime and 12-month 
prevalence rates of AUD are about 29 percent 
and 14 percent, respectively (Grant et al., 2015). 
Past-month prevalence rates of misuse of other 
substances by adults ages 26 and older include 
(CBHSQ, 2019): 
• 8.6 percent for cannabis. 
• 0.7 percent for cocaine. 
• 1.0 percent for pain relievers. 
• 0.5 for tranquilizers. 
• 0.4 percent for stimulants. 
• 0.1 percent for prescription sedatives. 
• 0.4 percent for hallucinogens. 
• 0.2 percent for heroin. 
• 0.1 percent for inhalants. 
Substance-Induced Mental Disorders 
The toxic effects of substances can mimic 
mental disorders in ways that can be diffcult 
to distinguish from mental illness. This section 
focuses on a general description of symptoms of 
mental illness that are the result of substances 
or medications—a condition called substance-
induced mental disorders. 
DSM-5 substance-induced mental disorders 
include: 
• Substance-induced depressive disorders. 
• Substance-induced bipolar and related 
disorders. 
• Substance-induced anxiety disorders. 
• Substance-induced psychotic disorders. 
• Substance-induced obsessive-compulsive and 
related disorders. 
• Substance-induced sleep disorders. 
• Substance-induced sexual dysfunctions. 
• Substance-induced delirium. 
• Substance-induced neurocognitive disorder. 
The frst four of the listed substance-induced 
mental disorders are the most common in 
addiction, discussed further in the section, 
“Specifc Substance-Induced Mental Disorders.” 
Exhibit 4.16 summarizes substances and the 
substance-induced mental disorders associated 
with each. 
Chapter 4 121 
TIP 42
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Substance Use Disorder Treatment for People With Co-Occurring Disorders 
EXHIBIT 4.16. Substances and Corresponding Substance-Induced 
Mental Disorders 
SUBSTANCE SUBSTANCE-INDUCED MENTAL DISORDER 
Alcohol • Psychotic disorders 
• Bipolar disorders 
• Depressive disorders 
• Anxiety disorders 
• Sleep disorders 
Caffeine • Anxiety disorders • Sleep disorders 
Cannabis • Psychotic disorders • Anxiety disorders 
Hallucinogens • Psychotic disorders 
• Bipolar disorders 
• Depressive disorders 
• Anxiety disorders 
Inhalants • Psychotic disorders 
• Depressive disorders 
• Anxiety disorders 
Opioids • Depressive disorders 
• Anxiety disorders 
• Sleep disorders 
Sedatives • Psychotic disorders 
• Bipolar disorders 
• Depressive disorders 
• Anxiety disorders 
• Sleep disorders 
Stimulants (e.g., cocaine, 
amphetamines) 
• Psychotic disorders 
• Bipolar disorders 
• Depressive disorders 
• Anxiety disorders 
• Sleep disorders 
WARNING TO COUNSELORS: INDEPENDENT VERSUS SUBSTANCE-
INDUCED MENTAL DISORDERS 
The symptoms of substance-induced mental disorders may be identical to those of independent but co-
occurring mental disorders. Accurate assessment of a mental disorder cannot occur while an individual is 
actively using substances. Knowing the difference between the two is key because they may (or may not) 
need to be treated differently and will have different prognoses. Mental disorder symptoms resulting from 
intoxication or withdrawal often need no formal treatment and will resolve on their own and quickly. 
Also keep in mind the bidirectional and unstable temporal relationship between mental disorders and 
SUDs. Whether a substance is causing psychiatric symptoms or vice versa is often unclear, and the answer 
can change over time. Each disorder can affect the other reciprocally. Even when a substance clearly is 
responsible for the emergence of a mental disorder/psychiatric symptoms, that does not preclude the 
possibility of an independent mental disorder developing in the future. In fact, an individual can have 
both a substance-induced and an independent mental disorder. For example, a client may present with 
well-established independent and controlled bipolar I disorder and AUD in remission, but the same client 
could be experiencing amphetamine-induced auditory hallucinations and paranoia from an amphetamine 
misuse relapse over the last 3 weeks. 
Even when the psychiatric diagnosis has not been established, the client’s co-occurring symptoms should 
still be treated (with nonmedication). Counselors should not withhold treatment simply because a 
determination about the origin of the mental disorder has not yet been made. 
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General Considerations 
Substance-induced mental disorders are distinct 
from independent co-occurring mental disorders 
in that all or most of the psychiatric symptoms 
are the direct result of substance use. This 
does not mean that substance-induced disorders 
preclude co-occurring mental disorders, only 
that the specifc symptom cluster at a specifc 
point in time is more likely the result of substance 
use, misuse, intoxication, or withdrawal than of 
underlying mental illness. 
Even when the psychiatric diagnosis has not 
been established, the client’s co-occurring 
symptoms should still be treated (with 
nonmedication). Counselors should not withhold 
treatment simply because a determination about 
the origin of the mental disorder has not yet 
been made. 
Symptoms of substance-induced mental 
disorders run the gamut from mild anxiety 
and depression (these are the most common 
across all substances) to full-blown manic and 
other psychotic reactions (much less common). 
For example, acute withdrawal symptoms from 
physiological depressants such as alcohol and 
benzodiazepines are hyperactivity, elevated blood 
pressure, agitation, and anxiety (i.e., “the shakes”). 
On the other hand, those who “crash” from 
stimulants are tired, withdrawn, and depressed. 
Because clients vary greatly in how they respond to 
both intoxication and withdrawal given the same 
exposure to the same substance, and also because 
different substances may be taken at the same 
time, prediction of any particular substance-related 
syndrome has its limits. What is most important 
is to continue to evaluate psychiatric symptoms 
and their relationship to abstinence or ongoing 
substance misuse over time. Most substance-
induced symptoms begin to improve within hours 
or days after substance use has stopped. Notable 
exceptions to this are psychotic symptoms caused 
by heavy and longterm amphetamine misuse 
and dementia (e.g., problems with memory, 
concentration, problem solving) caused by using 
substances directly toxic to the brain, which most 
commonly include alcohol, inhalants like gasoline, 
and amphetamines. 
Exhibit 4.17 offers an overview of the most 
common classes of misused substances and the 
accompanying psychiatric symptoms seen in 
intoxication and withdrawal. 
EXHIBIT 4.17. Substance-Induced Mental Disorder Symptoms (by Substance) 
ALCOHOL 
Intoxication. In most people, moderate to heavy consumption is associated with euphoria, mood lability, 
decreased impulse control, and increased social confdence (i.e., getting high). Symptoms may appear 
hypomanic but are often followed by next-day mild fatigue, nausea, and dysphoria. 
Withdrawal. Following acute withdrawal (a few days), some people will experience continued mood 
instability, fatigue, insomnia, reduced sexual interest, and hostility for weeks or months, so-called 
“protracted withdrawal.” Symptoms of alcohol withdrawal include agitation, anxiety, tremor, malaise, 
hyperrefexia (exaggeration of refexes), mild tachycardia (rapid heartbeat), increasing blood pressure, 
sweating, insomnia, nausea or vomiting, and perceptual distortions. More severe withdrawal is 
characterized by severe instability in vital signs, agitation, hallucinations, delusions, and often seizures. 
Alcohol-induced deliriums after high-dose drinking are characterized by fuctuating mental status,
confusion, and disorientation and are reversible once both alcohol and its withdrawal symptoms are gone. 
CANNABIS 
Intoxication. Consumption typically results in a “high” feeling followed by symptoms including euphoria, 
sedation, lethargy, impairment in short-term memory, diffculty carrying out complex mental processes, 
impaired judgement, distorted sensory perceptions, impaired motor performance, and the sensation that 
time is passing slowly. Occasionally, the individual experiences anxiety (which may be severe), dysphoria, 
or social withdrawal. 
Continued on next page 
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Withdrawal. Cessation or substantial reduction in heavy or prolonged cannabis use may result in fatigue, 
yawning, diffculty concentrating, and rebound periods of increased appetite and hypersomnia that 
follow initial periods of loss of appetite and insomnia. 
HALLUCINOGENS 
Intoxication. Hallucinogens produce visual distortions and frank hallucinations. Some people who use 
hallucinogens experience a marked distortion of their sense of time and feelings of depersonalization. 
Hallucinogens may also be associated with drug-induced panic, paranoia, and even delusional states 
in addition to the hallucinations. Hallucinogen hallucinations usually are more visual (e.g., enhanced 
colors and shapes) as compared with schizophrenic-type hallucinations, which tend to be more auditory 
(e.g., voices). Phencyclidine (PCP) causes dissociative and delusional symptoms and may lead to violent 
behavior and amnesia of the intoxication. 
OPIOIDS 
Intoxication. Opioid intoxication is characterized by intense euphoria and feelings of well-being. 
Withdrawal. Withdrawal can result in agitation, severe body aches, gastrointestinal symptoms, dysphoria, 
and craving to use more opioids. Symptoms during withdrawal vary—some will become acutely anxious 
and agitated, whereas others will experience depression and anhedonia. Even with abstinence, anxiety, 
depression, and sleep disturbance can persist as a protracted withdrawal syndrome. 
SEDATIVES 
Intoxication. Acute intoxication with sedatives like diazepam is similar to what is experienced with alcohol. 
Withdrawal. Withdrawal symptoms are also similar to alcohol and include mood instability with anxiety 
or depression, sleep disturbance, autonomic hyperactivity, tremor, nausea or vomiting, and, in more 
severe cases, transient hallucinations or illusions and grand mal seizures. There are reports of a protracted 
withdrawal syndrome characterized by anxiety, depression, paresthesias, perceptual distortions, muscle 
pain and twitching, tinnitus, dizziness, headache, derealization and depersonalization, and impaired 
concentration. Most symptoms resolve in weeks, but some symptoms, such as anxiety, depression, 
tinnitus, and paresthesias (sensations such as prickling, burning, etc.), have been reported to last a year or 
more after withdrawal for some. 
STIMULANTS (INCLUDES COCAINE AND AMPHETAMINES) 
Intoxication. Mild to moderate intoxication from cocaine, methamphetamine, or other stimulants is 
associated with euphoria, and a sense of internal well-being, and perceived increased powers of thought, 
strength, and accomplishment. In fact, low to moderate doses of amphetamines may actually increase 
certain test-taking skills temporarily in those with ADHD and even in people who do not have ADHD. 
However, as more substance is used and intoxication increases, attention, ability to concentrate, and 
function decrease. 
With cocaine and methamphetamines, dosing is almost always beyond the functional window. As dosage 
increases, the chances of impulsive dangerous behaviors, which may involve violence, promiscuous sexual 
activity, and others, also increases. 
Withdrawal. After intoxication comes a crash in which the person is desperately fatigued, depressed, and 
often craves more stimulant to relieve these withdrawal symptoms. This dynamic is why it is thought that 
people who misuse stimulants often go on week- or month-long binges and have a hard time stopping. 
Even with several weeks of abstinence, many people who are addicted to stimulants report a dysphoric 
state that is marked by anhedonia (absence of pleasure) or anxiety. Heavy, long-term amphetamine use 
appears to cause long-term changes in the functional structure of the brain, and this is accompanied by 
long-term problems with concentration, memory, and, at times, psychotic symptoms. 
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INDUCED VERSUS INDEPENDENT
MENTAL DISORDERS: THE 
IMPORTANCE OF TREATMENT 
It will not always be clear whether a client’s 
mental disorder or symptoms are independent 
or caused by long-term substance use or 
withdrawal. But withholding treatment until 
this determination is made is inhumane and 
unethical. Individuals should be engaged in 
treatment that addresses their co-occurring 
psychiatric symptoms, even if the origin of the 
co-occurring mental disorder is unclear. 
If counselors struggle to differentiate an
independent from a substance-induced mental
disorder, they should: 
• Observe the client and watch for changes in 
symptoms (e.g., do symptoms abate once the 
person is abstinent from the substance for a 
length of time?). 
• Reevaluate the client to help discern 
whether the symptoms/disorder is caused 
by withdrawal, protracted withdrawal, or the 
neurological effects of chronic substance use. 
• Offer nonmedication treatment (e.g., SUD 
interventions or mental health services) for 
all symptoms, regardless of whether a formal 
diagnosis has been established. 
Diagnoses of substance-induced mental 
disorders will typically be provisional and will 
require reevaluation—sometimes repeatedly. 
Many apparent acute mental disorders may really 
be substance-induced disorders, such as in those 
clients who use substances and who are acutely 
suicidal. 
Some people who appear to have substance-
induced mental disorders turn out to have 
a substance-induced mental disorder and 
independent mental disorder. Consider 
preexisting mood state, personal expectations, 
drug dosage, and environmental surroundings 
in understanding of how a particular client 
might experience a substance-induced disorder. 
Treatment of the SUD and an abstinent period of 
weeks or months may be required for a defnitive 
diagnosis of an independent, co-occurring mental 
disorder. As described in Chapter 3, SUD treatment 
programs and clinical staff can concentrate on 
screening for mental disorders and determining 
the severity and acuity of symptoms, along with an 
understanding of the client’s support network and 
overall life situation. 
Specifc Substance-Induced Mental Disorders 
This section briefy discusses the most common
substance-induced mental disorders in clinical
populations: substance-induced depressive, anxiety,
bipolar, and psychotic disorders. Diagnostic criteria
for all substance-induced mental disorders, including
the four mentioned, are nearly identical and
comprise fve general characteristics (Exhibit 4.18). 
EXHIBIT 4.18. Features of DSM-5 Substance-Induced Mental Disorders 
A. The disorder represents a clinically signifcant symptomatic presentation of a relevant mental disorder. 
B. There is evidence from the history, physical examination, or laboratory fndings of both of the following: 
1. The disorder developed during or within 1 month of a substance intoxication or withdrawal or taking a 
medication; and 
2. The involved substance/medication is capable of producing the mental disorder. 
C. The disorder is not better explained by an independent mental disorder (i.e., one that is not substance- 
or medication-induced). Such evidence of an independent mental disorder could include the following: 
1. The disorder preceded the onset of severe intoxication or withdrawal or exposure to the medication; or 
Continued on next page 
Chapter 4 125 
TIP 42
 
 
 
 
 
 
 
 
 
 
 
 
Substance Use Disorder Treatment for People With Co-Occurring Disorders 
Continued 
2. The full mental disorder persisted for a substantial period of time (e.g., at least 1 month) after the 
cessation of acute withdrawal or severe intoxication or taking the medication. This criterion does not 
apply to substance-induced neurocognitive disorders or hallucinogen persisting perception disorder, 
which persist beyond the cessation of acute intoxication or withdrawal. 
D. The disorder does not occur exclusively during the course of a delirium. 
E. The disorder causes clinically signifcant distress or impairment in social, occupational, or other 
important areas of functioning. 
Source: APA (2013, p. 488). Reprinted with permission from the DSM-5 (Copyright © 2013). APA. All Rights Reserved. 
EXHIBIT 4.19. Substances That Precipitate or Mimic Common Mental 
Disorders 
MENTAL DISORDER SUBSTANCES THAT 
MIMIC MENTAL 
DISORDERS DURING USE 
(INTOXICATION) 
SUBSTANCES THAT MIMIC MENTAL 
DISORDERS AFTER USE (WITHDRAWAL) 
Depression and dysthymia Alcohol, benzodiazepines, 
opioids, barbiturates, 
cannabis, steroids 
(chronic), stimulants 
(chronic) 
Alcohol, benzodiazepines, barbiturates, 
opioids, steroids (chronic), stimulants 
(chronic) 
Anxiety disorders Alcohol, amphetamine 
and its derivatives, 
cannabis, cocaine, 
hallucinogens, 
intoxicants and PCP, 
inhalants, stimulants 
Alcohol, cocaine, opioids, sedatives, 
hypnotics, anxiolytics, stimulants 
Bipolar disorders and mania Stimulants, alcohol, 
hallucinogens, inhalants 
(organic solvents), 
steroids (chronic, acute) 
Alcohol, benzodiazepines, barbiturates, 
opioids, steroids (chronic) 
Psychosis Alcohol, anxiolytics, 
cannabis, hallucinogens 
(e.g., PCP), inhalants, 
sedatives, hypnotics, 
stimulants 
Alcohol, sedatives, hypnotics, anxiolytics 
Exhibit 4.19 lists substances most likely to induce/ 
mimic depressive, anxiety, bipolar, and psychotic
disorders. 
Substance-induced depressive disorders 
The lifetime prevalence of substance-induced
depressive disorders in the general community is
0.26 percent (Blanco et al., 2012). Observed rates
among clinical populations are much higher. For
instance, in a study of people seeking treatment
for co-occurring depressive disorders and SUDs,
24 percent had substance-induced depression;
rates varied by substance. Among those with
12-month alcohol dependence, prevalence of
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substance-induced MDD was 22 percent; for
past-year cocaine dependence, 22 percent; and for
past-year heroin dependence, nearly 37 percent
(Samet et al., 2013). In another study of people
with SUDs, 60 percent of people with depression
had a substance-induced rather than independent
depressive disorder (Conner et al., 2014). DSM-5
notes that although about 40 percent of people
with AUD develop MDD, only about one-third to
one-half are cases of independent depression,
meaning as much as 75 percent of occurrences
of depressive disorders in the context of AUD
could be because of intoxication or withdrawal
(APA, 2013). Depressive disorders or their symptoms
could also be because of the long-term effects of
substance use. 
Diagnosis of a substance-induced versus 
independent depressive disorder can be diffcult 
given that many people with SUDs do have 
mood symptoms, like depressed affect, and
intoxication and withdrawal from substances can 
mirror symptoms of depression. During the frst 
months of abstinence, many people with SUDs 
may exhibit symptoms of depression that fade 
over time and are related to acute withdrawal. 
Because depressive symptoms during withdrawal 
and early recovery may result from SUDs and 
not an underlying depression, a period of time 
should elapse before depression is diagnosed. This 
does not preclude the importance of addressing 
depressive symptoms during the early stage of 
recovery, before diagnosis. Further, even if an 
episode of depression is substance induced, that 
does not mean that it should not be treated. 
Overall, the process of addiction can result in 
biopsychosocial disintegration, leading to PDD or 
depression often lasting from months to years. 
Substance-induced mood alterations can result
from acute and chronic drug use as well as from
drug withdrawal. Substance-induced depressive
disorders, most notably acute depression lasting
from hours to days, can result from sedative– 
hypnotic intoxication. Similarly, prolonged or
subacute withdrawal, lasting from weeks to months,
can cause episodes of depression, and sometimes is
accompanied by suicidal ideation or attempts.
Stimulant withdrawal may provoke episodes of 
depression lasting from hours to days, especially 
following high-dose, chronic use. Acute stimulant 
withdrawal generally lasts from several hours to 
1 week and is characterized by depressed mood, 
agitation, fatigue, voracious appetite, and insomnia 
or hypersomnia (oversleeping). Depression 
resulting from stimulant withdrawal may be severe 
and can be worsened by the individual’s awareness 
of substance use–related adverse consequences. 
Symptoms of craving for stimulants are likely and 
suicide is possible. Protracted stimulant withdrawal 
often includes sustained episodes of anhedonia 
(absence of pleasure) and lethargy with frequent 
ruminations and dreams about stimulant use. 
Stimulant cessation may be followed for several 
months by bursts of dysphoria, intense depression, 
insomnia, and agitation. These symptoms may 
be either worsened or lessened depending on 
the provider’s treatment attitudes, beliefs, and 
approaches. It is a delicate balance—between 
allowing time to observe the direction of symptoms 
to treating the client’s presenting symptoms 
regardless of origin. 
Substance-Induced Anxiety Disorders 
The prevalence of substance-induced anxiety
disorders in the community is unreported and
thought to be quite low (less than 0.1 percent),
although likely higher in clinical samples (APA, 2013). 
Licit and illicit substances can cause symptoms that 
are identical to those in anxiety. In addition, many 
medications, toxins, and medical procedures can 
cause or are associated with an eruption of anxiety. 
Moreover, these reactions vary greatly from mild
manifestations of shortlived symptoms to full-blown
manic and other psychotic reactions, which are not 
necessarily short lived. 
Symptoms that look like anxiety may appear 
either during use or withdrawal. Alcohol, am-
phetamine and its derivatives, cannabis, cocaine, 
hallucinogens, intoxicants and phencyclidine 
and its relatives have been reported to cause 
the symptoms of anxiety during intoxication. 
Withdrawal from alcohol, cocaine, illicit opioids, 
and also caffeine and nicotine can also cause 
manifestations of anxiety. Similarly, withdrawal from 
depressants, opioids, and stimulants invariably 
includes potent anxiety symptoms. 
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Substance-Induced Bipolar Disorders 
Epidemiologic data on substance-induced mania or 
bipolar disorders in the U.S. general population are 
not readily available. 
A number of substances of misuse (as well as 
prescribed medications and several medical 
conditions) are also associated with manic-
like phenomena. Acute manic symptoms may 
be induced or mimicked by intoxication with 
stimulants, steroids, hallucinogens, or polydrug 
combinations. They may also be caused by 
withdrawal from depressants such as alcohol. 
Individuals experiencing acute mania with its 
accompanying hyperactivity, psychosis, and often 
aggressive and impulsive behavior should be 
referred to emergency mental health professionals. 
Stimulant-induced episodes of mania may include 
symptoms of paranoia lasting from hours to days. 
Stimulants such as cocaine and amphetamines 
cause potent psychomotor stimulation. Stimulant 
intoxication generally includes increased mental 
and physical energy, feelings of well-being and 
grandiosity, and rapid, pressured speech. Chronic, 
high-dose stimulant intoxication, especially with 
sleep deprivation, may prompt a manic episode. 
Symptoms may include euphoric, expansive, or 
irritable mood, often with fight of ideas, severe 
social functioning impairment, and insomnia. 
Substance-Induced Psychosis 
This condition is very rare; exact prevalence 
rates are unknown (APA, 2013). In frst-episode 
psychosis, 7 percent to 25 percent of cases are 
substance induced (APA, 2013). 
CASE STUDIES: IDENTIFYING DISORDERS 
George M. is a 37-year-old divorced man who was brought to the ED intoxicated. His blood alcohol level 
was 0.27, and the toxicology screen was positive for cocaine. He was also suicidal (“I’m going to do it right 
this time!”). He has a history of three psychiatric hospitalizations and two inpatient SUD treatments. Each 
psychiatric admission was preceded by substance use. 
George M. never followed through with mental health services. He sometimes attended AA, but not 
recently. 
Teresa G. is a 37-year-old divorced woman who was brought into a detoxifcation unit 4 days ago with a 
blood alcohol level of 0.21. She is observed to be depressed, withdrawn, with little energy, feeting suicidal 
thoughts, and poor concentration, but states she is just fne, not depressed, and life was good last week 
before her relapse. She has never used substances (other than alcohol) and began drinking alcohol 
only 3 years ago. However, she has had several alcohol-related problems since then. She has a history of 
three psychiatric hospitalizations for depression, at ages 19, 23, and 32. She reports a positive response to 
antidepressants. She is currently not receiving mental health services or SUD treatment. She is diagnosed 
with AUD (relapse) and substance-induced depressive disorder, with a likely history of, but not active, major 
depression. 
Discussion: Many factors must be examined when making initial diagnostic and treatment decisions. For 
example, if George M.’s psychiatric admissions were 2 or 3 days long, usually with discharges related to 
leaving against medical advice, decisions about diagnosis and treatment would be different (i.e., this is likely 
a substance-induced suicidal state and referral at discharge should be to an SUD treatment agency rather 
than a mental health center) than if two of his psychiatric admissions were 2 or 3 weeks long with clearly 
defned manic and psychotic symptoms continuing throughout the course, despite aggressive use of 
mental health services and medication (this is more likely a person with both bipolar disorder and AUD who 
requires integrated treatment for both his severe AUD and bipolar disorder). 
Similarly, if Teresa G. became increasingly depressed/withdrawn in the past 3 months, and had for a month 
experienced disordered sleep, poor concentration, and suicidal thoughts, she would be best diagnosed with 
MDD with acute alcohol relapse, not substance-induced depressive disorder secondary to alcohol relapse. 
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Heavy users of psychoactive substances, like 
cannabis, amphetamines, and cocaine, are 
vulnerable to substance-induced psychosis, 
especially clients with cooccurring schizophrenia 
and bipolar disorders. Antidepressants can also 
precipitate psychotic episodes, as can medications 
like prescribed steroids and nonsteroidal anti-
infammatory drugs, antiviral agents, antibiotics, 
anticholinergics, antihistamines, muscle relaxants, 
and opioids. Any number of physical illnesses or 
medication reactions, from brain tumors to steroid 
side effects, can cause a psychotic episode or 
psychotic behavior. Virtually any substance taken 
in very large quantities over a long enough 
period can lead to a psychotic state. 
Differential diagnosis among psychotic disorders
can be challenging, even for experienced clinicians
and diagnosticians, especially when substances
are involved. When a client presents in a psychotic
state, any immediate or recent substance use is
diffcult to determine, and it may be impossible to
discern whether the hallucinations or delusions are
caused by substance use. If the hallucinations or
delusions can be attributed to substance use but are
prominent and beyond what one might expect from
intoxication alone, the episode would be described
as a substance-induced psychotic disorder.
Hallucinations that the person knows are solely the
result of substance use are not considered indicative
of a psychotic episode; instead, they are diagnosed
as substance intoxication or substance withdrawal
with the specifer “with perceptual disturbances”
(APA, 2013). 
Cross-Cutting Topics: Suicide and
Trauma 
Suicide risk and trauma status are relevant to care
planning, client safety, and treatment outcomes
across many CODs. This section briefy addresses
each issue and offers guidance to help addiction
counselors understand why both need to be actively
considered as part of assessment and treatment. 
Ample literature discusses suicide, mental 
disorders, and addiction. This section is not 
intended to thoroughly review all aspects of 
suicide-related assessment, management, and 
prevention techniques for COD populations; 
readers instead are directed to TIP 50, Addressing 
Suicidal Thoughts and Behaviors in Substance 
Abuse Treatment (CSAT, 2009) for more 
information. The aim of this text is to ensure that 
readers have a broad and general understanding 
of the high risk of suicidal thoughts and behaviors 
in clients with CODs and feel confdent in knowing 
how to prevent and respond to such events. 
Similarly, trauma has been a signifcant topic of 
research in the behavioral health literature. What 
follows is an abbreviated summary of the link 
between trauma and mental disorders and SUDs 
and how addiction counselors can offer trauma-
informed services. Readers should consult TIP 
57, Trauma-Informed Care in Behavioral Health 
Services (SAMHSA, 2014b) for more guidance in 
this area. 
For both suicide and trauma, readers are reminded 
to review Chapter 3 for assessment techniques and 
tools, Appendix B for links to suicide prevention 
materials and other resources, and Appendix C for 
counselor tools like trauma screeners. 
Suicide 
Suicide is a common risk factor that pertains 
to nearly all CODs and particularly those 
involving addiction and MDD, bipolar disorder, 
schizophrenia, PTSD, or PDs (Yuodelis-Flores 
& Ries, 2015). Suicidality itself is not a mental 
disorder, but it is considered a high-risk behavior of 
signifcant public health concern (Hogan & Grumet, 
2016). Substance-induced or exacerbated suicidal 
ideations, intentions, and behaviors are possible 
complications of SUDs, especially for clients with 
co-occurring mental disorders. 
The topic of suicidality is critical for SUD treatment 
counselors working with clients who have CODs. 
SUDs alone increase suicidality (Yuodelis-Flores & 
Ries, 2015), whereas the added presence of some 
mental disorders doubles the already heightened 
risk (O’Connor & Pirkis, 2016). The risk of suicide 
is greatest when relapse occurs after a substantial 
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These populations (Department of Health and Human Services, 2012) are vulnerable to suicide risk; many 
are susceptible to addiction or CODs as well: 
• American Indians/Alaska Natives 
• Individuals who have lost a loved one to suicide 
• Clients involved in criminal justice/child welfare 
systems 
• Clients who engage in nonsuicidal self-injury 
• Individuals with a history of previous suicide 
attempt 
• Individuals with debilitating physical conditions 
• Clients with mental disorders, SUDs, or both 
• Individuals in the LGBTQ community 
• Members of the armed forces and veterans 
• Middle-aged and older men 
period of abstinence—especially if there is 
concurrent fnancial or psychosocial loss. Every 
agency that offers SUD counseling must also 
have a clear protocol in place that addresses the 
recognition and treatment (or referral) of people 
who may be suicidal. 
Prevalence 
Suicide is the 10th leading cause of death in the 
United States among people ages 10 and older 
(Stone et al., 2019). Suicide is the second leading 
cause of death for people ages 10 to 34 and the 
fourth leading cause of death for those ages 35 
and 54 (NIMH, 2019). Per the Centers for Disease 
Control and Prevention (CDC), from 1999 to 2018, 
suicide rates in the United States increased 41 
percent, from 10.5 to 14.8 per 100,000 people 
(CDC, 2019). Suicide rates among men remain 
more than 3 times higher (23.4 per 100,000 in 
2018) than among women (6.4 per 100,000 in 
2018) (CDC, 2020). 
Almost half (46 percent) of all individuals in the 
United States who died by suicide between 
2014 and 2016 had a known mental health 
condition, and 54 percent were in treatment at 
the time of death (Stone et al., 2019). Depression 
According to NSDUH data (CBHSQ, 2019), in 2018: 
• About 10.7 million U.S. adults ages 18 or older 
thought seriously of dying by suicide (4.3 
percent of adults). 
• 3.3 million U.S. adults made suicide plans (1.3 
percent). 
• 1.4 million U.S. adults made nonfatal suicide 
attempts (0.6 percent). 
was the most common mental disorder diagnosis 
among those who completed suicide (75 percent); 
other major mental disorder diagnoses included 
anxiety (17 percent), bipolar disorders (15 percent), 
schizophrenia (5 percent), and PTSD (4 percent) 
(Stone et al., 2019). 
Suicide and SUDs 
Substance misuse makes people susceptible 
to self-harm; indeed, suicide is the leading 
cause of death among people with addiction 
(CSAT, 2009). From 2014 to 2016, 28 percent 
of people who died by suicide had problematic 
substance use, including 32 percent of people 
with a known mental health disorder (Stone et al., 
2019). Of these individuals with known psychiatric 
problems, 39 percent tested positive for alcohol, 
39 percent for benzodiazepines, 29 percent for 
opioids, 23 percent for cannabis, 10 percent for 
amphetamines, and 6 percent for cocaine (Stone et 
al., 2019). 
Alcohol factors prominently into suicide (Darvishi, 
Farhadi, Haghtalab, & Poorolajal, 2015). Acute 
alcohol intoxication increases the risk of suicide 
attempt by nearly 7 times and in some studies, 
if use is heavy, by as much as 37 times (Borges 
et al., 2017). This risk appears to increase with 
corresponding increases in consumption; as such, 
populations with AUD have higher rates of suicide 
than people without problematic alcohol use 
(Yuodelis-Flores & Ries, 2015). 
Other substances also carry an increased risk of 
self-harm, as suicidal behavior is prominent in 
OUD, cocaine use disorder, and polysubstance 
use (Yuodelis-Flores & Ries, 2015). Among 
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individuals with a history of substance misuse 
who died by suicide in 2014 (Fowler, Jack, Lyons, 
Betz, & Petrosky, 2018), the most commonly 
involved nonmedication substances were alcohol 
(51 percent), opioids (23 percent), and cannabis 
(almost 14 percent). Furthermore, among all suicide 
cases that year, opioids were the direct cause of 
death in 27 percent of people and alcohol in 13 
percent (Fowler et al., 2018). The overall suicide 
rate of U.S. veterans with an SUD is estimated 
at 75.6 per 100,000 people and is highest 
among those who misuse sedatives, followed by 
amphetamines, opioids, cannabis, alcohol, and 
cocaine (Bohnert, Ilgen, Louzon, McCarthy, & Katz, 
2017). People who report misusing prescription 
medication, and in particular pain relievers, also 
appear to be vulnerable to suicidal ideation (Ford 
& Perna, 2015). 
The link between substance misuse and suicide 
may relate to the capacity of substances, especially 
alcohol, to quell inhibition, leading to poor 
judgment, mood instability, and impulsiveness. 
Depression, comorbid with suicide risk and 
substance misuse, may moderate this relationship. 
A population-based sample of people currently 
using alcohol and with a history of depressed mood 
(Sung et al., 2016) found that those with a positive 
history of suicide attempt were signifcantly more 
likely than those without such a history to have 
problematic substance use, including 21 percent 
with alcohol abuse or dependence and nearly 40 
percent with illicit drug abuse or dependence. Yet 
alcohol dependence in this sample signifcantly 
increased the odds of suicidal ideation and suicide 
attempt even among people without a history of 
depressed mood. This suggests that depressed 
mood alone cannot account for the relationship 
between alcohol misuse and risk of suicide, 
although it undoubtedly increases the odds. 
Many psychiatric illnesses have a heightened 
risk of suicidal thoughts and behaviors further 
exacerbated in the presence of co-occurring 
addiction. Risk factors for suicide that have been 
identifed in the general population, such as a 
family history of suicide attempt or completion 
and access to frearms, also apply to people 
with CODs and make self-harm more likely. 
Additionally, certain individuals with CODs may 
be at even further risk based on the presence 
of contributing factors that frequently appear 
in populations with mental disorders and 
SUDs. For instance, having a chronic physical 
health condition (such as traumatic brain injury or 
infectious disease), experiencing homelessness, 
being a military veteran, and past involvement in 
the criminal justice system are all associated with 
suicide-related ideation, gestures, attempts, or 
deaths (Ahmedani et al., 2017; Cook, 2013; Jahn 
et al., 2018; Kang et al., 2015; Tsai & Cao, 2019) 
and may further compromise the safety of people 
with CODs. A history of adverse life experiences, 
like childhood maltreatment or intimate partner 
violence, also signifcantly increases risk of 
self-harm (especially in people with CODs) and is 
addressed in the section “Trauma.” 
Prevention and Management of Suicidal 
Behaviors
Although a rare event, suicide is often—but not 
always—preventable. All SUD treatment clients 
should receive at least a basic screening for 
suicidality, and all SUD treatment professionals 
should know how to conduct at least basic 
screening and triage. (To learn more about suicide 
screening, see Chapter 3 of this TIP.) SAMHSA’s 
Five-Step Evaluation and Triage (SAMHSA, 2009b) 
recommends using the following process for 
identifying and responding to threat of self-harm: 
1. Identify risk factors. 
2. Identify protective factors. 
3. Conduct a suicidal inquiry into the client’s 
thoughts, plans, behaviors, and intents. 
4. Determine the level of risk and appropriate 
interventions. 
5. Document risk, rationale, intervention, and 
follow-up procedures. 
Addiction counselors should regularly assess 
and monitor all clients with CODs for suicidal 
ideation, gestures, plans, and attempts and 
especially clients with depressive disorders, 
bipolar disorders, PTSD, schizophrenia, or PDs. 
Routine assessment should be an integral part of 
treatment but is especially critical during times of 
high stress or increased substance use (including 
relapse) as well as at intake, following any suicidal 
behavior, following reports of suicidal ideation, 
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and just before discharge. Information should be 
collected on the client’s: 
• Personal and family history of suicidal thoughts 
and behaviors. 
• Plan for suicide. 
• Reasons for not following through with past 
plans for suicide. 
• Reasons for not following through with the 
current plan for suicide. 
• Current support system. 
• Means and access to lethal methods (e.g., 
frearms). 
• History and current symptoms of impulsivity. 
• Depressed mood, feelings of hopelessness, or 
both. 
• Protective factors (e.g., coping skills, spiritual/ 
religious beliefs). 
Asking a client directly about his or her desire 
to die by suicide does not make self-harm more 
likely and in fact can yield helpful information. 
Note that people may deny such thoughts or plans 
despite having them. Thus, direct questioning 
alone is an insuffcient risk mitigation strategy. 
Suicide risk assessment scales might be useful 
in this regard (see Chapter 3 and Appendix C 
for suicide risk and self-harm screening tools) 
but often lack the specifcity and sensitivity to 
adequately detect impending suicidal behaviors 
(Bolton, Gunnell, & Turecki, 2015). Providers 
also should not rely solely on suicide measures. 
Instead, suicide screening should include thorough 
investigation of all major signs, symptoms, and risk 
factors associated with self-harm in mental health, 
addiction, or COD populations. 
Safety planning is critical in suicide risk mitigation. 
Suicide “contracts” are written statements in which 
the person who is suicidal states that he or she 
will not kill himself but rather call for help, go to 
an ED, or other seek other assistance if he or she 
becomes suicidal. These contracts are not effective 
alone for a client who is suicidal. Such contracts 
often help make clients and therapists less anxious 
RESOURCE ALERT: SUICIDE PREVENTION RESOURCES FOR 
COUNSELORS 
• American Counseling Association (ACA): 
−Suicide Prevention Tip Sheet (https://www.counseling.org/docs/default-source/Communications-/ 
suicide-prevention-fnal.pdf?sfvrsn=2) 
−Counselor Training in Suicide Assessment, Prevention, and Management (www.counseling.org/docs/ 
default-source/vistas/article_65d15528f16116603abcacff0000bee5e7.pdf?sfvrsn=4f43482c_6) 
−Developing Clinical Skills in Suicide Assessment, Prevention, and Treatment (www.counseling.org/ 
publications/frontmatter/72861-fm.pdf) 
• International Association for Suicide Prevention’s Guidelines for Suicide Prevention (www.iasp.info/ 
suicide_guidelines.php) 
• SAMHSA: 
− Suicide Prevention Resource Center (www.sprc.org/) 
− Suicide Assessment Five-Step Evaluation and Triage for Mental Health Professionals (https://store. 
samhsa.gov/system/fles/sma09-4432.pdf) 
− TIP 50, Addressing Suicidal Thoughts and Behaviors in Substance Abuse Treatment (https://store. 
samhsa.gov/product/TIP-50-Addressing-Suicidal-Thoughts-and-Behaviors-in-Substance-Abuse-
Treatment/SMA15-4381) 
− Video companion to TIP 50, Addressing Suicidal Thoughts and Behaviors in Substance Abuse 
Treatment (www.youtube.com/watch?v=1n2Qzlheuzc&feature=youtu.be) 
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about a suicidal condition, but studies have never 
shown these contracts to be effective at preventing 
suicide. Rather, safety contracts help focus on the 
key elements that are most likely to keep clients 
safe, such as agreeing to remove the means a 
client is most likely to use to commit suicide. 
Counselors and other providers should know 
their own skills and limitations in engaging, 
screening, assessing, and intervening with 
suicidal clients and work out these problems with 
a supervisor before an emergency. Providers also 
should know what immediate onsite and offsite 
resources are available to help with someone 
identifed as suicidal. To learn more about 
suicide prevention, see “Resource Alert: Suicide 
Prevention Resources for Counselors.” 
No empirical treatments for suicide exist. However, 
interventions that reduce symptoms of SUDs and 
mental illness can help mitigate suicide risk and 
decrease self-harm behaviors by improving mood 
and enhancing support and coping skills. Some 
research supports the use of psychotherapies such 
as CBT and dialectical behavior therapy in reducing 
parasuicidal behavior and suicide attempts, but the 
overall evidence base is small (Bolton et al., 2015). 
Pharmacotherapy—particularly antidepressants— 
can reduce suicidal behavior in people ages 25 
years and older. Yet paradoxically, some studies 
show that it actually increases suicide in people 
ages 25 and younger (Bolton et al., 2015). Certain 
mood stabilizers and antipsychotic medications 
also may reduce self-harm in people with bipolar 
disorder, schizophrenia, and other psychotic 
disorders (Bolton et al., 2015). 
The frst steps in suicide intervention, and thus 
crisis stabilization, are contained in the process 
of a good engagement and evaluation. Asking 
suicide-related questions, exploring the context 
CASE STUDY: COUNSELING AN SUD TREATMENT CLIENT WHO IS SUICIDAL 
Beth, a 44-year-old woman, comes to the SUD treatment center complaining that drinking too much 
causes problems for her. She has tried to stop drinking before but always relapses. The counselor fnds that 
she has been sleeping and eating poorly and calling in sick to work. She spends much of the day crying and 
thinking of how alcohol, which destroyed her latest signifcant relationship, has ruined her life. She takes 
pain medication for a chronic back problem, which complicates her situation. The counselor tells her of a 
therapy group that is a good ft, tells her how to register, and arranges some individual counseling to set 
her on the right path. The counselor tells her she has done the right thing by coming in for help and offers 
encouragement about her ability to stop drinking. 
Beth misses her next appointment. The counselor calls her home and learns from her roommate that Beth 
tried to commit suicide after leaving the SUD treatment center. She took an overdose of opioids and is 
recovering in the hospital. The ED staff had found Beth under the infuence of alcohol upon admission. 
Discussion: Although Beth provided information that showed she was depressed, the counselor did not 
explore the possibility of suicidal thinking. Counselors always should ask if the client has been thinking 
of suicide, whether or not the client mentions depression. Clients, in general, may not answer a very 
direct question or may hint at something darker without mentioning it directly. Interpreting the client’s 
response requires sensitivity on the part of the counselor. It is important to realize that such questions 
do not increase the likelihood of suicide. Clients who, in fact, are contemplating suicide are more likely to 
feel relieved that the subject has now been brought into the light and can be addressed with help from 
someone who cares. 
The client reports taking alcohol and pain medications. Alcohol impairs judgment and, like pain 
medications, depresses brain and body functions. The combination of substances increases the risk of 
suicide or accidental overdose. Readers are encouraged to think through this case and apply the risk 
assessment strategy included in Chapter 3 and use the tools in Appendix C, imagining what kind of 
answers the counselor might have received. Readers could consider interventions and referrals that would 
have been possible in their treatment settings. 
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of those impulses, evaluating support systems, 
considering the lethality of means, and assessing 
the client’s motivation to seek help are in 
themselves an intervention. Such an interview 
will often elicit the client’s own insight and 
problem solving and may result in a decrease in 
suicidal impulses. 
If, however, the client experiences little or no 
relief after this process, psychiatric intervention is 
required, especially if the client has a cooccurring 
mental disorder or medical disorder in which 
the risk of suicide is elevated or if the client has 
a history of suicide attempts. If either or both is 
true, arrangements should be made for transfer 
to a facility that can provide more intensive 
psychiatric evaluation and treatment. Emergency 
ADVICE TO THE COUNSELOR: COUNSELING A CLIENT WHO IS SUICIDAL 
• All SUD treatment clients should receive at least a brief screening for suicide, such as: “In the past, have 
you ever been suicidal or made a suicide attempt? Do you have any of those feelings now?” 
• All SUD treatment staff should be able to screen for suicidality and basic mental disorders (e.g., 
depression, anxiety disorders, PTSD). 
• Screen for suicidal thoughts or plans with anyone who makes suicidal references, appears seriously 
depressed, or who has a history of suicide attempts. Treat all suicide threats with seriousness. 
• Inquire directly about a client’s depressed mood or agitation. For example: 
− “You know, you seem to be pretty down. How depressed are you?” 
− The issue may arise via general questions. For example, a client may state, “I don’t use crack much 
anymore. I get really down when I’m coming off it.” The counselor may then ask, “How down have you 
gotten? Were you ever suicidal? How are you doing now?” 
• The suicidal client is more likely to engage with the counselor and reveal suicidality if the counselor 
responds to clues given by the client and inquires sensitively about them. Saying, “You seem pretty 
uncomfortable and nervous—is there something I can do to help?” to an agitated client opens a door to 
further assessment. 
• If the client screens positive, use the risk assessment strategy described in Chapter 3 to more 
thoroughly investigate suicide intent. Further screening/assessment should be documented to protect 
both the client and the counselor. This means writing information on evaluation forms or making 
additional notes, even if suicide-related items are not included on the form used. 
• Assess the client’s risk of self-harm by asking about what is wrong, why now, whether specifc plans 
have been made to commit suicide, past attempts, current feelings, and protective factors. (See Chapter 
3 and Appendix C for a risk assessment protocol and screening measures.) 
• Develop a safety and risk management process with the client that involves a commitment on the 
client’s part to follow advice, remove the means to commit suicide (e.g., a gun), and agree to seek help 
and treatment. Avoid sole reliance on “no suicide contracts.” 
• Assess the client’s risk of harm to others. 
• Clients who are actively suicidal should be evaluated by a psychiatrist onsite immediately, or a case 
manager or counselor should escort the client to emergency psychiatric services. Where available, 
mobile crisis service, including a psychiatrist, is a quick-response resource for management of the client 
who is suicidal. 
Continued on next page 
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Continued 
• Be caring and supportive. The seriously suicidal client should have someone to contact 24 hours a day, 
and frequent telephone contact between the client and the contact person usually is indicated. 
• Provide availability of contact 24 hours per day until psychiatric referral is realized. Refer clients with 
serious plans, previous attempts, or SMI for psychiatric intervention or obtain the assistance of a 
psychiatric consultant for the management of these clients. 
• Monitor and develop strategies to ensure medication adherence. 
• Interventions should seek to increase support available to the client from family and community, and 
should provide immediate interventions, including medication to stabilize the client’s mental state, if 
needed. 
• Families and individuals often beneft from education about depression and suicidality, including 
warning signs, resources for help, and the importance of addressing this problem. Education often 
provides individuals with a sense of hope and realistic expectations. 
• Develop long-term recovery plans to treat substance misuse. Longer term treatment concerns for a 
client who has been suicidal focus on long-term treatment strategies for CODs or on other risk factors 
that have culminated in a suicidal event. In this case, treatment becomes long-term prevention. 
• In people with serious and persistent mental disorders (e.g., bipolar disorder), long-term medication 
compliance is key in preventing suicide. Just as essential as medication and medication compliance, 
however, is the need to rebuild hope in the future and engender the belief that recovery from co-
occurring disorders is possible and that one has a sense of purpose, value, empowerment, and role in 
one’s own recovery. 
• Review all such situations with the supervisor or treatment team members. 
• Document thoroughly all client reports and counselor suggestions. 
procedures should be in place so the counselor 
can accomplish this transfer even when a 
psychiatrist or clinical supervisor/director is not 
available. Once the client is stabilized and is safe 
to return to a less restrictive setting, he or she 
should return to the program. 
Trauma 
DSM-5 defnes trauma as “as exposure to actual or 
threatened death, serious injury, or sexual violence 
in one or more of the following ways: (a) directly 
experiencing the traumatic event; (b) witnessing, 
in person, an event as it occurred to others; (c) 
learning that the traumatic event occurred to 
a close family member or close friend; and (d) 
experiencing repeated or extreme exposure to 
aversive details of the traumatic event(s)” (APA, 
2013, p. 271). 
For many people with mental disorders, SUDs, 
or both, past or current trauma is a prominent 
driver of negative outcomes such as psychiatric 
hospitalizations; suicide attempts; self-harm 
behaviors; arrest; aggression; and substance 
use initiation, escalation (from occasional use, 
to regular use, to misuse/heavy use/addiction), 
treatment dropout, and relapse (Kumar, Stowe 
Han, & Mancino, 2016; Lijffjt, Hu, & Swann, 2014; 
Stinson, Quinn, & Levenson, 2016). Data from the 
National Longitudinal Study of Adolescent to Adult 
Health (Quinn et al., 2016) confrm that exposure to 
childhood trauma (e.g., sexual/emotional/physical 
abuse, neglect, witnessing violence) signifcantly 
increases the risk of adulthood prescription pain 
reliever misuse (PPRM) and injection drug use. 
This risk only grows as the number of traumas 
experienced increases; in the study, exposure 
to one trauma increased the risk of PPRM by 
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WARNING TO COUNSELORS: RETHINKING TRAUMA 
When providers hear the term “trauma,” they probably get a specifc picture in their mind of what a client 
with trauma looks like—a woman who has been physically abused by her husband, a man who faced 
combat as a Marine, a woman who was date raped while in college. These are indeed common examples of 
trauma, but addiction counselors who only think of trauma in prototypical terms will overlook clients who 
have faced adversities and are in need of help. When thinking about clients with trauma: 
Do not think only of women. Men experience trauma, and although at lower rates than women, their 
adversities are just as serious and potentially damaging. 
Do not think only of military veterans or of people who served in combat. Rates of trauma and PTSD are 
certainly high in military populations, but trauma happens to people from all walks of life. Among active 
duty military personnel and veterans, people can experience trauma even if they were not directly involved 
in combat. (See the section “Special Considerations: Trauma and Military Personnel.”) 
Do not think only of physical violence. Emotional abuse and neglect are damaging and can have just as 
serious an impact as physical or sexual abuse (Norman et al., 2012). 
Do not think only of young people. PTSD is less prevalent in older adults, but up to 52 percent of people 
ages 50 and older have had at least one traumatic event in their lives (Choi, DiNitto, Marti, & Choi, 2017). 
Remember that someone may not have a PTSD diagnosis but still have PTSD symptoms, a history of 
trauma, or both. These people may be just as much in need of treatment as someone with a full-blown 
diagnosis. Also, PTSD and its symptoms are easily mistaken for other disorders, such as BPD and depressive 
disorders (especially MDD). Although the person may not meet suffcient criteria for PTSD, he or she may 
have traumatic stress reactions that need to be addressed. Subclinical traumatic stress reactions are more 
commonly expressed through depressive symptoms. Do not assume that just because someone does 
not have a PTSD diagnosis that he or she is not in need of trauma-informed care. 
34 percent; two traumas, by 50 percent; three 
traumas, by 70 percent; and four traumas, by 217 
percent. Emotional and physical abuse nearly 
doubled the risk of injection drug use. 
Prevalence 
Traumatic events are common in people with CODs
in part because they are so widely prevalent in the
general population. Almost 90 percent of people in
the United States have a lifetime history of exposure
to at least one traumatizing event, typically the
death of family/close friend because of violence/ 
accident/disaster; physical or sexual assault; disaster;
or accident/fre (Kilpatrick et al., 2013).
Trauma and CODs 
As noted in the section “PTSD,” trauma in people 
with addiction, mental illness, or both is the 
norm rather than the exception (SAMHSA, 
2014b). In more than 600 people receiving SUD 
treatment, 49 percent reported a lifetime history of 
physical or sexual abuse, and women were 5 times 
more likely than men to report lifetime trauma 
(Keyser-Marcus et al., 2015). In people with SMI, 
trauma exposure is common, with prevalence rates 
ranging from 25 percent to 72 percent for physical 
abuse, 24 percent to 49 percent for sexual abuse, 
and 20 percent to 47 percent for PTSD (Mauritz, 
Goossens, Draijer, & van Achterberg, 2013). 
Twelve-month or lifetime rates of DSM-5 drug use 
disorder (i.e., an SUD excluding alcohol) carries 
increased odds of having PTSD (Grant et al., 2016), 
and 12-month or lifetime PTSD increases the odds 
of having a past-year or lifetime SUD (Goldstein et 
al., 2016). 
Adverse life experiences are highly coincident 
with SUDs and mental disorders, and vice versa: 
• Current PTSD prevalence in addiction 
populations is likely 15 percent to 42 percent 
(Vujanovic et al., 2016). 
• In active duty military personnel, prevalence 
rates of various comorbid mental disorders and 
SUDs in people with PTSD have been estimated 
at 49 percent for depressive disorders, 36 
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percent for GAD, and almost 27 percent for 
AUD (Walter, Levine, Highfll-McRoy, Navarro, & 
Thomsen, 2018). 
• Among a sample of U.S. adults with any lifetime 
trauma, 47 percent screened positive for PTSD, 
almost 47 percent for GAD, and 42 percent 
for depression (Ghafoori, Barragan, & Palinkas, 
2014). 
• Between 28 percent and 43 percent of people 
with PTSD have an SMI (Lu et al., 2013). 
• People with past-year or lifetime PTSD are at 
signifcant risk of developing any number of 
comorbid mental disorders, including any mood 
disorder (2.4 to 3 times the odds), bipolar I 
disorder (2.1 to 2.2 times), any anxiety disorder 
(2.6 to 2.8 times), GAD (2 to 2.2 times), panic 
disorder (2.1 times), and BPD (2.8 to 3.3 times) 
(Goldstein et al., 2016). 
• People with adverse childhood events (e.g., 
abuse, neglect) are more likely to report lifetime 
drug use, past-year moderate-to-heavy alcohol 
use, lifetime suicide attempt, and past-year 
depressed mood than people without such a 
history (Merrick et al., 2017). Emotional abuse in 
childhood is linked with 6 times the odds for a 
lifetime suicide attempt (Merrick et al., 2017). 
Trauma-Informed Treatment of CODs 
Historically, trauma has not been adequately 
addressed in SUD treatment, given provider 
fear that doing so would worsen mental and 
addiction problems. However, research indicates 
the opposite—that failing to address trauma 
in people with SUDs leads to worse outcomes
(Brown, Harris, & Fallot, 2013). 
Trauma-informed care means attending to trauma-
related symptoms and also creating a treatment 
environment that is responsive to the unique needs 
of individuals with histories of trauma. Treatment 
is focused on reducing specifc symptoms and 
restoring functioning but also broader goals like 
building resiliency, reestablishing trust, preventing 
retraumatization, and offering hope for the future. 
Creating a supportive, safe treatment environment 
is crucial. Counselors must realize how the setting 
and their interactions with clients who have trauma 
can affect treatment adherence, retention, and 
outcomes. 
Trauma-informed care for people with mental 
disorders, SUDs, or both often includes (SAMHSA, 
2014b): 
• Psychoeducation, especially about the 
relationship between trauma, mental health, and 
addiction. Psychoeducation is also needed to 
help normalize symptoms and reassure clients 
that their experiences are not unusual, “wrong,” 
or “bad.” 
• Teaching coping and problem-solving skills to 
foster effective stress management. 
• Discussing retraumatization and developing 
strategies to prevent further victimization. 
• Helping clients feel empowered and in control 
of their lives. 
• Establishing a sense of safety in clients’ daily 
lives and in treatment. 
• Promoting resilience and offering hope for 
change and improvement. 
• Identifying and responding adaptatively to 
triggers, like intrusive thoughts, feelings, and 
sensations. 
• Building a therapeutic alliance, which fosters 
trust, confdence, and self-worth—all keys to 
healing. 
• Using trauma-specifc interventions, like: 
- CBT. 
- Cognitive processing therapy. 
- Exposure therapy. 
- Eye movement desensitization/reprocessing. 
- Affective regulation. 
- Distress tolerance and stress inoculation. 
- Peer support services from other people who 
have a trauma history and are thriving. 
TIP 57, Trauma-Informed Care in Behavioral 
Health Services (SAMHSA, 2014b) and SAMHSA’s 
“Concept of Trauma and Guidance for a Trauma-
Informed Approach” (SAMHSA, 2014c) will help 
addiction and mental health professionals tailor 
their services in a way that is respectful of and 
sensitive to clients’ trauma-related needs. Chapter 
6 discusses adapting treatments for CODs to 
female clients with trauma. 
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ADVICE TO THE COUNSELOR: COUNSELING A CLIENT WITH TRAUMA 
• Clients need not only to feel safe in the treatment environment, but also to feel safe from their trauma 
symptoms, many of which are intrusive, overwhelming, and distressing. 
• Ensure interventions/interactions do not distress or traumatize clients. Avoid: 
−Being overly confrontational or argumentative with clients. 
−Discounting and dismissing clients’ experiences and feelings. 
−Minimizing or ignoring clients’ responses and needs. 
− Pushing clients to talk in greater detail about their trauma. 
− Violating clients’ physical boundaries. 
• Educate clients about the link between trauma and mental disorders, SUDs, or both. 
• Normalize clients’ reactions and feelings; this helps validate their experiences and offers a sense of relief. 
• Help clients identify triggers and learn more adaptive ways to cope and respond to them. This reduces
maladaptive distress management strategies like substance use, self-injurious behaviors, and avoidance. 
• Although trauma is an important focus of treatment, it does not need to be the sole focus. In fact, 
constantly focusing on the trauma can be overwhelming and emotionally draining for clients. 
• Include specifc SUD treatment approaches and techniques to address addiction symptoms. 
• Use an integrated trauma and SUD recovery model that fully addresses mental and substance-related 
needs. 
• Explore with clients their readiness for change using the Stages of Change Model. This aids treatment 
matching, fosters better adherence/completion rates, and increases clients’ chances for long-term 
recovery. 
Special Considerations: Trauma and Military 
Personnel 
Active duty and veteran members of the military 
are highly susceptible to trauma and all of its 
deleterious aftereffects. PTSD prevalence is 
signifcantly higher than that of the general 
population and civilian clinical samples, including 
9 percent among a sample of more than 4 million 
veterans in primary care settings (Trivedi et al., 
2015), 23 percent among Operations Enduring 
Freedom and Iraqi Freedom (OEF/OIF) veterans 
(Fulton et al., 2015), 21 percent in Gulf War 
veterans (Dursa, Barth, Schneiderman, & Bossarte, 
2016), and 8.5 percent to 12.2 percent of Vietnam 
War veterans (Marmar et al., 2015). 
About 20 percent of veterans have CODs (Trivedi 
et al., 2015); 16 percent have PTSD and SUDs 
specifcally (Mansfeld, Greenbaum, Schaper, 
Banducci, & Rosen, 2017). In a sample of (OEF/ 
OIF) veterans, 63 percent of people with SUD 
also had PTSD (Seal et al., 2011). Other common 
mental disorders in this population include SMI, 
depression, and anxiety; all tend to co-occur 
often (Exhibit 4.20). These illnesses are linked with 
increased hospitalizations, ED use, and mortality, 
with SMI and SUDs being particularly damaging 
(Trivedi et al., 2015). 
Many veterans seek treatment outside of the 
Veterans Health Administration, so community 
addiction counselors should prepare to work 
with them. Counseling veteran or active duty 
military populations requires a slightly different 
knowledge base, clinical approach, and skillset 
than civilian populations. SUD counselors should 
note that (Briggs & Reneson, 2010; Teeters, 
Lancaster, Brown, & Back, 2017): 
• War zone stress reactions often require 
specialized care and an understanding of the 
experiences faced by soldiers in combat. 
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COMORBID 
MENTAL 
ILLNESSES 
PRIMARY MENTAL ILLNESS 
SUD 21.9 percent 23.2 percent 22.1 percent 29.0 percent — 
SMI 8.8 percent 8.0 percent 10.2 percent — 12.8 percent 
Anxiety 13.9 percent 19.4 percent — 13.3 percent 12.7 percent 
Depression 48.1 percent — 55.0 percent 29.5 percent 37.8 percent 
PTSD — 33.2 percent 27.1 percent 22.4 percent 24.6 percent 
Specifc 
Disorder 
PTSD Depression Anxiety SMI SUD 
EXHIBIT 4.20. Veterans and CODs 
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Source: Trivedi et al. (2015). 
• Military-related trauma exposure does not
include only direct combat. For instance, people
working in intelligence gathering and medical
personnel are often deployed to war zones
where they witness horrifc acts of violence and
are potential targets of violence themselves.
• Female veterans often have specifc service
needs, such as those to address military sexual
trauma (e.g., sexual assault, harassment),
intimate partner violence, and child care. (Note
that men also can be victims of military sexual
trauma, albeit at far lower rates than reported
by women. Do not assume that military sexual
trauma is solely a women’s issue.)
• Many veterans are hesitant to seek SUD
treatment or mental health services because
of fear that doing so could negatively affect
their career advancement. Concerns about
confdentiality are thus understandably very high
in these clients.
• Shame, embarrassment, and stigma over
mental health and addiction are prominent.
Military culture fosters some behaviors and
mindsets that can be adaptive in combat—like
independence, being “masculine,” and not
showing “weakness”—but make seeking
treatment much harder.
• Suicide risk is high in veterans. It requires active
monitoring and management throughout
treatment, particularly for military personnel
with childhood trauma, PTSD, military sexual
trauma, or depression (Carroll, Currier,
McCormick, & Drescher, 2017; Cunningham
et al., 2017; Kimerling, Makin-Byrd, Louzon,
Ignacio, & McCarthy, 2016; McKinney, Hirsch, & 
Britton, 2017; Pompili et al., 2013). 
Indepth discussions about prevention programming 
and treatment for military populations with 
trauma, suicide risk, SUDs, mental disorders, or 
a combination thereof is beyond the scope of 
this TIP. However, ample information is available 
elsewhere. The following resources offer helpful 
guidance about working with military professionals 
who engage in substance misuse or have mental 
illness, including trauma, suicidality, and CODs: 
• ACA:
- Suicide Among Veterans and the Implications
for Counselors (www.counseling.org/docs/
default-source/vistas/suicide-among-vet-
erans-and-the-implications-for-counselors.
pdf?sfvrsn=3803a659_11)
- Comparison of Civilian Trauma and Combat
Trauma (https://pdfs.semanticscholar.org/
eff2/8af43d3feaac7bac3cc5bb789bd4d5f 
100ec.pdf)
- Counseling Addicted Veterans: What
to Know and How to Help (https://
pdfs.semanticscholar.org/9742/967aac-
815ca02c4f599b36be996d0b10d3d9.pdf)
• The Department of Veterans Affairs’ National
Center for PTSD (www.ptsd.va.gov/):
- Practice Recommendations for Treatment
of Veterans with Comorbid Substance Use
Disorder and Posttraumatic Stress Disorder
(www.mentalhealth.va.gov/providers/sud/ 
docs/SUD_PTSD_Practice_Recommendations.
pdf)
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- Veteran Outreach Toolkit: Preventing Veteran 
Suicide Is Everyone’s Business (www.va.gov/ 
ve/docs/outreachToolkitPreventingVeteran-
SuicideIsEveryonesBusiness.pdf) 
- National Strategy for Preventing Veteran 
Suicide, 2018–2028 (www.mentalhealth. 
va.gov/suicide_prevention/docs/ 
Offce-of-Mental-Health-and-Suicide-
Prevention-National-Strategy-for-Preventing-
Veterans-Suicide.pdf) 
• SAMHSA’s Addressing the Substance Use 
Disorder Service Needs of Returning Veterans 
and Their Families (www.samhsa.gov/sites/ 
default/fles/veterans_report.pdf) 
• Community Anti-Drug Coalitions of America’s 
Strategies for Addressing Substance Abuse 
in Veteran Populations (www.cadca.org/sites/ 
default/fles/mckesson_toolkit_1.pdf) 
Conclusion 
The material in this chapter is intended to increase 
SUD treatment counselors’ and other providers’ 
familiarity with mental disorders terminology 
and criteria, as well as to provide advice on how 
to proceed with clients who demonstrate these 
disorders. The consensus panel encourages 
counselors to continue to increase their 
understanding of mental disorders by using the 
resource material referenced in each section (and 
in Appendix C), attending courses and conferences 
in these areas, and engaging in dialog with mental 
health professionals who are involved in treatment. 
At the same time, the panel urges continued work 
to develop improved treatment approaches that 
address substance use in combination with specifc 
mental disorders, as well as better translation of 
that work to make it more accessible to the SUD 
treatment feld. 
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• Building a positive therapeutic alliance is a 
cornerstone of effective, high-quality, person-
centered care for all clients, especially those 
with co-occurring disorders (CODs). Clients 
with CODs often experience stigma, mistrust, 
and low treatment engagement. 
• CODs are complex and are associated with 
certain clinical challenges that, if unaddressed, 
can compromise the counselor–client 
relationship and impinge on quality of care, 
potentially leading to suboptimal outcomes. 
• Strategies and approaches like empathic 
support, motivational enhancement, relapse 
prevention techniques, and skill building help 
strengthen clients’ ability to succeed and 
make long-term recovery more likely. 
• Certain mental disorders are complex, 
chronic, and diffcult to treat, including major 
depressive disorder (MDD), anxiety disorders, 
posttraumatic stress disorder (PTSD), and 
serious mental illness2 (SMI). Clients with these 
disorders may have unique symptoms and 
limitations in function. 
• Empirically based substance use disorder 
(SUD) treatment approaches can help 
counselors address these unique symptoms 
and functional limitations in ways that 
will minimize their potential to disrupt the 
therapeutic relationship and impede positive 
treatment outcomes. 
Establishing and maintaining a successful 
therapeutic relationship with clients can enhance 
treatment engagement, participation, and 
outcomes. Building a good therapeutic relationship 
with clients who have CODs is especially important, 
yet doing so can be diffcult. The frst part of this 
chapter reviews guidelines and techniques for 
building rapport and optimizing outcomes when 
providing SUD treatment to clients who have 
CODs. The chapter also describes how to modify 
general treatment principles to suit the needs of 
clients with COD—particularly useful when working 
with clients in Quadrants II and III. (Chapter 3 
addresses the Four Quadrants Model of service 
provision.) The second part describes evidence-
based techniques for building therapeutic rapport 
and effectively counseling clients with CODs 
involving specifc mental disorders—MDD, anxiety 
disorders, PTSD, and SMI. 
The material in this chapter is consistent with 
national or state consensus practice guidelines for 
COD treatment and consonant with many recom-
mendations therein: 
• Counselors must be able to address common 
clinical challenges, like managing feelings 
and biases that could arise when working with 
clients who have CODs (sometimes called 
countertransference). 
• Together, providers and clients should monitor 
clients’ disorders and symptoms by examining 
the status of each disorder and alerting each 
other to signs of relapse. 
• Counselors can help clients with functional 
defcits in areas such as understanding 
instructions by using repetition, skill-building 
strategies, and other accommodations to aid 
progress. 
² SMI: A diagnosable mental, behavioral, or emotional disorder (other than developmental disorders or SUDs) that persists 
long enough to meet diagnostic criteria and that causes functional impairment suffcient to substantially disrupt major life 
activities (Substance Abuse and Mental Health Services Administration [SAMHSA], 2017). 
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• The consensus panel recommends that 
counselors primarily use a supportive, 
empathic, and culturally responsive approach 
when working with clients who have CODs. 
Counselors need to distinguish behaviors and 
beliefs of cultural origin from those that may 
indicate a mental disorder. 
• Counselors and other service providers should 
use motivational enhancement and relapse 
prevention strategies consistent with each 
client’s specifc stage of recovery. These 
strategies are helpful regardless of the severity of 
a client’s mental disorder. 
This chapter is intended for counselors and other 
behavioral health service providers, supervisors, 
and administrators. Throughout this chapter, 
“Advice to the Counselor” boxes highlight 
practical guidance for counselors. 
Competencies for Working With
Clients Who Have CODs
Before establishing therapeutic rapport with clients 
who have CODs, treatment providers frst must 
ensure that they possess integrated competencies 
for working with the COD population. This means 
having the specifc attitudes, values, knowledge, 
and skills needed to provide appropriate services 
to individuals with CODs in the context of the 
providers’ job and program setting. 
Just as other types of integration exist on a
continuum, so too does integrated competency.
Some interventions or programs require only basic
competency in welcoming, screening, and assessing
individuals with CODs to identify their treatment
needs. Other interventions, programs, or job
functions (e.g., those of supervisory staff) may require
more advanced integrated competency. Clients with
more complex or unstable disorders require providers
with higher levels of integrated competency.
They also require more formal mechanisms within
programs to coordinate various staff members,
providing effective integrated treatment. 
The mental health service and SUD treatment 
systems are moving toward identifcation of a 
basic, required level of integrated competency 
for all providers. Many states are developing 
curriculums for initial and ongoing training and 
supervision to help providers achieve competency. 
Other states have created career ladders and 
certifcation pathways to encourage providers to 
achieve greater competency and to reward them 
for this achievement. (See Chapter 8 for further 
discussion of counselor competencies.) 
Guidelines for a Successful
Therapeutic Relationship
This section reviews 10 guidelines for forming a 
good therapeutic relationship with clients who 
have CODs, thereby increasing their chances of 
successful long-term recovery. 
Develop and Use a Therapeutic Alliance 
To Engage Clients in Treatment 
Research suggests that a therapeutic alliance is a
strong, if not essential, factor in supporting recovery
from mental disorders and SUDs (Kelly, Greene, &
Bergman, 2016; Shattock, Berry, Degnan, & Edge,
2018; Zugai, Stein-Parbury, & Roche, 2015). The
therapeutic alliance can foster desirable outcomes
by improving symptoms, functioning, treatment
engagement, treatment satisfaction, and quality
of life (Dixon, Holoshitz, & Nossel, 2016; Kidd,
10 GUIDELINES FOR 
DEVELOPING SUCCESSFUL 
THERAPEUTIC RELATIONSHIPS 
WITH CLIENTS WHO HAVE CODS 
1. Develop and use a therapeutic alliance to 
engage clients in treatment. 
2. Maintain a recovery perspective. 
3. Ensure continuity of care. 
4. Address common clinical challenges (e.g., 
countertransference, confdentiality). 
5. Monitor psychiatric symptoms (including 
symptoms of self-harm). 
6. Use supportive and empathic counseling; 
adopt a multiproblem viewpoint. 
7. Use culturally responsive methods. 
8. Use motivational enhancement. 
9. Teach relapse prevention techniques. 
10. Use repetition and skill building to address 
defcits in functioning. 
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Given the proliferation of research over the past few decades on technology-based interventions in 
behavioral health services, some researchers have explored how technology can affect client–counselor 
relationships in COD treatment. A pilot study from Ben-Zeev, Kaiser, and Krzos (2014) examined the use 
of mobile phone technology to monitor clients with SMI and SUDs. Using daily text messages over 12 
weeks, team members routinely texted clients (in what the study authors termed “hovering”) reminders 
of upcoming appointments, inquiries about medication adherence, general suggestions about managing 
symptoms, and, as needed, crisis management. At the end of the trial, participant ratings of therapeutic 
alliance with providers who “hovered” were signifcantly higher than those for providers who did not use 
the intervention. Most clients were satisfed with the technology, and 87 percent said it helped them feel 
more in control of their lives. 
Davidson, & McKenzie, 2017). For clients with
SMI (e.g., bipolar disorder, schizophrenia), better
therapeutic alliance has been linked to a reduction
in symptoms, fewer hospitalizations, greater
antipsychotic medication adherence, and improved
client self-esteem (Garcia et al., 2016; Shattock et
al., 2018). Studies of people with SUDs or CODs
also suggest that a strong therapeutic alliance is a
signifcant predictor of treatment retention, symptom
reduction, enhanced abstinence-related self-effcacy,
and more days of abstinence (Campbell, Guydish,
Le, Wells, & McCarty, 2015; Connors et al., 2016;
Maisto et al., 2015).
However, the personal beliefs of individuals with 
CODs, such as mistrust of treatment providers 
and fear of stigma, can be barriers to treatment 
seeking, access, and engagement (Priester et 
al., 2016) and can make establishing a close, 
trusting client–provider relationship challenging. 
Developing an effective relationship with clients who
have SMI and SUDs can be especially diffcult. Some
individuals have little insight, lower motivation to 
change, and less ability to seek/access care than 
people without CODs (Pierre, 2018). Challenges 
may be more apparent in clients with SUDs and co-
occurring psychosis, as they may have emotional/ 
cognitive dysfunctions inhibiting their ability to 
participate in treatment (Priester et al., 2016). The 
presence and level of clinical and functional defcits 
varies widely from one person with CODs to the 
next, and among all people with CODs over the 
course of their illness and lifetime. 
To foster treatment engagement for clients with 
CODs, therapeutic relationships must build on 
clients’ existing capacities. The therapeutic alliance 
is the cornerstone of the COD recovery process. 
Once established, the alliance is rewarding for 
both client and provider and facilitates their joint 
participation in a full range of therapeutic activities. 
Counselors should document alliance-building 
activities to help manage risk. 
Maintain a Recovery Perspective 
Varied Meanings of “Recovery” 
The word “recovery” has different meanings in
different contexts. SUD treatment providers may
think of clients who have changed their substance
use behavior as being “in recovery” for the rest of
their lives (but not necessarily in formal treatment
forever). Mental health clinicians may think of
ADVICE TO THE COUNSELOR: 
FORMING A THERAPEUTIC 
ALLIANCE 
The consensus panel recommends these 
approaches to form a therapeutic alliance with 
clients who have CODs: 
• Demonstrate an understanding and 
acceptance of clients. 
• Help clients clarify the nature of their diffculties.
• Indicate that you will work together with clients.
• Communicate to clients that you will help 
them help themselves. 
• Express empathy and a willingness to listen to 
clients’ understanding of their problems. 
• Assist clients in solving external problems 
directly and immediately. 
Chapter 5 143 
TIP 42
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Substance Use Disorder Treatment for People With Co-Occurring Disorders 
ADVICE TO THE COUNSELOR: MAINTAINING A RECOVERY PERSPECTIVE 
The consensus panel recommends these approaches for maintaining a recovery perspective in treating CODs:
• Assess each client’s stage of change (see the section “Using Motivational Enhancement Consistent With 
Clients’ Specifc Stage of Change”). 
• Ensure that treatment stage and expectations are consistent with each client’s stage of change. 
• Use client empowerment to motivate change. 
• Foster continuous support. 
• Provide continuity of treatment. 
• Acknowledge that recovery is a long-term process; support and applaud even small gains by clients. 
recovery as a process in which the client moves
toward specifc behavioral goals in stages; in this
conceptualization, recovery is assessed by whether
these goals are achieved. In mutual-support
programs, recovery implies not only abstinence
from substances but also a commitment to “working
the program,” which includes group members
changing the way they act with others and taking
responsibility for their actions. People with mental
disorders may see recovery as the process of
reclaiming a meaningful life beyond mental illness,
with symptom control and positive life activity. 
Generally, it is recognized that recovery does 
not refer solely to a change in substance use 
but also to a change in an unhealthy way of 
living. Markers such as improved health, better 
ability to care for oneself and others, increased 
independence, and enhanced self-worth indicate 
progress in recovery. 
Implications of the Recovery Perspective 
The recovery perspective as developed in the SUD 
treatment feld has two main features: 
1. It acknowledges that recovery is a long-term 
process of internal change. 
2. It recognizes that these internal changes proceed
through various stages (see De Leon [1996] and
Prochaska et al. [1992] for a detailed description). 
The recovery perspective generates two main 
principles for practice: 
• Develop a treatment plan that provides for 
continuity of care over time. In preparing 
this plan, the provider should recognize that 
treatment may occur in different settings over 
time (e.g., residential, outpatient). The plan 
should refect that much of the recovery process 
is client driven and typically occurs outside of, or 
following, professional treatment (e.g., through 
participation in mutual support). Providers 
should reinforce long-term participation in these 
settings. 
• Use interventions that match the tasks and 
challenges specifc to each stage of the 
COD recovery process. Doing so enables 
providers to use sensible stepwise approaches 
in developing and using treatment protocols. 
Markers that are unique to individuals—such as 
those related to their cultural, social, or spiritual 
context—should be considered. Providers 
should engage clients in defning markers of 
progress that are meaningful to them in each 
stage of recovery. 
Stages of Change and Stages of Treatment 
Working within the recovery perspective requires 
a thorough understanding of the interrelationship 
between stages of change (as originally defned by 
Prochaska et al., 1992, and built upon by De Leon, 
1996) and stages of treatment (see the section 
“Using Motivational Enhancement Consistent 
With Clients’ Specifc Stage of Change”). De Leon 
developed a measure of motivation for change 
and readiness for treatment—Circumstances, 
Motivation, and Readiness Scales—and provided 
scores for samples of people with CODs (De 
Leon, Sacks, Staines, & McKendrick, 2000). The 
144 Chapter 5 
TIP 42
 
 
 
 
 
 
 
 
Chapter 5—Strategies for Working With People Who Have Co-Occurring Disorders 
scales have a demonstrated relationship with 
retention in general SUD treatment populations 
and programs (Ali, Green, Daughters, & Lejuez, 
2017). A meta-analysis (Krebs, Norcross, Nicholson, 
& Prochaska, 2018) found that client stage or 
readiness level of change predicted psychotherapy 
outcomes among people with SUDs, eating 
disorders, anxiety disorders, depressive disorders, 
borderline personality disorder, and CODs (e.g., 
PTSD and alcohol dependence). The authors 
suggest tailoring goal setting, treatment processes, 
and resources to each client’s stage of change 
to optimize outcomes. Expectations for clients’ 
progress through treatment stages (e.g., outreach, 
stabilization, early-middle-late primary treatment, 
continuing care, long-term care) should be 
consistent with clients’ stages of change. 
Client Empowerment and Responsibility 
The recovery perspective emphasizes clients' 
empowerment and responsibility and their network 
of family and signifcant others. Per Green, 
Yarborough, Polen, Janoff, and Yarborough (2015), 
achieving sobriety can be a major step in building 
clients’ feelings of self-effcacy and confdence 
to further achieve recovery in SMI and can be a 
turning point in advancing their personal growth, 
improving functioning, and meeting recovery goals. 
Continuous Support 
The recovery perspective highlights the need 
for continuing recovery support. Providers 
encourage clients to build a support network that 
offers respect, acceptance, and appreciation. 
For example, an important element of long-term 
participation in Alcoholics Anonymous (AA) is 
the sense of belonging or a “home.” AA offers 
this supportive environment without producing 
overdependence because members are expected 
to contribute, as well as receive, support. 
Ensure Continuity of Care 
Continuity of treatment fows from a recovery 
perspective and is a guiding principle in its own 
right. Continuity of treatment implies that COD 
services are constant. Treatment continuity for 
clients with CODs begins with proper, thorough 
identifcation, assessment, and diagnosis. Per a 
review by McCallum et al. (2015), continuity of care 
for people with CODs means providing: 
• Care that is regular and consistent over time. 
• Care that is continually adjusted to the client’s 
needs. 
• Continuity in the counselor–client relationship, 
such as through ongoing and reliable contact. 
• Continuity across services via case management, 
coordination of care, and linkage to resources. 
• Continuity in the transfer of care, including 
maintaining contact (as appropriate) even after 
handoff. 
On a program level (Padwa, Larkins, Crevecoeur-
MacPhail, & Grella, 2013), continuity of care for 
clients with CODs can include having structures, 
procedures, and training in place that enables 
providers to: 
• Assess and monitor mental disorder and SUD 
symptoms. 
• Develop discharge planning that continually 
supports clients through community resources 
(e.g., peer recovery support services, mutual 
support). 
• Ensure medication needs are met (e.g., 
medication checks are scheduled, prescription 
refll procedures are in place) for people on 
pharmacotherapy. 
More discussion of how counselors can ensure 
continuity of care for clients with CODs across 
different treatment settings can be found in 
Chapters 2 and 7. 
Address Common Clinical Challenges 
Ease Discomfort and Reluctance 
Providers’ ease in working toward a therapeutic 
alliance is affected by their comfort level in working 
with clients who have CODs. SUD counselors 
may fnd some clients with SMI or severe SUDs 
to be threatening or unsettling. This discomfort 
may result from lack of experience, training, or 
mentoring. Likewise, some mental health clinicians 
may feel uncomfortable or intimidated by clients 
with SUDs. Providers need to recognize certain 
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ADVICE TO THE COUNSELOR: MITIGATING RELAPSE BY MANAGING THE 
RECOVERY ENVIRONMENT 
To guide clients through recovery and ensure delivery of comprehensive, recovery-oriented care, 
counselors must help clients establish and maintain a supportive recovery environment. This environment 
is more than where clients live; it compasses clients’ entire physical, emotional, social, educational, and 
vocational world. 
Understanding limitations in clients’ recovery environments is critical to helping them prevent relapse
and problem solve barriers. Environmental obstacles and lack of support can sabotage clients’ recovery
efforts and can be diffcult to overcome without assistance from a mental health or addiction professional.
Counselors can help clients with CODs create a life conducive to recovery by assessing areas of 
functioning and symptoms and offering services relevant to the American Society of Addiction Medicine’s 
Patient Placement Criteria, Third Revision, Domain 6 (Mee-Lee et al., 2013). This means working with 
clients to identify and explore: 
• The client’s current living situation, including the physical living space, the people who co-occupy their 
home, and the surrounding community (e.g., Is it safe? Is it disruptive to recovery? Does the client live in 
an area where illicit substances are easily accessible?). 
• The client’s available supports for all biopsychosocial needs, whether related to illness or broader 
areas of living, like social life, work, and relationships. For instance, does the client have reliable 
transportation? What about child care? Does the client have people in his or her life to rely on for 
tangible and emotional support? Is the client able to maintain primary care and behavioral health 
appointments? 
• Threats to support in the client’s life, such as friends or loved ones who actively misuse substances or 
family members who are unsupportive of SUD treatment? 
• Whether the client engages in peer support, 12-Step support, or other mutual-support programs. 
• Educational or occupational matters that facilitate or hinder recovery. For instance, is the client employed?
Does his or her supervisor know that the client is in recovery (and supportive of this)? Is the client working to
complete his or her degree, and does the client value degree completion as a recovery goal? 
• Whether the client is engaged in meaningful activities with family, friends, partners, coworkers, classmates,
or peers. Also, does the client have hobbies or otherwise regularly engage in pleasant activities? 
• Whether the client is involved in the criminal justice system, child welfare system, or both. 
• Whether the client needs fnancial assistance (e.g., applying for Social Security Disability Insurance). 
patterns that invite these feelings and not let them 
interfere with clients’ treatment. Providers who fnd 
it challenging to form a therapeutic alliance with 
clients who have CODs should consider whether 
their diffculty is related to: 
• The client’s diffculties. 
• A limitation in their own experience and skills. 
• Demographic differences between themselves
and their clients in areas such as age, gender,
education, socioeconomic status, race, or ethnicity. 
• Countertransference (see the section “Manage 
Countertransference”). 
A consultation with a supervisor or peer to discuss 
this issue is important. Often these reactions can 
be overcome with further experience, training, 
supervision, and mentoring. 
Individuals with CODs may also feel challenged
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in forming a therapeutic relationship with their
treatment providers. They often experience
demoralization and despair, given the complexity of
having multiple behavioral health concerns and the
diffculty of achieving treatment success. Inspiring
hope often is a necessary precursor that allows
clients to give up short-term relief for long-term
work, even when there is some uncertainty in
timeframe and beneft. 
Manage Countertransference 
Providers should understand diffculties related 
to countertransference and be familiar with 
strategies to manage it. Although the concept 
of countertransference is somewhat dated 
and infrequently used in the COD literature, it 
can help providers understand how their past 
experiences can infuence current attitudes 
toward certain clients. Transference describes the 
process whereby clients project attitudes, feelings, 
reactions, and images from the past onto their 
providers. For example, the client may regard the 
provider as an “authoritative father,” “know-it-all 
older brother,” or “interfering mother.” 
Countertransference is now understood to be a 
normal part of providers’ treatment experience. 
Particularly when working with clients who have 
ADVICE TO THE COUNSELOR:  
MANAGING 
COUNTERTRANSFERENCE 
The consensus panel recommends this 
approach to manage countertransference with 
clients who have CODs: 
• Be aware of strong personal reactions and 
biases toward clients. 
• Get further supervision when 
countertransference is suspected and may be 
interfering with counseling. 
• Receive formal and periodic clinical 
supervision; counselors should have 
opportunities to discuss countertransference 
with their supervisors and with other staff at 
clinical team meetings. 
multiple, complicated problems, providers are 
as vulnerable as clients to feelings of pessimism, 
despair, and anger, as well as desires to abandon 
treatment. Less experienced providers may fnd 
it harder to identify countertransference, access 
feelings evoked by interactions with clients, name 
those feelings, and keep feelings from interfering 
with the counseling relationship. 
SUDs and mental disorders are stigmatized by 
the general public. Stigma can also be present 
among providers. Mental health clinicians who 
usually do not treat people with SUDs may not 
have worked out their own responses to substance 
misuse, which can infuence their interactions with 
these clients. Providers working with clients who 
have SMI may have more negative beliefs about 
and express more negative attitudes toward clients 
with SMI than those without such diagnoses (Smith, 
Mittal, Chekuri, Han, & Sullivan, 2017; Stone et 
al., 2019). Providers who treat clients with SMI can 
beneft from working with supervisors to uncover 
and correct underlying harmful thoughts and 
attitudes. 
Similarly, SUD treatment providers may be 
unaware of their own reactions to people with 
specifc mental disorders and may have diffculty 
preventing these reactions from infuencing 
treatment. Their negative attitudes or beliefs 
may be communicated, directly or subtly, to the 
client—for example, through thoughts like, “I was 
depressed too, but I never took medications for 
it—I just worked the Steps and got over it. So why 
should this guy need medication?” 
Negative feelings generated by countertrans-
ference can worsen over time. Some research 
indicates that providers treating clients with CODs 
may feel less satisfed with their jobs and increas-
ingly frustrated with their clients the longer they 
stay in practice (Avery et al., 2016). 
Providers’ negative attitudes toward clients with
CODs can have a signifcant impact on treatment
services and outcomes. For example, countertrans-
ference may result in providers failing to offer timely,
appropriate treatment and having poor communica-
tion with their clients (Avery et al., 2016). (For a full
discussion of countertransference in SUD treatment,
see Powell & Brodsky, 2004.) Countertransference
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Providers have a duty to be aware of federal 
rules under the Health Insurance Portability and 
Accountability Act and any additional regulations 
in their states dictating what information they 
can and cannot share with other providers (as 
well as caregivers and family members) and 
under which circumstances. 
problems are particularly signifcant when working 
with people who have CODs, because people with 
SUDs and mental disorders may evoke strong 
feelings in providers that could become barriers 
to treatment if providers allow such feelings 
to interfere. Providers may feel angry, used, 
overwhelmed, confused, anxious, uncertain how to 
proceed with a case, or just worn out. 
Cultural concerns may cause strong yet unspoken 
feelings, creating countertransference and trans-
ference. Counselors working with clients in their 
area of expertise may be familiar with countertrans-
ference, but working with an unfamiliar population 
will introduce different kinds and combinations of 
feelings. 
Protect Confdentiality 
Confdentiality and privacy are relevant to every 
clinical situation and are especially important 
for clients with SMI, SUDs, or both. These 
conditions can be complex and debilitating, and 
they are associated with an increased risk of harm 
to self and others. Furthermore, people receiving 
SUD treatment in federally funded programs are 
protected by additional regulations that affect 
information sharing, privacy, and consent. More 
information about these regulations is available 
online (www.samhsa.gov/about-us/who-we-are/ 
laws-regulations/confdentiality-regulations-faqs). 
RESOURCE ALERT: FEDERAL 
AND STATE MENTAL HEALTH 
PRIVACY AND CONFIDENTIALITY 
REGULATIONS 
Mental health regulations regarding privacy, 
confdentiality, and information sharing 
(including duty to warn laws) vary by state. 
Counselors can stay up-to-date on regulations in 
the state(s) in which they practice by accessing 
information and resources available online: 
• SAMHSA’s Directory of Single State Agencies 
for Substance Abuse Services (https://www. 
samhsa.gov/sites/default/fles/single-state-
agencies-directory-08232019.pdf) 
• National Conference of State Legislatures’ 
Mental Health Professionals Duty to Warn 
(www.ncsl.org/research/health/mental-health-
professionals-duty-to-warn.aspx) 
General resources about the protection of 
mental health clients’ and SUD treatment 
clients’ rights include: 
• Department of Health and Human Services’ 
Mental Health Information Privacy FAQs (www. 
hhs.gov/hipaa/for-professionals/faq/mental-
health/index.html) 
• SAMHSA’s Laws and Regulations (www. 
samhsa.gov/about-us/who-we-are/ 
laws-regulations) 
• SAMHSA’s Substance Abuse Confdentiality 
Regulations FAQs (www.samhsa.gov/ 
about-us/who-we-are/laws-regulations/ 
confdentiality-regulations-faqs) 
However, confdentiality is not absolute. Contexts 
in which to be mindful of protections related 
to client privacy and confdentiality—and the 
limitations of those protections—include: 
• When collaborating with other providers, 
especially those outside of the behavioral 
health feld. All clients have a right to privacy 
and confdentiality. There are federal as well 
as state regulations that dictate the type of 
information providers can share with other 
providers while upholding those rights for their 
clients. Remember that counselors who practice 
in more than one location must follow the 
regulations in each of the states in which they 
see clients. (See “Resource Alert: Federal and 
State Mental Health Privacy and Confdentiality 
Regulations.”) 
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• When working in a setting with electronic 
health records (EHRs). The proliferation of EHRs 
has helped foster easier record sharing between 
mental health and general medical clinicians 
but also poses a risk to confdentiality that, if 
breached, could seriously damage client trust in 
the counselor and in the psychotherapy process 
in general (Shenoy & Appel, 2017). 
• When working with clients who verbalize 
specifc threats of harm to a third party. If 
the counselor has reason to believe a violent 
act is foreseeable and is directed at a specifc 
person, breach of confdentiality may be 
appropriate or even required by the state’s 
duty to warn mandate. Counselors should seek 
consultation, as needed and as appropriate 
given the volatility of the situation. If employed 
by an agency, follow required treatment facility 
policies/procedures as well. 
• When treating clients with trauma/PTSD. 
Trauma survivors may be mistrustful and 
concerned about privacy, posing barriers to 
treatment (Kantor, Knefel, & Lueger-Schuster, 
2017). Trauma in the context of ongoing 
intimate partner violence, child maltreatment, 
sexual assault, or elder abuse raises ethical and 
legal concerns about breaching confdentiality 
under duty to warn laws. 
• When working with clients ages 18 and 
under, including students. Discussion of 
pediatric and adolescent mental disorders 
and substance misuse is beyond the scope of 
this TIP. Information on laws affecting mental 
health clinicians and addiction counselors is 
available via American Academy of Pediatrics’ 
Confdentiality Laws Tip Sheet (www.aap.org/ 
en-us/advocacy-and-policy/aap-health-initiatives/ 
healthy-foster-care-america/Documents/ 
Confidentiality_Laws.pdf) and in the resource 
alert about federal and state privacy and 
confdentiality regulations. 
Providers must understand how to involve 
family members, when appropriate, without 
jeopardizing client privacy and confdentiality. 
Families often want to be involved in the care of a 
loved one with CODs—especially if the individual 
has a history of nonadherence to medication and 
other treatment and does not have other support 
systems in place. Sometimes, family members or 
caregivers must be involved because the client 
lacks capacity to make independent healthcare 
decisions. 
Recommended practices for involving families 
(Rowe, 2012) in a client’s COD treatment include: 
• Involving family members in planning and 
implementing treatments to the extent possible 
(after discussing their involvement with the 
client and obtaining his or her written consent). 
• Conveying the same respect and empathy
toward family members as toward clients to build
rapport. 
• Developing a contract that spells out what type 
of information families will and will not receive 
and what role they can play in their loved one’s 
treatment. 
Monitor Psychiatric Symptoms 
Joint Treatment Planning 
When SUD counselors work with clients who 
have CODs, especially those who need medi-
cations or are receiving mental health services 
separately from SUD treatment, it is especially 
important that they participate in developing 
client treatment plans and monitoring clients’ 
psychiatric symptoms. The SUD counselor should, 
at minimum, be knowledgeable of the overall 
treatment plan to permit reinforcement of the 
plan’s mental health aspects as well as aspects 
specifc to recovery from SUDs. It is equally 
important for clients to participate in developing 
their COD treatment plans. 
For example, for a client with bipolar disorder 
and alcohol use disorder (AUD) who is receiving 
treatment at both an SUD treatment agency and 
a local mental health center, the treatment plan 
might include individual SUD treatment counseling, 
medication management, and group therapy. In 
another example, for a client taking lithium, the 
SUD treatment provider may assist in medication 
monitoring by asking such questions as, “How are 
your meds helping you? Are you remembering 
to take them? Are you having any problems 
with them? Do you need to check in with the 
prescribing doctor?” 
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Psychiatric Medications 
Providers should ask clients with CODs to bring in 
all medications to counseling sessions. Providers 
can then ask clients in what manner, when, and 
how they are taking medications. They can also ask 
whether clients feel that the medication is helping 
them, and how. Doing so presents an opportunity 
for providers and their clients to review and discuss 
attitudes toward medication and clients’ typical 
patterns in taking medication. Some clients may 
not disclose that they have discontinued their 
medications, but when asked to bring in their 
medications, they may bring medication bottles 
that are completely full. Providers should help 
educate clients about the effects of medication, 
teach clients to monitor themselves (if possible), 
and consult with clients’ physicians whenever 
appropriate. 
ADVICE TO THE COUNSELOR: 
MONITORING PSYCHIATRIC 
SYMPTOMS 
The consensus panel recommends these 
approaches to monitoring psychiatric symptoms 
in clients with CODs: 
• Obtain a mental status examination to 
evaluate clients’ overall mental health and 
danger profle. Ask about clients’ symptoms 
and use of medication and look for signs of 
mental disorders regularly. 
• Keep track of changes in symptoms. 
• Ask clients directly and regularly about the 
extent of their depression and associated 
suicidal thoughts. 
Status of Psychiatric Symptoms 
SUD counselors should monitor changes in severity 
and number of psychiatric symptoms over time. For 
example, most clients present for SUD treatment 
with anxiety or depressive symptoms. Such 
symptoms are substance induced (see Chapter 
4) if they occur within 30 days of intoxication or 
withdrawal. 
Substance-induced symptoms tend to follow the 
principle of “what goes up, must come down,” 
and vice versa. Clients who have just ended a 
binge on stimulants will seem tired and depressed 
(clients using methamphetamines may present 
with psychotic symptoms that require medication). 
Conversely, those who recently stopped taking 
depressants (e.g., alcohol, opioids) will likely seem 
agitated and anxious. These substance-induced 
symptoms result from substance withdrawal and 
usually persist for days or weeks. Substance-related 
depression may follow (which can be seen as a 
neurotransmitter depletion state) and may begin to 
improve within a few weeks. If depressive or other 
symptoms persist, then a co-occurring (additional) 
mental disorder is likely, and a differential 
diagnostic process should ensue. Such symptoms 
may be appropriate targets for establishing a 
diagnosis or determining treatment choices. 
SUD treatment providers can use various tools 
to help monitor psychiatric symptoms. Some 
tools consist only of questions and require no 
formal instrument. For example, to gauge the 
status of depression quickly, providers can ask a 
client: “On a scale of 0 to 10, with 0 being your 
best day and 10 your worst, how depressed are 
you?” This simple scale, used from session to 
session, can provide much useful information. SUD 
treatment providers should also monitor adherence 
to prescribed medication by asking clients 
regularly for information about their use of these 
medications and their effects. 
To identify changes, providers should track psychiatric
symptoms clients mention at the outset of treatment
from week to week. For example, one may ask, “Last
week you mentioned low appetite, sleeplessness,
and feeling hopeless—are these symptoms better or
worse now?” Providers should also ascertain whether
clients follow their suggestions to alleviate symptoms,
and if so, with what result.
Chapter 3 and Appendix C also address screening
and assessment tools for mental disorders and SUDs. 
Potential for Harm to Self or Others 
According to the Centers for Disease Control 
and Prevention (2018), 46 percent of people 
who die by suicide have a known mental health 
issue; 28 percent have problematic substance 
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use. Individuals with CODs are at increased risk of 
self-harm (e.g., cutting, suicide attempt) or harm 
to others compared with people who do not have 
CODs (Carra et al., 2014; Haviland, Banta, Sonne, 
& Przekop, 2016; Tiet & Schutte, 2012). 
Providers should always ask explicitly about 
suicide or the intention to harm someone else 
when client assessment indicates that either is 
an issue. For clients who mention or seem to be 
experiencing depression or sadness, explore the 
extent to which suicidal thinking is present. (To 
learn about duty to warn laws in each state, see 
“Resource Alert: Federal and State Mental Health 
Privacy and Confdentiality Regulations” in the 
previous section of this chapter.) 
Follow-up services for clients who screen positive 
for suicide risk or have tried to commit suicide 
or other self-injurious behaviors may effectively 
prevent future harmful behaviors (including 
completed suicides), but more research in this 
area is needed (Brown & Green, 2014). Follow-up 
services can include: 
• Conducting a full suicide risk assessment (see 
Chapter 3). 
• Contacting the client (e.g., sending letters or 
postcards) to express care and concern. 
• Scheduling follow-up appointments in person or 
by phone to discuss the treatment plan. 
• Making home visits (as appropriate). 
• Administering follow-up psychiatric and suicide 
risk assessments throughout the course of care. 
Chapter 4 covers general approaches to prevent-
ing suicide and managing clients who have tried 
to commit suicide or are at risk for self-harm. 
Instructions on screening for risk of harm to self or 
others appear in Chapter 3 and Appendix C. 
Use Supportive and Empathic Counseling 
A supportive and empathic counseling style 
is one of the keys to establishing an effective 
therapeutic alliance with clients who have CODs. 
According to Lockwood, empathy is “the ability 
to vicariously experience and to understand the 
affect of other people”; it is the foundation adults 
use for relating to and interacting with other adults 
(Lockwood, 2016, p. 256). 
ADVICE TO THE COUNSELOR: 
USING AN EMPATHIC STYLE 
Empathy is a key skill for the SUD counselor, 
without which little could be accomplished. Bell 
(2018, p. 111) notes that “it is the job of counselor 
educators and supervisors to instill and nourish 
the trait of empathy, while building skills that 
relay empathy to the client.” An empathic style is 
one that: 
• Involves taking the client’s perspective and 
trying to see life from his or her worldview. 
• Tries to connect with clients who are diffcult 
or are engaging in behaviors the counselor 
disagrees with or cannot otherwise relate to 
(e.g., misusing substances, breaking the law). 
• Is mindful, compassionate, and warm rather 
than judgmental and accusatory. 
• Is focused on listening to—rather than talking 
at—the client. 
• Includes nonverbal communication (e.g., open 
body positioning, direct eye contact, nodding 
along). 
• Conveys refective listening via techniques like
repetition and parroting, using verbal cues
like “I see” or “Tell me more about that,” and
paraphrasing content and feelings (“So, you’re
saying that he left, and then you decided to go
to the bar. Do I have that right?” or “I hear that
you were extremely angry about that”). 
• Demonstrates comfort by expressing sympathy,
consolation, and refexive reassurance (i.e.,
phrasing designed to alleviate anxiety and
worry without promising a certain outcome— 
such as saying, “Just give it your best shot, and
let’s see how things play out” instead of saying,
“Everything will be just fne”). 
See also Treatment Improvement Protocol (TIP)
35, Enhancing Motivation for Change in Substance
Use Disorder Treatment (SAMHSA, 2019c).
Sources: Bell (2018); Kelley & Kelley (2013). 
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In empathic counseling, providers model 
behaviors that can help clients build more pro-
ductive relationships. Providers’ empathy helps 
clients begin to recognize and own their feelings, 
which is an essential step toward managing them. 
In learning to recognize and manage their own 
feelings, clients will also learn to empathize with 
the feelings of others. 
Empathic counseling must be consistent over 
time to keep the alliance intact, especially for 
clients with CODs. Clients with CODs often have 
lower motivation to address mental illness or 
substance misuse, fnd it harder to understand 
and relate to others, and need strong support and 
understanding to make major lifestyle changes 
such as adopting abstinence. Support and empathy 
from providers can help maintain the therapeutic 
alliance, increase client motivation, and assist with 
medication adherence. 
Confrontation and Empathy 
Historically, addiction research defned 
confrontation as an aggressive, argumentative 
communication tactic to pressure people who 
misused substances into treatment. Confrontation 
has more recently come to be seen as a supportive, 
honest approach to warning or advising at-risk 
individuals about harmful behaviors (Polcin, 
Galloway, Bond, Korcha, & Greenfeld, 2010; 
Polcin, Mulia, & Laura, 2012). 
SUD treatment providers often feel tension 
between offering clients empathic support and 
addressing clients’ potential minimization, evasion, 
dishonesty, and denial. However, providers can be 
empathic and frm at once. Straightforward, factual 
presentation of conficting material or problematic 
behavior in an inquisitive, caring manner can 
be confrontational yet supportive. Achieving a 
balance of empathy and frmness is critical for 
providers to maintain therapeutic alliances with 
clients who have CODs. 
Structure and Support 
Clients with CODs beneft from a careful balance 
of structured versus free time. Free time is 
both a trigger for substance use cravings and a 
negative infuence for many individuals with mental 
disorders. Thus, management of free time is of 
particular concern for clients with CODs. Clients 
with CODs need strategies to better manage 
their free time, such as by structuring one’s day to 
include meaningful activities and to avoid activities 
that are risky. Providers can help clients plan their 
free time (especially weekends) to introduce new 
pleasurable activities that may alleviate symptoms 
and offer satisfaction through means other than 
substance use. Other activities that can help 
structure clients’ time are working on vocational 
and relationship matters in treatment. 
In addition to structure, clients’ daily activities 
need to have opportunities for receiving support 
and encouragement. Counselors should work 
with clients to create a healthy support system of 
friends, family, and activities. 
Mutual support is a key tool providers can 
introduce to clients with CODs. Dual recovery 
mutual supports are increasingly available in most 
large communities. Providers play an important 
role in helping clients with CODs access and 
beneft from such resources. (Chapter 7 has more 
information on mutual-support approaches for 
people with CODs.) If groups for clients who do 
not speak English are unavailable locally, providers 
can seek resources in nearby communities or, if 
the number of clients in need warrants, organize a 
group for those who speak the same non-English 
language. 
A provider can assist a client with CODs in 
accessing mutual support by: 
• Helping the client locate an appropriate 
group. The provider should be aware of 
available local mutual-support programs 
and dual recovery mutual-support groups, 
especially those that are friendly to clients 
with CODs, have other members with CODs, 
or are designed specifcally for people with 
CODs. The provider can gain awareness by 
visiting groups to see how they are conducted, 
discussing groups with colleagues, updating 
personal lists of groups periodically, and 
gathering information from clients. The provider 
should ensure that the group selected is a 
good ft for the client in terms of its members’ 
ages, genders, and cultural characteristics. 
Some communities offer alternatives to 
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CASE STUDY: HELPING A CLIENT FIND A SPONSOR 
Linda, a 24-year-old woman, had attended her mutual-support group for about 3 months. Although she 
knew she should ask someone to sponsor her, she was shy and afraid of rejection. She had identifed a few 
women who might be good sponsors, but each week in counseling, she stated that she was afraid to reach 
out. No one had approached her about sponsorship either, although the group members seemed “friendly 
enough.” The counselor suggested that Linda share, in the next group meeting, that she’d like a sponsor 
but has been feeling shy and hadn’t wanted to be rejected. The counselor and Linda role-played this act 
of sharing during a counseling session. The counselor reminded Linda that it was okay to feel afraid and 
reassured her that, if she couldn’t share at the next meeting, they would talk about what had stopped her. 
After the next meeting, Linda related that she almost shared but got scared at the last minute. She felt bad
that she had missed an opportunity. She and the counselor talked about getting it over with, and Linda
resolved to reach out, starting her sharing statement with, “It’s hard for me to talk in public, but I want to
work this program, so I’m telling you all that I know it’s time to get a sponsor.” This counseling work helped
Linda convey her need to the group. The response from group members was helpful to Linda, as several
women offered to meet with her and talk about sponsorship. This experience also helped Linda become more
attached to the group and learn a new skill for seeking help. Although Linda was helped through counseling
strategies alone, others who are anxious in social settings may need medications in addition to counseling. 
mutual-support groups, such as Secular 
Organizations for Sobriety. 
• Helping the client prepare to participate 
appropriately in the group. Some clients, 
particularly those with SMI or anxiety about 
group participation, beneft when providers 
offer an explanation of the group process in 
advance. The provider should inform the client 
of the structure of a meeting, expectations 
of sharing, and how to participate. The client 
may need to rehearse the kinds of things that 
are and are not appropriate to share at such 
meetings. The provider should also teach the 
client how to politely decline to participate and 
when this would be appropriate. The counselor 
should be familiar enough with group function 
and dynamics to walk the client through the 
meeting process before attending. 
• Helping overcome barriers to group 
participation. The provider should be aware 
of the genuine diffculties the client may have 
in connecting with a group. Although clients 
with CODs, like any clients, may have some 
ambivalence about change, they also may have 
legitimate barriers they cannot remove on 
their own. For example, a client with cognitive 
diffculties may need help working out how 
he or she can physically get to the meeting. 
The provider may need to write down detailed 
instructions for this client that another would 
not need (e.g., “Catch the number 9 bus on 
the other side of the street from the treatment 
center, get off at Main Street, and walk 3 blocks 
to the left to the white church. Walk in at the 
basement entrance and go to Room 5.”) 
• Debriefng the client after he or she has 
attended a mutual-support group to help 
process reactions and prepare for future 
attendance. The provider’s work does not end 
with referral to a mutual-support group. The 
provider must be prepared to help the client 
overcome any obstacles after attending the 
frst group to ensure engagement. Often, this 
involves a discussion of the client’s reaction to 
the group and a clarifcation of how he or she 
can participate in future groups. 
Use Culturally Appropriate Methods 
Research is lacking on the ethnic/racial diversity of 
populations with CODs. Limited published studies 
suggest that although CODs are more frequently 
observed among Whites, non-White Americans 
also experience CODs. A report (Mericle, Ta Park, 
Holck, & Arria, 2012) estimated lifetime prevalence 
of CODs at 5.8 percent among Latinos, 5.4 percent 
among African Americans, and 2.1 percent among 
Asians. Whites, by comparison, had a lifetime 
prevalence of 8.2 percent. 
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Notable gaps exist in the rates of behavioral health
service access, utilization, and completion among
diverse racial and ethnic groups compared with
Whites (Cook, Trinh, Li, Hou, & Progovac, 2017;
Holden et al., 2014; Maura & Weisman de Mamani,
2017; Nam, Matejkowski, & Lee, 2017; Saloner & Le
Cook, 2013; Sanchez, Ybarra, Chapa, & Martinez,
2016). This is attributable to multiple factors such as
underassessment, underdiagnosis, and underreferral
(Priester et al., 2016) as well as cultural barriers like
language differences, fear of stigma, and shame
(Holden et al., 2014; Keen, Whitehead, Clifford,
Rose, & Latimer, 2014; Masson et al., 2013; Maura 
& Weisman de Mamani, 2017; Pinedo, Zemore, 
& Rogers, 2018). Culturally responsive care and 
cultural competence training among behavioral 
health staff are needed to help break down barriers
to service access and improve treatment outcomes
for diverse populations with CODs. 
Understanding Clients’ Cultural Backgrounds 
Population shifts are resulting in increasing 
numbers of diverse racial and ethnic groups in 
the United States (Colby & Ortman, 2014). Each 
geographic area has its own cultural mix. To 
provide effective COD treatment to people of 
various cultural groups, providers should learn 
as much as possible about characteristics of their 
clients’ cultural groups. 
Of particular importance are culturally based 
conventions of social interaction, styles of 
interpersonal communication, concepts of healing, 
views of mental illness, and perceptions of 
substance use. For example, some cultures may 
tend to somaticize symptoms of mental disorders, 
and clients from such groups may expect treatment 
providers to offer relief for physical complaints. 
These clients may be offended by too many 
probing, personal questions early in treatment and 
never return. 
Similarly, COD treatment providers need to 
understand culturally based concepts of and ex-
pectations surrounding families. Providers should 
learn each client’s role in the family and its cultural 
signifcance (e.g., expectations of the oldest son, a 
daughter’s responsibilities to her parents, the role 
of a grandmother as matriarch). 
Providers should not make assumptions about 
clients based on their perception of the clients’ 
culture. An individual client’s level of acculturation 
and specifc experiences may result in that person 
identifying with the dominant culture or other 
cultures. For example, a person from India adopted 
by African American parents at an early age may 
know little about the cultural practices in his birth 
country. A provider working with this client would 
need to acknowledge the birth country and explore 
the client’s associations with it as well as what 
those associations might mean. The client’s country 
of origin may have little infuence on his cultural 
beliefs or practices. 
Chapter 6 of this TIP further discusses culture-re-
lated topics in COD treatment, including how 
counselors can reduce racial/ethnic disparities 
and use culturally adapted services. For more 
information about cultural competence in general 
behavioral health services, see TIP 59, Improving 
Cultural Competence (SAMHSA, 2014a), which 
is available free of charge online (https://store. 
samhsa.gov/system/fles/sma14-4849.pdf). 
Using Motivational Enhancement 
Consistent With Clients’ Specifc Stage 
of Change 
Motivational interviewing (MI) is a client-
centered approach that enhances clients’ 
internal motivation to change by exploring and 
resolving ambivalence (Miller & Rollnick, 2013). 
MI involves accepting a client’s level of motivation, 
whatever it is, as the only possible starting point 
for change. For example, if a client says she has no 
interest in changing the amount or frequency of 
her drinking, but is interested in complying with an 
SUD assessment to be eligible for something else 
(such as the right to return to work or a housing 
voucher), the SUD treatment provider would 
avoid arguing with or confronting her. Instead, the 
provider would focus on establishing a positive 
rapport with the client—even remarking on the 
positive aspects of the client’s desire to return to 
work or take care of herself by obtaining housing. 
The provider would work with available openings 
to probe the areas in which the client does have 
motivation to change in hopes of eventually 
affecting the client’s drinking or drug use. 
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For an indepth discussion of MI and how to apply 
its principles to stages of change in clients with 
SUD, see TIP 35, Enhancing Motivation for Change 
in Substance Use Disorder Treatment (SAMHSA, 
2019c). 
Guiding Processes of MI 
Four overlapping processes guide the practice of 
MI (Miller & Rollnick, 2013). 
1. Engaging: The counselor uses strategies to 
establish rapport and help build a trustful 
relationship with the client. Techniques include 
asking open- rather than close-ended questions, 
using refective listening, summarizing 
statements from the client, and determining his 
or her readiness to change. 
2. Focusing: The counselor helps direct the 
conversation and process as a whole through 
agenda setting and identifying a target behavior 
of change. 
3. Evoking: The counselor helps clients express 
their motivations or reasons for change. Use of 
change talk (expressing a desire to change) is 
core to this process and helps clients recognize 
how their substance use is affecting their lives. 
It helps clients recognize and respond to sustain 
talk (expressing a desire not to change), which 
creates ambivalence and should be minimized. 
Use of open-ended questions and refective 
listening by the counselor will facilitate this 
process. 
4. Planning: The counselor collaborates with the 
client to develop a plan for change. The plan is 
critical for putting ideas about and reasons for 
change into action. The counselor works with 
clients to identify a specifc change goal (like 
reducing the number of drinks per day), explore 
possible strategies that will lead to the change, 
create steps to make the change, and problem-
solve possible obstacles to achieving lasting 
behavior change. 
The details of these strategies and techniques 
are presented in TIP 35, Enhancing Motivation 
for Change in Substance Use Disorder Treatment 
(SAMHSA, 2019c) and in Miller and Rollnick’s 
manual, Motivational Interviewing: Helping People 
Change (2013). 
Matching Motivational Strategies to Clients’ 
Stage of Change 
The motivational strategies providers use should
be consistent with their clients’ stage of change
(i.e., precontemplation, contemplation, preparation,
action, maintenance, termination). A client with
CODs could be at one stage of recovery or change
for his or her mental disorder and another for his or
her SUD, which can complicate selection of strat-
egies. Furthermore, a client may be at one stage
of change for one substance and another stage
of change for another substance. For example, a
client who has combined alcohol and cocaine use
disorders with co-occurring panic disorder may
be in the contemplation stage (i.e., aware that a
problem exists and considering overcoming it, but
not committed to taking action) in regard to alcohol
use, precontemplation (i.e., unaware that a problem
exists, with no intention of changing behavior) in
regard to cocaine use, and action (i.e., actively
modifying behavior, experiences, or environment to
overcome the problem) for the panic disorder.
Evaluating clients’ motivational state is an 
ongoing process. Court mandates, rules for clients 
engaged in group therapy, the treatment agency’s 
operating restrictions, and other factors may act as 
barriers to implementing specifc MI strategies in 
particular situations. 
MI and CODs 
MI has been shown to be effective or effca-
cious in improving behavior change—such 
as treatment engagement, attendance, and 
resistance—as well as enhancing motivation and 
confdence in people with mental or substance 
misuse problems, including comorbid conditions 
(Baker, Thornton, Hiles, Hides, & Lubman, 2012; 
Keeley et al., 2016; Laakso, 2012; Romano & 
Peters, 2015). MI also appears to be effective in 
helping clients with SUD reduce substance misuse 
and associated behaviors and consequences 
(DiClemente, Corno, Graydon, Wiprovnick, & 
Knoblach, 2017). For instance, a review of studies 
on COD interventions for people involved in the 
criminal justice system found MI helpful in reducing 
self-reported substance misuse (Perry et al., 2015). 
In a sample of people with PTSD seeking SUD 
treatment (Coffey et al., 2016), trauma-focused 
motivational enhancement therapy was associated 
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with signifcantly greater reductions in PTSD 
symptoms versus a control condition (12 sessions 
of healthy lifestyle education). At 6 months after 
treatment, just 6 percent of participants in the 
motivational enhancement therapy group had a 
positive urine drug screen for at least one illicit 
substance, compared with almost 13 percent in the 
healthy lifestyle control group. 
Motivational strategies may be helpful with 
people who have SMI, but more research 
is needed. A 3-week MI intervention yielded 
improvements in medication adherence, self-ef-
fcacy, and motivation to change among clients 
receiving outpatient treatment for bipolar disorder 
(McKenzie & Chang, 2015). Results concerning MI 
and improved adherence to pharmacotherapy for 
clients with schizophrenia are generally negative, 
but some research suggests that MI reduces 
psychotic symptoms and hospitalization rates 
(Vanderwaal, 2015). A meta-analysis of MI plus 
cognitive–behavioral therapy (CBT) as an adjunct to 
or replacement for treatment as usual for co-occur-
ring AUD and depression (Riper et al., 2014) found 
small but positive effects in decreasing alcohol 
consumption and improving depressive symptoms. 
Although more research is warranted, it appears
that MI strategies may be applied successfully to
the treatment of clients with CODs, especially in: 
• Assessing clients’ perceptions of their problems. 
• Exploring clients’ understanding of their disorders. 
• Examining clients’ desire for continued treatment. 
• Ensuring client attendance at initial sessions. 
• Expanding clients’ willingness to take 
responsibility for change. 
Teaching Relapse Prevention Techniques 
SAMHSA (2011) considers relapse prevention a 
critical component of integrated programming 
for effective COD treatment. The long-term 
course of comorbid mental illness and addiction is 
often marked by (sometimes multiple) instances of 
relapse and remission (Luciano, Bryan, et al., 2014; 
Xie, Drake, McHugo, Xie, & Mohandas, 2010). 
Per the National Institute on Drug Abuse (NIDA), 
relapse is “a return to drug use after an attempt 
to stop” (NIDA, 2018c). Others defne relapse as 
“a setback that occurs during the behavior change 
In relapse prevention, providers recognize 
that lapses (single episodes or brief returns 
to substance use) are an expected part of 
overcoming SUDs. Lapses do not signal failure or 
loss of all treatment progress. 
process, such that progress toward the initiation or 
maintenance of a behavior change goal (e.g., absti-
nence from drug use) is interrupted by a reversion 
to the target behavior” (Hendershot, Witkiewitz, 
George, & Marlatt, 2011, p. 2). 
A variety of SUD relapse prevention models are
described in the literature (Hendershot et al., 2011;
Melemis, 2015). However, all relapse prevention
approaches include anticipating problems likely to
arise in maintaining change, acknowledging them
as high-risk situations for resumed substance use,
and helping clients develop strategies to cope
with those situations without having a lapse.
To prevent relapse, providers and clients must 
understand the types of triggers and cues that 
precede it. These warning signs precede exposure 
to events, environments, or internal processes 
(high-risk situations) where or when resumed 
substance use is likely. A lapse may occur in 
response to these high-risk situations unless the 
client is able to implement effective coping strate-
gies quickly and adequately. 
For clients with CODs who require medication 
to manage disruptive or disorganizing mental 
disorder symptoms, providers must address 
lapses in medication regimen adherence. In these 
cases, a “lapse” is defned as not taking prescribed 
medication. This type of lapse is different from 
lapses that involve returns to substance misuse for 
self-medication or pleasure seeking. 
Counseling for relapse prevention can occur
individually or in small groups, and may include
practice or role-play to help clients learn how
to cope effectively with high-risk situations.
Relapse prevention approaches have many common
elements (Daley & Marlatt, 1992) that highlight the
need for clients to: 
1. Have a range of cognitive and behavioral coping 
strategies to handle high-risk situations and 
relapse warning signs. 
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2. Make lifestyle changes that decrease the need 
for alcohol, drugs, or tobacco. 
3. Increase healthy activities. 
4. Be prepared to interrupt lapses so that they do 
not end in full-blown relapse. 
5. Resume or continue to practice relapse 
prevention skills even when a full-blown relapse 
does occur by renewing their commitment to 
abstinence rather than giving up the goal of 
living a drug-free life. 
NIDA (2018) includes relapse prevention therapy 
(RPT) in its list of effective SUD treatment 
approaches. RPT helps people maintain health 
behavior changes by teaching them to anticipate 
and cope with relapse. RPT strategies fall into fve 
categories (Marlatt, 1985): 
• Assessment procedures help clients appreciate 
the nature of their problems in objective terms, 
to measure motivation for change, and to 
identify risk factors that increase the probability 
of relapse. 
• Insight/awareness-raising techniques help 
clients adjust their beliefs about the behavior 
change process (e.g., viewing it as a learning 
process). Via self-monitoring, RPT also helps 
clients identify patterns of emotion, thought, 
and behavior related to SUDs and co-occurring 
mental disorders. 
• Coping-skills training strategies teach clients 
behavioral and cognitive strategies to avoid 
relapse. 
• Cognitive strategies help clients manage urges 
and craving, identify early warning signals of 
relapse, and reframe reactions to an initial lapse. 
• Lifestyle modifcations (e.g., meditation, exercise)
strengthen clients’ overall coping capacity. 
The goal of RPT is to teach clients to recognize
increasing relapse risk and to intervene at earlier
points in the relapse process. Thus, RPT fosters
client progress toward maintaining abstinence and
living a life in which lapses occur less often and are
less severe. RPT frames a lapse as a “fork in the
road,” or a crisis. Each lapse has elements of danger
(progression to full-blown relapse) and opportunity
(reduced relapse risk in the future because of the
lessons learned from debriefng the lapse).
RPT encourages clients to create a balanced 
lifestyle that will help them manage their CODs 
more effectively and fulfll their needs without 
using substances to cope with life’s demands and 
opportunities. In delivering RPT, providers can: 
• Explore with clients the positive and negative 
consequences of continued substance use 
(“decisional balance,” as discussed in the 
motivational interviewing section of this 
chapter). 
• Help clients recognize high-risk situations for 
returning to substance use. 
• Teach clients skills to avoid high-risk situations or 
cope effectively with them. 
• Develop a relapse emergency plan for damage 
control to limit lapse duration/severity. 
• Support clients in learning how to identify and 
cope with substance-related urges and cravings. 
Empirical Evidence Supporting Use of RPT in 
COD Treatment 
Much of the empirical literature on RPT addresses 
its application in SUD treatment. In this context, 
RPT has demonstrated strong and consistent 
effcacy versus no treatment and similar effcacy to 
other active treatments on outcomes like reduced 
relapse risk and severity, increased treatment gains, 
and greater use of treatment matching (Bowen 
et al., 2014; Hendershot et al., 2011). Research 
also supports RPT for enhancing substance use 
outcomes among people with CODs. 
In treating people with bipolar disorder and AUD 
(Farren, Hill, & Weiss, 2012), integrated group 
therapy focused on relapse prevention strategies 
was associated with greater abstinence, fewer days 
of substance misuse, and fewer days of alcohol use 
to intoxication than controls/treatment as usual. 
RPT with prolonged exposure therapy is linked 
to marked improvement in client- and provider-
reported SUD and PTSD symptom severity and 
past-week substance use (Ruglass et al., 2017). 
RPT Adaptations for Clients With CODs 
RPT adaptations for clients with CODs should 
address their full range of symptoms and 
circumstances. Adapted RPT should support 
adherence to treatment (including medication 
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adherence—particularly critical for people with 
psychotic or bipolar disorders), improve social func-
tioning, and help clients meet basic living needs 
(e.g., fnding housing, gaining stable employment). 
The aspects of RPT most useful for improving 
recovery from CODs (Subodh, Sharma, & Shah, 
2018; Weiss & Connery, 2011) include: 
• Encouraging abstinence. 
• Promoting adherence to mood-stabilizing 
medication. 
• Supporting habits associated with stable mood, 
like good sleep hygiene. 
• Promoting recovery by teaching clients 
strategies for: 
- Avoiding, recognizing, and responding 
to high-risk situations that are likely to 
exacerbate substance- or mood-related 
symptoms and problems. 
- Using substance-refusal skills. 
• Addressing multiple areas of functioning, 
including interpersonal functioning. 
• Using family-focused interventions, especially 
for clients who have demonstrated diffculty with 
adhering to treatment/medication or who have 
problems with cognition or insight. 
• Facilitating engagement in mutual-support 
groups. 
In a small qualitative analysis of men with CODs 
(Luciano, Bryan, et al., 2014), client-reported 
relapse prevention strategies deemed helpful for 
maintaining at least 1 year of sobriety included: 
• Building a supportive community, including 
peers in treatment. 
• Establishing a meaningful daily routine (e.g., 
going to work, attending school, exercising). 
• Adopting a healthy mindset that helped 
individuals stay mindful of cravings and 
other symptoms, develop insight about the 
relationship between substance use and mental 
illness, and maintain a sense of responsibility 
(to themselves and to others) to live a life of 
recovery. 
RPT-based SUD interventions with integrated 
components to address PTSD are supported by 
a growing number of studies, refecting the feld’s 
recognition that trauma commonly co-occurs with 
addiction (Swopes, Davis, & Scholl, 2017; Vrana, 
Killeen, Brant, Mastrogiovanni, & Baker, 2017; 
Vujanovic, Smith, Green, Lane, & Schmitz, 2018). In 
just one example of trauma-informed RPT adapta-
tions to address CODs, Vallejo and Amaro (2009) 
adapted a mindfulness-based stress reduction 
program for relapse prevention among women 
with SUDs and trauma/PTSD to better address 
trauma sensitivity and risk of relapse. Modifcations 
included: 
• Centrally focusing on stress management as a 
key skill in preventing relapse. 
• Using shorter and more structured sessions. 
• Altering body scan activities during mindfulness 
exercises to reduce anxiety and promote 
feelings of safety (e.g., having participants 
perform body scans with eyes open rather than 
ADVICE TO THE COUNSELOR: USING RELAPSE PREVENTION METHODS IN 
COD TREATMENT 
The consensus panel recommends using the following relapse prevention methods with clients who have 
CODs: 
• Provide relapse prevention education on both mental disorders and SUDs and their interrelations. 
• Teach clients skills to resist pressure to stop psychotropic medication and to increase medication adherence.
• Encourage attendance at dual recovery groups and teach social skills necessary for participation. 
• Use daily inventory to monitor psychiatric symptoms and symptom changes. 
If relapse occurs, use it as a learning experience to investigate triggers with the client. Reframe the 
relapse as an opportunity for self-knowledge and a step toward ultimate success. 
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closed; avoiding a detailed focus on scanning 
parts of the body that could be triggering or 
retraumatizing, like the pelvic area). 
• Using a more fexible curriculum that emphasized
early identifcation of warning signs of relapse. 
• Having counselors available to work with clients 
on uncomfortable feelings that arose in sessions. 
• PTSD-related adaptations may be particularly 
important when providing RPT for women, in 
whom trauma-related symptoms have been 
shown to predict returns to substance use 
(Heffner, Blom, & Anthenelli, 2011). 
Integrated Treatment 
RPT and other CBT approaches to mental health 
counseling and SUD treatment allow providers to 
treat CODs in an integrated way by: 
1. Conducting a detailed functional analysis of the 
relationships between substance use, mental 
disorder symptoms, and any reported criminal 
conduct. 
2. Evaluating unique and common high-risk factors for
each problem and gauging how they interrelate. 
3. Assessing cognitive and behavioral coping skills 
defcits. 
4. Implementing cognitive and behavioral coping 
skills training tailored to the specifc needs 
of each client with respect to substance use, 
symptoms of mental disorder, and criminal 
conduct. 
Chapter 7 further discusses integrated treatments 
and their outcomes for clients with CODs. 
Use Repetition and Skill Building To 
Address Defcits in Functioning 
In applying the approaches described previously, 
providers should keep in mind that clients 
with CODs often have cognitive limitations, 
including diffculty concentrating. Sometimes, 
these limitations are transient and improve during 
the frst several weeks of treatment. Other times, 
symptoms persist for long periods. In some 
cases, individuals with specifc disorders (e.g., 
schizophrenia, attention defcit hyperactivity 
disorder) may manifest these symptoms as part of 
their disorder. 
General treatment strategies to address cognitive 
limitations in clients with CODs include: 
• Being more concrete and less abstract in 
communicating ideas. 
• Using simpler concepts. 
• Having briefer discussions. 
• Repeating core concepts many times. 
• Presenting information in multiple formats 
(verbally; visually; affectively through stories, 
music, and experiential activities). 
• Using role-playing to practice real-life situations 
with clients who have cognitive limitations (e.g., 
having a client practice “asking for help” by 
phone using a prepared script individually with 
the counselor, or in a group to obtain feedback 
from the members). 
Compared with individuals who have no ad-
ditional disorders or disabilities, people with 
CODs and additional defcits require more SUD 
treatment to attain and maintain abstinence. 
Abstinence requires clients to develop and use a 
set of SUD recovery skills. Clients with co-occurring 
mental disorders face additional challenges that 
require learning yet more diverse skills. They also 
may require more support that provides treatment 
in smaller steps with more practice, rehearsal, and 
repetition. The challenge is not to provide more 
intensive or complicated treatment for clients 
CASE STUDY: USING REPETITION 
AND SKILL BUILDING WITH A 
CLIENT WHO HAS CODs 
In individual counseling sessions with Susan, a 
34-year-old White woman with bipolar disorder 
and AUD, the counselor observes that she 
frequently forgets details of her recent past, 
including discussions and decisions made in 
recent counseling sessions. Conclusions the 
counselor thought were clear in one session 
seem fuzzy by the next. The counselor adjusts 
course, starting sessions with a brief review of the 
last session. The counselor allows time at the end 
of each session for a review. Susan has diffculty 
remembering appointment times and other 
responsibilities, so the counselor also helps her 
devise a system of reminders. 
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with CODs, but rather to tailor the skill acquisi-
tion process to the needs and abilities of each 
client. 
Guidance for Working With
Clients Who Have Specifc
Co-Occurring Mental Disorders 
Clients with certain mental disorders may have 
specifc treatment needs and do best with particular
counseling approaches tailored to their diagnosis
and levels of functioning. This is especially true for
mental disorders known to be highly disabling,
distressing, longstanding, or diffcult to treat—such
as depression, anxiety, PTSD, and SMI. These
mental disorders are also the most likely to co-occur
with substance misuse. This section of Chapter 5
offers guidance for SUD treatment, mental health
service, and other providers on how best to deliver
SUD treatment and build rapport with clients who
have these disorders. Chapter 4 covers diagnosis
and management of the specifc mental disorders
discussed. 
MDD 
Depression commonly co-occurs with SUDs (Lai et 
al., 2015), and each can exacerbate the other. To 
optimize treatment outcomes, counselors working 
with clients who have an SUD and MDD should: 
• Use integrated CBT treatment approaches. 
Review studies and meta-analyses confrm 
CBT’s effectiveness in improving symptoms and 
decreasing substance misuse among people 
with depression and SUDs, particularly when 
integrated with additional treatment strategies 
such as RPT or MI (Baker et al., 2012; Riper et 
al., 2014; Vujanovic et al., 2017). CBT treatment 
elements most helpful for clients with depression 
and SUDs include (Vujanovic et al., 2017): 
- Functional analysis of situations in which 
substance use is likely to occur and of 
situations associated with depressive 
symptoms. 
- Cognitive training to identify and reframe 
maladaptive thoughts associated with 
increased substance use as well as with 
negative mood. 
- Behavioral skills to address craving, coping 
with stressful situations, and improving mood. 
• Incorporate behavioral activation (BA) 
techniques into CBT treatment. BA techniques 
are often used in CBT to help clients improve 
their mood by reengaging in pleasant and 
rewarding behaviors. BA supports clients in 
identifying rewarding activities and goals, 
barriers to engaging in those activities (e.g., 
avoidance triggers), and solutions for reducing 
avoidance. Research on BA for depression 
and SUDs is still growing, but early evidence 
suggests that CBT with BA is feasible and 
effcacious in reducing negative mood, 
increasing activation of pleasant behaviors, 
and improving treatment retention (Daughters, 
Magidson, Lejuez, & Chen, 2016; Martínez-
Vispo, Martínez, López-Durán, Fernández del 
Río, & Becoña, 2018; Vujanovic et al., 2017). 
• Remain vigilant for double depression.
Not all clients with depression and SUDs will
meet criteria for MDD, but they may still have
distressing, impairing depressive symptoms that
would beneft from treatment. Counselors need
to look for clients with “double depression,” or
the occurrence of persistent depressive disorder
and intermittent major depressive episodes. In
a sample of clients seeking SUD treatment, 14
percent had double depression (Diaz, Horton,
& Weiner, 2012) and reported higher levels of
alcohol dependence and lower quality of life than
participants with dysthymia only or MDD only. 
• Perform (or give referrals for) medication 
evaluations. Antidepressants can be highly 
effective in treating MDD, but not all clients will 
need medication. Evaluation by a psychiatrist 
can help determine whether pharmacotherapy is 
warranted. 
• Be mindful of the unclear temporal 
relationship between depression and 
substance misuse, as this can affect treatment 
planning. Providers may be tempted to 
assume that a client is misusing substances to 
self-medicate for depression or that a client’s 
depression is substance induced. But the 
relationship between substance misuse and 
depression is multifactorial, with more research 
needed to clarify those factors. Although the 
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self-medication hypothesis has some support, 
several factors affect the temporal-causal 
relationship between depression and substance 
misuse, like sociocultural factors (e.g., income-
to-poverty ratio) and demographics (Lo, Cheng, 
& de la Rosa, 2015). Counselors should not 
make treatment decisions based on assumptions 
that alleviating depressive symptoms will reduce 
substance misuse or vice versa. CODs tend 
to be intertwined in complex ways and often 
require multiple trials of various approaches to 
treatment. 
Anxiety Disorders 
Despite high rates of elevated anxiety among SUD 
populations, research on the complex relationship 
between substance misuse and anxiety is still 
developing. The emerging picture suggests that 
anxiety can be a risk for substance misuse (such as 
through avoidance coping or self-medication) and 
that substance use, craving, and withdrawal can 
lead to increases in anxiety. 
Counselors treating clients for anxiety disorders 
and SUDs should be mindful that: 
• Anxiety needs to be assessed early in 
treatment. Anxiety is related to more severe 
substance dependence and is associated 
with higher rates of treatment dropout and 
posttreatment relapse (McHugh, 2015; Smith & 
Randall, 2012; Vorspan, Mehtelli, Dupuy, Bloch, 
& Lépine, 2015). Identifying clients with elevated 
anxiety early in SUD treatment could help 
providers better address risks for premature 
treatment termination or posttreatment relapse. 
Screening for elevated anxiety early in treatment 
can also identify clients who may require 
additional skills to help them manage elevated 
distress related to stopping or decreasing their 
substance use (e.g., distress associated with 
withdrawal, worsening of anxiety symptoms 
previously self-managed with drugs or alcohol). 
• The type of anxiety disorder can affect 
treatment engagement, participation, and 
retention. For instance, individuals with 
elevated social anxiety may be reluctant to 
speak during group treatment or to share their 
social worries with their counselors for fear of 
being judged or ridiculed. This can impede 
their ability to participate in and beneft from 
group or even individual SUD treatments. 
Counselors should discuss with anxious clients 
their reasons for treatment noncompliance 
when relevant. Sometimes, anxious clients have 
diffculty adhering to treatment because of their 
symptoms or anxiety-related avoidance, not 
because of low motivation. 
• Anxiety symptoms can mimic or occur as a 
part of withdrawal from substances: 
- Anxiety is a commonly reported withdrawal 
symptom (Craske & Stein, 2016). When 
clients reduce or stop using substances, 
their anxiety may increase as a result of 
withdrawal. 
- Anxiety sensitivity (fear of anxiety-related 
sensations) is related to premature treatment 
termination (Belleau et al., 2017), in part 
because clients with this sensitivity face 
additional diffculty tolerating physical 
symptoms of withdrawal. People may 
misinterpret physical symptoms of withdrawal 
(e.g., increased heart rate, sweating, sleep 
problems, irritability) as signs of a medical 
problem. Anxiety symptoms and anxiety 
sensitivity can also evolve into full-blown 
anxiety disorders if left untreated, making 
clients vulnerable for returns to substance 
use. 
• Integrated treatments are highly recommended: 
- Given the worse outcomes associated with 
treating anxiety and SUDs in isolation, 
clients may beneft from an integrated 
approach. Given the bidirectional relationship 
between the two conditions, addressing 
both simultaneously in integrated counseling 
can mitigate relapse and provide a holistic 
approach to treatment. 
- Effective techniques include psychoeducation 
about the nature of anxiety (e.g., the 
relationship between thoughts, feelings, 
and behaviors; normalizing anxiety), CBT 
(including anxiety monitoring, thought 
restructuring, clarifying cognitive distortions, 
exposure therapy, and relaxation training), 
medication, motivational enhancement, 
mindfulness, and encouraging a healthy 
lifestyle (e.g., good sleep hygiene, engaging 
in physical activity). 
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PTSD 
People with PTSD or histories of trauma are 
susceptible to substance misuse, often as a coping 
mechanism. People with both PTSD and SUDs 
tend to have worse clinical symptoms than people 
with either disorder alone, including a higher risk 
of suicide (SAMHSA, 2014b). Providers whose 
clients have PTSD and SUDs can improve treatment 
success if they: 
• Treat disorders concurrently. Integrated, 
concurrent treatments are effective; clients may 
prefer them over sequential treatment (Banerjee 
& Spry, 2017; Flanagan et al., 2016; SAMHSA, 
2014b). Additionally, some symptoms of PTSD 
may worsen during abstinence. Do not make 
the mistake of thinking that treating the SUD 
will necessarily alleviate the PTSD. Both must be 
treated jointly. In some instances, medication for 
PTSD may also be needed. 
• Help clients increase their feelings of safety 
at the outset of treatment through techniques 
such as grounding exercises, establishing 
routines in treatment, discussing safety-
promoting behaviors, and developing a safety 
plan to help the client feel confdent, prepared, 
and in control (SAMHSA, 2014b). 
• Take steps to help prevent retraumatization 
of clients. This includes being sensitive to 
clients’ triggers (e.g., allowing a client to sit 
facing the door instead of with his or her back 
to it), sensitively addressing clients acting out 
in response to triggering events, listening for 
cues that cause reactions and behaviors, and 
teaching clients to identify and manage trauma-
related triggers (SAMHSA, 2014b). 
• Adjust the pace, timing, and length of sessions 
to the needs of clients. Do not rush clients 
into talking about their trauma, and stay alert 
for signs of clients feeling overwhelmed by the 
intensity or speed of the intervention (SAMHSA, 
2014b). Creating safety and enhancing coping 
skills to manage traumatic stress reactions are 
key aspects of helping clients heal from trauma. 
• Recognize the cyclical relationship between
trauma and substance use. Using substances
places people at greater risk for additional
traumatic events. These traumas increase
risks of substance misuse. Counselors need to
educate clients about this to help safeguard
them from harm. 
Chapter 4 provides more information about 
trauma-informed care for people with CODs. 
SMI 
People with SMI and SUDs often have complex 
recovery trajectories with drastic shifts in symptoms 
and functioning, employment, housing, family life, 
social relationships, and physical health. Counselors 
working with clients who have SMI and SUDs 
should be aware that: 
• Although integrated treatments work for 
many clients with SMI and SUDs, this approach 
has different levels of success. Integrated 
treatment for SMI and SUDs has demonstrated 
mixed results in the empirical literature (Chow 
et al., 2013; Hunt, Siegfried, Morley, Sitharthan, 
& Cleary, 2013). It may help improve psychiatric 
symptoms better than nonintegrated treatment 
in outpatient and residential settings and may 
be better at reducing alcohol consumption, but 
not drug use, in residential settings compared 
with outpatient settings. However, some 
studies have found no signifcant effects of 
integrated versus nonintegrated treatments. 
For some clients with SMI and SUDs, parallel 
treatment may be preferable and should not be 
ruled out as an option after frst trying to treat 
concurrently. 
• Many SMI symptoms, like psychosis, apathy, 
and cognitive dysfunction, can undermine 
treatment participation and adherence. 
Treatment should address (Horsfall, Cleary, 
Hunt, & Walter, 2009): 
- Managing positive and negative symptoms of 
psychosis. 
- Increasing coping skills. 
- Improving social skills, including 
communication with others. 
- Enhancing problem-solving abilities. 
- Building distress tolerance. 
- Increasing motivation. 
- Learning how to set and achieve goals. 
- Expanding social support networks (including 
peer supports). 
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Given these potential cognitive, social, and 
functional challenges, counselors may need to use 
sessions that are shorter, more fexible, adapted to 
client impairments, and lower in intensity. 
• SMI often requires medication for symptom 
stabilization. Counselors should consider 
referring clients not currently on medication 
or not being followed by a psychiatrist for a 
medication evaluation, especially for clients who 
are unstable or experiencing positive psychiatric 
symptoms (e.g., hallucinations, delusions). 
• Clients may need assistance with basic living 
needs. Securing reliable housing and gainful 
employment are often among the greatest 
stressors people with SMI experience (Horsfall 
et al., 2009). Vocational rehabilitation and 
housing assistance should be provided as a part 
of comprehensive COD care to help increase 
the chances of long-term recovery. Certain 
clients may also need help from counselors in 
connecting with the criminal justice system. 
• Encouraging abstinence may indirectly help 
improve psychiatric symptoms. Stopping 
substance use can give clients a sense of 
accomplishment and self-effcacy that can fuel 
their confdence in being able to recover from 
their mental illness as well (Green, Yarborough, 
et al., 2015). 
Conclusion 
Therapeutic alliance is a critical component 
of counseling essential to clients’ success and 
long-term recovery. People with CODs often face 
numerous diffculties in managing complex and 
fuctuating symptoms as well as the effects of 
symptoms on everyday living, including their ability 
to function as a productive and healthy member 
of society, hold down a job, maintain housing, 
and have fulflling relationships. Experiences of 
stigma and feelings of hopelessness can contribute 
to clients’ mistrust or low motivation to initiate, 
engage in, and complete treatment. 
Providers working with people who have CODs 
should be aware of basic approaches that can 
support the therapeutic relationship and make 
interventions more effective. Although there is no 
one-size-fts-all approach for treating CODs, the 
techniques, skills, and interventions described in 
this chapter should help counselors contribute 
to the recovery process in a way that is evidence 
based, person centered, and maximally benefcial 
to clients. 
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• The recovery community is diverse. Assessment,
diagnosis, and treatment of substance use
disorders (SUDs), mental disorders, or both (co-
occurring disorders [CODs]) should be inclusive
of all people who need services. 
• People experiencing homelessness, those 
involved in the criminal justice system, 
women, and people who identify with diverse 
racial/ethnic groups have historically been 
underserved, often have unique needs and 
presenting symptoms, and face certain 
barriers to care (and thus to recovery) that 
counselors can help address. 
• Counselors may need to adapt treatment 
approaches to clients with CODs to ensure 
the most benefcial outcomes for these 
groups. Adaptations are possible across a 
wide spectrum, involving basic to increasingly 
complex modifcations. Regardless of 
complexity, all population-specifc adaptations 
should aim to improve the therapeutic 
alliance, increase clients’ engagement in 
services, and give people with CODs the best 
chances for long-term recovery. 
• Ample resources are available to help counselors
tailor SUD treatment and mental health services
to the needs of special populations with CODs. 
Some people with CODs are especially vulnerable 
to treatment challenges and poor outcomes— 
namely, women, people from diverse racial/ethnic 
backgrounds, people experiencing homelessness, 
and people involved in the criminal justice system. 
This chapter describes proven and emerging 
COD treatment strategies that can effectively 
address substance misuse in these populations 
and is intended for counselors, other treatment/ 
service providers, supervisors, and administrators. 
It describes unique aspects of CODs among 
specifc populations and offers recommendations 
to SUD treatment providers, other behavioral 
health service providers, program supervisors/ 
administrators, and primary care providers who 
may encounter clients with CODs in their practice. 
A complete description of the demographic, socio-
cultural, and other aspects of the noted populations
and related treatment programs and models is
beyond the scope of this Treatment Improvement
Protocol (TIP). However, readers can fnd more
detailed information about population-specifc
behavioral health services in other TIPs, including:
• TIP 44, Substance Abuse Treatment for Adults 
in the Criminal Justice System (Center for 
Substance Abuse Treatment, 2005b). 
• TIP 51, Substance Abuse Treatment: Addressing 
the Specifc Needs of Women (Substance Abuse 
and Mental Health Services Administration 
[SAMHSA], 2009b). 
MILITARY PERSONNEL 
Active duty military members and veterans are 
a unique, complex population at risk for CODs, 
trauma, posttraumatic stress disorder (PTSD), 
and suicidal ideation. They often lack access to 
suffcient behavioral health services. Providers 
will need to make special considerations 
regarding military culture (especially surrounding 
stigma toward mental illness) and circumstances, 
such as deployments and family stress, to provide 
behavioral health services that are responsive 
to this population’s needs. See the “Trauma” 
section in Chapter 4 for more information on 
military personnel. Chapter 4 also lists resources 
that address some of the specifc behavioral 
health needs of the military population and how 
counselors can best meet those needs. 
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• TIP 55, Behavioral Health Services for People 
Who Are Homeless (SAMHSA, 2013). 
• TIP 57, Trauma-Informed Care in Behavioral 
Health Services (SAMHSA, 2014b). 
• TIP 59, Improving Cultural Competence
(SAMHSA, 2014a). 
People Experiencing Homelessness 
Homelessness continues to be one of the United 
States’ most intractable and complex social 
problems, although homelessness affects only 
about 0.2 percent of the U.S. population (Willison, 
2017). The Department of Housing and Urban 
Development (Henry et al., 2020) reported that 
approximately 568,000 people experienced 
homelessness in the United States on any given 
night in 2019. Moreover, the prevalence of 
homelessness is rising. From 2018 to 2019, the 
number of individuals experiencing homelessness 
rose by 3 percent and the number living in 
unsheltered locations increased by 9 percent; 
the number experiencing chronic homelessness 
increased by 9 percent (Henry et al., 2020). 
Among more than 36,000 U.S. adults who 
participated in the 2012–2013 Wave 3 of the 
National Epidemiologic Survey on Alcohol 
and Related Conditions (Tsai, 2018), lifetime 
homelessness was about 4 percent and 
past-year homelessness was 1.5 percent. Risk of 
homelessness was associated with a history of 
mental illness (including serious mental illness 
[SMI]), lifetime tobacco use, and lifetime suicide 
attempt, among other demographic and social 
variables (Tsai, 2018). 
Homelessness, Mental Health, and 
Substance Misuse 
The prevalence of substance misuse and mental 
illness among people experiencing homelessness 
is high. Solari and colleagues (2017) found that 
about 37 percent of adults in permanent support-
ive housing programs had a mental disorder; 10 
percent, substance abuse; and 29 percent, CODs. 
Further statistics paint a similar picture: 
• Stringfellow et al. (2016) reported that 3-month 
substance use among individuals experiencing 
homelessness was 50 percent for alcohol, 19 
percent for cannabis, 16 percent for cocaine, 
7.5 percent for opioids, and 6.5 percent 
for sedatives. Furthermore, 59 percent of 
individuals who took the Alcohol, Smoking, 
and Substance Involvement Screening Test had 
moderate or high risk for substance misuse. 
• In a study of more than 870,000 veterans with 
SMI, 7 percent experienced homelessness 
(Hermes & Rosenheck, 2016). 
• Among a sample of women experiencing 
homelessness who were seeking treatment in 
primary care settings (Upshur, Jenkins, Weinreb, 
Gelberg, & Orvek, 2017), self-reported rates 
of SUDs or mental disorders greatly exceeded 
those in the general population. Specifcally, 
women reported rates higher than the general 
population for: 
- SMI (4 times higher). 
- Major depressive disorder (MDD; 5 times 
higher). 
- Alcohol use disorder (AUD; 4 times higher). 
- Any drug use disorder (12 times higher). 
• A study of people 50 and older experiencing 
homelessness (Spinelli et al., 2017) found that: 
- 38 percent had current symptoms of MDD. 
- 33 percent had current symptoms of PTSD. 
- 19 percent had at least one lifetime 
hospitalization for psychiatric symptoms. 
- 33 percent reported experiencing childhood 
physical abuse, and 13 percent experienced 
childhood sexual abuse. 
- 63 percent had used an illicit substance in the 
previous 6 months; the most commonly used 
illicit substances were cannabis (48 percent), 
cocaine (38 percent), opioids (7 percent), and 
amphetamines (7 percent). 
- 49 percent drank alcohol in the past 6 
months, including 26 percent whose alcohol 
use was of moderate or greater severity and 
15 percent whose use was of high severity. 
- 10 percent reported binge drinking. 
166 Chapter 6 
TIP 42
 
 
 
 
 
 
 
 
Chapter 6—Co-Occurring Disorders Among Special Populations 
People experiencing homelessness often have 
CODs. In 2010, about 17 percent of adults enrolled 
in permanent supportive housing programs had 
CODs; this increased to 22 percent in 2014, 25 
percent in 2015, and 29 percent in 2016 (Solari 
et al., 2016; Solari et al., 2017). Among women 
experiencing homelessness and seeking primary 
health care, 26 percent reported at least one 
mental disorder and one SUD (Upshur et al., 2017). 
In a sample of veterans experiencing homeless-
ness, 77 percent had at least one previous mental 
disorder diagnosis; 47 percent, a substance-related 
diagnosis; and 37 percent, a COD diagnosis (Ding, 
Slate, & Yang, 2017). 
The Importance of Housing 
Housing is more than just physical shelter. It is 
a social determinant of health and is essential 
for individual physical, emotional, and socioeco-
nomic wellbeing. Housing affects communities, 
governments, and nations through its impact on 
the economy, healthcare system, workforce, and 
more. 
Housing for veterans and civilians with mental 
disorders, SUDs, or CODs is particularly important. 
Homelessness in these populations is associated 
with negative treatment-system factors, including 
• Increased emergency department (ED) usage 
(Cox, Malte, & Saxon, 2017; Moulin, Evans, 
Xing, & Melnikow, 2018). 
• Higher ED costs (Mitchell, Leon, Byrne, Lin, & 
Bharel, 2017). 
• Greater usage of inpatient services (Cox et al., 
2017). 
• Higher risk of incarceration/criminal justice 
involvement (Cusack & Montgomery, 2017; 
Polcin, 2016). 
People experiencing homelessness who screened 
at highest risk for an SUD had lower scores of 
social support and higher scores of psychological 
distress compared with those who screened at low 
or moderate risk (Stringfellow et al., 2016). Those 
with highest SUD risk also reported more diffculty 
paying for food, shelter, and utilities; were less 
likely to have medical insurance; and experienced 
more episodic health conditions. 
Service Models for People With CODs 
Who Are Experiencing Homelessness 
To address substance misuse, mental illness, or 
both in clients who lack housing, providers can 
choose among several service models, including: 
• Supportive housing—housing combined with 
access to services and supports to address the 
needs of individuals without housing so that 
they may live independently in the community. 
This model is an option for individuals and 
families who have lived on the street for longer 
periods of time or whose needs can best be met 
by services accessed through their housing. 
• Linear housing—housing that is contingent on 
completion of treatment for SUDs or mental 
disorders. Subsidized housing programs 
participating in this model typically require 
abstinence as a condition of housing, often 
through completion of residential treatment. 
• Integrated treatment—receipt of housing 
concurrently with addiction/mental health 
services. 
To help clients with CODs address housing 
needs, treatment programs need to establish 
ongoing relationships with housing authorities, 
landlords, and other housing providers. Groups 
and seminars that discuss housing diffculties may 
be necessary to help clients with CODs transition 
from residential treatment to supportive or inde-
pendent housing. To ease clients’ transition, an 
effective strategy COD treatment programs can 
use is to coordinate housing tours with supportive 
housing programs. 
Relapse prevention efforts are essential to help 
clients with CODs maintain housing. Substance 
misuse may disqualify clients from public housing in 
the community (Curtis, Garlington, & Schottenfeld, 
2013). 
TIP 55, Behavioral Health Services for People 
Who Are Homeless (SAMHSA, 2013) offers more 
information on treatment and recovery support 
approaches specifc to people experiencing or at 
risk for homelessness. 
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Supportive Housing Model 
A systematic literature review (Benston, 2015) 
found that permanent supportive housing 
programs for people experiencing homelessness 
and mental illness often led to better housing 
stability (e.g., percentage of participants housed 
versus not housed at the end of the study, 
proportion of time spent in stable housing versus 
experiencing homelessness, number of days 
housed versus homeless) compared with control 
conditions. Although the studies reported mixed 
results because of variations in design, results, 
and defnitions of “housing,” some, but not all, 
found that supportive housing was associated 
with improvement in psychiatric symptoms and 
reduced substance use. 
Similarly, an earlier literature review of treatments 
for people with CODs who were experiencing 
homelessness recommended use of supportive 
housing rather than treatment only or linear 
models (Sun, 2012). Another review (Rog et al., 
2014) found that, among people with CODs, 
supportive housing was associated with reduced 
homelessness and improvements in housing 
tenure, less ED use, fewer hospitalizations, and 
better client satisfaction (compared with linear 
housing models). 
Housing First 
The Housing First (HF) model provides housing no 
matter where a person is in recovery from SUDs 
or mental disorders. HF is one of the best-known 
and well-researched approaches to supportive 
housing. SAMHSA supports the HF model as a 
preferred approach for addressing homelessness 
in individuals with mental illness, SUDs, or 
both, as does the U.S. Interagency Council on 
Homelessness (2014). (See “Resource Alert: 
Implementing Supportive Housing Programs.”) 
HF helps people with CODs (including SMI) 
establish stable housing and is associated with 
good housing retention rates (Collins, Malone, & 
Clifasef, 2013; Pringle et al., 2017; Watson, Orwat, 
Wagner, Shuman, & Tolliver, 2013). In some studies, 
HF is associated with better SUD outcomes than 
treatment only (Padgett, Stanhope, Henwood, 
& Stefancic, 2011). However, research on SUD 
outcomes in HF has generally had mixed results 
(Paquette & Pannella Winn, 2016). Compared with 
linear housing models, Kertesz, Crouch, Milby, 
Cusimano, and Schumacher (2009) found that HF 
showed better housing stability and retention and, 
in some cases, favorable reductions in substance 
misuse severity—but both models beneftted 
people experiencing homelessness with SMI, SUDs, 
or both. 
The following examples of supportive housing 
models have successfully reduced homelessness 
and enhanced outcomes among people with SUDs, 
mental disorders, or both. 
RESOURCE ALERT: IMPLEMENTING SUPPORTIVE HOUSING PROGRAMS 
For guidance on implementation of supportive housing programs, see the following resources: 
• The National Alliance to End Homelessness’s toolkit for adopting an HF approach (https:// 
endhomelessness.org/wp-content/uploads/2009/08/adopting-a-housing-frst-approach.pdf) 
• Pathways to Housing training and consultation (www.pathwayshousingfrst.org/training) 
• SAMHSA’s Permanent Supportive Housing Evidence-Based Practices toolkit (https://store.samhsa.gov/ 
product/Permanent-Supportive-Housing-Evidence-Based-Practices-EBP-KIT/SMA10-4510)
• United States Interagency Council on Homelessness’s Implementing Housing First in Permanent 
Supportive Housing fact sheet (www.usich.gov/resources/uploads/asset_library/Implementing_Housing_ 
First_in_Permanent_Supportive_Housing.pdf) 
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Pathways to Housing 
The well-known and heavily researched Pathways 
to Housing program is an example of HF-based 
supportive housing. The program was originally 
designed (Tsemberis & Eisenberg, 2000; 
Tsemberis, Moran, Shinn, Asmussen, & Shern, 
2003) to serve a highly visible and vulnerable 
segment of New York’s population experiencing 
homelessness: people with CODs who were 
living in the streets, parks, subway tunnels, and 
similar places. It has since been expanded to 
other areas, including Washington, DC, Vermont, 
Pennsylvania, and Canada. Pathways to Housing 
refects a client-centered perspective and offers 
clients experiencing homelessness the option 
of moving directly into a furnished apartment of 
their own. However, clients must agree to receive 
case management and work with a representative 
payee to ensure that rent and utilities are paid 
and resources are well managed (Tsemberis & 
Eisenberg, 2000). Pathways to Housing uses 
assertive community treatment (ACT) teams to 
offer clients an array of support services in twice-
monthly sessions. Vocational, medical, behavioral 
health, and other services are among the options. 
Highlights of outcomes reported from Pathways to 
Housing programs include the following: 
• Pathways to Housing DC (2017) reported a 
91-percent housing success rate. 
• Pathways to Housing PA (2018) supplied 2,992 
hours of medical, mental, and SUD treatment 
services and 2,996 hours of paid transitional 
employment. Additionally, 100 percent of clients 
retained housing through the frst year, and 65 
percent were in SUD treatment after 6 months. 
• Over about 3 years, Pathways to Housing VT 
achieved an 85-percent housing retention rate, 
and mean number of days spent homeless 
decreased signifcantly over the course of a 
year (11 days at baseline vs. 2 days at 12-month 
follow-up) (Stefancic et al., 2013). 
Linear Housing Model 
The linear model provides housing contingent
on abstinence from substances. It was once the
preferred approach for aiding people with SUDs,
mental disorders, or CODs who were experiencing
homelessness. Research has since shown this
approach to produce less favorable housing retention
outcomes than supportive housing (Kertesz et al.,
2009; Polcin, 2016). Linear models often require
completion of an SUD treatment program (typically
residential treatment) in addition to abstinence
before housing is provided, yet SUD treatment
completion rates are frequently low. Often, linear
programs also lack access to and control of stable,
permanent housing, which contributes to low rates
of housing stability compared with permanent
supportive housing programs such as HF (Kertesz et
al., 2009; Polcin, 2016).
Linear programs do appear effective in helping
clients improve substance use outcomes.
Therapeutic communities (TCs), an example of the
linear model, have been shown to reduce substance
use and psychiatric symptoms, but according to some
research, may not produce robust improvements
in housing status (Kertesz et al., 2009). Compared
with usual care (e.g., receiving day treatment only),
the Birmingham approach to the linear housing
model can improve both housing and substance use
outcomes. This approach offers referrals for private
or public housing only upon completion of a compre-
hensive, community-based SUD treatment program
that includes behavioral interventions, employment
training, and community reinforcement and supports
(e.g., relapse prevention, goal setting, rewards for
achieving objectively defned recovery goals). The
Birmingham approach has signifcantly improved
abstinence, housing stability (especially among clients
THE ROLE OF RECOVERY 
HOUSING FOR PEOPLE WITH 
CODs 
Recovery housing is a critical issue for all 
clients with CODs—not just those experiencing 
homelessness. Without stable supportive 
housing, achieving and maintaining long-term 
recovery is less likely. The National Alliance for 
Recovery Residences maintains a resource library 
on recovery housing to help providers learn 
about the various types of recovery residences, 
how recovery housing affects client outcomes, 
and how to support clients in identifying and 
obtaining housing that best meets their recovery 
needs (https://narronline.org/resources/). 
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who achieve longer term abstinence), and employ-
ment; program retention has been moderate to high
(Kertesz et al., 2009). 
Integrated Housing and Treatment Models 
People experiencing homelessness often have 
diverse, complex treatment and support needs. 
Thus, a multifactorial, fexible, integrated 
approach to addressing clients’ behavioral 
health and housing needs may be preferable, in
some cases, to the more structured housing service
models described previously (Polcin, 2016). The
Comprehensive, Continuous, Integrated System of
Care is an integrated COD treatment approach that
has been adapted to include housing and employ-
ment supports. In one program using this approach
(Harrison, Moore, Young, Flink, & Ochshorn, 2008),
homelessness decreased by 90 percent, permanent
housing increased by 202 percent, unemployment
decreased by 16 percent, and employment increased
by 1,215 percent. The program also showed decreases
in number of days of past-month illicit substance use,
and past-month substance use declined over the
course of 6 months. Other signifcant improvements
included (Moore, Young, Barrett, & Ochshorn, 2009):
• Decreased need for SUD treatment and 
psychological/emotional services. 
ADVICE TO THE COUNSELOR: 
WORKING WITH CLIENTS 
WHO HAVE CODs AND ARE 
EXPERIENCING HOMELESSNESS 
The consensus panel recommends that providers: 
• Address the housing needs of clients. 
• Help clients obtain housing. 
• Teach clients skills for maintaining housing. 
• Collaborate with shelter workers and other 
providers of services to people experiencing 
homelessness. 
• Address real-life concerns in addition to
housing, such as SUD treatment, legal/ 
criminal justice matters, Supplemental Security
Insurance/entitlement applications, problems
related to children, and health care.
• Increased receipt of needed SUD treatment and 
psychological/emotional services. 
• Reductions in unmet medical needs. 
• Decreased self-reported mental disorder 
symptoms. 
People Involved in the Criminal
Justice System 
Estimated rates of mental disorders and SUDs in 
prison populations vary but are consistently high, 
often exceeding general population rates (Fazel, 
Yoon, & Hayes, 2017; Reingle Gonzalez & Connell, 
2014; Marotta, 2017). Among those incarcerated in 
U.S. state prisons (Prins, 2014), mental disorders of 
highest prevalence include: 
• 9 percent to 29 percent for current MDD. 
• 5.5 percent to 16 percent for bipolar disorder. 
• 1 percent (women), 5.5 percent (men and 
women), and 7 percent (men) for panic disorder. 
• 2 percent to 6.5 percent for schizophrenia. 
In a sample of more than 8,000 U.S. inmates
(Al-Rousan et al., 2017), nearly 48 percent had a
history of mental illness, 29 percent had an SMI,
and 26 percent had an SUD. About 48 percent of
those with a mental illness also misused substances.
People on probation or parole from 2002 to 2014
had signifcantly higher rates of Diagnostic and
Statistical Manual of Mental Disorders, Fourth
Edition (DSM-IV) SUDs than U.S. adults not on
probation or parole (Fearn et al., 2016); 13 percent
had alcohol abuse (vs. 4 percent), 15 percent had
alcohol dependence (vs. 3 percent), 2 percent had
illicit drug abuse (vs. 0.3 percent), and 8 percent
had illicit drug dependence (vs. 1 percent). 
Rationale for Treatment 
Inmates with a history of mental illness or CODs 
are at higher risk of violence (Peters et al., 2017). 
They are more likely to be charged with violent 
crimes before incarceration and to experience 
or perpetrate prison-related assaults during 
incarceration (Wood, 2013). 
The rationale for providing SUD treatment
in the criminal justice system is based on the
well-established link between substance misuse
and criminal behavior. The overall goal of SUD
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Among individuals in the criminal justice system, 
comorbid SMI and SUDs substantially increase 
the risk of multiple reincarcerations compared 
with having either disorder alone (Baillargeon et 
al., 2010). However, the odds of incarceration are 
reduced when people engage in SUD treatment 
(Luciano, Belstock, et al., 2014). 
treatment for criminal offenders, especially those
who have engaged in violence, is to reduce
criminality.
Evidence suggests that people with CODs can be
effectively treated while incarcerated (Peters et
al., 2017). Unfortunately, despite the high need for
services, lifetime treatment rates among offenders
with CODs are low: approximately 38 percent have
received any type of previous behavioral health
services; 27 percent, inpatient or outpatient SUD
treatment; 4 percent, inpatient mental health
services; 7 percent, both SUD treatment and
mental health services; and 16 percent, any type of
behavioral health service during the past year (Hunt,
Peters, & Kremling, 2015). 
Treatment Features, Approaches, and 
Empirical Evidence 
Several features distinguish COD treatment 
programs currently available in the criminal justice 
system from other treatment programs: 
• Staff are trained and experienced in treating 
both mental disorders and SUDs. 
• Both disorders are treated as “primary.” 
• Treatment services are integrated if possible. 
• Treatment is comprehensive, fexible, and 
individualized. 
• The focus of the treatment is long term. 
Treatment frameworks that yield positive results
for incarcerated people with CODs include
integrated dual disorder treatment (IDDT), risk-
need-responsivity (RNR) models, and CBT (Peters 
et al., 2017): 
• IDDT models integrate SUD treatment and 
mental health services in a single setting; 
professionals with training in both sets of 
disorders address all symptoms concurrently. 
IDDT treatments can be adapted for 
incarcerated populations to address criminal 
thinking and reduce risk of recidivism. 
• RNR models match service intensity to clients’ 
risk of recriminalization after release, which 
tends to be high in people with CODs. RNR 
programs are often highly focused on reducing 
substance misuse, which is strongly linked 
to reincarceration. Additional recidivism risk 
factors addressed through this framework 
include reducing antisocial attitudes and beliefs, 
addressing family and relationship problems, 
enhancing education and employment skills, and 
encouraging prosocial activities. 
• CBT can be tailored to offenders with CODs by 
addressing antisocial thoughts and maladaptive 
behaviors, increasing coping skills to reduce 
substance use (e.g., urges, cravings) and 
criminal behavior, and cognitive restructuring to 
decrease criminal thinking. 
These and other COD treatment approaches 
can be implemented across a range of criminal 
justice settings and services, including as part of 
prebooking diversion programs, drug and mental 
health courts, reentry programs, and probation 
supervision. Many prison- and jail-based treat-
ments for offenders with CODs have generated 
positive results for reincarceration (especially for 
TCs). Certain interventions, including case manage-
ment via mental health drug courts, motivational 
interviewing combined with cognitive training, and 
interpersonal psychotherapy, often show no effect 
RESOURCE ALERT: SAMHSA 
PUBLICATIONS ON SCREENING,
ASSESSMENT, AND TREATMENT
FOR CRIMINAL JUSTICE 
POPULATIONS 
• TIP 44, Substance Abuse Treatment for Adults 
in the Criminal Justice System (https://store. 
samhsa.gov/system/fles/sma13-4056.pdf) 
• SAMHSA’s Screening and Assessment of 
Co-Occurring Disorders in the Justice System 
(https://store.samhsa.gov/system/fles/sma15-
4930.pdf) 
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on criminal activity and drug use—possibly because
of small sample sizes and the low quality of studies
(Perry et al., 2015; Peters et al., 2017). However,
some research does report positive outcomes,
suggesting that COD treatment should not be
dismissed outright. For instance, a COD wraparound
intervention for drug courts resulted in signifcant
reductions in the average number of nights spent
in jail, alcohol use, and drug use, and increases in
full-time employment (Smelson et al., 2018). 
Evidence in Support of Postrelease 
Treatment and Follow-Up 
In the past decade, several studies have 
established the importance of linking institutional 
services to community services (of various kinds). 
Postrelease programs often include reentry courts, 
ACT, and integrated case management services, 
all of which should offer comprehensive services 
to address mental health, SUDs, and housing and 
employment needs. 
Forensic adaptations to continuous care for CODs 
via ACT can be leveraged to improve criminal 
justice–related, substance-related, and functional 
outcomes. Integrated, comprehensive approaches 
to postrelease treatment and follow-up may help 
reduce rearrest and reconvictions when adapted 
for criminal justice populations. Adaptations may 
include modifcations like inclusion of a reentry 
plan, transportation to and supervision for 
treatment visits, and acquisition/reinstatement of 
fnancial assistance (e.g., Social Security income, 
Medicaid; Peters et al., 2017). 
Smith, Jennings, and Cimino (2010) used a stage 
progressive recovery model of ACT to help 
offenders with CODs transition from incarceration 
on an inpatient forensic unit to community living. 
Participants were provided stage-specifc skills and 
interventions (e.g., support to improve self-care, 
medication management, relapse prevention, 
enhanced socialization). Stages of treatments were 
tied to behavioral rewards and increased privileges 
(such as less supervision) and included assessment 
and orientation, a CBT program, a prerelease 
stage, and conditional release and community 
continuing care programming. Ninety percent 
of individuals who completed the program had 
“overall success” (e.g., no psychiatric state hospital 
readmissions and no rearrests following release), 75 
percent maintained substance abstinence, and 82 
percent maintained steady housing (i.e., keeping 
a consistent home without being evicted, ejected, 
or changing residences more than three times 
in any year). Interestingly, of the fve individuals 
who were rearrested following release, all had 
maintained substance abstinence, stable housing, 
and employment. 
Meanwhile, Cusack, Morrissey, Cuddeback, Prins, 
and Williams (2010) compared forensic adaptations 
of ACT for criminal justice–involved individuals 
who had mental illness, SUDs, or CODs with usual 
treatment. They found reductions in jail bookings 
and psychiatric hospitalizations, increases in the 
use of outpatient mental health services, increases 
in the odds of staying out of jail after release, and 
decreases in inpatient psychiatric service costs and 
per-person jail costs. 
Women 
Women with CODs can be served in mixed-
gender COD programs using the same strategies 
mentioned elsewhere in this TIP. However, 
specialized COD programs do exist that address 
In 2002, the National Institute on Drug Abuse 
(NIDA) established the Criminal Justice Drug 
Abuse Treatment Studies Series to fund regional 
research centers meant to forge partnerships 
between SUD treatment providers and the 
criminal justice system. The goal is to foster 
the design and testing of approaches to better 
integrate in-prison treatment and postprison 
services. In 2008, NIDA launched the second 
wave of studies; these focused specifcally on 
testing interventions in prison settings, including 
provision of medication-assisted treatment (MAT) 
and screening and assessment to identify SUDs 
and co-occurring health conditions and mental 
disorders. 
An archive of related studies and publications is 
available online (www.icpsr.umich.edu/icpsrweb/ 
NAHDAP/series/244/studies). 
Other NIDA justice system research initiatives 
are also available online (www.drugabuse.gov/ 
researchers/research-resources/criminal-justice-
drug-abuse-treatment-studies-cj-dats). 
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pregnancy and childcare diffculties as well as 
certain kinds of trauma, violence, and victimization. 
These issues are sometimes best dealt with in 
women-only programs. 
Substance Misuse and Mental Illness in 
Women 
Although women exhibit lower rates of SUDs than 
men do, prevalence rates are still high. According 
to 2018 National Survey on Drug Use and Health 
(NSDUH) data, about 17 percent of women ages 
18 and older reported past-year use of illicit 
drugs, about 4 percent reported past-month 
heavy alcohol use, and about 22 percent engaged 
in past-month binge alcohol use (Center for 
Behavioral Health Statistics and Quality [CBHSQ], 
2019). 
In the United States, mental illness prevalence 
estimates are higher for women than men. The 
2018 NSDUH showed that approximately 15 
percent of men ages 18 and older reported 
a past-year mental illness compared with 
approximately 23 percent of women. However, 
rates for men and women are very similar for SMI 
(3.4 percent for men and 5.7 percent for women), 
CODs (4.0 percent for men and 3.4 for women), 
and combined SUDs with SMI (1.1 percent for men 
and 1.4 percent for women). More women than 
men with any mental illness received mental health 
services in 2018, whether including or excluding 
SMI (CBHSQ, 2019). 
Treatment Approaches for Women 
SUD treatment 
Women disproportionately face barriers to 
treatment related to children and child care. 
Responsibility for care of dependent children is 
one of the most signifcant barriers women face in 
entering treatment, because many programs will 
not enroll women who lack child care (Taylor, 2010). 
Women who enter treatment sometimes risk losing 
public fnancial assistance and custody of their 
children, making the decision to begin treatment 
a diffcult one (Taylor, 2010). However, women 
accompanied by their children into treatment can 
achieve successful outcomes. The Iowa Pregnant 
and Postpartum Women’s Residential Treatment 
Program (https://idph.iowa.gov/substance-abuse/ 
programs/ppw), funded through a SAMHSA grant, 
reported a 76-percent treatment completion rate 
and 90.5-percent abstinence rate from drugs and 
alcohol at 5 to 8 months after admission (Jones & 
Arndt, 2017). 
Other barriers to SUD treatment women face 
include (McHugh, Votaw, Sugarman, & Greenfeld, 
2018; Taylor, 2010): 
• Fear of stigma, shame, and embarrassment, 
especially among women with a history of sex 
work. 
• Lack of support from partners, family, or friends. 
• Inability to afford the high cost of treatment; 
women are less likely than men to have health 
insurance or suffcient funds to cover costs. 
• Lack of programs that serve women and 
children. 
• Denial or tendency to attribute substance-
related problems to sources other than the 
addiction itself (like stress or physical health). 
• Avoidance of programs including men, 
particularly if there is a history of physical or 
sexual abuse. 
• Presence of a co-occurring mental illness, 
especially PTSD, depression, anxiety, or an 
eating disorder. CODs in women may lead to 
diffculty initiating, engaging in, and completing 
treatment. 
Women differ from men in their SUD treatment 
initiation and participation behaviors and needs 
(Grella, 2008; McHugh et al., 2018; NIDA, 2018d): 
• Women are more likely to be referred to 
or enter treatment via community-based 
social services, like welfare and child welfare 
programs, and are less likely to enter via the 
criminal justice system. 
• Women are more likely to require public 
assistance to pay for treatment. 
• Women may be more likely to initiate treatment 
after fewer years of substance misuse than men, 
but their clinical profles are often more severe 
(e.g., greater psychosocial distress, greater odds 
of trauma experience, higher childcare burden, 
worse functional impairment). They also tend to 
start substance use at a later age but progress 
from frst use to addiction faster than men do. 
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• Women with SUDs have a higher reported 
prevalence of mental disorders, particularly 
internalizing conditions (e.g., depression, 
anxiety, eating disorders, PTSD) and lower 
self-esteem, whereas men with SUDs are more 
likely to exhibit externalizing conditions (e.g., 
antisocial personality disorder [PD]). 
• Whereas women with SUDs report having more 
diffculty with emotional problems, their male 
counterparts report having more trouble with 
functioning (e.g., work, money, legal problems). 
Regarding treatment outcomes, large-scale 
randomized clinical trials have been mixed in their 
fndings but generally fnd no gender differences. 
Over the past two decades, there has been 
an increase in policy and research supporting 
the need for gender-sensitive SUD treatments. 
Compared with mixed-gender approaches (Grella, 
2008; McHugh et al., 2018), some women-specifc 
programs have been linked to: 
• Better treatment retention and substance use 
outcomes (including abstinence). 
• Better client satisfaction, comfort, and self-
reported feelings of safety. 
• Reduced risk of criminal activity and 
incarceration. 
• Higher rates of receiving continuity of care. 
Positive outcomes are especially likely in 
programs that include residential treatment 
with in-house accommodations for children, 
outpatient treatments that incorporate 
family therapy, and comprehensive services 
that address women-specifc needs (e.g., 
case management, pregnancy-related services, 
parenting training/classes, child care, job training, 
and continuing care). Gender-specifc treatments 
are effective in several subpopulations of women, 
including those with children, CODs, trauma 
history, or criminal justice system involvement 
(McHugh et al., 2018). 
Programs offering COD treatment have a re-
sponsibility to address women’s specifc needs. 
Mixed-gender programs need to be responsive 
to women’s needs. Women in mixed-gender 
outpatient programs require careful, appro-
priate counselor matching and the availability 
of specialized women-only groups to address 
sensitive topics such as trauma, parenting, stigma, 
and self-esteem. Strong administrative policies 
pertaining to sexual harassment, safety, and 
language must be clearly stated and upheld. The 
same responsibility exists for residential programs 
designed for women who have multiple and 
complex needs and require a safe environment for 
stabilization, intensive treatment, and an intensive 
recovery support structure. Residential treatment 
for pregnant women with CODs should provide 
integrated SUD and mental disorder treatment and 
primary medical care, as well as attention to related 
problems and disorders. The needs of women in 
residential care depend in part on the severity and 
complexity of their co-occurring mental disorders. 
Other areas meriting attention include past or 
present history of domestic violence or sexual 
abuse, physical health, and pregnancy or parental 
status. 
Exhibit 6.1 lists suggestions for gender-responsive
SUD treatment. TIP 51, Substance Abuse Treatment:
Addressing the Specifc Needs of Women (SAMHSA,
2009c) offers more information on adapting
behavioral health services to the needs of women. 
COD Treatment 
The treatment barriers and socioeconomic 
burdens facing women with either SUDs or 
mental illness alone are multiplied for women 
with both conditions, leading to substantial 
challenges that make recovery more diffcult and 
relapse more likely. Women with SUDs frequently 
have comorbid mental disorders, including SMI 
(Evans, Padwa, Li, Lin, & Hser, 2015). This leads to 
more severe symptoms, worse functioning, lower 
quality of life, and more complex treatment needs 
than for women who only have SUDs. Specifcally, 
women with CODs (particularly involving SMI, like 
bipolar disorder or psychosis) are more likely than 
women with only SUDs to (Evans et al., 2015): 
• Experience homelessness. 
• Be unmarried. 
• Have a past history of physical or sexual abuse. 
• Receive public assistance. 
• Have a longer substance use history. 
• Have more severe alcohol use–related problems. 
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EXHIBIT 6.1. Adapting Treatment Services to Women’s Needs 
• Use nonconfrontational, strengths-based, trauma-informed treatment approaches. 
• Offer evidence-based interventions that have been researched specifcally in female populations. 
• Ensure staff training and competencies regarding women-specifc problems in substance misuse. 
• Provide: 
- Prenatal/postnatal services. 
- Women-only groups. 
- Parenting training/counseling. 
- Trauma/abuse counseling and other services. 
- Education about and referral to women’s health services. 
• Use gender-specifc assessments (including assessment of intimate partner violence and trauma). 
• Offer services related to child care and children’s needs, including: 
- Onsite child care or, for residential settings, live-in accommodations for children. 
- Screening and assessments for children. 
- Child and family counseling (or referral for those services). 
- Coordinated care with child welfare/children’s protective services. 
• Ensure the physical treatment environment is safe and secure. Being in close proximity to schools, 
child care, and public transportation is also desirable. 
Sources: Grella (2008); Tang, Claus, Orwin, Kissin, & Arieira (2012). 
• Have more severe problems related to 
employment. 
• Have more severe medical conditions. 
• Have greater family dysfunctions. 
• Be on psychiatric medication. 
Services for women with CODs should address 
these disparities. Women with CODs may also lack 
social support compared with women who have 
only SUDs; counselors should help women with 
CODs locate and use supportive services (Brown, 
Harris, & Fallot, 2013). 
Women receiving treatment for SUDs or CODs
often beneft from trauma-informed approaches.
Trauma is present in an overwhelming majority of
women with CODs (SAMHSA, 2015c), regardless
of their age. Most women have a history of at least
one adverse childhood experience, often abuse
(Choi et al., 2017). However, women with CODs
are less likely than women with SUDs only to enter
treatment and to receive ongoing care (Bernstein et
al., 2015), despite mental disorders and SUDs both
being disabling in women and a common cause of
inpatient hospitalization (Bennett, Gibson, Rohan,
Howland, & Rankin, 2018).
Women with CODs—and particularly with 
SMI and SUDs—often do not receive services 
for their conditions. Of women who entered 
SUD treatment with a co-occurring mental 
illness (Evans et al., 2015), almost 30 percent 
with a comorbid mental disorder received no 
mental health services over the course of 8 years, 
including 7 percent with co-occurring psychosis, 
13 percent with bipolar disorder, and 20 percent 
with depressive disorder. 
Pregnancy and CODs 
Pregnancy can both aggravate and diminish the 
symptoms of co-occurring mental illness. Women 
with schizophrenia may experience a worsening 
of symptoms, whereas women with bipolar 
disorder have exhibited lower rates of new onset 
or recurrence of symptoms (Jones, Chandra, 
Dazzan, & Howard, 2014). Ample research has 
examined MDD during the prenatal, perinatal, and 
postnatal periods. Antidepressant discontinuation 
or untreated depression during pregnancy can 
exacerbate symptoms, including those related 
to risk of suicide, and worsen outcomes for both 
Chapter 6 175 
TIP 42
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Substance Use Disorder Treatment for People With Co-Occurring Disorders 
mother and child (Gentile, 2017; Vigod, Wilson, 
& Howard, 2016). However, pregnancy has been 
linked to lower substance use in women, even 
if abstinence is temporary (Muhuri & Gfroerer, 
2009; SAMHSA, 2009c). Compared with women 
who have a single disorder or no disorder, 
pregnant women with CODs are at elevated 
risk for negative perinatal outcomes, including 
birth complications, premature birth, low infant 
birthweight, nonadherence to prenatal care, child 
developmental delays, and poorer psychosocial 
functioning (Benningfeld et al., 2010; Lee King, 
Duan, & Amaro, 2015). 
Topics To Address With Co-Occurring Mental 
Illness 
Careful treatment plans are essential for 
pregnant women with mental disorders. Plans 
should address childbirth and infant care. Women 
often are concerned about the effects of their 
medication on their fetuses. Treatment programs 
should aim to maintain medical and mental stability 
during clients’ pregnancies and collaborate with 
other healthcare providers to ensure coordination 
of treatment. 
Experts recommend a multidisciplinary 
approach to perinatal COD treatment, including 
consultation with providers in obstetrics, addiction, 
mental health, and pediatrics on pharmacotherapy 
(e.g., selective serotonin-reuptake inhibitors 
[SSRIs], MAT for opioid use disorder [OUD]), 
individual counseling (e.g., CBT, exposure, other 
trauma-based therapies), SUD treatment, prenatal 
care, maternal education, health promotion, and 
linkage to social services (Goodman, Milliken, 
Theiler, Nordstrom, & Akerman, 2015). 
Pregnant women with CODs report desiring SUD 
treatment that includes (Kuo et al., 2013): 
• More fexible treatment schedules. 
• Longer sessions. 
• Assistance with transportation to and from 
sessions. 
• Group treatments. 
• Interpersonal support (from partners, friends, 
family, and counselors). 
• Linkage to community resources (like mutual-
support programs). 
• Treatment environments that convey a sense of 
safety and comfort. 
When women are parenting, it can often 
retrigger their own childhood traumas. Therefore, 
providers need to balance growth and healing with 
coping and safety. Focusing on women’s desire to 
be good mothers, the sensitive counselor will be 
alert to guilt, shame, denial, and resistance related 
to dealing with these problems, as recovering 
women gain awareness of effective parenting skills. 
Providers should allow for evaluation over time 
for women with CODs. Reassessments should 
occur as mothers progress through treatment. 
Pharmacological Considerations 
Prescribers should be aware that pregnant
women must understand the risks and benefts
of taking medications and sign informed consent
forms verifying receipt and understanding
of the information provided to them. Certain
psychoactive medications are associated with
birth defects, especially in the frst trimester of
pregnancy; weighing potential risk/beneft is
important. In most cases, a sensible direction can
be found through consultation with physicians
and pharmacists who have expertise in treating
pregnant women with mental disorders. Screen
women for dependence on substances that can
produce life-threatening withdrawal for the mother:
alcohol, benzodiazepines, and barbiturates. These
substances, as well as opioids, can also cause a
withdrawal syndrome in babies, who may need
treatment. Make pregnant women aware of
wraparound services to assist them in managing
newborns, such as food, shelter, and medical
clinics for inoculations. Also ensure that women
are informed of programs that can help with
developmental or physical problems the infant may
experience as a result of alcohol or drug exposure.
Postpartum Depression and Psychosis 
The term “postpartum depression” (PPD) in 
Diagnostic and Statistical Manual of Mental 
Disorders (5th ed.; DSM-5; American Psychiatric 
Association [APA], 2013) refers to MDD in which 
the most recent depressive episode has an onset 
either during pregnancy or within 4 weeks after 
delivery. DSM-5 designates such cases through 
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PREGNANCY AND MAT FOR OUD 
The approval of three medications by the Food and Drug Administration to treat OUD—methadone, 
buprenorphine, and naltrexone—has given the primary care and behavioral health felds powerful new 
tools to fght the opioid epidemic and save lives. 
Considerations for MAT to address OUD in pregnant women include the following: 
• MAT is possible for women with OUD who are pregnant and should be actively considered, given the 
wealth of evidence showing its effectiveness in reducing opioid use and preventing overdose. 
• Pregnant women should be considered for methadone or transmucosal buprenorphine treatment. 
• Pregnant women treated with methadone or sublingual or buccal buprenorphine have better outcomes 
than pregnant women not in treatment who continue to misuse opioids. 
• Little research has examined the use of naltrexone during pregnancy. It should not be used with women 
who are pregnant. Instead, they should be referred for an evaluation for methadone or buprenorphine. 
• Neonatal abstinence syndrome may occur in newborns of pregnant women who take buprenorphine. 
Women receiving opioid agonist therapy while pregnant should talk with their healthcare provider about 
neonatal abstinence syndrome and how to reduce it. 
• An obstetrician and an SUD treatment provider should deliver collaborative treatment, and the woman 
should be offered counseling and other behavioral health services as needed. 
Source: SAMHSA (2018c). 
the MDD specifer “with peripartum onset.” (See 
Chapter 4 for DSM-5 diagnostic criteria for MDD.) 
PPD prevalence estimates vary, given differences 
in timeframes researchers use to defne the 
postpartum period. According to DSM-5 (APA, 
2013), 3 percent to 6 percent of women will 
experience a major depressive episode either 
during pregnancy or in the weeks and months 
following childbirth. In a sample of 10,000 mothers 
screened for depression 4 to 6 weeks following 
delivery, 14 percent were positive for depression 
(Wisner et al., 2013). Forty percent had postpartum 
onset, 33 percent had onset during pregnancy, and 
27 percent had onset prior to pregnancy. Thoughts 
of self-harm occurred in 19 percent. 
PPD is considered distinct from postpartum 
“blues,” which is a mild, transient depression 
occurring most commonly within 3 to 5 days after 
delivery in about 30 percent to 80 percent of 
women after childbirth (Buttner, O’Hara, & Watson, 
2012; Jones & Shakespeare, 2014). Prominent in its 
causes are a woman’s emotional letdown following 
the excitement and fears of pregnancy and 
delivery, the discomforts of the period immediately 
after giving birth, hormonal changes, fatigue from 
loss of sleep during labor and while hospitalized, 
energy expenditure at labor, and anxieties about 
caring for the newborn at home. Symptoms 
include weepiness, insomnia, depression, anxiety, 
poor concentration, moodiness, and irritability. 
These symptoms tend to be mild and transient, 
and women usually recover completely with rest 
and reassurance. Anticipation and preventive 
reassurance throughout pregnancy can prevent 
postpartum blues from becoming a problem. 
Women with sleep deprivation should be assisted 
in getting proper rest. Follow-up care should 
ensure that the woman is making suffcient 
progress and not heading toward a relapse to 
substance use. 
Moderate-to-strong risk factors for PPD include 
prior history of depression, anxiety, or other 
mental distress during pregnancy; prepregnancy 
mental disorder diagnosis (especially depression); 
presence of postpartum blues; psychosocial stress 
(e.g., poor marital relationships, lack of social 
support, child care-related distress); and certain 
personality traits and features (i.e., neuroticism, low 
self-esteem) (O’Hara & McCabe, 2013). 
Prospects for recovery from PPD are good with 
supportive mental health counseling (especially 
for acute cases) accompanied as needed by 
pharmacotherapy, particularly in severe PPD 
(Thomson & Sharma, 2017). Various forms of 
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counseling (e.g., CBT, behavioral activation, 
interpersonal therapy), pharmacotherapy 
(e.g., SSRIs, selective norepinephrine reuptake 
inhibitors), and brain stimulation (e.g., 
electroconvulsive therapy, repetitive transcranial 
magnetic stimulation) have all been successful 
in treating PPD (Guille, Newman, Fryml, Lifton, 
& Epperson, 2013; O’Hara & Engeldinger, 2018; 
Thomson & Sharma, 2017). Additionally, the 
drug brexanolone received FDA approval for 
treating PDD in 2019. Because some medications 
pass into breastmilk and can cause infant 
sedation, women should consult an experienced 
psychiatrist or pharmacist for details on 
pharmacotherapy. 
Patients with PPD need to be monitored for 
thoughts of suicide, infanticide, and progression 
of psychosis in addition to their response to 
treatment. Postpartum psychosis is a serious 
but rare mental disorder, with frst lifetime onset 
occurring in 0.25 to 0.6 per 1,000 births (Bergink, 
Rasgon, & Wisner, 2016). Women with this disorder 
may lose touch with reality and experience 
delusions, hallucinations, and disorganized speech 
or behavior. Women most likely to be diagnosed 
with postpartum psychosis have a previous 
diagnosis or family history of bipolar disorder or 
other psychotic disorders (e.g., schizophrenia, 
schizoaffective disorder) (Davies, 2017). Other 
studies reviewed by Bergink and colleagues 
(2016) indicate that physiological factors, such as 
hormonal, immunological, and circadian rhythm 
disturbances, can increase the risk of postpartum 
psychosis in women who are already genetically 
vulnerable (e.g., those with a personal or family 
history of bipolar disorder, those with certain 
variants of the serotonin transporter gene). Typical 
onset is 3 to 10 days after delivery (Bergink et al., 
2016). 
Postpartum psychosis is associated with an 
increased risk of suicide and infanticide (Bergink 
et al., 2016; Brockington, 2017). As such, the 
severity of the symptoms mandates immediate 
evaluation (for diagnosis and for safety), which 
often needs to be performed in an inpatient 
setting, and treatment with benzodiazepines, 
lithium, antipsychotics, electroconvulsive therapy, 
or a combination thereof (Bergink et al., 2016; 
Doucet, Jones, Letourneau, Dennis, & Blackmore, 
2011). The risk of self-harm or harm to the baby 
needs to be assessed. Monitoring of mother–infant 
pairs by trained personnel can limit risks. 
PPD and Substance Misuse 
Little research has examined the relationship 
between PPD and substance use. One review 
of substance use in postpartum women found 
that problematic alcohol use occurred in 1.5 
percent to 8 percent and drug use (cocaine and 
prescription psychoactive drugs) occurred in 2.5 
percent (Chapman & Wu, 2013). Among women 
who reported using substances postpartum or who 
had a positive history of substance misuse, PPD 
was highly prevalent (20 percent to 46 percent). 
However, the women participating in these studies 
were likely to have had higher rates of depression 
than the general population to begin with because 
of low income and socially marginalized status 
(e.g., teenage mothers). The review also found 
that alcohol or illicit drug use was associated with 
higher scores of depression in postpartum women. 
These fndings are consistent with an earlier review 
(Ross & Dennis, 2009) that similarly observed 
an association between substance use and an 
increased risk of PPD. 
Women, Trauma, and Violence 
Up to 80 percent of women seeking SUD 
treatment have a lifetime history of physical 
or sexual victimization, often traced back to 
childhood (Cohen, Field, Campbell, & Hien, 
2013). Intimate partner violence is also strongly 
connected to women’s substance misuse and 
mental illness (Macy, Renz, & Pelino, 2013; Mason 
& Dumont, 2015). In addition to SUDs, trauma-
exposed individuals in the community who have 
PTSD are at an increased risk for MDD, dysthymic 
disorder, bipolar I and II disorders, generalized 
anxiety disorder, panic disorder, agoraphobia 
without panic disorder, social and specifc phobias, 
and lifetime suicide attempt (Pietrzak, Goldstein, 
Southwick, & Grant, 2011). 
People seeking SUD treatment who have PTSD 
are 14 times more likely to have an SUD than 
people without PTSD (McCauley, Killeen, Gros, 
Brady, & Back, 2012). In the general public, 
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lifetime prevalence rates of PTSD (full or partial) 
are two times higher in women than in men, with 
46 percent of people with full PTSD also meeting 
criteria for an SUD (Pietrzak et al., 2011). Women 
who are incarcerated have even higher rates of 
each disorder—88 percent with full or partial PTSD 
and 87 percent with an SUD (Wolff et al., 2011). 
Women with trauma/PTSD may misuse substances 
to avoid intrusive, distressing symptoms (e.g., 
fashbacks, nightmares) or to numb themselves to 
emotional pain (Dass-Brailsford & Saflian, 2017). 
Few SUD treatment programs assess for, treat, 
or educate clients about trauma and instead 
focus on managing the addiction (Macy et al., 
2013). This is a serious defciency, given the many 
interrelated consequences of failing to address 
trauma. Greater violence leads to more serious 
substance misuse and other addictions (e.g., eating 
disorders, sexual addiction, compulsive exercise), 
along with higher rates of depression, self-harm, 
and suicidal impulses. People with PTSD and 
AUD, for example, are vulnerable to more severe 
symptoms, greater risk of comorbid mood and 
PDs, worse physical functioning, and higher risk 
of suicide attempt than those with either disorder 
alone (Blanco et al., 2013). SUDs place women at 
higher risk of future trauma through associations 
with dangerous people and lowered self-protection 
when using substances (e.g., going home with a 
stranger after drinking). 
Integrated trauma-informed treatment programs 
and approaches may be equally or more eff-
cacious or effective than usual care in reducing 
substance misuse and psychiatric symptoms. 
Examples include integrated CBT, Seeking Safety, 
the Treatment Affect Regulation: Guide for 
Education and Therapy program, the Addictions 
and Trauma Recovery Integration program, the 
Concurrent Treatment of PTSD and Substance Use 
Disorders Using Prolonged Exposure program, and 
the Trauma Recovery and Empowerment Model 
(Dass-Brailsford & Saflian, 2017; Killeen, Back, & 
Brady, 2015). 
For more information about trauma and for 
guidance on offering trauma-informed care, see 
Chapter 4. 
For more detailed information, including 
individual and other models of trauma healing, 
see: 
• TIP 51, Substance Abuse Treatment: Addressing 
the Specifc Needs of Women (https://store. 
samhsa.gov/system/fles/sma15-4426.pdf). 
• TIP 57, Trauma-Informed Care in Behavioral 
Health Services (https://store.samhsa.gov/ 
system/fles/sma14-4816.pdf). 
People of Diverse Racial/Ethnic
Backgrounds 
As racial and ethnic diversity in the United States 
increases, the need to address cultural differences 
in mental health and SUD treatment access, 
provision, and outcomes is becoming more urgent. 
Per NSDUH data (CBHSQ, 2019), 2.9 percent of 
Whites had a past-year illicit drug use disorder 
in 2018 versus about 3.4 percent of African 
Americans, 4.0 percent of American Indians and 
Alaskan Natives, 3 percent of Latinos, and 1.6 
percent of Asian Americans. AUD, prevalence was 
5.7 percent among Whites, 4.5 percent among 
African Americans, 7.1 percent among American 
Indians or Alaskan Natives, 5.3 percent among 
Latinos, and 3.8 percent among Asian Americans. 
Approximately 16 percent of African American 
adults ages 18 and older had any past-year mental 
illness in 2018; similar rates occurred in other 
groups, including Latinos (16.9 percent) and Asian 
Americans (14.7 percent). By comparison, 20.4 
percent of Whites and 22.1 percent of American 
Indians and Alaska Natives reported any past-year 
mental illness. 
Cultural Perceptions of Substance Misuse, 
Mental Disorders, and Healing 
Clients may have culturally determined concepts 
of what it means to misuse substances or to have 
a mental disorder, what causes these disorders, 
and how they may be “cured.” Providers are 
encouraged to explore these concepts with 
people who are familiar with the cultures 
represented in their client population and with 
the clients themselves. Counselors should be 
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alert to differences in how their role and the 
healing process are perceived by people who 
are of cultures other than their own. Whenever 
appropriate, familiar healing practices meaningful 
to clients should be integrated into treatment. An 
example would be the use of acupuncture to calm 
a Chinese client or help control cravings. 
Cultural Perceptions and Diagnosis 
Being aware of cultural and ethnic bias in 
diagnosis is important. For example, in the 
past some African Americans were stereotyped 
as having paranoid PDs, whereas women have 
been diagnosed frequently as being histrionic or 
borderline. American Indians with spiritual visions 
have been misdiagnosed as delusional or as having 
borderline or schizotypal PDs. Diagnostic criteria 
should be tempered by sensitivity to cultural 
differences in behavior and emotional expression 
and by an awareness of the provider’s own 
biases and stereotyping. 
Treatment Access and Utilization 
Compared with Whites, other racial/ethnic 
populations make up a smaller percentage of
the U.S. population with mental disorders, SUDs,
or both. Yet concerns remain about treatment
access and use, as people of diverse ethnic/racial
backgrounds are disproportionately uninsured
(Kaiser Family Foundation, 2017; Sohn, 2017). Racial 
and ethnic populations have historically faced more 
fnancial and nonfnancial barriers to health care in 
general than Whites, including low cultural compe-
tency in their treatment providers (Mitchell, 2015). 
These barriers lead to worse health outcomes (e.g., 
increased morbidity, worse quality of care) as well 
as higher healthcare costs. Similarly, marginalized 
groups face systemic, organizational, cultural, and 
attitudinal obstacles to SUD treatment and mental 
health services (Holden et al., 2014; Keen et al., 
2014; Masson et al., 2013; Maura & Weisman de 
Mamani, 2017; Pinedo, Zemore, & Rogers, 2018), 
including: 
• Fear of stigma and feelings of shame. 
• Mistrust of providers. 
• Language barriers. 
• Logistical obstacles (e.g., lack of transportation, 
lengthy wait times). 
• Fearing the provider will not understand the 
client’s culture, religion, or circumstances (e.g., 
immigration) or that the services won’t be 
culturally responsive. 
• Lack of insurance. 
• Not knowing where to go for treatment. 
• Not believing treatment is needed. 
• Lacking confdence in treatment effectiveness. 
• Family factors (e.g., lack of support, pressure 
RACIAL/ETHNIC DISPARITIES AND SMI 
Findings from a 2017 review of ethnic/racial disparities in the diagnosis and treatment of SMI suggest that: 
• African Americans, Asian Americans, and Latinos offered mental health services in medical settings are 
more likely than Whites to receive a schizophrenia spectrum diagnosis. 
• African Americans are more likely than Whites to be diagnosed with schizophrenia (and in one study 
were more than four times likely). 
• African Americans are more likely than Whites to get higher doses of antipsychotics and are less likely to 
be prescribed newer generation antipsychotics (which have fewer side effects). 
• Mental health service retention is lower for African Americans than for Whites. 
• African Americans have worse mental health outcomes following inpatient treatment than Whites. 
• Minorities are more likely to drop out of treatment by psychologists, psychiatrists, and general 
practitioners. 
• African Americans are less likely than Whites to receive continuing care (e.g., medication management, 
outpatient visits/follow-up services) following hospital discharge. 
• Diverse racial and ethnic populations in medical settings are more likely to use emergency rather than 
community services and thus are more likely to be hospitalized than Whites. 
Source: Maura & Weisman de Mamani (2017). 
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to not enter treatment, withdrawal of fnancial 
help, not including family in treatment). 
The effects of these barriers are refected in 
lagging rates of treatment access, utilization, 
and completion for mental illnesses, SUDs, 
or CODs by diverse ethnic/racial populations 
compared with Whites (Cook et al., 2017; Holden 
et al., 2014; Maura & Weisman de Mamani, 2017; 
Nam et al., 2017; Saloner & Le Cook, 2013; 
Sanchez et al., 2016). This inequity may result 
from underassessment, underdiagnosis, and 
underreferral (Priester et al., 2016) as well as from 
cultural barriers. 
Rates of SUD treatment provided in criminal 
justice facilities, in which racial/ethnic populations 
are overrepresented compared with Whites 
(Pew Research Center, 2018), also reveal cultural 
disparities (Nicosia, Macdonald, & Arkes, 2013). 
Whites who are incarcerated and have an SUD are 
more likely than African Americans and Latinos 
to receive SUD treatment and more likely to have 
SUD treatment and mental health services as a part 
of their sentencing requirements (Nowotny, 2015). 
Reducing Racial/Ethnic Disparities 
Recommended approaches to improving 
disparities in treatment access, utilization, and 
completion center on implementing healthcare 
and funding policy changes (e.g., legislation to 
increase awareness about disparities, expanding 
state Medicaid funding for treatment programs) 
and improving workforce cultural responsiveness 
(Morgan, Kuramoto, Emmet, Stange, & Nobunaga, 
2014; Saloner & Le Cook, 2013; Wile & Goodwin, 
2018). For instance, culturally responsive 
organizational practices (e.g., diverse hiring, staff 
training, linkage with surrounding community) and 
acceptance of public insurance have reduced gaps 
in service access and provision for low-income 
minority racial/ethnic populations by reducing 
wait time and improving SUD treatment retention 
(Guerrero, 2013). 
Integrated and person-centered care also may 
help reduce healthcare disparities through strate-
gies such as (Maura & Weisman de Mamani, 2017; 
Sanchez et al., 2016): 
• Using bilingual case managers. 
• Maintaining a diverse workforce. 
• Ensuring staff are trained in culturally responsive 
care. 
• Using multilingual mutual-support programs. 
• Using patient navigators to help clients access 
community resources and overcome logistical 
barriers (e.g., keeping appointments). 
• Performing assessments that address clients’ 
cultural concepts/understanding of their 
symptoms. 
• Using culturally relevant interpretations and 
frameworks to describe mental disorders 
(e.g., depression) rather than solely relying on 
Western defnitions. 
• Eliciting client preferences about treatment 
decisions, including giving the option to forego 
medication in favor of psychotherapy. 
• When appropriate, including family in the 
treatment process and in education about 
mental illness. 
• Using patient-centered communication to 
improve client education and reduce stigma, 
shame, and misunderstanding. 
• Using sensitive, empathic, person-centered 
communication to build trust and enhance 
rapport. 
• Providing culturally adapted evidence-based 
treatments when possible. 
For more information about developing 
and implementing culturally responsive and 
competent services, see TIP 59, Improving Cultural 
Competence (SAMHSA, 2014a). 
Cultural Diferences and Treatment: 
Empirical Evidence on Efectiveness 
Studies of cultural differences in COD treatment 
are scarce. However, culturally adapted mental 
health services have been linked to small-to-mod-
erate benefts compared with nonadapted 
treatments, placebo, waitlists, and usual care
(Cabassa & Baumann, 2013). For example, a review 
of culturally responsive mental health services for 
people with SUDs (Gainsbury, 2017) reported that: 
• Culturally tailored psychosocial interventions 
increase treatment engagement and 
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ADVICE TO THE COUNSELOR: USING CULTURALLY APPROPRIATE 
METHODS 
The consensus panel recommends these modifcations to provide culturally appropriate COD treatment: 
• Adapting interventions by altering the content of materials or communications to refect racial/ethnic or 
cultural facts, values, imagery, beliefs, and norms. Engage members of the community (such as through 
focus groups) to ensure content adaptations are appropriate, accurate, and relevant. 
• Use translated materials to meet the needs of clients for whom English is not a primary language. 
Simplifed materials (such as those using illustrations, which can be more universally understood) are 
also desirable. 
• Tailor services by culturally matching counselors to clients (if possible) and via culture-specifc 
resources. 
• When able, implement programs directly in the community where clients reside. 
• Take into account the client’s cultural beliefs about mental health, substance use, help-seeking 
behavior, causes of problems, and approaches to treatment. Similarly, in some cultures, there may be 
strong beliefs about the role of the family in the treatment of mental illness, substance misuse, or both; 
those beliefs may need to be accounted for when treatment planning. 
Source: Healey et al. (2017). 
participation, enhance client–provider alliance, 
reduce early treatment discontinuation, and 
improve symptoms. 
• Cultural competence training for staff is 
associated with improved communication, 
more accurate diagnosis, a positive therapeutic 
alliance, and greater client satisfaction. 
• Providing treatment in a client’s native language 
or dialect can lead to better treatment 
outcomes and may be more infuential than 
matching the provider’s race/ethnicity to that of 
the client. 
• Providers who show greater comfort with openly 
discussing cultural identities and values with 
clients may have better client retention rates 
than those who are uneasy talking about such 
topics. 
Cultural competence should be a goal for 
programs as well as providers. In a study of more 
than 350 nationally representative outpatient SUD 
treatment programs (Guerrero & Andrews, 2011), 
program cultural competence—namely, managers’ 
culturally sensitive beliefs—predicted reduced 
client wait time and increased retention among 
Latinos and African Americans. Program leadership 
can infuence staff uptake of culturally responsive 
care, translating to potentially better outcomes for 
clients. 
Conclusion 
To effectively fll practice gaps and more 
comprehensively address the widespread problem 
of unmet COD treatment needs, behavioral health 
service providers and programs need to recognize 
groups who have been historically underserved. 
The recovery community is diverse, and counselors 
may need to think outside of the box in adapting 
traditional techniques and perspectives to better 
meet the individual needs of all clients. Using a 
cookie-cutter approach for all clients in all settings 
increases the likelihood of improper diagnosis and 
treatment and is inconsistent with expert guidance 
on providing comprehensive, person-centered, 
recovery-oriented care. 
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• Co-occurring disorders (CODs) are 
undertreated conditions that exact a serious 
toll on both the individuals living with them as 
well as on their families, caregivers, and society 
as a whole. Early and effective treatments 
offer people the opportunity to live fulflling, 
healthy, productive lives. 
• Available treatment models work by 
leveraging education, support, resources, and 
other services drawn from multiple sources, 
such as healthcare professionals collaborating 
across primary care service, mental health 
services, and substance use disorder (SUD) 
treatment; mutual-support programs; 
professionals in the recovery community; and 
peer recovery support specialists. 
• Treatment providers should not operate in silos
nor should they use treatments in isolation.
The best way to serve people with CODs is to
offer services and programs that are integrated,
comprehensive, person centered, and recovery
oriented in their structure, milieu, and practice. 
• Counselors and programs need to provide 
effective interventions across multiple settings 
because people with mental disorders and 
SUDs often move among across levels of care, 
and this should not be a barrier to receiving 
needed evidence-based services. 
• Although psychosocial services are often 
a cornerstone of interventions for CODs, 
counselors working with this population 
should be familiar with medication treatment, 
as many effective pharmacotherapies are 
available to help people reduce at least some 
of their symptoms and make appreciable gains 
in functioning. 
Of the 9.2 million adults who had CODs in 2018,
approximately half received no treatment at all, and
only 8 percent received care for both conditions
(Center for Behavioral Health Statistics and Quality,
2019). What happens to people with CODs who
enter traditional SUD treatment settings? What
can counselors, other providers, supervisors, and
administrators do to help people with CODs more
successfully access needed services? How can
programs provide the best possible services to
clients? What treatment options are available, and
to what extent are they supported by science? This
chapter is addressed to counselors, other treatment/ 
service providers, supervisors, and administrators
and seeks to answer these and other important
questions about the management of co-occurring
mental illness and addiction. 
This chapter examines treatment models (e.g., 
integrated care, assertive community treatment 
[ACT], intensive case management [ICM], mutual-
support and peer-based programs) and treatment 
settings (e.g., therapeutic communities [TCs], 
outpatient and residential care, acute care and 
other medical settings) for clients with CODs. It 
opens with an overview of general COD treatment 
considerations, including types of programs, levels 
of service (and matching clients to appropriate 
levels), episodes of treatment, integrated versus 
nonintegrated treatment, culturally competent 
services, and barriers to care. The bulk of the 
material then focuses on three areas: treatment 
models, treatment settings, and pharmacotherapy. 
Specifc interventions, like cognitive–behavioral 
therapy (CBT), behavioral therapy, multidimensional 
family therapy, and dialectical behavior therapy, are 
beyond the scope of this Treatment Improvement 
Protocol (TIP). Readers should already possess a 
basic understanding of and working familiarity with 
these commonly used SUD treatments. Rather, the 
material is focused on describing the models and 
settings in which such interventions are provided. 
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Regarding pharmacotherapy, the chapter is 
not intended to offer exhaustive guidance on 
medication for CODs, and prescribers are not 
the intended primary audience of this chapter. 
However, counselors and other providers working 
with people who have CODs will encounter people 
taking medication and thus need to become 
familiar with medication names, side effects, and 
warnings about harmful interactions (especially with 
alcohol) and other adverse consequences. 
Several examples of program models designed to 
serve COD populations are included throughout 
this chapter, as are “Advice to the Counselor” 
boxes to provide readers who have basic 
backgrounds with the most immediate practical 
guidance for implementing various program 
models in different treatment settings. To an 
extent, this chapter works hand in hand with 
the programmatic perspectives of Chapter 8 by 
discussing how to design and implement programs 
in various settings. Administrators will beneft from 
reviewing this information but should also be sure 
to read Chapter 8 for additional information about 
workforce hiring, training, and retention. 
Treatment Overview 
Treatment Programs 
A mental health program offers an organized array 
of services and interventions focused on treating 
mental disorders, providing acute stabilization 
or ongoing treatment. These programs exist in 
various settings, like traditional outpatient mental 
health centers (e.g., psychosocial rehabilitation 
programs, outpatient clinics) or more intensive 
inpatient treatment units. Many such programs 
treat signifcant numbers of individuals with CODs. 
Programs more advanced in treating people with 
CODs may offer various interventions for SUDs 
(e.g., motivational interviewing, SUD counseling, 
skills training) in the context of the ongoing mental 
health services. 
An SUD treatment program offers an organized 
array of services and interventions focused on 
treating SUDs, providing both stabilization and 
ongoing treatment. SUD treatment programs 
more advanced in treating people with CODs 
may offer a variety of interventions for mental 
disorders (e.g., symptom management training, 
psychopharmacology,) in the context of the 
ongoing SUD treatment. 
Program Types 
The American Society of Addiction Medicine 
(ASAM; Mee-Lee et al., 2013) describes three 
types of service programs for people with CODs: 
• Co-occurring–capable (COC) programs are SUD 
treatment programs that mainly focus on SUDs 
but can also treat patients with subthreshold 
or diagnosable but stable mental disorders 
(Mee-Lee et al., 2013). These programs may 
offer mental health services onsite or by referral. 
COC programs in mental health focus mainly 
on mental disorders but can treat patients with 
subthreshold or diagnosable but stable SUDs 
(Mee-Lee et al., 2013). COC programs have 
addiction counselors onsite or available through 
referral. 
• Co-occurring–enhanced programs have a higher 
level of integration of SUD treatment and 
mental health services, staff trained to recognize 
the signs and symptoms of both disorders, and 
competence in providing integrated treatment 
for mental disorders and SUDs at the same time. 
• Complexity-capable programs are designed to 
meet the needs of individuals (and their families) 
with multiple complex conditions that extend 
beyond just CODs. Physical and psychosocial 
conditions and treatment areas of focus often 
include chronic medical illnesses (e.g., HIV 
and other infectious diseases), trauma, legal 
matters, housing diffculties, criminal justice 
system involvement, unemployment, education 
diffculties, childcare or parenting diffculties, 
and cognitive dysfunctions. 
Levels of Service 
Because mental disorders and SUDs are complex 
and vary in their severity and consequences, a 
wide range of levels of service are needed, from 
high-intensity inpatient medical service to periodic 
outpatient treatment. Not all people with CODs 
will require the full continuum of services, and 
not all clients will move through levels of care 
in a linear fashion. Clients can transition to and 
from greater and lower intensity services and 
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should be offered services based on clinical need 
(e.g., symptom severity, functional ability, person’s 
overall level of stability) and stage of change. 
The Level of Care Utilization System (LOCUS; 
American Association of Community 
Psychiatrists, 2016) describes six major domains 
of service levels for people with CODs: 
1. Recovery Maintenance/Health Management 
2. Low Intensity Community Based Services 
3. High Intensity Community Based Services 
4. Medically Monitored Non-Residential Services 
5. Medically Monitored Residential Services 
6. Medically Managed Residential Services 
Chapter 3 further addresses levels of care, including
services/populations associated with each.
Treatment Matching to Levels of Service 
Using the Quadrants of Care 
Effective treatment matching is an essential 
component of quality care for people with CODs 
that benefts the healthcare system as a whole. 
Treatment matching not only ensures clients 
receive the appropriate type and dose of service 
needed, it can help reduce unnecessary lengths 
of stay for residential treatment and helps reserve 
use of costly healthcare resources for those who 
truly require complex interventions. The widely 
used Four Quadrant Model (Ries, 1993; Exhibit 
7.1) provides a framework for treatment decision 
making and prioritizing service needs for clients 
with CODs based on symptom/disorder severity. 
It has good concurrent and predictive validity 
(McDonell et al., 2012). 
Under this conceptualization, clients are catego-
rized accordingly: 
• Category I: Less severe mental disorder/less 
severe SUD 
• Category II: More severe mental disorder/less 
severe SUD 
• Category III: Less severe mental disorder/more 
severe SUD 
• Category IV: More severe mental disorder/more 
severe SUD 
For a more detailed description of each quadrant 
and how to integrate treatment matching into 
the assessment process using the Four Quadrant 
Model, see Chapter 3. 
EXHIBIT 7.1. The Four Quadrants of Care 
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Episodes of Treatment 
An individual with CODs can participate in 
recurrent episodes of treatment involving acute 
stabilization (e.g., crisis intervention, detoxifcation, 
psychiatric hospitalization) and specifc ongoing 
treatment (e.g., mental health–supported housing, 
day treatment for mental illness, or residential 
treatment for SUDs). Counselors should recognize 
the reality that clients engage in a series of 
treatment episodes, as many individuals with CODs 
progress gradually through repeated involvement 
in treatment. 
Integrated Versus Nonintegrated 
Treatment 
Providers generally treat CODs in one of three 
ways (Morisano, Babor, & Robaina, 2014): 
1. Sequential or serial treatment, in which the 
client is treated for one disorder at a time. 
This has been the historic approach, but its 
effectiveness is dubious and may lead to worse 
outcomes given that, in some conditions, 
treatment of one disorder can worsen symptoms 
of the other (e.g., exposure therapy for a client 
with posttraumatic stress disorder [PTSD] might 
lead to anxiety and distress and subsequent 
alcohol use as a form of coping). 
2. Simultaneous or parallel treatment, wherein 
the client is treated for both disorders but by 
separate providers and in separate systems. 
Although an improvement over sequential 
treatment, this approach does not lead to 
collaborative, comprehensive care. 
3. Integrated treatment, which is the preferred 
method because it addresses all of a client’s 
diagnoses and symptoms within one service 
system/agency/program and through a single 
team of providers working closely together. 
Integrated treatment is a means of actively 
combining interventions intended to address 
SUDs and mental disorders in order to treat 
both disorders, related problems, and the whole 
person more effectively. 
Integrated treatments for people with CODs 
have demonstrated superiority to nonintegrated 
approaches and help improve substance use, 
mental illness symptoms, treatment retention, 
cost effectiveness, and client satisfaction (Kelly & 
Daley, 2013; Morisano et al., 2014). For an indepth 
discussion, see the section “Integrated Care” later 
in this chapter. 
Culturally Responsive Treatment 
One defnition of cultural competence refers 
to “effective, equitable, understandable, and 
respectful quality care and services that are 
responsive to diverse cultural health beliefs and 
practices, preferred languages, health literacy and 
other communication needs” (Offce of Minority 
Health, 2018). Treatment providers should view 
clients with CODs and their treatment in the 
context of their language, culture, ethnicity, 
geographic area, socioeconomic status, gender, 
age, sexual orientation, religion, spirituality, and 
physical/cognitive disabilities. 
Cultural factors that may have an impact on 
treatment include heritage, history and experience, 
beliefs, traditions, values, customs, behaviors, 
institutions, and ways of communicating. The 
client’s culture may include distinctive ways of 
understanding disease or disorder, including 
mental disorders and SUDs, which the provider 
needs to understand. Referencing a model of 
disease that is familiar to the client can help 
communication and enhance treatment. Counselors 
should educate themselves about the cultural 
factors that are important to racial/ethnic groups 
that their clients represent. 
Clients, not counselors, defne what is cultur-
ally relevant to them. Making assumptions, 
however well intentioned, about the client’s 
cultural identity can damage the relationship 
with a client. For example, a client of Hispanic 
origin may be a third-generation U.S. citizen, fully 
acculturated, who feels little or no connection with 
her Hispanic heritage. A counselor who assumes 
this client shares the beliefs and values of many 
Hispanic cultures would be making an erroneous 
generalization. Similarly, it is helpful to remember 
that all of us represent multiple cultures. Clients are 
more than their racial/ethnic identities. A 20-year-
old African-American man from the rural south may 
identify, to some extent, with youth, rural south, 
or African-American cultural elements—or might, 
instead, identify more strongly with another cultural 
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element that is not readily apparent, such as his 
faith. Counselors are advised to open a respectful 
dialog with clients around the cultural elements 
that have signifcance to them. 
For discussion of cultural competence in SUD 
treatment, see TIP 59, Improving Cultural 
Competence (SAMHSA, 2014a). Chapter 6 
addresses cultural competency for counselors 
whose clients have CODs. 
Barriers to Treatment 
People with CODs usually have extensive 
treatment needs, which unfortunately often go 
unmet. Among the approximately 8.5 million 
U.S. adults ages 18 and older with a past-year 
SUD and any mental illness in 2018, less than 10 
percent received treatment for both disorders 
(Center for Behavioral Health Statistics and Quality, 
2019). Similarly, from 2008 to 2014, 52 percent of 
people with CODs received neither mental health 
REDUCING BARRIERS TO CARE: WHAT CAN COUNSELORS AND 
ADMINISTRATORS DO? 
• Use person-centered approaches in assessing and treating clients with CODs. Consider factors such as: 
- The client’s gender, age, race/ethnicity, or other demographic characteristic that could affect how the 
client experiences his or her illnesses and treatment. 
- The client’s cultural background, including birth status (i.e., native born vs. immigrant). 
- The client’s degree of acculturation and acculturation stress. 
- The client’s history of trauma. 
- The client’s current functional status (including housing and educational/vocational status). 
- Whether the client is experiencing any cognitive disabilities because of her or her diagnoses 
(particularly if the person has a psychotic disorder). 
- The interaction style to which the person best responds (e.g., Direct? Nonconfrontational?). 
• Consider offering harm-reduction treatments in addition to abstinence-based services. Programs that 
limit themselves to abstinence-only treatments may fail to engage and retain clients who are not ready to 
stop substance use altogether but are otherwise amenable to treatment. 
• Offer informal pretreatment services for people who are awaiting intake/appointments. 
• Adapt services to the logistical demands facing clients. For instance: 
- When possible, offer appointments throughout the week and at various times (including before and 
after normal business hours to accommodate people who work or attend school full time). 
- Use remote services (e.g., telehealth) to reach and engage clients who are immobile or live at a distance. 
• Make integrated care a priority. Programs that offer comprehensive services that work to 
simultaneously address all of a client’s needs, using the same set of providers, are more likely to keep 
clients engaged and participating in treatment than ones that are fragmented. Treating substance 
use and mental disorders in isolation hinders counselors’ ability to help clients address all aspects of 
functioning and disability, including their housing status, medication needs, and family relationships. 
These factors require attention because they can become reasons for clients to drop out. 
• Use a staged approach to interventions (i.e., engagement, persuasion, active treatment, relapse 
prevention) that is tailored to clients’ readiness to change and is fexible, as clients often move through 
stages in a nonlinear fashion. Motivational interviewing can help determine clients’ readiness for 
interventions and aids in the creation of personally meaningful and realistic treatment goals. 
• Use assertive community outreach, such as ICM and ACT services, as these foster therapeutic alliance 
and reduce practical/logistical barriers to treatment access and adherence (e.g., providing in-home 
services). 
• Emphasize COD leadership within programs. Programs need to have a director on staff whose primary 
job is to oversee COD programming, services, fdelity, and staff competency/training. 
Sources: Priester et al. (2016); SAMHSA (2009a). 
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RESOURCE ALERT: FINDING QUALITY TREATMENT FOR SUBSTANCE USE 
DISORDERS 
SAMHSA’s fact sheet helps people with SUDs make decisions about quality services and learn where to locate
SUD treatment facilities and providers (https://store.samhsa.gov/system/fles/pep18-treatment-loc.pdf). 
services nor SUD treatment in the prior year (Han, 
Compton, Blanco, & Colpe, 2017). People might 
avoid pursuing treatment given lack of afford-
ability, lack of knowledge about where to access 
treatment, and low perceived treatment need (e.g., 
not feeling ready to stop using substances, feeling 
like they could handle mental illness on their own) 
(Han, Compton, et al., 2017). Other common 
obstacles to accessing and benefting from COD 
treatment include (Priester et al., 2016): 
• Attitudinal and motivational barriers. 
• Personal beliefs about and cultural conceptions 
of mental illness, addiction, and treatment. 
• A lack of culturally sensitive/responsive 
assessments and treatments. 
• Gender-specifc factors. (e.g., a history of 
violence/abuse/trauma among women). 
• Racial/ethnic factors. (e.g., lower rates of 
diagnosis and treatment referral for minorities 
than for Whites.) 
• Stigma. 
• Impaired cognition and insight (particularly 
among people with serious mental illness [SMI]). 
• Logistical barriers (e.g., lack of transportation, 
childcare needs, limited access to resources). 
• Limited social support. 
• High levels of distress. 
• Providers’ inability to identify CODs because 
of inadequate training, lack of comprehensive 
screening and assessment procedures, or both. 
• A dearth of COD-specialized services across 
inpatient and outpatient settings. 
• Social, political, systemic, and legal barriers 
(e.g., poor service availability, insurance 
barriers). 
• Socioeconomic factors, like low income, 
relying on public assistance, being uninsured, 
or Medicaid restrictions affecting program 
reimbursement. 
• Organizational “red tape” leading to delays in 
care and lack of service provision. 
Some populations, such as women, diverse racial/ 
ethnic groups , people involved in the criminal 
justice system, and individuals experiencing 
homelessness, are especially vulnerable to 
treatment access challenges and poor outcomes. 
Learn more about these groups and how to adapt 
services to meet their needs in Chapter 6. 
Treatment Models
Integrated Care 
Integrated interventions are specifc treatment 
strategies or techniques in which interventions for 
CODs are combined in a single session/interaction 
or in a series of interactions/multiple sessions. 
Integrated interventions can include a wide range 
of techniques. Some examples include: 
• Integrated screening and assessment processes. 
• Dual recovery mutual-support group meetings. 
• Dual recovery groups (in which recovery skills for 
both disorders are discussed). 
• Motivational enhancement interventions 
(individual or group) that address both mental 
and substance use problems. 
• Group interventions for people with the triple 
diagnosis of mental disorder, SUD, and another 
problem, such as a chronic medical condition 
(e.g., HIV), trauma, homelessness, or criminality. 
• Combined psychopharmacological 
interventions, in which a person receives 
medication designed to reduce addiction to or 
cravings for substances as well as medication for 
a mental disorder. 
Integrated interventions can be part of a single 
program or can be used in multiple program 
settings. 
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INTEGRATED CARE: PARTNERSHIPS FOR PHARMACOTHERAPY 
Recovery-oriented systems of care foster both integrated care for the simultaneous treatment of mental 
illness and SUDs but also foster critical processes, like active linkages, warm handoffs, and ongoing follow-
up from one stage or environment of care to the next. This is particularly important for people with SMI 
because these diagnoses tend to require lifelong monitoring and management of potentially debilitating 
symptoms. If a client is not responding to a nonpharmacological treatment, consider whether: 
• An alternative treatment or service (e.g., a different psychotherapeutic approach, medication, mutual 
support) is needed. 
• The treatment is a good match the client’s level of service need. 
• The treatment is a good match for the client’s readiness for change. 
Given that medication often plays a role in helping people with SMI achieve and sustain recovery, it may 
be worth considering whether referral of clients with CODs (and especially SMI) to a provider qualifed to 
assess for pharmacologic options is needed. 
Behavioral health programs should encourage the provider making that referral to do a warm handoff and 
follow up with the client in 2 to 4 weeks to determine how well the medication is working and whether 
the client has any concerns. If pharmacotherapy is being provided offsite (e.g., to a methadone clinic), the 
provider will need to obtain the client’s written consent to discuss with the prescribing provider how the 
client is faring, whether medication seems to be effective, and whether any nonpharmacologic treatments 
or services need to be tailored in any way as a result of the client taking medication. 
For more guidance about medication treatments for CODs, see the section “Pharmacotherapy” at the end of
this chapter. Also see the text box “Knowing When To Refer for Medication Management” within that section.
Empirical Evidence of Integrated Care for 
CODs 
The integrated model of care is considered a 
best practice for serving people with CODs. (See 
“Resource Alert: Implementing Integrated Care for 
People With CODs.”) It has been linked to many 
desirable substance-, psychiatric-, functional-, and 
service-related outcomes, including decreased 
substance use and abstinence (Drake, Bond, et 
al., 2016; Flanagan et al., 2016; Kelly & Daley, 
2013; McGovern et al., 2015; Ruglass et al., 2017; 
Schumm & Gore, 2016; Sterling, Chi, & Hinman, 
2011); improved mental functioning (Alterman, Xie, 
& Meier, 2011; Drake, Bond, et al., 2016; Flanagan 
et al., 2016; Kelly & Daley, 2013; McGovern, 
Lambert-Harris, Ruglass, et al., 2017); decreased 
emergency department (ED) visits, inpatient hos-
pitalizations, and healthcare costs (Morse & Bride, 
2017); gains in independent housing and com-
petitive employment (Drake, Bond, et al., 2016); 
improved life satisfaction or quality of life (Drake, 
Bond, et al., 2016); and greater client satisfaction 
(Schulte, Meier, & Stirling, 2011). 
Integrated COD care can be effective across different
settings and in diverse populations, including: 
• In residential facilities (McKee, Harris, & 
Cormier, 2013). Here, integrated care has been 
associated with signifcant reductions in mental 
illness symptoms, improvements in COD-related 
knowledge and skills, increased self-esteem, 
and good client satisfaction—even among 
clients with complex, challenging clinical and 
psychosocial histories (e.g., presence of PTSD, 
polysubstance misuse, childhood maltreatment, 
adolescent substance misuse, unstable housing, 
reliance on public assistance, being unemployed 
or out of school). 
• In a variety of criminal justice–related settings, 
such as prebooking diversion programs, drug 
or mental health courts, in jails or prisons, and 
as a part of community release (Peters et al., 
2017; Rojas & Peters, 2015). Integrated COD 
care has been linked to desirable outcomes 
such as improved psychiatric symptoms, 
reduced substance use, and decreased rates of 
reoffending and recidivism. 
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RESOURCE ALERT: IMPLEMENTING INTEGRATED CARE FOR PEOPLE WITH 
CODs 
• SAMHSA’s Integrated Treatment for Co-Occurring Disorders Evidence-Based Practices KIT 
(https://store.samhsa.gov/product/Integrated-Treatment-for-Co-Occurring-Disorders-Evidence-Based-
Practices-EBP-KIT/SMA08-4366) 
• Case Western Reserve’s Center for Evidence-Based Practices. Integrated Dual Disorder Treatment 
Clinical Guide (www.centerforebp.case.edu/client-fles/pdf/iddtclinicalguide.pdf) 
• With people experiencing homelessness 
(Polcin, 2016; Smelson et al., 2016). In these 
populations, integrated COD treatment can 
help reduce substance use and mental illness 
symptoms while, depending on the housing 
service model used, also increasing housing 
stability and retention. 
Assertive Community Treatment 
Developed in the 1970s by Stein and Test (Stein & 
Test, 1980; Test, 1992) for clients with SMI, the ACT 
model was designed as an intensive, long-term 
approach to providing services for those who 
were reluctant to engage in traditional treatment 
approaches and who required signifcant outreach 
and engagement activities. ACT has evolved and 
been modifed to address the needs of individuals 
with mental disorders (especially SMI) and co-
occurring SUDs (De Witte et al., 2014; Fries & 
Rosen, 2011; Manuel, Covell, Jackson, & Essock, 
2011; Young, Barrett, Engelhardt, & Moore, 2014). 
Program Model 
ACT programs typically use intensive outreach 
activities, active and continued engagement 
with clients, and a high intensity of services. 
Multidisciplinary teams, including specialists in key 
areas of treatment, provide a range of services to 
clients. Members typically include mental health 
and SUD treatment counselors, case managers, 
nursing staff, and psychiatric consultants. The ACT 
team provides the client with practical assistance in 
life management as well as direct treatment, often 
within the client’s home environment, and remains 
responsible and available 24 hours a day (SAMHSA, 
2008). The team has the capacity to intensify 
services as needed and may make several visits 
each week (or even per day) to a client. Caseloads 
are kept smaller than other community-based 
treatment models to accommodate the intensity 
of service provision (a 1:10 staff-to-client ratio is 
typical). 
ACT Activities and Interventions 
Examples of ACT interventions include (Bond & 
Drake, 2015; SAMHSA, 2008): 
• Outreach/engagement. To involve and 
sustain clients in treatment, counselors and 
administrators must develop multiple ways 
to attract, engage, and reengage clients. 
Expectations for clients are often minimal to 
nonexistent, especially in programs serving very 
resistant or hard-to-reach clients. 
• Practical assistance in life management. This 
feature incorporates case management activities 
that facilitate linkages with support services in 
the community, including employment services. 
Whereas the role of a counselor in the ACT 
approach includes standard counseling, in many 
instances substantial time also is spent on life 
management and behavioral management 
matters. 
• Tangible support. For some clients, especially 
with SMI, help with logistical and everyday 
functional needs is critical to ensuring treatment 
access, engagement, participation, and 
retention. Supportive care can include assistance 
with housing, benefts/insurance, transportation, 
and child care. 
• Counseling. The nature of the counseling 
activity is matched to the client’s motivation and 
readiness for treatment. Interventions may also 
involve family and other support networks as 
appropriate. 
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NINE ESSENTIAL FEATURES OF 
ACT 
1. Services that are provided in the community 
rather than in clinic offces 
2. Assertive engagement with active outreach 
3. Holistic approaches that address clients’ 
symptoms, medication needs, housing 
diffculties, fnancial needs, and other areas of 
daily living (e.g., transportation) 
4. A multidisciplinary team of mental health 
service and SUD treatment professionals 
(e.g., counselors, psychiatrists, social workers, 
psychiatric and mental health nurses 
[specialty practice registered nurses], case 
managers) 
5. Providing clients with services directly rather 
than utilizing referrals to other professionals 
6. Integrated services that are tailored to 
comprehensively and simultaneously address 
a client’s full range of clinical, functional, 
vocational, social, and everyday living needs 
7. A low client–provider ratio (usually about 10 
clients per provider) 
8. Continuous care, including 24/7 emergency 
services 
9. Focus on helping to support long-term rather 
than acute recovery 
Source: Bond & Drake (2015). 
• Crisis assessment and intervention. This is 
provided during extended service hours (24 
hours a day, ideally through a system of on-call 
rotation). 
Key Modifcations for Integrating COD 
Treatment 
As applied to CODs, the goals of the ACT model 
are to engage the client in a helping relationship, 
to assist in meeting basic needs (e.g., housing), 
to stabilize the client in the community, and to 
provide direct and integrated SUD treatment and 
mental health services. The standard ACT model 
as developed by Test (1992) has been modifed 
to include treatment for people who have SUD as 
well as SMI (Bond & Drake, 2015) and to address 
common needs within the COD community (e.g., 
housing needs, criminal justice–related needs). Key 
elements in this evolution have been (Neumiller et 
al., 2009): 
• Offering direct SUD interventions for clients 
with CODs (often through the inclusion of an 
addiction counselor on the multidisciplinary 
team) or, if not possible, referral to SUD 
treatment. 
• Using a COD-based model of care that focuses 
on specialized services, a nonconfrontational 
and supportive milieu, and recovery-oriented 
stages of care. 
• Providing higher intensity of services via “mini-
teams” of case managers, mental health service 
and SUD treatment providers, and consumer 
advocates. 
• Adapting ACT to support housing placement, 
such as: 
- Integrating a Housing First (HF) model of 
supportive permanent housing. 
- Including outreach workers and assistants to 
give providers more time with clients. 
- Placing time limits on services to encourage 
client engagement in interventions that 
support independent living (like employment 
and vocational training). 
- Monitoring psychiatric symptoms and 
medication response. 
- Offering SUD treatment/education. 
- Adding residential housing as a temporary 
solution for clients in the process of obtaining 
independent stable housing. 
• Modifying for criminal justice settings/ 
populations (Lamberti et al., 2017; Landess & 
Holoyda, 2017; Marquant, Sabbe, Van Nuffel, 
& Goethals, 2016) by collaborating with 
and including criminal justice agencies and 
professionals (e.g., probation offcers) in the 
ACT team; using court sanctions or other legal 
leverage to increase motivation and treatment 
participation/retention; applying forensic 
rehabilitation strategies to target factors 
associated with reoffending and recidivism; 
and educating and training providers in unique 
aspects of criminal justice–mental health 
collaboration. 
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SUD treatment strategies are related to the client’s
motivation and readiness for treatment and include: 
• Enhancing motivation (for example, through use 
of motivational interviewing). 
• Cognitive–behavioral skills for relapse prevention. 
• Mutual-support programming, including peer 
recovery supports to strengthen recovery. 
• Psychoeducational instruction about addictive 
disorders. 
For clients uninterested in abstinence, motivational 
approaches to ACT can highlight the detrimental 
effects of substance use on their lives and those of 
the people around them. Therapeutic interventions 
are then modifed to meet the client’s current stage 
of change and receptivity. Learn more in Chapter 
5 and in TIP 35, Enhancing Motivation for Change 
in Substance Use Disorder Treatment (SAMHSA, 
2019c). 
Populations Served 
When modifed as described previously for CODs, 
the ACT model is capable of including clients with 
greater mental and functional disabilities who 
do not ft well into many traditional treatment 
approaches. The characteristics of those served 
by ACT programs for CODs include people with 
an SUD and mental illness, SMI (e.g., intractable 
depression, bipolar disorder, schizophrenia and 
other psychotic disorders), serious functional 
impairments, avoidance of or poor response to 
traditional outpatient mental health services and 
SUD treatment, homelessness, criminal justice 
involvement, or some combination thereof. 
Consequently, clients targeted for ACT often are 
high users of expensive service delivery systems 
(EDs and hospitals) as immediate resources for 
mental health and SUD services. 
Empirical Evidence for ACT 
The ACT model has been researched widely as 
a means of providing community-based services 
to people with chronic mental illness. The low 
caseload ratio and delivery of community-based 
services, combined with intensive attention, 
structure, monitoring, and outreach, are benefcial 
for people with SMI, because SMI is typically 
unstable and highly disabling. For instance, 
a randomized trial of integrated ACT versus 
standard case management found ACT signifcantly 
improved medication adherence among people 
with psychotic disorders and SUDs over a 3-year 
period (Manuel et al., 2011). 
Research on ACT for individuals with CODs has 
been somewhat limited compared with research 
on ACT for mental illness alone, and fndings 
to date have been mixed. ACT demonstrated 
superiority to standard clinical case management 
in reducing alcohol use and incarcerations among 
people with CODs plus antisocial personality 
disorder (PD) but not people with CODs without 
antisocial PD (ASPD; Frisman et al., 2009). 
However, this study used a small sample size 
and lacks generalizability. ACT combined with 
integrated dual disorder treatment (including from 
an addiction specialist) for people with SMI and 
SUD (Morse, York, Dell, Blanco, & Birchmier, 2017) 
improved symptoms of SUDs and mental illness, 
including decreasing alcohol use but not drug 
use or overall substance use. In a SAMHSA grant-
funded program that provided ACT and integrated 
COD treatment services to people experiencing 
chronic homelessness (Young et al., 2014), ACT 
was associated with improved housing stability, 
global mental health, past-month depression and 
anxiety, client self-esteem and decision-making 
abilities, treatment satisfaction, and treatment 
RESOURCE ALERT: IMPLEMENTING ACT FOR PEOPLE WITH CODs 
• SAMHSA’s ACT for Co-Occurring Disorders Evidence-Based Practices KIT 
(https://store.samhsa.gov/product/Assertive-Community-Treatment-ACT-Evidence-Based-Practices-EBP-
KIT/sma08-4344) 
• Georgia Department of Behavioral Health & Developmental Disabilities Program Tool Kit for ACT
(https://dbhdd.georgia.gov/sites/dbhdd.georgia.gov/fles/related_fles/document/Georgia%20Toolkit%20 
for%20ACT%20Teams%20docxfnal%202015.pdf) 
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engagement but not self-reported alcohol or illicit 
drug use. In a review of outpatient treatments for 
schizophrenia and SUD (De Witte et al., 2014), 
integrated ACT outperformed treatment as usual 
in terms of substance use, hospitalizations, stable 
housing, and negative and disorganized symptoms 
of psychosis but was no better than integrated 
case management at reducing substance use and 
improving psychiatric symptom severity. 
These mixed fndings are likely due in part to ACT’s 
unproven ability to ameliorate SUDs. A review of 
randomized clinical trials of ACT for substance 
misuse (Fries & Rosen, 2011) found that it helped 
reduce alcohol and drug use over time when 
supplemented with SUD treatment. But effects 
were small, and reductions in substance use were 
typically no better than those from other treatment 
approaches (e.g., case management). This suggests 
that traditional ACT is likely not an effective 
addiction management tool on its own but when 
used with adjunctive SUD treatment (e.g., inclusion 
of addiction counselors, use of contingency 
management for abstinence) may be as effective as 
case management at improving substance-related 
outcomes. Nevertheless, based on the weight 
of evidence, ACT is a recommended treatment 
model for clients with CODs, especially when 
used as an integrated treatment with adjunct 
substance use services. 
Examples of ACT Programs 
The University of Washington Program for ACT 
The University of Washington’s Program for ACT 
(PACT) was established to provide outreach-based 
services to clients with mental and addiction needs, 
particularly people with SMI and SUDs. Washington 
PACT teams carry a low caseload (1:10 provider– 
client ratio) and use high-intensity, multidisciplinary 
services (e.g., 24/7 care, treatments predominantly 
offered in the community), including CBT, SUD 
treatment, family psychoeducation, motivational 
interviewing, pharmacotherapy, relapse prevention, 
crisis management, psychiatric rehabilitation, 
community outreach, social skills training, and 
supported education/employment services. The 
program currently has 15 teams located throughout 
Washington State. Program reports indicate up to 
60 percent of Washington PACT team clients have 
CODs. 
RESOURCE ALERT: UNIVERSITY 
OF WASHINGTON PACT 
IMPLEMENTATION AND 
ENGAGEMENT TOOLS 
The PACT program website lists resources to 
help programs implement ACT and improve 
client engagement (https://depts.washington. 
edu/ebpa/projects/revised_comprehensive_ 
assessment_r-ca). Resources include: 
• A blank weekly client schedule form. 
• A sample daily staff schedule. 
• A sample client contact log. 
• An ACT Transition Assessment Scale to assess 
client readiness to step down to less intensive 
services. 
• The PACT Comprehensive Assessment Scale, 
used to help programs assess the client/family 
needs and determine which program services 
would best serve the client. 
• A sample case study. 
• Putting It Together Worksheet, used to 
summarize content from assessment and 
develop a treatment plan. 
• Checklist of areas for further assessment and 
tools for follow-up assessment. 
• Links to specifc assessment tools for: 
− PTSD. 
− Suicide risk. 
− Alcohol use disorder (AUD). 
− SUD. 
− Client ambivalence to change. 
− Recovery assessment. 
− Strengths assessment. 
−Nicotine use. 
− Psychiatric rehabilitation. 
Mercy Maricopa ACT Program 
Mercy Maricopa, an integrated physical and 
behavioral health Medicaid managed care 
plan, offers an ACT program of 23 ACT teams 
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(including 3 forensic ACT programs) specifcally 
focused on people with SMI. ACT teams provide 
comprehensive, multidisciplinary wraparound 
care including psychiatric and SUD treatment, 
medication management, case management, social 
services, vocational rehabilitation, housing and 
vocational assistance, and peer support. 
A healthcare analysis from 2018 (NORC, 2018) 
found that, pre–post enrollment in the ACT 
program, clients incurred signifcantly lower 
overall facility costs ($608 less per member per 
quarter), overall professional service costs ($485 
less), behavioral health service costs ($410 less), 
and total behavioral health costs ($808 less). Total 
spending from pre- to postprogram participation 
decreased by $734 but was not signifcant. 
Pharmacy expenditures were signifcantly higher 
following ACT program participation ($246 more). 
ACT clients had signifcantly less ED utilization and 
fewer psychiatric hospitalizations from baseline 
to postprogram participation. Compared to a 
matched comparison group not participating in the 
ACT program, ACT clients had signifcantly lower 
rates of ED utilization. 
Integrated Case Management 
The earliest model of case management was 
primarily a brokerage model. Linkages to services 
were based on clients’ individual needs, but case 
managers provided no formal clinical services. 
Over time, it became apparent that providers 
could provide more effective case management 
services. Thus, clinical case management largely 
supplanted the brokerage model. ICM emerged as 
a strategy in the late 1980s and early 1990s. It was 
designed as a thorough, long-term service to assist 
clients with SMI (particularly those with mental and 
functional disabilities and a history of not adhering 
to prescribed outpatient treatment) by establishing 
and maintaining linkages with community-based 
service providers. 
ICM is not a precisely defned term but rather is 
used in the literature to describe an alternative to 
both traditional case management and ACT. The 
goals of the ICM model are to engage individuals 
in a trusting relationship, assist in meeting their 
basic needs (e.g., housing), and help them access 
and use brokered services in the community. The 
fundamental element of ICM is a low caseload 
per case manager, which translates into more 
intensive and consistent services for each client. 
TIP 27, Comprehensive Case Management for 
Substance Abuse Treatment (Center for Substance 
Abuse Treatment [CSAT], 2000b), contains more 
information on the history of case management, 
both how it has developed to meet the needs of 
clients in SUD treatment (including clients with 
CODs) and specifc guidelines about how to 
implement case management services. 
Program Model 
ICM programs typically involve outreach and 
engagement activities, brokering of community-
based services, direct provision of some support/ 
counseling services, and a higher intensity of 
services than standard case management. The 
integrated case manager assists the client in 
selecting services, facilitates access to these 
services, and monitors the client’s progress through 
services provided by others (inside or outside the 
program structure or by a team). Client roles in 
this model include serving as a partner in selecting 
treatment components. 
In some instances, the ICM model uses 
multidisciplinary teams similar to ACT. The 
composition of the ICM team is determined by the 
resources available in the agency implementing 
the programs. The team often includes a 
cluster-set of case managers rather than the 
specialists prescribed as standard components 
of the treatment model. The ICM team may 
offer services provided by ACT teams, including 
practical assistance in life management (e.g., 
housing) and some direct counseling or other 
forms of treatment. Caseloads are kept smaller 
than those in other community-based treatment 
models (typically, the client–counselor ratio 
ranges from 15:1 to 25:1) but larger than those in 
the ACT model. Because the case management 
responsibilities are so wide ranging and require a 
broad knowledge of local treatment services and 
systems, a typically trained counselor may require 
some retraining or close, instructive supervision in 
order to serve effectively as a case manager. 
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ADVICE TO ADMINISTRATORS: 
TREATMENT PRINCIPLES FROM 
ICM 
• Select clients with more mental/functional 
disabilities who are resistant to traditional 
outpatient treatment. 
• Use a low caseload per case manager to 
accommodate more intensive services. 
• Assist in meeting basic needs (e.g., housing). 
• Facilitate access to and utilization of brokered 
community-based services. 
• Provide long-term support, such as counseling 
services. 
• Monitor the client’s progress through services 
provided by others. 
• Use multidisciplinary teams. 
Treatment Activities and Interventions 
Examples of ICM activities and interventions 
include: 
• Engaging the client in an alliance to facilitate 
the process and connecting the client with 
community-based treatment programs. 
• Assessing needs, identifying barriers to 
treatment, and facilitating access to treatment. 
• Offering practical help with life management; 
facilitating linkages with community support 
services. 
• Making referrals to treatment programs offered 
by others in the community; see also TIP 27 
(CSAT, 2000b) for guidance on establishing 
linkages for service provision and interagency 
cooperation. 
• Advocating for the client with treatment 
providers and service delivery systems. 
• Monitoring progress. 
• Providing counseling and support to help the 
client maintain stability in the community. 
• Crisis intervention. 
• Assisting in integrating treatment services by 
facilitating communication between service 
providers. 
Key Modifcations of ICM for CODs 
Key ICM modifcations from basic case manage-
ment for clients with CODs include: 
• Using direct interventions for clients with CODs, 
such as enhancing motivation for treatment 
and discussing the interactive effects of mental 
disorders and SUDs. 
• Making referrals to providers of integrated 
SUD treatment and mental health services 
or, if integrated services are not available or 
accessible, facilitating communication between 
separate brokered mental health service and 
SUD treatment providers. 
• Coordinating with community-based services 
to support the client’s involvement in mutual-
support groups and outpatient treatment 
activities. 
Empirical Evidence 
Most published literature on ICM has focused on 
mental illness, with fewer U.S. studies examining 
SUD or CODs. ICM may help people with SMI 
reduce hospitalizations, stay in treatment longer, 
and improve social functioning. But many of these 
studies are considered to be of low quality (e.g., 
small sample sizes, fawed methodology or study 
design), and fndings are not consistently better 
than those from standard care or other non-ICM 
approaches (Dieterich et al., 2017). Some research-
ers have reported positive effects of ICM for SMI in 
terms of: 
• Increasing social integration among people in 
supported housing and acquisition of Section 8 
housing vouchers (Tsai & Rosenheck, 2012). 
• Improving physical health (e.g., weight, blood 
pressure) among veterans (Harrold et al., 2018). 
• Reducing mental illness hospitalizations (by 70
percent); average number of days hospitalized for
mental illness (by 75 percent); and average 30-day
inpatient psychiatric service costs, outpatient
psychiatric service costs, and outpatient medical
service costs (Kolbasovsky, 2009).
Studies of ICM and substance use in U.S. 
populations are tentatively positive, but the 
research is limited in number and generalizability. In 
women with substance misuse receiving Temporary 
Assistance for Needy Families (Morgenstern et al., 
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2009), ICM was associated with greater rates of 
short-term and long-term abstinence and a greater 
likelihood of being employed full time than was 
usual care (i.e., screening and referral). In a related 
study, Kuerbis, Neighbors, and Morgenstern 
(2011) observed paradoxical moderating effects of 
depression on ICM substance use outcomes such 
that women with substance misuse and higher 
scores of depression who participated in the ICM 
program had better SUD treatment engagement 
and fewer drinks per drinking days than women 
in the program with lower scores of depression. 
Women with higher depression also exhibited 
higher or equal rates of SUD treatment attendance 
and percentage of days abstinent than less-
depressed women. Hence, the ICM program was 
effective at improving addiction outcomes and may 
be especially so among women with comorbid high 
depression. 
Regarding CODs, ICM appears effective in 
specifc populations (e.g., veterans, people with 
housing needs, individuals in the criminal justice 
system), although the magnitude of effect of these 
programs is unclear, as is whether they are superior 
to ACT or other approaches. A rural-based ICM for 
people with and without CODs (Mohamed, 2013) 
helped more military veterans with CODs engage 
in rehabilitation, housing, vocational, and addiction 
services than it did veterans without CODs. The 
ICM program was associated with improvements 
in mental disorder symptoms, distress, quality 
of life, treatment satisfaction, income, and days 
employed; however, there were no differences in 
any of these variables between veterans with and 
without CODs. 
Malte, Cox, and Saxon (2017) also examined 
veterans receiving ICM but with a focus on 
promoting housing stability and addiction recovery. 
Almost 60 percent of program participants had a 
comorbid depressive disorder, 43 percent PTSD, 31 
percent an anxiety disorder, 21 percent a psychotic 
disorder, and 19 percent a bipolar disorder. Over 
time, participants increased their percentage of 
days spent in their own home or in transitional 
housing; decreased days spent homeless or living 
with others; increased rates of 30-day abstinence; 
and improved their Addiction Severity Index (ASI) 
scores (legal, drug, and psychiatric composite 
scales). However, none of these improvements 
were signifcantly different from those observed in 
the control condition (a housing support group). 
Nevertheless, the addiction/housing ICM program 
was associated with more days spent in SUD 
treatment (almost 53 days longer than controls), 
greater treatment participation, and higher 
treatment satisfaction. 
The Northern Kentucky Female Offender Reentry 
Project (McDonald & Arlinghaus, 2014) examined 
ICM among incarcerated women with SMI, SUDs, 
or both (78 percent had a COD). Compared with 
women who only participated in the program while 
incarcerated, women who participated during 
imprisonment and after release demonstrated 
better outcomes in educational attainment (e.g., 
obtaining a General Equivalency Degree, enrolling 
in college after release), obtaining part- or full-time 
work, SUD treatment and mental health service 
engagement, and recidivism. 
Examples of ICM Programs 
SAMHSA’s Cooperative Agreement to Beneft 
Homeless Individuals 
SAMHSA’s Cooperative Agreement to Beneft
Homeless Individuals (CABHI) programs use
integrated approaches, including ICM, to address
addiction, mental illness, and medical, housing, and
employment needs. Funding is administered as part
of SAMHSA’s Recovery Support Strategic Initiative,
with the overarching goal of helping people with
SUDs, SMI, or CODs reduce the experience of
homelessness (e.g., via subsidized and supportive
housing). The program was initiated in 2011 to
provide funding to public and nonproft entities
and was expanded in 2013 to offer funds to help
establish or enhance statewide service infrastructure
and planning. It again expanded in 2016 to include
more communities (including tribal communities)
and nonproft organizations. Integrated services
offered by CABHI programs include community
outreach; screening, assessment, and treatment for
addictions, mental illness, or both; peer recovery
support services; and ICM. 
The Extended Hope Project in Yolo County, 
California, is a CABHI recipient (2016–2019) 
offering integrated treatments to improve housing 
stability, behavioral and physical health, and 
criminal justice status for people in Yolo County 
with CODs who are experiencing homelessness. 
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The program includes: 
• A screening, assessment, and triage service 
to link clients with outreach workers to assess 
clients for needed services and enroll them in 
case management. 
• An ICM and treatment team, including case 
managers, who responded to crisis needs, 
worked with clients on shared treatment 
decision making, and helped develop tailored 
treatment plans; peer recovery support 
specialists, who provided mentorship, support, 
and education; and an employment specialist to 
aid with job placement. 
• Collaboration with a housing navigator to 
help connect clients with permanent housing 
placement and teach eviction prevention 
strategies. 
Pathways to Housing, Inc.’s HF Programs 
The HF program uses the supportive permanent
housing model (see Chapter 6) to help people with
CODs obtain stable housing and prevent future
homelessness (Tsemberis, 2010). Originally launched
in New York City in 1992, programs now also exist
in Washington, DC, Vermont, Pennsylvania, and
Canada. HF programs do not require clients to
achieve abstinence before enrolling and instead
integrate SUD and mental disorder treatment with
housing support services (e.g., ACT or ICM).
The Tulsa Housing and Recovery Program, a 
recipient of the SAMHSA Services in Supportive 
Housing 5-year grant in 2009, is a collaboration 
between community mental health centers and 
housing providers that offers SUD treatment, 
mental health services, and supportive housing (via 
the HF model) to individuals with CODs who are 
experiencing homelessness. Integrated services 
and ICM are key components of the program. From 
2009 to 2013, the program reported numerous 
improved outcomes (Shinn & Brose, 2017), 
including the following: 
• 94 percent of clients retained in housing (i.e., 
continuously housed for 12 months or longer) 
• 72 percent of clients reduced their substance 
use at 6 months 
• 70 percent scored at minimal or no risk for 
substance misuse at 6 months 
• 69 percent reported at least 3 months of 
abstinence 
• 79 percent had a reduction in self-reported 
trauma symptoms at 6 months 
• 81 percent achieved trauma-related treatment 
gains in 6 months 
• 100 percent of clients were successfully linked 
to healthcare services through peer support and 
nurse-led assessment and triage 
Comparison of ACT and ICM 
Both ACT and ICM share the following key activi-
ties and interventions: 
• Focus on increased treatment participation 
• Client management 
• Abstinence as a long-term goal, with short-term 
supports 
• Stagewise motivational interventions 
• Psychoeducational instruction 
• Cognitive–behavioral relapse prevention 
• Encouraging participation in mutual-support 
programs 
• Supportive services 
• Skills training 
• Crisis intervention 
• Individual counseling 
Diferences Between ACT and ICM 
ACT is more intensive than most ICM approaches.
The ACT emphasis is on developing a therapeutic
alliance with the client and delivery of service
components in the client’s home, on the street, or in
program offces (based on the client’s preference).
ACT services are provided predominantly by the
multidisciplinary staff of the ACT team, and the
program often is located in the community (Bond &
Drake, 2015; Ellenhorn, 2015). Most ACT programs
provide services 16 hours a day on weekdays,
8 hours a day on weekends, plus on-call crisis
intervention, including visits to the client’s home
at any time, day or night, with the capacity to
make multiple visits to a client on any given day.
Caseloads usually are 10:1. ICM programs typically
include fewer hours of direct treatment, but they
may include 24-hour crisis intervention; the focus of
ICM is on brokering community-based services for
the client. ICM caseloads range up to 25:1. 
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The ACT multidisciplinary team shares responsibility
for the entire defned caseload of clients and meets 
frequently (ideally, teams meet daily) to ensure that 
all members are fully up-to-date on clinical matters. 
Although team members may play different roles, 
all are familiar with every client on the caseload. 
The nature of ICM team functioning is not as 
defned, and cohesion is not necessarily a focus of 
team functioning; the ICM team can operate as a 
loose organization of independent case managers 
or as a cohesive unit in a manner similar to ACT. 
Also, the ACT model can include the clients’ family 
within treatment services (White, McGrew, Salyers, 
& Firmin, 2014), which is not always true for ICM 
models. 
ICM most frequently involves the coordination of 
services across different systems over extended 
periods of time, whereas ACT integrates and 
provides treatment for CODs within the team. As 
a consequence, advocacy with other providers 
is a major component of ICM, but advocacy 
in ACT focuses on ancillary services. The ACT 
multidisciplinary team approach to treatment 
emphasizes providing integrated treatment for 
clients with CODs directly, assuming that the team 
members include both mental health and SUD 
treatment counselors and are fully trained in both 
approaches. 
Recommendations for Extending ACT and 
ICM in SUD Treatment Settings 
ACT and ICM models translate easily to SUD 
treatment. The consensus panel offers fve recom-
mendations for successful use of ACT and ICM in 
SUD treatment with clients who have CODs: 
1. Use ACT and ICM for clients who require 
considerable supervision and support. ACT 
is a treatment alternative for those clients 
with CODs who have a history of sporadic 
adherence with continuing care or outpatient 
services and who require extended monitoring 
and supervision (e.g., medication monitoring 
or dispensing) and intensive onsite treatment 
supports to sustain their tenure in the 
community (e.g., criminal justice clients). For this 
subset of the COD population, ACT provides 
accessible treatment supports without requiring 
return to a residential setting. The typical ICM 
program is capable of providing less intense 
levels of monitoring and supports, but can still 
provide these services in the client’s home on a 
more limited basis. 
2. Develop ACT programs, ICM programs, or 
both selectively to address the needs of 
clients with SMI who have diffculty adhering 
to treatment regimens most effectively. 
ACT, which is a more complex and expensive 
treatment model to implement than ICM, 
has been used for clients with SMI who have 
diffculty adhering to a treatment regimen. 
Typically, these are among the highest users 
of expensive (e.g., ED, hospital) services. ICM 
programs can be used with treatment-resistant 
clients who are clinically and functionally 
capable of progressing with much less intensive 
onsite counseling and less extensive monitoring. 
3. Extend and modify ACT and ICM for other 
clients with CODs in SUD treatment. With 
their strong tradition in the mental health feld, 
particularly for clients with SMI, ACT and ICM 
are attractive, accessible, and fexible treatment 
approaches that can be adapted for individuals 
with CODs. Components of these programs can 
be integrated into SUD treatment programs. 
4. Add SUD treatment components to existing 
ACT and ICM programs. Incorporating 
methods from the SUD treatment feld, such as 
substance use education, peer mutual support, 
and greater personal responsibility, can continue 
to strengthen the ACT approach as applied to 
clients with CODs. The degree of integration of 
substance use and mental health components 
within ACT and ICM depends on the ability of 
the individual case manager/counselor or the 
team to provide both services directly or with 
coordination. 
5. Extend the empirical base of ACT and ICM 
to further establish their effectiveness for 
clients with CODs in SUD treatment settings.
The empirical base for ACT derives largely from 
application among people with SMI and needs 
to be extended to establish frm support for the 
use of ACT across the entire COD population. 
In particular, adding an evaluation component 
to new ACT programs in SUD treatment can 
provide documentation currently lacking in 
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VOCATIONAL SERVICES AND TREATMENT MODELS 
Vocational rehabilitation has long been one of the services offered to clients recovering from mental 
disorders and, to some degree, to those recovering from SUDs. The fact is that many individuals with CODs 
are not working, including 9 percent who are unemployed and 23 percent not in the labor force for other 
reasons (e.g., disabled, retired, in school) (Center for Behavioral Health Statistics and Quality, 2019). However, 
it is unreasonable to expect employers to tolerate employees who are actively using alcohol on the job or 
who violate their drug-free workplace policies. 
Vocational support is vital because steady and unsteady work among people with CODs has been linked 
to improvement in symptoms, achieving independent housing, and enhanced quality of life (McHugo, 
Drake, Xie, & Bond, 2012). Vocational programs and supported employment can help clients with CODs 
gain competitive employment, more work hours, and increased earnings (Frounfelker, Wilkniss, Bond, 
Devitt, & Drake, 2011; Luciano & Carpenter-Song, 2014; Marshall et al., 2014; Mueser, Campbell, & Drake, 2011). 
Therefore, if work is to become an achievable goal for individuals with CODs, vocational rehabilitation and 
supported employment should be integrated into comprehensive COD recovery services. 
Vocational services can be incorporated into many treatment models, including ACT and ICM. For more 
information about incorporating vocational rehabilitation into treatment, see TIP 38, Integrating Substance 
Abuse Treatment and Vocational Services (SAMHSA, 2000). 
the feld concerning the effectiveness and cost 
beneft of ACT in treating the person who 
misuses substances with co-occurring mental 
disorders in SUD treatment settings. The 
limitations of ICM have been listed in previous 
sections. Providers should use ACT or ICM to 
meet clients’ needs as indicated by assessment. 
Dual Recovery Mutual-Support Programs 
The dual recovery mutual-support movement is 
emerging from two cultures: the 12-Step recovery 
movement and, more recently, the culture of the 
mental health consumer movement. This section 
describes both, as well as other, consumer-driven 
psychoeducational efforts. 
In the past decade, mutual-support approaches 
have emerged for people with CODs. Mutual-
support programs apply a broad spectrum 
of personal responsibility and peer support 
principles, usually including 12-Step programs. 
These programs are gaining recognition as more 
meetings are being held in both agency and 
community settings throughout the United States, 
Canada, and abroad. 
In recent years, dual recovery mutual-support 
organizations have emerged as a source of support 
for people in recovery from CODs (Bogenschutz 
et al., 2014b; Monica, Nikkel, & Drake, 2010; 
Zweben & Ashbrook, 2012). Mental health 
advocacy organizations—including the National 
Alliance for the Mentally Ill and the National 
Mental Health Association—offer resources to help 
locate dual recovery mutual-support organizations 
(see “Resource Alert: Locating Mutual-Support 
Groups for People With CODs” and Appendix B). 
At the federal level, SAMHSA also has produced 
documents identifying dual recovery mutual-
support organizations (Center for Mental Health 
Services, 1998; CSAT, 1994). 
Several areas inform the rationale for establishing 
dual recovery programs as additions to mutual-sup-
port programs (Bogenschutz et al., 2014b; Timko, 
Sutkowi, & Moos, 2010; Zweben & Ashbrook, 
2012): 
• Stigma and prejudice: Stigma related to 
both SUDs and mental illness continues to 
be problematic, despite the efforts of many 
advocacy organizations. Unfortunately, these 
negative attitudes may surface within a meeting. 
When this occurs, people in dual recovery may 
fnd it diffcult to maintain a level of trust and 
safety in the group setting. 
• Inappropriate or controversial advice
(confused bias): Many members of addiction 
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recovery groups recognize the real problem of 
cross-addiction and are aware that people use 
certain prescription medications as intoxicating 
drugs. Confusion about the appropriate role of 
psychiatric medication exists, and as a result, 
some members may offer well-intended, but 
inappropriate, advice by cautioning newcomers 
against using medications. Clearly, confused bias 
against medications may create either of two 
problems. First, newcomers may follow inappro-
priate advice and stop taking their medications, 
causing a recurrence of symptoms. Second, 
newcomers quickly may recognize confused 
bias against medications within a meeting, feel 
uncomfortable, and keep a signifcant aspect of 
their recovery a secret. 
• Interpersonal connectedness: Individuals with 
CODs often experience diffculty establishing 
and maintaining close personal relationships. 
The presence of a mental disorder could make 
establishing rapport and developing an alliance 
with mutual-support program members and 
sponsors more diffcult, subsequently hindering 
participation and causing clients to feel reluctant 
about sharing their stories and struggles with 
others who are only facing addiction rather than 
both illnesses. 
• Direction for recovery: A strength of traditional 
mutual-support program fellowships is their 
ability to offer direction for recovery that is 
based on years of collective experience. The 
new dual recovery programs offer an oppor-
tunity to begin drawing on the experiences 
that members have encountered during both 
the progression of their CODs and the process 
of their dual recovery. In turn, that body of 
experience can be shared with fellow members 
and newcomers to provide direction into the 
pathways to dual recovery. 
• Acceptance: Mutual-support program fellow-
ships provide meetings that offer settings for 
recovery. Dual recovery meetings may offer 
members and newcomers a setting of emotional 
acceptance, support, and empowerment. This 
condition provides opportunities to develop 
a level of group trust in which people can feel 
safe and able to share their ideas and feelings 
honestly while focusing on recovery from both 
illnesses. 
Although a dual-focused mutual-support program
is clearly preferable, people with CODs can still
derive beneft from attending traditional mutual-
support groups, such as Alcoholics Anonymous
(AA). A meta-analysis of 22 studies examining AA
attendance by people with CODs (Tonigan, Pearson,
Magill, & Hagler, 2018) found a signifcant effect of
increased alcohol abstinence compared with people
with CODs who did not attend AA. Attending and
being involved in AA and other non-COD-based
mutual-support groups appears to help young
adults with CODs improve abstinence, although
rates of abstinence may not improve as signifcantly
as in young adults with SUDs alone (Bergman,
Greene, Hoeppner, Slaymaker, & Kelly, 2014). 
Dual Recovery Mutual-Support Approaches 
Dual recovery mutual-support program fellowship 
groups recognize the unique value of people 
in recovery sharing their personal experiences, 
strengths, and hope to help other people in 
recovery. This section provides an overview 
of emerging mutual-support fellowships 
and describes a model mutual-support 
psychoeducational group. 
Mutual-Support Groups 
Four dual recovery mutual-support organizations 
have gained recognition in the feld. Each 
fellowship is an independent and autonomous 
membership organization with its own principles, 
steps, and traditions. Dual recovery fellowship 
members are free to interpret, use, or follow the 
program in a way that meets their own needs. 
Members use the program to learn how to manage 
their addiction and mental disorders together. The 
following section provides additional information 
on the mutual-support model. (See also “Resource 
Alert: Locating Mutual-Support Groups for People 
With CODs.”) 
1. Double Trouble in Recovery (DTR). This 
organization provides 12 Steps that are based 
on a traditional adaptation of the original 12 
Steps. For example, the identifed problem in 
Step 1 is changed to CODs, and the population 
to be assisted is changed in Step 12 accordingly. 
The organization provides a format for meetings 
that are chaired by members of the fellowship. 
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2. Dual Disorders Anonymous. This organization 
follows a similar format to DTR. It provides a 
meeting format that is used by group members 
who chair the meetings. 
3. Dual Recovery Anonymous. This organization 
provides 12 Steps adapted and expanded 
from the traditional 12 Steps, similar to DTR 
and Dual Disorders Anonymous. The terms 
“assets” and “liabilities” are used instead of the 
traditional term “character defects.” In addition, 
it incorporates affrmations into 3 of the 12 
Steps. Similar to other dual recovery fellowships, 
this organization provides a suggested meeting 
format that is used by group members who chair 
the meetings. 
4. Dual Diagnosis Anonymous. This organization 
provides a hybrid approach that uses 5 addi-
tional steps in conjunction with the traditional 
12 Steps. The fve steps differ from those of 
other dual recovery groups in underscoring the 
potential need for medical management, clinical 
interventions, and therapies. Similar to other 
dual recovery fellowships, this organization 
provides a meeting format that is used by group 
members who chair the meetings. 
The dual recovery fellowships are membership 
organizations rather than consumer service delivery 
programs. The fellowships function as autonomous 
networks, providing a system of support parallel 
to traditional clinical or psychosocial services. 
Meetings are facilitated by members, who 
are responsible, and take turns “chairing” or 
“leading” the meetings for fellow members and 
newcomers. Meetings are not led by professional 
counselors (unless a member is a professional 
counselor and takes a turn at leading a meeting), 
nor are members paid to lead meetings. However, 
the fellowships may develop informal working 
relationships or linkages with professional providers 
and consumer organizations. 
Dual recovery mutual-support program fellowships
do not provide specifc clinical or counseling
interventions, classes on psychiatric symptoms,
or any services similar to case management. Dual
recovery fellowships maintain a primary purpose of
members helping one another achieve and maintain
dual recovery, prevent relapse, and carry the
message of recovery to others who experience dual
disorders. Dual recovery mutual-support program
members who take turns chairing their meetings are
members of their fellowship as a whole. Anonymity
of meeting attendees is preserved because group
facilitators do not record the names of their fellow
members or newcomers. Fellowship members carry
out the primary purpose through the service work of
their groups and meetings. 
Groups provide various types of meetings, such 
as step study meetings, in which the discussion 
revolves around ways to use the fellowship’s 12 
Steps for personal recovery. Another type of 
meeting is a topic discussion meeting, in which 
members present topics related to dual recovery 
and discuss how they cope with situations by 
applying the recovery principles and steps of their 
fellowship. Hospital and institutional meetings 
may be provided by fellowship members to 
individuals currently in hospitals, treatment 
programs, or criminal justice settings. 
Fellowship members who are experienced in
recovery may sponsor newer members. Newcomers
may ask a member they view as experienced to help
them learn fellowship recovery principles and steps. 
Outreach by fellowship members may provide 
information about their organization to agencies 
and institutions through inservice programs, 
workshops, or other types of presentations. 
Access and Linkage 
The fellowships are independent organizations 
based on 12-Step principles and traditions that 
generally develop cooperative and informal 
relationships with service providers and other 
organizations. The fellowships can be seen as 
providing a source of support that is parallel to 
formal services, that is, participation while receiving 
treatment and continuing care services. 
Referral to dual recovery fellowships is informal: 
• An agency may provide a “host setting” for 
one of the fellowships to hold its meetings. The 
agency may arrange for its clients to attend the 
scheduled meeting. 
• An agency may provide transportation for its 
clients to attend a community meeting provided 
by one of the fellowships. 
Chapter 7 201 
TIP 42
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Substance Use Disorder Treatment for People With Co-Occurring Disorders 
RESOURCE ALERT: LOCATING MUTUAL-SUPPORT GROUPS FOR PEOPLE 
WITH CODs 
• Dual Recovery Anonymous. Index of Registered  Dual Recovery Anonymous 12-Step Meetings 
(www.draonline.org/meetings.html) 
• Faces & Voices of Recovery. Mutual Aid Groups for Co-Occurring Health Conditions, including groups 
specifcally for co-occurring mental disorders and SUDs (https://facesandvoicesofrecovery.org/resources/ 
mutual-aid-resources/) 
• SAMHSA. Behavioral Health Treatment Services Locator. Self-Help, Peer Support, and Consumer Groups 
(https://fndtreatment.gov/) 
• An agency may offer a schedule of community 
meetings provided by one of the fellowships as 
a support to referral for clients. 
Common Features of Dual Recovery Mutual-
Support Fellowships 
Dual recovery fellowships tend to have the 
following in common: 
• A perspective describing CODs and dual 
recovery 
• A series of steps providing a plan to achieve and 
maintain dual recovery 
• Literature describing the program for members 
and the public 
• A structure for conducting meetings in a way 
that provides a setting of acceptance and 
support 
• Plans for establishing an organizational 
structure to guide growth of membership, 
that is, a central offce, fellowship network of 
area intergroups, groups, and meetings. An 
“intergroup” is an assembly of people made up 
of delegates from several groups in an area. It 
functions as a communications link upward to 
the central offce or offces and outward to all 
the area groups it serves. 
Empirical Evidence 
Empirical evidence suggests that participation in 
mutual-support programs contributes substantially 
to members’ progress in dual recovery and should 
be encouraged. Specifcally, studies have found the 
following positive outcomes: 
• Among veterans with an SUD and depression, 
lower scores of depression and lower future 
alcohol use (Worley, Tate, & Brown, 2012) 
• Fewer days of alcohol and other substance 
use, better scores of mental health, and fewer 
self-reported substance-related problems 
(Rosenblum et al., 2014; Woodhead, Cowden 
Hindash, & Timko, 2013) 
• Greater treatment attendance and possibly 
increased alcohol abstinence and decreased 
drinks per drinking day over time (but not 
necessarily better than usual care) (Bogenschutz 
et al., 2014b) 
Qualitative studies (Hagler et al., 2015; Matusow 
et al., 2013; Penn, Brooke, Brooks, Gallagher, & 
Barnard, 2016; Roush, Monica, Carpenter-Song, 
& Drake, 2015) exploring perspectives of clients 
with CODs who engage in mutual-support services 
(e.g., 12-Step and SMART Recovery) also detail 
numerous perceived benefts from these programs, 
such as: 
• Fellowship building (e.g., meeting others with 
similar problems). 
• Addressing spiritual needs/topics (this may be 
considered a negative aspect by some clients). 
• Building camaraderie, affliation, and a sense of 
community. 
Dual recovery mutual-support programs recognize the unique value of people in recovery sharing their 
personal experiences, strengths, and hope to help other people in recovery. 
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• Having a “safe space” to share experiences 
without fear of judgment or rejection. 
• Increased knowledge/insight about mental 
illness and SUDs (especially how they 
interrelate). 
• Learning skills and tools that facilitate recovery. 
• Feeling empowered. 
• Developing a sense of hope for recovery. 
• Access to therapy/therapeutic services that would
otherwise be inaccessible, given lack of insurance. 
Peer Recovery Support Services 
The inclusion of peer supports—people who have 
experienced addiction, mental illness, or both 
and are in recovery—in SUD and mental illness 
recovery processes has increased substantially in 
the past decade. Peer recovery support services 
can help improve long-term recovery by increasing 
abstinence, decreasing inpatient services and 
hospitalization, and improving functioning (Bassuk, 
Hanson, Greene, Richard, & Laudet, 2016; Chinman 
et al., 2014; Davidson, Bellamy, Guy, & Miller, 2012; 
Reif, Braude, et al., 2014). 
Research suggests that peer-based services help 
people with mental disorders and SUDs improve 
clinical and functional outcomes (Acri, Hooley, 
Richardson, & Moaba, 2017; Bassuk et al., 2016; 
Chapman, Blash, Mayer, & Spetz, 2018; Chinman 
et al., 2014; Reif, Braude, et al., 2014; SAMHSA, 
2017). These include: 
• Rates of abstinence. 
• Number of days abstinent. 
• Relapse rates. 
• Treatment engagement. 
• Treatment retention. 
• Residential treatment use. 
• Rehospitalization. 
• Adherence to treatment plan. 
• Treatment completion. 
• Treatment satisfaction. 
• Relationships with treatment providers. 
• Housing stability. 
• Probation/parole status. 
• Number of criminal justice charges. 
• Recovery capital. 
• Mental disorder symptoms. 
• Knowledge about mental illness and SUDs. 
• Family functioning, including parenting abilities. 
• Access to social supports. 
Little research has examined the use of peer 
supports for CODs. Given the success of peer 
services in promoting recovery and wellness in 
people with either mental illness or addiction, it 
is reasonable to hypothesize that peer support 
could also be effective for individuals with both. 
O’Connell, Flanagan, Delphin-Rittmon, & Davidson 
(2017) found inclusion of peer supports for 
people with co-occurring psychosis and substance 
misuse signifcantly improved positive (but not 
negative) symptoms of psychosis, number of 
days of alcohol use, number of days experiencing 
alcohol-related problems, self-rated importance 
of getting treatment for alcohol misuse, feelings 
of relatedness, social functioning, and inpatient 
readmissions relative to a treatment as usual 
condition. Evidence-based interventions for CODs, 
such as ACT and integrated therapies, were not 
originally designed to include peer support, but 
more and more, peer providers are becoming a 
formal part of COD treatment teams (Harrison, 
Cousins, Spybrook, & Curtis, 2017). Including peers 
in COD services might improve staff treatment 
fdelity, which is critical for ensuring that evidence-
based services produce intended outcomes 
(Harrison et al., 2017). 
Treatment Settings 
Therapeutic Communities 
The goals of TCs are to promote abstinence from 
alcohol and illicit drug use, and to effect a global 
change in lifestyle, including attitudes and values. 
The TC views substance misuse as a disorder 
of the whole person, refecting problems in 
conduct, attitudes, moods, values, and emotional 
management. Treatment focuses on abstinence, 
coupled with social and psychological change 
that requires a multidimensional effort, involving 
intensive mutual support, typically in a residential 
setting. Residential TC treatment duration is 
typically 6 to 12 months, although treatment 
duration has been decreasing under the infuence 
of managed care and other factors. 
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In a defnitive book titled The Therapeutic 
Community: Theory, Model, and Method, De Leon 
(2000) provided a full description of the TC for 
SUD treatment to advance research and guide 
training, practice, and program development. 
Descriptions of TCs also appear in the National 
Institute on Drug Abuse (NIDA, 2015) Research 
Report titled Therapeutic Communities (https:// 
d14rmgtrwzf5a.cloudfront.net/sites/default/fles/ 
therapueticcomm_rrs_0723.pdf). 
TCs have demonstrated positive outcomes in 
substance misuse and SUD treatment retention (De 
Leon, 2015; NIDA, 2015). A review of randomized 
and nonrandomized trials of TCs (Vanderplasschen 
et al., 2013) found that, compared with control 
conditions, TCs gave advantages in employment, 
psychological symptoms, and family/social 
relationships. SUD outcomes were variable but 
generally favored the TC condition. Relapse rates 
among TC clients also varied widely but were 
relatively high (25 percent to 55 percent returned 
to substance use within 12 to 18 months), although 
time to relapse was typically longer in TCs than in 
control conditions. This is consistent with earlier 
research from Malivert, Fatséas, Denis, Langlois, 
& Auriacombe (2012) that associated TCs with 
decreased substance use but high relapse rates. 
Clients in TCs with lower relapse rates tended 
to stay longer in treatment and continuing care 
than people who relapsed more quickly. Forensic 
outcomes were consistently positive for recidivism, 
rearrests, and reincarceration, even over time (3 
years and 5 years). Again, TCs plus continuing care 
were associated with even greater improvements in 
abstinence and rearrests than TCs only. 
Modifed TCs for Clients With CODs 
The modifed TC (MTC) approach adapts 
the principles and methods of the TC to the 
circumstances of the client with CODs. The 
illustrative work in this area has been done 
with people with CODs, both men and women, 
providing treatment based on community-as-
method—that is, the community is the healing 
agent. This section focuses on MTCs as a potent 
residential model for SUD treatment; most of this 
section applies to both TCs and other residential 
SUD treatment programs. 
WHAT MAKES TCs WORK? 
It remains unclear how and why TCs are 
effective at improving outcomes for people 
recovering from addiction. Pearce and Pickard 
(2013) suggest that TCs are effective because 
of their ability to promote in clients a sense of 
belongingness, which is associated with better 
self-esteem and feelings of acceptance and 
happiness. TCs promote belongingness through 
high frequency of client contacts that are positive 
in nature, that exhibit mutual concern for the 
client’s wellbeing, and that occur over a long 
period of time. 
The other key mechanism is the ability of TCs 
to promote in clients a sense of responsible 
agency. This includes the ability to: (1) “refect on 
one’s behavior, make decisions about how one 
wants to do things differently, form resolutions, 
and commit to change” as well as (2) “to see this 
resolution or commitment through: not to waver 
from the chosen course, or, if one wavers, to fnd 
a way to get back on track rather than sink into 
despair” (Pearce & Pickard, 2013, p. 7). Responsible 
agency has been linked to greater self-effcacy 
and ability to change behaviors (and sustain 
those new behaviors over time). TCs promote 
responsible agency through motivational 
interviewing; cognitive interventions like CBT 
or dialectical behavior therapy; and by helping 
clients understand the relationships between 
thoughts, emotions, and behaviors. 
Treatment Activities/Interventions 
All program activities and interactions, singly and 
in combination, are designed to produce change. 
Interventions are grouped into four categories— 
community enhancement (to promote affliation 
with the TC community), therapeutic/educative (to 
promote expression and instruction), community/ 
clinical management (to maintain personal and 
physical safety), and vocational (to operate the 
facility and prepare clients for employment). 
Implementation of the groups and activities listed 
in Exhibit 7.2 establishes the TC community. 
Although each intervention has specifc individual 
functions, all share community, therapeutic, and 
educational purposes. 
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EXHIBIT 7.2. TC Activities and 
Components 
• Maintaining highly structured daily regimens 
that include: 
- Morning and evening house meetings 
- Daily jobs/tasks 
- Individual therapy sessions 
- Group therapy sessions 
- Seminars and education meetings 
• Adhering to clearly articulated expectations 
(accompanied by rewards and punishments to 
help shape adaptive behaviors) 
• Vocation or educational activities, or both 
• Social activities to increase bonding among 
housemates and help client establish healthy, 
supportive networks, such as: 
- Group discussions, including group therapy, 
to help change behaviors and cognitions and 
build new skills 
- Community meetings to review the rules, 
goals, and procedures of the TC 
- Education meetings (e.g., seminars) 
- Role-playing activities 
- Games and recreational activities 
Source: NIDA (2015). 
Key Modifcations 
The MTC alters the traditional TC approach in 
response to the client’s psychiatric and addic-
tion-related symptoms, cognitive impairments, 
reduced level of functioning, short attention span, 
and poor urge control. A noteworthy alteration 
is the change from encounter group to confict 
resolution group. Confict resolution groups have 
the following features: 
• Staff led and staff guided throughout 
• Three highly structured and often formalized 
phases: 
- Feedback on behavior from one participant 
to another 
- Opportunity for both participants to explain 
their position 
- Resolution between participants with plans 
for behavior change 
• Substantially reduced emotional intensity; 
emphasis on instruction and learning of new 
behaviors 
• Persuasive appeal for personal honesty, 
truthfulness in dealing with others, and 
responsible behavior to self and others 
To create an MTC program for clients with CODs, 
three fundamental alterations can be applied: 
• Increased fexibility 
• Decreased intensity 
• Greater individualization 
More recent adaptations also can include: 
• Accepting clients on medication-assisted 
treatment (MAT) for opioid use disorder (OUD) 
and, in some cases, incorporating medication 
into treatment plans (NIDA, 2015). 
• Placing greater limits on long-term residential 
treatment, given rising healthcare costs (NIDA, 
2015). 
• Teaming with a medical facility that provides 
integrated healthcare services so that the TC 
can be considered a federally qualifed health 
center and thus help increase treatment access 
for vulnerable populations, including people 
with CODs (NIDA, 2015; Smith, 2012). 
Nevertheless, the central TC feature remains; 
the MTC, like all TC programs, seeks to develop 
a culture in which clients learn through mutual 
support and affliation with the community to 
foster change in themselves and others. Respect 
for ethnic, racial, and gender differences is a basic 
tenet of all TC programs and is part of teaching 
the general lesson of respect for self and others. 
Exhibit 7.3 summarizes the key modifcations 
necessary to address the unique needs of clients 
with CODs. 
Role of the Family 
Many MTC clients come from highly impaired, 
disrupted family situations. MTC programs offer 
them a new frame of reference and support group. 
Some clients do have available intact families or 
family members who are supportive. For these 
clients, MTC programs offer various family-
centered activities like special family weekend 
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EXHIBIT 7.3. TC Modifcations for People With CODs 
STRUCTURAL 
MODIFICATIONS 
PROCESS 
MODIFICATIONS 
INTERVENTION MODIFICATIONS 
There is increased fexibility in 
program activities. 
Sanctions are fewer with 
greater opportunity 
Orientation and instruction are emphasized 
in programming/planning. 
Meetings and activities are 
shorter. 
for corrective learning 
experiences. Individual counseling is provided more 
frequently to enable clients to absorb the TC 
experience. 
There is greatly reduced 
intensity of interpersonal 
interaction. 
Engagement and 
stabilization receive more 
time and effort. 
Task assignments are individualized. 
More explicit affrmation is 
given for achievements. 
Breaks are offered frequently during work 
tasks. 
Greater sensitivity is shown to 
individual differences. 
Progression through 
the program is paced 
individually, according 
Individual counseling and instruction are 
more immediately provided in work-related 
activities. 
Greater responsiveness to the 
special developmental needs 
of the individual. 
to the client’s rate of 
learning. Engagement is emphasized throughout 
treatment. 
More staff guidance is given 
in the implementation of 
activities; many activities 
remain staff assisted for a 
considerable period of time. 
Criteria for moving to the 
next phase are fexible to 
allow lower functioning 
clients to move through 
the program phase 
Activities are designed to overlap. 
There is greater staff 
responsibility to act as role 
models and guides. 
system. 
Activities proceed at a slower pace. 
Smaller units of information 
are presented gradually and 
are fully discussed. 
Live-out reentry 
(continuing care) is an 
essential component of 
Individual counseling is used to assist in the 
effective use of the community. 
Greater emphasis is placed on 
assisting individuals. 
the treatment process. 
The confict resolution group replaces the 
encounter group. 
Increased emphasis is placed 
on providing instruction, 
practice, and assistance. 
Clients can return to 
earlier phases to solidify 
gains as necessary. 
Source: Sacks & Sacks (2011). 
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ADVICE TO ADMINISTRATORS: RECOMMENDED TREATMENT AND 
SERVICES FROM THE MTC MODEL 
In addition to the general guidelines for working with people who have CODs described in Chapter 5, the 
following treatment recommendations are derived from MTC work and are applicable across all models: 
• Treat the whole person. 
• Provide a highly structured daily regimen. 
• Use peers to help one another. 
• Rely on a network or community for both support and healing. 
• Regard all interactions as opportunities for change. 
• Foster positive growth and development. 
• Promote change in behavior, attitudes, values, and lifestyle. 
• Teach, honor, and respect cultural values, beliefs, and differences. 
visiting, family education and counseling sessions, 
and, if children are involved, classes focused 
on prevention. All such activities occur later in 
treatment to facilitate client reintegration into the 
family and into mainstream living. 
Empirical Evidence 
A series of studies has established that: 
• MTCs affect a wide range of clinical and 
functional variables, including substance use, 
mental disorder symptoms, criminal behavior, 
employment, and housing (Sacks, McKendrick, 
Sacks, & Cleland, 2010). For instance, a review 
of TCs and MTCs (Magor-Blatch, Bhullar, 
Thomson, & Thorsteinsson, 2014) reported 
reduced substance use (including increased 
abstinence and reduced risk of relapse), 
decreased criminal behavior (including 
rearrests and reincarcerations), and improved 
psychological functioning among diverse 
populations, including people with CODs. 
However, benefts were more consistent from 
pre–post treatment than when comparing TCs/ 
MTCs with control groups (e.g., no treatment, 
other treatment). 
• Among people involved in the criminal justice 
system who have CODs, MTCs can effectively 
reduce SUD and mental illness symptoms, 
delay relapse, improve social functioning, 
reduce criminal activity, and decrease recidivism 
compared with traditional TCs (Magor-Blatch et 
al., 2014; Peters et al., 2017). MTCs also appear 
to reduce reincarceration better than parole 
supervision (Sacks, Chaple, Sacks, McKendrick, 
& Cleland, 2012). 
• People with CODs and HIV receiving MTC 
continuing care had a greater decrease in SUD 
and mental illness symptoms at 6 months than 
people receiving standard continuing care 
(Sacks, McKendrick, Vazan, Sacks, & Cleland, 
2011). Larger improvements were observed 
in MTC clients who had higher levels of 
psychosocial functioning and health at the start 
of treatment. 
• MTCs can meet the various needs of pregnant 
and parenting women with SUDs—many of 
whom have co-occurring mental disorders, 
experiences with homelessness, criminal justice 
involvement, or a combination thereof. One 
such program (Bromberg, Backman, Krow, & 
Frankel, 2010) reduced recidivism, promoted 
long-term abstinence (about 90 percent of 
clients remained abstinent for 2 years after 
program completion), and facilitated drug-free 
births and healthy infant development. 
Outpatient SUD Treatment 
Treatment for SUDs occurs most frequently in 
outpatient settings—a term that encompasses a 
variety of disparate programs (Cohen, Freeborn, & 
McManus, 2013; NIDA, 2018b; SAMHSA, 2019a). 
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RESOURCE ALERT: HOW TO IMPLEMENT TC/MTC PROGRAMMING 
Guidance on designing and implementing TCs/MTCs is available online through various manuals, reports, 
and other documentation. Some of the publications in the following list are specifc to a particular 
organization or state. However, they can still serve as useful tools for informing the types of services, 
structures, and processes needed to make TC/MTC programming successful: 
• NIDA’s Therapeutic Communities Research Report (https://d14rmgtrwzf5a.cloudfront.net/sites/default/ 
fles/therapueticcomm_rrs_0723.pdf) 
• The Arkansas Department of Human Services’ Therapeutic Communities Certifcation Manual (https:// 
humanservices.arkansas.gov/images/uploads/dpsqa/DBHS_Therapuetic_Communities_Certifcation_-_ 
FINAL.pdf) 
• Missouri Department of Corrections and Maryville Treatment Center’s Therapeutic Community Program 
Handbook (www.law.umich.edu/special/policyclearinghouse/Documents/MO%20-%20Maryville%20 
Treatment%20Center%20Therapeutic%20Community%20Program%20Handbook.pdf) 
• National Institute of Justice’s Program Profle: Modifed Therapeutic Community for Offenders With 
Mental Illness and Chemical Abuse Disorders (www.crimesolutions.gov/ProgramDetails.aspx?ID=90) 
• University of Delaware Center for Drug and Alcohol Studies. Therapeutic Community Treatment 
Methodology: Treating Chemically Dependent Criminal Offenders in Corrections (www.cdhs.udel.edu/ 
content-sub-site/Documents/CDHS/CTC/Treating%20Chemically%20Dependent%20Criminal%20 
Offenders%20in%20Corrections.pdf) 
Some offer high-intensity services, like several 
hours of treatment each week, which can include 
mental health and other support services as well 
as individual and group counseling for substance 
misuse; others provide minimal services, such 
as only one or two brief sessions to give clients 
information and refer them elsewhere (NIDA, 
2018b). Some agencies offer outpatient programs 
that provide services several hours per day and 
several days per week, thus meeting the LOCUS 
criteria for High Intensity Community Based 
Services. 
Typically, treatment includes individual and 
group counseling, with referrals to appropriate 
community services. Until recently, there were few 
specialized approaches for people with CODs in 
outpatient SUD treatment settings. 
Many individuals with CODs have multiple 
health and social problems that complicate their 
treatment. Evidence from prior studies indicates 
that a mental disorder often makes effective 
SUD treatment harder because of cognitive, 
psychosocial, and economic barriers that hinder 
engagement and retention (Priester et al., 2016). 
Outpatient treatment programs are available 
widely and serve the most clients (Cohen et al., 
2013; SAMHSA, 2019a), so using current best 
practices from the SUD treatment and mental 
health felds is vital. Doing so enables these 
programs to use the best available treatment 
models to reach the greatest possible number of 
people with CODs. 
Prevalence 
Outpatient SUD treatment programs are the most 
common form of SUD treatment setting in this 
country. In 2018, 83 percent of SUD treatment 
facilities in the United States offered outpatient 
services (SAMHSA, 2019a). Specifcally, 77 percent 
offered regular outpatient services, 46 percent 
intensive outpatient, 14 percent day treatment 
or partial hospitalization, 10 percent outpatient 
detoxifcation, and 28 percent outpatient 
methadone/buprenorphine maintenance or 
naltrexone treatment. 
CODs are commonly found in clients who enter 
SUD treatment. In 2018, 50.2 percent of individuals 
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in SUD treatment had a COD, and 99.8 percent 
of SUD treatment facilities reported having 
clients with CODs (SAMHSA, 2019a). Despite the 
complexity of CODs, outpatient programs have 
good capacity (e.g., organization structures and 
policies) to meet the treatment needs of these 
populations, perhaps even more so than intensive 
outpatient programs and residential programs 
(Lambert-Harris, Saunders, McGovern, & Xie, 
2013). 
Empirical Evidence of Efectiveness 
Outpatient settings can be paired with a variety 
of treatment approaches to help clients with 
CODs successfully improve substance-related 
mental health outcomes and functional outcomes, 
including frequency of substance use, abstinence, 
relapse risk, mental illness symptom remission, 
psychiatric hospitalizations, social functioning, 
having independent housing, gaining competitive 
employment, and life satisfaction (Drake, Bond, et 
al., 2016; Haller, Norman, et al., 2016; McDonell 
et al., 2013). Most integrated treatments—such as 
those combining CBT, motivational interviewing, 
and family services—are offered in outpatient, not 
residential, settings and have a strong evidence 
base supporting their effectiveness for CODs (Kelly 
& Daley, 2013), including SMI with SUDs (Cleary, 
Hunt, Matheson, & Walter, 2009; De Witte et al., 
2014). 
Outpatient COD treatment can yield positive 
outcomes even when treatment is not tailored 
specifcally to CODs. Tiet and Schutte (2012) 
reviewed the differential benefts of COD 
treatment at either addiction, mental illness, or 
COD outpatient treatment programs. All clients 
improved in 6-month abstinence and suicide 
attempts compared with baseline, although people 
attending COD outpatient settings did not fare any 
better on these outcomes than clients completing 
outpatient treatment from SUD clinics or mental 
health service clinics. 
Outpatient treatment can also be leveraged 
as a form of continuing care, such as following 
discharge from hospitalization or release from 
jail/prison, to help clients maintain long-term 
recovery and wellness (Grella & Shi, 2011). 
Six-month outpatient ACT for men with SMI and 
SUD (Noel, Woods, Routhier, & Drake, 2016) 
was effective in sustaining improvements clients 
experienced during the previous 6 months in 
residential treatment, including improvements in 
mental health, substance use, housing, education, 
employment, family functioning, spirituality, and 
sleep hygiene. Outpatient mental health services 
focused on supporting community reintegration 
following release from jail were associated with 
12-month declines in number of arrests and 
number of days in jail among people with CODs 
and people with mental disorders only (Alarid & 
Rubin, 2018). 
Evidence suggests that intensive outpatient 
treatment for people with CODs can improve 
substance misuse and increase abstinence among 
a range of populations, including civilians and 
veterans, women, people from diverse racial/ethnic 
backgrounds, uninsured individuals, and people 
experiencing homelessness (McCarty et al., 2014). 
Intensive outpatient treatment has been associated 
with decreases in psychological symptoms and 
distress, decreases in the average number of 
days per week of substance use, improvements in 
Global Assessment of Functioning scores, and high 
client satisfaction (Wise, 2010). 
Designing Outpatient Programs for Clients 
With CODs 
People with CODs vary in their motivation for 
treatment, nature and severity of their SUD (e.g., 
drug of choice, polysubstance misuse), and nature 
and severity of their mental disorder. However, 
most clients with CODs in outpatient treatment 
have less serious and more stabilized mental and 
SUD symptoms than those in residential treatment 
(Mee-Lee et al., 2013). 
Outpatient treatment can be the primary 
treatment or provide continuing care for clients 
after residential treatment, offering fexibility in 
activities/interventions and intensity of treatment. 
Treatment failures occur for people with SMI 
and those with less serious mental disorders for 
several reasons, among the most important being 
that programs lack resources to provide time for 
mental health services and medications that would 
likely improve recovery rates and recovery time 
signifcantly. 
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RESOURCE ALERT: OUTPATIENT SUD TREATMENT 
• SAMHSA’s TIP 47, Substance Abuse: Clinical Issues in Intensive Outpatient Treatment 
(https://store.samhsa.gov/system/fles/sma13-4182.pdf) 
• SAMHSA’s TIP 46, Substance Abuse: Administrative Issues in Outpatient Treatment 
(https://store.samhsa.gov/system/fles/toc.pdf) 
If lack of funding prevents the full integration of 
mental health assessment and medication services 
within an SUD treatment agency that provides 
outpatient services, establishing a collaborative 
relationship with a mental health agency (through 
a memorandum of agreement) would ensure that 
the services for the clients with CODs are adequate 
and comprehensive. In addition, modifcations are 
needed to both treatment design interventions 
and staff training to ensure implementation of 
interventions appropriate to the needs of the client 
with CODs. 
To meet the needs of specifc populations 
among people with CODs, the consensus panel 
encourages outpatient treatment programs to 
develop special services for populations that 
are represented in signifcant numbers in their 
programs. Examples include women, women 
with dependent children, individuals and families 
experiencing homelessness, and racial/ethnic 
populations. (Information on how programs can 
adapt services to these and other vulnerable 
populations can be found in Chapter 6.) Types of 
CODs will vary depending on the subpopulation 
targeted; each program must deal with CODs in a 
different manner, often by adding other treatment 
components for CODs to existing program models. 
Referral and Placement 
Careful assessment will help identify those clients 
who require more secure inpatient treatment 
settings (e.g., clients who are actively suicidal 
or homicidal), as well as those who require 
24-hour medical monitoring, those who need 
detoxifcation, and those with serious SUDs who 
may require a period of abstinence or reduced use 
before they can engage actively in all treatment 
components. Information about the full screening 
and assessment process, which includes referral, is 
in Chapter 3. 
Counselors should view clients’ placement in 
outpatient care in the context of continuity of 
care and the network of available providers and 
programs. Outpatient treatment programs may 
serve a variety of functions, including outreach/ 
engagement, primary treatment, and continuing 
care. Ideally, a full range of outpatient SUD 
treatment programs would include interventions 
for unmotivated, disaffliated clients with CODs, 
as well as for those seeking abstinence-based 
primary treatments and those requiring continuity 
of supports to sustain recovery. 
Likewise, ideal outpatient programs will facilitate
access to services through rapid response to
all agency and self-referral contacts, imposing
few exclusionary criteria, and using some client/ 
treatment matching criteria to ensure that all
referrals can be engaged in some level of treatment.
Additional criteria for admission may be imposed
on the treatment agency by individual states,
insurance companies, or other funding sources. Per
the consensus panel, treatment providers should
not place clients in a higher level of care (i.e., more
intense) than necessary. A client who may remain
engaged in a less intense treatment environment
may drop out in response to the demands of a more
intense treatment program. 
Engagement and Retention 
Because clients with CODs often have lower
treatment engagement, every effort should be
made to use treatment methods with the best
prospects for increasing engagement. Clients with
CODs, especially those opposed to traditional
treatment approaches and those who do not accept
that they have CODs, can have diffculty committing
to and maintaining treatment. By providing
continuous outreach, engagement, direct assistance
with immediate life problems (e.g., housing),
advocacy, and close monitoring of individual needs,
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IMPROVING ENGAGEMENT AND 
ADHERENCE OF CLIENTS WITH 
CODS IN OUTPATIENT SETTINGS 
• Implement behavioral continuing care 
contracts for clients transitioning from 
residential treatment into outpatient care. 
• Use reminders (e.g., mailed appointment cards, 
telephone calls); offer feedback before sessions 
to promote attendance. 
• Follow up by phone with clients who miss 
appointments. 
• Reinforce attendance to appointments with
praise and other rewards (e.g., earning a
completion certifcate after attending a certain
number of sessions, earning a medal or other
recognition for completing all required sessions). 
• Offer peer recovery support services. 
• Use incentives to increase clients’ buy-in to 
the need for and importance of treatment. 
Incentives related to assistance with housing 
and employment may be particularly 
meaningful and effective. 
• Rather than solely creating treatment goals 
focused centrally around abstinence, work with 
clients to develop treatment goals focused 
on reducing the harmful effects of substance 
use (e.g., reducing homelessness by gaining 
independent housing). 
• People with CODs who have positive family 
relationships are more likely to stay engaged 
in treatment. Encourage clients lacking family 
support to reach out to relatives and try to 
gain their support. With permission from the 
client, include family in treatment and educate 
them on the importance of being a source of 
emotional and tangible support for the client. 
• Helping clients understand the connection 
between substance use and negative 
outcomes (e.g., legal problems, housing and 
employment instability, exacerbating mental 
disorder symptoms) can help them understand 
the need for treatment. This is vital because 
perceived need for treatment is a common 
barrier to entering and staying engaged in SUD 
treatment. 
Sources: Brown, Bennett, Li, & Bellack (2011); Demarce, 
Lash, Stephens, Grambow, & Burden (2008); Mangrum 
(2009). 
the ACT and ICM models provide techniques that
enable clients to access services and foster the
development of treatment relationships.
Discharge Planning 
Discharge planning is important to maintain 
gains achieved through outpatient care. Clients 
with CODs leaving an outpatient SUD treatment 
program have a number of continuing care options. 
These options include mutual-support programs, 
relapse prevention groups, continued individual 
counseling, mental health services (especially 
important for clients who will continue to require 
medication), as well as ICM monitoring and 
supports. A carefully developed discharge plan, 
produced in collaboration with the client, will 
identify and match client needs with community 
resources, providing supports to sustain progress 
achieved in outpatient treatment. The provider 
seeks to develop a support network for the client 
that involves family, community, recovery groups, 
friends, and signifcant others. 
Clients with CODs often need a range of services
besides SUD treatment and mental health services.
Generally, prominent needs include housing and
case management services to establish access to
community health and social services. In fact, these
two services should not be considered “ancillary,”
but key ingredients for clients’ successful recovery.
Without a place to live and some degree of
economic stability, clients with CODs are likely to
return to substance use or experience a return of
symptoms of mental disorder. Every SUD treatment
provider should keep strong and current linkages
with community resources to help address these
and other client needs. Clients with CODs often
will require a wide variety of services that cannot be
provided by a single program. 
Discharge planning for clients with CODs 
must ensure continuity of services, medication 
management, and support, without which client 
stability and recovery are severely compromised. 
Relapse prevention interventions after outpatient 
treatment need to be modifed so clients can 
recognize symptoms of SUD or mental disorder 
relapse on their own, use symptom management 
techniques (e.g., self-monitoring, reporting 
to a “buddy,” group monitoring), and access 
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assessment services rapidly, as the return of 
psychiatric symptoms can often trigger substance 
use relapse. 
Developing positive peer networks is another
important facet of discharge planning for
continuing care. The provider seeks to develop a
support network for the client that involves family,
community, recovery groups, friends, and signifcant
others. If a client’s family of origin is not healthy
and supportive, other networks can be accessed
or developed for support. Programs also should
encourage client participation in mutual-support
programs, particularly those that focus on CODs
(e.g., dual recovery mutual-support groups).
These groups can provide a continuing supportive
network for the clients, who usually can continue to
participate in such programs even if they move to a
different community. Therefore, these groups are an
important method of providing continuity of care. 
The consensus panel also recommends that 
programs working with clients who have CODs try 
to involve advocacy groups in program activities. 
These groups can help clients become advocates 
themselves, furthering the development and 
responsiveness of the treatment program while 
enhancing clients’ sense of self-esteem and 
providing a source of affliation. 
Residential SUD Treatment 
Residential treatment for SUDs comes in a variety 
of forms, including long-term residential treatment 
facilities, criminal justice-based programs, halfway 
houses, and short-term residential programs. The 
long-term residential SUD treatment facility is the 
primary treatment site and the focus of this section 
of the TIP. Historically, residential SUD treatment 
facilities have provided treatment to clients with 
more serious and active SUDs but with less severe 
mental disorders. Most providers now agree 
that the prevalence of people with SMI entering 
residential SUD treatment facilities has risen. 
Prevalence 
In 2018, 24 percent of SUD treatment facilities in 
the United States offered any residential treatment 
(SAMHSA, 2019a). Specifcally, 14 percent offered 
short-term residential care; 19 percent, long-term 
care; and 8 percent, residential detoxifcation. 
Clients admitted to long-term residential care 
tend to have more severe substance misuse and 
psychiatric problems. Veterans with SUDs and 
PTSD admitted to residential treatment reported 
worse PTSD symptoms, more frequent substance 
use, more time spent around high-risk people or 
places, and fewer days spent at work or school 
than veterans with SUDs and PTSD who entered 
outpatient care (Haller, Colvonen, et al., 2016). 
Other studies have found an increased rate of 
suicide attempt and violence (as a victim and as a 
perpetrator) among people with CODs entering 
residential treatment (Havassy & Mericle, 2013; 
Watkins, Sippel, Pietrzak, Hoff, & Harpaz-Rotem, 
2017) as well as lower treatment retention rates, 
particularly in people with ASPD and SUD (Meier & 
Barrowclough, 2009). 
Empirical Evidence of Efectiveness 
Evidence from large-scale, longitudinal, multisite 
treatment studies supports the effectiveness 
of residential SUD treatment (Reif, George, et 
al., 2014; Weinstein, Wakeman, & Nolan, 2018). 
Residential SUD treatment generally results 
in signifcant improvements in substance use, 
mental health, employment, and physical and 
social functioning. Residential treatment for 
CODs is linked to improved SUD outcomes (e.g., 
illicit drug and alcohol use), mental disorder 
symptoms, quality of life, and social/community 
functioning, even if treatment is not integrated 
(Reif, George, et al., 2014). A multisite study of 
residential COD treatment programs in Tennessee 
and California (Schoenthaler et al., 2017) found 
signifcant reductions in illicit substance use per 
month, intoxication per month, alcohol use days 
per month, and ASI drug and alcohol composite 
scores from 1 month before treatment admission to 
12-month postdischarge. 
Designing Residential Programs for Clients 
With CODs 
To design and develop services for clients with
CODs, providers and administrators can undertake a
series of interrelated program activities. The specifc
MTC model that appeared previously in this chapter
serves as a frame of reference in the following
sections, but it is not a prescriptive model.
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Intake 
Chapter 3 further addresses screening and
assessment. This section addresses intake procedures
for people with CODs in residential SUD treatment
settings. The four interrelated intake steps are: 
1. Written referral. Referral information from 
other programs or services can include the 
client’s psychiatric diagnosis, history, current 
level of mental functioning, medical status 
(including results of screening for tuberculosis, 
HIV, sexually transmitted disease, hepatitis), 
and assessment of functional level. Referrals 
also may include a psychosocial history and a 
physical examination. 
2. Intake interview. An intake interview is 
conducted at the program site by a counselor or 
clinical team. At this time, the referral material 
is reviewed for accuracy and completeness, and 
each client is interviewed to determine if the 
referral is appropriate in terms of the history of 
mental and substance use problems. The client’s 
residential and treatment history is reviewed 
to assess the adequacy of past treatment 
attempts. Furthermore, each client’s motivation 
and readiness for change are assessed, and 
the client’s willingness to accept the current 
placement as part of the recovery process is 
evaluated. Screening instruments, such as those 
described in Chapter 3 and located in Appendix 
C, can be used in conjunction with this intake 
interview. 
3. Program review. Each client should receive a 
complete description of the program and a tour 
of the facility to ensure that both are acceptable. 
This review includes a description of the daily 
operation of the program in terms of groups, 
activities, and responsibilities; a tour of the 
physical site (including sleeping arrangements 
and communal areas); and an introduction to 
some of the clients who are already enrolled in 
the program. 
4. Team meeting. At the end of the intake 
interview and program review, the team meets 
with the client to decide whether to proceed 
with admission to the program. The client’s 
receptivity to the program is considered, and 
additional information (e.g., involvement with 
the justice system, suicide attempts) is obtained 
as needed. It should be noted that the decision-
making process is inclusive; that is, a program 
accepts referrals as long as the clients meet the 
eligibility criteria, are not currently a danger to 
self or others, do not refuse medication, express 
a readiness and motivation for treatment, and 
accept the placement and the program as part 
of their recovery process. 
Engagement and Retention 
Clients with CODs need to be engaged in 
treatment so they can fully use available services. 
Successful engagement helps clients view the 
treatment program as an important resource. To 
accomplish this, the program must meet essential 
needs and ensure psychiatric stabilization. 
Residential treatment programs can accomplish this 
by offering a wide range of services that include 
both targeted services for mental disorders and 
SUDs and other wraparound services, including 
medical, social, and work-related activities. The 
extensiveness of residential services has been well 
documented (Reif, George, et al., 2014). 
Clients in residential settings for SUDs are three
times more likely to complete treatment than
those in outpatient settings (Stahler, Mennis, &
DuCette, 2016). Retention in treatment is associated
with positive outcomes, and identifying factors
that predict length of stay can inform practices
to improve engagement and adherence. Shorter
stays in residential care are linked to older age,
male gender, and low readiness for change
(Morse, Watson, MacMaster, & Bride, 2015). Better
retention in residential SUD treatment settings is
linked to younger age, White race/ethnicity (vs.
African Americans and Latinos), type of SUD (i.e.,
non-OUD), more severe ASI medical-, employment-,
and psychiatric-related scale scores, and greater
readiness for change (Choi, Adams, MacMaster, &
Seiters, 2013). 
Discharge Planning 
Discharge planning follows many of the same 
procedures discussed in the section on outpatient 
treatment. However, several other important points 
apply to residential programs: 
• Discharge planning begins upon entry into the 
program. 
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• The latter phases of residential placement 
should be devoted to developing with the client 
a specifc discharge plan and beginning to 
follow some of its features. 
• Discharge planning often involves continuing in 
treatment as part of continuity of care. 
• Obtaining housing, when needed, is an integral 
part of discharge planning. 
Given the chronic and cyclical nature of SUDs 
and mental disorders, continuing care following 
residential services (such as the provision of lower 
intensity outpatient treatment postdischarge) 
can help optimize client stability and functioning. 
Individuals with SUDs who receive continuing care 
are retained in treatment and maintain abstinence 
more so than clients who do not participate in 
continuing care (McKay, 2009). 
Acute Care and Other Medical Settings 
Although not strictly speaking SUD treatment 
settings, acute care and other medical settings are 
included here because important SUD treatment 
and mental health services occur in medical units. 
Acute care refers to short-term care provided in 
intensive care units, brief hospital stays, and EDs. 
Individuals with substance misuse or mental illness 
often access care from primary care clinics as 
opposed to specialty care settings. People going 
to EDs for treatment for mental disorders and 
SUDs is also on the rise. 
The integration of SUD treatment with primary 
medical care can be effective in reducing both 
medical problems and levels of substance use. 
Clients can be more readily engaged and retained 
in SUD treatment if that treatment is integrated 
with medical care than if clients are referred to 
a separate SUD treatment program—especially 
individuals with SUDs who have chronic medical 
needs (Drainoni et al., 2014; Hunter, Schwartz, 
& Friedmann, 2016). Extensive treatment for 
SUDs and co-occurring mental disorders may be 
unavailable in acute care settings given constraints 
on time and resources; however, brief assessments, 
referrals, and interventions can help move clients 
to the next level of treatment. 
More information on particular topics relating to 
SUD screening and treatment in acute and medical 
care settings can be found in TIP 45, Detoxifcation 
From Alcohol and Other Drugs (CSAT, 2006b). 
More information on the use and value of brief 
interventions can be found in TIP 34, Brief 
Interventions and Brief Therapies for Substance 
Abuse (CSAT, 1999a). 
RECOMMENDATIONS FOR CONTINUING CARE FOLLOWING DISCHARGE 
FROM RESIDENTIAL TREATMENT 
• Clients should be engaged in continuing care services for a minimum of 3 to 6 months following discharge. 
• Scheduling of continuing care appointments should occur prior to discharge so that appointments are 
already in place by the time a client leaves inpatient care. 
• To facilitate monitoring, programs should implement formal follow-up procedures to ensure staff maintain
contact with clients regularly at set time points (e.g., 30 days, 6 months), ideally for at least 12 months.
• Clients should be educated about the importance of continuing care and the availability of treatment 
options following residential treatment, including the use of pharmacotherapy with outpatient services. 
• Residential staff should introduce clients to outpatient providers before discharge so as to provide a 
“warm handoff” and foster rapport-building between clients and their continuing care providers. 
• Programs should be fexible in offering a wide range of continuing care services to meet clients’ 
scheduling and daily living needs (e.g., offer outpatient therapy groups 5 days per week, use telehealth 
services so clients who live at a distance and are unable to travel to outpatient services regularly can still 
access treatment). 
• Counselors should link clients to mutual-support programs and other community-based supports and 
resources available. 
Sources: Proctor & Herschman (2014); Rubinsky et al. (2017). 
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HOW COMMON ARE MENTAL DISORDERS AND SUDS IN ACUTE CARE 
AND OTHER MEDICAL SETTINGS? 
• More than 70 percent of primary care visits are related to psychosocial needs (National Association of 
State Mental Health Program Directors, 2012). 
- In a sample of 2,000 adults in primary care clinics in four states, 36 percent met Diagnostic and 
Statistical Manual of Mental Disorders (5th ed.; American Psychiatric Association, 2013) criteria for an 
SUD in the last year, including almost 22 percent with a moderate/severe SUD (Wu et al., 2017). About 28 
percent endorsed past-year illicit drug or nonmedical medication use. 
- From 2012 to 2014 (Cherry, Albert, & McCaig, 2018), 26 percent of mental health offce visits in large 
metropolitan areas, 44 percent of visits in small-to-medium metropolitan areas, and 54 percent of visits 
in rural areas were to primary care. 
• Of the 1.18 billion ambulatory medical visits that occurred between 2009 and 2011 (Lagisetty, Maust, 
Heisler, & Bohnert, 2017), 17.6 million involved an SUD diagnosis. 
- This included 8.6 percent for AUD, 64.2 percent for tobacco use disorder, and 9.6 percent for OUD. 
- Among the people with an SUD, 13.4 percent also had anxiety, 5.7 percent had depression, and 2.3 
percent had bipolar disorder. 
• Data from the National Hospital Ambulatory Medical Care Survey indicate that from 2005 to 2011, mental 
and substance use–related ED visits increased from 27.9 per 1,000 visits to 35.1 per 1,000 visits, with 
the greatest increases observed in people ages 25 to 44 (Ayangbayi, Okunade, Karakus, & Nianogo, 2017). 
Odds of visits were higher in people who were uninsured or on public health insurance, or had been 
discharged from a hospital in the previous week. 
• Individuals with CODs are more likely than people without CODs to use EDs for mental disorder
and SUD-related needs (Moulin et al., 2018), as are individuals experiencing homelessness (Lam, Arora,
& Menchine, 2016). 
Prevalence 
In 2018, 5 percent of SUD treatment facilities in 
the United States were hospital-based inpatient 
services (SAMHSA, 2019a). Specifcally, 4 percent 
of facilities offered hospital-based treatment and 
5 percent offered hospital-based detoxifcation. In 
2018, 40 percent of general hospitals offered COD 
programming (SAMHSA, 2019b). 
Empirical Evidence of Efectiveness 
Over the past two decades, signifcant research 
has emerged in support of team-based, integrated 
behavioral health services in acute medical 
care settings (e.g., EDs, primary care clinics). 
Collaborative behavioral health service models 
are feasible and can be as effective as (and in 
some cases even more effective than) usual care 
in identifying and managing SMI, SUDs, or CODs 
(Chan, Huang, Bradley, & Unutzer, 2014; Chan, 
Huang, Sieu, & Unutzer, 2013; Kumar & Klein, 
2013; Park, Cheng, Samet, Winter, & Saitz, 2015; 
Walley et al., 2015). Integrated, collaborative 
behavioral health services can improve mental 
disorder symptoms (including remission and 
recovery), treatment adherence, treatment 
satisfaction, quality of life (mental and physical), 
medication adherence, and social functioning 
and are cost-effective and valued by clients 
(Epstein, Barry, Fiellin, & Busch, 2015; Goodrich, 
Kilbourne, Nord, & Bauer, 2013). Most of these 
studies are focused on mental health services, 
with comparatively fewer examining integrated 
SUD treatment, but research suggests addiction 
models also are feasible and can produce positive 
outcomes (Goodrich et al., 2013), including 
long-term abstinence (Savic, Best, Manning, & 
Lubman, 2017). Primary care–based SUD treatment 
may also help reduce length of inpatient stay and 
ED utilization while also increasing recovery coach 
contacts and use of addiction pharmacotherapy 
(i.e., buprenorphine and naltrexone) (Wakeman et 
al., 2019). 
Primary care–based SUD treatment can reduce 
gaps in service use by offering treatment in a 
setting that clients prefer. More than 42,000 
U.S. adults were screened for SUDs to assess 
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willingness to enter SUD treatment based on 
service setting (Barry, Epstein, Fiellin, Fraenkel, & 
Busch, 2016). Those who screened positive but 
were not currently enrolled in SUD treatment were 
randomized to one of three hypothetical treatment 
setting vignettes: treatment in a specialty drug 
treatment center (i.e., usual care), primary care, or 
collaborative care in a primary care setting. About 
a quarter (24.6 percent) of people with an SUD 
and 18 percent with AUD who were randomized 
to specialty care were willing to enter treatment, 
whereas more people randomized to the primary 
care setting were willing to enter treatment (37 
percent with an SUD; 20 percent with AUD). 
Similarly, more people randomized to the primary/ 
collaborative care setting were willing to enter 
treatment than people in the specialty care setting 
(34 percent with an SUD; almost 21 percent with 
AUD). Nonspecialty settings like primary care 
clinics may be desirable for individuals needing 
SUD treatment because of a perceived lack of 
stigma attached to medical facilities (compared 
with, for instance, methadone clinics) and the 
ability of medical settings to address both SUD 
treatment and physical healthcare needs in one 
location (Barry et al., 2016). 
Designing Acute Medical and Primary Care 
Programs for Clients With CODs 
Programs that rely on identifcation (i.e., screening
and assessment) and referral occupy a service niche
in the treatment system. To succeed, they need
a clear view of treatment goals and limitations.
Effective linkages with various community-based
SUD treatment facilities are essential to ensure an
appropriate response to client needs and to facilitate
access to additional services when clients are ready.
The discussion that follows highlights the essential 
features of providing treatment to clients with 
CODs in acute care and other medical settings. 
Screening and Assessment in Acute and Other 
Medical Settings 
Clients entering acute care or other medical facilities
generally are not seeking SUD treatment. Often,
providers (primary care and mental health) are not
familiar with SUDs. Their lack of expertise can lead
THE INTEGRATION OF CARE FOR MENTAL HEALTH, SUBSTANCE ABUSE 
AND OTHER BEHAVIORAL HEALTH CONDITIONS INTO PRIMARY CARE: 
AMERICAN COLLEGE OF PHYSICIANS (ACP) POSITION PAPER 
1. The ACP supports the integration of behavioral health care into primary care and encourages its 
members to address SUDs and mental disorders within the limits of their competencies and resources. 
2. The ACP recommends that public and private health insurance payers, policymakers, and primary 
care and behavioral health care professionals work toward removing payment barriers that impede 
behavioral health and primary care integration. Stakeholders should also ensure the availability of 
adequate fnancial resources to support the practice infrastructure required to effectively provide such 
care. 
3. The ACP recommends that federal and state governments, insurance regulators, payers, and other 
stakeholders address behavioral health insurance coverage gaps that are barriers to integrated care. 
This includes strengthening and enforcing relevant nondiscrimination laws. 
4. The ACP supports increased research to defne the most effective and effcient approaches to integrate 
behavioral health care in the primary care setting. 
5. The ACP encourages efforts by federal/state governments and training and continuing education 
programs to ensure an adequate workforce to provide for integrated behavioral health care in primary 
care settings. 
6. The ACP recommends that all relevant stakeholders initiate programs to reduce the stigma associated 
with behavioral health. These programs need to address negative perceptions held by the general 
population and by many physicians and other providers. 
Source: Crowley & Kirschner (2015). 
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to unrealistic expectations or frustrations, which may
be directed inappropriately toward the client. 
Even in the absence of indepth training in 
addiction medicine, primary care and mental 
health service providers can quickly and easily 
screen clients for SUDs using brief, validated 
instruments—leading to better detection of SUDs, 
more client–provider discussions about substance 
misuse, and overall improvements in care (Jones, 
Johnston, Biola, Gomez, & Crowder, 2018; Savic 
et al., 2017). (Chapter 3 contains a full description 
of screening and assessment procedures and 
instruments applicable to CODs, including those 
that can be used in primary care settings; select 
instruments are also located in Appendix C.) 
Although addiction screening can and should be 
offered in both nonurgent and urgent medical 
care settings, approaches may need to be im-
plemented differently for each. O’Grady, Kapoor, 
and colleagues (2019) describe use of a screening, 
brief intervention, and referral for treatment (often 
referred to as SBIRT) program for people with or 
at risk for addiction that was implemented at EDs 
and primary care clinics. Compared with people 
screened as high risk for substance misuse in the 
primary care clinics, those screened as high risk in 
the EDs were signifcantly more likely to also have 
unstable housing, be unemployed, have self-re-
ported “extreme” stress, have “serious” depres-
sion or anxiety, and have poor current health. They 
also reported higher addiction screening scores 
and more frequent substance use than people in 
the primary care clinics. Prescreening in the EDs 
was less likely to be completed than in primary 
care because clients were more likely to be in acute 
states, actively intoxicated, or have altered mental 
status. Further, more than one-third of people who 
prescreened positive for substance misuse did not 
receive full screening and intervention. This fnding 
is consistent with results from two longitudinal 
surveys of 1,500 ED physicians that found only 15 
percent to 20 percent of clients were screened 
for substance misuse and only 19 percent to 26 
percent of ED physicians reported using a formal 
addiction screening tool (Broderick Kaplan, Martini, 
& Caruso, 2015). 
These data are worrisome, given feedback from the 
American College of Emergency Physicians (2017) 
that ED professionals are, “positioned and qualifed 
to mitigate the consequences of alcohol misuse 
through screening programs, brief intervention, 
and referral to treatment” and that EDs should 
maintain “wide availability of resources necessary 
to address the needs of patients with alcohol-
related problems and those at-risk for them.” ED 
staff may therefore require additional training 
to better recognize and respond to clients with 
addiction, particularly those with severe disorders. 
Formal procedures may also be needed to foster 
successful referral and implementation of brief 
interventions (e.g., education, harm reduction). 
Interventions 
Several differences exist in behavioral health 
service provision (including addiction services) 
in medical settings versus traditional mental 
health service settings (Exhibit 7.4). Acute medical 
settings may be less likely than mental health clinics 
to have SUD treatment providers on staff, unless 
the setting offers integrated care. For this reason, 
acute care and other medical settings should have 
formal procedures in place so providers know 
when clients require referral for specialty addition 
treatment versus in-offce brief interventions (e.g., 
education about substance use, harm reduction 
tips) (Shapiro, Coffa, & McCance-Katz, 2013). 
Pharmacologic treatment is likely easier for clients 
to access in medical settings than in mental health 
centers because of the widespread availability 
of onsite prescribers. Pharmacologic treatment 
should be offered based on the latest evidence-
based best practices (e.g., TIP 63, Medications for 
Opioid Use Disorder [SAMHSA, 2018c]; Veterans 
Administration (VA)/Department of Defense (DoD) 
Clinical Practice Guidelines for the Management of 
Substance Use Disorders [VA/DoD, 2015]). See the 
section “Pharmacotherapy” for a full discussion of 
medication treatment of people with CODs. 
In integrated settings, treatment planning will 
often need to occur in collaboration with the other 
team providers (Savic et al., 2017). To this end, 
providers likely will need to engage in greater 
sharing of confdential client information than in 
nonintegrated, traditional settings to foster case 
management and coordination of services (Savic et 
al., 2017). Clients need to be briefed about these 
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limits to confdentiality at intake and their consent 
documented. 
Exhibit 7.5 offers a sample (not exhaustive) 
listing of questions that addiction providers 
and administrators should consider if they 
wish to integrate their services with primary 
care settings. (Also see “Resource Alert: How 
To Integrate Primary Care and Behavioral Health 
Services for People With SMI.”) 
Historically, providers in acute care settings have 
not been concerned with treating SUDs beyond 
detoxifcation, stabilization, and referral. However, 
as the uptake of brief interventions increases and 
as the healthcare feld’s awareness grows about the 
importance of detecting and treating SUDs and 
mental disorders, treatment options are expanding 
beyond just stabilization and referral. In EDs, case 
managers help triage “high users” (who often 
include people with SUDs, mental disorders, or 
both [Minassian, Vilke, & Wilson, 2013; Moulin et 
EXHIBIT 7.4. Traditional Mental Health Settings Versus Integrated 
Mental Health–Primary Care Settings 
FACTOR TRADITIONAL MENTAL 
HEALTH SETTING 
INTEGRATED MENTAL HEALTH–PRIMARY 
CARE SETTING 
Service Provision Individualized/case based Population based (e.g., services are for all of 
those attending the primary care clinic, the 
community served by the clinic) 
Service Target(s) The client/family The client/family, other colleagues in the 
integrated system with whom the mental 
health provider collaborates (e.g., the primary 
care provider), community at large 
Intensity and Length of Care Comprehensive and 
long-term (as needed) 
Comprehensive but briefer, more episodic, 
and with larger caseload turnover 
Client Motivation Usually high (unless 
treatment is compulsory, 
such as in forensic cases) 
Often ambivalent, hesitant; clients may be 
less amenable to advice or referral for services 
Client Confdentiality High; other providers 
may or may not be 
involved in the client’s 
care 
Moderate; client information is regularly 
shared with other integrated care team 
members 
Focus of Treatment Skill oriented and 
symptom focused but 
also exploratory (e.g., 
interpersonal therapy, 
psychodynamic therapy) 
Tends to be more concrete, skills oriented, and 
symptom based 
Source: Joseph, Kester, O’Brien, & Huang (2017). 
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EXHIBIT 7.5. Redesigning Addiction Services for Integration With Primary
Care: Questions for Addiction Providers and Administrators To Consider 
Administrative Questions 
• Is integration a part of your organization’s vision and mission? 
• What type of integration do you want to implement? Different options include: 
- Addressing substance use problems only. 
- Addressing substance use in primary care. 
- Addressing all substance use and mental disorder needs without primary care. 
- Addressing all substance use and mental disorder needs with primary care. 
• Have you developed a strategic plan related to integration? 
• Do you/your staff understand the primary care and SUD needs of the population you are serving? 
• Do you have administrative policies in place to support integration (e.g., confdentiality, billing and 
reimbursement, ethics)? 
• What clinical and business practices in your organization need to change to facilitate integration? 
Capacity/Resource Questions 
• Do you have existing relationships (formal or informal) with other service providers in mental health and 
primary care? If not, what needs to be done to establish those relationships? 
• What existing community resources can you draw on (e.g., community coalitions, prevention programs)? 
• Do you have relationships with medical providers at various levels of care (e.g., inpatient, outpatient) so 
you can refer clients seamlessly across the entire continuum of care? 
• Do you have staff and other resources to treat primary care- and substance-related disorders? Is your 
organization licensed to provide these services? If not, what licensing regulations need to be met? 
• Does your program have staff with a range of expertise and competencies in providing integrated care 
(e.g., case management, care coordination, wellness programming)? 
• Does your program currently offer any integrated components, even if on an informal basis and not part 
of a defned program structure (e.g., as-needed use of case management to coordinate services)? 
Financing Questions 
• Do you have professional staff capable of providing billable primary care or mental health services? 
• What expenditures—such as hiring staff or investing in training or other resources—might be required? 
• What proft does your organization need to make to support your integrated care vision (key elements: 
number of consumers seen; how often they are seen per year; payer mix; reimbursement per visit)? 
• Can you organization accept all types of payment (i.e., Medicaid, Medicare, private insurance)? 
• What do you need to learn about joining provider networks of major payers? 
Clinical Supports Questions 
• Does your organization use a certifed electronic medical records system? 
• Can your records system create patient data registries (or link to existing registries) to support 
integration? 
• Does your records system have a formal way of documenting coordination of care? 
• Does your records system have a formal way of documenting physical health-related services? 
Source: SAMHSA-Health Resources and Services Administration Center for Integrated Health Solutions (2013). 
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RESOURCE ALERT: HOW TO INTEGRATE PRIMARY CARE AND 
BEHAVIORAL HEALTH SERVICES FOR PEOPLE WITH SMI 
Milbank Memorial Fund’s Integrating Primary Care into Behavioral Health Settings: What Works for 
Individuals with Serious Mental Illness (www.milbank.org/wp-content/uploads/2016/04/Integrating-
Primary-Care-Report.pdf)
al., 2018; Smith, Stocks, & Santora, 2015]) to ap-
propriate levels of care (e.g., admission, outpatient 
referral) (Turner & Stanton, 2015). Aspects of case 
management interventions—which are typically 
delivered not solely by case managers but collab-
oratively with other ED team members like nurses, 
physicians, and social workers—that can reduce ED 
visits, and in some cases reduce ED costs (Kumar & 
Klein, 2013) include: 
• Educating clients about and linking them to 
community resources to address symptoms/ 
problems. 
• Offering referral to mental health services and 
SUD treatment. 
• Assisting clients with transportation needs. 
• Assisting clients with fnancial benefts/public 
assistance. 
• Performing crisis intervention. 
• Helping clients acquire stable housing. 
• Working with clients to create an ED treatment 
plan or other individualized care plan. 
• Following up with clients after discharge, 
including when providing referrals to specialty 
care. 
Interview-based interventions, like motivational 
interviewing and brief negotiated interviews, 
decrease alcohol and illicit drug use in some 
studies, but other studies have reported 
inconsistent results (Hawk & D’Onofrio, 2018). 
Some research suggests that brief ED interventions 
affect substance use no more than minimal 
screening alone (Bogenschutz et al., 2014a), 
possibly because people presenting to the ED 
with substance-related problems tend to have 
higher levels of severity. Overdose education and 
distribution of naloxone kits are also being used 
increasingly in EDs, given the surge of evidence 
demonstrating the effectiveness of MAT for 
OUD; however, evidence for their effectiveness in 
preventing overdose and substance use over time 
has yet to be borne out (Hawk & D’Onofrio, 2018). 
Research on the placement of peer recovery 
support specialists in EDs also appears to be 
promising but is still in its early stages (Ashford, 
Meeks, Curtis, & Brown, 2018; Samuels et 
al., 2018). The AnchorED Program in Rhode 
Island found that, during its frst year, use of 
certifed recovery coaches in the ED for people 
experiencing opioid overdose resulted in high 
engagement of recovery support services after 
discharge (83 percent), including enrollment at 
a local recovery community organization (Joyce 
& Bailey, 2015). Only 5 percent of people who 
engaged with the recovery coach experienced 
repeat ED visits. From 2016 to 2017, 87 percent of 
people engaged with AnchorED recovery coaches 
after ED discharge, and 51 percent accepted 
service referrals (e.g., inpatient treatment program, 
outpatient treatment program, MAT program) 
(Waye et al., 2019). However, more evidence is 
needed to elucidate the effcacy and effectiveness 
of peer-based approaches for ED populations. 
Pharmacotherapy 
This TIP does not comprehensively discuss 
pharmacotherapies for SUDs and mental illness. 
This section is an overview of medications for 
certain SUDs (i.e., OUD, AUD) and for mental 
disorders likely to co-occur with SUDs. The aim 
of this section is to foster appropriate monitoring 
and treatment planning by educating counselors 
about common medications that clients with 
CODs may be taking and side effects they may 
experience. For indepth discussion of medication 
for opioid addiction, see TIP 63, Medications for 
Opioid Use Disorder (SAMHSA, 2018c). “Resource 
Alert: Learning More About Pharmacotherapy and 
CODs” offers more information about medication 
treatment for CODs. 
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Medication for Mental Illness 
Mental disorders are diseases of the brain or 
central nervous system. They affect a person’s 
thinking, emotions, and mood. Medications 
can relieve distressing symptoms and improve 
functioning for people with mental illness, and 
they work in a variety of ways. Medications may 
be effective for more than one disorder but be 
referred to by the condition they are most often 
used to treat. For example, a medication may be 
referred to as an “antidepressant” but also help 
with anxiety or an eating disorder. Antipsychotic 
medications are typically associated with diseases 
like schizophrenia but may also be used for bipolar 
disorder or severe depression. Because the 
same medication can be used to treat various 
disorders, always ask clients for which condition 
they take a medication. 
A person may have a history of taking different 
medications in the past or may report a change 
in his or her medications while working with a 
counselor. People need different medications 
depending on how their illness is expressing itself 
(e.g., which symptoms are most severe or most 
disabling). Medications used to treat the frst 
episode of a mental illness may be different from 
those used later in disease course. Age may affect 
medication selection and dosage; aging affects 
metabolism and the bioavailability of some drugs. 
Sometimes a medication becomes less effective 
over time and will have to be changed or another 
medication added. There may also be periods 
when no medication is used at all. 
Medication Management 
A person with a mental illness should be cared 
for by a team of providers, which may include 
a primary care provider, a psychiatrist, and 
a behavioral health professional, such as a 
psychologist, social worker, or counselor. Different 
members of the care team may serve as primary 
contact over time. Medications will typically 
be prescribed by the primary care provider or 
psychiatrist. The team should work together 
to monitor the effects and side effects of the 
medication. Monitoring may include blood tests 
and checking blood pressure and weight. 
KNOWING WHEN TO REFER FOR 
MEDICATION MANAGEMENT 
Sometimes a nonprescribing professional 
in behavioral health (e.g., licensed clinical 
social workers, addiction counselors, most 
psychologists) will need to refer a client for an 
evaluation to explore pharmacotherapy options 
and appropriateness. Such situations include 
when a client: 
• Has not had success improving symptoms 
or functioning after trying multiple 
psychotherapies. 
• Has had limited success improving symptoms 
or functioning with psychotherapy but is still 
experiencing symptoms that are distressing or 
interfere with the person’s functioning. 
• Wants to be abstinent but has had diffculty 
stopping substance use (especially use of 
opioids or alcohol). 
• Reports having previous success with a 
medication and expresses an interest in trying 
the medication again. 
• Has (or is suspected to have): 
- Psychotic symptoms (e.g., hallucinations, 
delusions). 
- Schizophrenia. 
- Severe depression (especially with suicidal 
thoughts, behaviors, or attempts). 
- Bipolar disorder or mania. 
Equally important is knowing to whom you 
should refer clients for medication evaluation. 
You should refer to primary care or behavioral 
health professionals with prescribing privileges, 
such as: 
• A physician. 
• A psychiatrist. 
• An advanced practice registered nurse (especially
a psychiatric/mental health specialty nurse). 
Considerations for the SUD Treatment 
Provider 
A patient who appears sedated, agitated, or
intoxicated may be experiencing a medication side
effect or other medical illness. Medications that
work in the brain are considered “psychotropic,"
meaning they affect a person’s mental state. Drugs
of misuse are psychotropic, too. The benefts, side
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effects, and drug interactions of medications for
mental illness can affect clients similarly to, or look
like some of the effects of, illicit substances. This
may be triggering for the client or those around him
or her or lead to misuse of prescribed medication.
Illicit substances and prescribed medications may
interact with one another, potentially reducing the
benefcial effects of the prescribed medication
(Lindsey, Stewart, & Childress, 2012). 
Medication for Depression 
Medication can be used to treat major depression 
at all levels of severity; it should be started early 
and combined with psychotherapy (American 
Psychiatric Association [APA], 2010; Schulz & 
Arora, 2015). The goal of medication is to relieve 
distressing symptoms and help restore function. 
Several classes of medications have been approved 
for treating depression (FDA, 2017), including 
selective serotonin reuptake inhibitors (SSRIs), 
serotonin norepinephrine reuptake inhibitors 
(SNRIs), tricyclic antidepressants (TCAs), and 
monoamine oxidase inhibitors (MAOIs). Each 
works in different ways but ultimately treats 
depression by changing the balance of chemicals 
(neurotransmitters) in the brain that regulate mood, 
such as serotonin, norepinephrine, and dopamine. 
Sometimes medication not specifcally approved 
for depression, such as mood stabilizers or anti-
psychotics, will be added to the antidepressant to 
address specifc symptoms (FDA, 2017). 
In 2019, FDA approved the frst ever nasal spray 
antidepressant (FDA, 2019), derived from a pain 
reliever called ketamine. The spray (esketamine) 
is specifcally for treatment-resistant major 
depression and is designed to begin relieving 
symptoms, in a matter of hours. Its release 
represents the frst time FDA has approved a 
new antidepressant since the medication Prozac 
entered the market in 1988. 
Side Efects 
Common side effects when antidepressants are 
started or when the dose is increased are nausea, 
vomiting, and diarrhea (Exhibit 7.6). These usually 
improve in a few weeks. Side effects such as weight 
gain, sleep disturbances, and sexual dysfunction 
can be longer lasting. Some medication side effects 
may mimic signs of intoxication or withdrawal 
or may be triggering for clients. Medication for 
depression might increase suicidal thoughts in 
young adults (i.e., people ages 18 through 24). 
Some antidepressants are associated with birth 
defects or cause the newborn to experience a 
withdrawal syndrome. 
Medication for Anxiety Disorders 
Anxiety disorders are best treated with combined 
psychotherapy and medication (Benich, Bragg, 
& Freedy, 2016). Medication can help relieve 
distressing symptoms. Antidepressants and 
benzodiazepines are the most common classes 
EXHIBIT 7.6. Side Effects of Antidepressants 
MEDICATION CLASS SIDE EFFECTS 
SSRI High blood pressure, headache, sexual dysfunction, hyperalertness, restlessness, 
teeth grinding, sweating, internal bleeding, insomnia, nausea/vomiting, 
osteopenia 
SNRI Dry mouth, sexual dysfunction, hyperalertness, restlessness, sweating, insomnia, 
nausea/vomiting, weight gain 
TCA Irregular heart rhythm, low blood pressure with risk of falls, constipation, dry 
mouth, sweating, sedation, weight gain 
MAOI High blood pressure, low blood pressure with risk of falls, weight gain 
Other Seizure, insomnia, nausea/vomiting, sedation, weight gain 
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A NOTE ABOUT SEROTONIN SYNDROME 
Serotonin syndrome is a potentially fatal condition caused by too much serotonin (Bartlett, 2017). It can 
occur if a person takes too much of a prescribed SSRI or SNRI or when multiple prescribed medications 
interact. Over-the-counter cold and allergy medications and certain illicit substances (e.g., cocaine, other 
stimulants, opioids) can also cause serotonin syndrome. 
Mild serotonin syndrome can look like opioid withdrawal. More serious serotonin syndrome can look like 
intoxication with a stimulant or hallucinogen or withdrawal from a benzodiazepine. Fever, dangerously 
high blood pressure, and seizure can lead to organ failure and death if the syndrome is not recognized and 
treated. Counselors should remain vigilant for and seek medical evaluation for possible serotonin syndrome 
when clients with CODs present with unexpected withdrawal or intoxication symptoms. 
of FDA-approved medication for anxiety. 
Antidepressants in the SSRI and SNRI classes are 
considered frst-line therapy. Benzodiazepines 
should generally be used only for short periods, 
taken per a schedule rather than as needed (Benich 
et al., 2016). Taking benzodiazepines with opioids 
markedly increases the risk of overdose (NIDA, 
Revised March 2018). 
Benzodiazepines can cause dependence after 
relatively brief periods of regular use. People 
dependent on benzodiazepines will experience 
withdrawal if they stop taking them abruptly. 
Side effects of antidepressants prescribed for 
anxiety are the same as those for depression 
(Exhibit 7.6). Benzodiazepines carry an increased 
risk of central nervous system depression, which 
can lead to sedation, fatigue, dizziness, and 
impaired driving ability (Bandelow, Michaelis, & 
Wedekind, 2017). Older adults taking benzodiaze-
pines can have negative changes in cognition, such 
as memory, learning, and attention. Older adults 
taking benzodiazepines are thus at an increased 
risk of falls and fracture (Markota, Rummans, 
Bostwick, & Lapid, 2016). 
Medication for PTSD 
Medication combined with psychotherapy can be 
effective in relieving symptoms of PTSD (VA/DoD, 
2017). The FDA has approved two SSRIs for the 
The pharmacist from whom a client gets his 
or her prescriptions may be a helpful source 
of information if counselors have concerns or 
questions about side effects or drug interactions. 
treatment of PTSD. Studies are also underway to 
explore the beneft of using certain antipsychotics 
in PTSD. 
Medication for Bipolar Disorder 
Bipolar disorder is typically managed with both 
medication and psychotherapy, given its lifelong 
course and need for continuous treatment 
(SAMHSA, 2016). The goal of medication in 
bipolar disorder is to prevent or suppress mania 
while relieving depression (Fountoulakis et al., 
2017). Sometimes people will have already 
begun treatment for depression when mania 
presents for the frst time. When this happens, 
the antidepressant may be stopped and restarted 
later. Medications used to treat bipolar disorder 
are often referred to as “mood stabilizers.” This 
is not a single class of medication but a group of 
different types of medications that reduce the 
abnormal brain activity that causes mania and 
rapidly changing mood states. Mood stabilizers, 
antiseizure medications, and antipsychotic 
medications may be used to treat bipolar 
disorder; sometimes these medications are used in 
combination. 
Mood Stabilizers 
Medication to prevent severe mood fuctuations 
can be effective at treating mania, particularly the 
frst-line medication lithium (Fountoulakis et al., 
2017). Mood stabilizers treat and prevent mania 
by decreasing abnormal activity in the brain. 
People taking lithium need to see a physician 
regularly for monitoring of blood levels and kidney 
and thyroid functioning. Side effects that may 
improve with time are nausea, diarrhea, dizziness, 
muscle weakness, fatigue, and feeling “dazed.” 
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Other symptoms are likely to continue, such as 
fne tremor, frequent urination, and thirst. Lithium 
can cause skin disorders like acne, psoriasis, and 
rashes. Serious side effects include irregular heart 
rhythm and serotonin syndrome. Anesthesia and 
antidepressants are associated with serotonin 
syndrome when taken with lithium. Elevated 
blood levels of lithium can cause uncontrollable 
shaking, clumsiness, ringing in the ears, slurred 
speech, and blurred vision. Salt, caffeine, alcohol, 
other medications, and dosing mistakes can 
cause lithium toxicity, which can be a medical 
emergency. 
Antiseizure Medication 
Antiepileptic medications can be used to treat 
bipolar disorder (Fountoulakis et al., 2017; National 
Institute of Mental Health [NIMH], 2016). These 
medications may have both benign and life-
threatening side effects, including rash, damage to 
internal organs, and a decrease in blood cells (e.g., 
platelets, white blood cells). These medications 
can interact negatively with medications used to 
treat common medical concerns, such as diabetes 
and high blood pressure. They also can make 
hormonal contraceptives less effective. Other 
serious side effects include peeling or blistering of 
the skin, bruising, bleeding, weakness, headache, 
stiff neck, chest pain, nausea/vomiting, vision 
changes, swelling of the face/eyes/lips, dark urine, 
yellowing of the skin or eyes, abnormal heartbeat, 
loss of appetite, and abdominal pain. Common but 
less-serious side effects include blurred or double 
vision; dizziness; uncontrollable movements; 
sleepiness; weight change; ringing in the ears; hair 
loss; back, stomach, or joint pain; painful menstrual 
periods; confusion; diffculty speaking; and dry 
mouth. 
Antipsychotic Medication 
Antipsychotic medication may be used to treat 
mania with psychosis. See the section “Medication 
for Schizophrenia and Other Psychotic Disorders” 
for detailed information about the medications. 
Tobacco smoke affects how medications 
are absorbed, spread through the body, are 
metabolized, and eliminated by the body; how 
medications work can also be affected (Lucas & 
Martin, 2013). Changing the amount of tobacco 
smoked, including stopping or starting, can 
interfere with medication effectiveness or risk of 
side effects. 
Medication for Schizophrenia and Other 
Psychotic Disorders 
Antipsychotics are the most common medications 
for schizophrenia and other psychotic disorders 
(Lally & MacCabe, 2015; Patel, Cherian, Gohil, & 
Atkinson, 2014). They have many side effects and 
require careful monitoring. Most are taken daily, 
but a few long-lasting forms can be administered 
once or twice a month. 
Antipsychotics are divided into two categories: 
“frst-generation” or “typical” antipsychotics and 
“second-generation” or “atypical” antipsychotics. 
Both types can be used to help treat schizophrenia 
and mania related to bipolar disorder. Some 
antipsychotics have a wider range of uses, 
including severe depression, generalized anxiety 
disorder, obsessive-compulsive disorder, PTSD, 
dementia, and delirium. Symptoms such as 
agitation and hallucinations may remit within a 
few days of starting the medication, whereas 
delusions may take a few weeks to resolve. The 
full effect of an antipsychotic may not be seen for 
up to 6 weeks. A person may need to stay on the 
antipsychotic for months or years to stay well. 
Side Efects 
All antipsychotics have the potential to cause side 
effects such as drowsiness, dizziness, restlessness, 
dry mouth, constipation, nausea, vomiting, blurred 
vision, low blood pressure, and uncontrollable 
muscle movements (NIMH, 2016). People who 
take antipsychotics need to have their blood cell 
counts, blood glucose, and cholesterol monitored 
by a healthcare provider. Care should be taken 
when starting or stopping other medications, 
given the many potential drug interactions, 
not all of which are known. The typical or frst-
generation antipsychotics may cause rigidity and 
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muscle spasms, tremors, and restlessness. They 
may also cause a condition of abnormal muscle 
movements called tardive dyskinesia, which can 
persist even when the medication is discontinued. 
Some antipsychotics cause electrocardiogram 
abnormalities, such as QT prolongation, a 
condition in which the heart takes longer to 
recharge between beats. An individual can 
overdose on antipsychotics, especially if they are 
combined with alcohol or other sedating drugs. 
Medication for Attention Defcit 
Hyperactivity Disorder 
Attention defcit hyperactivity disorder (ADHD) 
in adults may be treated with short- or long-
acting stimulants, nonstimulant medications, 
and behavioral therapy (NIMH, 2016). Typically, 
a nonstimulant medication is prescribed frst; 
a stimulant is prescribed only if nonstimulant 
response is insuffcient. Stimulant medications help 
people with ADHD focus and feel calmer but can 
cause euphoria (SAMHSA, 2015a). 
Stimulants may be misused by people who have 
no prescription. Typically, people who misuse 
stimulants are motivated to improve academic/ 
work performance and hope to experience 
enhanced concentration and alertness rather than 
euphoria. Many people who consistently misuse 
prescription stimulants exhibit symptoms of ADHD. 
Adults who are prescribed stimulants for ADHD 
may misuse them by taking larger doses than 
prescribed. Some evidence exists that adults who 
misuse stimulants prescribed to them are more 
likely to report misuse of other substances as well 
(Wilens et al., 2016). 
No specifc guidelines exist on whether stimulants 
should be prescribed for co-occurring ADHD in 
people with SUDs. Available research is unclear as 
to whether stimulants are effective for ADHD in 
the presence of an SUD. Although effcacious in 
reducing ADHD symptoms, stimulant medications 
generally do not alleviate SUD symptoms (Cunill 
et al., 2015; De Crescenzo et al., 2017; Luo & 
Levin, 2017). Thus, ADHD medication alone, if 
used at all, is an insuffcient treatment approach 
for ADHD-SUD (Crunelle et al., 2018; Zulauf et 
al., 2014). Stimulants do have misuse potential, 
but current evidence suggests that most people 
with ADHD and SUD generally do not divert or 
misuse stimulant medication for ADHD (e.g., to 
experience euphoria) (Luo & Levin, 2017). However, 
diversion can and does occur in some people. Use 
of long-acting or extended-release medication or 
of antidepressants instead of stimulants can help 
reduce the chances of diversion and misuse. 
Medications for ADHD can have potentially life-
threatening cardiovascular side effects (Sinha,
Lewis, Kumar, Yeruva, & Curry, 2016). Changes in
heart rhythm and blood pressure can occur that raise
risk of stroke and heart attack, especially in adults
with preexisting heart conditions (Zukkoor, 2015).
These medications should be prescribed cautiously
and with consideration of the client’s personal and
family history of cardiovascular problems. Combined
medication and psychotherapy may provide the
best long-term relief of ADHD symptoms (Arnold,
Hodgkins, Caci, Kahle, & Young, 2015). 
Medication for PDs 
No medications are FDA approved to treat any PD. 
Antidepressants, mood stabilizers, antipsychotics, 
and antianxiety medications can be prescribed to 
target symptoms/improve function. 
Medication for Feeding and Eating Disorders 
Medication is generally not a frst-line or standalone
treatment approach for eating disorders, and only
one medication—the SSRI fuoxetine (Prozac)—is
approved by the FDA to treat these conditions
(specifcally, bulimia nervosa [BN]) (Davis & Attia,
2017). Other antidepressants may be effective for
the management of BN and binge eating disorder
(BED) but have been relatively less successful with
anorexia nervosa (AN; Davis & Attia, 2017). Second-
generation antipsychotics (notably olanzapine) may
offer a promising pharmacotherapy option for AN,
but more research is needed (Davis & Attia, 2017).
Certain stimulants known to suppress appetite have
shown some success with reducing symptoms of
BED (Davis & Attia, 2017).
Medication for SUDs 
Because SUDs are brain-based diseases, 
pharmacologic research has explored the 
development of agents that can effectively 
target disruptions in neurotransmitters and 
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neuromodulators that occur as a part of addiction. 
These medications often help reduce withdrawal 
symptoms or craving, which in turn can make 
abstinence easier to achieve and sustain. In 
general, pharmacotherapy for SUDs is considered 
supportive rather than curative and is typically 
combined with psychotherapy, behavioral 
counseling, psychoeducation, mutual support, 
other recovery services, or a combination of these. 
The sections that follow briefy discuss 
medications for AUD and OUD. Currently no 
FDA-approved pharmacotherapies exist for 
cocaine, methamphetamine, or cannabis use 
disorders. Clinicians often use FDA-approved 
nicotine replacement therapy and nonnicotine 
medications to manage tobacco use disorder. 
Tobacco use is outside the scope of this TIP, so 
these pharmacotherapies are not discussed. 
Readers interested in learning more can review 
FDA’s guidance about medication to support 
tobacco cessation (www.fda.gov/ForConsumers/ 
ConsumerUpdates/ucm198176.htm). 
Medication use by people battling addiction 
has been controversial given attitudes by some 
providers and mutual-support programs, like AA 
and Narcotics Anonymous, that view medication 
use as incompatible with abstinence and 
therefore not a valid part of recovery. Counselors 
should be sensitive to this and educate clients 
about the potential value of medication as well as 
possible negative reactions they might face from 
some mutual-support programs and addiction 
professionals. 
Medication is not a cure for addiction and 
is not right for everyone. But the science 
is clear: in certain instances (e.g., for OUD), 
pharmacotherapy can not only help improve 
lives, it can help save them as well. 
Medication for AUD 
Three medications are FDA approved for AUD 
(disulfram, naltrexone, and acamprosate), and 
each has a different mechanism of action. These 
include disincentivizing use by causing unpleasant 
side effects (e.g., nausea, headache, vomiting) 
when alcohol is consumed (disulfram); blocking 
the euphoric effects of intoxication (naltrexone); 
and normalizing neurotransmitter activity 
that is dysregulated in addiction and during 
withdrawal (acamprosate). Other medications, 
including anticonvulsants, antipsychotics, and 
antidepressants, can help reduce consumption and 
craving and potentially help support abstinence 
(Akbar, Egli, Cho, Song, & Noronha, 2018). 
Medication for OUD 
Unlike AUD and other SUDs, pharmacotherapy 
(with or without adjunctive psychosocial 
treatment) is the recommended approach 
to managing OUD. Ample research strongly 
supports the effectiveness of MAT` for OUD in 
increasing abstinence, preventing or reversing 
overdose, reducing risk of relapse, and mitigating 
negative outcomes associated with opioid 
addiction, like infectious diseases and incarceration 
(SAMHSA, 2018c). FDA-approved medications 
for OUD include methadone, buprenorphine, 
and naltrexone. In addition, the FDA-approved 
rescue medication naloxone can rapidly reverse 
opioid overdose and prevent fatality. Readers 
should consult TIP 63, Medications for Opioid 
Use Disorder (SAMHSA, 2018c), for extensive 
information about opioid pharmacotherapy and 
its role in helping clients manage symptoms and 
achieve long-term recovery. 
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RESOURCE ALERT: LEARNING MORE ABOUT PHARMACOTHERAPY AND CODs 
Pharmacology interventions can be safe and effective for many individuals with CODs. Although 
prescribing is outside the practice of addiction counselors, licensed clinical social workers, and most 
psychologists, all providers should become familiar with common psychotropic medications, their side 
effects, and their potential risks. Following are several resources to help nonprescribing behavioral health 
service providers learn more about pharmacotherapy for mental disorders and SUDs: 
• SAMHSA’s TIP 63, Medications for Opioid Use Disorder (https://store.samhsa.gov/product/ 
TIP-63-Medications-for-Opioid-Use-Disorder) 
• SAMHSA’s Medication for the Treatment of Alcohol Use Disorder: A Brief Guide (https://store.samhsa.gov/ 
system/fles/sma15-4907.pdf) 
• APA’s Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder 
(https://psychiatryonline.org/doi/pdf/10.1176/appi.books.9781615371969) 
• National Library of Medicine’s Drug Information Portal (https://druginfo.nlm.nih.gov/drugportal/) 
• FDA’s Medication Guides (www.fda.gov/drugs/drugsafety/ucm085729.htm) 
• NIMH’s Mental Health Medications (www.nimh.nih.gov/health/topics/mental-health-medications/index. 
shtml) 
• University of Washington’s Commonly Prescribed Psychotropic Medications (https://aims.uw.edu/ 
resource-library/commonly-prescribed-psychotropic-medications) 
Conclusion 
CODs are exceedingly common in both the SUD 
population and the mental illness population, and 
addiction counselors should expect to see both 
conditions in their work. A wide range of treatment 
approaches are available and can be adapted to 
the specifc needs of people with CODs, including 
their symptoms as well as their stages of change 
and readiness to engage in services. Because the 
disease course of SUDs and mental disorders is 
often unstable and unpredictable, counselors must 
be ready to offer COD-appropriate interventions 
across all settings, including nontraditional settings 
like jails and prisons. Continuous, integrated 
treatment modalities that link clients with resources 
and supports in the community give people with 
addiction the best chances at achieving lasting 
recovery. 
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• Mental health and addiction labor force 
problems directly affect treatment access, 
quality, and cost. Without addressing gaps in 
personnel and training, the behavioral health 
feld will struggle to meet the needs of the 
growing numbers of people living with co-
occurring disorders (CODs). 
• Although current workforce challenges may 
seem daunting, substance use disorder (SUD) 
treatment supervisors and administrators can 
help confront and overcome these diffculties 
by creating, implementing, and sustaining 
professional development and training 
opportunities within their organizations. 
This in turn will help support the uptake and 
utilization of best practices. 
• Recruitment and retention priorities are 
urgently needed because of the challenging 
nature of the addiction and mental health 
service professions, which leads to high rates 
of staff burnout and turnover. 
• Professional education and accreditation, 
combined with mentoring and supervision, 
can help increase adoption of core and 
advanced clinical competencies, increase 
providers’ comfort with working with people 
who have CODs, reduce stigma surrounding 
the profession/feld, and provide structured 
career development. 
Availability, quality, and cost of SUD treatment and 
mental health services are intricately tied to the 
current state of the behavioral health workforce. 
Without a robust, sizeable labor force, how will 
people with mental disorders and addiction 
problems have their needs met? Without enough 
trainees entering the feld or staff willing to stay in 
their jobs long term, how will addiction and mental 
health service organizations keep their doors open? 
What sort of ripple effects might an understaffed 
or ill-prepared workforce have on our healthcare 
system, economy, and society as a whole? 
Rather than serve as a primer on labor diffculties 
in the mental health and addiction felds, this 
chapter—addressed primarily to supervisors and 
administrators—provides an informative update on 
the current state of mental health and addictions 
professions. The goal is to help supervisors, 
administrators, and other organizational leadership 
understand aspects of the workforce relevant to 
their organization’s ability to provide high-quality, 
cost-effective, evidence-based services for CODs 
and help them feel better prepared to address 
workforce gaps in their own agency. 
This chapter is divided into two main sections: 
• The frst half addresses recruitment, hiring, and 
retention in the behavioral health workforce. 
Finding, getting, and keeping the right 
employees is critical to ensuring the long-term 
sustainability, viability, and effectiveness of the 
feld. Toward that end, the chapter contains links 
to practical, web-based resources for programs 
and administrators, including toolkits and 
manuals. 
• The second half of this chapter focuses on 
ensuring the competency and professional 
development of program staff. This section 
includes detailed discussions about the role of 
training, supervision, and credentialing, all of 
which are necessary components of preparing 
the feld to deliver evidence-based care and 
fostering increased service provision. 
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Note that general guidelines aimed at supervisors
and administrators serving people with CODs are
in Chapter 2 and information about implementing
various treatment models and settings is in
Chapter 7.
This chapter discusses training needs for 
addiction counselors working with clients who 
have CODs. However, any behavioral health 
service provider in any setting (e.g., primary 
care, a social worker’s offce, SUD treatment, a 
psychologist’s/psychiatrist’s offce) should have 
the skills and competencies to recognize CODs 
and provide at least a basic screening that 
encompasses CODs, with enough knowledge 
of community resources to refer for integrated 
COD treatment if the provider can’t provide such 
treatment himself/herself. 
Recruitment, Hiring, and
Retention
As of March 2020, the Health Resources and 
Services Administration (HRSA) has identifed 
approximately 5,537 mental health professional 
shortage areas in the United States, requiring 6,387 
mental health practitioners to fll the shortage 
(HRSA, 2020). The behavioral health workforce 
is fraught with profession gaps and similar 
challenges that serve as barriers to treatment 
access for people with mental disorders and 
SUDs. For instance (Olfson, 2016; Weil, 2015): 
• Formal education in psychology and psychiatry 
is time consuming and costly, making it harder 
to recruit and retain trainees. 
• The number of medical trainees specializing in 
psychiatry is shrinking. 
• Within psychiatry, types of services provided are 
variable (e.g., medication management only vs. 
psychotherapy and pharmacotherapy). 
• Psychiatrists are less likely to accept Medicaid 
than other medical specialties, which is 
particularly damaging to individuals with serious 
mental illness (SMI), like schizophrenia, who 
often require public assistance. Psychologists 
also are unlikely to accept Medicaid given low 
reimbursement rates. 
• Psychologists and psychiatrists tend to 
be disproportionately clustered in certain 
geographic regions, leaving shortages in rural 
areas (vs. more affuent urban and suburban 
areas) and particular regions of the United 
States (e.g., Midwest, Deep South). 
• People with SMI are grossly underserved due 
in part to factors like lack of formal training 
opportunities in SMI and low provider comfort 
with working with these populations. 
• Social workers and primary care providers can 
help fll critical workforce and service gaps 
A focus group of mental health and SUD treat-
ment providers identifed organizational and sys-
tem-related factors they believed hindered their 
ability to adequately care for clients with CODs 
(Padwa, Guerrero, Braslow, & Fenwick, 2015): 
• Lack of support for COD services, such as 
low allocation of resources, discontinuing 
consultations with outside COD experts, 
discontinuing onsite drug testing of clients, and 
not implementing integrated care procedures 
even when already developed by staff 
• Lack of COD training opportunities 
• An inability to bill for CODs (e.g., certain 
organizations would only permit billing for 
mental health services and not SUD treatment) 
• Lack of local addiction services, which make 
coordinating care, referring clients to specialty 
services, and linking clients to needed 
resources more diffcult. Even when these 
services are present, available slots are limited 
and wait-times are often long. 
• Large caseloads and limited time to work with 
clients 
• Diffculty initiating and maintaining contact 
with outside SUD treatment providers, 
especially with providers in residential 
treatment settings 
• Fragmented, nonintegrated care that results 
in different providers using different (and 
sometimes opposing) treatment approaches 
with the same client. This is particularly 
problematic when clients on pharmacotherapy 
attend mutual-support groups or treatment 
programs that strongly discourage 
psychotropic medication. 
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left by psychiatry and psychology (particularly 
in treating clients with SMI), but this will 
require additional training in behavioral health 
assessment, diagnosis, and treatment and better 
compensation. 
Recruitment and Retention 
The documented workforce shortage in SUD 
treatment and mental health services underscores 
the need for aggressive, effective, and even 
creative recruitment and hiring strategies and 
policies. Extended vacancies in behavioral health 
service positions leave programs—and the clients 
they serve—vulnerable to negative outcomes 
like further turnover, high stress, low morale, and 
fragmented, ineffective care. 
The ability to recruit and hire quality, long-term 
employees frst requires attracting the right 
candidates. Job postings and advertisements 
in multiple outlets, such as websites, on social 
media, at job fairs, in newspapers, and within the 
community, can increase exposure and widen the 
potential pool of applications. Less traditional but 
nonetheless effective places to advertise include 
churches, synagogues, and other faith-based 
organizations; community welfare agencies and 
housing offces; shopping centers; and health 
clinics and senior centers. Staff referral incentives 
encourage current employees to act as recruiters 
and also help increase retention. 
Exhibit 8.1 outlines steps from the Substance 
Abuse and Mental Health Services Administration’s 
(SAMHSA) Recruitment and Retention Toolkit, 
designed to aid behavioral health service 
organizations in building more effective 
recruitment, hiring, and retention practices. The 
toolkit offers a six-step approach and includes 
numerous resources (e.g., templates, samples, 
worksheets) to guide programs at each step 
(see “Resource Alert: Recruitment and Retention 
Resources for the Behavioral Health Workforce”). 
EXHIBIT 8.1. Building an Effective Recruitment and Retention Plan for 
Behavioral Health Service Providers 
• Step 1. Gather organizational baseline information. Before programs can effectively recruit and hire 
the right personnel, they frst need to assess the landscape: What are the current retention rates for 
healthcare providers? What previously used recruitment and hiring strategies have proved effective and 
ineffective for the feld? What can be learned about job satisfaction from exit interviews? 
• Step 2. Decide on a priority recruitment and retention focus (job position). Programs should gather 
and analyze data to identify their most pressing hiring needs and challenges. This should result in 
programs selecting the most urgent priority position to fll. 
• Step 3. Analyze the selected job position. Once a priority position is selected from Step 2, programs 
need to identify the benefts and challenges of the position to develop a clear and accurate position 
description. 
• Step 4. Write an accurate job description. The position description needs to be articulate, direct, and 
thorough to attract the best ftting, most qualifed candidates possible. 
• Step 5. Identify the strategy and intervention. Programs can choose from among several options the 
best recruitment or retention strategy that fts their needs and that they feel will be most effective at 
helping them overcome their specifc challenges. 
• Step 6. Develop an action plan. At this step, the strategy and intervention are implemented. In 
preparation, programs should develop and assign specifc tasks; appoint managers to oversee the 
process; defne outcomes for their intervention; determine steps for monitoring, communicating about, 
and assessing the intervention’s effectiveness; and fnalize the implementation plan. 
Source: SAMHSA (n.d.). 
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RESOURCE ALERT: RECRUITMENT AND RETENTION RESOURCES FOR THE 
BEHAVIORAL HEALTH WORKFORCE 
• Addiction Technology Transfer Center (ATTC) Network’s National Workforce Report 2017: Strategies for 
Recruitment, Retention, and Development of the Substance Use Disorder Treatment and Recovery 
Services Workforce (https://attcnetwork.org/centers/global-attc/national-workforce-study) 
• Behavioral Health Education Center of Nebraska’s Retention Toolkit (www.naadac.org/assets/2416/ 
samhsa-naadac_workforce_bhecn_retention_toolkit2.pdf) 
• National Association for Alcoholism and Drug Abuse Counselors (NAADAC) and SAMHSA webinar, Focus 
on the Addiction and Mental Health Workforce: Increasing Retention For Today and Tomorrow (www. 
naadac.org/assets/2416/2016-09-12_wf_retention_webinarslides.pdf) 
• SAMHSA Recruitment and Retention Toolkit (http://toolkit.ahpnet.com/Home.aspx) 
Reducing Staf Turnover 
Behavioral health service provider turnover and 
burnout can strain organizational infrastructure, 
prevent clients from receiving much-needed 
services, and weaken the feld as a whole. The 
Department of Labor’s Bureau of Labor Statistics 
estimates a national turnover rate across all 
professions of around 3.7 percent (Bureau of Labor 
Statistics, February 11, 2020). By comparison, 
turnover in the behavioral health feld is quite 
high. Among addiction counselors and supervisors, 
average annual turnover has been estimated to 
range between 23 percent and 33 percent (Eby, 
Burk, & Maher, 2010; Knight, Broome, Edwards, 
& Flynn, 2011; Laschober & Eby, 2013) and 
between approximately 17 percent and 26 percent 
among mental health therapists and supervisors 
(Beidas et al., 2016; Bukach, Ejaz, Dawson, & 
Gitter, 2017). In both sectors, turnover is usually 
voluntary—an additional cause for concern. 
Reasons for behavioral health service providers to 
leave their jobs voluntarily include burnout (driven 
by factors like high workload and not having a clear 
understanding of job roles and duties), low levels 
of support from supervisors and coworkers, and job 
dissatisfaction (related to high workload and poor 
supervisory relationships) (Garner & Hunter, 2014; 
Yanchus, Periard, & Osatuke, 2017; Young, 2015). 
(Also see the section “Avoiding Burnout.”) 
Turnover is destabilizing to an agency for 
numerous reasons (Young, 2015). Turnover often 
negatively affects an organization’s capacity to 
serve clients, effciency, proft-earning potential, 
operational spending, and staff morale and stress 
levels. The issue of staff turnover is especially 
important for professionals working with clients 
who have CODs because of the limited workforce 
pool and the high investment of time and effort 
involved in developing a trained workforce. It 
matters, too, because of the crucial importance of 
the treatment relationship to successful outcomes. 
Rapid turnover disrupts the context in which 
recovery occurs. Clients in such agencies may 
become discouraged about the possibility of being 
helped by others. 
Turnover sometimes results from the unique 
professional and emotional demands of working 
with clients who have CODs. On the other hand, 
most providers in this area are very dedicated 
and fnd the work to be rewarding. Evidence 
suggests that turnover may be connected to 
providers’ feelings of preparedness to serve clients 
with CODs. SUD treatment providers who leave 
an organization but stay in the feld (program 
turnover) are more likely to have formal education, 
training, and experience in SUDs than addiction 
counselors who leave an organization and withdraw 
from the feld entirely (profession turnover) 
(Eby, Laschober, & Curtis, 2014). This suggests 
that programmatic training and professional 
development could help strengthen not only the 
individual agency but the workforce as a whole. 
Turnover in the addiction feld is linked to 
attitudinal and organizational predictors, including 
lower job satisfaction, lower job involvement, 
less support from supervisors or coworkers, and 
poor role manageability (Garner & Hunter, 2014). 
These factors are largely modifable and are 
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EXHIBIT 8.2. Reducing Staff Turnover in Programs for Clients With CODs 
To decrease staff turnover, whenever possible, programs should: 
• Hire staff members who have familiarity with both SUDs and mental disorders and have a positive regard 
for clients with either disorder. 
• Hire staff members who are critically minded and can think independently, but who are also willing to 
ask questions and listen, remain open to new ideas, maintain fexibility, work cooperatively, and engage in 
creative problem-solving. 
• Provide staff with a framework of realistic expectations for the progress of clients with CODs. 
• Establish reasonable client caseloads and scheduled time during work hours to follow-up with case 
management matters and paperwork. 
• Provide opportunities for consultation among staff members who share the same client (including 
medication providers). 
• Ensure that supervisory staff are supportive and knowledgeable about areas specifc to clients with CODs. 
• Provide and support opportunities for further education and training. 
• Provide structured opportunities for staff feedback in the areas of program design and implementation. 
• Solicit feedback from staff about their perceptions of the work environment, including levels of support, 
civility, resource needs, and relationships with supervisors. 
• Conduct exit interviews with departing employees to gather perspectives on areas for improvement. 
• Promote knowledge of, and advocacy for, CODs among administrative staff, including those in decision-
making positions (e.g., directors) and others (e.g., fnancial offcers, billing personnel, state reporting monitors). 
• Provide a desirable work environment through adequate compensation, salary incentives for COD 
expertise, opportunities for training and for career advancement, involvement in quality improvement or 
clinical research activities, and efforts to adjust workloads. 
important targets for monitoring and implementing 
programmatic changes to help providers feel 
satisfed, supported, and competent on the job 
(Yanchus et al., 2017). Exhibit 8.2 offers methods 
for reducing staff turnover. 
Avoiding Burnout 
A logical approach to reducing turnover is to 
prevent the occurrence of burnout. Burnout 
has been reported in as much as 67 percent of 
professionals in the mental health feld (Morse, 
Salyers, Rollins, Monroe-DeVita, & Pfahler, 2012). 
Reasons mirror those for turnover, including, but 
not limited to, demanding workloads and not 
feeling rewarded by one’s work (Young, 2015). 
Often, mental health service and SUD treatment 
providers are expected to manage growing and 
more complex caseloads. “Compassion fatigue” 
may occur when the pressures of work erode 
a counselor’s spirit and outlook and begin to 
interfere with the counselor’s personal life; see 
also Treatment Improvement Protocol (TIP) 36, 
Substance Abuse Treatment for Persons With Child 
Abuse and Neglect Issues (Center for Substance 
Abuse Treatment [CSAT], 2000c, p. 64). Assisting 
clients who have CODs is diffcult and emotionally 
taxing; the danger of burnout is considerable. 
Program administrators must maintain awareness 
of the problem of burnout and the benefts of 
reducing turnover. Program administrators must 
demonstrate interest in staff well-being to sustain 
morale and team cohesion. 
To lessen burnout among counselors working with 
a demanding caseload that includes clients with 
CODs, behavioral health service organizations 
should (Atkinson, Rodman, Thuras, Shiroma, & 
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RESOURCE ALERT: DEALING WITH 
STRESS IN BEHAVIORAL HEALTH 
SERVICE SETTINGS 
SAMHSA’s Recruitment and Retention Toolkit 
chapter, Dealing With Stress in the Workplace: 
Frustration, Stress, and Compassion Fatigue/ 
Burnout (http://toolkit.ahpnet.com/Dealing-with-
Stress-in-the-Workplace.aspx) 
Lime, 2017; Oser, Biebel, Pullen, & Harp, 2013; 
Morse et al., 2012): 
• Create a collegial environment for staff, 
particularly by encouraging support between 
coworkers. 
• Increase the amount of supervision given to 
staff, not only for skill building but because 
supervision can serve as another outlet for 
emotional support and encouragement much 
needed by providers. 
• Advocate for and help staff cultivate self-care 
and self-compassion. For instance, provide 
staff with cognitive–behavioral interventions 
to improve their coping skills, foster positive 
attitudes, and increase relaxation, and promote 
mindfulness. 
• Decrease workloads, increase provider 
autonomy, and clarify roles and expectations. 
Competency and Professional
Development 
This section focuses on some key areas programs 
face in developing a workforce able to meet the 
needs of clients with CODs. These include: 
• The attitudes and values providers must have to 
work successfully with these clients. 
• Essential competencies for providers (basic, 
intermediate, and advanced). 
• Opportunities for continuing professional 
development as well as professional licensure. 
Areas of weakness exist in many COD programs’
services, staff training/supervision, and staff com-
petencies (Petrakis, Robinson, Myers, Kroes, &
O’Connor, 2018). Of 256 U.S. addiction treatment
and mental health service programs surveyed
(McGovern et al., 2014), only 18 percent of SUD
programs and 9 percent of mental disorder
programs were COD capable. In a survey of 30
publicly funded COD programs (Padwa et al., 2013): 
• About 43 percent met or exceeded criteria for 
COD-capable programming. 
• About half had mission statements, organizational
certifcation and licensure, service coordination,
and fnancial incentives focused on treating either
mental illness or SUDs but not both. 
• 24 of 30 programs could only bill for mental 
health services or SUD treatment but not both. 
• 18 programs routinely used clinical interview 
assessment techniques adapted to CODs, 
but only 6 of those programs had formal 
standardized screening tools for CODs. Only 
fve programs had formal procedures in place to 
conduct comprehensive assessments of clients 
who screen positive for CODs. 
• Most programs lacked stagewise treatments 
specifcally for CODs, including a lack of 
psychoeducation about and recovery support 
for both mental disorders and SUDs. 
• 18 programs had onsite prescribers. 
• 23 programs used supervision and consultation 
to address mental conditions and substance 
use. However, most programs did not have 
licensed or otherwise competently trained 
staff to provide COD services other than 
pharmacotherapy management. 
• Over 80 percent of the sites offered direct staff 
training in basic competencies (e.g., prevalence, 
signs and symptoms, assessment procedures), 
but only about 57 percent of programs had 
staff with at least some advanced competency 
training in treating CODs. 
The consensus panel underscores the importance 
of an investment in creating a supportive 
environment for staff that encourages professional 
development to include skill acquisition, values 
clarifcation, training, and competency attainment 
equal to an investment in new COD program 
development. An organizational commitment to 
both is necessary for successful implementation 
of programs. Examples of staff support may 
include standards of practice related to consistent 
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high-quality supervision, favorable tuition 
reimbursement and release-time policies, helpful 
personnel policies related to bolstering staff 
wellness practices, and incentives or rewards 
for work-related achievement. Together these 
elements help create an environment in which 
high-quality service can thrive. 
In support of all behavioral health service providers 
embodying the “no wrong door” policy for service 
readiness, the consensus panel strongly suggests 
all administrators consider providing COD 
training as part of their workforce development 
for staff, even if their program is not a specialty 
COD program. 
Attitudes and Values 
Attitudes and values guide the way providers 
meet client needs and affect the overall treatment 
climate. They not only determine how the client 
is viewed by the provider (thereby generating 
assumptions that could either facilitate or deter 
achievement of the highest standard of care), but 
also profoundly infuence how the client feels as 
he or she experiences a program. Attitudes and 
values are particularly important in working with 
clients who have CODs because the counselor is 
confronted with two disorders that require complex 
interventions. 
Attitudes and values are important targets of
professional development and training. Some
research indicates that behavioral health service
providers and trainees have more negative attitudes
toward people with SMI and with SUDs—either
separately or in combination—than they do toward
people with medical or other mental disorders, and
that attitudes toward individuals with comorbid
SUDs and psychotic disorders in particular are
among the most negative and worsen over time
(Avery et al., 2016; Avery et al., 2017; Avery &
Zerbo, 2015; Mundon, Anderson, & Najavits, 2015).
Education-focused training and increased exposure
to SMI, SUD, and COD populations could potentially
help increase provider comfort, competency, and
confdence while diluting personal biases that
directly affect clinical care. 
The essential attitudes and values for working with
clients who have CODs shown in Exhibit 8.3 are
adapted from Technical Assistance Publication
21, Addiction Counseling Competencies: The
Knowledge, Skills, and Attitudes of Professional
Practice (CSAT, 2006a). The consensus panel
believes these attitudes and values also are
consistent with the attitudes and values of the vast
majority of those who commit themselves to the
challenging felds of SUD treatment and mental
health services. 
EXHIBIT 8.3. Essential Attitudes and Values for Providers Serving 
Clients With CODs 
• Desire and willingness to work with people who have CODs 
• Appreciation of the complexity of CODs 
• Openness to new information 
• Awareness of personal reactions and feelings 
• Recognition of the limitations of one’s own personal knowledge and expertise 
• Recognition of the value of client input into treatment goals and receptivity to client feedback 
• Patience, perseverance, and therapeutic optimism 
• Ability to use diverse theories, concepts, models, and methods 
• Flexibility of approach 
• Cultural competence 
• Belief that all people have strengths and are capable of growth and development 
• Recognition of the rights of clients with CODs, including the right and need to understand assessment 
results and the treatment plan 
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How To Improve Providers’ Attitudes Toward 
Clients With CODs 
Several strategies can help reduce stigma and 
negative attitudes and opinions among behavioral 
health service providers about people with CODs. 
These include (Avery et al., 2016): 
• Increasing didactic and clinical exposure to 
clients with these disorders to improve provider 
knowledge and experience. 
• Providing education about commonly held 
negative attitudes and misperceptions about 
CODs, and encouraging trainees to refect on 
and discuss their own experiences and beliefs 
(e.g., via journaling, writing refection papers). 
• Offering supervision and mentorship by senior 
providers trained in addiction medicine with 
experience working with CODs. 
Provider Competencies 
Provider competencies are the specifc and 
measurable skills providers must possess. Several 
states, university programs, and expert committees 
have defned the key competencies for working 
with clients who have CODs. Typically, these 
competencies are developed by training mental 
health and SUD treatment counselors together, 
often using a case-based approach that allows 
trainees to experience the insights each feld 
affords the other. 
One challenge of training is to include culturally 
sensitive methods and materials that refect 
consideration for the varying levels of expertise 
and background of participants. The consensus 
panel recommends viewing competencies as basic, 
intermediate, and advanced to foster continuing 
professional development of all counselors and 
clinicians in the feld of CODs. Clearly, the sample 
competencies listed within each category cannot 
be completely separated from each other (e.g., 
competencies in the “basic” category may require 
some competency in the “intermediate” category). 
Still, the groupings within each category refect, on 
the whole, different levels of provider competency. 
Providers in the feld face unusual challenges and 
often provide effective treatment while working 
within their established frameworks. In fact, 
research studies previously cited have established 
the effectiveness of SUD treatment approaches in 
working with people who have low- to moderate-
severity mental disorders. Still, the classifcation 
of competencies supports continued professional 
development and promotes training opportunities. 
Basic, intermediate, and advanced competencies 
are discussed further in the following sections. See 
also “Resource Alert: Oregon Health Authority’s 
Competency Checklists for COD Providers” 
and Technical Assistance Publication (TAP) 21, 
Addiction Counseling Competencies (CSAT, 2006a) 
for more examples of provider skills within these 
competency categories. 
Basic Competencies 
Every SUD treatment and mental health service 
program should require counselors to have certain 
basic skills. Basic COD competencies include 
having a perfunctory understanding and working 
knowledge of the prevalence of CODs, screening 
and assessment procedures, common signs and 
symptoms, how to triage clients appropriately (e.g., 
referring for specialty care, engaging in treatment), 
how to provide brief interventions, and how to 
engage clients in treatment decision making 
(SAMHSA, 2011b). In keeping with the principle 
that there is “no wrong door,” the consensus 
panel recommends that clinicians working in SUD 
treatment settings be able to carry out the mental 
health–related activities shown in Exhibit 8.4. 
Intermediate Competencies 
Intermediate competencies encompass skills 
in engaging SUD treatment clients with CODs, 
screening, obtaining and using mental health 
assessment data, treatment planning, discharge 
planning, mental health system linkage, supporting 
medication, running basic mental disorder 
education groups, and implementing routine and 
emergent mental disorder referral procedures. 
In a mental health unit, mental health providers 
would exhibit similar competencies related to 
SUDs. The consensus panel recommends the 
intermediate level competencies shown in Exhibit 
8.5, developed jointly by the New York State Offce 
of Mental Health and the New York State Offce of 
Alcohol and Substance Abuse Services. 
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RESOURCE ALERT: OREGON HEALTH AUTHORITY’S COMPETENCY 
CHECKLISTS FOR COD PROVIDERS 
The Oregon Health Authority maintains a resource webpage (www.oregon.gov/oha/HSD/AMH/Pages/Co-
occurring.aspx) that includes checklists for ensuring that behavioral health service providers working with 
clients who have CODs meet basic, intermediate, and advanced competencies: 
• Basic Competencies (www.oregon.gov/oha/HSD/AMH/CoOccurring%20Resources/Basic%20 
Compentencies%20Checklist.pdf) 
• Intermediate Competencies (www.oregon.gov/oha/HSD/AMH/CoOccurring%20Resources/ 
Intermediate%20Compentencies%20CheckList.pdf) 
• Advanced Competencies 
• (www.oregon.gov/oha/HSD/AMH/CoOccurring%20Resources/Advanced%20Competencies%20Checklist.pdf) 
EXHIBIT 8.4. Examples of Basic Competencies Needed To Treat People 
With CODs 
• Perform a basic screening to determine whether CODs might exist and be able to refer the client for a 
formal diagnostic assessment by someone trained to do this. 
• Form a preliminary impression of the nature of the disorder a client may have, which can be verifed by 
someone formally trained and licensed in mental disorder diagnosis. 
• Conduct a preliminary screening to determine whether a client poses an immediate danger to self or 
others and coordinate any subsequent assessment with appropriate staff and consultants. 
• Be able to engage the client in such a way as to enhance and facilitate future interaction. 
• Deescalate the emotional state of a client who is agitated, anxious, angry, or in another vulnerable 
emotional state. 
• Manage a crisis involving a client with CODs, including a threat of suicide or harm to others. This may 
involve seeking out assistance by others trained to handle certain aspects of such crises—for example, 
processing commitment papers and related matters. 
• Refer a client to the appropriate mental health service or SUD treatment facility and follow up to ensure 
the client receives needed care. 
• Coordinate care with a mental health counselor serving the same client to ensure that the interaction of 
the client’s disorders is well understood and that treatment plans are coordinated. 
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EXHIBIT 8.5. Six Intermediate 
Competencies for Treating 
People With CODs 
• Competency I: Integrated Diagnosis of
Substance Abuse and Mental Disorders.
Differential diagnosis, terminology (defnitions),
pharmacology, laboratory tests and physical
examination, withdrawal symptoms, cultural
factors, effects of trauma on symptoms, staff
self-awareness
• Competency II: Integrated Assessment of
Treatment Needs. Severity assessment, lethality/ 
risk, assessment of motivation/readiness for
treatment, appropriateness/treatment selection
• Competency III: Integrated Treatment Planning. 
Goal setting/problem solving, treatment 
planning, documentation, confdentiality,3
legal/reporting standards, documenting clinical 
concerns for managed care providers 
• Competency IV: Engagement and Education. 
Staff self-awareness, engagement, motivating, 
educating 
• Competency V: Early Integrated Treatment 
Methods. Emergency/crisis intervention, 
knowledge of and access to treatment services, 
when and how to refer or communicate 
• Competency VI: Longer Term Integrated 
Treatment Methods. Group treatment, 
relapse prevention, case management, 
pharmacotherapy, alternatives/risk education, 
ethics, confdentiality,3 mental health, reporting 
requirements, family interventions 
3 Confdentiality is governed by the federal
“Confdentiality of Alcohol and Drug Abuse Patient
Records” regulations (42 C.F.R. Part 2) and the federal
“Standards for Privacy of Individually Identifable Health
Information” (45 C.F.R. Parts 160 and 164). 
Advanced Competencies 
At the advanced level, the practitioner goes beyond
an awareness of the addiction and mental health
felds as individual disciplines to a more sophisticated
appreciation for how CODs interact. This enhanced
awareness leads to an improved ability to provide
appropriate integrated treatment. At a minimum,
advanced competencies in CODs should include
possessing an indepth knowledge of specifc
EXHIBIT 8.6. Examples of 
Advanced Competencies for 
Treatment of People With CODs 
• Understand the transtheoretical model and 
how client motivation and readiness to change 
affect behavior. 
• Learn to enhance motivation via motivational 
interviewing and motivational enhancement 
therapy skills. 
• Be aware of the relapse prevention model 
and integrating relapse prevention skills into 
treatments. 
• Use criteria from Diagnostic and Statistical 
Manual of Mental Disorders (5th ed.; American 
Psychiatric Association [APA], 2013) to assess 
substance-related and other mental disorders. 
• Understand the effects of level of functioning 
and degree of disability related to both 
substance-related and mental disorders, 
separately and combined. 
• Apply knowledge of psychotropic medications, 
their actions, medical risks, side effects, and 
possible interactions with other substances. 
• Use integrated models of assessment,
intervention, and recovery for people having
both substance-related and mental disorders,
as opposed to sequential treatment efforts that
resist integration. 
• Collaboratively develop and implement an
integrated treatment plan based on thorough
assessment that addresses both/all disorders
and establishes sequenced goals based on
urgent needs, considering the stage of recovery,
stage of change, and level of engagement. 
• Involve the person, family members, and other 
supports and service providers (including peer 
supports and those in the natural support 
system) in establishing, monitoring, and 
refning the current treatment plan. 
• Help clients expand their social networks and 
systems of support. 
therapies and treatment interventions, assessment
and diagnosis procedures, and basic knowledge of
pharmacotherapies (SAMHSA, 2011b). Exhibit 8.6
gives examples of advanced skills.
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Supervision 
Staff working in COD programs need relational 
skills (Petrakis et al., 2018), skills that are best 
learned through clinical supervision. A lack of 
high-quality supervision can hinder the ability of 
individual providers and programs as a whole to 
provide effective, evidence-based treatments 
for clients with COD (Petrakis et al., 2018; Sacks 
et al., 2013). To feel capable and confdent in 
delivering appropriate treatments, providers 
need regular, ongoing, structured supervision 
that not only addresses specifc aspects of 
individual caseloads but broad didactics about 
COD populations as a whole. Active listening, 
interviewing techniques, the ability to summarize, 
and the capacity to provide feedback are all 
skills that can be best modeled by a supervisor. 
Strong, active supervision of ongoing cases 
is a key element in assisting staff to develop, 
maintain, and enhance relational skills. (See also 
“Resource Alert: Competencies and Training for 
SUD Treatment Supervisors.”) Leadership efforts 
among supervisors, administrators, management, 
and senior staff help improve the uptake and 
provision of evidence-based COD services by 
providers and help processes for treating clients 
with CODs become part of the culture of the 
organization, leading to better outcomes for 
clients. Such efforts include actively championing 
and encouraging COD-specifc clinical training 
and supervision practices and securing resources 
to support integrated care (Guerrero, Padwa, 
Lengnick-Hall, Kong, & Perrigo, 2015). 
To achieve COD capability, SAMHSA (2011b) 
recommends that programs ideally offer supervi-
sion that: 
• Is provided by professionals with licensure/ 
certifcation in the addiction feld, such as 
licensed/certifed addiction counselors, clinical 
psychologists, psychiatrists, clinical social 
workers, psychological counselors, marriage and 
family therapists, and specialty practice nurse 
practitioners (psychiatric and mental health 
nurses). 
• Is provided formally and routinely, preferably 
onsite. Otherwise, supervision should at least 
be available as needed and offered on a 
semistructured basis. 
• Includes a focus on assessment and treatment 
skill development and, at the very least, should 
cover topics of case disposition and crisis 
management. 
• Is performed individually, in groups, or both. 
• Uses multiple methods of oversight, such as 
reviewing provider–supervisor rating forms, 
reviewing audio/video recordings of client 
sessions, direct observation, or a combination 
thereof. 
Continuing Professional Development 
The consensus panel is aware that many providers 
in the SUD treatment and mental health services 
felds have effectively performed the diffcult task 
of providing services for clients with CODs, often 
without much guidance from established research 
and knowledge or systematized approaches. The 
landscape has changed, and a solid knowledge 
base is now available to the counselor. However, 
that knowledge typically is scattered through many 
journals and reports. This TIP makes an effort to 
integrate the available information. Counselors 
reading this TIP can review their own knowledge 
RESOURCE ALERT: COMPETENCIES AND TRAINING FOR SUD TREATMENT 
SUPERVISORS 
• Family Health International 360’s Training Curriculum on Drug Addiction Counseling Trainer Manual. 
Chapter 9: Clinical Supervision and Support (www.fhi360.org/sites/default/fles/media/documents/ 
Training%20Curriculum%20on%20Drug%20Addiction%20Counseling%20-%20Chapter%209.pdf) 
• SAMHSA’s TAP 21-A: Competencies for Substance Abuse Treatment Clinical Supervisors (https://store. 
samhsa.gov/system/fles/sma12-4243.pdf) 
• SAMHSA’s Recruitment and Retention Toolkit chapter on Supervision Intervention Strategies (http:// 
toolkit.ahpnet.com/Supervision-Intervention-Strategies.aspx) 
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and determine what they need to continue their 
professional development. 
Counselors should check with their states’ 
certifcation bodies to determine whether training 
leading to formal credentials in counseling people 
with CODs is available (also see the Section “COD/ 
Addiction Certifcation in Health Disciplines” for 
links to websites that offer such information). 
Appendix B also lists some resources counselors 
can use to enhance their professional knowledge 
and development. 
Education and Training 
Although many program staff who treat clients with 
CODs possess basic skills, advanced provider skills 
and specialized training in CODs are frequently 
lacking (Padwa et al., 2013; Petrakis et al., 2018; 
Sacks et al., 2013). Training (along with supervision) 
in mental health service and SUD treatment can 
be effective in improving providers’ competence 
and treatment fdelity, which in turn have been 
associated with reductions in the severity of clients’ 
mental illness symptoms and substance use (Meier 
et al., 2015). Inadequate staff training is a barrier 
to people with CODs receiving needed treatment 
(Padwa et al., 2015). Rather than focusing on staff 
performance, like managing large caseloads and 
increasing billable hours, providers may beneft 
more from COD-specifc training to enhance their 
knowledge of and comfort with treating clients 
who have co-occurring SUDs (Padwa et al., 2015). 
Staff in integrated primary care and behavioral 
health service settings report desiring more 
education, training, and support related to SUD 
treatment services (Zubkoff, Shiner, & Watts, 2016), 
including: 
• Hiring more staff, especially professionals with 
previous knowledge and experience in SUDs. 
• Additional tangible resources (e.g., more 
therapy rooms). 
• More guidance in providing brief addiction 
interventions, such as motivational interviewing. 
• Training on how to address clients with complex 
SUD-related needs. 
• Education about the availability of different SUD 
treatment options. 
• Quick and easy access to as-needed 
The scope of practice that addiction counselors 
must follow legally and under which they can be 
reimbursed varies from state to state (University 
of Michigan Behavioral Health Workforce 
Research Center, 2018). In some states, practice 
privileges are broad, and in others they are 
quite restrictive. For instance, certain states 
mandate that addiction counselors can only 
conduct assessments and provide treatments 
for SUDs, limiting their ability to serve clients 
with CODs. Certifcation requirements and 
authorized services also are inconsistent. The 
lack of standardized training, credentialing, and 
practices makes it diffcult for the behavioral 
health feld as a whole to effectively respond to 
gaps in COD treatment access and provision. 
consultations (e.g., phone-based consultations 
with peers with experience in treating SUDs). 
Discipline-Specifc Education 
Staff education and training are fundamental 
to all SUD treatment programs. Few university-
based programs offer a formal curriculum on 
CODs, despite some improvement during the 
past decade. Many professional organizations are 
promoting the development of competencies and 
practice standards for intervening with substance 
use problems, including the American Psychiatric 
Association, American Psychological Association, 
American Society of Addiction Medicine, National 
Association of Social Workers, and American 
Counseling Association. They are also specifcally 
encouraging faculty members to enhance their 
knowledge in this area so they can better prepare 
their students to meet the needs of clients with 
CODs. The consensus panel encourages all 
such organizations to identify standards and 
competencies for their membership related to 
CODs and to encourage the development of 
training for specifc disciplines. 
Because the consequences of both addiction 
and mental disorders can present with physical 
or psychiatric manifestations, medical students, 
internal medicine and general practice residents, 
and general psychiatry residents all need to be 
educated in the problems of CODs. Too few hours 
of medical education are devoted to the problems 
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MEETING THE GROWING DEMAND FOR ADDICTION COUNSELORS IN 
THE FUTURE: FARING WELL OR FALLING SHORT? 
HRSA (2018) projects the number of addiction counselors will increase by 6 percent from 2016 to 2030. 
However, during that same time period, they calculate a 21-percent increase in the demand for addiction 
counselors, leaving a defcit of 13,600 full-time addiction counselor positions in the labor force. When 
calculating the supply and demand while also accounting for the millions of Americans who will have 
unmet behavioral health service needs, demand will exceed supply by 38 percent. Under this scenario, 
there would be a defcit of nearly 35,000 addiction counselors. 
of addiction and mental disorders. Medication 
can play a critical role in the treatment of CODs, 
so having adequately trained physicians who can 
manage medication therapies for clients with CODs 
is important. 
Continuing Education and Training 
Many SUD treatment counselors learn through
continuing education and facility-sponsored
training. Continuing education and training involves
participation in a variety of courses and workshops
from basic to advanced level offered by a number
of training entities. The strength of continuing
education and training courses and workshops is
that they provide the counselor with the opportunity
to review and process written material with a
qualifed instructor and other practitioners. 
Continuing education is useful because it can 
respond rapidly to the needs of a workforce 
that has diverse educational backgrounds and 
experience. To have practical utility, competency 
training must address the day-to-day concerns 
that counselors face in working with clients who 
have CODs. The educational context must be rich 
with information, culturally sensitive, designed for 
adult students, and must include examples and 
role models. Ideally, the instructors have extensive 
A recent survey (SAMHSA, 2018e) that asked 
approximately 13,600 SUD treatment facilities 
nationwide about their quality assurance 
practices found that almost 98 percent included 
continuing education among their standard 
operating procedures. Nearly all facilities (almost 
94 percent) regularly conducted case reviews 
between providers and supervisors. About 92 
percent conducted client satisfaction surveys. 
experience as practitioners in the feld. 
Continuing education is essential for effective 
provision of services to people with CODs, but it is 
not suffcient in and of itself. Counselors must have 
ongoing support, supervision, and opportunity 
to practice new skills if they are to truly integrate 
COD content into their practice. 
Cross-Training 
Cross-training is the simultaneous provision of 
material and training to more than one discipline at 
a time (e.g., addiction and social work counselors; 
addiction counselors and corrections offcers). 
Counselors who have primary expertise in either 
addiction or mental health will be able to work 
far more effectively with clients who have CODs 
if they have some degree of cross-training in the 
other feld. The consensus panel recommends that 
counselors of either feld receive at least basic level 
cross-training in the other feld to better assess, 
refer, understand, and work effectively with the 
large number of clients with CODs. Cross-trained 
individuals who know their primary feld of training 
well and also have an appreciation for the other 
feld, provide a richness of capacity that cannot 
be attained using any combination of personnel 
familiar with one system alone. 
Cross-training facilitates interaction and 
communication between the counselors from 
each discipline. This helps to remove barriers, 
increase understanding, and promote integrated 
work. Cross-training is particularly valuable for 
staff members who will work together in the 
same program. Consensus panel members have 
found cross-training very valuable in mental health 
services, SUD treatment, and criminal justice work. 
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EXHIBIT 8.7. Certifcation for Health Professions 
PROFESSION CERTIFICATION IN SUDS OR CODS 
Physicians Physicians from any specialty, including primary care, psychiatry, and internal 
medicine can become certifed by the American Society of Addiction Medicine 
(ASAM). Psychiatrists can receive added qualifcations in Addiction Psychiatry 
through the formal American College of Graduate Medical Education Board 
Certifcation process or through the American Academy of Addiction Psychiatry 
(AAAP). Osteopathic physicians from any specialty can receive addiction 
qualifcations through the American Osteopathic Association: 
• ASAM Addiction Medicine Certifcation (www.asam.org/education/certifcation-
MOC) 
• AAAP (www.aaap.org/clinicians/) 
• American Osteopathic Academy of Addiction Medicine (https://aoaam.org/ 
PCSS-waiver-eligibility-training) 
• American Board of Preventive Medicine Addiction Medicine Certifcation 
(www.theabpm.org/become-certifed/subspecialties/addiction-medicine/) 
Nurses Registered nurses can gain licensure in addiction medicine through a partnership 
between the Addictions Nursing Certifcation Board and the Center for Nursing 
Education and Testing, Inc. 
• Certifed Addictions Registered Nurse (www.cnetnurse.com/carn-exam) 
• Certifed Addictions Registered Nurse–Advanced Practice (www.cnetnurse.com/ 
ap-carn-exam) 
Psychologists • The Society of Addiction Psychology (Division 50 of the American 
Psychological Association) offers credentialing in addiction psychology (https:// 
addictionpsychology.org/education-training/certifcation). 
• Psychologists can also obtain Master Addiction Counselor With Co-Occurring 
Disorders Component credentials from NAADAC (www.naadac.org/mac). 
Social Workers The National Association of Social Workers offers a Certifed Clinical Alcohol, 
Tobacco & Other Drugs Social Worker credential (www.socialworkers.org/Careers/ 
Credentials-Certifcations/Apply-for-NASW-Social-Work-Credentials/Certifed-
Clinical-Alcohol-Tobacco-Other-Drugs-Social-Worker). 
Counselors NAADAC offers several certifcations in addiction and COD specialties: 
• National Certifed Addiction Counselor, Level I (www.naadac.org/ncac-i) 
• National Certifed Addiction Counselor, Level II (www.naadac.org/ncac-ii) 
• Master Addiction Counselor With Co-Occurring Disorders Component 
(www.naadac.org/mac) 
The International Certifcation & Reciprocity Consortium also offers counselor 
certifcations in CODs: Advanced Alcohol and Drug Counselor (certifcation for 
CODs) (https://internationalcredentialing.org/creds/aadc) 
Other • Adler Graduate School offers in-person and online training leading to a 
Certifcate in Co-Occurring Disorders and Addiction Counseling; providers may 
need to meet additional state-specifc licensure requirements (http://alfredadler. 
edu/programs/certifcate/certifcate-in-COD). 
• Breining Institute offers credentialing as a Certifed Co-Occurring Disorders 
Specialist (www.breining.edu/index.php/professional-certifcation/certifed-co-
occurring-disorders-specialist-ccds/). 
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National Training Resources 
Curriculums and other educational materials are 
available through ATTCs, universities, state entities, 
and private consultants. These materials can help 
enhance the ability of SUD treatment counselors 
to work with clients who have mental disorders, 
as well as to enable mental health personnel to 
improve their efforts with people who have SUDs. 
ATTCs offer workshops, courses, and online remote 
location courses. (See Appendix B for training 
sources.) 
COD/Addiction Certifcation in Health 
Disciplines 
The disciplines of medicine and psychology 
have recognized subspecialties in CODs with a 
defned process for achieving a certifcate in this 
area. Exhibit 8.7 summarizes current information 
on certifcation by discipline. Drug and alcohol 
certifcation requirements vary by state (review 
at https://addictionstraininginstitute.com/ 
certifcations-in-forida/) as do addiction counselor 
requirements (www.addiction-counselors.com/). 
Conclusion 
The consensus panel strongly encourages 
counselors to acquire competencies specifc to 
working effectively with clients who have CODs. 
Juggling a high-stress, demanding workload 
with continuing professional development is 
diffcult. The panel urges agency and program 
administrators, including line-level and clinical 
supervisors, to develop COD competencies 
themselves and to support and encourage 
continuing workforce education and training. 
To the extent possible, they should customize 
education and training efforts—in content, 
schedule, and location—to meet the needs of 
counselors in the feld. That is, bring the training 
to the counselor. Rewards can include salary and 
advancement tied to counselors’ efforts to increase 
effectiveness in serving clients with CODs, shown 
via job performance. Clinicians in primary care 
settings, community mental health centers, or 
private mental health offces also should enhance 
their knowledge of alcohol and drug use in clients 
with mental diffculties. 
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Appendix B—Resources 
Training for Providers and
Administrators 
Sources of Training in Substance Use 
Disorders 
Addiction-Counselors.com (www.addiction-coun-
selors.com/): A website to help professionals 
and trainees fnd state-by-state information 
about substance use disorder (SUD) counseling 
requirements. 
Addictions Nursing Certifcation Board and the 
Center for Nursing Education and Testing, Inc.
Offers certifcation in addiction nursing. 
• Certifed Addictions Registered Nurse: www. 
cnetnurse.com/carn-exam
• Certifed Addictions Registered Nurse-Advanced 
Practice: www.theabpm.org/become-certifed/ 
subspecialties/addiction-medicine/ 
Addiction Technology Transfer Center (ATTC) 
Network (https://attcnetwork.org/centers/global-
attc/products-resources-catalog): Find local ATTC. 
Course offerings vary. 
• Curricula, lectures, videos, and printed 
training materials available through ATTCs: 
https://attcnetwork.org/centers/global-attc/ 
products-resources-catalog
• Directory of ATTC trainers: https://attcnetwork. 
org/trainers
Addictions Training Institute (https:// 
addictionstraininginstitute.com/certifcations-
in-forida/): Florida-based organization offering 
national certifcation in addiction counseling. 
Maintains a listing of drug and alcohol counseling 
certifcates offered by state. 
American Academy of Addiction Psychiatry (www. 
aaap.org/clinicians/): Offers professional education 
and trainee resources for psychiatrists. 
American Board of Preventive Medicine 
Addiction Medicine Certifcation (www.theabpm. 
org/become-certifed/subspecialties/addiction-
medicine/): Offers physicians subspecialty 
certifcation in addiction medicine. 
American Osteopathic Academy of Addiction 
Medicine (www.aoaam.org/Essentials-and-
Advanced): Offers physicians basic and advanced 
courses for in addiction medicine. 
Hazelden Betty Ford Foundation (www. 
hazeldenbettyford.org/education): Hazelden offers 
training opportunities at many levels and locations, 
including graduate degree and certifcation 
programs, medical and professional education 
programs, and addiction psychology training 
(a clinical practicum, doctoral internships, and 
postdoctoral psychology residency training). 
International Certifcation & Reciprocity 
Consortium (IC&RC) (https:// 
internationalcredentialing.org/): IR&RC is the 
largest credentialing body in addiction prevention, 
treatment, and recovery. They offer six credential 
in addiction counseling, prevention, supervision, 
and peer recovery. The Advanced Alcohol & Drug 
Counselor certifcate provides credentialing for 
co-occurring disorder (CODs) services: https:// 
internationalcredentialing.org/creds/aadc. 
NAADAC, the Association for Addiction 
Professionals (www.naadac.org/): Oversees the 
National Certifcation Commission for Addiction 
Professionals, through which NAADAC is a leading 
provider of national credentialing in addiction 
counseling. 
• National Certifed Addiction Counselor, Level I: 
www.naadac.org/ncac-i
• National Certifed Addiction Counselor, Level II: 
www.naadac.org/ncac-ii 
• International and State Certifcation 
Boards: www.naadac.org/ 
state-international-certifcation-boards
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National Association of Social Workers’ (NASW) 
Certifed Clinical Alcohol, Tobacco & Other Drugs 
Social Worker (www.socialworkers.org/Careers/ 
Credentials-Certifcations/Apply-for-NASW-Social-
Work-Credentials/Certifed-Clinical-Alcohol-
Tobacco-Other-Drugs-Social-Worker): Offers social 
workers certifcation in addiction services. 
Society of Addiction Psychology (Division 50 of 
the American Psychological Association (https:// 
addictionpsychology.org/education-training/ 
certifcation): Offers psychologists credentialing in 
addiction care. 
Rutgers Center of Alcohol & Substance Use 
Studies (https://alcoholstudies.rutgers.edu/): 
Offers professional development opportunities for
addiction counselors and professionals in related
felds, including the criminal justice system. Their
programs are accredited by multiple state and
national organizations, including the National Board
for Certifed Counselors, NAADAC, and NASW. 
SAMHSA 
• Technical Assistance Publication (TAP) 21, 
Addiction Counseling Competencies: The 
Knowledge, Skills, and Attitudes of Professional 
Practice: https://store.samhsa.gov/system/fles/ 
sma12-4171.pdf   
• TAP 21-A: Competencies for Substance Abuse 
Treatment Clinical Supervisors https://store. 
samhsa.gov/system/fles/sma12-4243.pdf 
Sources of Training in Mental Health 
American Counseling Association (ACA; www. 
counseling.org/continuing-education/overview):
Home study courses, learning institutes, and onsite 
training. 
American Psychological Association (www. 
apa.org/education/ce): Home study and other 
approved courses, including some COD-specifc 
offerings (see Continuing Education programs 
under the topic “addiction”). 
American Psychiatric Association (APA) (https:// 
education.psychiatry.org/): The organization’s 
Learning Center provides online courses and 
Continuing Education programs, including some 
in CODs (search the catalog of courses at https:// 
education.psychiatry.org/Users/ProductList.aspx. 
SAMHSA: Offers online mental health training in 
numerous areas: 
• Disaster Technical Assistance Training: www. 
samhsa.gov/dtac/education-training 
• Mental Health First Aid Training: www.samhsa. 
gov/homelessness-programs-resources/ 
hpr-resources/mental-health-frst-aid-training
Sources of Training in CODs 
Addiction Technology Transfer Center (ATTC) 
Network (https://attcnetwork.org/centers/global-
attc/products-resources-catalog): Find local ATTC. 
Course offerings vary. 
• Curricula, lectures, videos, and printed 
training materials available through ATTCs: 
https://attcnetwork.org/centers/global-attc/ 
products-resources-catalog
• Directory of ATTC trainers: https://attcnetwork. 
org/trainers
Adler Graduate School (https://alfredadler. 
edu/programs/certifcate/certifcate-in-COD): A 
nonproft educational institute based in Minnesota 
that offers online training toward a Certifcate in 
Co-Occurring Substance Use and Mental Health 
Disorders. 
Breining Institute’s Certifed Co-Occurring 
Disorders Specialist (www.breining.edu/index.php/ 
professional-certifcation/certifed-co-occurring-
disorders-specialist-ccds/): This higher education 
institution is specifcally for addiction professionals 
and offers numerous courses and certifcations, 
including in CODs. 
IC&RC (https://internationalcredentialing. 
org/): IR&RC is the largest credentialing body in 
addiction prevention, treatment, and recovery. 
They offer six credential in addiction counseling, 
prevention, supervision, and peer recovery. The 
Advanced Alcohol & Drug Counselor certifcate 
provides credentialing for COD services: https:// 
internationalcredentialing.org/creds/aadc. 
NAADAC, the Association for Addiction 
Professionals (www.naadac.org/): Oversees the 
National Certifcation Commission for Addiction 
Professionals, through which NAADAC is a leading 
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provider of national credentialing in addiction 
counseling. They offer two credentials in CODs: 
• Master Addiction Counselor With Co-Occurring 
Disorders Component: www.naadac.org/mac
• The Oregon Health Authority: Provides a 
directory of resources on CODs to assist 
counselors, administrators, and programs with 
implementation and training. 
• Checklists for counselor competencies: www. 
oregon.gov/oha/HSD/AMH/Pages/Co-
occurring.aspx 
• Basic Competencies: www.oregon.gov/oha/ 
HSD/AMH/CoOccurring%20Resources/ 
Basic%20Compentencies%20Checklist.pdf 
• Intermediate Competencies: www.oregon.gov/ 
oha/HSD/AMH/CoOccurring%20Resources/ 
Intermediate%20Compentencies%20CheckList. 
pdf 
• Advanced Competencies: www.oregon.gov/ 
oha/HSD/AMH/CoOccurring%20Resources/ 
Advanced%20Competencies%20Checklist.pdf
Other Resources for Counselors,
Providers, and Programs 
Publications 
National Institute on Alcohol Abuse and 
Alcoholism (NIAAA; www.niaaa.nih.gov/ 
publications): Offers resources, including 
fact sheets, educator resources, videos, and 
professional education materials. 
National Institute on Drug Abuse (NIDA; www. 
drugabuse.gov/publications): NIDA publishes a 
wide variety of treatmentrelated materials. 
• Comorbidity: Substance Use Disorders and 
Other Mental Illness: www.drugabuse.gov/ 
publications/drugfacts/comorbidity-substance-
use-disorders-other-mental-illnesses
• Common Comorbidities With Substance 
Use Disorders: www.drugabuse.gov/ 
publications/research-reports/common-
comorbidities-substance-use-disorders/ 
introduction 
• Criminal Justice Drug Abuse Treatment Studies 
Series archive of publications and research: 
www.icpsr.umich.edu/icpsrweb/NAHDAP/ 
series/244/studies
• Other NIDA justice system-related research 
initiatives: www.drugabuse.gov/researchers/ 
research-resources/criminal-justice-drug-abuse-
treatment-studies-cj-dats
National Institute of Mental Health (NIMH; www. 
nimh.nih.gov/health/publications/index.shtml):
NIMH provides manuals and research reports, 
including texts on disorders and conditions that 
commonly co-occur with SUDs, such as depression, 
anxiety, posttraumatic stress disorder (PTSD), 
schizophrenia, trauma, and suicide risk. 
SAMHSA (https://store.samhsa.gov/profession-
al-research-topics): Offers numerous publications 
on a range of evidence-based topics in prevention, 
treatment, workforce development, and more. 
• TAP 21-A, Competencies for Substance Abuse 
Treatment Clinical Supervisors: https://store. 
samhsa.gov/system/fles/sma12-4243.pdf 
• TIP 27, Comprehensive Case Management 
for Substance Abuse Treatment: https://store. 
samhsa.gov/system/fles/sma15-4215.pdf
• TIP 34, Brief Interventions and Brief Therapies 
for Substance Abuse: https://store.samhsa.gov/ 
system/fles/sma12-3952.pdf
• TIP 35, Enhancing Motivation for Change 
in Substance Use Disorder Treatment: 
https://store.samhsa.gov/product/ 
TIP-35-Enhancing-Motivation-for-Change-
in-Substance-Use-Disorder-Treatment/ 
PEP19-02-01-003 
• TIP 38, Integrating Substance Abuse Treatment 
and Vocational Services: https://store.samhsa. 
gov/system/fles/sma12-4216.pdf
• TIP 44, Substance Abuse Treatment for Adults 
in the Criminal Justice System: https://store. 
samhsa.gov/system/fles/sma13-4056.pdf
• TIP 45, Detoxifcation and Substance Abuse 
Treatment: https://store.samhsa.gov/system/ 
fles/sma15-4131.pdf 
• TIP 46, Substance Abuse: Administrative Issues 
in Outpatient Treatment: https://store.samhsa. 
gov/system/fles/toc.pdf 
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• TIP 47, Substance Abuse: Clinical Issues in 
Intensive Outpatient Treatment: https://store. 
samhsa.gov/system/fles/sma13-4182.pdf
• TIP 48, Managing Depressive Symptoms in 
Substance Abuse Clients During Early Recovery: 
https://www.ncbi.nlm.nih.gov/books/NBK64057/ 
• TIP 50, Addressing Suicidal Thoughts and 
Behaviors in Substance Abuse Treatment: 
https://store.samhsa.gov/product/ 
TIP-50-Addressing-Suicidal-Thoughts-and-
Behaviors-in-Substance-Abuse-Treatment/ 
SMA15-4381 
• TIP 51, Substance Abuse Treatment: Addressing 
the Specifc Needs of Women: https://store. 
samhsa.gov/system/fles/sma15-4426.pdf 
• TIP 52, Clinical Supervision and Professional 
Development of the Substance Abuse 
Counselor: https://store.samhsa.gov/system/ 
fles/sma14-4435.pdf
• TIP 55, Behavioral Health Services for People 
Who Are Homeless: https://store.samhsa. 
gov/product/TIP-55-Behavioral-Health-
Services-for-People-Who-Are-Homeless/ 
SMA15-4734 
• TIP 57, Trauma-Informed Care in Behavioral 
Health Services: https://store.samhsa.gov/ 
system/fles/sma14-4816.pdf 
• TIP 59, Improving Cultural Competence: https:// 
store.samhsa.gov/system/fles/sma14-4849.pdf
• TIP 63, Medications for Opioid Use 
Disorder: https://store.samhsa.gov/product/ 
TIP-63-Medications-for-Opioid-Use-Disorder 
• SAMHSA’s Concept of Trauma and Guidance 
for a Trauma-Informed Approach: https://store. 
samhsa.gov/system/fles/sma14-4884.pdf
• Screening and Assessment of Co-occurring 
Disorders in the Justice System: https://store. 
samhsa.gov/system/fles/sma15-4930.pdf 
Treatment Locators 
Addiction Recovery Guide’s Treatment Locators 
(www.addictionrecoveryguide.org/treatment/ 
treatment_locators): A listing of treatment locators, 
including methadone providers. 
Department of Veterans Affairs Veterans Affairs 
Substance Use Disorder Program Locator (www. 
va.gov/directory/guide/SUD.asp): This website 
provides an interactive treatment locator for 
Veterans Affairs SUD treatment programs. 
Faces & Voices of Recovery Guide to 
Mutual Aid Support Resources (http:// 
facesandvoicesofrecovery.org/resources/mutual-
aid-resources/): Offers a comprehensive listing of 
12-Step and non-12-Step recovery support groups 
throughout the United States and online. 
Foundations Recovery Network Finding 
Treatment for Drug Addiction (www. 
dualdiagnosis.org/addiction-treatment/): Includes a 
listing of resources to fnd treatment for CODs. 
National Alliance of Advocates for Buprenorphine
Treatment (www.treatmentmatch.org/TM_index. 
php): Offers a free, 24/7, anonymous treatment
matching service for patients and providers.
SAMHSA 
• SAMHSA’s Behavioral Health Treatment Services 
Locator is a confdential and anonymous source 
of information for patients and providers about 
treatment facilities in the United States or 
U.S. Territories for SUDs and mental disorders 
(https://fndtreatment.gov/). 
• Finding Quality Treatment for Substance Use 
Disorders indicates how and where to locate 
addiction treatment facilities and providers 
(https://store.samhsa.gov/system/fles/pep18-
treatment-loc.pdf). 
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General Resources 
Confdentiality 
Health and Human Services’ Mental Health 
Information Privacy FAQs: (www.hhs.gov/hipaa/ 
for-professionals/faq/mental-health/index.html): 
A listing of mental health-related privacy and 
confdentiality questions by topic areas (e.g., 
disclosures for coordinated care, group therapy, 
disclosures to law enforcement). 
National Conference of State Legislatures’ 
Mental Health Professionals Duty to Warn
(www.ncsl.org/research/health/mental-health-
professionals-duty-to-warn.aspx): A searchable 
database of duty to warn laws for mental health 
professionals by state. 
SAMHSA 
• Directory of Single State Agencies for Substance 
Abuse Services: https://www.samhsa.gov/ 
sites/default/fles/single-state-agencies-
directory-08232019.pdf 
• SAMHSA’s Laws and Regulations (https:// 
www.samhsa.gov/about-us/who-we-are/ 
laws-regulations) 
Supervision 
Family Health International 360’s Training 
Curriculum on Drug Addiction Counseling 
Trainer Manual. Chapter 9: Clinical Supervision 
and Support (www.fhi360.org/sites/default/fles/ 
media/documents/Training%20Curriculum%20 
on%20Drug%20Addiction%20Counseling%20 
-%20Chapter%209.pdf): This training manual 
offers basic guidance for addiction counseling 
supervision, including case conferencing and 
helping supervisees avoid burnout. 
SAMHSA 
• Supervision Intervention Strategies (http:// 
toolkit.ahpnet.com/Supervision-Intervention-
Strategies.aspx): This section of SAMHSA’s 
Recruitment and Retention Toolkit provides 
indepth information about effective supervision, 
including communication and motivation 
strategies, confict negotiation, and performance 
appraisal. 
• TIP 52, Clinical Supervision and Professional 
Development of the Substance Abuse 
Counselor (https://store.samhsa.gov/system/ 
fles/sma14-4435.pdf): This TIP provides 
guidance on teaching, coaching, consulting, and 
mentoring functions of clinical supervisors in 
addiction treatment. 
Workforce Recruitment and Retention 
ATTC Network’s National Workforce Report 
2017: Strategies for Recruitment, Retention, and 
Development of the Substance Use Disorder 
Treatment and Recovery Services Workforce
(https://attcnetwork.org/centers/network-
coordinating-offce/product/national-workforce-
report-national-qualitative-report):This nationwide 
survey summarizes fndings on recruitment and 
retention challenges facing the addiction recovery 
labor force. 
Behavioral Health Education Center of 
Nebraska’s Retention Toolkit (www.naadac.org/ 
assets/2416/samhsa-naadac_workforce_bhecn_ 
retention_toolkit2.pdf): This toolkit was developed 
to help behavioral health employers improve 
retention. Although developed out of Nebraska, 
the toolkit offers suggestions and resources that 
can be used by any behavioral health service 
organization. 
SAMHSA 
• Focus on the Addiction and Mental Health 
Workforce: Increasing Retention For Today and 
Tomorrow: www.naadac.org/assets/2416/2016-
09-12_wf_retention_webinarslides.pdf
• Recruitment and Retention Toolkit: http:// 
toolkit.ahpnet.com/Home.aspx 
• Dealing With Stress in the Workplace: 
Frustration, Stress, and Compassion Fatigue/ 
Burnout: http://toolkit.ahpnet.com/Dealing-
with-Stress-in-the-Workplace.aspx 
• Dual Diagnosis Capability in Addiction 
Treatment (DDCAT) Toolkit (version 4.0): www. 
centerforebp.case.edu/client-fles/pdf/ddcat-
toolkit.pdf 
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Criminal Justice System Military Populations 
NIDA American Counseling Association (ACA) 
• Criminal Justice Drug Abuse Treatment Studies 
Series archive of publications and research: 
www.icpsr.umich.edu/icpsrweb/NAHDAP/ 
series/244/studies
• Other NIDA justice system-related research 
initiatives: www.drugabuse.gov/researchers/ 
research-resources/criminal-justice-drug-abuse-
treatment-studies-cj-dats 
SAMHSA 
• GAINS Center for Behavioral Health and Justice 
Transformation: www.samhsa.gov/gains-center
• TIP 44, Substance Abuse Treatment for Adults 
in the Criminal Justice System: https://store. 
samhsa.gov/system/fles/sma13-4056.pdf
• Screening and Assessment of Co-occurring 
Disorders in the Justice System: https://store. 
samhsa.gov/system/fles/sma15-4930.pdf
Homelessness 
Housing First 
• The National Alliance to End Homelessness’s 
toolkit for adopting a Housing First approach: 
https://endhomelessness.org/wp-content/ 
uploads/2009/08/adopting-a-housing-frst-
approach.pdf
• United States Interagency Council on 
Homelessness’s Implementing Housing First 
in Permanent Supportive Housing fact sheet: 
www.usich.gov/resources/uploads/asset_library/ 
Implementing_Housing_First_in_Permanent_ 
Supportive_Housing.pdf
Pathways to Housing 
• Resources: https://pathwaystohousingpa.org/ 
housing-frst-university/HFU-resources# 
• PA Training Institute’s training and technical 
assistance: https://pathwaystohousingpa.org/ 
Training
SAMHSA’s Permanent Supportive Housing
Evidence-Based Practices Toolkit (https://store. 
samhsa.gov/product/Permanent-Supportive-Housing-
Evidence-Based-Practices-EBP-KIT/SMA10-4510):
This toolkit describes key aspects of supportive
housing for people with mental disorders. 
• Suicide Among Veterans and the Implications 
for Counselors: www.counseling.org/ 
docs/default-source/vistas/suicide-among-
veterans-and-the-implications-for-counselors. 
pdf?sfvrsn=3803a659_11 
• Comparison of Civilian Trauma and Combat 
Trauma: https://pdfs.semanticscholar.org/ 
eff2/8af43d3feaac7bac3cc5bb789bd4d5f100ec. 
pdf 
• Counseling Addicted Veterans: What 
to Know and How to Help: https:// 
pdfs.semanticscholar.org/9742/967aac-
815ca02c4f599b36be996d0b10d3d9.pdf 
Community Anti-Drug Coalitions of America’s 
Strategies for Addressing Substance Abuse 
in Veteran Populations (www.cadca.org/sites/ 
default/fles/mckesson_toolkit_1.pdf): This toolkit 
was created to help programs implement addiction 
prevention strategies targeting veterans in their 
communities. 
Department of Veterans Affairs national Center 
for PTSD (www.ptsd.va.gov/): 
• Practice Recommendations for Treatment 
of Veterans with Comorbid Substance Use 
Disorder and Posttraumatic Stress Disorder: 
www.mentalhealth.va.gov/providers/sud/docs/ 
SUD_PTSD_Practice_Recommendations.pdf 
• Veteran Outreach Toolkit: Preventing Veteran 
Suicide is Everyone’s Business: www.va.gov/ve/ 
docs/outreachToolkitPreventingVeteranSuicideI-
sEveryonesBusiness.pdf 
• National Strategy for Preventing Veteran 
Suicide 2018–2028: www.mentalhealth.va.gov/ 
suicide_prevention/docs/Offce-of-Mental-
Health-and-Suicide-Prevention-National-
Strategy-for-Preventing-Veterans-Suicide.pdf
SAMHSA’s Addressing the Substance Use Disorder 
Service Needs of Returning Veterans and Their 
Families (www.samhsa.gov/sites/default/fles/ 
veterans_report.pdf): This report summarizes 
fndings from case studies in nine states that 
implemented addiction prevention and treatment 
services for returning veterans and their families. 
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Women 
The Iowa Pregnant and Postpartum Women’s
Residential Treatment Program (https://idph. 
iowa.gov/substance-abuse/programs/ppw): Offers
provider resources for treating pregnant and
postpartum women with addiction, including an
intake form, follow-up strategies, a client satisfaction
survey, and documentation requirements. 
SAMHSA 
• TIP 51, Substance Abuse Treatment: Addressing 
the Specifc Needs of Women: https://store. 
samhsa.gov/system/fles/sma15-4426.pdf
• TIP 57, Trauma-Informed Care in Behavioral 
Health Services: https://store.samhsa.gov/ 
system/fles/sma14-4816.pdf 
Integrated Care 
Case Western Reserve’s Center for Evidence-
Based Practices. Integrated Dual Disorder 
Treatment Clinical Guide (www.centerforebp.case. 
edu/client-fles/pdf/iddtclinicalguide.pdf): This 
manual offer guidance on developing an Integrated 
Dual Disorder Treatment (IDDT) program. 
Milbank Memorial Fund’s Integrating Primary 
Care into Behavioral Health Settings: What 
Works for Individuals with Serious Mental 
Illness (SMI) (www.milbank.org/wp-content/ 
uploads/2016/04/Integrating-Primary-Care-
Report.pdf): This report offers guidance on key 
implementation techniques to help programs 
treating clients with SMI learn how to integrate 
their services into primary care settings. 
SAMHSA’s Integrated Treatment for Co-
Occurring Disorders Evidence-Based Practices 
KIT (https://store.samhsa.gov/product/Integrated-
Treatment-for-Co-Occurring-Disorders-Evidence-
Based-Practices-EBP-KIT/SMA08-4366): This toolkit 
reviews the principles of integrated care for CODs 
and includes video and written materials. 
Assertive Community Treatment (ACT) 
Case Western Reserve’s Center for Evidence-
Based Practices. Integrated Dual Disorder 
Treatment Clinical Guide (www.centerforebp.case. 
edu/client-fles/pdf/iddtclinicalguide.pdf): This 
manual offers guidance on developing an IDDT 
program. 
Georgia Department of Behavioral Health 
& Developmental Disabilities Program Tool 
Kit for ACT (https://dbhdd.georgia.gov/sites/ 
dbhdd.georgia.gov/fles/related_fles/document/ 
Georgia%20Toolkit%20for%20ACT%20Teams%20 
docxfnal%202015.pdf): This toolkit is designed 
to support programs launching ACT services and 
covers such areas as staff requirements, critical 
services, treatment intensity, and program capacity. 
SAMHSA’s ACT for Co-Occurring Disorders 
Evidence-Based Practices KIT (https://store. 
samhsa.gov/product/Assertive-Community-
Treatment-ACT-Evidence-Based-Practices-EBP-KIT/ 
sma08-4344): This toolkit reviews the principles 
of assertive community outreach for clients with 
CODs and includes video and written materials. 
University of Washington Program for ACT 
(https://depts.washington.edu/ebpa/projects/ 
pact): Program resources offered here are wide 
ranging and include addiction and mental 
disorder assessment scales, sample staff and client 
schedules, a case study, a transition assessment 
tool, and other relevant client measures (e.g., stage 
of change, recovery beliefs, violence risk). 
Therapeutic Communities 
Arkansas Department of Human Services 
Therapeutic Communities Certifcation Manual 
(https://humanservices.arkansas.gov/images/ 
uploads/dpsqa/DBHS_Therapuetic_Communities_ 
Certifcation_-_FINAL.pdf): Summarizes the 
standards and certifcation requirements for 
therapeutic communities (TCs) under the Arkansas 
Department of Human Services, Division of 
Behavioral Health Services. 
Missouri Department of Corrections and 
Maryville Treatment Center Therapeutic 
Community Program Handbook (www.law.umich. 
edu/special/policyclearinghouse/Documents/ 
MO%20-%20Maryville%20Treatment%20 
Center%20Therapeutic%20Community%20 
Program%20Handbook.pdf): Describes therapeutic 
community (TC) structure, roles, procedures, and 
guidelines. 
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National Institute of Justice’s Program 
Profle: Modifed Therapeutic Community for 
Offenders With Mental Illness and Chemical 
Abuse Disorders (www.crimesolutions.gov/ 
ProgramDetails.aspx?ID=90): Offers guidance on 
adapting the TC model to people with CODs who 
are involved in the criminal justice system. 
NIDA Research Report, Therapeutic Communities
(https://d14rmgtrwzf5a.cloudfront.net/sites/default/ 
fles/therapueticcomm_rrs_0723.pdf): This research
report describes the purpose of TCs, evidence of
their effectiveness, fundamental components, and
adaptations to special populations, including people
experiencing homelessness, women, and people in
the criminal justice system.
University of Delaware Center for Drug and 
Alcohol Studies. Therapeutic Community 
Treatment Methodology: Treating Chemically 
Dependent Criminal Offenders in Corrections
(www.cdhs.udel.edu/content-sub-site/Documents/ 
CDHS/CTC/Treating%20Chemically%20 
Dependent%20Criminal%20Offenders%20in%20 
Corrections.pdf): This slide deck offers material on 
the use of TCs in criminal justice settings, including 
relapse prevention, use and misuse of therapeutic 
tools, and staff roles and functions. 
Suicide Prevention 
ACA 
• Suicide Prevention Tip Sheet: www.counseling. 
org/docs/default-source/Communications-/ 
suicide-prevention-fnal.pdf?sfvrsn=2
• Counselor Training in Suicide Assessment, 
Prevention, and Management: www. 
counseling.org/docs/default-source/vistas/ 
article_65d15528f16116603abcacff0000bee5e7. 
pdf?sfvrsn=4f43482c_6
• Developing Clinical Skills in Suicide Assessment, 
Prevention, and Treatment: www.counseling.org/ 
publications/frontmatter/72861-fm.pdf 
APA’s Practice Guidelines (2016) 
Recommendations Regarding Assessment 
of Suicide As Part of the Initial Psychiatric 
Assessment (https://stopasuicide.org/assets/docs/ 
APAPracticeGuidelines.pdf): A checklist of items 
to assess in determining suicide risk and history 
during an initial psychiatric assessment. 
International Association for Suicide Prevention’s 
Guidelines for Suicide Prevention (www.iasp.info/ 
suicide_guidelines.php): A summary of prevention 
and risk-reduction strategies for behavioral health 
service providers. 
National Suicide Prevention Lifeline (https:// 
suicidepreventionlifeline.org/ or 1-800-273-8255): 
Funded by SAMHSA, this national network of local 
crisis centers offer free and confdential support 
to people in suicidal crisis or emotional distress 24 
hours a day, 7 days a week. Professional initiatives 
to promote public knowledge of suicide prevention 
are also provided: https://suicidepreventionlifeline. 
org/professional-initiatives/
SAMHSA 
• Suicide Prevention Resource Center: www.sprc. 
org/ 
• Suicide Assessment Five-Step Evaluation and 
Triage for Mental Health Professionals: https:// 
store.samhsa.gov/system/fles/sma09-4432.pdf 
• TIP 50, Addressing Suicidal Thoughts and 
Behaviors in Substance Abuse Treatment: 
https://store.samhsa.gov/product/ 
TIP-50-Addressing-Suicidal-Thoughts-and-
Behaviors-in-Substance-Abuse-Treatment/ 
SMA15-4381 
• Video companion to TIP 50, Addressing 
Suicidal Thoughts and Behaviors in Substance 
Abuse Treatment: www.youtube.com/ 
watch?v=1n2QZlheuzc&feature=youtu.be 
Trauma 
SAMHSA’s TIP 57, Trauma-Informed Care in 
Behavioral Health Services (https://store.samhsa. 
gov/system/fles/sma14-4816.pdf): Includes 
guidance for working with behavioral health clients 
with trauma and for implementing trauma-informed 
programming. 
Veterans Affairs National Center for PTSD (www. 
ptsd.va.gov/): The National Center for PTSD is one 
of the world’s largest repositories of PTSD-related 
education and resources, designed to improve 
patient care, increase provider knowledge, and 
help clients and families better understand this 
condition. Many of the Center’s publications, tools, 
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and resources are aimed at military personnel (e.g., 
deployment measures) but many are useful for and 
applicable to civilian populations as well. 
Veterans Affairs/Department of Defense Clinical 
Practice Guideline for the Management of 
Posttraumatic Stress Disorder and Acute Stress 
Disorder (www.healthquality.va.gov/guidelines/ 
MH/ptsd/VADoDPTSDCPGFinal012418.pdf): 
Evidence-based guidelines for treating trauma and 
extreme stress in military populations, including 
treatment recommendations and algorithms. 
Medication Management 
SAMHSA 
• TIP 63, Medications for Opioid Use Disorder 
(https://store.samhsa.gov/product/TIP-63-
Medications-for-Opioid-Use-Disorder): A 
compendium of the latest evidence in support 
of Food and Drug Administration (FDA)-
approved pharmacotherapy for opioid use 
disorder (OUD). 
• Medication for the Treatment of Alcohol Use 
Disorder: A Brief Guide (https://store.samhsa. 
gov/system/fles/sma15-4907.pdf): Offers a 
succinct summary of medications for AUD, 
including how to discuss them with clients, 
integrating medication into treatment, and 
medications for people with CODs. 
APA’s Practice Guideline for the Pharmacological 
Treatment of Patients With Alcohol Use Disorder 
(https://psychiatryonline.org/doi/pdf/10.1176/appi. 
books.9781615371969): Clinical practice guideline 
to inform the use of mediation for AUD. 
National Library of Medicine’s Drug Information 
Portal (https://druginfo.nlm.nih.gov/drugportal/): 
A searchable database organized by medication 
name and category. 
FDA’s Medication Guides Database (www. 
accessdata.fda.gov/scripts/cder/daf/index. 
cfm?event=medguide.page): A searchable index of 
FDA-approved medications. 
NIMH’s Mental Health Medications (www.nimh. 
nih.gov/health/topics/mental-health-medications/ 
index.shtml): A brief summary of psychotropic 
medication, their uses, and their side effects. 
University of Washington’s Commonly Prescribed 
Psychotropic Medications (https://aims. 
uw.edu/resource-library/commonly-prescribed-
psychotropic-medications): A printable factsheet of 
common antidepressant, antianxiety, antipsychotic, 
and mood stabilizing medication. 
Client and Family Resources 
Organizations 
Hazelden Betty Ford Foundation (www. 
hazeldenbettyford.org/recovery/families-friends): 
Includes support and tools for clients, families, and 
friends. 
Learn to Cope (www.learn2cope.org/): A secular 
mutual-support group that offers education, 
resources, and peer support for families of people 
with SUDs (although primarily focused on OUD). 
They also maintain an online forum, but groups are 
only available in a few states. 
Legal Action Center (www.lac.org): Offers 
information about the rights of people with 
criminal records, HIV/AIDS, and SUDs. 
Mental Health America (www. 
mentalhealthamerica.net/): A nonproft community-
based organization that aims to improve public 
knowledge of mental disorders and enhance 
prevention and treatment strategies. It includes 
over 200 affliates in 41 states, 6,500 affliate staff, 
and over 10,000 volunteers. 
National Alliance on Mental Illness (NAMI; www. 
nami.org): The largest grassroots educational, peer 
support, and mental health advocacy organization 
in the United States. Founded in 1979 by a 
group of family members of people with mental 
disorders, NAMI has developed into an association 
of hundreds of local affliates, state organizations, 
and volunteers. 
National Empowerment Center (https://power2u. 
org/): The Center has an extensive resource 
listing including a directory of consumer-run 
organizations, peer support, and webinars. 
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National Suicide Prevention Lifeline (https:// 
suicidepreventionlifeline.org/ or 1-800-273-8255): 
Funded by SAMHSA, this national network of local 
crisis centers offer free and confdential support 
to people in suicidal crisis or emotional distress 24 
hours a day, 7 days a week. 
Parents of Addicted Loved Ones (https:// 
palgroup.org/): A secular support group for parents 
who have a child with an SUD. They only have 
meetings in some states but also host telephone 
meetings.
Mutual-Support Programs 
Alcoholics Anonymous (AA; www.aa.org): Offers 
group meetings for people who have problems 
relating to drinking and wish to stop. AA sponsors 
offer members personal support from experienced 
individuals. 
Al-Anon Family Groups (www.al-anon.org): 
Group meetings in which friends and families 
of people with substance use problems share 
experiences and learn to apply Al-Anon principles 
to their situations. Sponsorship helps members 
get personal support from more experienced 
individuals in the program. 
Cocaine Anonymous (https://ca.org/): A mutual-
support program for people with cocaine use 
disorder. Cocaine Anonymous follows the 12-Step 
tradition and offers meetings worldwide. 
Dual Disorders Anonymous ([847] 781-1553): A 
mutual-support program with 48 groups in several 
states (more than half in Illinois). This program is 
modeled after AA. 
Dual Diagnosis Anonymous of Oregon (www. 
ddaoforegon.com/). This mutual-support program 
uses AA’s 12 Step plus fve more focused on CODs. 
The organization has chapters in several states and 
in Canada. 
Dual Recovery Anonymous (www.draonline.org/): 
This mutual-support program follows 12-Step 
principles to support people in recovery from 
addiction and emotional/mental illness. It focuses 
on preventing relapse and actively improving 
quality of members’ lives via a mutual-support 
community. 
Dual Diagnosis Recovery Network (www. 
dualdiagnosis.org/resource/ddrn/): Part of 
Foundations Recovery Network, the Dual Diagnosis 
Recovery Network is an advocacy group for people 
with CODs. They offer information on mutual-
support programs, outreach, and education. 
Emotions Anonymous (http://emotionsanonymous. 
org/): A 12-Step fellowship based on AA for people 
with any emotional diffculties (not only clinical 
mental disorders). Groups are located in more than 
30 countries, with more than 600 active groups, 
including Skype and phone meetings. 
Faces and Voices of Recovery (http:// 
facesandvoicesofrecovery.org/): Offers recovery 
stories, news and events information, publications, 
and webinars.
Heroin Anonymous (www.heroinanonymous.org): 
A nonproft fellowship of individuals in recovery 
from heroin addiction and committed to helping 
each other stay sober. This organization holds local 
support meetings, a directory of which can be 
found on their website. 
Narcotics Anonymous (NA; www.na.org/): A 
global, community-based organization with 
a multilingual, multicultural membership that 
supports recovery from addiction through a 
12-Step program, including regular attendance 
at group meetings. The group offers an ongoing 
support network for maintaining a drug-free 
lifestyle. NA does not focus on any particular 
addictive substance. 
Nar-Anon Family Groups (www.nar-anon.org/): 
Group meetings in which friends and family of 
people with drug use problems can share their 
experiences and learn to apply the 12-Steps 
Nar-Anon program to their lives. Nar-Anon offers 
individualized support from experienced members 
acting as sponsors. 
National Mental Health Consumers’ Self-Help 
Clearinghouse (www.mhselfhelp.org/): The 
organization has developed and offers a resource 
kit providing the names and contacts for resources 
and information on substance addictions, co-
occurring disorders, services, and mutual help 
support. 
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Pills Anonymous (www.pillsanonymous.org): A 
12-Step mutual-support fellowship that holds 
regular meetings in which individuals in recovery 
from addiction to medication can share their 
experiences, build their strengths, and offer hope 
for recovery to one another. 
Recoveries Anonymous (www.r-a.org/): A 12-Step 
mutual fellowship that welcomes people with 
a broad range of problems, from addictions, 
to mental disorders, to “problem behaviors” 
(e.g., compulsive spending, risk-taking, suicidal 
behaviors). 
Schizophrenia Alliance (https://sardaa.org/ 
schizophrenia-alliance/sa-group-locations/): 
Operating under the auspices of the Schizophrenia 
and Related Disorders Alliance of America, this 
12-Step mutual-support program offers information 
and fellowship for people with schizophrenia 
or other psychotic disorders, including bipolar 
disorder. They hold meetings among 150 groups 
throughout 31 states. 
Secular Organizations for Sobriety (www. 
sossobriety.org/): A nonproft, nonreligious network 
of autonomous, nonprofessional local groups that 
help people achieve and maintain abstinence from 
alcohol and drug addiction. 
Self-Management and Recovery Training (SMART 
Recovery; www.smartrecovery.org/): SMART 
Recovery a self-empowering addiction recovery 
support group that teaches science-based tools 
for addiction recovery and grants access to an 
international recovery community of mutual-
support groups. 
Women for Sobriety (https://womenforsobriety. 
org/): An abstinence-based mutual-support 
program that helps women fnd individual paths 
to recovery by acknowledging their unique needs 
in recovery. It is not affliated with other recovery 
organizations. It offers tools to help women 
in recovery develop coping skills focused on 
emotional growth, spiritual growth, self-esteem, 
and a healthy lifestyle. 
Publications and Other Resources 
American Society of Addiction Medicine (www. 
asam.org/resources/patient-resources): Includes 
a treatment locator, listing of client and family 
support group, and a treatment guideline about 
opioid addiction.
Foundations Recovery Network Articles and 
Publications (www.dualdiagnosis.org/resource/):
Offers material on COD treatment, gender-specifc
concerns, family functions, mutual support, advocacy,
and success stories. 
National Institute on Alcohol Abuse and 
Alcoholism (www.rethinkingdrinking.niaaa.nih.gov/ 
help-links/): Provides links to patient and family 
education, help lines, and other recovery resources 
NIDA (www.drugabuse.gov/nidamed-medical-
health-professionals/tool-resources-your-practice/ 
patient-materials): Patient materials include online 
tools, booklets, and fact sheets about substance 
misuse, prevention, and treatment. 
SAMHSA (https://store.samhsa.gov/): Provides 
patient and family educational tools about SUD 
and co-occurring mental illness. 
• No Longer Alone. A Story About Alcohol, 
Drugs, Depression, and Trauma: https://store. 
samhsa.gov/system/fles/sma13-4781eng.pdf
• People Recover. An Educational Comic Book on 
Co-Occurring Disorders: https://store.samhsa. 
gov/product/people-recover/sma13-4712
• Should You Talk to Someone About a Drug, 
Alcohol, or Mental Health Problem? (https:// 
store.samhsa.gov/product/Should-You-Talk-to-
Someone-About-a-Drug-Alcohol-or-Mental-
Health-Problem-/sma15-4585). This publication 
is available in English, Cambodian, Chinese, 
Russian, and Vietnamese. 
• Steve’s Path to a Better Life: Alcohol and 
Depression: https://store.samhsa.gov/system/ 
fles/sma16-5013.pdf
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Online Boards and Chat Rooms 
12-Step forums: Some AA meetings are available 
online, each with their own view of medication. 
• The AA online intergroup directory lists 
numerous online AA meetings: www.aa-
intergroup.org/
Bipolar World Online (https://bipolarworld.org/): 
This online community includes support chat, an 
online forum, online journals, and articles about 
bipolar disorder. 
Facebook forums and groups: A handful of COD 
and addiction recovery organizations maintain 
a presence on Facebook because of the ease of 
creating online mutual-support and chat groups. 
• Dual Diagnosis Co-Occurring Mental 
Illness and Substance Disorders 
Treatment Programs: www.facebook.com/ 
FirstDualDiagnosisTreatmentandPrograms1984/
• Recovery Group for Dual Diagnosis: www. 
facebook.com/events/139669280229645/ 
• Secular Organizations for Sobriety: www. 
facebook.com/groups/251215211975/
LifeRing Secular Recovery Dual Diagnosis 
Recovery Online Support Groups (https://www. 
lifering.org/post/lifering-offers-dual-diagnosis-
recovery-support-group-online). 
Mental Health America Online Support 
Groups (https://www.inspire.com/groups/ 
mental-health-america/). 
SMART Recovery Online Forum (www. 
smartrecovery.org/community/forum.php). 
Mobile Apps 
Foundations Recovery Network (www.dualdiag-
nosis.org/apps-for-addiction-recovery-and-mental-
health/): maintains a listing of COD, SUD, and 
mental illness-related mobile apps. 
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Biopsychosocial Intake Forms 
A sample assessment form is included in a 
PDF that is linked to the Providers Clinical 
Support System (PCSS) website. Go to 
https://30qkon2g8eif8wrj03zeh041-wpengine. 
netdna-ssl.com/wp-content/uploads/2017/09/ 
Intake-Assessment-3.pdf and see pages 23–32 of 
the PDF. 
Suicide and Safety Screening and 
Assessment Tools 
Columbia-Suicide Severity Rating Scale (http:// 
cssrs.columbia.edu/the-columbia-scale-c-ssrs/ 
cssrs-for-communities-and-healthcare/#flter=. 
general-use.english): Numerous versions of this 
screener are available for different populations, 
including adults, adolescents, and people with 
cognitive diffculties. Versions are also available for 
certain settings, including general care settings, 
military settings, schools, and military settings. 
Furthermore, this screener can be downloaded in 
both English and Spanish. 
HUMILIATION, AFRAID, RAPE, 
AND KICK 
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• H: Humiliation-Within the last year, have you 
been humiliated or emotionally abused in 
other ways by your partner or your ex-partner? 
• A: Afraid-Within the last year, have you been 
afraid of your partner or ex-partner? 
• R: Rape-Within the last year, have you been 
raped or forced to have any kind of sexual 
activity by your partner or ex-partner? 
• K: Kick-Within the last year, have you been 
kicked, hit, slapped, or otherwise physically 
hurt by your partner or ex-partner? 
Source: Sohal, Eldridge, & Feder (2007). Adapted 
from material distributed under the terms of the 
Creative Commons Attribution License (https:// 
creativecommons.org/licenses/by/2.0/). 
Mental Disorder Screening and
Assessment Tools 
Addiction Severity Index: This is a semistructured 
interview that takes approximately an hour to 
administer. Information on administration and 
scoring can be found at https://pubs.niaaa.nih.gov/ 
publications/assessingalcohol/InstrumentPDFs/04_ 
ASI.pdf. The interview is available for free 
online, including here: (http://adai.washington. 
edu/instruments/pdf/addiction_severity_index_ 
baseline_followup_4.pdf). 
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Substance Use Disorder Treatment for People With Co-Occurring Disorders 
MENTAL HEALTH SCREENING FORM-III 
Please circle “yes” or “no” for each question. 
1. Have you ever talked to a psychiatrist, psychologist, therapist, social worker, or counselor 
about an emotional problem? Yes No 
2. Have you ever felt you needed help with your emotional problems, or have you had 
people tell you that you should get help for your emotional problems? Yes No 
3. Have you ever been advised to take medication for anxiety, depression, hearing voices, or 
for any other emotional problem? Yes No 
4. Have you ever been seen in a psychiatric emergency room or been hospitalized for 
psychiatric reasons? Yes No 
5. Have you ever heard voices no one else could hear or seen objects or things which others 
could not see? Yes No 
6. (a) Have you ever been depressed for weeks at a time, lost interest or pleasure in most
activities, had trouble concentrating and making decisions, or thought about killing Yes No 
yourself?
(b) Did you ever attempt to kill yourself? Yes No 
7. Have you ever had nightmares or fashbacks as a result of being involved in some 
traumatic/terrible event? For example, warfare, gang fghts, fre, domestic violence, rape, 
incest, car accident, being shot or stabbed? Yes No 
8. Have you ever experienced any strong fears? For example, of heights, insects, animals, dirt, 
attending social events, being in a crowd, being alone, being in places where it may be 
hard to escape or get help? Yes No 
9. Have you ever given in to an aggressive urge or impulse, on more than one occasion, that 
resulted in serious harm to others or led to the destruction of property? Yes No 
10. Have you ever felt that people had something against you, without them necessarily 
saying so, or that someone or some group may be trying to infuence your thoughts or 
behavior? Yes No 
11. Have you ever experienced any emotional problems associated with your sexual interests, 
your sexual activities, or your choice of sexual partner? Yes No 
12. Was there ever a period in your life when you spent a lot of time thinking and worrying 
about gaining weight, becoming fat, or controlling your eating? For example, by 
repeatedly dieting or fasting, engaging in much exercise to compensate binge eating, 
taking enemas, or forcing yourself to throw up? Yes No 
13. Have you ever had a period of time when you were so full of energy and your ideas came 
very rapidly, when you talked nearly nonstop, when you moved quickly from one activity 
to another, when you needed little sleep, and when you believed you could do almost 
anything? Yes No 
14. Have you ever had spells or attacks when you suddenly felt anxious, frightened, or
uneasy to the extent that you began sweating, your heart began to beat rapidly, you
were shaking or trembling, your stomach was upset, or you felt dizzy or unsteady, as if
you would faint? Yes No 
Continued on next page 
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15. Have you ever had a persistent, lasting thought or impulse to do something over and over 
that caused you considerable distress and interfered with normal routines, work, or social 
relations? Examples would include repeatedly counting things, checking and rechecking 
on things you had done, washing and rewashing your hands, praying, or maintaining a 
very rigid schedule of daily activities from which you could not deviate. Yes No 
16. Have you ever lost considerable sums of money through gambling or had problems at 
work, in school, or with your family and friends as a result of your gambling? Yes No 
17. Have you ever been told by teachers, guidance counselors, or others that you have a 
special learning problem?
Yes No 
Instructions and scoring information are available online. (https://idph.iowa.gov/Portals/1/Files/SubstanceAbuse/jackson_ 
mentalhealth_screeningtool.pdf). 
Source: Carroll & McGinley (2000). Reprinted with permission. 
Substance Use/Misuse Screening
and Assessment Tools 
National Institute on Drug Abuse (NIDA)-
Modifed Alcohol, Smoking, and Substance 
Involvement Screening Test (ASSIST) (www. 
drugabuse.gov/nmassist/): NIDA developed 
an abbreviated version of the World Health 
Organization’s (WHO) ASSIST tool called the NIDA-
Modifed ASSIST that can be completed online. 
PCSS – Clinical Tools: https://pcssnow.org/ 
resources/clinical-tools 
ALCOHOL USE DISORDERS IDENTIFICATION TEST 
PATIENT: Because alcohol use can affect your health and can interfere with certain medications and 
treatments, it is important that we ask some questions about your use of alcohol. Your answers will remain 
confdential, so please be honest. 
For each question in the chart below, place an X in one box that best describes your answer. 
NOTE: In the U.S., a single drink serving contains about 14 grams of ethanol or “pure” alcohol. Although 
the drinks below are different sizes, each one contains the same amount of pure alcohol and counts as a 
single drink: 
12 f oz. of 
beer 
(about 5% 
alcohol) 
8-9 f oz. of 
malt liquor 
(about 7% 
alcohol) 
5 f oz. of 
wine 
(about 12% 
alcohol) 
1.5 f oz. of 
hard liquor 
(about 40% 
alcohol) = = = 
QUESTIONS 0 1 2 
1. How often do you have a 
drink containing alcohol? 
Never Monthly or 
less 
2 to 4 times 
a month 
2 to 3 times 
a week 
4 or more 
times a 
week 
Continued on next page 
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Continued 
2. How many drinks 
containing alcohol do 
you have on a typical day 
when you are drinking? 
1 or 2 3 or 4 5 or 6 7 to 9 10 or more 
3. How often do you have 
5 or more drinks on one 
occasion? 
Never Less than 
monthly 
Monthly Weekly Daily or 
almost 
daily 
4. How often during the last 
year have you found that 
you were not able to stop 
drinking once you had 
started? 
Never Less than 
monthly 
Monthly Weekly Daily or 
almost 
daily 
5. How often during the 
last year have you failed 
to do what was normally 
expected of you because 
of drinking? 
Never Less than 
monthly 
Monthly Weekly Daily or 
almost 
daily 
6. How often during the last 
year have you needed a 
frst drink in the morning 
to get yourself going after 
a heavy drinking session? 
Never Less than 
monthly 
Monthly Weekly Daily or 
almost 
daily 
7. How often during the 
last year have you had a 
feeling of guilt or remorse 
after drinking? 
Never Less than 
monthly 
Monthly Weekly Daily or 
almost 
daily 
8. How often during the 
last year have you been 
unable to remember 
what happened the night 
before because of your 
drinking? 
Never Less than 
monthly 
Monthly Weekly Daily or 
almost 
daily 
9. Have you or someone 
else been injured 
because of your 
drinking? 
No Yes, but not 
in the last 
year 
Yes, during 
the last 
year 
10. Has a relative, friend, 
doctor, or other health 
care worker been 
concerned about your 
drinking or suggested 
you cut down? 
No Yes, but not 
in the last 
year 
Yes, during 
the last 
year 
Total 
Source: Babor et al. (2001). 
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THE ALCOHOL USE DISORDERS IDENTIFICATION TEST -CONCISE 
How often do you have a drink containing alcohol? 
□ Never □ 2-3 times a week 
□ Monthly or less □ 4 or more times a week 
□ 2-4 times a month 
How many standard drinks containing alcohol do you have on a typical day? 
□ 1 or 2 □ 7 to 9 
□ 3 to 4 □ 10 or more 
□ 5 to 6 
How often do you have six or more drinks on one occassion? 
□ Daily or almost daily Less than monthly 
□ Weekly 
□ 
□  Never 
□ Monthly 
The AUDIT-C tool, along with scoring instructions and further information, is available online at https://www.queri. 
research.va.gov/tools/alcohol-misuse/alcohol-faqs.cfm#3. 
Source: Bush, Kivlahan, McDonell, Fihn, & Bradley (1998). Reprinted from material in the public domain. 
MICHIGAN ALCOHOLISM SCREENING TEST 
Yes No Points 
0. Do you enjoy drinking now and then? 
1. * Do you feel you are a normal drinker? (“normal” - drink as much or less than most 
people) □ □ (2) 
2. Have you ever awakened the morning after some drinking the night before and 
found that you could not remember a part of the evening? □ □ (2) 
□ □ (1) 
□ □ (2) 
□ □ (1) 
□ □ (2) 
□ □ (2) 
□ □ (5) 
□ □ (1) 
3. Does your wife, husband, a parent, or other near relative ever worry or complain 
about your drinking? 
4. * Can you stop drinking without a struggle after one or two drinks? 
5. Do you ever feel guilty about your drinking? 
6. * Do friends or relatives think you are a normal drinker? 
7. * Are you able to stop drinking when you want to? 
8. Have you ever attended a meeting of Alcoholics Anonymous (AA)? 
9. Have you gotten into physical fghts when drinking? 
Continued on next page 
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Continued 
10. Has your drinking ever created problems between you and your wife, husband, a 
parent, or other relative? □ □ (2) 
□ □ (2) 
□ □ (2) 
□ □ (2) 
□ □ (2) 
11. Has your wife, husband (or other family members) ever gone to anyone for help 
about your drinking? 
12. Have you ever lost friends because of your drinking? 
13. Have you ever gotten into trouble at work or school because of drinking? 
14. Have you ever lost a job because of drinking? 
15. Have you ever neglected your obligations, your family, or your work for two or more 
days in a row because you were drinking? □ □ (2) 
□ □ (1) 
□ □ (2) 
□ □ (2) 
□ □ (5) 
□ □ (5) 
□ □ (2) 
□ □ (2) 
□ □ (2) 
□ □ (2) 
16. Do you drink before noon fairly often? 
17. Have you ever been told you have liver trouble? Cirrhosis? 
18. ** After heavy drinking have you ever had Delirium Tremens (D.T.s) or severe 
shaking, or heard voices, or seen things that are really not there? 
19. Have you ever gone to anyone for help about your drinking? 
20. Have you ever been in a hospital because of drinking? 
21. Have you ever been a patient in a psychiatric hospital or on a psychiatric ward 
of a general hospital where drinking was part of the problem that resulted in 
hospitalization? 
22. Have you ever been seen at a psychiatric or mental health clinic or gone to any 
doctor, social worker, or clergyman for help with any emotional problem, where 
drinking was part of the problem? 
23. *** Have you ever been arrested for drunk driving, driving while intoxicated, or 
driving under the infuence of alcoholic beverages? (if YES, How many times?__) 
24. *** Have you ever been arrested, or taken into custody even for a few hours, 
because of other drunk behavior? (if YES, How many times?__) 
* Alcoholic response is negative 
** 5 points for Delirium Tremens 
*** 2 points for each arrest 
SCORING 
Add up the points for every question you answered with YES, for Q23 and Q24 multiply 
the number of times by points 
0 - 3 No apparent problem 
4 Early or middle problem drinker 
5 or more Problem drinker (Alcoholic) 
This instrument is available online at www.ncbi.nlm.nih.gov/books/NBK64829. 
Source: Adapted from Selzer (1971). 
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SIMPLE SCREENING INSTRUMENT FOR SUBSTANCE ABUSE 
During the past 6 months: 
1. Have you used alcohol or other drugs? (such as wine, beer, hard liquor, pot, coke, heroin 
or other opiates, uppers, downers, hallucinogens, or inhalants) Yes No 
Yes No 
Yes No 
Yes No 
2. Have you felt that you use too much alcohol or other drugs? 
3. Have you tried to cut down or quit drinking or using drugs? 
4. Have you gone to anyone for help because of your drinking or drug use? 
(such as Alcoholics Anonymous, Narcotics Anonymous, Cocaine Anonymous, 
counselors, or a treatment program) 
5. Have you had any of the following?
Put a check mark next to any problems you have experienced.
□ Blackouts or other periods of memory loss? 
□ Injury to your head after drinking or using drugs? 
□ Convulsions or delirium tremens (DTs)? 
□ Hepatitis or other liver problems? 
□ Felt sick, shaky, or depressed when you stopped drinking or using drugs? 
□ Felt “coke bugs” or a crawling feeling under the skin after you stopped 
using drugs? 
□ Injury after drinking or using? 
□ Used needles to shoot drugs? 
Circle “yes” if at least one of the eight items above is checked 
6. Has your drinking or other drug use caused problems between you and your family 
or friends? 
7. Has your drinking or other drug use caused problems at school or at work? 
8. Have you been arrested or had other legal problems? (such as bouncing bad checks, 
driving while intoxicated, theft, or drug possession) 
9. Have you lost your temper or gotten into arguments or fghts while drinking or 
using drugs? 
10. Do you need to drink or use drugs more and more to get the effect you want? 
11. Do you spend a lot of time thinking about or trying to get alcohol or other drugs? 
12. When drinking or using drugs, are you more likely to do something you wouldn’t 
normally do, such as break rules, break the law, sell things that are important to you, or 
have unprotected sex with someone? 
13. Do you feel bad or guilty about your drinking or drug use? 
The next questions are about lifetime experiences. 
14. Have you ever had a drinking or other drug problem? 
15. Have any of your family members ever had a drinking or drug problem? 
16. Do you feel that you have a drinking or drug problem now? 
Source: Center for Substance Abuse Treatment (CSAT; 1994). Reprinted from material in the public domain. 
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Substance Withdrawal Screening Tools 
CLINICAL INSTITUTE NARCOTIC ASSESSMENT SCALE FOR WITHDRAWAL 
SYMPTOMS 
Parameters Based on Questions 
and Observation 
Findings Points 
1. Abdominal changes: 
Do you have any pains in your 
abdomen? Crampy abdominal 
pain, diarrhea, active bowel 
sounds. 
No abdominal complaints, normal 
bowel sound. Reports waves of 
crampy abdominal pain. 0  1  2  
2. Changes in temperature: Do 
you feel hot or cold? Clammy to 
touch. Uncontrolled shivering. 
None reported. Reports feeling 
cold, hands cold and clammy to 
touch. Uncontrolled shivering. 
0  1  2  
3. Nausea and vomiting: 
Do you feel sick in your stomach? 
Have you vomited? 
No nausea or vomiting. Mild 
nausea; no retching or vomiting. 
Intermittent nausea with dry 
heaves. Constant nausea; 
frequent dry heaves and/or 
vomiting. 
0  2  4  6  
4. Muscle aches: Do you have any 
muscle cramps? 
No muscle aching reported, arm 
and neck muscles soft at rest. 
Mild muscle pains. Reports severe 
muscle pains, muscles in legs, 
arms or neck in constant state of 
contraction. 
0  1  3  
Parameters Based on 
Observation Alone 
Findings Points 
5. Goose fesh None visible. Occasional goose 
fesh but not elicited by touch; 
not permanent. Prominent goose 
fesh in waves and elicited by 
touch. Constant goose fesh over 
face and arms. 
0  1  2  3  
6. Nasal congestion No nasal congestion or sniffing. 
Frequent sniffing. Constant 
sniffing, watery discharge. 
0  1  2  
7. Restlessness Normal activity. Somewhat more 
than normal activity; moves legs 
up and down; shifts position 
occasionally. Moderately fdgety 
and restless; shifting position 
frequently. Gross movement 
most of the time or constantly 
thrashes about. 
0  1  2  3  
Continued on next page 
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8. Tremor None. Not visible but can be felt 
fngertip to fngertip. Moderate 
with patient’s arm extended. 
Severe even if arms not extended. 
0  1  2  3  
9. Lacrimation None. Eyes watering; tears at 
corners of eyes. Profuse tearing 
from eyes over face. 
0  1  2  
10. Sweating No sweat visible. Barely 
perceptible sweating; palms 
moist. Beads of sweat obvious on 
forehead. Drenching sweats over 
face and chest. 
0  1  2  3  
11. Yawning None. Frequent yawning. 
Constant uncontrolled yawning. 0  1  2  
TOTAL SCORE Sum of points for all 11 parameters 
Minimum score = 0, Maximum score = 31. The higher the score, the more severe the withdrawal syndrome. Percent of 
maximal withdrawal symptoms = total score/31 x 100%. 
Source: Peachey & Lei (1988). Adapted with permission of John Wiley and Sons Inc.; permission conveyed through 
Copyright Clearance Center, Inc. 
CLINICAL INSTITUTE WITHDRAWAL ASSESSMENT OF ALCOHOL SCALE, REVISED 
Patient: _________  Date: ______  Time: ________ (24 hour clock, midnight = 00:00) 
Pulse or heart rate, taken for one minute: _______  Blood pressure: ______ 
NAUSEA AND VOMITING – Ask “Do you feel 
sick to your stomach? Have you vomited?” 
Observation. 
0 no nausea and no vomiting 
1 mild nausea with no vomiting 
2 
3 
4 intermittent nausea with dry heaves 
5 
6 
7  constant nausea, frequent dry heaves  
and vomiting 
TACTILE DISTURBANCES – Ask “Have you any 
itching, pins and needles sensations, any burning, any 
numbness, or do you feel bugs crawling on or under 
your skin?” Observation. 
0 none 
1  very mild itching, pins and needles, burning  
or numbness 
2  mild itching, pins and needles, burning or numbness 
3  moderate itching, pins and needles, burning  
or numbness 
4 moderately severe hallucinations 
5 severe hallucinations 
6 extremely severe hallucinations 
7 continuous hallucinations 
Continued on next page 
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TREMOR – Arms extended and fngers 
spread apart. Observation. 
0 no tremor 
1  not visible, but can be felt fngertip  
to fngertip 
2 
3 
4 moderate, with patient’s arms extended 
5 
6 
7 severe, even with arms not extended 
AUDITORY DISTURBANCES – Ask “Are you more aware 
of sounds around you? Are they harsh? Do they frighten 
you? Are you hearing anything that is disturbing to 
you? Are you hearing things you know are not there?” 
Observation. 
0 not present 
1 very mild harshness or ability to frighten 
2 mild harshness or ability to frighten 
3 moderate harshness or ability to frighten 
4 moderately severe hallucinations 
5 severe hallucinations 
6 extremely severe hallucinations 
7 continuous hallucinations 
PAROXYSMAL SWEATS – Observation. 
0 no sweat visible 
1 barely perceptible seating, palms moist 
2 
3 
4 beads of sweat obvious on forehead 
5 
6 
7 drenching sweats 
VISUAL DISTURBANCES – Ask “Does the light appear 
to be too bright? Is its color different? Does it hurt your 
eyes? Are you seeing anything that is disturbing to 
you? Are you seeing things you know are not there?” 
Observation. 
0 not present 
1 very mild sensitivity 
2 mild sensitivity 
3 moderate sensitivity 
4 moderately severe hallucinations 
5 severe hallucinations 
6 extremely severe hallucinations 
7 continuous hallucinations 
ANXIETY – Ask “Do you feel nervous?” 
Observation. 
0 no anxiety, at ease 
1 mild anxious 
3 
4  moderately anxious, or guarded, so  
anxiety is inferred 
5 
6 
7  equivalent to acute panic states as seen 
in severe delirium or acute schizophrenic 
reactions 
HEADACHE, FULLNESS IN HEAD – Ask "Does your 
head feel different? Does it feel like there is a band 
around your head?" Do not rate for dizziness or 
lightheadedness. Otherwise, rate severity. 
0 not present 
1 very mild 
2 mild 
3 moderate 
4 moderately severe 
5 severe 
6 very severe 
7 extremely severe 
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Continued 
AGITATION – Observation. 
0 normal activity 
1 somewhat more than normal activity 
2 
3 
4 moderately fdgety and restless 
5 
6 
7  paces back and forth during most of the  
interview, or constantly thrashes about 
ORIENTATION AND CLOUDING OF SENSORIUM – Ask 
“What day is this? Where are you? Who am I?” 
0 oriented and can do serial additions 
1 cannot do serial additions or is uncertain about date 
2 disoriented for date by no more than 2 calendar days 
3 disoriented for date by more than 2 calendar days 
4 disoriented for place/or person 
Total CIWA-Ar Score______ 
Rater’s initials ______ 
Maximum Possible Score 67 
Source: Sullivan, Sykora, Schneiderman, Naranjo, & Sellers (1989). 
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Substance Use Disorder Treatment for People With Co-Occurring Disorders 
Trauma Screening and Assessment Tools 
PRIMARY CARE PTSD SCREEN FOR DSM-5 
Sometimes things happen to people that are unusually or especially frightening, horrible, or traumatic. 
For example: 
• A serious accident or fre 
• A physical or sexual assault or abuse 
• An earthquake or food 
• A war 
• Seeing someone be killed or seriously injured 
• Having a loved one die through homicide or suicide 
Have you ever experienced this kind of event? 
If no, screen total = 0. Please stop here. 
If yes, please answer the questions below. 
In the past month, have you… 
1. Had nightmares about the event(s) or thought about the event(s) when you did not want to? 
2.  Tried hard not to think about the event(s) or went out of your way to avoid situations that reminded you 
of the event(s)? 
3. Been constantly on guard, watchful, or easily startled? 
4.  Felt numb or detached from people, activities, or your surroundings? 
5. Felt guilty or unable to stop blaming yourself or others for the event(s) or any problems the event(s) 
may have caused? 
Information about administration and scoring is available online (www.ptsd.va.gov/professional/assessment/documents/ 
pc-ptsd5-screen.pdf). 
Source: Prins et al. (2015). Reprinted from material in the public domain. 
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PTSD CHECKLIST FOR DSM-5 
Instructions: Below is a list of problems that people sometimes have in response to a very stressful 
experience. Please read each problem carefully and then circle one of the numbers to the right to indicate 
how much you have been bothered by that problem in the past month. 
In the past month, how much were you bothered by: 
Not 
at all 
A 
little 
bit Moderately 
Quite 
a bit Extremely 
1 Repeated, disturbing, and unwanted memories of the 
stressful experience? 
0 1 2 3 4 
2 Repeated, disturbing dreams of the stressful 
experience? 
0 1 2 3 4 
3 Suddently feeling or acting as if the stressful 
experience were actually happening again (as if you 
were actually back there reliving it)? 
0 1 2 3 4 
4 Feeling very upset when someone reminded you of 
the stressful experience? 
0 1 2 3 4 
5 Having strong physical reactions when something
reminded you of the stressful experience (for example,
heart pounding, trouble breathing, sweating)? 
0 1 2 3 4 
6 Avoiding memories, thoughts, or feelings related to 
the stressful experience? 
0 1 2 3 4 
7 Avoiding external reminders of the stressful 
experience (for example, people, places, 
conversations, activities, objects, or situations)? 
0 1 2 3 4 
8 Trouble remembering important parts of the stressful 
experience? 
0 1 2 3 4 
9 Having strong negative beliefs about yourself, other 
people, or the world (for example, having thoughts 
such as: I am bad, there is something seriously 
wrong with me, no one can be trusted, the world is 
completely dangerous)? 
0 1 2 3 4 
10 Blaming yourself or someone else for the stressful 
experience or what happened after it? 
0 1 2 3 4 
11 Having strong negative feelings such as fear, horror, 
anger, guilt, or shame? 
0 1 2 3 4 
12 Loss of interest in actitivies that you used to enjoy? 0 1 2 3 4 
13 Feeling distant or cut off from other people? 0 1 2 3 4 
14 Trouble experiencing positive feelings (for example, 
being unable to feel happiness or have loving feelings 
for people close to you)? 
0 1 2 3 4 
15 Irritable behavior, angry outbursts, or acting 
aggressively? 
0 1 2 3 4 
Continued on next page 
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Continued 
16 Taking too many risks or doing things that could 
cause you harm? 
0 1 2 3 4 
17 Being "superalert" or watchful or on guard? 0 1 2 3 4 
18 Feeling jumpy or easily startled? 0 1 2 3 4 
19 Having diffculty concentrating? 0 1 2 3 4 
20 Trouble falling or staying asleep? 0 1 2 3 4 
Information about administration and scoring is available online (www.ptsd.va.gov/professional/assessment/adult-sr/ptsd-
checklist.asp). 
Source: Weathers et al. (2013). Reprinted from material in the public domain. 
Levels of Care Tool 
Level of Care Utilization System for 
Psychiatric and Addiction Services 
(LOCUS; https://drive.google.com/fle/ 
d/0B89glzXJnn4cV1dESWI2eFEzc3M/view): The 
LOCUS Adult Version 20 is a lengthy measure that 
assesses many areas of symptoms and functioning 
to determine level of care. 
Functioning and Disability Tools 
WHO’s Disability Assessment Schedule 2.0 
(WHODAS 2.0; www.who.int/classifcations/icf/ 
whodasii/en/): Various versions are available in the 
following locations: 
• WHODAS 2.0 36-item version, self-
administered: www.who.int/classifcations/icf/ 
WHODAS2.0_36itemsSELF.pdf 
• WHODAS 2.0 36-item, interviewer-
administered: www.who.int/classifcations/icf/ 
WHODAS2.0_36itemsINTERVIEW.pdf
• WHODAS 2.0 12-item, self-administered: 
www.who.int/classifcations/icf/ 
WHODAS2.0_12itemsSELF.pdf?ua=1
• WHODAS 2.0 12-item, interviewer-
administered: www.who.int/classifcations/icf/ 
WHODAS2.0_12itemsINTERVIEW.pdf
Stage of Change Tools 
The Stages of Change Readiness and Treatment 
Eagerness Scale (https://casaa.unm.edu/inst/ 
socratesv8.pdf): This scale is available in two 
formats: one for alcohol use and one for drug use. 
The University of Rhode Island Change 
Assessment Scale (https://habitslab.umbc.edu/ 
urica/): Multiple short- and long-form versions of 
this measure are available, including for alcohol 
use, drug use, and initiating psychotherapy. 
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SAMPLE TREATMENT PLAN FOR CASE EXAMPLE GEORGE T. (CHAPTER 3) 
Problem Intervention Goal 
Cocaine use disorder Outpatient treatment Abstinence 
• Work problem primary • EAP monitoring • Negative urinalysis results 
reason for referral • Family meetings • Daily recovery plans 
• Family and work support • Work support group 
• Resists 12-Step • Teach skills to manage symptoms 
• Mental symptoms trigger without using 
use • 12-Step meetings 
• Action phase 
Rule out AUD 
• No clear problem 
• May trigger cocaine use 
• Precontemplation phase 
• Outpatient motivational 
enhancement; thorough 
evaluation of role of alcohol in 
patient’s life, including family 
education 
• Move into contemplation phase of 
readiness to change 
• Willing to consider the risk of use 
or possible abuse 
Bipolar disorder • Medication management • Maintain stable mood 
• Long history • Help take medication while in • Able to manage fuctuating mood 
• On lithium 
• Some mood symptoms 
• Maintenance phase 
recovery programs 
• Bipolar Support Alliance 
meetings 
• Advocate/collaborate with 
prescribing health professional 
• Identify mood symptoms as 
triggers 
symptoms that do occur without 
using cocaine or other substances 
to regulate his bipolar disorder 
CONSIDERATIONS IN TREATMENT MATCHING 
Variable Key Data 
Acute safety needs 
Determines need 
for immediate acute 
stabilization to establish 
safety prior to routine 
assessment 
• Immediate risk of harm to self or others 
• Immediate risk of physical harm or abuse from others (Mee-Lee et al., 2013) 
• Inability to provide for basic self-care 
• Medically dangerous intoxication or withdrawal 
• Potentially lethal medical condition 
• Acute severe mental symptoms (e.g., mania, psychosis) leading to inability 
to function or communicate effectively 
Quadrant assignment 
Guides the choice of the 
most appropriate setting 
for treatment 
• Serious, persistent mental illness (SPMI) vs. non-SPMI 
• Severely acute or disabling mental symptoms vs. mild to moderate severity 
symptoms 
• High (e.g., active SUD) vs. low (e.g., hazardous substance use) severity SUD 
• Substance dependence in full vs. partial remission (Mee-Lee et al., 2013; 
American Psychiatric Association, 2013) 
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Continued 
Variable Key Data 
Level of care 
Determines client’s 
program assignment 
• Dimensions of assessment for each disorder using criteria from the LOCUS 
Diagnosis • Specifc diagnosis of each mental disorder and SUD, including distinction 
Determines the between and SUD and substance-induced symptoms 
recommended treatment • Information about past and present successful and unsuccessful treatment 
intervention efforts for each diagnosis 
• Identifcation of trauma-related disorders and culture-bound syndromes, in 
addition to other mental disorders and substance-related problems 
Disability • Cognitive defcits, functional defcits, and skill defcits that interfere with 
Determines case 
management needs 
ability to function independently or follow treatment recommendations 
and that may require varying types and amounts of case management or 
and whether a support 
standard intervention is • Specifc functional defcits that may interfere with ability to participate in 
suffcient—at capable SUD treatment in a particular program setting and may therefore require a 
or intermediate level— co-occurring–enhanced setting rather than a co-occurring–capable one 
or whether a more 
advanced “enhanced” 
level intervention is 
• Specifc defcits in learning or using basic recovery skills that require 
modifed or simplifed learning strategies 
essential 
Strengths and skills 
Determines areas of prior 
success around which to 
organize future treatment 
interventions and areas of 
skill building to manage 
either disorder 
• Areas of particular capacity or motivation in relation to general life 
functioning (e.g., capacity to socialize, work, or obtain housing) 
• Ability to manage treatment participation for any disorder (e.g., familiarity 
and comfort with 12-Step programs, commitment to medication 
adherence) 
Availability and 
continuity of recovery 
support 
Determines whether 
to establish continuing 
relationships and existing 
relationship availability to 
provide contingencies to 
promote learning 
• Presence or absence of continuing treatment relationships, particularly 
mental disorder treatment relationships, beyond the single episode of care 
• Presence or absence of an existing and ongoing supportive family, 
peer support, or therapeutic community; quality and safety of recovery 
environment (Mee-Lee et al., 2013) 
Continued on next page 
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Continued 
Variable Key Data 
Cultural context • Areas of cultural identifcation and support in relation to each of the 
Determines most following 
culturally appropriate • Ethnic or linguistic culture identifcation (e.g., attachment to traditional 
treatment interventions American-Indian cultural healing practices) 
and settings • Cultures that have evolved around treatment of mental disorders and SUDs 
(e.g., identifcation with 12-Step recovery culture; commitment to mental 
health empowerment movement) 
• Gender and gender identity 
• Sexual orientation 
• Rural vs. urban 
Problem domains • Is there impairment, need, or (conversely) strength in any of the following 
Determines problems areas 
to be solved specifcally, • Financial 
and opportunities for 
contingencies to promote 
treatment participation 
• Legal 
• Employment 
• Housing 
• Social/family 
• Medical, parenting/child protective, abuse/victimization/victimizer 
Phase of recovery/stage • Requirement for acute stabilization of symptoms, engagement, or 
of change (for each motivational enhancement 
problem) • Active treatment to achieve prolonged stabilization 
Determines appropriate 
phase-specifc or stage-
specifc treatment 
• Relapse prevention/maintenance 
• Rehabilitation, recovery, and growth 
intervention and • In the motivational enhancement sequence, precontemplation, 
outcomes contemplation, preparation, action, maintenance, or relapse (Prochaska & 
DiClemente, 1992) 
• Engagement, stabilization/persuasion, active treatment, or continuing care/ 
relapse prevention (Mueser & Gingerich, 2013; SAMHSA, 2009a) 
Additional Screening Tools for
Common Mental Disorders 
Depression. Patient Health Questionnaire 
(PHQ-9): https://www.hiv.uw.edu/page/ 
mental-health-screening/phq-9 
Anxiety. General Anxiety Disorder 7-item 
(GAD-7) Scale: https://www.hiv.uw.edu/page/ 
mental-health-screening/gad-7 
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SAMHSA Knowledge Application Program Resources 
TIPs may be ordered or downloaded for free from SAMHSA’s Publications Ordering 
webpage at https://store.samhsa.gov. Or, please call SAMHSA at 1-877-SAMHSA-7 
(1-877-726-4727) (English and Español). 
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